INTERNATIONAL CONGRESS 2015 AMSTERDAM
netherlands, 26–30 september
CONGRESS GUIDE
ERSCONGRESS.ORG
ERS-CTS China Day Saturday 26 September, 2015 Room: Forum 09:00–17:00 GAIN NEW SCIENTIFIC KNOWLEDGE IN your own language FROM DEDICATED SESSIONS IN CHINESE. Aims
Target audience
Leading specialists from China will share the stage with the ERS leadership to discuss key issues in respiratory medicine, providing the opportunity to hear about the latest scientific developments in Chinese.
The session is aimed at specialists in respiratory medicine from China. There will be simultaneous translation from English to Mandarin and slides will be shown with Chinese text.
Headsets and translated slides will be used to provide translations of the full session. There will be opportunities for questions and discussion after the presentations.
09:00–13:00 “Advances in pulmonology” I Advances in airway disease diagnosis and management
14:00–17:00 “Advances in pulmonology” II Advances in lung infection, parenchymal disease diagnosis and lung cancer
09:00 Tobacco control: the most feasible and challenging way for disease prevention in China Chen Wang (Beijing, China) 09:30 Asthma-COPD overlap syndrome? Elisabeth H.D. Bel (Amsterdam, Netherlands) 10:00 Small airway disorders in COPD Nanshan Zhong (Guangzhou, China) 10:30 Coffee break 11:00 COPD and comorbidity: common pathways of accelerated ageing Peter J. Barnes (London, United Kingdom) 11:30 Asthma in China: current and future challenges Shen Huahao (Hangzhou, China) 12:00 Advances in COPD management Jørgen Vestbo (Manchester, United Kingdom) 12:30 Current situation of paediatric asthma diagnosis and treatment in China Shen Kunling (Beijing, China) 13:00 Lunch
14:00 Drug-resistant tuberculosis in Europe Giovanni Battista Migliori (Varese, Italy) 14:30 Clinical features and management of human infections by avian influenza Bin Cao (Beijing, China) 15:00 Tea break 15:30 New treatments for pulmonary fibrosis Ulrich Costabel (Essen, Germany) 16:00 Early diagnosis strategy of lung cancer in China Chunxue Bai (Shanghai, China) 16:30 Roundtable discussion and closing remarks
ERS-RRS Russia Day Saturday 26 September, 2015 Room: 13.1 09:30–17:00 Gain new scientific knowledge in your own language from dedicated sessions in Russian. Aims Leading specialists from Russia will share the stage with the ERS leadership to discuss key issues in respiratory medicine, providing the opportunity to hear about the latest scientific developments in Russian.
used to provide translations of the full session. There will be opportunities for questions and discussion after the presentations.
Target audience
This meeting is designed to update respiratory professionals on the latest developments in the respiratory field. Headsets and translated slides will be
The session is aimed at specialists in respiratory medicine from Russia. There will be simultaneous translation from English to Russian and slides will be shown with Russian text.
09:30–11:15 Community-acquired pneumonia in adults
13:45–15:30 COPD, asthma, and infection
09:30 10:00 10:30 11:00
Epidemiology of community-acquired pneumonia CAP management algorithm Panel discussion Coffee break
11:15–12:45 Community-acquired pneumonia in children
11:15 Scientific and practical program “CAP in children” (clinical recommendations for Russia and CIS countries) 11:45 Pneumonia and smoking in children 12:15 Panel discussion 12:45 Lunch break
13:45 14:10 14:30 14:55 15:15
COPD from phenotypes to personalised therapy Infection and asthma Difficult asthma Panel discussion Coffee break
15:30–17:00 Tuberculosis in the Russian Federation: achievements and challenges
15:30 TB in Russia today and the adapted national anti-TB strategy 16:00 International collaboration on TB problems: the European community and Russia - past and future 16:30 Panel discussion and closing remarks
ERS-ALAT-SBPT-SEPAR-SPP
Spanish and Portuguese Day Sunday 27 September, 2015 at the ERS International Congress Amsterdam, Netherlands Room: Auditorium 08:30–16:45 GAIN NEW SCIENTIFIC KNOWLEDGE IN your own language FROM DEDICATED SESSIONS IN SPANISH AND PORTUGUESE.
The session is aimed at specialists in respiratory medicine from Spanish and Portuguese speaking countries. There will be simultaneous translation from English to Spanish and Portuguese and slides will be shown with Spanish and Portuguese text.
12:45–14:30 Poster session and Keynote Lecture Healthy Lungs For Life ALAT/ERS/SEPAR/SBPT/SPP International societies symposium 12:45 Poster viewing and discussion (light snack and coffee will be available) 13:45 Introduction by Prof. Dr E. Bel 13:50 Keynote Lecture «Cardiopulmonary research and medicine: translational bridges» by Prof. Dr Valentin Fuster 14:25 Closure remarks
14:45–16:45 Spanish/Portuguese Day: Tobacco control policies: preventing interference from the tobacco-industry 14:45 Exposing tobacco industry interference in policymaking: the role of research and ERS 15:15 Tobacco control policies in Latin America 15:45 Tobacco control policies in Portugal 16:15 Tobacco control policies in Spain PNEU
MO
LO
DE RA EI
GIA
ADE BRASI ED L CI
08:30 Exercise training in COPD 09:00 Home-rehabilitation: is it effective? 09:30 Impact of COPD and its comorbidities on exercise capacity 10:00 Can exercise change the evolution of respiratory disease? 10:30 Break 10:45 New models in home-respiratory care 11:15 Asthma-COPD overlap syndrome: more than just two diseases in the same patient 11:45 Schistosomiasis as the main cause of pulmonary hypertension 12:15 Why are the ALAT COPD guidelines 2014 different?
Target audience
1937
E TISIOL O
SO
08:30–12:45 Exercise and other behavioral life styles for good lung health worldwide Healthy Lungs For Life ALAT/ERS/SEPAR/SBPT/SPP International societies symposium
used to provide translations of the full session. There will be opportunities for questions and discussion after the presentations.
A
Leading specialists from Spanish and Portuguese speaking countries will share the stage with the ERS leadership to discuss key issues in respiratory medicine, providing the opportunity to hear about the latest scientific developments in Spanish and Portuguese. This meeting is designed to update respiratory professionals on the latest developments in the respiratory field. Headsets and translated slides will be
GI
Aims
ERS Oncology Day Tuesday 29 September, 2015 07:00–19:00 JOIN US FOR
the first-ever Oncology Tuesday
ERS INTERNATIONAL CONGRESS.
AT THE
The day will focus on the field of lung cancer, covering science through to practical skills. It will also include hands-on skills training from leading specialists.
Oncology Tuesday will take you through the latest developments in the field and include practical training sessions including a live endoscopy session.
07:00–08:15
12:50–14:40
– Industry Early Morning Symposium. Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient Organised by Novartis Pharma AG
07:00– 08:15
– Challenging clinical cases. CC6 Multidisciplinary team discussion in thoracic oncology
08:30–10:30
– Symposium. NSCLC: sequence, timing, and modality of multi-line therapies
08:30 –10:30
– Symposium. Lung cancer screening: how to implement a comprehensive preventive approach
08:30–10:30
– Live pulmonary endoscopy. Lung cancer
10:45–12:45
– Symposium. Resistance to therapy in lung cancer
Thematic Poster Sessions – Cell biology of lung cancer and new biomarkers – Diagnosis and therapy of lung cancer – Quality management in lung cancer – Lung cancer: prognostic factors and features of oncogenedriven tumours – Thoracic oncology around the world: rare cases and local features – Malignant pleural effusions and mesothelioma – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
14:45–16:45
– Symposium. Stop immune tolerance in lung cancer!
17:30–19:00
– Industry Evening Mini Symposium. OncologyTreatment of advanced NSCLC: Evidence, insights and understanding Organised by Boehringer Ingelheim International GmbH
NEW E-PROGRAMME AREA If you wish to access the congress programme at any time, please visit our new e-programme areas
SEARCH THE PROGRAMME
PLAN YOUR CONGRESS VISIT
The ERS Congress Final Programme APP is available as a free download for iPhone, iPad and iPod Touch (iOS 7.0 and higher) and Android phones and tablets (4.0 and higher).
ERS INTERNATIONAL NAL 5 CONGRESS 2015 AMSTERDAM netherlands ds 26 – 30 september
ACCESS THE FLOOR PLAN
NEW FOR 2015
Rate sessions SEARCH FOR CITY AND CONGRESS INFORMATION
ERSCONGRESS.ORG / MOBILE
Industry Bus
ERS Stand
7.2
7.1
World Village
Hall 7
Hall 6 Exhibition
Non - restricted Area
Hall 3
Auditorium
Exhibition
D Rooms
SPR
2.1
Hall 2 Registration
INDUSTRY MEETING ROOMS (BALCONY)
13.2
G Rooms
Hall 13
Press Centre
FD
PLEASE FIND THE E-PROGRAMME AREAS HERE
13.1
Europe Foyer
E Rooms
Forum
Non - restricted Area
Clinical Resource Area
5.2
Hall 5
ERS
Hall 1 Exhibition
Restricted Area
INDUSTRY MEETING ROOMS (BALCONY)
Emerald
5.1 The Overflow Room
4.2
Hall 4 4.1 Amtrium
ERS Lounge
Elicium
L Rooms
E Poster
Exhibition (Non-restricted Area) Exhibition (Restricted Area) ERS Services Rooms E-Programme
Hall 14
SPR FD
Thematic Posters
ENTRANCE Metro
COMMIT TED TO LUNG HE ALTH BY SUPPORTING ERS 2015
Speakers Preview Room Finance Desk Catering Area
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015
Room L001
Session 1
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW1 Inhaler techniques - train the trainer Aims : To provide participants with the knowledge, skills and tools needed to demonstrate the use of inhalation devices and to coach and teach patients effectively. Workstation 1: Overview of the different types of models and how they function. Workstation 2: This workstation will provide participants with the skills and knowledge needed to guide and train a patient to successfully use an inhaler. Workstation 3: An overview on how inhalers perform in real life scenarios will be given. The preferences and views of patients regarding which inhalers are most practical to use will be discussed. Workstation 4: This workstation will teach participants how to successfully administer medication and how to avoid common mistakes. Track(s) : Physiology Tag(s) : Clinical Target audience : Nurses, technologists, clinicians, fellows, physiologists and pharmacists. Chairs : Daniel Schuermans (Brussels, Belgium) Introduction
1
Workstation 1: Inhalation devices Eric Derom (Gent, Belgium)
2
Workstation 2: How to train a patient Job van der Palen (Enschede, Netherlands)
3
Workstation 3: Inhaler techniques Marit Leine (Røyse, Norway), Betty Frankemoelle (Heemskerk, Netherlands)
4
Workstation 4: Medication Frans H.C. de Jongh (Enschede, Netherlands)
5
Room L002
Session 2
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW2 Research bronchoscopies Aims : Bronchoscopy is widely used for sampling biological material used for research tools. This workshop will provide practical skills for clinical and research purposes. Previous experience in this field is not required. Workstation 1: The indications and procedures that are useful for starting up a protocol that involves research bronchoscopies will be identified. The following will also be discussed: how to select the participating individuals (patients and control subjects); issues around obtaining informed consent; safety procedures; and technical issues that should be considered when obtaining bronchoscopic samples such as bronchoalveolar lavage (BAL) and bronchial biopsies. Workstation 2: The steps involved in processing BAL samples will be discussed, including BAL collection, the preparation of cytological smears, and preparation for further analyses of the cells and solutes contained in the BAL. Workstation 3: The steps in bronchial tissue collection and preparation will be demonstrated along with the processing procedures used to fix and embed tissue, and then cut and stain the tissue blocks. Immunohistochemical applications and evaluation of tissue immunostaining will also be presented and discussed. Workstation 4: Participants will be briefed on the different cytological and histological patterns of bronchoscopic samples. A practical approach towards categorising samples and quantifying inflammatory cells and biomarkers, and how to use the results for clinical and research purposes, will be illustrated. Target audience : Allergologists, allied health professionals, clinicians, fellows, immunologists, junior members, nurses, paediatricians, pathologists, patients, pharmaceutical industry representatives, pulmonologists, researchers, residents, respiratory physicians, scientists, students and thoracic endoscopists. Chairs : Guy F Joos (Gent, Belgium) Introduction
6
Workstation 1: How to perform research bronchoscopy Fabio L. M. Ricciardolo (Orbassano (Turin), Italy)
7
Workstation 2: How to process bronchoalveolar lavage (BAL) Pascal Chanez (Marseille, France)
8
Workstation 3: Preparation and processing of bronchial biopsies Antonino Di Stefano (Veruno, Italy)
9
1
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 Workstation 4: Microscopical examination of BAL and bronchial biopsies Thais Mauad (Sao Paulo, Brazil)
Room L001
Session 17
10
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW3 Inhaler techniques - train the trainer Aims : To provide participants with the knowledge, skills and tools needed to demonstrate the use of inhalation devices and to coach and teach patients effectively. To provide participants with the knowledge, skills and tools needed to demonstrate the use of inhalation devices and to coach and teach patients effectively. Workstation 1: Overview of the different types of models and how they function. Workstation 2: This workstation will provide participants with the skills and knowledge needed to guide and train a patient to successfully use an inhaler. Workstation 3: An overview on how inhalers perform in real life scenarios will be given. The preferences and views of patients regarding which inhalers are most practical to use will be discussed. Workstation 4: This workstation will teach participants how to successfully administer medication and how to avoid common mistakes. Track(s) : Physiology Tag(s) : Clinical Target audience : Nurses, technologists, clinicians, fellows, physiologists and pharmacists. Chairs : Marit Leine (Røyse, Norway) Introduction
113
Workstation 1: Inhalation devices Daniel Schuermans (Brussels, Belgium)
114
Workstation 2: How to train a patient Georgia Narsavage (Morgantown, United States of America)
115
Workstation 3: Inhaler techniques Titia Klemmeier-Boekhout (Bedum, Netherlands), Elly Janssen (Nijmegen, Netherlands)
116
Workstation 4: Medication Mike Thomas (Southampton, United Kingdom)
117
Room L002
Session 18
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW4 Research bronchoscopies Aims : Bronchoscopy is widely used for sampling biological material used for research tools. This workshop will provide practical skills for clinical and research purposes. Previous experience in this field is not required. Workstation 1: The indications and procedures that are useful for starting up a protocol that involves research bronchoscopies will be identified. The following will also be discussed: how to select the participating individuals (patients and control subjects); issues around obtaining informed consent; safety procedures; and technical issues that should be considered when obtaining bronchoscopic samples such as bronchoalveolar lavage (BAL) and bronchial biopsies. Workstation 2: The steps involved in processing BAL samples will be discussed, including BAL collection, the preparation of cytological smears, and preparation for further analyses of the cells and solutes contained in the BAL. Workstation 3: The steps in bronchial tissue collection and preparation will be demonstrated along with the processing procedures used to fix and embed tissue, and then cut and stain the tissue blocks. Immunohistochemical applications and evaluation of tissue immunostaining will also be presented and discussed. Workstation 4: Participants will be briefed on the different cytological and histological patterns of bronchoscopic samples. A practical approach towards categorising samples and quantifying inflammatory cells and biomarkers, and how to use the results for clinical and research purposes, will be illustrated. Target audience : Allergologists, allied health professionals, clinicians, fellows, immunologists, junior members, nurses, paediatricians, pathologists, patients, pharmaceutical industry representatives, pulmonologists, researchers, residents, respiratory physicians, scientists, students and thoracic endoscopists. Chairs : Guy F Joos (Gent, Belgium) Introduction
118
Workstation 1: How to perform research bronchoscopy Adam Barczyk (Katowice, Poland)
119
2
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 Workstation 2: How to process bronchoalveolar lavage (BAL) Rene Lutter (Amsterdam, Netherlands)
120
Workstation 3: Preparation and processing of bronchial biopsies Susan Jane Wilson (Southampton, United Kingdom)
121
Workstation 4: Microscopical examination of BAL and bronchial biopsies Jon Ward (Southampton, United Kingdom)
122
Room L001
Session 32
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW5 Inhaler techniques - train the trainer Aims : To provide participants with the knowledge, skills and tools needed to demonstrate the use of inhalation devices and to coach and teach patients effectively. To provide participants with the knowledge, skills and tools needed to demonstrate the use of inhalation devices and to coach and teach patients effectively. Workstation 1: Overview of the different types of models and how they function. Workstation 2: This workstation will provide participants with the skills and knowledge needed to guide and train a patient to successfully use an inhaler. Workstation 3: An overview on how inhalers perform in real life scenarios will be given. The preferences and views of patients regarding which inhalers are most practical to use will be discussed. Workstation 4: This workstation will teach participants how to successfully administer medication and how to avoid common mistakes. Track(s) : Physiology Tag(s) : Clinical Target audience : Nurses, technologists, clinicians, fellows, physiologists and pharmacists. Chairs : Daniel Schuermans (Brussels, Belgium) Introduction
184
Workstation 1: Inhalation devices Eric Derom (Gent, Belgium)
185
Workstation 2: How to train a patient Job van der Palen (Enschede, Netherlands)
186
Workstation 3: Inhaler techniques Marit Leine (Røyse, Norway), Marko Sturm (Hengelo, Netherlands)
187
Workstation 4: Medication Frans H.C. de Jongh (Enschede, Netherlands)
188
Room L002
Session 33
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW6 Research bronchoscopies Aims : Bronchoscopy is widely used for sampling biological material used for research tools. This workshop will provide practical skills for clinical and research purposes. Previous experience in this field is not required. Workstation 1: The indications and procedures that are useful for starting up a protocol that involves research bronchoscopies will be identified. The following will also be discussed: how to select the participating individuals (patients and control subjects); issues around obtaining informed consent; safety procedures; and technical issues that should be considered when obtaining bronchoscopic samples such as bronchoalveolar lavage (BAL) and bronchial biopsies. Workstation 2: The steps involved in processing BAL samples will be discussed, including BAL collection, the preparation of cytological smears, and preparation for further analyses of the cells and solutes contained in the BAL. Workstation 3: The steps in bronchial tissue collection and preparation will be demonstrated along with the processing procedures used to fix and embed tissue, and then cut and stain the tissue blocks. Immunohistochemical applications and evaluation of tissue immunostaining will also be presented and discussed. Workstation 4: Participants will be briefed on the different cytological and histological patterns of bronchoscopic samples. A practical approach towards categorising samples and quantifying inflammatory cells and biomarkers, and how to use the results for clinical and research purposes, will be illustrated. Target audience : Allergologists, allied health professionals, clinicians, fellows, immunologists, junior members, nurses, paediatricians, pathologists, patients, pharmaceutical industry representatives, pulmonologists, researchers, residents, respiratory physicians, scientists, students and thoracic endoscopists. Chairs : Bruno Balbi (Veruno, Italy) Introduction
189
3
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 Workstation 1: How to perform research bronchoscopy Fabio L. M. Ricciardolo (Orbassano (Turin), Italy)
190
Workstation 2: How to process bronchoalveolar lavage (BAL) Pascal Chanez (Marseille, France)
191
Workstation 3: Preparation and processing of bronchial biopsies Antonino Di Stefano (Veruno, Italy)
192
Workstation 4: Microscopical examination of BAL and bronchial biopsies Thais Mauad (Sao Paulo, Brazil)
193
Room G104-105
Session 4
09:00 - 17:15
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Postgraduate course: PG1 Spirometry – train the trainer HERMES Spirometry training programme Aims : To provide participants with the knowledge and tools to teach high quality spirometry and to provide the necessary training for those who would like to train and certify participants for the European Spirometry Driving Licence Part 1 and Part 2 within Europe. Track(s) : Physiology Tag(s) : Clinical Target audience : All those interested in learning how to train others in spirometry, including pulmonologists, respiratory therapists, respiratory physicians, general practitioners, nurses, and lung function technologists/scientists. The ERS Spirometry train-the-trainer programme is also aimed at those who would like to become directors or instructors of the European Spirometry Driving License training. Chairs : Irene Steenbruggen (Zwolle, Netherlands), Brendan Cooper (Birmingham, United Kingdom) 09:00
Welcome and introduction to the course Odile Van Eck (Waalre, Netherlands)
20
09:40
Overview of the European Spirometry Driving License training programmes Brendan Cooper (Birmingham, United Kingdom), Irene Steenbruggen (Zwolle, Netherlands)
21
10:10
Principles of teaching and learning Walther N. K. A. van Mook (Maastricht, Netherlands)
22
10:50
Break
23
11:10
European Spirometry Driving Licence specific teaching and training Julie Lloyd (Birmingham, United Kingdom)
24
11:40
Practical session on presentation and facilitation skills Vera Habes (Ultrecht, Netherlands), Odile Van Eck (Waalre, Netherlands)
25
12:10
Presentation from participants
26
12:50
Lunch
27
13:50
Providing effective feedback Walther N. K. A. van Mook (Maastricht, Netherlands)
28
14:30
Discussion and feedback practical session Vera Habes (Ultrecht, Netherlands), Odile Van Eck (Waalre, Netherlands)
29
15:10
Break
30
15:40
Principles of assessment Walther N. K. A. van Mook (Maastricht, Netherlands)
31
16:10
Assessment of the European Spirometry Driving Licence programme Julie Lloyd (Birmingham, United Kingdom)
32
16:50
Organising a European spirometry training programme Felip Burgos (Barcelona, Spain)
33
17:05
Evaluation
34
4
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015
Room 5.1
Session 6
09:30 - 17:30
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Postgraduate course: PG2 Asthma and COPD Updates in assessment and treatment Aims : To discuss the problems associated with obstructive lung diseases on the basis of experience and the published literature. Tag(s) : Translational Target audience : Paediatric and adult pulmonologists, epidemiologists, health professionals, public health physicians, and scientists interested in the aetiology and prevention of lung disease. Chairs : Ian Douglas Pavord (Oxford, United Kingdom), Marielle Pijnenburg (Rotterdam, Netherlands) 09:30
The burden of obstructive lung diseases Anne Lindberg (Boden, Sweden)
40
10:15
Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Omar Usmani (London, United Kingdom)
41
11:00
Break
42
11:30
Monitoring COPD – state-of-the-art physiological, imaging, and biomarker assessments Roland Buhl (Mainz, Germany)
43
12:15
Asthma exacerbations in children: the paediatrician’s view Bart Rottier (Groningen, Netherlands)
44
13:00
Lunch
45
14:00
Asthma phenotypes Sally Wenzel (Pittsburgh, United States of America)
46
14:45
COPD phenotypes Christopher E. Brightling (Leicester, United Kingdom)
47
15:30
Break
48
16:00
Exacerbations of obstructive lung disease Norbert Krug (Hannover, Germany)
49
16:45
The future: treating specific endotypes Peter J. Barnes (London, United Kingdom)
50
Room G106-107
Session 10
09:30 - 17:30
Registration for this course is additional to the congress registration fee and is €180 or €150 for the early bird registration.
Postgraduate course: PG3 Cardiorespiratory monitoring in critically ill patients Physiological principles of monitoring. Linked to the educational skills workshops EW7, EW9 and EW11. Aims : To analyse the fundamental concepts of monitoring, such as accuracy, precision, signal-to-noise ratio, and possible sources of error; to promote understanding of the underlying physiological principles of each monitoring system; and to apply these concepts to clinical situations in simulated scenarios. Track(s) : Intensive care Tag(s) : Clinical Target audience : Consultant physicians in the pulmonary, critical care and anaesthesiology fields, residents in training, medical students, nurses, and respiratory therapists. Chairs : Antonio Artigas (Sabadell (Barcelona), Spain), David A. Kaufman (Charlottesville, United States of America) 09:30
Introduction to monitoring Amal Jubran (Hines, United States of America)
68
10:05
Monitoring gas exchange David A. Kaufman (Charlottesville, United States of America)
69
10:40
Respiratory mechanics 1: physiological bases of monitoring airway pressures during mechanical ventilation Laurent Brochard (Toronto, Canada)
70
11:15
Break
71
5
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015
11:45
Respiratory mechanics 2: oesophageal manometry and interactions between the patient and the ventilator Paolo Pelosi (Milan, Italy)
72
12:20
Patient-ventilator asynchrony: diagnosis and treatment Lluís Blanch (Sabadell, Spain)
73
12:55
Lunch
74
13:55
Monitoring during non-invasive positive pressure ventilation Raffaele Scala (Arezzo, Italy)
75
14:30
Physiological basis of monitoring with central venous and pulmonary artery catheters and their clinical use Antonio Artigas (Sabadell (Barcelona), Spain)
76
15:05
Cardiopulmonary interactions: functional haemodynamic monitoring Jean-Louis Teboul (Le Kremlin-Bicêtre, France)
77
15:40
Break
78
16:10
Cardiovascular monitoring during resuscitation: between physiology and pragmatism Daniel De Backer (Braine-l'Alleud, Belgium)
79
16:45
How to use monitoring data to make wise clinical decisions Martin J. Tobin (Hines, United States of America)
80
Room 5.2
Session 5
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG4 Multidisciplinary approach to noninvasive ventilation (NIV) Aims : To indicate the NIV treatment options in various clinical settings. These treatments will be discussed in the context of the perspectives of the clinical subspecialists and nurses who are involved in treating patients with NIV. Track(s) : Intensive care Sleep Paediatric Tag(s) : Clinical Target audience : Adult and paediatric pulmonologists, somnologists, respiratory care specialists, adult and paediatric intensive care specialists, nurses, respiratory therapists, fellows, and residents. Chairs : Paolo Navalesi (Vercelli, Italy), Cesare Gregoretti (Turin, Italy) 09:30
Sleep studies for assessing abnormal events during NIV Jesus Gonzalez (Montlignon, France)
35
10:15
NIV in the ICU: when to start and when to end Stefano Nava (Bologna, Italy)
36
11:00
Break
37
11:30
NIV in the paediatric patient with acute respiratory insufficiency Paola Papoff (Rome, Italy)
38
12:15
The importance of staff training in NIV Alanna Hare (London, United Kingdom)
39
Room D203-204
Session 11
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG5 Treatment of emphysema Pharmacological and non-pharmacological options for hyperinflated lungs Aims : Hyperinflation and emphysema are COPD phenotypes that require special attention. The available treatment modalities will be presented and the possible algorithms will be discussed. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows, and residents. Chairs : Pallav L Shah (London, United Kingdom), Lowie Vanfleteren (Horn, Netherlands)
6
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 09:30
The burden of emphysema Klaus Friedrich Rabe (Grosshansdorf, Germany)
81
10:15
Hyperinflation and exercise – how to implement physical activity Thierry Troosters (Leuven, Belgium)
82
11:00
Break
83
11:30
Single, double, or triple inhalers: the value of the drugs Peter M.A. Calverley (Liverpool, United Kingdom)
84
12:15
Toys or tools – the role of interventional procedures Felix J.F. Herth (Heidelberg, Germany)
85
Room E103
Session 15
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG6 Cell-matrix dynamics in lung injury and repair Focusing on epithelial cells, immune cells, and interstitial cells Aims : To review the cell-matrix interactions that occur in response to chronic injury and during repair and lung tissues remodelling, with a specific focus on the interactions that involve epithelial, immune and interstitial cells. These interactions play crucial roles in the outcome of different types of lung tissue injuries. Tag(s) : Basic Target audience : Pulmonologists, respiratory physicians, respiratory therapists, clinical and basic researchers, thoracic surgeons, pulmonary oncologists, radiologists, pathologists, and trainees. Chairs : Silke Meiners (Munich, Germany), Christian M. Kaehler (Innsbruck, Austria) 09:30
Introduction Silke Meiners (Munich, Germany), Christian M. Kaehler (Innsbruck, Austria)
101
09:35
Role of epithelial cells Melanie Koenigshoff (Munich, Germany)
102
10:15
Role of immune cells Joanna Domagala-Kulawik (Warsaw, Poland)
103
10:55
Break
104
11:30
Role of fibroblasts Martin Kolb (Hamilton, Canada)
105
12:10
Role of the matrix Eric White (Ann Arbor, United States of America)
106
12:50
A global viewpoint Silke Meiners (Munich, Germany), Christian M. Kaehler (Innsbruck, Austria)
107
Room E104-106
Session 9
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG7 Basic respiratory mechanics Models, measurements, and uses in clinical practice Aims : The mechanics of breathing is best described in terms of airways resistance and lung compliance. However, these measurements are not readily available in clinical practice and instead clinicians must focus on the indirect information available from spirometry. The great advantage of spirometry is its known immediate reproducibility and limited between-test variation in both healthy and diseased settings. These properties, coupled with its extensive use in clinical decision making, ensure that spirometry will be used to manage respiratory disease for the foreseeable future. One particular advantage of spirometry is the availability of age- and height-related normal values against which any recording can be judged. This PG course on basic respiratory mechanics will help clinicians to better understand and interpret lung function test results. Track(s) : Physiology Tag(s) : Basic Target audience : Pulmonologists, respiratory therapists, respiratory physicians, clinical researchers, general practitioners, research fellows, nurses, and trainees. Chairs : Michael Polkey (London, United Kingdom), Samuel Verges (Grenoble, France)
7
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 09:30
Modelling respiratory mechanics: a multi-scale approach Jason H.T. Bates (Burlington, United States of America)
63
10:15
Measuring respiratory mechanics: invasive and noninvasive systems Andrea Aliverti (Milan, Italy)
64
11:00
Break
65
11:30
Using respiratory mechanics to explain and interpret spirometry John Gibson (Newcastle upon Tyne, United Kingdom)
66
12:15
Using respiratory mechanics to study exercise limitation in disease Lee Romer (Uxbridge, United Kingdom)
67
Room D201-202
Session 14
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG8 Airway and lung fibrosis How epigenetic changes affect fibroblasts and novel therapeutic approaches Aims : To describe the key challenges and features of lung fibrosis; to discuss how epigenetic changes such as miRNAs can affect fibroblast development and function; to compare the progress made in understanding lung fibrosis to the advances made in elucidating the role of fibrosis in liver disease; and to demonstrate how these advances in science will lead to the development of novel therapeutic approaches. Tag(s) : Translational Target audience : Pulmonologists, emergency medicine doctors, respiratory physicians, clinical researchers, general practitioners, research fellows, basic scientists, intensivists, nurses, pathologists, and trainees. Chairs : Bruno Balbi (Veruno, Italy), Charles Pilette (Brussels, Belgium) 09:30
Pulmonary fibrosis: key features and challenges Elisabetta Renzoni (London, United Kingdom)
96
10:15
MicroRNAs in the pathogenesis of pulmonary fibrosis Ivana V. Yang (Denver, United States of America)
97
11:00
Break
98
11:30
Resolution of liver fibrosis Speaker to be confirmed
99
12:15
Future clinical perspectives Oliver Eickelberg (Munich, Germany)
100
Room E102
Session 13
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG9 Lower respiratory tract infection in children Evaluation and management Aims : To show how to diagnose and manage common and uncommon lower respiratory tract infections in children. Track(s) : Paediatric Infection Tag(s) : Translational Target audience : Pulmonologists, respiratory therapists, respiratory physicians, clinical researchers, research fellows, and intensivists. Chairs : Jonathan Grigg (London, United Kingdom), Ernst Eber (Graz, Austria) 09:30
Evaluation of the child with recurrent chest infections Mark Everard (Perth, Australia)
91
10:15
Management and prevention of non-cystic fibrosis bronchiectasis Alexander Möller (Zurich, Switzerland)
92
11:00
Break
93
11:30
Acute bronchiolitis – prevention, diagnosis, and new approaches to management Fabio Midulla (Rome, Italy)
94
12:15
Uncommon lower respiratory infections in childhood Paul Aurora (London, United Kingdom), Speaker to be confirmed
95
8
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015
Room 13.2
Session 12
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG10 Malignant pleural effusion management From standard cytopathology to molecular biology Aims : To understand the new roles that molecular biology and histo-/cytopathology play in the diagnosis and management (treatment and prognosis) of malignant pleural effusions, and how to use these techniques (processing and data interpretation) in clinical practice. Track(s) : Oncology Tag(s) : Clinical Target audience : Trainees, pulmonary physicians, thoracic surgeons, pathologists, molecular biologists, and scientists. Chairs : Philippe Astoul (Marseille, France), Marcin Skrzypski (Sopot, Poland) 09:30
Which material in which disease? Sebastian Fernandez Bussy (Santiago, Chile)
86
10:15
How to send your material to pathology Philipp A. Schnabel (Homburg/Saar, Germany)
87
11:00
Break
88
11:30
Interpretation of the results in the clinic Arnaud Scherpereel (Lille, France)
89
12:15
Atypical mesothelial hyperplasia and other pitfalls in MPE diagnosis Françoise Galateau-Salle (Caen, France)
90
Room G109
Session 16
09:30 - 13:00
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG11 Emerging infectious diseases and pandemic planning PREPARE FP7 EU-funded project Aims : To provide participants with an essential up-to-the minute guide to handling emerging pandemic threats; to describe the key lessons that should be learnt from the Ebola and influenza epidemics; to detail the role of antivirals; and to provide an update regarding current trials in pandemic management. Track(s) : Infection Tag(s) : Clinical Target audience : Respiratory physicians, intensivists, microbiologists, allied health professionals, scientists, primary care and public health teams, and PREPARE EU project team members. Chairs : Anita Simonds (London, United Kingdom), Stefano Aliberti (Milan, Italy) 09:30
Emerging pathogens: what's new, what's next? Speaker to be confirmed
108
10:15
Ebola: challenges for public health – what have we learnt? Marion Koopmans (Rotterdam, Netherlands)
109
11:00
Break
110
11:30
Preventing the next influenza pandemic Albert Osterhaus (Hannover, Germany)
111
12:15
Antiviral therapy – the evidence base and clinical trials Alike van der Velden (Utrecht, Netherlands)
112
Room G109
Session 31
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG12 Surgical treatment of emphysema Volume reduction and lung transplantation Aims : To show how to identify patients with emphysema who may benefit from either volume reduction or transplantation. The pros and cons of both procedures will be discussed. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, and respiratory physiotherapists.
9
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 Chairs : Gilbert Massard (Strasbourg, France), Federica Meloni (Pavia, Italy) 14:00
The role of imaging in patient evaluation Walter De Wever (Leuven, Belgium)
179
14:45
Candidate selection and outcome after endoscopic volume reduction Stefano Gasparini (Ancona, Italy)
180
15:30
Break
181
16:00
Candidate selection and outcome after surgical lung volume reduction (LVR) Didier Schneiter (Zurich, Switzerland)
182
16:45
Lung transplant indications and outcomes Jens Gottlieb (Hannover, Germany)
183
Room 5.2
Session 23
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG13 Monitoring physical activity Current practice and future insights Aims : Physical activity monitors are becoming more sophisticated. This session will provide an updated overview of the current state of the art of physical activity monitoring. Track(s) : Physiology Tag(s) : Clinical, Healthy Lungs for Life (HLfL) Target audience : Allied respiratory professionals, pulmonary rehabilitation specialists, and clinicians. Chairs : Fabio Pitta (LONDRINA/PR, Brazil), Judith Garcia Aymerich (Barcelona, Spain) 14:00
How physical activity blends into the clinical assessment of patients Elena Gimeno-Santos (Barcelona, Spain)
138
14:45
Technical aspects of physical activity monitoring Heleen Demeyer (Halle, Belgium)
139
15:30
Break
140
16:00
Evaluating the success of physical activity monitoring Henrik Watz (Grosshansdorf, Germany)
141
16:45
How to make interventions more successful in the future Marilyn Moy (West Roxbury, United States of America)
142
Room D201-202
Session 29
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG14 Antibiotic stewardship for respiratory infections In the era of MDR pathogens Aims : To review hot topics and unresolved questions in the management of LRTI caused by MDR pathogens and to discuss the current approaches to antibiotic stewardship that are recommended by international guidelines. Track(s) : Infection Tag(s) : Translational Target audience : Pulmonologists, intensivists, emergency medicine doctors, nurses, respiratory physicians, clinical researchers, research fellows, and trainees. Chairs : George Dimopoulos (Athens, Greece), Mark Andrew Woodhead (Manchester, United Kingdom) 14:00
MDR pathogens in respiratory diseases Eva Polverino (Barcelona, Spain)
169
14:45
Inhaled antibiotics: an answer to MDR pathogens? Jordi Rello (Barcelona, Spain)
170
15:30
Break
171
16:00
Biomarkers and rapid diagnostics in antibiotic stewardship Daiana Stolz (Basel, Switzerland)
172
10
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 16:45
Effective strategies for designing a stewardship program Keertan Dheda (Cape Town, South Africa), Speaker to be confirmed
Room E103
Session 30
173
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG15 Gene-environment interactions in lung disease Understanding gene-environment interactions and the different exposures that occur at different stages of life Aims : To review the gene-environment interactions that underlie lung disease and the effects of different exposures that occur at various stages of development (e.g., the perinatal period, youth, and adulthood). How genetically susceptible high-risk groups can be identified and the possible targeted interventions at each stage of life will also be discussed. Track(s) : Epidemiology/Environment Tag(s) : Basic Target audience : Paediatric and adult pulmonologists, epidemiologists, health professionals, public health physicians, and scientists interested in the aetiology and prevention of lung disease. Chairs : Carlos Andres Jimenez Ruiz (Madrid, Spain), H. Marike Boezen (Groningen, Netherlands) 14:00
What are gene-environment interactions and how do they underlie lung disease? Erik Melén (Stockholm, Sweden)
174
14:45
Prenatal gene-environment interactions and epigenetics in asthma David A. Schwartz (Denver, United States of America)
175
15:30
Break
176
16:00
Gene variant-methylation interactions and asthma risk John Holloway (Southampton, United Kingdom)
177
16:45
Interaction between genes and smoking on lung function: a genome-wide approach Stephanie London (Research Triangle Park, United States of America)
178
Room E102
Session 28
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG16 Sleep and disordered breathing Update on diagnostic assessment Aims : The demand for sleep studies in respiratory medicine is increasing, which makes it necessary to use simpler diagnostic methods when possible. The technical aspects of full PSG or simpler studies and their impact on the diagnosis of SDB in adults and children will be discussed. Track(s) : Sleep Tag(s) : Clinical Target audience : Adult and paediatric pulmonologists, clinical researchers, general practitioners, research fellows, nurses, and trainees. Chairs : Renata L. Riha (Edinburgh, United Kingdom), Wilfried De Backer (Edegem (Antwerp), Belgium) 14:00
The pros and cons of digital systems in sleep data acquisition and the role of sensors Ramón Farré Ventura (Barcelona, Spain)
164
14:45
Type III devices – scoring strategies in limited systems Juan Fernando Masa Jiménez (Cáceres, Spain)
165
15:30
Break
166
16:00
Oximetry: does it play a role in screening for OSA? Dirk Sommermeyer (Karlsruhe, Germany)
167
16:45
New aspects of investigations in childhood sleep-disordered breathing Refika Hamutcu Ersu (Istanbul, Turkey)
168
Room D203-204
Session 26
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG17 Lung fibrosis and sarcoidosis Different diagnostic approaches and treatment modalities
11
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 Aims : To describe the different diagnostic approaches and treatment modalities in adult and paediatric patients with interstitial lung diseases. Tag(s) : Clinical Target audience : Paediatric and adult pulmonologists, epidemiologists, health professionals, public health physicians, and scientists interested in the aetiology and prevention of lung disease. Chairs : Joachim Muller-Quernheim (Freiburg, Germany), Venerino Poletti (Forli, Italy) 14:00
The pathomechanism of lung fibrosis and sarcoidosis Manuela Funke-Chambour (Bern, Switzerland)
154
14:45
The diagnostic and therapeutic standard Katerina Antoniou (Heraklion, Greece)
155
15:30
Break
156
16:00
Chronic interstitial lung in children: diagnosis and treatment Annick Clement (Paris, France)
157
16:45
Lung transplantation: the pros and cons Geert Verleden (Leuven, Belgium)
158
Room E104-106
Session 25
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG18 Advanced respiratory and cardiovascular testing In health and respiratory disease Aims : At the end of the course, the participants will understand the physiological constraints of exercise tolerance and its application in clinical practice; appreciate the optimal methods for testing lung mechanics and spirometry; understand the different formats of exercise tests, their advantages and disadvantages, and their different prognostic values in adults and children; and appreciate the usefulness of exercise testing for evaluating pharmacological and non-pharmacological interventions in clinical practice. Track(s) : Physiology Tag(s) : Clinical Target audience : Pulmonologists, respiratory therapists, respiratory physicians, clinical researchers, general practitioners, research fellows, intensivists, nurses, and trainees. Chairs : Brigitte Fauroux (Paris, France), Susan Ward (Crickhowell, United Kingdom) 14:00
Respiratory mechanics: changes in disease Pierantonio Laveneziana (Paris, France)
149
14:45
Measuring dyspnoea in health and disease Denis O'Donnell (Kingston, Canada)
150
15:30
Break
151
16:00
Exercise testing to evaluate muscle strength/endurance and pulmonary rehabilitation Rik Gosselink (Leuven, Belgium)
152
16:45
Lung function tests in preschool children Enrico Lombardi (Florence, Italy)
153
Room 13.2
Session 27
14:00 - 17:30
Registration for this course is additional to the congress registration fee and is €120 or €90 for the early bird registration.
Postgraduate course: PG19 Interventional pulmonology Major indications and therapeutic modalities Aims : To describe the major indications and therapeutic modalities in interventional pulmonology on the basis of the current literature. Track(s) : Intensive care Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows, and residents. Chairs : Stylianos Orfanos (Athens, Greece), Otto Chris Burghuber (Vienna, Austria) 14:00
Solitary pulmonary nodule – how to handle the problem Christophe Dooms (Leuven, Belgium)
12
159
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 14:45
Haemoptysis – a practical work-up Arschang Valipour (Vienna, Austria)
160
15:30
Break
161
16:00
Bronchoscopy in the ICU – when is it recommended? Daniela Gompelmann (Heidelberg, Germany)
162
16:45
Imaging in the ICU – indications and pitfalls Sebastian Ley (Munich, Germany)
163
Room 13.1
Session 7
09:30 - 11:15
Session: Russia Day: Community-acquired pneumonia (CAP) in adults Aims : Session organised in collaboration with the Russian Respiratory Society. The aims of the sessions are to discuss the epidemiology, diagnosis, and management of lung diseases in adults and children. This session will be translated into Russian. Target audience : Pulmonologists, GPs, paediatricians, and laboratory diagnostics specialists. Chairs : Alexander Sinopalnikov (Moscow, Russian Federation), Tobias Welte (Hannover, Germany) 09:30
Epidemiology of community-acquired pneumonia (CAP) Antoni Torres Marti (Barcelona, Spain)
51
10:00
CAP management algorithm Alexander G. Chuchalin (Moscow, Russian Federation)
52
10:30
Panel discussion
53
11:00
Coffee break
54
Room 13.1
Session 19
11:15 - 12:45
Session: Russia Day: Community-acquired pneumonia (CAP) in children Aims : Session organised in collaboration with the Russian Respiratory Society. The aims of this session are to discuss the epidemiology, diagnosis, and management of lung diseases in children. This session will be translated from English to Russian. Target audience : Pulmonologists, GPs, paediatricians, and laboratory diagnostics specialists. Chairs : Elena Kondiurina (Novosibirsk, Russian Federation), Eva Polverino (Barcelona, Spain) 11:15
Scientific and practical program “CAP in children” (clinical recommendations for Russia and CIS countries) Natalya Geppe (Moscow, Russian Federation)
123
11:45
Pneumonia and smoking in children Elif Dagli (Istanbul, Turkey)
124
12:15
Panel discussion
125
12:45
Lunch break
126
Room 13.1
Session 22
13:45 - 15:30
Session: Russia Day: COPD, asthma, and infection Aims : Session organised in collaboration with the Russian Respiratory Society. The aims of this session are to discuss epidemiology, diagnosis, and management of lung diseases in adults and children. This session will be translated from English to Russian. Target audience : Pulmonologists, GPs, paediatricians, and laboratory diagnostics specialists. Chairs : Alexander G. Chuchalin (Moscow, Russian Federation), Wisia Wedzicha (London, United Kingdom) 13:45
COPD from phenotypes to personalised therapy Marc Miravitlles (Barcelona, Spain)
133
14:10
Infection and asthma Vera Nevzorova (Vladivostok, Primorsky Krai, Russian Federation)
134
13
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 14:30
Difficult asthma Andrey Belevskiy (Moscow, Russian Federation)
135
14:55
Panel discussion
136
15:10
Coffee break
137
Room 13.1
Session 34
15:30 - 17:00
Session: Russia Day: Tuberculosis in the Russian Federation: achievements and challenges Aims : Session organised in collaboration with the Russian Respiratory Society. The aims of this session are to discuss the epidemiology, diagnosis, and management of lung diseases in adults and children. The session will be translated into Russian. Target audience : Pulmonologists, GPs, paediatricians, and laboratory diagnostics specialists. Chairs : Alexander G. Chuchalin (Moscow, Russian Federation), Giovanni Sotgiu (Porto Torres, Italy) 15:30
TB in Russia today and the adapted national anti-TB strategy Irina Vasilyeva Anatolievna (Moscow, Russian Federation)
194
16:00
International collaboration on TB problems: the European community and Russia - past and future Giovanni Battista Migliori (Varese, Italy)
195
16:30
Panel discussion and closing remarks
196
Room Forum
Session 3
09:00 - 13:00
Session: China Day "Advances in pulmonology" I Advances in airway disease diagnosis and management Aims : Session organised in collaboration with the Chinese Thoracic Society. Leading specialists from China will share the stage with ERS leadership to discuss key issues in respiratory medicine, providing the opportunity to hear about the latest scientific developments in Chinese. This meeting is designed to update respiratory professionals on the latest developments in the respiratory field. Headsets and translated slides will be used to provide translations of the full session. There will be opportunities for questions and discussion after the presentations. There will be simultaneous translation from English to Mandarin and slides will be shown with Chinese script. Target audience : The session is aimed at specialists in respiratory medicine from China. Chairs : Elisabeth H.D. Bel (Amsterdam, Netherlands), Chen Wang (Beijing, China) 09:00
Tobacco control: the most feasible and challenging way for disease prevention in China Chen Wang (Beijing, China)
11
09:30
Asthma-COPD overlap syndrome? Elisabeth H.D. Bel (Amsterdam, Netherlands)
12
10:00
Small airway disorders in COPD Nanshan Zhong (Guangzhou, China)
13
10:30
Coffee break
14
11:00
COPD and comorbidity: common pathways of accelerated ageing Peter J. Barnes (London, United Kingdom)
15
11:30
Asthma in China: current and future challenges Huahao Shen (Hangzhou, China)
16
12:00
Advances in COPD management Jørgen Vestbo (Manchester, United Kingdom)
17
12:30
Current situation of paediatric asthma diagnosis and treatment in China Kunling Shen (Beijing, China)
18
13:00
Lunch
19
Room Forum
Session 24
Session: China Day "Advances in pulmonology" II Advances in lung infection, parenchymal disease diagnosis and lung cancer
14
14:00 - 17:00
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 Aims : Session organised in collaboration with the Chinese Thoracic Society. Leading specialists from China will share the stage with ERS leadership to discuss key issues in respiratory medicine, providing the opportunity to hear about the latest scientific developments in Chinese. This meeting is designed to update respiratory professionals on the latest developments in the respiratory field. Headsets and translated slides will be used to provide translations of the full session. There will be opportunities for questions and discussion after the presentations. There will be simultaneous translation from English to Mandarin and slides will be shown with Chinese script. Target audience : The session is aimed at specialists in respiratory medicine from China. Chairs : Peter J. Barnes (London, United Kingdom), Chunxue Bai (Shanghai, China), Nanshan Zhong (Guangzhou, China) 14:00
Drug-resistant tuberculosis in Europe Giovanni Battista Migliori (Varese, Italy)
143
14:30
Clinical features and management of human infections by avian influenza Bin Cao (Beijing, China)
144
15:00
Tea break
145
15:30
New treatments for pulmonary fibrosis Ulrich Costabel (Essen, Germany)
146
16:00
Early diagnosis strategy of lung cancer in China Chunxue Bai (Shanghai, China)
147
16:30
Roundtable discussion and closing remarks
148
Room 4.1
Session 8
09:30 - 13:00
Session: Primary Care Programme Management of COPD and other respiratory conditions in clinical practice Aims : To provide the latest insights into and evidence for the diagnosis and management of respiratory symptoms and diseases in the primary care setting. Tag(s) : Clinical, Translational Target audience : Clinicians, GPs, family physicians, pulmonary specialists, allied respiratory professionals, and respiratory patient representatives. Chairs : Bjorn Stallberg (Uppsala, Sweden), Persijn Honkoop (Leiden, Netherlands), Hilary Pinnock (Edinburgh, United Kingdom), Janwillem Kocks (Groningen, Netherlands) 09:30
Breathlessness: the patient's experience Dominique Hamerlijnck (Amsterdam, Netherlands)
55
09:45
Breathlessness: respiratory, cardiac, or something else? Jaime Correia de Sousa (Porto, Portugal)
56
10:15
Breathlessness: a physiotherapist's approach to management Margareta Emtner (Uppsala, Sweden)
57
10:45
Wheezing infants: a practical primary care approach? James Y. Paton (Glasgow, United Kingdom)
58
11:15
Break
59
11:30
Coughing children: what is normal and when to worry Iain Small (Peterhead, United Kingdom)
60
12:00
Chronic cough in adults: causes and management Alyn Hugh Morice (Cottingham, United Kingdom)
61
12:30
Wheeze and obstructive symptoms in adults: asthma or COPD or asthma/COPD overlap syndrome? Niels Chavannes (Leiden, Netherlands)
62
Room Elicium 2
Session 20
HERMES examination: Adult and Paediatric respiratory medicine examinations
15
12:00 - 17:30
ERS International Congress 2015 DETAILED PROGRAMME SATURDAY 26 SEPTEMBER, 2015 Aims : The HERMES Examinations are in line with the ERS commitment to achieving the highest possible standards of practice in respiratory medicine and harmonising training across Europe. This examination will be a knowledge-based examination with multiple choice questions (MCQ) in English. A European Diploma in Adult or Paediatric Respiratory Medicine will be conferred from the ERS Educational Activities Department upon successful completion of this examination in the Diploma Category. The examination can also be taken as a self-assessment or in-training assessment. Register now via MyERS The blueprint for this examination will be based on the European syllabus. This examination is held annually under the authority of the European Respiratory Society. Chairs : Konrad E. Bloch (Zurich, Switzerland), Robert Dinwiddie (London, United Kingdom)
Room G102-103
Session 21
13:00 - 17:30
Session: ERS Career Development Fellowships (former ERS Fellows Get-Together) Aims : This session presents ERS fellowship programmes to young scientists interested in developing their career in research and training. Speakers will talk about their experience and benefits of a fellowship in someone's career. This session is also a unique networking opportunity for meeting with ERS Officers, past and current fellowship récipients, and with other prospective young scientists. Tag(s) : Basic, Clinical, Translational Target audience : Basic scientist, Clinical researcher, Research fellow, Trainee/Student, MD, MSc, PhD, post-doctoral and allied health professionals. Chairs : Maria Gabriela Belvisi (London, United Kingdom), Stephen T. Holgate (Southampton, United Kingdom) 13:30
A career with ERS - Past ERS fellow Renata L. Riha (Edinburgh, United Kingdom)
127
13:50
ERS Top notch researcher. Nicolas Reynoird (La Tronche, France)
128
14:10
Host and fellowship recipient share their experience together Kelly Ann Berube (Cardiff, United Kingdom), Kati Huttunen (Cardiff, United Kingdom)
129
14:30
NC3Rs presentation - importance of planning and experimental design when applying for fellowships Anthony Holmes (St Neots, United Kingdom)
130
14:55
ERS Junior Members Committee (JMC) Agnes Boots (Maastricht, Netherlands)
131
15:20
Fellowship in industry
132
16:00
Cocktail & Networking
Room G109
Session 36
17:45 - 18:15
Group members' meeting: Group 7.1 Members' Meeting "Paediatric respiratory physiology and sleep" Chairs : Enrico Lombardi (Florence, Italy), Graham Hall (West Perth, Australia)
16
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Room G102-103
Session 39
07:00 - 08:15
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Challenging clinical cases: CC1 Diagnosis and management of MDR-TB Aims : To discuss the clinical management of MDR-TB, from diagnosis to treatment. Track(s) : Infection Tag(s) : Clinical Target audience : Pulmonologists, respiratory physicians, general practitioners and trainees Chairs : Antonino Catanzaro (San Diego, United States of America) 07:00
Introduction
205
07:10
Diagnosis of MDR-TB Ximena Gonzalo (London, United Kingdom)
206
07:35
Treatment of MDR-TB Florian von Groote-Bidlingmaier (Cape Town, South Africa)
207
08:00
Discussion
208
Room 13.2
Session 40
07:00 - 08:15
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Challenging clinical cases: CC2 Central or obstructive sleep apnoea? Aims : To present challenging central and obstructive sleep apnoea cases to facilitate discussion on the pathophysiology and suitable treatment option. Track(s) : Sleep Tag(s) : Clinical Target audience : Clinicians and allied health physicians working in the field of sleep disordered breathing and those with an interest in sleep physiology. Chairs : Mary Morrell (London, United Kingdom) 07:00
Introduction
209
07:10
Case presentation - sleep apnoea Renata L. Riha (Edinburgh, United Kingdom)
210
07:35
Discussant - sleep apnoea Raphael Heinzer (Lausanne, Switzerland)
211
08:00
Discussion
212
Room L002
Session 47
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW7 Cardiorespiratory monitoring in critically-ill patients Linked to the postgraduate course. Aims : A crucial skill for clinicians is to monitor patients in the ICU and other areas where the critically ill or unstable patient may be found (the operating theatre, post-operative care unit, and emergency department). This session will review the basic principles and current technology of critical care monitoring, with a special focus on cardio-pulmonary monitoring. With this course, we hope that clinicians will better understand the fundamental physiological and theoretical principles of monitoring, thereby enhancing their ability to use clinical data and recognise where errors may occur. This course is taught at the “virtual bedside” by using small groups and case-based scenarios. Track(s) : Intensive care Tag(s) : Clinical Target audience : Consultant physicians in the pulmonary, critical care and anaesthesiology fields, residents in training, medical students, nurses, and respiratory therapists. Chairs : David A. Kaufman (Charlottesville, United States of America) Introduction
222
Workstation 1: Electrical impedance tomography of the lung Inez Frerichs (Kiel, Germany)
223
17
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Workstation 2: Ventilator waveforms Paolo Navalesi (Vercelli, Italy)
224
Workstation 3: Patient-ventilator asynchrony Lluís Blanch (Sabadell, Spain)
225
Workstation 4: Functional haemodynamic monitoring Sheldon Magder (Montreal, Canada)
226
Room L001
Session 46
08:00 - 10:20
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Educational skills workshop: EW8 Radiological – pathological correlations for clinicians Aims : To illustrate and highlight radiological-pathological correlations in different lung diseases. Professionals interested in respiratory medicine often have a certain knowledge regarding the interpretation of radiological images but are less well informed about how to recognise radiological-pathological correlations. When participating in interdisciplinary conferences and advisory boards (for example, when dealing with ILDs and severe cases of lung emphysema, and when making therapeutic decisions in lung cancer), it is necessary to correlate clinical, radiological, and pathological findings. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, oncologists, radiologists, pathologists, practitioners, basic scientists, trainees, technicians and professionals dealing with lung diseases. Chairs : Philipp A. Schnabel (Homburg/Saar, Germany) Introduction
217
Workstation 1: Lung emphysema Claus Peter Heussel (Heidelberg, Germany)
218
Workstation 2: Interstitial fibrosis Catherine Beigelman-Aubry (Paris, France)
219
Workstation 3: Lung cancer Walter De Wever (Leuven, Belgium)
220
Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Annette Fisseler-Eckhoff (Wiesbaden, Germany)
221
Room L002
Session 70
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW9 Cardiorespiratory monitoring in critically-ill patients Linked to the postgraduate course. Aims : A crucial skill for clinicians is to monitor patients in the ICU and other areas where the critically ill or unstable patient may be found (the operating theatre, post-operative care unit, and emergency department). This session will review the basic principles and current technology of critical care monitoring, with a special focus on cardio-pulmonary monitoring. With this course, we hope that clinicians will better understand the fundamental physiological and theoretical principles of monitoring, thereby enhancing their ability to use clinical data and recognise where errors may occur. This course is taught at the “virtual bedside” by using small groups and case-based scenarios. Track(s) : Intensive care Tag(s) : Clinical Target audience : Consultant physicians in the pulmonary, critical care and anaesthesiology fields, residents in training, medical students, nurses, and respiratory therapists. Chairs : Antonio Artigas (Sabadell (Barcelona), Spain) Introduction
432
Workstation 1: Electrical impedance tomography of the lung Paolo Pelosi (Milan, Italy)
433
Workstation 2: Ventilator waveforms David A. Kaufman (Charlottesville, United States of America)
434
Workstation 3: Patient-ventilator asynchrony Gastón Murias (Buenos Aires, Argentina)
435
18
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Workstation 4: Functional haemodynamic monitoring Xavier Monnet (Paris, France)
Room L001
Session 69
436
10:40 - 13:00
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Educational skills workshop: EW10 Radiological – pathological correlations for clinicians Aims : To illustrate and highlight radiological-pathological correlations in different lung diseases. Professionals interested in respiratory medicine often have a certain knowledge regarding the interpretation of radiological images but are less well informed about how to recognise radiological-pathological correlations. When participating in interdisciplinary conferences and advisory boards (for example, when dealing with ILDs and severe cases of lung emphysema, and when making therapeutic decisions in lung cancer), it is necessary to correlate clinical, radiological, and pathological findings. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, oncologists, radiologists, pathologists, practitioners, basic scientists, trainees, technicians and professionals dealing with lung diseases. Chairs : Arnaud Scherpereel (Lille, France) Introduction
427
Workstation 1: Lung emphysema
428
Workstation 2: Interstitial fibrosis Sara Tomassetti (Forli, Italy)
429
Workstation 3: Lung cancer Sebastian Ley (Munich, Germany)
430
Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Giulio Rossi (Modena, Italy)
431
Room L002
Session 149
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW11 Cardiorespiratory monitoring in critically-ill patients Linked to the postgraduate course. Aims : Monitoring patients in the ICU and other areas where the critically ill or unstable patient may be found (operating theatre, postoperative care unit, and emergency department) is a crucial skill for clinicians. This session will review basic principles and current technology of critical care monitoring, with a special focus on cardio-pulmonary monitoring. With this course, we hope that clinicians will better understand fundamental physiologic and theoretical principles of monitoring to enhance their ability to use clinical data and recognise where errors may occur. This course is taught at the “virtual bedside” using small groups and case-based scenarios. Track(s) : Intensive care Tag(s) : Clinical Target audience : Consultant physicians in the pulmonary, critical care and anaesthesiology fields, residents in training, medical students, nurses, and respiratory therapists. Chairs : David A. Kaufman (Charlottesville, United States of America) Introduction
1404
Workstation 1: Electrical impedance tomography of the lung Inez Frerichs (Kiel, Germany)
1405
Workstation 2: Ventilator waveforms Paolo Navalesi (Vercelli, Italy)
1406
Workstation 3: Patient-ventilator asynchrony Gastón Murias (Buenos Aires, Argentina)
1407
Workstation 4: Functional haemodynamic monitoring Sheldon Magder (Montreal, Canada)
1408
Room L001
Session 148
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW12 Radiological – pathological correlations for clinicians
19
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Aims : To illustrate and highlight radiological-pathological correlations in different lung diseases. Professionals interested in respiratory medicine often have a certain knowledge regarding the interpretation of radiological images but are less well informed about how to recognise radiological-pathological correlations. When participating in interdisciplinary conferences and advisory boards (for example, when dealing with ILDs and severe cases of lung emphysema, and when making therapeutic decisions in lung cancer), it is necessary to correlate clinical, radiological, and pathological findings. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, oncologists, radiologists, pathologists, practitioners, basic scientists, trainees, technicians and professionals dealing with lung diseases. Chairs : Bogdan Dragos Grigoriu (Iasi, Romania) Introduction
1399
Workstation 1: Lung emphysema Claus Peter Heussel (Heidelberg, Germany)
1400
Workstation 2: Interstitial fibrosis Catherine Beigelman-Aubry (Paris, France)
1401
Workstation 3: Lung cancer Walter De Wever (Leuven, Belgium)
1402
Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Annette Fisseler-Eckhoff (Wiesbaden, Germany)
1403
Room G109
Session 140
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME1 Diagnosing COPD Distinguishing between emphysema and chronic bronchitis Aims : To describe the different diagnostic approaches and treatment modalities for COPD Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows, and residents Chairs : 13:00
Diagnosing COPD: distinguishing between emphysema and chronic bronchitis Gianna Camiciottoli (Firenze, Italy)
Room G104-105
Session 138
1378
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME2 Malignant pleural effusions: from diagnosis to management Aims : To show how to reliably diagnose malignant pleural effusion (MPE) as fast as possible and to provide an updated summary of the (symptomatic and/or aetiological) management of MPE on the basis of clinical cases. Track(s) : Oncology Tag(s) : Clinical Target audience : pulmonary physicians and trainees, thoracic surgeons, (thoracic) oncologists, pathologists, and researchers involved in pleural diseases Chairs : 13:00
Malignant pleural effusions: from the diagnosis to the management Nick Maskell (Bristol, United Kingdom)
Room G110
Session 141
1377
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME3 Mechanical ventilation: a friend and a foe Aims : -To understand the benefits and complications of mechanical ventilation Track(s) : Intensive care Tag(s) : Clinical Target audience : Critical care physicians, respiratory care physicians, pulmonologists, respiratory therapists, physiotherapists, critical care nurses, scientists
20
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Chairs : 13:00
Mechanical ventilation: a friend and a foe Theodoros Vassilakopoulos (Kantza, Greece)
Room Auditorium
1379
Session 49
08:30 - 12:45
Session: Spanish/Portuguese Day: Exercise and other lifestyle behaviour for good lung health worldwide Aims : Session organised in collaboration with ERS/ALAT/SEPAR/SBPT/SPP. Leading specialists from each country will share the stage with the ERS leadership to discuss key issues in respiratory medicine, providing the opportunity to hear about the latest scientific developments in Spanish and Portuguese. This meeting is designed to update respiratory professionals on the latest developments in the respiratory field. There will be opportunities for questions and discussion after the presentations. Presentations given in Portuguese and Spanish will be translated to English. Tag(s) : Healthy Lungs for Life (HLfL) Target audience : The session is aimed at specialists in respiratory medicine from Spanish and Portuguese speaking countries. Chairs : Alejandro Casas Herrera (Bogota, Colombia), Joan B. Soriano (MADRID, Spain), Inmaculada Alfageme Michavila (Sevilla, Spain) 08:30
Exercise training in COPD (presentation in Spanish by ALAT representative) Martin Sivori (Buenos Aires, Argentina)
232
09:00
Home-rehabilitation: is it effective? (presentation in Portuguese by SBPT representative) Jose Roberto De Brito Jardim (Sao Paulo, Brazil)
233
09:30
Impact of COPD and its comorbidities on exercise capacity (presentation in Spanish by SEPAR representative) Joaquim Gea Guiral (Barcelona, Spain)
234
10:00
Can exercise change the evolution of respiratory disease? (presentation in Portuguese by SPP representative) Maria Fatima Miguel Rodrigues (Lisboa, Portugal)
235
10:30
Break
236
10:45
New models in home-respiratory care (presentation in Portuguese by SPP representative) João Carlos Winck (Vila Nova de Gaia, Portugal)
237
11:15
Asthma-COPD overlap syndrome: more than just two diseases in the same patient (presentation in Spanish by SEPAR representative) Luis Pérez de Llano (Lugo, Spain)
238
11:45
Schistosomiasis as the main cause of pulmonary hypertension (presentation in Portuguese by SBPT representative) Rogério De Souza (Sao Paulo, Brazil)
239
12:15
Why the ALAT COPD guidelines 2014 are different? (presentation in Spanish by ALAT representative) María Montes de Oca (Caracas, Venezuela)
240
Room Auditorium
Session 91
12:45 - 14:30
Session: Spanish/Portuguese Day: Poster session and keynote Lecture Aims : Session organised in collaboration with ERS/ALAT/SEPAR/SBPT/SPP. Leading specialists from each country will share the stage with ERS leadership to discuss key issues in respiratory medicine, providing the opportunity to hear about the latest scientific developments in Spanish and Portuguese. This session is designed to update respiratory professionals on the latest developments in the respiratory field. Presentations given in Portuguese and Spanish will be translated to English (except for Poster Session, which will be in Spanish or Portuguese only). There will be opportunities for questions and discussion after the presentations. Tag(s) : Healthy Lungs for Life (HLfL) Target audience : The session is aimed at specialists in respiratory medicine from Spanish/Portuguese speaking countries. Chairs : Elisabeth H.D. Bel (Amsterdam, Netherlands), Giovanni Battista Migliori (Varese, Italy) 12:45
Poster viewing and discussion (light snack and coffee will be available): http://k4.ersnet.org/prod/v2/Front/Program/Session?e=5&session=3980
21
633
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 13:45
Introduction Elisabeth H.D. Bel (Amsterdam, Netherlands)
634
13:50
Keynote Lecture "Cardiopulmonary research and medicine: translational bridges" Valentin Fuster (Madrid, Spain)
635
14:25
Closure remarks
636
Room Auditorium
Session 151
14:45 - 16:45
Session: Spanish/Portuguese Day: Tobacco control policies Preventing interference from the tobacco-industry Aims : Session organised in collaboration with ERS/ALAT/SEPAR/SBPT/SPP. International societies symposium. After the meeting, the audience will be aware of the process behind the creation and approval of this working group. In addition, the main aims of this working group, who its members are, the main activities that it developed during 2015 and its proposals for the next year will be described. Presentations given in Portuguese and Spanish will be translated to English. Track(s) : Epidemiology/Environment Tag(s) : Healthy Lungs for Life (HLfL) Target audience : Pulmonologists, clinicians, surgeons, physiologists, and allied respiratory professionals. Chairs : Carlos Andres Jimenez Ruiz (Madrid, Spain), Daniel Buljubasich Sincovich (Rosario, Argentina) 14:45
Exposing tobacco industry interference in policy-making: the role of research and ERS Sofia Belo Ravara (Lisboa, Portugal)
1414
15:15
Tobacco control policies in Latin America Jose Miguel Chatkin (Porto Alegre, Brazil)
1415
15:45
Tobacco control policies in Portugal Ana Maria Ferreira Rodrigues Figueiredo
1416
16:15
Tobacco control policies in Spain Segismundo Solano Reina (Madrid, Spain)
(Coimbra, Portugal)
Room Elicium 1
1417
Session 37
07:00 - 08:15
How to: Reach targeted education outcomes Aims : To discuss best practice in evidence-based simulation training and to gain an insight into best practice in workplace-based assessments, such as observation, feedback and regular follow-up with residents. Target audience : Anyone who is involved in clinical teaching/clinical assessment as a teacher, learner or programme director Chairs : Frank W.J.M. Smeenk (Eindhoven, Netherlands) 07:00
Introduction
197
07:10
Using simulation for training and certification of technical skills Lars Konge (Virum, Denmark)
198
07:35
Using workplace based assessment for training and assessment of non-technical skills Erik Driessen (Maastricht, Netherlands)
199
08:00
Discussion
200
Room 2.1
Session 38
07:00 - 08:15
How to: Deliver bad news Aims : To enable clinicians to deliver bad news while paying sufficient attention to the following issues: gathering adequate information from the patient, providing the necessary medical information as well as support to the patient, and collaborating with the patient in developing a strategy or treatment plan for the future. Target audience : Pulmonologists, emergency medicine doctors, respiratory therapists, respiratory physicians, general practitioners, intensivists, nurses, pathologists, radiologists, thoracic surgeons, otolaryngologist and trainees. Chairs : Stefano Nava (Bologna, Italy) 07:00
Introduction
201
22
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 07:10
Equivocal diagnoses - handling uncertainty when breaking bad news Andrew Bush (London, United Kingdom)
202
07:35
What comes next? The SPIKES protocol and the subject of prognosis Nicolas Schönfeld (Berlin, Germany)
203
08:00
Discussion
204
Room G104-105
Session 41
07:30 - 08:20
Group members' meeting: Group 1.2 Members' Meeting "Rehabilitation and chronic care" Chairs : Ioannis Vogiatzis (Athens, Greece), Frits M.E. Franssen (Horn, Netherlands)
Room E102
Session 42
07:30 - 08:20
Group members' meeting: Group 3.2 Members' Meeting "Airway cell biology and immunopathology" Chairs : Clifford Taggart (Belfast, United Kingdom), Silke Meiners (Munich, Germany)
Room G109
Session 43
07:30 - 08:20
Group members' meeting: Group 5.1 Members' Meeting "Airway pharmacology and treatment" Chairs : Gaetano Caramori (Ferrara, Italy), Reinoud Gosens (Groningen, Netherlands)
Room G111
Session 44
07:30 - 08:20
Group members' meeting: Group 5.2 Members' Meeting "Monitoring airway disease" Chairs : Stylianos Loukides (Voula, Athens, Greece), Jose Luis Lopez-Campos Bodineau (Sevilla, Spain)
Room 7.1
Session 48
08:30 - 10:30
Grand round: It is bleeding in the lung, but it is not a lung cancer - an interactive session and Ceremony for the ERS Pulmonary Arterial Hypertension Lifetime Achievement Award Aims : To present four cases in which the aetiology of haemoptysis is not trivial: alveolar haemorrhage, acute pulmonary infections, diseases of the pulmonary arteries, and chronic sarcoidosis. At the end of this session, participants should be able to give the best diagnostic strategy based on the clinical examination and radiological findings in these different situations. They should also be able to prescribe the appropriate tests to confirm their diagnostic hypotheses. Finally, they should be able to prescribe the first-line treatments including corticosteroids, anti-infection drugs, and to determine whether there is a need for interventional radiology. Tag(s) : Clinical Target audience : Pneumologists and non-pneumologists, clinicians (especially those interested in internal medicine, infectiology, imaging and emergency), juniors, and seniors who want improve their knowledge in the field. Chairs : Jacques Cadranel (Paris, France), Venerino Poletti (Forli, Italy) 08:30
Ceremony for the ERS Pulmonary Arterial Hypertension Lifetime Achievement Award Andrew Peacock (Glasgow, United Kingdom), Speaker to be confirmed
227
08:40
A man with pulmonary infiltrates and acute renal failure Vincent Cottin (Lyon, France)
228
09:07
A young man with nodules and an enlarged right pulmonary artery Agnès Hamzaoui (Tunis, Tunisia)
229
09:34
A farmer with a history of gastric cancer Paolo Spagnolo ( Liestal, Switzerland)
230
10:01
A man with a prior history of sarcoidosis Robert P. Baughman (Cincinnati, United States of America)
231
Room 7.2
Session 50
08:30 - 10:30
Symposium: The emergence of drug-resistant tuberculosis in Europe: no cure possible? Aims : To gain insights into the mechanism of bacterial drug resistance, learn about the molecular epidemiology of M. tuberculosis and the biological mechanisms that facilitate bacterial transmission, become alert about the latest official drug resistance surveillance data, become aware of the latest treatment outcome data, learn about the latest research findings regarding optimisation of the management of M/XDR-TB, become aware of the key aspects of the consensus statement for the management of M/XDR-TB and understand the WHO strategy for TB control and elimination.
23
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Track(s) : Infection Tag(s) : Translational Target audience : Clinicians, microbiologists, epidemiologists, specialist nurses, and scientists interested in tuberculosis and other respiratory infections. Chairs : Martin J. Boeree (Nijmegen, Netherlands), Masoud Dara (Copenhagen, Denmark) 08:30
Patient's testimonial Gabriela Spita (Iasi, Romania)
241
08:42
Molecular epidemiology of M. tuberculosis drug resistance in Europe Dick van Soolingen (Nijmegen, Netherlands)
242
09:09
Drug-resistant tuberculosis in the European Union and European economic area Marieke van der Werf (Stockholm, Sweden)
243
09:36
Management of patients with M/XDR-tuberculosis in Europe Christoph Lange (Borstel, Germany)
244
10:03
Elimination of tuberculosis at a times of emerging drug resistance Denis Falzon (Geneva, Switzerland)
245
Room Elicium 2
Session 51
08:30 - 10:30
Symposium: Weaning from mechanical ventilation: new insights Aims : To describe the concepts of simple, difficult, and prolonged weaning, the new weaning strategies in adult and paediatric populations; and the possible use of computer-driven protocols to facilitate weaning in paediatric patients. Track(s) : Intensive care Infection Tag(s) : Clinical Target audience : Pulmonologists, intensivists, respiratory therapists, and paediatricians. Chairs : Cesare Gregoretti (Turin, Italy), Leo M.A. Heunks (Nijmegen, Netherlands), Marc Moss (Denver, United States of America) 08:30
What’s well established and what’s new in weaning: an update Laurent Brochard (Toronto, Canada)
246
09:00
COPD patients: weaning and beyond Nicholas Hart (London, United Kingdom)
247
09:30
Weaning in children: from basic physiology to a computer-driven extubation protocol Philippe Jouvet (Montreal, Canada)
248
10:00
NIV to facilitate weaning: not only COPD Miquel Ferrer Monreal (Barcelona, Spain)
249
Room 4.2
Session 52
08:30 - 10:30
Symposium: Acute lung injury research: are we doing the right things? Aims : To very critically re-evaluate various aspects of current basic and translational research in acute lung injury (ALI). It will scrutinise potentially fundamental flaws in the present ALI research, i.e. the quality of our preclinical science, adequacy of our academic environment, strategies for linking preclinical studies and clinical trials, and validity of our target itself. The symposium intentionally encourages bold, stimulating and challenging arguments and discussions between the speakers and the audience, to be facilitated by the chairs. It will generate an ethos across the international scientific community in this field, to make serious efforts in a consorted fashion towards real progress in effective translation. Track(s) : Intensive care Tag(s) : Translational Target audience : Scientists and clinicians in the field of respiratory and critical care who are interested in the basic mechanisms of acute lung injury (ALI) and the clinical translation for these mechanisms into therapies for acute respiratory distress syndrome (ARDS). Chairs : Rory Morty (Bad Nauheim, Germany), Masao Takata (London, United Kingdom) 08:30
Introduction by the Chairs
250
08:40
Are we doing sloppy preclinical science using inadequate models? Stefan Uhlig (Aachen, Germany)
251
09:05
Is the current publishing and funding environment ruining our research? Sadis Matalon (Birmingham, United States of America)
252
24
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 09:30
Are we wasting money on premature and badly designed clinical trials? Danny McAuley (Belfast, United Kingdom)
253
10:00
Reality or illusion: should we target ALI as a whole? Wolfgang M. Kuebler (Toronto, Canada)
254
Room 5.2
Session 53
08:30 - 10:30
Symposium: Preschool wheeze: new insights Aims : To describe the recent epidemiological knowledge that permits the wheezing phenotypes in preschool children to be distinguished more precisely, provide updated information about the specific risk factors for persistence of asthma into school age, describe the roles that allergy and bacterial infections play in the development of wheezing in preschool children, review the controversy regarding antibiotic use in early childhood and its association with the development of asthma and describe the latest recommendations of the ERS task force on preschool wheeze. Track(s) : Paediatric Tag(s) : Translational Target audience : Paediatricians, paediatric and adult pulmonologists, GPs and nurses. Chairs : Özge Yilmaz (Manisa, Turkey), Angela Zacharasiewicz (Vienna, Austria) 08:30
Risk factors for persistent wheeze into school age: what is helpful? Alexander Möller (Zurich, Switzerland)
255
09:00
Preschool wheezing and the role of allergy in its pathogenesis, treatment, and prognosis Adnan Custovic (Manchester, United Kingdom)
256
09:30
Role of bacterial infection in preschool wheeze: a risk factor for persistent wheeze and a reason for treatment failure? Michael Kabesch (Regensburg, Germany)
257
10:00
An update on the 2008 Task Force on preschool wheezing Paul L. P. Brand (Zwolle, Netherlands)
258
Room Elicium 1
Session 54
08:30 - 10:30
Symposium: My patient had major thoracic and abdominal surgery: what happens next? Aims : At the end of this symposium, the audience will have gained broad insights into the multidisciplinary and interdisciplinary treatment of patients undergoing major thoracic or abdominal surgery; understand the importance of nutritional screening and the efficacy of nutritional interventions in patients undergoing major thoracic or abdominal surgery; have an impression of the possible psychological complications that can occur before and after surgery and the interventions that can be used to tackle these complications; understand the impact of major surgery on functional status, exercise tolerance, muscle function and, ADL activities; and have an overview of the role of physiotherapeutic care within the multidisciplinary treatment of surgery patients. Track(s) : Intensive care Physiology Tag(s) : Clinical Target audience : Clinicians, surgeons, physiotherapists, nutritionists, psychologists, nurses, and researchers. Chairs : Chris Burtin (Diepenbeek, Belgium), Annette Boehler (Zurich, Switzerland) 08:30
Patient testimonial Martin Price (Oxfordshire, United Kingdom)
259
08:50
Can catabolism and immune responses be altered with proper nutritional management in patients undergoing major thoraco-abdominal surgery? Martin Hübner (Lausanne, Switzerland)
260
09:15
Psychological aspects of the surgical patient: is the recovery all in your head… Speaker to be confirmed
261
09:40
Functional consequences of surgery: there can be no good without the bad Gill Arbane (London, United Kingdom)
262
10:05
Physiotherapy before and after surgery: not only better early than late, but also better late than never? Paula Agostini (Birmingham, United Kingdom)
263
Room Forum
Session 55
Oral Presentation: Advances in the therapy of lung cancer
25
08:30 - 10:30
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Chairs : Jean-Paul Sculier (Brussels, Belgium), Fernando Gamarra (Straubing, Germany) OA264
LATE-BREAKING ABSTRACT: Overall survival after the introduction of CT-based follow-up after resection of lung cancer. A population based quality assurance analysis Niels-Christian Gerner Hansen (Odense C, Denmark), Niels-Chr. G. Hansen, Stefan Starup Jeppesen, Erik Jakobsen
OA265
Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung: LUX-Lung 8 (LL8), a phase III trial Shirish Gadgeel (Detroit, United States of America), Shirish Gadgeel, Jean-Charles Soria, Enriqueta Felip, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem Göker, Vassileios Georgoulias, Wei Li, Dolores Isla, Salih Zeki Guclu, Alessandro Morabito, Young Joo Min, Andreas Ardizzoni, Bushi Wang, Vikram Chand, Glenwood Goss, For the LUX-Lung 8 Investigators
OA266
Enhanced FGFR signaling correlates with erlotinib/bevacizumab response in advanced non-squamous non-small cell lung cancer Anca Franzini (St Gallen, Switzerland), Anca Franzini, Florent Baty, Martin Brutsche
OA267
Clinical characteristics of 32 patients with BRAF V600E-mutated lung adenocarcinoma Audrey Benguigui (Rouen, France), Audrey Benguigui, Florian Guisier, Aude Lamy, Suzanna Bota, Samy Lachkar, Mathieu Salaün, Luc Thiberville
OA268
Cox-2 inhibitors in the treatment of small cell lung cancer patients Efimia Boutsikou (Thessaloniki, Greece), Efimia Boutsikou, Paul Zarogoulidis, Tania Konstanta, Sofia Lampaki, Lefteris Vlogiaris, Dionisis Spyratos, Konstantinos Zarogoulidis
OA269
Does smoking status after a diagnosis of lung cancer matter? Impact of quitting on 1 year survival Rachel Roberts (llanelli, United Kingdom), Rachel Roberts, Keir Lewis
OA270
A phase III trial comparing concomitant radiochemotherapy (RT-CT) with cisplatin (P) and docetaxel (D) as induction versus consolidation in patients with locally advanced unresectable non-small cell lung cancer (NSCLC). An ELCWP study Thierry Berghmans (Brussels, Belgium), Thierry Berghmans, Jean-Jacques Lafitte, Marianne Paesmans, Anne-Pascale Meert, Arnaud Scherpereel, Oswald Van Cutsem, Benoit Colinet, Paul Van Houtte, Martine Roelandts, Nathalie Leclercq, Jean-Paul Sculier
OA271
Consolidation maintenance oral vinorelbine following concurrent chemoradiation of intravenous vinorelbine and cisplatin in patients with unresectable stage III non-small cell lung cancer Yaser Ahmad (Assuit, Egypt), Yaser Elkelhy, Samer Eid, M.M. Omar, Tarek Salah
Room 5.1
Session 56
08:30 - 10:30
Oral Presentation: Best abstracts in pulmonary rehabilitation and chronic care Aims : The competition of 5 selected abstracts will take place during the session. Prizes, supported by Invacare) will be announced. Chairs : Ioannis Vogiatzis (Athens, Greece), Frits M.E. Franssen (Horn, Netherlands)
OA272
Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT) Fanny W.S. Ko (Shatin, Hong Kong), Fanny W.S. Ko, Nai-Kwong Cheung, Timothy Rainer, Christopher C.M. Lum, Ivor Wong, David S.C. Hui
OA273
Effectiveness of home tele-rehabilitation on functional capacity and daily physical activity in COPD patients Maroula Vasilopoulou (Athens, Thrakomakedones, Greece), Maroula Vasilopoulou, Andriana I. Papaioannou, Nikolaos Chynkiamis, Theodora Vasilogiannakopoulou, Stavroula Spetsioti, Zafeiris Louvaris, Eleni Kortianou, Otilia Kocsis, Athanasios Tsopanoglou, Chrysoula Feridou, Eustathia Plataniti, Alexia Thomopoulou, Georgios Kaltsakas, Nikolaos G. Koulouris, Ioannis Vogiatzis
OA274
The REVIVE study: A randomised controlled trial of the effect of a programme of exercise on physical function in survivors of critical illness after discharge from the intensive care unit Kathryn McDowell (Northern Ireland, United Kingdom), Kathryn McDowell, Brenda O’Neill, Bronagh Blackwood, Chris Clarke, Evie Gardner, Paul Johnston, Michaeline Kelly, John McCaffrey, Brian Mullan, Sally Murphy, John Trinder, Gavin Lavery, Daniel F. McAuley, Judy M. Bradley
OA275
Effect of telehealthcare on exacerbations and hospital admissions in COPD: A randomised controlled trial Charlotte Suppli Ulrik (Virum, Denmark), Thomas Ringbæk, Allan Green, Lars Chr. Laursen, Ejvind Frausing, Eva Brøndum, Charlotte Suppli Ulrik
OA276
Evaluation of the impact of a pulmonary rehabilitation program on exercise capacity in LAM Mariana Sponholz Araujo (Sao Paulo, Brazil), Mariana Sponholz Araujo, Bruno Guedes Baldi, André Luis Pereira de Albuquerque, Carolina Salim Gonçalves Freitas, Ronaldo Adib Kairalla, Celso Ricardo Fernandes de Carvalho, Carlos Roberto Ribeiro de Carvalho
26
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 OA277
Policy Statement on Pulmonary Rehabilitation Carolyn Rochester (New Haven, United States of America)
OA278
LATE-BREAKING ABSTRACT: Increasing physical activity in patients with COPD using a telecoaching program: A multicenter RCT Heleen Demeyer (Halle, Belgium), Heleen Demeyer, Zafeiris Louvaris, Rebecca Tanner, Noah Rubio, Anja Frei, Corina de Jong, Elena Gimeno Santos, Maarten Spruyt, Matthias Loeckx, Sara Buttery, Claire Yerramasu, Gilbert Buesching, Alexandra Strassmann, Ignasi Serra, Roberto Rabinovich, Iannis Vogiatzis, Michael Polkey, Judith Garcia Aymerich, Thierry Troosters
Room 13.1
Session 57
08:30 - 10:30
Oral Presentation: Emerging data on (e-)cigarettes and their health hazards Chairs : Philip Tønnesen (Glostrup, Denmark), Luke J. Clancy (Dublin, Ireland) OA279
Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice Constantinos Glynos (Athens, Greece), Constantinos Glynos, Sofia-Irida Bibli, Athanasia Pavlidou, Paraskevi Katsaounou, Ioannis Kalomenidis, Spyros Zakynthinos, Andreas Papapetropoulos
OA280
Assessment of throat-hit and desire to switch from tobacco to e-cigarette during blind test of e-liquid and e-cigarette Bertrand Dautzenberg (Paris, France), Bertrand Dautzenberg, Aledandre Scheck, Celine Kayal, Marie-Dominique Dautzenberg
OA281
Did the tobacco industry know that smoking caused cystic fibrosis-like lung disease before the scientific community? Elif Dagli (Istanbul, Turkey), Elif Dagli
OA282
Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece Paraskevi Katsaounou (Athens, Greece), Paraskevi Katsaounou, Aikaterini Bilitou, Vasilis Tsekouras
OA283
Efficacy of varenicline among smokers enrolled on a public health tobacco control program (HM-TCP) in the reallife setting Maria da Penha Uchoa Sales (Fortaleza, Brazil), Maria da Penha Sales, Fernando Aguiar, Maria Irenilza Oliveira
OA284
Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions Heikki Ekroos (Kerava, Finland), Heikki Ekroos, Kirsi Kautiainen, Mikko Puhakka, Helena Liira, Juha Laine, Kari Linden, Jarmo Hahl
Room 2.1
Session 58
08:30 - 10:30
Oral Presentation: Hot topics on airway diseases: new horizons in treatment Chairs : Gaetano Caramori (Ferrara, Italy), Kian Fan Chung (London, United Kingdom) OA285
LATE-BREAKING ABSTRACT: Long-term efficacy of A1-PI therapy in RAPID and RAPID extension trials Noel Gerard McElvaney (Dublin, Ireland), N. Gerard McElvaney, Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, Niels Seersholm, James Stocks, Robert Sandhaus, Oliver Vit, Michael Fries, Jonathan M. Edelman
OA286
LATE-BREAKING ABSTRACT: Anti-inflammatory effect of RP6557, a dual PI3K d/? inhibitor, in glucocorticoid insensitive human neutrophils from chronic obstructive pulmonary disease patients Xavier Milara (Valencia, Spain), Javier Milara, Adela Serrano, Julio Cortijo, Srikant Viswanadha, Swaroop Vakkalanka
OA287
LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils Guy Brusselle (Ghent, Belgium), Guy Brusselle, Matthew Germinaro, Sherrine Eid, James Zangrilli
OA288
LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3muscarinic M3 receptor heterodimers Kevin Bacon (San Diego, United States of America), Kevin Bacon, Emma Moss, Karen Bingham, Louis-Philippe Boulet, Mark Fitzgerald, Gail Gauvreau, Paul O²Byrne, Taylor Gilliland, Tracy Handel, Tai-Wei Ly, Stefen Boehme
OA289
LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data Sally Wenzel (Pittsburgh, United States of America), Sally Wenzel, Mario Castro, Bingzhi Zhang, Gianluca Pirozzi, E. Rand Sutherland, Neil Graham, Robert R. Evans, Mariana Louis-Tisserand, Ariel Teper
OA290
LATE-BREAKING ABSTRACT: Effect of QAW039, an oral prostaglandin D2 receptor (DP2/CRTh2) antagonist, upon bronchial epithelial integrity in treatment-resistant asthma in a randomized, placebo controlled study Rachid Berair (Birmingham, United Kingdom), Rachid Berair, Sherif Gonem, Amisha Singapuri, Ruth Hartley, Marie Laurencin, Gerald Bacher, Bjoern Holzhauer, Michelle Bourne, Vijay Mistry, Ian Pavord, Adel Mansur, Andrew Wardlaw, Salman Siddiqui, Richard Kay, Chris Brightling
27
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
OA291
LATE-BREAKING ABSTRACT: Transcriptomic fingerprinting in severe adult-onset asthma shows type2-high and inflammatory-cell gene signatures in the U-BIOPRED cohort Pieter-Paul Hekking (Amsterdam, Netherlands), P.P. Hekking, M.J. Loza, S. Pavlidis, B. De Meulder, F. Baribaud, C. Auffray, A.H. Wagener, A.T. Bansal, A.R. Sousa, J. Corfield, E.H. Bel, I.M. Adcock, K.F. Chung, R. Djukanovic, P.J. Sterk
OA292
LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation Suzanne Cohen (Cambridge, United Kingdom), Suzanne Cohen, Ian Scott, Jayesh Majithiya, Laura Rapley, Benjamin Kemp, Nicholas Bond, Dorothy Sims, Christopher Brightling, Robin Butler, Daniel Higazi, Dominic Corkill, Richard May, Tomas Mustelin, Matthew Sleeman
Room 4.1
Session 59
08:30 - 10:30
Oral Presentation: A bout de souffle: hypoxia and sleep-disordered breathing Chairs : Maria Bonsignore (Palermo, Italy), Chair to be confirmed
OA293
LATE-BREAKING ABSTRACT: Effects of long term intermittent hypoxia (IH) mimicking obstructive sleep apnea (OSA) on spontaneous tumorigenesis in aged mice Teresa Gallego-Martin (Valladolid, Spain), Teresa Gallego-Martin, Ana Obeso, Sara Yubero, Elena Olea, Elvira GonzalezObeso, Ramón Farré, Constancio Gonzalez
OA294
Hypertension induced by chronic intermittent hypoxia: Effects of carvedilol in a rat model Lucilia Diogo (Lisbon, Portugal), Lucilia N. Diogo, Sofia A. Pereira, Ana R. Nunes, Ricardo A. Afonso, Ana I. Santos, Emilia C. Monteiro
OA295
Neural respiratory drive (NRD) during continuous positive airway pressure (CPAP) titration in awake obese subjects with obstructive sleep apnoea (OSA) Sichang Xiao (London, United Kingdom), Sichang Xiao, Johan D. Bastianpillai, Culadeeban Ratneswaran, Martino F. Pengo, Yuanming Luo, Caroline J. Jolley, John Moxham, Joerg Steier
OA296
Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase Anne Briançon-Marjollet (Grenoble, France), Anne Briançon-Marjollet, Denis Monneret, Marion Henri, Florence HazanePuch, Jean-Louis Pépin, Patrice Faure, Diane Godin-Ribuot
OA297
Oxidative stress after withdrawal of CPAP for OSA John Stradling (Oxford, United Kingdom), John Stradling, Esther Schwarz, Christian Schlatzer, Ari Manuel, Regent Lee, Charalambos Antoniades, Malcolm Kohler
OA298
The role of hypoxia and the circadian rhythm in sleep apnoea Tessa Jaspers (London, United Kingdom), Tessa Jaspers, Mary Morrell, Anita Simonds, Ian Adcock, Andrew Durham
OA299
Impact of continuous positive airway pressure on liver injury induced by obstructive sleep apnea: Data from randomized controlled trials Jean-Louis Pepin (Grenoble, France), Ingrid Jullian-Desayes, Renaud Tamisier, Jean-Pierre Zarski, Judith Aron-Wisnewsky, Sandrine H. Launois, Nathalie Arnol, Karine Clement, Patrick Levy, Marie Joyeux-Faure, Jean-Louis Pepin
OA300
Pharmacologically increasing cerebral blood flow reduced central sleep apnea severity at high altitude Keith Burgess (Sydney, Australia), Keith Burgess, Samel Lucas, Katie Burgess, Kate Sprecher, Joseph Donnelly, Aparna Basnet, Philip Ainslie
Room Emerald
Session 60
08:30 - 10:30
Oral Presentation: Lung function: effects on method, machine and disease on the measurement Chairs : Waldemar Tomalak (Rabka-Zdroj, Poland), Jellien Makonga-Braaksma (Woudenberg, Netherlands) OA301
LATE-BREAKING ABSTRACT: Ultrasound capnography: A simple and indirect way to assess airways resistance Paolo Ruggeri (Messina, Italy), Paolo Ruggeri, Salvatore Calcaterra, Francesco Nucera, Irene Coppolino, Giuseppe Girbino
OA302
The impact of gas analysis technique on the measurement of single breath gas transfer (TLCO) Joanna Shakespeare (Coventry, United Kingdom), Joanna Shakespeare, Natalie O’Reilly, Rhian Hughes, David Parr
OA303
Postural change in lung capillary blood volume is less in pulmonary hypertension (PH) compared to healthy controls Patrick Jak (Amsterdam, Netherlands), Jerica Sinkeldam, Ivo Van der Lee, Herman Groepenhoff, Patrick Jak
OA304
Non-invasive measures to detect ventilatory limitation during exercise Kevin De Soomer (Antwerp, Belgium), Kevin De Soomer, Karlien Van Den Eynde, Pjotr Even, Wilfried De Backer, Ellie Oostveen
28
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
OA305
Decisive factors during treadmill and cycle exercise in patients with chronic obstructive pulmonary disease María Alfonso Imizcoz (Pamplona, Spain), María Alfonso, Pilar Cebollero, Juan Bautista Gáldiz Iturri, Sonia Herrero, Vanesa López, Milagros Antón, Javier Hueto
OA306
Validation of the oxygen uptake efficiency slope in children with cystic fibrosis and tetralogy of Fallot Paul Burns (Glasgow, United Kingdom), Paul D. Burns, James Y. Paton, Caroline King, Patrick Jamieson
OA307
Effect of posture on lung clearance index (LCI) and lung volumes in children with early stage cystic fibrosis lung disease Laurie Smith (Sheffield, United Kingdom), Laurie Smith, Felix Horn, Helen Marshall, Ina Aldag, Chris Taylor, Jim Wild, Alex Horsley
OA308
FEV1 predictions from NHANESIII and ERS/GLI12 differ significantly Olinto Linares (Murray, United States of America), Olinto Linares Perdomo, Dave Collingridge, Matthew Hegewald, Robert L. Jensen, John Hankinson, Alan Morris
Room E104-106
Session 61
08:30 - 10:30
Poster Discussion: Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques Chairs : Lars Konge (Virum, Denmark), Prashant Nemichand Chhajed (Mumbai, India)
PA309
Bronchoscopic evaluation of the lower airways in patients with persistent severe asthma Carmen Angela Centeno Clemente (Barcelona, Spain), Carmen Centeno Clemente, Carla Torres, Felipe Andreo, Carlos Martínez Rivera, David Ramos Barbón, Gloria Bonet Papell, Anna Plana Bonamaisó, Sebastián Gagatek, José Sanz Santos, Juan Ruiz Manzano
PA310
Clinical and pathological characteristics of patients with bronchial anthracosis and anthracofibrosis Ülkü Aka Aktürk (Istanbul, Turkey), Ulku aka Akturk, Nagihan Durmus Kocak, Aysun Sengul, Selahattin Oztas, Elif Yelda Niksarlioglu, Murat Kavas, Feyyaz Kabadayi, Dilek Yavuz, Dilek Ernam
PA311
Comparative study between different methods of aliquots suction during bronchoalveolar lavage Ayman Baess (Alexandria, Egypt), Mohamed Atta, Ayman Baess, Reham Moftah, Ebtesam Abomandour
PA312
Preliminary results from a prospective randomized trial comparing manual vs wall suction in the performance of bronchoalveolar lavage (BAL) María del Valle Somiedo Gutiérrez (Madrid, Spain), María del Valle Somiedo, Luis Seijo, Felipe Campo, Iker FernándezNavamuel, Javier Flandes
PA313
Diagnostic value of conventional transbronchial needle aspiration without an on-site cytopathologist: Experience of 363 procedures Abdulsamet Sandal (Ankara, Turkey), Ozge Ozturk, Abdulsamet Sandal, Sevilay Karahan, Berrin Er, Sevgen Onder, Deniz Koksal, Emin Maden, Salih Emri
PA314
Efficacy of conventional TBNA in patients with mediastinal adenopathies - A role of cytopathologist Ilya Sivokozov (Moscow, Russian Federation), Ilya Sivokozov, Eduard Artemkin, Andrey Zaytsev, Galina Evgushenko, Dmitry Dedushkin
PA315
Effectiveness of simulation with virtual reality in bronchoscopy training Ediva Myriam Borriello (Naples, Italy), Ediva Myriam Borriello, Francesca Allidi, Irene Bellesi, Stefano Orsi, Lorenzo Corbetta
PA316
Rigid bronchoscopy-essential experience for respiratory trainees? Shruthi Konda (London, United Kingdom), Shruthi Konda, Srividya Narayan, Praveen Molanguri, Brendan Madden
PA317
Learning EBUS-TBNA – A 6-year experience at a single institution Sveinung Sørhaug (Trondheim, Norway), Sveinung Sørhaug, Harald Hjelde, Peter Hatlen, Håkon Olav Leira, Bjarte Nesvik, Raymond Hollund, Majid Salarinejad, Kristin Nesgård, Dag Ole Nordhaug, Tore Amundsen
PA318
Tracheal oxygen supplementation during flexible bronchoscopy: A pilot study Jonas Yserbyt (leuven, Belgium), Jonas Yserbyt, Nikolaas De Maeyer, Christophe Dooms, Vincent Ninane
PA319
Assessment of patients’ satisfaction with flexible bronchoscopy: Initial Egyptian experience Ashraf Madkour (Cairo, Egypt), Ashraf Madkour, Nehad Osman, Samar Sharkawy, Ashraf Gomaa
PA320
Feasability of flexible bronchoscopy under sedation without local anaesthesia of the pharynx Maik Häntschel (Tübingen, Germany), Maik Häntschel, Ahmed Ehab, Michael Böckeler, Almut Oberle, Werner Spengler, Mariella Zahn-Paulsen, Hubert Hautmann, Jürgen Hetzel
29
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA321
Sedation regimens comparison during flexible bronchoscopy: Dexmedetomidine, alfentanil and lidocaine Moussa Riachy (Beirut, Lebanon), Moussa Riachy, Georges Khayat, Ihab Ibrahim, Zeina Aoun-Bacha, Georges Dabar, Taha Bazarbachi, Nadine Khalil, Bassem Habr
PA322
Comparison of comfort scores comparing bronchoscopy with conscious sedation or anaesthetist controlled sedation; a randomised prospective trial Timothy Edwards (Brisbane, Australia), Joseph Churton, Timothy Edwards, David Fielding, Farzad Bashirzadeh, Andrew Pattison
PA323
Conscious sedation during flexible bronchoscopy: A nationwide survey in Switzerland Thomas Gaisl (Zurich, Switzerland), Thomas Gaisl, Malcolm Kohler, Ludwig Heuss, Marco Zalunardo, Daniel Bratton, Martin Frey, Daniel Franzen
PA324
Prospective randomized trial evaluating ketamine for adult bronchoscopy Oren Fruchter (Tel-Aviv, Israel), Oren Fruchter, Yair Manevich, Uri Carmi, Dror Rosengarten, Mordechai Kramer
PA325
Features and safety of deep sedation in endosonography. Comparative study between the airway and the esophageal route Eli Nancy Perez Rodas (Barcelona, Spain), Eli Nancy Perez Rodas, Carmen Centeno Clemente, Felipe Andreo Garcia, Enrique Cases Viedma, Pere Vila Caral, Jose Sanz Santos, Andres Briones Gomez, Carlos Martinez Rivera, Pere Serra Mitja, Juan Ruiz Manzano
PA326
Satisfaction of patients and operators from sedation in EBUS-TBNA; the ’SEDATE’ study Georgia Hardavella (Aghia Paraskevi, Athens, Greece), Georgia Hardavella, Claire McCann, Laura Succony, Ricardo Jose, Ricky Thakrar, Sam Janes, Sarah Chieveley-Williams, Neal Navani
Room G102-103
Session 62
08:30 - 10:30
Poster Discussion: Kaleidoscope of nursing research Chairs : Anne-Marie Russell (Holmfirth, West Yorkshire, United Kingdom), Birthe Dahl Hellquist (Risskov, Denmark) PA327
Feasibility of a new individualized nursing care intervention in COPD, the COPD-GRIP intervention Saskia Weldam (Utrecht, Netherlands), Saskia Weldam, Jan-Willem Lammers, Marieke Zwakman, Marieke Schuurmans
PA328
Patient perspectives of the COPD-GRIP intervention, a new nursing care intervention in COPD Marieke Zwakman (Utrecht, Netherlands), Marieke Zwakman, Saskia Weldam, Jan-Willem Lammers, Marieke Schuurmans
PA329
Palliative care for people with COPD: A neglected area in the primary sector Camilla Askov Mousing (Randers SØ, Denmark), Camilla Askov Mousing, Helle Timm, Marit Kirkevold, Kirsten Lomborg
PA330
The experiences of spouses as informal caregiver of patients with severe chronic obstructive pulmonary disease Dorthe Bove (Hellerup, Denmark), Dorthe Gaby Bove, Ann-Britt Zakrisson, Julie Midtgaard, Kirsten Lomborg, Dorthe Overgaard
PA331
Patient rated WHO functional class and psychological distress are strongly associated with dyspnoea in pulmonary hypertension Janelle Yorke (Manchester, United Kingdom), Janelle Yorke, Iain Armstrong, Christi Deaton, Malcolm Campbell, Mark Pilling, Linda McGowan, Paul Sephton
PA332
The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views Geraldine A. Burge (Solihull, United Kingdom), Geraldine Burge, Vicky Moore
PA333
Development of the interstitial lung disease multidiciplinary team meeting 2005-2013 Sherwood Burge (Solihull, United Kingdom), Geraldine Burge, Salman Ghani, Dimitrina Petkova, John Reynolds, Madava Djearman, Shahid Hussain, Ed Hoey, Simon Trotter, Gerald Langman, Abdul Faizal, Sherwood Burge
PA334
Is repeated education about small volume nebulizer aerosol, by an expert respiratory nurse to colleagues, needful? Daniel Schuermans (Brussels, Belgium), Daniel Schuermans, Pascale Oumaziz, Fatima Snoussi, Annemie Schoonis, Geert Celis
PA335
A research approach to practice change: Competency-based orientation for intensive care nurses (CORE-ICU): Supported by BHPr/HRSA)/DHHS under 5 D11HP09553-05-00 grant Georgia Narsavage (Morgantown, United States of America), Georgia Narsavage, Mary Fanning, Yea-Jyh Chen, Members of CORE-ICU Team
PA336
How does asthma affect the day-to-day life of sufferers? Michele Dunne (Dublin, Ireland), Michele Dunne, Mary Hughes
PA337
The prevalence and impact of cannabis smoking in clinical trial patients with chronic obstructive pulmonary disease Wai Yee James (London, United Kingdom), Wai Yee James, Neil Barnes, Ian Stone
30
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA338
Identifying undiagnosed COPD through searches of UK routine primary care databases Kate Lippiett (Winchester, United Kingdom), Kate Lippiett, Kate Gillett, Jayne Longstaff, Carla Astles, Lucy Rigge, Rachel Dominey, Kimm Lawson, Andy Powell, Anoop Chauhan, Mike Thomas, Tom Wilkinson
PA339
Patients’ perception on long-term domiciliary oxygen therapy Ilda Godoy (Botucatu, Brazil), Giovanna H. Bueno, Irma Godoy, Ilda Godoy
Room G104-105
Session 63
08:30 - 10:30
Poster Discussion: Occupational factors in COPD and bronchitis Chairs : Carl Reynolds (Fareham, United Kingdom), Chair to be confirmed
PA340
LATE-BREAKING ABSTRACT: Breathtaking jobs: Respiratory work disability by occupation in a sample from the general population in Norway Anne Kristin Moller Fell (Skien, Norway), Anne Kristin M. Fell, Regine Abrahamsen, Paul K. Henneberger, Martin V. Svendsen, Kjell Torèn, Johny Kongerud
PA341
Remote secondhand smoke exposure is associated with progressive airflow limitation during exercise Jeroen Geerts (Nijmegen, Netherlands), Jeroen Geerts, Wendy Ching, Sarah Dalton, Warren Gold, Mehrdad Arjomandi
PA342
Prevalence of chronic obstructive pulmonary disease (COPD) amongst farmers in rural India Rahul Kodgule (Pune, India), Jyoti Londhe, Rahul Kodgule, Sanjay Juvekar, Sapna Madas, Anurag Agrawal, Sundeep Salvi
PA343
Occupational organic dust exposure and risk of chronic obstructive pulmonary disease (COPD) in Denmark Anne Vested (Aarhus C, Denmark), Anne Vested, Ioannis Basinas, Gunnar Toft, Hans Kromhout, Torben Sigsgaard, Henrik Albert Kolstad, Ane Marie Thulstrup, Inge Wouters, Dick Heederik, øyvind Omland, Gitte Jacobsen, Vivi Schlünssen
PA344
Irish farmers lung health study- A study of the respiratory health of the Irish farming population Breda Cushen (Kilkenny, Ireland), Breda Cushen, Noreen Donoghue, Donna Langan, Tara Cahill, Eimear Nic Donnacha, Olivia Healy, Fiona Keegan, Mark Browne, Imran Sulaiman, Anthony O’Regan
PA345
The effect of occupational farming on lung function development in young adults: A 15 year follow-up study Anneli Clea Bolund (Aarhus C, Denmark), Anneli C.S. Bolund, Martin R. Miller, Ioannis Basinas, Grethe Elholm, øyvind Omland, Torben Sigsgaard, Vivi Schlünssen
PA346
Occupational exposure and 4-year incidence of COPD among 45-84-year old Danes Else Würtz (Tjele, Denmark), Else Würtz, Vivi Schlünssen, Tine Malling, Charlotte Brasch-Andersen, Jens Georg Hansen, øyvind Omland
PA347
Chronic bronchitis and COPD among textile workers in Pakistan: Findings from a cross-sectional survey ambreen sahito (karachi, Pakistan), Asaad Ahmed Nafees, Zafar Fatmi, Muhammad Masood Kadir, Nalini Sathiakumar, Ambreen Sahito
PA348
Work-related COPD risk in the population-based UK Biobank cohort study Sara De Matteis (London, United Kingdom), Sara De Matteis, Debbie Jarvis, Sally Hutchings, Lesley Rushton, Paul Cullinan
PA349
Chronic cough and phlegm in relation to occupational exposures in a prospective cohort study (ECRHS III) Theodore Lytras (Acharnes, Greece), Theodore Lytras, Hans Kromhout, Josep Maria Antó, Per Bakke, Geza Benke, Paul Blanc, Sandra Dorado, Johan Hellgren, Mathias Holm, Deborah Jarvis, Amar Jayant Mehta, David Miedinger, Maria C. Mirabelli, Dan Norbäck, Mario Olivieri, Vivi Schlünssen, Isabel Urrutia, Simona Villani, Manolis Kogevinas, Jan-Paul Zock
PA350
Spirometry in industrial workers for the early detection of COPD Tatsiana Rybina (Minsk, Belarus), Tatsiana Rybina, Volha Kardash, Igar Manichev, Victar Scherbitzky
PA351
Molecular and cytological features of occupational chronic obstructive pulmonary disease in subjects exposed to different environmental factors Lioubov Shpagina (Novosibirsk, Novosibirsk Oblast, Russian Federation), Lioubov Shpagina, Olga Kotova, Ilya Shpagin, Oksana Gerasimenko
PA352
Effect of biomass exposure on lung function Baran Balcan (Istanbul, Turkey), Baran Balcan, Selcuk Akan, Berrin Ceyhan
PA353
Workplace exposures as risk factors for COPD, asthma and allergic rhinitis in Turkey (WORK-CAT study) Emel Kurt (Eskisehir, Turkey), Emel Kurt, Ahmet Ugur Demir, Peri Arbak, Fatma Evyapan, Tarkan Ozdemir, Unal Sahin, Elif Yilmazel Ucar
31
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA354
Knowledge, attitude and practice regarding occupational COPD among the pulmonologists and other physicians Marta Wiszniewska (Lodz, Poland), Marta Wiszniewska, Aneta Kleniewska, Diana Tymoszuk, Agnieszka LipinskaOjrzanowska, Jolanta Walusiak-Skorupa
PA355
A new web-based tool to collect and code lifetime job-histories in large population-based studies Sara De Matteis (London, United Kingdom), Sara De Matteis, Debbie Jarvis, Magda Wheatley, Alan Young, Heather Young, Lesley Rushton, Paul Cullinan
PA356
Asthma, COPD and the risk of disability pension - 11 year register-based follow-up study Irmeli Lindstrom (Helsinki, Finland), Irmeli Lindström, Ritva Luukkonen, Tuula Vasankari, Merja Kanervisto, Markku Heliövaara, Annette Kainu, Paula Pallasaho
PA357
Future job instability in older workers can be predicted by breathlessness and airflow obstruction Joanna Szram (London, United Kingdom), Joanna Szram, Susan Schofield, Paul Cullinan
Room G106-107
Session 64
08:30 - 10:30
Poster Discussion: Bronchiectasis and NTM infections: clinical aspects and research outlook Chairs : Michael Loebinger (London, United Kingdom), Chair to be confirmed PA358
Non CF-bronchiectasis: Aetiologic, clinical, radiological, microbiological and functional profile in a Greek population Christina Triantafyllidou (Athens, Greece), Christina Triantafillidou, Michail Toumbis, Petros Bakakos, Kyriaki Tsikritsaki, Adamantia Liapikou, Katerina Malagari, Katerina Dimakou
PA359
Hacettepe University experience: Clinical evaluation of 218 primary ciliary dyskinesia patients Nagehan Emiralioglu (Ankara, Turkey), Nagehan Emiralioglu, Ugur özçelik, Ebru Yalçin, Deniz Dogru Ersöz, Nural Kiper
PA360
Atorvastatin as an anti inflammatory in bronchiectasis Pallavi Bedi (Edinburgh, United Kingdom), Pallavi Bedi, James Chalmers, Adriano Rossi, Adam Hill
PA361
Effectiveness and adherence to treatment with nebulized colistimethate sodium (Promixin®) in non-cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa (PsA) ROCIO JIMENO GALVAN (, Spain), Rocío Jimeno, Belén Navas, Jose Manuel Vaquero, Francisco Casas, Alicia Padilla, Enrique Gonzzlez-Moya, Manuel Arenas, Juan Carlos Bioque, Jose Luis López-Campos, Soledad Cano, Silvia Merlos, Agustin Valido
PA362
Audit investigating self-management of bronchiectasis at University Hospital Llandough, Wales Sabena Ali (Bristol, United Kingdom), Sabena Ali, Jamie Duckers, Dawn Lau
PA363
A single isolation of pseudomonas aeruginosa predicts poor quality of life and increased exacerbation frequency in adult bronchiectasis james hill (Dundee, United Kingdom), James Hill, Duncan Renton, Hani Abo-Leyah, Megan Crichton, Simon Finch, Thomas Fardon, James Chalmers
PA364
The impact of acute air pollution fluctuations on non-cystic fibrosis bronchiectasis pulmonary exacerbations: A casecrossover analysis Pieter Goeminne (Bornem, Belgium), Pieter Goeminne, Pallavi Bedi, Michal Kicinski, Lauren Richardson, Kees De Hoogh, Ben Nemery, Tim Nawrot, Michael Loebinger, Adam Hill, Lieven Dupont
PA365
DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Melissa McDonnell (Galway, Ireland), Melissa McDonnell, Michael O’Mahony, David Breen, J.J. Gilmartin, Anthony O’Regan, Robert Rutherford
PA366
Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype Melissa McDonnell (Galway, Ireland), Melissa McDonnell, O’Mahony Michael, Breen David, O’Regan Anthony, Rutherford Robert
PA367
Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization Victoria ALCARAZ SERRANO (Barcelona, Spain), Victoria Alcaraz, Eva Polverino, Edmundo Rosales, Rosa Maria Giron, Rosario Mendendez, Montserrat Vendrell, Antoni Torres
PA368
Nontuberculous mycobacteria in the Danish population, incidence rate and clinical importance during 24 years Thomas Stig Hermansen (Rødovre, Denmark), Thomas Hermansen, Troels Lillebaek, Erik Svensson, Pernille Ravn
PA369
Patterns of isolation and drug sensitivity in non-tuberculous mycobacteria Steven Cowman (London, United Kingdom), Steven Cowman, Burns Katie, Benson Susan, Wilson Robert, Loebinger Michael
32
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA370
The value of rapid speciation of nontuberculous mycobacteria (NTM) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF) Neeraj Shah (New Malden, United Kingdom), Neeraj Shah, Rebecca Gorton, Jennifer Canizales, Gina Birch, Timothy McHugh, Marc Lipman
PA371
Amikacin (AMK) minimum inhibitory concentrations (MICs) and mutational resistance in patients with treatmentrefractory nontuberculous mycobacteria (NTM) lung disease (LD) treated with liposomal amikacin for inhalation (LAI) Kenneth N. Olivier (Bethesda, United States of America), Kenneth N. Olivier, Gina Eagle, John P. McGinnis II, Liza Micioni, Barbara A. Brown-Elliott, Richard J. Wallace, Jr.
PA372
Feasibility study for a randomized controlled trial of pseudomonas aeruginosa eradication treatment in patients with bronchiectasis Hani Abo-Leyah (Dundee, United Kingdom), Hani Abo-Leyah, Marilyn Clark, James Hill, Thomas Fardon, James Chalmers
PA373
Patients in randomized clinical trials of bronchiectasis are only partially representative of clinical practice: A European cohort study James D. Chalmers (Perth, United Kingdom), James Chalmers, Melissa McDonnell, Pieter Goeminne, John Davidson, Robert Rutherford, Megan Crichton, Thomas Fardon, Adam Hill, Lieven Dupont, Stefano Aliberti, Anthony De-Soyza
PA374
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) James D. Chalmers (Perth, United Kingdom), James Chalmers, Eva Polverino, Anthony De Soyza, Felix Ringshausen, Marlene Murris, Wim Boersma, Antoni Torres, Montserrat Vendrell, J. Stuart Elborn, Francesco Blasi, Stefano Aliberti, On Behalf of the EMBARC Clinical Research Collaboration
Room 13.2
Session 65
08:30 - 10:30
Poster Discussion: Mucosal immunology: what’s new in 2015 Chairs : Mark Gjomarkaj (Palermo, Italy), Sukhwinder Singh Sohal (Launceston, Australia) PA375
Impaired monocyte chemotaxis in COPD Arjun Ravi (Greater Manchester, United Kingdom), Arjun Ravi, Jonathan Plumb, Jonathan Lemon, George Booth, Jorgen Vestbo, Dave Singh
PA376
The identification of distinct immunophenotypical subgroups in a COPD patient population based on predominating T-lymphocyte subsets Mona Bafadhel (Oxford, United Kingdom), Svenja Pahlke, Bart Hilvering, Samantha Thulborn, Mona Bafadhel
PA377
Alveolar macrophages phenotype in patients with asthma and its combination with gastroesophageal reflux disease with pulmonary manifestations Igor Malyshev (Fort Lee, United States of America), Igor Malyshev, Svetlana Lyamina, Georgy Yurenev, Igor Maev
PA378
Severe asthma is characterised by high levels of CRTH2 expressing cells in peripheral blood Bart Hilvering (Utrecht, Netherlands), Bart Hilvering, Linda Stoeger, Svenja Pahlke, Luzheng Xue, Ian Pavord
PA379
Enhanced neutrophil extracellular trap (NET) formation in sputum of stable COPD patients Frauke Pedersen (Großhansdorf, Germany), Frauke Pedersen, Sebastian Marwitz, Torsten Goldmann, Anne Kirsten, Helgo Magnussen, Klaus F. Rabe, Mohib Uddin, Henrik Watz
PA380
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis Baishakhi Ghosh (Bengaluru, India), Baishakhi Ghosh, Kanchan Pyasi, Jyoti Londhe, Sushma Jadhav, Sapna Madas, Bill Brashier, Sundeep Salvi, Peter Barnes, Louise Donnelly
PA381
Chymase-positive mast cells represent a major source for IL-17A in airway inflammation Premkumar Siddhuraj (Lund, Sweden), Premkumar Siddhuraj, Anders Bergqvist, Michiko Mori, Leif Bjermer, Jonas Erjefält
PA382
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS) Aleksandra Piechuta (Warszawa, Poland), Joanna Domagala-Kulawik, Iwona Osinska, Aleksandra Piechuta, Piotr Bielicki, Tomasz Skirecki
PA383
Monocyte sub-populations do not reflect differences in COPD macrophage phenotype Amy Day (London, United Kingdom), Amy Day, Peter Barnes, Louise Donnelly
PA384
Mapping of eosinophil and basophils in COPD lung tissues Prajakta Jogdand (Lund, Sweden), Prajakta Jogdand, Michiko Mori, Anders Bergqvist, Andrew Walls, Caroline Sanden, Jonas Erjefält
33
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA385
T regulatory cells: Immunomodulation by budesonide and formoterol on COPD patients Francesco Balbi (Genova, GE, Italy), Alessandra Chiappori, Chiara Folli, Francesco Balbi, Emanuela Caci, Gianni Melioli, Fulvio Braido, Giorgio Walter Canonica
PA386
LSC Abstract – Regulation of regulatory T cell (Treg) function by cAMP-responsive element binding protein (CREB) and upstream microRNAs Sabine Bartel (Borstel, Germany), Sabine Bartel, Marc Kästle, Elfriede Noessner, Oliver Eickelberg, Susanne KraussEtschmann
PA387
Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation Kylie Belchamber (London, United Kingdom), Kylie Belchamber, Richa Singh, Jadwiga Wedzicha, Peter Barnes, Louise Donnelly
PA388
Differential cigarette smoke and H2O2 induced cytokine release from macrophages in COPD Adam Loveridge (London, United Kingdom), Adam Loveridge, Jo Ann Rhodes, Peter Barnes, Louise Donnelly
PA389
Activation of the NOTCH signaling pathway stimulates migration of human B-lymphocytes Astrid Holzer (Innsbruck, Austria), Astrid Holzer, Kathrin Watzinger, Christian M. Kähler
PA390
Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cAMP in human macrophages Milena Sokolowska (Bethesda, United States of America), Milena Sokolowska, Li-Yuan Chen, Yueqin Liu, Asuncion Martinez-Anton, Hai-Yan Qi, Carolea Logun, Sara Alsaaty, Yong Hwan Park, Daniel L. Kastner, Jae Jin Chae, James H. Shelhamer
PA391
Prolonged emphysema development is caused by irreversible iBALT following smoking cessation in a cigarette smoke-induced COPD mouse model Gerrit John-Schuster (Neuherberg, Germany), Gerrit John-Schuster, Katrin Hager, Oliver Eickelberg, Ali önder Yildirim
PA392
Priming of inflammatory cells with NOTCH ligands stimulates migration Kathrin Watzinger (Innsbruck, Austria), Kathrin Watzinger, Christian M. Kaehler
Room E102
Session 66
08:30 - 10:30
Poster Discussion: COPD: interesting notes Chairs : Otto Chris Burghuber (Vienna, Austria), Marieke L. Duiverman (Gasselte, Netherlands)
PA393
LATE-BREAKING ABSTRACT: Phenotypes of COPD in central and Eastern Europe - The POPE study Vladimir Koblizek (Prague, Czech Republic), Vladimir Koblizek, Ruzena Tkacova, Attila Somfay, Branislava Milenkovic, Adam Barczyk, Kirill Zykov, Neven Tudoric, Kosta Kostov, Zuzana Zbozinkova, Jan Svancara, Jurij Sorli, Alvis Krams, Marc Miravitlles, Arschang Valipour
PA394
Myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring Olexandr Fesenko (Dnipropetrovsk, Ukraine), Tetyana Pertseva, Olexandr Fesenko
PA395
Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Begüm Ergan (Izmir, Turkey), Recai Ergun, Begum Ergan
PA396
Increased serum level of apelin in chronic obstructive pulmonary disease Ceylan Ayada (Kütahya, Turkey), Ceylan Ayada, ümran Toru, Osman Genç, Server Sahin, özlem Arik, Ismet Bulut
PA397
Innovations in differentiation of pulmonary and cardiac dyspnea genesis Olga Paraeva (Barnaul, Altay Krai, Russian Federation), Tatiana Martynenko, Olga Paraeva, Sergey Dronov, Yakov Shoyhet
PA398
CAT’ or ’mMRC’ – Which is a better symptom scale in recent GOLD COPD classification? Anantharaj Suresh (Chennai, India), Anantharaj Suresh, Sindhuja Giritharan
PA399
Automatic interactive system of bronchial obstructive diseases risk evaluation "electronic polyclinic" Vitaly Mishlanov (Perm, Russian Federation), Vitaliy Mishlanov, Vladimir Nedugov, Ekaterina Sivyak, Lilia Glavatskykh, Yaroslav Mishlanov, Anastasia Katkova
PA400
Evaluation of airway sGaw in Japanese COPD patients treated with triple therapy using salmeterol/fluticasone propionate 50/250 and tiotropium bromide Takio Takaku (Ibaraki, Japan), Takio Takaku, Takefumi Saito, Akinori Takeda, Katsuji Hashimoto, Akihiro Kobayashi, Tomoyuki Hayamizu, Gerald Hagan
PA401
Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Olga Kharevich (Minsk, Belarus), Kharevich Olga, Lapteva Irina, Lapteva Elena, Koroleva Elena, Grigorovich Irina
34
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA402
Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease Ivan Kremis (Tomsk, Russian Federation), Ekaterina Bukreeva, Elena Gereng, Ivan Kremis
PA403
Risk factors of poor outcomes after admission for a COPD exacerbations. Multivariate logistic predictive models Juan Luis García Rivero (Mompía (Santa Cruz de Bezana)-Cantabria, Spain), Juan Luis Garcia-Rivero, Cristina Esquinas, Miriam Barrecheguren, Patricia Garcia-Sidro, Elsa Naval, Carlos Martinez, Rosa Malo de Molina, P.J. Marcos, J.M. Diez, Alberto Herrejón, J.A. Ros, Sagrario Mayoralas, Manuel Valle, Marc Miravitlles
PA404
Risk factors of bronchial hyperresponsiveness in COPD Irina Trofimenko (Irkutsk, Irkutsk Oblast, Russian Federation), Irina Trofimenko, Boris Chernyak
PA405
Concurrent validity of screening measures to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease (COPD) Tina Phan (Joondalup, Australia), Tina Phan, Owen Carter, Grant Waterer, Li Ping Chung, Maxine Hawkins, Mel Ziman, Natalie Strobel
PA406
End of life care in oxygen-dependent chronic obstructive pulmonary disease and cancer: A national population based study Zainab Ahmadi (Karlskrona, Sweden), Zainab Ahmadi, Staffan Lunström, Christer Janson, Margareta Emtner, Peter Strang, David Currow, Magnus Ekström
PA407
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Alexander Mackay (London, United Kingdom), Alexander Mackay, Matthew Loza, Patrick Branigan, Siobhan George, Gavin Donaldson, Frederic Baribaud, Jadwiga Wedzicha
PA408
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Mónica Guerrero Perez (Odena, Spain), Monica Guerrero, Ernesto Crisafulli, Adamantia Liapikou, Arturo Huerta, Albert Gabarrus, Nestor Soler, Antoni Torres
PA409
Correction of endothelial dysfunction in patients with COPD and concomitant arterial hypertension Zara Nersesyan (Moscow, Russian Federation), Zara Nersesyan, Svetlana Ovcharenko, Tatyana Morozova
PA410
Influence of hospitalizations because of COPD exacerbation in the six-minute walk test (6MWT) AMAIA ARAMBURU OJEMBARRENA (Galdakao (Bizkaia), Spain), Amaia Aramburu, Amaia Garcia, Cristobal Esteban, Ane Anton, Francisco Javier Moraza, Myriam Aburto, Alberto Capelastegui
Room 7.1
Session 71
10:45 - 12:45
Grand round: Paediatrics - an interactive session Covering typical and difficult clinical questions Aims : To present paediatric cases with respiratory problems and typical and difficult clinical questions. The audience will be engaged in discussions about the best clinical care for these cases and will receive an update in paediatric respiratory medicine. Track(s) : Paediatric Target audience : Paediatricians and, other clinically active colleagues. Chairs : Ernst Eber (Graz, Austria), Paulo Marcio Condessa Pitrez (Porto Allegre, Brazil) 10:45
A child with persistent tachypnoea Monika Gappa (Wesel, Germany)
437
11:15
Digital clubbing in a 5 year-old boy Grazia Fenu (Florence, Italy)
438
11:45
When you hear hoofbeats, think of horses not zebras Sanne Kloosterman (Rotterdam, Netherlands)
439
12:15
A previously uncharacterised cause for a neonate with respiratory distress Colin Wallis (London, United Kingdom)
440
Room 7.2
Session 72
10:45 - 12:45
Session: Obstructive sleep apnoea in adults and children introducing the Cournand Lecture on inflammatory pathway activation by intermittent hypoxia Aims : To discuss how to recognise the child at risk for sleep-disordered breathing and the associated morbidity, summarise the value of polysomnography and other objective methods in determining severity of sleep-disordered breathing, present a stepwise treatment approach and compare diagnosis and management of sleep-disordered breathing in children and adults.
35
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Track(s) : Sleep Target audience : Respiratory physicians with an interest in paediatric OSAS, paediatric respiratory physicians, sleep medicine specialists and general paediatricians. Chairs : Maria Bonsignore (Palermo, Italy), Refika Hamutcu Ersu (Istanbul, Turkey) 10:45
Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea Silke Ryan (Dublin, Ireland)
441
11:25
ERS Statement: Obstructive sleep-disordered breathing in children 2-18 years old. Risk factors, associated morbidity, predictors of persistent disease and assessment of disease severity Athanasios G Kaditis (Athens, Greece)
442
11:52
Obstructive sleep-disordered breathing in children 2-18 years old: indications for treatment, stepwise treatment approach and recognition and management of persistent disease Stijn Verhulst (Antwerp, Belgium)
443
12:19
Diagnosis and management of OSAS in children and adults: similarities and differences Renata L. Riha (Edinburgh, United Kingdom)
444
Room Elicium 2
Session 73
10:45 - 12:45
Symposium: Practising personalised medicine: why, when, and how? Aims : To provide novel clinical insights in personalised medicine strategies for important pulmonary diseases, describe new and promising concepts relating to these diseases for the near future and discuss the impact of these developments on clinical practice and healthcare system finances. Tag(s) : Clinical Target audience : Scientists, clinician-scientists, and pulmonary physicians. Chairs : Catherine Greene (Dublin, Ireland), Claus Vogelmeier (Marburg, Germany) 10:45
COPD: can we improve treatment? Alvar Agusti Garcia-Navarro (Barcelona, Spain)
445
11:15
Asthma: are we already there? Ian Douglas Pavord (Oxford, United Kingdom)
446
11:45
Pneumonia: one size fits all? Bernd Schmeck (Marburg, Germany)
447
12:15
Pulmonary hypertension: what can we learn from studies? Marc Humbert (Paris, France)
448
Room 4.2
Session 74
10:45 - 12:45
Symposium: Air pollution health effects: from epidemiology to controlled human exposure Aims : To update the audience about current environmental epidemiology research (specifically on air pollution) in relation to pulmonary disease and its outcomes, provide a platform for risk assessment related to air pollution levels and pulmonary disease, discuss state-of-theart methods for gene-environment interaction analyses and epigenetics research (methylation in particular), highlight the mechanisms of disease onset and deterioration that were elucidated by controlled human exposure studies and establish an ERS platform for collaborations between epidemiologists, pulmonologists, paediatricians and experimentalists in this research area. Track(s) : Epidemiology/Environment Tag(s) : Translational Target audience : Epidemiologists, public health workers, policy makers, pulmonologists, paediatricians, general practitioners, geneticists, and experimental scientists. Chairs : Stephanie London (Research Triangle Park, United States of America), Valerie Siroux (La Tronche, France) 10:45
Relevance of air pollution exposure and gene-environment interactions in pulmonary disease Torben Sigsgaard (Aarhus, Denmark)
449
11:15
Effects of long-term air pollution exposure on lung function in children and adults Nicole Probst-Hensch (Basel, Switzerland)
450
11:45
Epigenetics and respiratory disease: linking genes and environmental exposure Erik Melén (Stockholm, Sweden)
451
36
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 12:15
Using controlled human exposure studies to elucidate the effects of air pollution on health Chris Carlsten (Vancouver, Canada)
Room 5.2
Session 75
452
10:45 - 12:45
Symposium: Robotics in pulmonology and thoracic surgery Aims : To provide updated information regarding the current and potential role of robotics procedures in treating malignant and nonmalignant disorders. Their advantages over open and VATS procedures will be described along with their limitations vs. classical techniques. Tag(s) : Clinical Target audience : Pulmonologists, surgeons, and thoracic oncologists. Chairs : Gilbert Massard (Strasbourg, France), Didier Lardinois (Basel, Switzerland) 10:45
Robotics in pulmonology and thoracic surgery: what, why, and when? Ralph Alexander Schmid (Bern, Switzerland)
453
11:15
The role of robotics in the treatment of NSCLC Franca Melfi (Pisa, Italy)
454
11:45
Robotic approaches to the anterior mediastinum for thymic diseases Jens C. Rückert (Berlin, Germany)
455
12:15
Robotic vs. open vs. VATS lymphadenectomy: feasibility vs. validity Speaker to be confirmed
456
Room Elicium 1
Session 76
10:45 - 12:45
Hot topics: Comorbidities in COPD and other chronic lung diseases Aims : To describe the importance of recognising and treating comorbidities in chronic lung diseases. Tag(s) : Clinical Target audience : Clinicians. Chairs : Leonardo Michele Fabbri (Modena, Italy), Bartolome R. Celli (Wellesley, United States of America) 10:45
COPD comorbidity networks Miguel Divo (Boston, United States of America)
457
11:15
Asthma: beyond the bronchus Minal R. Patel (Ann Arbor, United States of America)
458
11:45
Comorbidities in cystic fibrosis Barry Plant (Cork, Ireland)
459
12:15
Interstitial lung diseases: the impact of comorbidities Charlotte Hyldgaard (Åbyhøj, Denmark)
460
Room Forum
Session 77
10:45 - 12:45
Hot topics: IPF: an airway-derived disease? and Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award Aims : To describe the brand new findings in the field of IPF and to highlight their clinical implications. Tag(s) : Translational Target audience : Clinicians, scientists, and fellows in training. Chairs : Melanie Koenigshoff (Munich, Germany), Luca Richeldi (Southampton, United Kingdom) 10:45
Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award Antje Prasse (Hannover, Germany), Speaker to be confirmed
461
10:55
Shared pathways of lung development and misled repair during pulmonary fibrosis Speaker to be confirmed
462
11:22
Unexpected contribution of airway-derived epithelial cells to IPF progression Antje Prasse (Hannover, Germany)
463
37
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 11:49
Unexpected results of imaging in IPF Wim Wuyts (Rotselaar, Belgium)
464
12:16
The lessons from IPF clinical trials 1991-2014 Ganesh Raghu (Seattle, United States of America)
465
Room 5.1
Session 78
10:45 - 12:45
Oral Presentation: Adult bronchiectasis: risk factors and future perspectives Chairs : Tobias Welte (Hannover, Germany), Eva Polverino (Barcelona, Spain)
OA466
Idiopathic and post-infective bronchiectasis show no clinically important differences in outcomes or airway inflammatory profiles james hill (Dundee, United Kingdom), James Hill, Duncan Renton, Hani Abo-Leyah, Megan Crichton, Simon Finch, Thomas Fardon, James Chalmers
OA467
Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Melissa McDonnell (Galway, Ireland), Melissa McDonnell, Thomas Fardon, Robert Rutherford, James Chalmers
OA468
Determinants and assessment of excess cardiovascular risk in bronchiectasis Aarash Saleh (London, United Kingdom), Aarash Saleh, Bessie Kwok, Jeremy Brown, John Hurst
OA469
Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis Duncan Renton (Dundee, United Kingdom), Duncan Renton, James Hill, Hani Abo-Leyeh, Simon Finch, Megan Crichton, Thomas Fardon, Alison Dicker, James Chalmers
OA470
Azithromycin therapy and pseudomonas aeruginosa isolation in a non-cystic fibrosis bronchiectasis cohort Philip Mitchelmore (Exeter, United Kingdom), Philip Mitchelmore, Louise Anning, Victoria Carnell, Sarah Jephcote, Pia Charters, Tim Crowe, Christopher Dean, Anna Lowdon, Christopher Sheldon, Nicholas Withers
OA471
A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis Simon Finch (Dunfermline, United Kingdom), Simon Finch, Tom Fardon, Melissa Friel, James Chalmers
OA472
Non-CF bronchiectasis impact on hospital admissions – Need to change the paradigm João Henrique Cordeiro da Costa (Baguim do Monte - Gondomar, Portugal), João Cordeiro da Costa, Regina Monteiro
OA473
Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group Stefano Aliberti (Milan, Italy), Stefano Aliberti, Eva Polverino, Anthony De Soyza, Michael R. Loebinger, Rosario Menendez, Felix C. Ringshausen, Montserrat Vendrell, James D. Chalmers
Room 13.1
Session 79
10:45 - 12:45
Oral Presentation: Physical activity, exercise and rehabilitation in COPD and beyond Chairs : Fabio Pitta (LONDRINA/PR, Brazil), Chris Burtin (Diepenbeek, Belgium) OA474
The likelihood of improving physical activity increases with better functional exercise tolerance in COPD Matthias Loeckx (Leuven, Belgium), Matthias Loeckx, Christian Osadnik, Heleen Demeyer, Chris Burtin, Hans Van Remoortel, Daniel Langer, Wim Janssens, Thierry Troosters
OA475
Physical activity, exercise capacity and psycho-social factors during and after pulmonary rehabilitation in COPD Rita Priori (Cambridge, United Kingdom), Rita Priori, Marian K.J. Dekker, Maurice J.H. Sillen, Chevone M. Barretto, Privender K. Saini, Mareike Klee, Martijn A. Spruit
OA476
Acute physiological effects of partitioning exercise on exercise workload and quadriceps fatigue during resistance exercise in COPD Andre Nyberg (Québec, Canada), André Nyberg, Didier Saey, Mickaël Martin, François Maltais
OA477
Are COPD patients with fatigable quadriceps less physically active? Preliminary results Carlos Augusto Camillo (Leuven, Belgium), Carlos A. Camillo, Christian Osadnik, Chris Burtin, Heleen Demeyer, Miek Hornikx, Wim Janssens, Thierry Troosters
OA478
Effects of post exacerbation pulmonary rehabilitation (PEPR) on exercise tolerance, quality of life (QoL), anxiety, depression and healthcare utilisation Agnieszka Lewko (Croydon, United Kingdom), Agnieszka Lewko, Stephanie K.M. Harlow, Paul MacDonald, Melanie Irvin-Sellers
38
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
OA479
Increased fitness and weight-loss are associated with improvement in daily life physical activity and clinical control in obese asthmatics: A RCT Patricia Freitas (Sao Paulo, Brazil), Patricia D. Freitas, Palmira G. Ferreira, Aline G. Silva, Alberto Cukier, Rafael Stelmach, Regina Carvalho-Pinto, João M. Salge, Marcio C. Mancini, Milton A. Martins, Celso R.F. Carvalho
OA480
The effects of noninvasive positive pressure ventilation on exercise tolerance in hospitalized patients with decompensated heart failure: A randomised cross-over trial Igor Moraes (São Paulo, Brazil), Igor Moraes, Karen Kimoto, Marcos Fernandes, Samantha Grams, Wellington Yamaguti
OA481
Physical activity and sedentary behaviour in survivors of ARDS Jennifer Mackney (Callaghan, Australia), Jennifer Mackney, Sue Jenkins, Daniel Robins, Ken Havill, Megan Harrold, Kylie Hill
Room 2.1
Session 80
10:45 - 12:45
Oral Presentation: Advances in the future treatment of COPD Chairs : Gaetano Caramori (Ferrara, Italy), Irene Heijink (Groningen, Netherlands)
OA482
Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Fernando J. Martinez (Ann Arbor, United States of America), Fernando J. Martinez, Peter M.A. Calverley, Udo-Michael Goehring, Rachel Hodge, Leonardo M. Fabbri, Klaus F. Rabe
OA483
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Naimish Patel (Waltham, United States of America), Naimish Patel, Danen Cunoosamy, Tove Hegelund-Myrback, Rikard Pehrson, Ziad Taib, Paul Jansson, Sofia Lundin, Steven Greenaway, Graham Clarke, Leonard Siew
OA484
Favorable human safety, pharmacokinetics and pharmacodynamics of the autotaxin inhibitor GLPG1690, a potential new treatment in COPD Ellen van der Aar (Mechelen, Belgium), Ellen Van der Aar, Liesbeth Fagard, Julie Desrivot, Sonia Dupont, Bertrand Heckmann, Roland Blanque, Lien Gheyle, Jovica Ralic, Frédéric Vanhoutte
OA485
TSPO a new anti-inflammatory target in the airway of COPD Romain JEAN (Montpellier, France), Romain Jean, Estelle Bribes, Lucie Knabe, Aurélie Fort-Petit, Isabelle Vachier, Pascal Chanez, Arnaud Bourdin
OA486
Targeted silencing of master transcription factor SPDEF to reduce mucus production in airway diseases by epigenetic editing Juan Song (Groningen, Netherlands), Juan Song, Karolin Meyer, Loes E.M. Kistemaker, Reinoud Gosens, Pieter S. Hiemstra, Marianne Rots, Machteld Hylkema
OA487
Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation Samuel C M Yeo (London, United Kingdom), Samuel C.M. Yeo, Peter S. Fenwick, Peter J. Barnes, Louise E. Donnelly
OA488
Mitochondrial reactive oxygen species and glycolysis in airway smooth muscle cell proliferation in COPD Charalambos Michaeloudes (London, United Kingdom), Charalambos Michaeloudes, Paul Kirkham, Ian M. Adcock, Kian Fan Chung
OA489
Carbocisteine attenuates influenza virus A replication in the bronchoalveolar lavage fluids of virus-infected mice Shuichiro Maruoka (Tokyo, Japan), Shuichiro Maruoka, Sotaro Shikano, Yasuhiro Gon, Kazumichi Kuroda, Kaori Soda, Eriko Tsuboi, Ikuko Takeshita, Kazufumi Shimizu, Shu Hashimoto
Room 4.1
Session 81
10:45 - 12:45
Oral Presentation: Chest ultrasonography: an imaging modality with hidden features Chairs : Cedric Van Holsbeke (Kontich, Belgium), Chair to be confirmed OA490
The role of three-dimensional ultrasonography in the evaluation of pleural effusions Coskun Dogan (Istanbul, Turkey), Coskun Dogan, Tolga Sinan Güvenc, Gulsen Cigsar
OA491
Correlation of pleural effusions’ grayscale sonographic parameters with fluid’s analysis results Alexander Kalkanis (Kalampaka, Greece), Alexandros Kalkanis, Charalampos Varsamas, Theodora Kerenidi, Konstantinos Gourgoulianis, Zoe Daniil
OA492
Sensitivity of chest ultrasound in the detection of pneumonia in children Vojko Berce (Murska Sobota, Slovenia), Vojko Berce, Natalija Podgoršek, Anja Pintaric, Matjaž Homšak, Maja Tomazin, Brigita Koren
39
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
OA493
A combination of the Wells score with multiorgan ultrasound to stratify patients with suspected pulmonary embolism Argyro Chatziantoniou (Heraklion, Crete, Greece), Argyro Chatziantoniou, Peiman Nazerian, Simone Vanni, Chiara Gigli, Giuseppe Francesco Sferrazza Papa, Emanuela Gambetta, Mattia Tullio, Stefano Centanni, Giovanni Volpicelli
OA494
Lung ultrasound as first line imaging tool in pregnant women with respiratory symptoms Fabiano Di Marco (Trezzano, Italy), Fabiano Di Marco, Maria Adelaide Roggi, Silvia Terraneo, Giulia Michela Pellegrino, Rocco Francesco Rinaldo, Giuseppina Palumbo, Gianluca Imeri, Stefano Centanni
OA495
To demonstrate if in the emergency department the study of diaphragmatic motility with Ultrasound is useful for patients in respiratory distress (ARF) Lucia Morelli (Naples, Italy), Lucia Morelli, Mario Guarino, Fabio Numis, Rosario Zappalà, Ilario De Sio, Antonio Schiazzano, Biagio Liccardo, Alberto Forni, Francesca Martone
OA496
Accuracy of lung ultrasound in pleuritic chest pain: Preliminary data of a multicentric study Argyro Chatziantoniou (Heraklion, Crete, Greece), Argyro Chatziantoniou, Giuseppe Francesco Sferrazza Papa, Stefano Centanni, Peiman Nazerian, Michele Mondoni, Fabiano Di Marco, Silvia Terraneo, Giulia Pellegrino, Mariano Scozzafava, Sara Martinenghi, Mattia Tullio, Martina Piluso, Francesco Blasi, Giovanni Volpicelli
OA497
Pleural elastography. Evaluation of pulmonary lesions in the intensive care unit Delgado-Cidranes Ernesto (Madrid, Spain), Delgado-Cidranes Ernesto, Tirado-Conde Gema, Fernandez-Vaquero Miguel Angel, Estrada-Blanco Zuramis
Room Emerald
Session 82
10:45 - 12:45
Oral Presentation: Noninvasive ventilation in acute respiratory failure: the recipe for success Chairs : Raffaele Scala (Arezzo, Italy), Chair to be confirmed OA498
LATE-BREAKING ABSTRACT: A parametric procedure to compare domiciliary ventilator performances Emeline Fresnel (Saint Etienne du Rouvray, France), Emeline Fresnel, Jean-Francois Muir, Christophe Letellier
OA499
Randomised crossover trial of a pressure sensing visual feedback system to improve mask fitting in non-invasive ventilation (NIV) Anne-Kathrin Brill (Bern, Switzerland), Anne-Kathrin Brill, Mohammad Moghal, Mary Morrell, Anita K. Simonds
OA500
Hemodynamic consequences of NIV during acute respiratory failure. A prospective echocardiographic study Bouchra Lamia (Rouen, France), Bouchra Lamia, Stephanie Van Mossevelde, Luis-Carlos Molano, Antoine Cuvelier, JeanFrancois Muir
OA501
Respiratory intermediate care units: Noninvasive ventilation for severe acidotic patients Juan Fernando Masa Jiménez (Cáceres, Spain), Juan F. Masa, Isabel Utrabo, Javier Gómez de Terreros, Myriam Aburto, Cristóbal Esteban, Enric Prats, Belen Nuñez, ángel Ortega-González, Luis Jara-Palomares
OA502
Non invasive spontaneous dual ventilation in critically ill patients with chronic obstructive pulmonary disease Khaled Hussein (Assiut, Egypt), Khaled Hussein
OA503
Real-time measurement of transcutaneous PCO2 vs arterial/venous PCO2 in subjects with severe respiratory failure undergoing non-invasive ventilation on the emergency department – An observational study Christian Horvath (St. Gallen, Switzerland), Christian Horvath, Martin Brutsche, Florent Baty, Jochen Rüdiger
OA504
Relationship between f/VT ratio and acute respiratory acidosis in patients submitted to noninvasive mechanical ventilation (NPPV) Antonio Sircana (Turin, Italy), Sircana Antonio, Federica Ghione, Marta Moro, Fabrizio Bottino, Nicola Glorioso, Giorgio Carbone, Benato Maria Francesca, Purro Andrea
OA505
Better comfort and dyspnea scores with high-flow nasal cannula (HFNC) vs standard oxygen (SO) during breaks off noninvasive ventilation (NIV) Giulia Spoletini (Milan, Italy), Giulia Spoletini, Chiara Mega, Alia Khoja, Mona Alotaibi, Francesco Blasi, Stefano Nava, Nicholas Hill
Room E104-106
Session 83
10:45 - 12:45
Poster Discussion: Functional and imaging techniques for assessing lung, airway and respiratory muscles Chairs : Andrea Aliverti (Milan, Italy), Wilfried De Backer (Edegem (Antwerp), Belgium) PA506
Validating a new and comfortable method of visualizing lung ventilation in animals Volker Gross (Giessen, Germany), Oskar Seifert, Andreas Weissflog, Martin Kramer, Keywan Sohrabi, Volker Gross
40
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA507
Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Jan De Backer (Kontich, Belgium), Jan De Backer, Wim Vos, Cedric Van Holsbeke, Francisca Ferreira, Samir Vinchurkar, Bita Hajian, Wilfried De Backer
PA508
Impulse oscillometry measurements in adult patients with CF: Focus on reactance Waldemar Tomalak (Rabka-Zdroj, Poland), Waldemar Tomalak, Tomasz Piorunek, Joanna Gozdzik-Spychalska, Andrzej Pogorzelski, Magdalena Kostrzewska, Halina Batura-Gabryel
PA509
A model of extravascular lung water control Enrico Mazzuca (Ascoli Piceno, Italy), Enrico Mazzuca, Andrea Aliverti, Giuseppe Miserocchi
PA510
Identification of distinct ciliary beat pattern abnormalities by high-speed video microscopy in primary ciliary dyskinesia Johanna Raidt (Münster, Germany), Johanna Raidt, Julia Wallmeier, Rim Hjeij, Jörg Große-Onnebrink, Heike Olbrich, Niki T. Loges, Petra Pennekamp, Gerard Dougherty, Karsten Häffner, Heymut Omran, Claudius Werner
PA511
Disruption of tidal breathing in COPD by use of pneumotachograph and mouthpiece compared to non-contact measurement with structured light plethysmography (SLP) Pierantonio Laveneziana (Paris, France), Pierantonio Laveneziana, Claudia Llontop, Marie-Cecile Nierat, Agnès Bellocq, Christian Straus, Thomas Similowski
PA512
COPD phenotypes by high resolution computed tomography (HRCT) and ventilatory response to exercise Veronica Alfieri (Parma, Italy), Veronica Alfieri, Gianluca Milanese, Panagiota Tzani, Marina Aiello, Mario Silva, Nicola Sverzellati, Emilio Marangio, Alfredo Chetta
PA513
Evaluation of novel parameters of ventilation heterogeneity in asthma Sushiladevi Natarajan (Leicester, United Kingdom), Sushiladevi Natarajan, Marcia Soares, Sherif Gonem, John OwersBradley, Salman Siddiqui
PA514
Temporal variations of oscillometric reactance in COPD and ILD Thomas Schuessler (Montreal, Canada), Thomas Schuessler, Guy Drapeau, Geoffrey Maksym
PA515
Regional lung sound asynchrony in COPD patients Masamichi Mineshita (Kawasaki, Japan), Masamichi Mineshita, Hirotaka Kida, Hiroshi Handa, Hiroki Nishine, Naoki Furuya, Takeo Inoue, Shin Matsuoka, Teruomi Miyazawa
PA516
The value of diffusing capacity for nitric oxide and carbon monoxide in sickle cell disease Arnaud Chambellan (Nantes, France), Arnaud Chambellan, Stephanie Dirou, Berangere Ricolleau, Julie Graveleau, Agathe Masseau
PA517
Repeatability of 129Xe MR methods for quantification of interstitial thickness Neil Stewart (Sheffield, United Kingdom), Neil J. Stewart, Helen Marshall, Jim M. Wild
PA518
Can the intra-test variability of the single breath transfer factor of carbon monoxide method (TLCOsb) be improved to less than 5%? Patrick Flood-Page (Cardiff, United Kingdom), Stuart Marks, Rhys Jefferies, Patrick Flood-Page
PA519
A novel approach to evaluate trunk geometric-motion during rest and with postural changes Desiderio Cano Porras (Sao Paulo, Brazil), Desiderio C. Porras, Tyler Saumur, Polyana Mendes, Henrique T. Moriya, Karl Zabjek, Celso R.F. Carvalho, Dina Brooks, Sunita Mathur
PA520
Resonant frequency as a predictor of phase III slope of nitrogen single-breath washout in asthma Toshihiro Shirai (Shizuoka, Japan), Toshihiro Shirai, Kazutaka Mori, Tomoyoshi Tsuchiya, Masashi Mikamo, Takahito Suzuki, Eisuke Mochizuki, Shogo Sakurai, Taisuke Akamatsu, Satoru Morita, Kazuhiro Asada, Takafumi Suda
PA521
Single breath washout as alternative to multiple breath washout in patients with primary ciliary dyskinesia (PCD)? Sylvia Nyilas (basel, Switzerland), Sylvia Nyilas, Anne Schlegtendal, Sophie Yammine, Carmen Casaulta, Philipp Latzin, Cordula Koerner-Rettberg
PA522
Chest wall kinematics during exercise in patients with asthma Guilherme Fregonezi (Rio Grande do Norte, Brazil), Guilherme Fregonezi, Matheus Larcerda, Janaina Pinto, Antonela Lo Mauro, Vanessa Resqueti, Andrea Aliverti
PA523
Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD Shima Rafie (Pune, India), Shima Rafiei, Subhabrata Moitra, Bill Brashier, Sundeep Salvi, Sadhu Naik, Mohan Kulkarni
Room G102-103
Session 84
10:45 - 12:45
Poster Discussion: Biomarkers, immunology and molecular pathology of lung cancer Chairs : Lars Schmidt (Münster, Germany), Fernando Gamarra (Straubing, Germany)
41
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA524
Early response detection in systemic lung cancer treatment using cell-free methylated SHOX2 (mSHOX2) plasma DNA Bernd Schmidt (Halle, Germany), Bernd Schmidt, Julia Beyer, Dimo Dietrich, Nina Lambrecht, Michael Fleischhacker
PA525
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Elena Karampini (London, United Kingdom), Elena Karampini, Hassan Farah, Nahid Kamal, Paul Cane, Jane Moorhead, Sabine Pomplun, Juliet King, Tariq Sethi, James Spicer, Frank McCaughan
PA526
In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients Bernd Schmidt (Halle, Germany), Michael Fleichhacker, Hubertus Rolke, Clemens Oerding, Gerit Theil, Bettina Wollschläger, Bernd Schmidt
PA527
Peripheral blood lymphocytes indicate an immunosuppressive status in lung cancer María del Mar Valenzuela-Membrives (Granada, Spain), María del Mar Valenzuela Membrives, Abel Sanchez- Palencia Ramos, Francisco Perea García, Francisco Ruiz Cabello, Antonio Rodríguez, María Esther Farez Vidal
PA528
Comparative analysis of lymphoid subsets in peripheral blood and tumor-infiltrating lymphocytes of lung cancer patients María del Mar Valenzuela-Membrives (Granada, Spain), María del Mar Valenzuela- Membrives, Abel Sanchez- Palenci a- Ramos, Francisco Perea- García, Francisco Ruiz-Cabello, Pilar Jimenez, María Esther Farez-Vidal
PA529
Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation Vassiliki Karavana (Athens, Greece), Vassiliki Karavana, Giorgos Kazamias, Anna Panagiotou, Aggeliki Louka, Dimitra Kerdidani, Keli Antonogiannaki, Vassiliki Filaditaki, Charis Roussos, Dimitra Rontogianni, Spyros Zakynthinos, Filio Diamantea, Maria Tsoumakidou
PA530
Lung cancer immune cells exhibit inhibited inflammasome response Aikaterini D. Samara (Athens, Greece), Katerina D. Samara, Ismini Lasithiotaki, Eliza Tsitoura, Ioannis Giannarakis, Anna Psaraki, Eleni Bibaki, Irini Lambiri, Nikolaos Siafakas, Katerina M. Antoniou
PA531
Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer Jurgita Jackute (Kaunas, Lithuania), Jurgita Jackute, Marius Zemaitis, Darius Pranys, Brigita Sitkauskiene, Skaidrius Miliauskas, Raimundas Sakalauskas
PA532
CTLA-4 on regulatory T cells - Regulation of local immune response in lung cancer Iwona Osinska (Warszawa, Poland), Iwona Osinska, Anna Stelmaszczyk-Emmel, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik
PA533
Determination of antibodies against the red meat derived antigen Neu5Gc in patients with lung cancer. Probable association with disease development and progress Kelly Domvri (Thessaloniki, Greece), Konstantinos Zarogoulidis, Phaedra Eleftheriou, Kalliopi Domvri, Chrisanthi Chadziyianni, Christos Petrou, Konstantinos Barsamidis, Kyriaki Savidou, Spyridoula Tsitlakidou
PA534
MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma Elisa Lappi-Blanco (Oulu, Finland), Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson, Riitta Mäkitaro, Risto Bloigu, Siri Lehtonen, Timo Väisänen, Riitta Kaarteenaho
PA535
Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer patients Harry Gosker (Maastricht, Netherlands), Harry Gosker, Celine Op den Kamp, Marco Kelders, Annemarie Dingemans, Ramon Langen, Annemie Schols
PA536
Hypoxia-response gene signatures as predictive and prognostic biomarkers in advanced non-squamous non-small cell lung cancer patients Anca Franzini (St Gallen, Switzerland), Anca Franzini, Florent Baty, Martin Brutsche
PA537
Comprehensive evaluation of nuclear factorexpression patterns in non-small cell lung cancer Ioanna Giopanou (Rio, Patras, Greece), Ioanna Giopanou, Ioannis Lilis, Vassilios Papaleonidopoulos, Georgios Stathopoulos
PA538
Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules Piotr Kopinski (Bydgoszcz, Poland), Maciej Gawronski, Piotr Kopinski, Marek Jankowski, Arkadiusz Goede, Adam Szpechcinski, Joanna Chorostowska
PA539
EGFR mutations determine EGFR-MET crosstalk and MET inhibition in lung cancer Richard Lee (London, United Kingdom), Richard Lee, Elena Ortiz-Zapater, Gregory Weitsman, Gilbert Fruhwirth, Will Owen, Tony Ng, George Santis
42
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA540
MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance Giulia Stella (Pavia, Italy), Giulia Stella, Rebecca Senetta, Michele Zorzetto, Simona Inghilleri, Ludovica Verdun Di Cantogno, Paolo Comoglio, Paola Cassoni, Federica Meloni
PA541
P53 codon 72, GSST1, GSTM1 and CCR5del32 genetic polymorphism: Evidence of correlation between asthma and lung cancer Mariia Vasileva (Tomsk, Russian Federation), Mariia V. Vasileva, Nadejda V. Cherdyntseva, Polina A. Gervas, Valentina A. Belyavskaya, Vladimir V. Klimov
Room G104-105
Session 85
10:45 - 12:45
Poster Discussion: Latest insights into pulmonary rehabilitation Chairs : Sally J. Singh (Leicester, United Kingdom), Richard Zuwallack (Hartford, United States of America) PA542
Biofeedback for improving the effectiveness of pulmonary rehabilitation exercise in patients with chronic obstructive pulmonary disease Yu-Ju Chen (Taipei, Taiwan), Yu-Ju Chen, Liang-Hui Huang, Wann-Cherng Perng
PA543
Effects of introduction of obesity-specific interventions in a state-of-the-art pulmonary rehabilitation programme Paula Van Melick (Horn, Netherlands), Paula Van Melick, Frits Franssen, Inge Martens, Martijn Spruit, Emiel Wouters, Erica Rutten
PA544
Effects of routine inspiratory muscle training (IMT) as add-on to pulmonary rehabilitation (PR) in COPD Konrad Schultz (Bad Reichenhall, Germany), Konrad Schultz, Benjamin Krämer, Sebastian Fuchs, Silke Wingart, Nicola Lehbert, Veronika Huber, Dragan Stojanovic, Michael Wittmann, Danijel Jelusic, Michael Schuler
PA545
Exercise intensity during rehabilitation classes: Pulmonary, cardiac and heart failure. How does it compare to maximum capacity? Linzy Houchen-Wolloff (Oakham, United Kingdom), Linzy Houchen-Wolloff, Amye Watt, Sally Boyce, Sally Singh
PA546
Impact of pulmonary rehabilitation on cough and sputum symptom perception in patients with COPD Graziele Sobrinho (Southampton, United Kingdom), Graziele Coissi Sobrinho, Teresa James, Zoe Pond, Lindsay Welch, Susan Batchelor, Rhona Copp, Helen Potterton, Tracy Nash, Thomas Havelock, Tom M. Wilkinson
PA547
Quality of life (QoL) and dyspnea of COPD patients one year after a 3-week inpatient pulmonary rehabilitation (PR) Konrad Schultz (Bad Reichenhall, Germany), Konrad Schultz, Danijel Jelusic, Michael Wittmann, Michael Schuler
PA548
Effect of isolated pulmonary rehabilitation vs. associated with a specific protein supplement on exercise test in patients with bronchiectasis: A randomized study Luis Fernandez de Rota Garcia (Marbella (Malaga), Spain), Casilda Olveira, Luis Fernandez de Rota Garcia, Esperanza Doña Diaz, Francisco Javier Palenque Lobato, Nuria Porras Perez, Antonio Dorado Galindo, Rocio Martin Valero, Ana Maria Godoy, Gabriel Olveira
PA549
The role of interactive game-based system in pulmonary rehabilitation of patients with COPD Dewi Makhabah (Yogyakarta, Indonesia), Dewi Makhabah, Suradi Suradi, Muchsin Doewes
PA550
Effect of psychological factors on exercise capacity (EC) and health-related quality of life (HRQL) in COPD undergoing pulmonary rehabilitation (PR) Culadeeban Ratneswaran (London, United Kingdom), Culadeeban Ratneswaran, John Weinman, Nicholas Hart
PA551
Does carbon monoxide diffusing capacity (DLCO) effect results of pulmonary rehabilitation? Ilknur Naz (Izmir, Turkey), Hulya Sahin, Ilknur Naz, Nimet Aksel, Fevziye Tuksavul, Ayse Ozsoz
PA552
Can we identify patients that recover strength following hospitalisation for an acute exacerbation of chronic respiratory disease? Emma Chaplin (Leicester, United Kingdom), Emma Chaplin, Neil Greening, Emma Vincent, Theresa Harvey-Dunstan, Fayyaz Hussain, Johanna Williams, Mike Morgan, Mick Steiner, Sally Singh
PA553
How does regular exercise affect dyspnoe (TDI) and quality of life (CAT) of COPD-patients 1 year after an inpatient pulmonary rehabilitation (PR)? Danijel Jelusic (Bad Reichenhall, Germany), Danijel Jelusic, Michael Wittmann, Michael Schuler, Konrad Schultz
PA554
Mucociliary clearance and regular exercise: Responses of the nasal mucociliary transport of subjects with COPD Gabriel Brígida (Presidente Prudente, Brazil), Gabriel Brígida, Ercy Ramos, Renata David, Iara Trevisan, Marceli Leite, Bruna Spolador, Giovana Arévalo, Ana Freire, Juliana Uzeloto, Fabiano Lima, Dionei Ramos
PA555
The effect of outpatient pulmonary rehabilitation on COPD assessment test (CAT) and GOLD classification – A retrospective data analysis Stephanie Falschlehner (Großwetzdorf, Austria), Stephanie Falschlehner, Milos Petrovic, Elisabeth Czuchajda, Branko Ott, Angelika Forster, Anneliese Berger, Miriam Subhieh, Doris Schindler, Irmgard Derka, Ralf Harun Zwick
43
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA556
CAT and pulmonary rehabilitation: Where is the gain? Marilyn Houle Péloquin (Montreal, Canada), Marilyn Houle Péloquin, Mélina Lalande Gauthier, Benoit Sauvageau, Claude Poirier
PA557
Impact and benefits of pulmonary rehabilitation delivered in the primary care setting Mohit Bhutani (Edmonton, Canada), Mohit Bhutani, Colleen Makarowski, Kirsten Goddard, Tye Babb, Jessica Schaub
PA558
The patient perspective on challenges to participating in pulmonary rehabilitation: An international web-based survey Sarah Masefield (Sheffield, United Kingdom), Sarah Masefield, Pippa Powell, Carolyn Rochester, Giannis Vogiatzis
PA559
The EQ5D5L in COPD: Validity, responsiveness and minimum important difference (MID) Claire Nolan (Guildford, United Kingdom), Claire M. Nolan, Louise Longworth, Joanne Lord, Jane L. Canavan, Sarah E. Jones, Amy L. Clark, Faiza Chowdhury, Samantha S.C. Kon, William D.C. Man
Room G106-107
Session 86
10:45 - 12:45
Poster Discussion: The relevance of diagnostic and monitoring tools in clinical practice Chairs : Daiana Stolz (Basel, Switzerland), Stefan Krueger (Düsseldorf, Germany) PA560
LATE-BREAKING ABSTRACT: MERS-CoV screening for Indonesian Hajj pilgrims returning home from Mecca Muhammad Amin (Surabaya, Indonesia), Muhammad Amin, Arief Bakhtiar, Marwan
PA561
LATE-BREAKING ABSTRACT: Molecular diagnostics in the bronchoalveolar lavage in a large cohort of immunocompromised patients Daiana Stolz (Basel, Switzerland), Daiana Stolz, Reno Frei, Kathleen Jahn, Romana Calligaris-Maibach, Norina Reifer, Lilian Junker, Michael Tamm
PA562
LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Aliae AR Mohamed-Hussein (Assiut, Egypt), Aliae Mohamed-Hussein, Waleed Gamal Eldin, Mohamed Salah, Amal Abdellah, Aamaa Mohamed
PA563
LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study Viktoriya (known as Victoria) Kim (Winchester, United Kingdom), Viktoriya L. Kim, Ngaire A. Coombs, Karl J. Staples, Nicholas P. Williams, Kristoffer Ostridge, Malwina M. Wojtas, Mathieu Peeters, Emmanuel Aris, Jeanne-Marie Devaster, Simon C. Bourne, Tom M. Wilkinson
PA564
Chlamydophila pneumoniae was rarely detected in bronchoalveolar lavage fluid in patients with bacterial pneumonia using molecular methods Shingo Noguchi (Kitakyushu, Japan), Shingo Noguchi, Kazuhiro Yatera, Toshinori Kawanami, Kazumasa Fukuda, Kei Yamasaki, Keisuke Naito, Kentarou Akata, Hiroshi Ishimoto, Hatsumi Taniguchi, Hiroshi Mukae
PA565
Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort Nicholas Williams (Romsey, United Kingdom), Nicholas Williams, Kris Ostridge, Victoria Kim, Malwina M. Wojtas, Stephen Harden, Emmanuel Aris, Mathieu Peeters, Jeanne-Marie Devaster, Simon Bourne, Tom Wilkinson
PA566
The detection of free-living H. influenzae in the airways of patients with COPD Samantha Thulborn (Carterton, United Kingdom), Samantha Thulborn, Jennifer Cane, Alessandro Ceroni, Christopher Brightling, Ian Pavord, Mona Bafadhel
PA567
Increased total, secretory and NTHi-specific IgA in the COPD airway Karl J. Staples (Southampton, United Kingdom), Karl J. Staples, Stephen Taylor, Steve Thomas, Kristoffer Ostridge, Alice Richardson, Andrew C. Tuck, Stuart C. Clarke, Andrew Gorringe, Tom M.A. Wilkinson
PA568
Absence of human rhinovirus and respiratory syncytial virus in the lungs of patients with stable chronic obstructive pulmonary disease Styliani Giannakaki (Athens, Greece), Styliani Giannakaki, Lida Politi, Andriana Papaioannou, Nikolaos Spanakis, Georgios Arsenis, Vasiliki Filaditaki, Spyridon Zakynthinos, Napoleon Karagiannidis, Athanasios Tsakris
PA569
Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Satoshi Okamori (Tenri, Nara, Japan), Satoshi Okamori, Eisaku Tanaka, Nobuyoshi Hamao, Yuto Yasuda, Takashi Inao, Chie Morimoto, Ikkou Yasuda, Yusuke Kaji, Takehiro Yasuda, Seishu Hashimoto, Takashi Hajiro, Yoshio Taguchi
PA570
Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients Naseh Sigari (Sanandaj, Islamic Republic of Iran), Shilan Mohammadi, Soheila Khalilzadeh, Koroush Goudarzipour, Maryam Hassanzad, Alireza Mahdaviani, Nahid Aarabi, Mahin Pourabdollah, Naseh Sigari
44
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA571
Fungal PCR in the bronchoalveolar lavage for diagnosing invasive fungal disease Kristina Affolter (Aarau, Switzerland), Kristina Affolter, Kathleen Jahn, Elisabeth Wehrle-Wieland, Daniel Goldenberger, Michael Tamm, Nina Khanna, Daiana Stolz, Jörg Halter, Jakob Passweg
PA572
Clinical utility of quantitative cytomegalovirus detection in bronchial washing fluid in patients with hematologic malignancies Hwa Young Lee (Seoul, Republic of Korea), Hwa Young Lee, Joon Young Choi, Hea Yon Lee, Chin Kook Rhee, Dong Gun Lee
PA573
Computed tomography assessment of response to treatment in chronic pulmonary aspergillosis Cendrine Godet (Poitiers, France), Cendrine Godet, François Laurent, Anne Bergeron, Catherine Begeilman, Christophe Pison, Vincent Cottin, Patrick Germaud, Bruno Philippe, Boubou Camara, Cécile Toper, Guillaume Beraud, France Roblot, Jacques Cadranel
PA574
Model of diagnosis scoring, clinical and molecular profile of invasive pulmonary aspergillosis (IPA) in ICU patients Anna Roza (Jakarta, Indonesia), Anna Rozaliyani, Anwar Jusuf, Joedo Prihartono, Jacques Meis, Retno Wahyuningsih
PA575
Diagnostic value of pneumocystis-PCR in bronchoalveolar lavage in a clinical setting Markus Unnewehr (Dortmund, Germany), Markus Unnewehr, Felix Luecker, Patricia Bartsch, Bernhard Schaaf
PA576
Risk factors of pneumocytis pneumoniae in solid tumours: A case-control study Marine Desseigne (Lyon, France), Marine Desseigne, Virginie Avrillon, Anne Lise Bienvenu, Stéphane Picot, Jean Yves Blay, Sylvie Chabaud, Maurice Pérol
PA577
Cross-boarder surveillance of enterovirus-D68 in Europe during the 2014 North-American outbreak Coretta Van Leer (Groningen, Netherlands), Coretta Van Leer, Isabelle Schuffenecker, Randy Poelman, Laurence Josset, Hubert Niesters, Bruno Lina
Room 13.2
Session 87
10:45 - 12:45
Poster Discussion: Pulmonary hypertension: rare and hereditary causes of PAH Chairs : David Montani (Le Kremlin-Bicêtre, France), Paul Corris (Newcastle-upon-Tyne, United Kingdom) PA578
LATE-BREAKING ABSTRACT: The effect of volume overload on pulmonary hypertension in hemodialysis patients Süreyya Yilmaz (Diyarbakir, Turkey), Süreyya Yilmaz, Yasar Yildirim, Mahsuk Taylan, Melike Demir, Zülfükar Yilmaz, Aliveysel Kara, Fatma Aydin, Hadice Selimoglu Sen, Aziz Karabulut, Fusun Topcu
PA579
Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network Sven Günther (Le Kremlin-Bicêtre, France), Sven Günther, Frédéric Perros, Benoit Ranchoux, Laurent Godinas, Fabrice Antigny, Marie-Camille Chaumais, Peter Dorfmüller, Aurélie Hautefort, Nicolas Raymond, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani
PA580
Characteristics and outcomes of heritable pulmonary veno-occlusive disease due to EIF2AK4 mutations David Montani (Le Kremlin-Bicêtre, France), David Montani, Barbara Girerd, David Amar, Xavier Jais, Laurent Savale, Peter Dorfmuller, Jérome Lepavec, Mélanie Eyries, Florent Soubrier, Olivier Sitbon, Gérald Simonneau, Marc Humbert
PA581
Chemotherapy-induced pulmonary hypertension: Role of alkylating agents Frederic Perros (le Plessis-Robinson, France), Benoit Ranchoux, Sven Günther, Rozenn Quarck, Marie-Camille Chaumais, Peter Dorfmüller, Fabrice Antigny, Sébastian J. Dumas, Nicolas Raymond, Edmund Lau, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Gérald Simonneau, Kurt Stenmark, Sylvia Cohen-Kaminsky, Marc Humbert, David Montani, Frédéric Perros
PA582
Pulmonary arterial lesions and interstitial remodeling patterns in histology differentiate EIF2AK4 mutation-carriers from non-carriers with pulmonary veno-occlusive disease Esther Jeritza Nossent (Amsterdam, Netherlands), Esther Nossent, David Montani, Barbara Girerd, Frederic Perros, Florent Soubrier, Eli Fadel, Katrien Grünberg, Harm Jan Bogaard, Gerald Simonneau, Anton Vonk Noordegraaf, Marc Humbert, Peter Dorfmüller
PA583
microRNA profile in COPD patients with and without pulmonary hypertension Matthias Brock (Schlieren, Switzerland), Dinah Hertig, Caroline Leuenberger, Thomas Rechsteiner, Alex Soltermann, Silvia Ulrich, Walter Weder, Malcolm Kohler, Lars Huber, Matthias Brock
PA584
Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells Laura Moreno (Madrid, Spain), Daniel Morales-Cano, Bianca Barreira, Virginia Chamorro, Rachele Pandolfi, Beatriz De Olaiz Navarro, Andrés Esteban, Julio Cortijo, ángel Cogolludo, Laura Moreno, Francisco Pérez-Vizcaíno
45
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA585
Children’s genetic screening in hereditary haemorrhagic telangiectasia - Read more: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3266 Ralph Epaud (Créteil, France), Ralph Epaud, Nurcan Soysal, Suzanne Verlhac, Melanie Eyrie, Marie-France Carette
PA586
Epigenetic signature of right ventricular failure in pulmonary arterial hypertension François Potus (Quebec, Canada), Francois Potus, Evangelos Michelakis, Steeve Provencher, Sébastien Bonnet
PA587
Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Nuria Coll Bomfill (Barcelona, Spain), Nuria Coll-Bonfill, Melina Mara Musri, Nicholas Strieder, Jessica Garcia-Lucio, Isabel Blanco, Roberto Del pozo, Cristina Bonjoch, Victor Peinado, Joan Albert Barbera
PA588
Cigarette smoking alters microRNA expression profiling and contributes to pulmonary artery remodeling via targeting connective tissue growth factor Ran Wang (Hefei, China), Ran Wang, Gengyun Sun, Sijing Zhou
PA590
Functional analysis of the 5´UTR region of BMPR2 gene in pulmonary arterial hypertension Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Sheila Castro-Sánchez, Adolfo Baloira, Diana Valverde
PA591
Pulmonary arterial hypertension associated to HIV. Our experience Daniela Gonzalez Marcano (Alicante, Spain), Daniela González Marcano, Rafael León Allocca, Joan Gil Carbonell, Raquel García Sevila, Concepción Martinez Serrano
PA592
Elucidating signalling pathways in pulmonary hypertension using a microRNA knockout mouse model – In vitro and in vivo data Neil McGlinchey (Clydebank, United Kingdom), Neil McGlinchey, Victor Samillan, Mariola Kurowska-Stolarska, Charles McSharry, Margaret Nilsen, Mandy MacLean, Andrew Peacock, David Welsh
PA593
Functional characterization of BMPR2 gene in pulmonary arterial hypertension Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Vincenzo Lupo, María álvarez-Satta, Adolfo Baloira, Carmen Espinós, Diana Valverde
PA594
HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut Tasnime Issoufaly (Paris, France), Tasnime Issoufaly, David Zucman, Mehdi Ellouze, Sophie Hüe, Jean-Daniel Lelievre, Louis-Jean Couderc, Philippe Devillier, Veronique Godot, Colas Tcherakian
Room E102
Session 88
10:45 - 12:45
Poster Discussion: Exploring mechanisms in obstructive airway diseases Chairs : Alyn Hugh Morice (Cottingham, United Kingdom), Stylianos Loukides (Voula, Athens, Greece)
PA595
Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma Anastasia Papaporfyriou (Mandra, Greece), Anastasia Papaporfyriou, Petros Bakakos, Konstantinos Kostikas, Georgios Papatheodorou, Philip Emmanouil, Konstantina Kontogianni, Elissavet Konstantellou, Georgios Hillas, Patroklos Katafygiotis, Rodoula Trigidou, Nikolaos Koulouris, Spyridon Papiris, Stelios Loukidis
PA596
Immunocytochemistry evaluation of FKBP51 in induced sputum cells as a biomarker of glucocorticoid therapy in asthma Mihaela Zidarn (Golnik, Slovenia), Mihaela Zidarn, Susan Wilson, Peter Howarth
PA597
The airway microbiota is significantly altered in asthma patients with airway hyperresponsiveness to mannitol Asger Sverrild (Copenhagen, Denmark), Asger Sverrild, Pia Kiilerich, Celeste Porsbjerg, Anders Bergqvist, Jonas Erjefält, Karsten Kristiansen, Vibeke Backer
PA598
Rapamycin protects OVA induced asthma in mice through regulating autophagy Dong Yang (Shanghai, China), Dong Yang, Yan Mou, Ling Ye, Meiling Jin, Chunxue Bai
PA599
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Clair Barber (Southampton, United Kingdom), Clair Barber, Laurie Lau, Scott Elliott, Jon Ward, Kerry Gove, Tom Brown, Hitasha Rupani, Tim Hinks, Ratko Djukanovic, Ramesh Kurukulaaratchy, Anoop Chauhan, Karl J. Staples, Peter Howarth
PA600
Measuring differences in respiratory muscle activity in healthy and dyspnoeic children and determining the effect of salbutamol by surface electromyography (EMG) Anne Floor Brunger (Groningen, Netherlands), Anne Floor Brunger, Karin Smit, Elianne Vrijlandt, Leo Van Eykern
PA601
Small airway function in smokers without airway obstruction Kim Husemann (Singen, Germany), Kim Husemann, Yulia Zhukhovitskaya, Martin Kohlhäufl
46
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA602
Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients Antonino Di Stefano (Veruno, Italy), Antonino Di Stefano, Fabio L.M. Ricciardolo, Davide Vallese, Alessandro Pitruzzella, Francesca Magno, Isabella Gnemmi, Armando Capelli, Andrea Zanini, Francesco Cappello, Bruno Balbi
PA603
Airway hyperresponsiveness (AHR) to mannitol following regular inhaled corticosteroids (ICS) in Australian army and police recruits Clair Lake (Camperdown, Australia), Clair Lake, Clare Perry, Keith Wong, John Brannan
PA604
Correlation of spirometry with six minute walk test and grading of dyspnea Anand Patel (Vadodara, India), Anand Patel
PA605
iNOS expression is increased in peripheral airways of asthmatic patients Ellen Tufvesson (Lund, Sweden), Ellen Tufvesson, Cecilia Andersson, Julie Weidner, Jonas Erjefält, Leif Bjermer
PA606
Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease Jing Gao (Helsinki, Finland), Jing Gao, Steffen Ohlmeier, Pentti Nieminen, Tuula Toljamo, Sari Tiitinen, Tinja Kanerva, Lynne Bingle, Bianca Araujo, Mikko Rönty, Matti Höyhtyä, Colin Bingle, Witold Mazur, Ville Pulkkinen
PA607
Asthma control and sputum eosinophils: A longitudinal study in daily practice Sophie Demarche (Liege, Belgium), Sophie Demarche, Florence Schleich, Virginie Paulus, Monique Henket, Thierry Van Hees, Renaud Louis
PA608
Is ionizing radiation the risk factor for chronic obstructive pulmonary disease? Lyudmila I. Shvayko (Kiev, Ukraine), Liudmyla Shvaiko
PA609
Predictive factors of a positive methacholine challenge response based on data from a baseline respiratory function test Rafaela Campanha (Lisbon, Portugal), Rute Morgado, Cátia Oliveira, Rafaela Campanha, Susana Moreira, Richard Staats, Dina Escaleira, João Valença, Cristina Bárbara
PA610
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response Elissavet Konstantelou (Athens, Greece), Elissavet Konstantelou, Stylianos Loukides, Konstantinos Kostikas, Poluxeni Ntotsi, Zoe Tsilogianni, Anastasia Papaporfyriou, Georgios Papatheodorou, Spyridon Papiris, Nikolaos Koulouris, Petros Bakakos
PA611
Serum periostin in patients hospitalized for COPD exacerbations Elissavet Konstantelou (Athens, Greece), Elissavet Konstantelou, Andriana Papaioannou, Konstantinos Bartziokas, Georgios Papatheodorou, Anastasia Papaporfyriou, Sofia Pouriki, Nikolaos Koulouris, Spyridon Papiris, Petros Bakakos, Stylianos Loukides, Konstantinos Kostikas
PA612
Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD Keiko Wakahara (Nagoya, Japan), Keiko Wakahara, Yoshihiro Suzuki, Akira Shiraki, Toyokazu Sashio, Takashi Abe, Yukari Arakawa, Daiki Goto, Joe Shindoh, Yoshinori Hasegawa
Room D201-202
Session 89
10:45 - 12:45
Poster Discussion: COPD and lung function: risk factors and outcomes Chairs : Judith Garcia Aymerich (Barcelona, Spain), Eva Ronmark (Lulea, Sweden) PA613
COPD is associated with left ventricular size and function: Results from COSYCONET Peter Alter (Marburg, Germany), Peter Alter, Annika Karch, Henrik Watz, Armin Koch, Tobias Welte, Holger Schulz, Rudolf Jörres, Claus Vogelmeier
PA614
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults Om Prakash Kurmi (Oxford, United Kingdom), Om Kurmi, Liming Li, Kourtney Davis, Jenny Wang, Ling Yang, Yiping Chen, Yu Guo, Zheng Bian, Rory Collins, Richard Peto, Zhengming Chen
PA615
LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population Elizabeth Oelsner (New York, United States of America), Elizabeth Oelsner, Kristin Burkart, David Jacobs, Laura Loehr, Ravi Kalhan, George O’Connor, Michael Tsai, Wendy White, Richard Kronmal, Aaron Folsom, R. Graham Barr
PA616
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study Om Prakash Kurmi (Oxford, United Kingdom), Om Kurmi, Liming Li, Kourtney Davis, Jenny Wang, Ling Yang, Yiping Chen, Yu Guo, Zheng Bian, Rory Collins, Richard Peto, Zhengming Chen
PA617
GRACE scores in COPD patients with acute coronary syndromes: Performance and impact on secondary prevention Kieran Rothnie (London, United Kingdom), Kieran Rothnie, Liam Smeeth, Emily Herrett, Neil Pearce, Harry Hemingway, Jadwiga Wedzicha, Adam Timmis, Jennifer Quint
47
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA618
Ventilatory function as predictor of cardio-metabolic markers of cardiovascular disease: 10 year follow-up in young adults Vanessa Garcia Larsen (London, United Kingdom), Vanessa Garcia-Larsen, James Potts, Patricia Bustos, Hugo Amigo, Roberto Rona
PA619
The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype Mirko Di Martino (Rome, Italy), Mirko Di Martino, Nera Agabiti, Silvia Cascini, Ursula Kirchmayer, Valeria Belleudi, Danilo Fusco, Luigi Pinnarelli, Lisa Bauleo, Claudio Voci, Riccardo Pistelli, Marina Davoli
PA620
Chest CT measures of pectoralis muscle area predicts mortality in smokers Alejandro A Diaz (Arlington, United States of America), Alejandro Diaz, Rola Harmouche, James Ross, Raul San Jose Estepar, Gregory Kinney, John Hokanson, George Washko
PA621
Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study Lies Lahousse (Sint-Eloois-Vijve, Belgium), Lies Lahousse, Maartje Niemeijer, Marten Van den Berg, Peter Rijnbeek, Guy Joos, Albert Hofman, Oscar Franco, Jaap Deckers, Mark Eijgelsheim, Bruno Stricker, Guy Brusselle
PA622
Long-term outcome in non-reversible and reversible airway obstruction Sami Sawalha (Boden, Sweden), Sami Sawalha, Linnea Hedman, Eva Rönmark, Bo Lundbäck, Anne Lindberg
PA623
Growth differentiation factor-15 is a predictor for COPD exacerbations and survival Gunnar Husebø (Fana, Norway), Gunnar Husebø, Per Bakke, Jon Hardie, Lorena Lerner, Jeno Gyuris, Tomas Eagan
PA624
Oxygen desaturation in the six minute walk test is a predictor of decline in muscle mass in COPD patients Marie Waatevik (Bergen, Norway), Marie Waatevik, Ane Johannessen, Francisco Real, Marianne Aanerud, Jon Hardie, Per Bakke, Tomas Eagan
PA625
Lung function as a risk factor for low bone mineral density and hip fracture - The Hordaland health study Trine Herland (Bergen, Norway), Trine Herland, Ellen M. Apalset, Geir Egil Eide, Grethe S. Tell, Sverre Lehmann
PA626
Unemployment in COPD: Results from the BOLD study Marta Erdal (Bergen, Norway), Rune Grønseth, Marta Erdal, Wan C. Tan, Thorarinn Gislason, Sanjay K. Juvekar, Sundeep Salvi, Parvaiz A. Koul, Hasan Hafizi, William M. Vollmer, Michael Studnicka, Daniel Obaseki, A. Sonia Buist, Ane Johannessen
PA627
COPD symptoms/diagnoses and work exposure: A 20 years population-based survey Giuseppe Sarno (Pisa, Italy), Giuseppe Sarno, Sonia Cerrai, Sandra Baldacci, Sara Maio, Marzia Simoni, Franca Martini, Patrizia Silvi, Anna Angino, Martina Fresta, Francesco Di Pede, Francesco Pistelli, Laura Carrozzi, Giovanni Viegi
PA628
Productivity loss in COPD: Results from the BOLD study Rune Grønseth (Morvik, Norway), Rune Grønseth, Marta Erdal, Wan C. Tan, Thorarinn Gislason, Sanjay K. Juvekar, Sundeep Salvi, Parvaiz A. Koul, Hasan Hafizi, William M. Vollmer, Michael Studnicka, Daniel Obaseki, A. Sonia Buist, Ane Johannessen
PA629
LATE-BREAKING ABSTRACT: Endometriosis and the airways: Results from a population based Northern European cohort Francisco Gomez Real (Bergen, Norway), Francisco Gómez Real, Kai Triebner, Bryndís Benediktsdóttir, Karl Franklin, Mathias Holm, Rain Jgi, Bénédicte Leynaert, Eva Lindberg, Vivi Schlnssen, Cecilie Svanes
PA630
LATE-BREAKING ABSTRACT: Birth weight and lung function in later life: A systematic review & meta-analysis Jaymini Patel (London, United Kingdom), Neil J. Saad, Jaymini Patel, Cosetta Minelli, Kay Dickersin, Peter G.J. Burney
Room Auditorium
Session 90
12:45 - 14:30
Thematic Poster: Spanish/Portuguese Day: Poster session and Keynote Lecture Healthy Lungs for Life ALAT/ERS/SEPAR/SBPT/SPP International societies symposium - Poster viewing and discussion (light snack and coffee will be available) Tag(s) : Healthy Lungs for Life (HLfL) Chairs : Chair to be confirmed PA631
1. The effects of noninvasive positive pressure ventilation on exercise tolerance in hospitalized patients with decompensated heart failure: a randomised cross-over trial – Igor Moraes
PA632
2. Functional capacity variation after Pulmonary Rehabilitation in COPD patients - a survival predictor – Cláudia Guerreiro
48
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 3. A bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnea: a multicenter randomized controlled trial – Josep M Montserrat 4.
Efficacy of different treatment alternatives por obesity hypoventilation syndrome– Juan F. Masa
5. Effect of Corticosteroids on Treatment Failure among Hospitalized Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: a Randomized Clinical Trial – Antoni Torres 6. Streptococcus pneumoniae infection is an independent cause of cardiac rhythm alteration in communityacquired pneumonia – Francisco Sanz 7. Diagnostic yield of transbronchial criobiopsia in transplant patients and patients with suspected ILD – Margarita Herrera 8. Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study – Isabel Cifuentes 9. Airway resistance and obesity are independent factors for the occurrence of dynamic hyperinflation in asthmatics – Patricia D Freitas 10. Transthoracic echocardiography does not improve sPESI scale value in low risk pulmonary thromboembolism patients – Ana Gomez-Larrauri 11.
LSC Abstract - Functional metagenomics of respiratoy microbiome in exacerbated COPD – Laura Millares
12.
Changes in cognitive status during acute exacerbation of COPD – Marie Carmen Valenza
13.
Transfer factor of the lung for carbon monoxide (TLCO) in morbid obese subjects – Ebymar Arismendi
14.
Clinical and epidemiological features in H1N1 and H3N2 influenza A virus – Ana Lucia Figueredo
15. Aerobic exercise reduces pulmonary inflammation in diet-induced obesity in a HDM model of asthma through adipokines, IL-10, IL-17 and IL-23 signaling – Jefferson C J Aquino-Junior 16. COPD Assessment Test (CAT): validity and reproducibility in patients with non-cystic fibrosis bronchiectasis – Rejane Agnelo Silva de Castro
Hall 14-01
Session 92
12:50 - 14:40
Thematic Poster: Chronic airway disorders: miscellaneous aspects Chairs : Camille Taillé (Paris, France), Elisabetta Pace (Palermo, Italy), Chair to be confirmed PA637
LATE-BREAKING ABSTRACT: Microbiology and radiology of pneumonia in COPD Lydia Finney (London, United Kingdom), Lydia Finney, Sarah Elkin, Samuel Todd, Vijay Padmanaban, Patrick Mallia
PA638
LATE-BREAKING ABSTRACT: Discovering new treatments for asthma and COPD. The use of the human viral challenge model with a newly manufactured and characterised GMP human rhinovirus Rob Lambkin-Williams (Brighton, United Kingdom), Daniel Fullen, Bryan Murray, Ganesh Balaratnam, Julie Mori, Andrew Catchpole, Anthony Gilbert, Fiona Hughes, Rob Lambkin-Williams
PA639
LATE-BREAKING ABSTRACT: The effect of transmural pressure of the pharyngeal airway on upper airway obstruction in patients with obstructive sleep apnea Megumi Okuyama (Chiba, Japan), Megumi Okuyama, Shiroh Isono
PA640
LATE-BREAKING ABSTRACT: Oxygen titration and weaning with FreeO2 in COPD patients hospitalized for exacerbation. A randomized controlled pilot study Erwan L'Her (Brest, France), François Lellouche, Pierre-Alexandre Bouchard, Maude Roberge, Guillaume Babin, François Maltais, Yves Lacasse, Erwan L’Her
PA641
LATE-BREAKING ABSTRACT: Cough sensitivity parameters, airway inflammation and vocal cord dysfunction Study in normal menstrual cycle and oral contraceptives group Jana Plevkova (Martin, Slovakia), Jana Plevkova, Natalia Kavalcikova-Bogdanova, Lea Kovacikova, Tomas Buday, Kamil Biringer, Vladimir Calkovsky
PA642
ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent Alexandre Chabrol (Boulogne, France), Alexandre Chabrol, Louis Jean Couderc, Elisabeth Rivaud, Emilie Catherinot, Hélène Salvator, Laurence Beaumont, Colas Tcherakian
PA643
The influence of age on the delay of asthma diagnosis Karolina Lindner (Wroc aw, Poland), Karolina Lindner, Robert Pawlowicz, Zbigniew Machaj, Bernard Panaszek
49
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA644
Does having specialist asthma nurses improve adherence to national asthma guidelines? A comparison between two UK district general hospitals Adam Ainley (London, United Kingdom), Adam Ainley, Nadia Gildeh, Anna Seeley, Kirsty Lewis, Tara Maisel, Rebecca Jayasinghe, Jagan Muthurajah
PA645
The national alpha-1 antitrypsin deficiency registry in Poland Joanna Chorostowska-Wynimko (Warszawa, Poland), Joanna Chorostowska-Wynimko, Radoslaw Struniawski, Emil Wojda, Beata Wajda, Malgorzata Czajkowska-Malinowska, Pawel Kuca, Dariusz Gawryluk, Dariusz Jastrzebski, Anna Doboszynska, Jerzy Kozielski, Ewa Jassem, Pawel Sliwinski
PA646
Lower serum AIM/IgM ratio is associated with severe asthma Hiroki Kimura (Sapporo, Japan), Hiroki Kimura, Masaru Suzuki, Satoshi Konno, Hironi Makita, Hirokazu Kimura, Satoko Arai, Toru Miyazaki, Masaharu Nishimura
PA647
Phenotypic and molecular-genetic features of asthma-COPD overlap syndrome (ACOS) Vasiliy Belash (St.Petersburg, Russian Federation), Vasiliy Belash, Zhanna Mironova, Vasiliy Trofimov, Mikhail Zaraiski, Alexei Sazanov, Anna Ulitina
PA648
Peculiarities of climacteric syndrome in women with bronchial asthma, developed in the perimenopausal period, correction of these disorders Tetyana Chursinova (Dnipropetrovsk, Ukraine), Tetyana Pertseva, Tetyana Choursinova
PA649
Smoking in severe asthma Galina Sergeeva (Saint-Petersburg, Russian Federation), Galina Sergeeva, Alexander Emelyanov, Evgenia Leshenkova, Antonina Znakhurenko, Ludmila Kozireva
PA650
Adalimumab and etanercept induced asthma Canan Eren Dagli (ORDU, Turkey), Canan Eren Dagli, Recep Akgedik, Berna Botan Yildirim, Rezzan Gunaydin
PA651
Co-existence of eosinophilic granulomatosis with polyangiitis, HIV and HCV infection: A rare coincidence? Juliana Valério Pinaffi (Sao Paulo, Brazil), Juliana Pinaffi, Leticia Kawano-Dourado, Marcos Tavares, Telma Antunes, Carmen Barbas
PA652
An unusual presentation of pulmonary complication of crack abuse Thomas Galasso (Lodi, Italy), Thomas Galasso, Andrea Mazzetta, Valentina Conio, Eti Maria Giulia Di Vincenzo, Federica Meloni, Isa Cerveri
PA653
Neglected causes of acute respiratory failure in the elderly Rodolfo Ferrari (Cesena, Italy), Rodolfo Ferrari, Daniela Agostinelli, Annamaria Longanesi, Riccardo Voza, Mario Cavazza
PA654
Low level laser in monotherapy or in combination with leukotriene receptor antagonists in the treatment of allergic lung inflammation Auriléia Brito (Vargem Grande Paulista, Brazil), Auriléia Brito, Nicole Cristine Rigonato-Oliveira, Gabriel Moraes, Clariana Soares, Manoel Carneiro Oliveira Junior, Luana Beatriz Vitoretti, Rodolfo Paula Vieira, Ana Paula Ligeiro de Oliveira
Hall 14-02
Session 93
12:50 - 14:40
Thematic Poster: COPD: exacerbations, gas exchange and associated dysfunction Chairs : Marieke L. Duiverman (Gasselte, Netherlands), Job van Boven (Groningen, Netherlands), Claus Vogelmeier (Marburg, Germany), Josef Bolitschek (Steyr, Austria) PA655
Source of referral and other factors affecting readmission for patients with chronic obstructive pulmonary disease (COPD) Alex Budds (Manchester, United Kingdom), Alex Budds, Kim Su, Joanne Wright, Syed Mehdi, Imran Aziz, Abdul Ashish
PA656
Economic impact of point-of-care blood gas analysis in COPD patients ESTER ZAMARRON DE LUCAS (Madrid, Spain), Ester Zamarron-deLucas, Paloma Oliver, Antonio Buño, Rodolfo Alvarez-Sala, Pilar Fernandez-Calle, Maria Jose Alcaide, Raquel Casitas, Cristina Garcia-Quero, Aldara Garcia
PA657
Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate Ond ej Sobotík (Olomouc, Czech Republic), Ondrej Sobotik, Miloslav Marel, Alena Vlachova, Frantisek Petrik, Dmitry Rakita
PA658
The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis Vira Khorunzhaya (Kiev, Ukraine), Vira Khorunzhaya, Andrey Dorofeyev, Joanna Chorostowska-Wynimko, Adriana Rozy, Radoslaw Struniawski
50
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA659
Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD Viktoriia Yakovlieva (Saienko) (Dniepropetrovsk, Ukraine), Viktoriia Yakovlieva, Lyudmyla Konopkina, Tetyana Pertseva
PA660
FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Alizamin Sadigov (Baku, Azerbaijan), Alizaman Sadigov, Sakhavatdin Akhundov, Jeyhun Ismailzadeh, Gunel Sadigova
PA661
Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD Richa Singh (London, United Kingdom), Richa Singh, Alexander Mackay, Simon Brill, James Allinson, Peter Barnes, Louise Donnelly, Gavin Donaldson, Jadwiga Wedzicha
PA662
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease and coronary artery disease Vitalii Poberezhets (Vinnytsia, Ukraine), Vitalii Poberezhets, Yuriy Mostovoy, Hanna Demchuk
PA663
Right ventricle dysfunction predicts prognosis in COPD Daniela Graner Schuwartz Tannus Silva (Goiania, Brazil), Daniela Tannus-Silva, Joao Batista Silva, Jose Laerte Silva Júnior, Lays Silva, Leticia Morais, Marcus Conde, Marcelo Rabahi
PA664
Changes in inhalation therapy after combined assessment of COPD Arzu Mirici (Canakkale, Turkey), Muzaffer Onur Turan, Julide Celdir Emre, Sami Deniz, Aysegul Baysak, Pakize Ayse Turan, Arzu Mirici
PA665
COPD exacerbations in hypertensive patients in two ethnic groups in Macedonia Zoran Stojanovski (Skopje, FYROM (Macedonia)), Goran Andonovski, Zoran Stojanovski, Minov Jordan
PA666
COPD: Desadaptive illness behavior types patterns Yanina Galetskayte (Mocow, Russian Federation), Yanina Galetskayte, Svetlana Ovcharenko, Beatrice Volel
PA667
Potential markers of the progression of CRF in patients with COPD Titova Olga (Saint-Petersburg, Russian Federation), Titova Olga, Sklyarova Darya, Kuzubova Natalia, Gichkin Aleksey
PA668
Neurophysiological changes in muscles and nerves in COPD Mehmet Polatli (AYDIN, Turkey), Mehmet Polatli, Nefati Kiylioglu, Emine Yilmaz Celik, Emine Sirthan Afsin, Utku Ogan Akyildiz, Cengiz Tataroglu
PA669
Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD Iwona Damps-Konstanska (Gdynia, Poland), Iwona Damps-Konstanska, Katarzyna Puzniakowska, Marta GruchalaNiedoszytko, Michal Makowiecki, Katarzyna Swietnicka, Ewa Jassem
PA670
Integrated care in patients with advanced COPD prevent exacerbations Iwona Damps-Konstanska (Gdynia, Poland), Iwona Damps-Konstanska, Ewa Bandurska, Piotr Popowski, Katarzyna Swietnicka, Alicja Janowicz, Ewa Jassem
PA671
The effects of a supported discharge service (SDS) to COPD patients on length of hospital stay Jamie Crosswell (Ashford, United Kingdom), Jamie Crosswell, Geraldeen Guy, Sandip Banerjee
PA672
Is it possible to improve the prediction ability of the BODE index? AMAIA ARAMBURU OJEMBARRENA (Galdakao (Bizkaia), Spain), Amaia Aramburu, Txomin Zabala, Cristobal Esteban, Helena Guillermina Azcuna, Francisco Javier Moraza, Myriam Aburto, Irantzu Barrio, Inmaculada Arostegui, Alberto Capelastegui
PA673
Shape analysis of specific resistance loop contributes to diagnosis of airflow obstruction Marko Topalovic (Leuven, Belgium), Marko Topalovic, Vasileios Exadaktylos, Daniel Berckmans, Thierry Troosters, Wim Janssens
PA674
Scales of assesment in COPD. Correlation with clinical and functional parameters Juan Rodríguez López (Oviedo (Asturias), Spain), Juan Rodríguez-López, Jesús Allende, Jose María García-García, Manuel Villanueva, Jennifer Jiménez, Jose Antonio Gullón, Fernando álvarez-Navascués, Manuel ángel Martínez-Muñiz, Andrés Sánchez-Antuña
Hall 14-03
Session 94
12:50 - 14:40
Thematic Poster: COPD: chronic disease and comorbidities Chairs : András Bikov (Budapest, Hungary), Eric D. Bateman (Cape Town, South Africa), Wouter H. van Geffen (Groningen, Netherlands), Chair to be confirmed PA675
LATE-BREAKING ABSTRACT: Exploratory study of clinical phenotypes of airways disease with wheezing by cluster analysis Guo Yanfei (Beijing, China), Guo Yanfei, Ning Pu, Sun Tieying
51
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA676
LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Carlos Echevarria (Newcastle, United Kingdom), Carlos Echevarria, John Steer, Karen Heslop, Chris Stenton, Peter Hickey, Rodney Hughes, Meme Wijesinghe, Richard N. Harrison, Nick Steen, John Simpson, G. John Gibson, Stephen C. Bourke
PA677
LATE-BREAKING ABSTRACT: Prevalence of metabolic syndrome in COPD and its association with severity of disease Basanta Hazarika (Gawahati, India), Basanta Hazarika, M.K. Raghavendra, Sushmita Choudhary, Nita Basumotary, Kripash Sarmah, Jogesh Sharma
PA678
LATE-BREAKING ABSTRACT: Awareness of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease Erhan Ugurlu (Denizli, Turkey), Erhan Ugurlu, Hakan Alkan, Göksel Altinisik, Mukaddes Sener, Nese Dursunoglu, Sevin Baser, Sibel Özkurt, Fatma Evyapan
PA679
Cost and effectiveness of 2 years integrated care intervention in COPD Maurizio Moretti (Modena, Italy), Francesco Costa, Anna Porcu, Sara Balestracci, David Mignani, Fabiola Magnani, Tiziana Pianta, Biagio Marsiglia, Mariella Polselli, Andrea Macuzzi, Aldo Casani, Maurizio Moretti
PA680
Role of tuberculosis in COPD Hakan Günen (Istanbul, Turkey), Hakan Gunen, Halil Ibrahim Yakar, Erkan Pehlivan, Pinar Atagün, Selma Aydogan, Aylin Babalik, ümmühan Selvi, Tülay Yarkin, Begüm Aritan
PA681
Evaluation of individual activity descriptors of the MRC dyspnoea scale: Do they add up? Janelle Yorke (Manchester, United Kingdom), Janelle Yorke, Adam Garrow, Sarah Tyson, Naimat Khan, Chris Gibbons, Dave Singh, Jorgen Vestbo, Paul Jones
PA682
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Miriam Barrecheguren, Esther Rodriguez, Maria Sucena, Sandra Fernandez, Marc Miravitlles
PA683
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Kateryna Gashynova (Dniepropetrovsk, Ukraine), Kateryna Gashynova
PA684
Features of skeletal muscle dysfunction in COPD patients with obesity Vitalii Poberezhets (Vinnytsia, Ukraine), Vitalii Poberezhets, Yuriy Mostovoy, Hanna Demchuk
PA685
Can we consider the "frequent exacerbator" a reliable COPD phenotype? Francesca Bigazzi (Firenze, Italy), Francesca Bigazzi, Alessio Garcea, Elena Torricelli, Viola Bonti, Matteo Paoletti, Gianna Camiciottoli, Massimo Pistolesi
PA686
Costs of the patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease in a tertiary university hospital of Turkey Can Öztürk (Ankara, Turkey), Fatma Yildirim, Murat Türk, Can öztürk
PA687
Comorbidities in elderly smokers with COPD or CHF Bianca Beghe (Modena, Italy), Bianca Beghé, Alessia Verduri, Martina Garofalo, Sara Balduzzi, Monica Bortolotti, Michela Schito, Enrico Clini, Leonardo M. Fabbri, Piera Boschetto
PA688
Comorbidities in chronic obstructive pulmonary disease - Results of a national multicenter research project Renata Rubinsztajn (Warsaw, Poland), Renata Rubinsztajn, Marta Maskey-Warzechowska, Krzysztof Karwat, Ryszarda Chazan
PA689
Predictors of coronary heart disease in patients with COPD Anastasiia Savytska (Vinnitsa, Ukraine), Anastasiia Savytska
PA690
The relation of CAT and BODE index in assessing patients with COPD in sub Saharan Africa: Is CAT alone simple and good enough? Akor Alexander (Abuja, Nigeria), Alexander Akor, G.E Erhabor, Obaseki Daniel
PA691
Biomarkers in COPD- The role of resistin and leptin Vlasios Vitsas (Athens, Greece), Vlasios Vitsas, Kardara Matina, Vasileiou Aliki, Koutsoukou Antonia, Michalopoulou Pinelopi, Orfanos Stylianos, Tsoukalas Georgios, Kotanidou Anastasia
PA692
Optimal spirometric criterion for diagnosing COPD in patients with heart failure (HF): Fixed ratio (FR) or lower limit of normal (LLN)? Ivan Vishnivetsky (Kiev, Ukraine), Ivan Vishnivetsky, Iryna Boichenko, Anastasiia Borovtsova
PA693
What is the best biomarker of COPD stability? Bogdana Basina (Dnipropetrovsk, Ukraine), Bogdana Basina, Tetyana Pertseva, Lyudmila Konopkina
52
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA694
Proteinase-inhibitor system state in patients with COPD Olena B. Pavlenko (Dniepropetrovsk, Ukraine), Elena Pavlenko, Tetyana Pertseva
Hall 14-04
Session 95
12:50 - 14:40
Thematic Poster: Healthcare organisation and appropriateness in lung disorders Chairs : Alfredo Chetta (Parma, Italy), Carlos Silva Robalo Cordeiro (Coimbra, Portugal), Andreas Guenther (Giessen, Germany), Dario Olivieri (Parma, Italy)
PA695
LATE-BREAKING ABSTRACT: Validation of anindirect calorimetry method among healthy volunteers with noninvasive ventilation at different oxygen concentrations: An agreement study Nicolás Roux (Ciudad Autónoma de Buenos Aires, Argentina), Nicolás Roux, Patricia Guimaraens, Hernán Benito, Emiliano Gogniat, María de los Ángeles Carignano, Alejandro Midley, Claudia Kecskes, Sergio Giannasi, Eduardo San Román
PA696
Patients’ and healthcare professionals’ perceptions of oxygen therapy: A qualitative study Carol Kelly (Lancashire, United Kingdom), Carol Ann Kelly
PA697
An audit of electronic oxygen prescribing and bedside observations at a UK teaching hospital showing a high prevalence of risk factors for hypercapnia and a high incidence of hyperoxaemia Paul Whittemore (Manchester, United Kingdom), Paul Whittemore, Ronan O’Driscoll
PA698
Improving oxygen prescription outcomes – Is it time to educate the seniors? Charlotte Tai (Brentwood, United Kingdom), Charlotte Tai, Ruochen Li, Priya Roy, Sanjay Sharma, Bandipalyam Prathibha
PA699
Effect of computerized physician order entry in the prescribing errors in inpatient care in a pulmonology unit ALDARA GARCIA SANCHEZ (Madrid, Spain), Elena Villamañán, Aldara García-Sánchez, Ester Zamarron, Eduardo Armada, Yolanda Larrubia, Margarita Ruano, Alicia Herrero, Sergio Alcolea, Carlos Carpio, Rodolfo álvarez-Sala
PA700
Therapeutic warfarin dose dependence on age and smoking in acute pulmonary embolism Jolita Rackauskiene (Vilnius, Lithuania), Jolita Rackauskiene, Vaida Gedvilaite, Mindaugas Mataciunas, Mazvile Abrutyte, Olga Kusner, Edvardas Danila
PA701
Investigating inhaler device mastery in pharmacist trainees Sinthia Bosnic-Anticevich (Sydney, Australia), Sinthia Bosnic-Anticevich, Daina Lim, Jo Steel, Vicky Kritikos, Vasilis Nikolaou, Leif Bjermer, Henry Chrystyn, Frederico Lavorini, P.N. Richard Dekhuijzen, Cynthia Rand, Nicolas Roche, Lorraine Smith, Lisa Pong, Smita Shah, Nicholas Zwar, David Price
PA702
The impact of VAP staff education on VAP morbidity and mortality in Alexandria University Emad Ibrahim (Alexandria, Egypt), Ahmed Elmenshawy, Tarek Elbadawy, Hassan Abu khaber, Soad Hafez, Akram Fayed, Emad Ibrahim
PA703
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis Fatima Tashpulatova (Tashkent, Uzbekistan), Fatima Tashpulatova, Abduvahob Baboev, Abduvahob Baboev, Abduvahob Baboev
PA704
The bronchitis severity scale (BSS): A validated tool to assess the effect of pharmacotherapy in acute bronchitis Heinrich Matthys (Freiburg im Breisgau, Germany), Heinrich Matthys, Peter Kardos, Wolfgang Kamin, Thorsten Reineke, Siegfried Lehrl
PA705
Quality of life in worsening and non-worsening PAH patient’s in a 1 year follow-up: What’s going on? Laurence Halimi (Montpellier, France), Laurence Halimi, Nicolas Molinari, Gregory Marin, Anne Sophie Gamez, Clement Boissin, Isabelle Vachier, Arnaud Bourdin
PA706
Surfactant protein D (SPD) like marker of effectiveness ofphosphatidylcholine treatment outcomes in patients (pts) with community acquired pneumonia (CAP) Olga Shtepa (Dnipropetrovsk, Ukraine), Olga Shtepa, Tetyana Pertseva, Tetyana Kireyeva
PA707
Quality indicators for management of community-acquired pneumonia hiroaki kanemura (tokyo, Japan), Hiroaki Kanemura, Naoki Nishimura, Hiroshi Nakaoka, Takeshi Kimura, Naohiko Chounabayashi
PA708
Could procalcitonin (PCT) be a marker of effectiveness of antibiotic treatment (ABT) in pregnant with not severe community-acquired pneumonia (CAP)? Nataliia Kravchenko (Dniepropetrovsk, Ukraine), Nataliia Kravchenko, Tetyana Pertseva, Tetyana Kireeva
PA709
Assessment of factors influencing dyspnea sensation in patients hospitalized in India and Poland Mohankumar Thekkinkattil (Coimbatore, India), Mohankumar Thekkinkattil, Szymon Skoczynski, Grzegorz Brozek, T.S. Muthukumar, R. Monisha, Klaudia Glinka, Katarzyna Repetowska, Dawid Szumilas, Michalina Jamroz, Ewelina Rebizak, Patrycja Rzepka-Wrona, Adrianna Kawa, Beata Kotulska, Jan E. Zejda, Wladyslaw Pierzchala, Adam Barczyk
53
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA710
The role of specialist respiratory input in a busy acute medical unit: Implications for diagnosis, management and discharge Akhtar Ali Akhtar (Barnsley, United Kingdom), Akhtar Ali Akhtar, Sharon Dunning, Muhammad Hussain, Mohammad Ali, Muhammad Malik
PA711
Quality assessment of clinical practice guidelines for respiratory diseases in China: A systematic appraisal Mei Jiang (Guangzhou, China), Mei Jiang, Liyue Liao, Xiaoqing Liu, Weijie Guan, Yiming Li
PA712
Evaulating the use of an age-adjusted, semi-quantitative d-dimer James Harper (Malmesbury, United Kingdom), Rahul Shrimanker, James Harper, Harsita Patel, Andrew Stanton
PA713
Do patients with stress incontinence cough or do cough patients suffer from urinary incontinence? Jan Willem K. van den Berg (Zwolle, Netherlands), Robin Zoglmann, Tam Nguyen, Marian Engberts, Dominique Vaessen, Niels Patberg, Jan Van den Berg
PA714
The relationship between respiratory function and urinary leukotriene E4 in winter sports Lidiya Nikitina (Khanty-Mansi Autonomous Okrug, Russian Federation), Lidiya Nikitina, Svetlana Soodaeva, Fedor Petrovsky, Samira Gasymova, Valentina Kotlyarova, Yulia Petrovskaya, Alexandr Chuchalin
Hall 14-05
Session 96
12:50 - 14:40
Thematic Poster: Best abstracts in COPD management Chairs : Nick Hopkinson (London, United Kingdom), Milo Puhan (Zurich, Switzerland), Epaminondas Kosmas (Voula, Athens, Greece), Paolo Onorati (Alghero, Italy) PA715
Assessment of a new pressure manometer for use with an oscillating positive expiratory pressure (OPEP) device Jason Suggett (London, Canada), Jason Suggett, Neritan Alizoti, Adam Meyer
PA716
Home oxygen service- Assessment and review Joanna Hobbs (Waterlooville, United Kingdom), Jo Hobbs, Sue Channon
PA717
Role of illness behavior in pulmonary rehabilitation programs Yanina Galetskayte (Mocow, Russian Federation), Yanina Galetskayte, Svetlana Ovcharenko, Beatrice Volel
PA718
Does an exercise test change patients’ perception of their ability to exercise? Justina Ruksenaite (Leicester, United Kingdom), Justina Ruksenaite, Linzy Houchen, Paul Andrzejowski, Sally Singh
PA719
Mortality and readmissions in patients with severe COPD. Validation of the CODEX index Annie NAVARRO ROLON (Barcelona, Spain), Annie Navarro, Roser Costa, Mauricio Martinez, Ana Maria Lapuente, Carmen Vinas, Jose Luis Heredia, Pere Almagro
PA720
How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients? Laura Ciobanu (Iasi, Romania), Laura Ciobanu, Irina Pavaluc, Vasile Maciuc
PA721
The combined effects of manual chest squeezing coordinated expiration during exercise in patients with chronic obstructive pulmonary disease (COPD) Tomomi Ichiba (Hachiouji,Tokyo, Japan), Tomomi Ichiba, Tetsuo Miyagawa, Toru Tsuda
PA722
Poor agreement between chart-based and objectively identified comorbidities of COPD Filip J.J. Triest (Bilzen, Belgium), Filip J.J. Triest, Frits M.E. Franssen, Martijn A. Spruit, Miriam T.J. Groenen, Emiel F.M. Wouters, Lowie E. Vanfleteren
PA723
Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Laura Caram (Conchas, São Paulo, Brazil), Laura Caram, Renata Ferrari, André Bertani, Thaís Garcia, Carolina Bonfanti, Caroline Knaut, Suzana Tanni, Camila Corrêa, Irma Godoy
PA724
Changes in quality of life and physiological status in newly diagnosed COPD patients Muzaffer Onur Turan (Çanakkale, Turkey), Muzaffer Onur Turan, Turgay Kasan, Arzu Mirici
PA725
Evaluation of the validity and reliability of the CAT (COPD assessment test) questionnaire among COPD patients attending Masih Daneshvari Hospital Atefeh Fakharian (Tehran, Islamic Republic of Iran), Atefeh Fakharian, Firouzeh Talischi, Saeed Fallah Tafti
PA726
Validation of the 12-item partners in health scale to measure patient self-management behaviour and knowledge in Dutch patients with COPD Anke Lenferink (Oldenzaal, Netherlands), Anke Lenferink, Muirne Paap, Peter Harvey, Malcolm Battersby, Peter Frith, Paul Van der Valk, Wendy Van Beurden, Job Van der Palen, Tanja Effing
54
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA727
Efficacy of cough with mechanical in-exsufflation (MI-E) and high frequency chest wall oscillation (HFCWO) for airway clearance Tetsuo Miyagawa (Yokohama Kanagawa, Japan), Tetsuo Miyagawa, Tomomi Ichiba
PA728
COPD: Home visits program after admission with an exacerbation Jakob Lyngby Kjærgaard (Brønshøj, Denmark), Jakob Kjærgaard, Anette Bering, Mette Rosenberg, Jon Torgny Wilcke
PA729
Indicators of mortality for patients treated in a nurse-led COPD unit Alex Budds (Manchester, United Kingdom), Alex Budds, Kim Su, Joanne Wright, Syed Mehdi, Abdul Ashish, Imran Aziz
PA730
The effect of respiratory muscle training on dyspnea levels of subjects undergoing thoracic surgery Harun Ta k n (Denizli, Turkey), Harun Taskin, Orçin Telli Atalay, Gökhan Yuncu
PA731
Smoking habits and psychological comorbidities of patients with COPD Birgit Schwaighofer (Bad Reichenhall, Germany), Birgit Schwaighofer, Danijel Jelusic, Michael Wittmann, Michael Schuler, Konrad Schultz
PA732
Secondary prevention of osteoporosis (OP) in chronic obstructive pulmonary disease (COPD) Bianca Petri (Liverpool, United Kingdom), B.S. Petri, K. Morgan, C.W.J. Brockelsby, S.M.H. Kazmi
PA733
Understanding inequalities in COPD prevention and care policies across Europe Antje Finkwagner (Brussels, Belgium), Daniela Finizio, Michael Wilken, Isabel Saraiva, Sian Williams, Antje Fink-Wagner
Hall 14-06
Session 97
12:50 - 14:40
Thematic Poster: Latest insights in pulmonary rehabilitation and functional capacity Chairs : Zafeiris Louvaris (Agia Paraskevi, Attica, Greece), Rafael Mesquita (Maastricht, Netherlands), Frits M.E. Franssen (Horn, Netherlands), Eva Bernardi (Vazzola, Italy)
PA734
Exercise training is a determinant of weight-loss and improvement on asthma control, airway inflammation and psychosocial morbidity in obese asthmatics: A RCT Patricia Freitas (Sao Paulo, Brazil), Patricia D. Freitas, Palmira G. Ferreira, Aline G. Silva, Alberto Cukier, Rafael Stelmach, Regina Carvalho-Pinto, João M. Salge, Marcio C. Mancini, Milton A. Martins, Celso R.F. Carvalho
PA735
Behavior of stress and peripheral muscle strength in COPD patients submitted to periodized resistance training with elastic tubing Bruna Silva (Presidente Prudente, Brazil), Bruna Spolador de Alencar Silva, Dionei Ramos, Fabiano Francisco de Lima, Giovanna Altero Arévalo, Ana Paula Coelho Figueira Freire, Marceli Rocha Leite, Iara Buriola Trevisan, Juliana Souza Uzeloto, Renata Marques David, Gabriel Faustino Santa Brigida, Guilherme Yassuyuki Tacao, Giovana Navarro Bertolini, Luia Alberto Gobbo, Ercy Mara Cipulo Ramos
PA736
Variable physiological response to short-term high-intensity exercise training in men with advanced COPD Nanca Cebron Lipovec (Ljubljana, Slovenia), Nanca Cebron Lipovec, Annemie M.W.J. Schols, Ramon Langen, Daniel Omersa, Tatjana Kosten, Mitja Lainscak
PA737
The effect of outpatient pulmonary rehabilitation on patients with lung cancer – A retrospective data analysis Stephanie Falschlehner (Großwetzdorf, Austria), Stephanie Falschlehner, Milos Petrovic, Elisabeth Czuchajda, Branko Ott, Angelika Forster, Anneliese Berger, Miriam Subhieh, Doris Schindler, Irmgard Derka, Ralf Harun Zwick
PA738
Effects of additional manual therapy over inspiratory muscle training in patients with chronic obstructive pulmonary disease: A randomized controlled trial Yasemin Çirak (Ankara, Turkey), Yasemin çirak, Gül Deniz Yilmaz Yelvar, Yasemin Parlak Demir, Murat Dalkilinç, Deniz Kizilirmak, Bülent Bozkurt
PA739
Effect of nandrolone in underweight COPD patients following pulmonary rehabilitation Adriette Van der Weg (GRONINGEN, Netherlands), Adriette Van der Weg, Johan B. Wempe, Hester Van der Vaart
PA740
Change in the iBODE index during pulmonary rehabilitation predicts mortality in COPD Matthew Maddocks (London, United Kingdom), Matthew Maddocks, Wei Gao, Samantha S.C. Kon, Jane L. Canavan, Sarah E. Jones, Claire M. Nolan, Amy L. Clark, Michael I. Polkey, William D.-C. Man
PA741
Comorbidity burden and the effect on completion rates and response to pulmonary rehabilitation (PR) in COPD Djeya Kaliaraju (Uxbridge, United Kingdom), Djeya P. Kaliaraju, Claire M. Nolan, Jane L. Canavan, Sarah E. Jones, Amy L. Clark, Samantha S.C. Kon, William D.C. Man
PA742
Endurance training with ciclical incremental load, are there advantages? Ana Filipa Fernandes (Alcanena, Portugal), Filipa Fernandes, Nuno Sousa, Alcina Tavares, Rita Gomes, Madalena Reis, João Parreira, Filipa Carriço, Luís Ferreira
55
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA743
A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Fatim Mirza (Perak, Malaysia), Fatim Tahirah, Sue Jenkins, Siti Kamariah Othman, Rosmadi Ismail, Tengku Ismail, Kylie Hill
PA744
Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR) Claire Nolan (Guildford, United Kingdom), Claire M. Nolan, Jane L. Canavan, Sarah E. Jones, Samantha S.C. Kon, Faiza S. Chowdhury, Surinder S. Birring, Matthew Maddocks, Paul Cullinan, Toby Maher, William D.C. Man
PA745
Psychological assessment in COPD and lung cancer patients in pulmonary rehabilitation Zsofia Hodovan (Budapest, Hungary), Zsofia Hodovan, Emese Lorik, Janos Varga
PA746
A pilot of a weekend pulmonary rehabilitation programme for participants in employment Alice Craggs (London, United Kingdom), Alice Craggs, Claire Davey, Martin Sterry, Sheena Radford, Jane Simpson
PA747
The effect the pulmonary rehabilitation in rectus femoris cross-sectional area increase and exercise capacity in patients with chronic obstructive pulmonary disease pek Ozmen (Istanbul, Turkey), Ipek Ozmen, Elif Yildirim, Fevzi özçinar, Murat öztürk, özgür Yilmaz, Nurgül Yer, Nur Uçkun
PA748
6-minute walk test (6MWT) and Sit-to-Stand Test (STST) as outcome parameters in pulmonary rehabilitation (PR) of COPD patients Nicola Lehbert (Bad Reichenhall, Germany), Nicola Lehbert, Silke Wingert, Danijel Jelusic, Michael Wittmann, Michael Schuler, Konrad Schultz
PA749
Influence of perceived exercise exertion on changes in the CAT score in a standardised pulmonary rehabilitation programme Graziele Sobrinho (Southampton, United Kingdom), Graziele Coissi Sobrinho, Teresa James, Zoe Pond, Lindsay Welch, Susan Batchelor, Rhona Copp, Helen Potterton, Tracy Nash, Thomas Havelock, Tom M. Wilkinson
PA750
Relationship between 6MWT distance and VO2max and Wmax in lung transplant candidates undergoing pulmonary rehabilitation Leonor da Hora Lopes Meira (Leça da Palmeira, Portugal), Leonor Meira, Carla Damas, Paula Martins, Luís Gaspar, Emilia Araújo, Ermelinda Eusébio, Isabel Gomes
PA751
Effects of a periodized resistance training with elastic tubing in functional capacity and quality of life of patients with COPD Giovanna Arévalo (Brodowski, Brazil), Giovanna Arevalo, Dionei Ramos, Fábio Lira, Bruna Silva, Fabiano Lima, Juliana Uzeloto, Ana Paula Freire, Marceli Leite, Renata David, Iara Trevisan, Gabriel Brigida, Guilherme Tacao, Ercy Ramos
PA752
Why detection of cycling is important in activity monitoring Rob Van Lummel (The Hague, Netherlands), Rob C. van Lummel, Siete C. Frouws, Alex J. van ’t Hul, Jaap H. van Dieën, Johannes C.C.M. in ’t Veen
PA753
Reduction of hospital admissions after pulmonary rehabilitation of geriatric patients with COPD Stephanie Blindenbach (Utrecht, Netherlands), S. Blindenbach, J.E. Elgersma, J. v.d. Zeijden, H.J. Reesink, F. Brijker, M. Smalbrugge, J.W.F.A. Vrancken
Hall 14-07
Session 98
12:50 - 14:40
Thematic Poster: A morphological view of chest pathology Chairs : Aleksandar Grgic (Homburg/Saar, Germany), Cedric Van Holsbeke (Kontich, Belgium), Reinhard Kubale (Pirmasens, Germany), Chair to be confirmed PA754
Post pleural aspiration chest X-ray Sally Metcalfe (Chesire, United Kingdom), Sally Metcalfe, Wasim Jamal, M. Jamil Malik
PA755
Predicting 3-day outcome of initial treatment in primary spontaneous pneumothorax: Benefit of expiratory chest Xray Kazunori Tobino (Iizuka, Japan), Kazunori Tobino, Yuichiro Yasuda, Hiroki Ebana
PA756
Contrast-enhanced CT for detecting pleural malignancy at a large district general hospital Samal Gunatilake (Eastleigh, United Kingdom), Samal Gunatilake, William Storrar, Louise Parker, Suresh Babu, Lesley Bishop, Robin Clark, Anoop Chauhan
PA757
Pulmonary manifestations in severe strongyloidiasis: Review of 17 cases Daijiro Nabeya (Okinawa, Japan), Daijiro Nabeya, Shusaku Haranaga, Takeshi Kinjo, Gretchen Parrott, Ayako Uehara, Saifun Nahar, Teruhisa Tanaka, Tetsuo Hirata, Futoshi Higa, Masao Tateyama, Jiro Fujita
56
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA758
Fully automated labeling of sub-segmental airways in human airway trees Juerg Tschirren (Coralville, United States of America), Juerg Tschirren, Craig Vidal, Benjamin Baron, Philippe Raffy, Eric A. Hoffman
PA759
Imaging the upper airways in humans with endoscopic optical coherence microscopy at subcellular resolution Mario Pieper (Lübeck, Germany), Mario Pieper, Hinnerk Schulz-Hildebrandt, Barbara Wollenberg, Gereon Hüttmann, Peter König
PA760
Clinic and radiologic features and outcomes of amidrone induced alveolities under the influence of steroid treatment Natalya Yakovleva (Saint-Petersburg, Russian Federation), N. Yakoleva, A. Speranskaya, G. Orlova, V. Amosov, V. Zolotnitskaya
PA761
Non small cell lung cancer (NSCLC): 42 patients treated with computed tomography (CT) guided percutaneous microwave ablation Adamadia Liapikou (Athens, Greece), Petros Filippousis, Styliani Arapostathi, Nektaria Sidiropoulou, Kyriaki Tavernaraki, Paraskeyi Galani, Adamantia Liapikou, Loukas Thanos
PA762
Reproducibility of airway wall thickness measurements on CT in a lung cancer screening setting Esther Pompe (Utrecht, Netherlands), Esther Pompe, Michael Schmidt, Eva Van Rikxoort, Rozemarijn Vliegenthart, Matthijs Oudkerk, Harry De Koning, Bram Van Ginneken, Pim De Jong, Jan-Willem Lammers, Firdaus Mohamed Hoesein
PA763
CT assessment of lobar heterogenity and fissure integrity in pulmonary emphysema for bronchoscopic lung volume reduction with valve Akifumi Tsuzuku (Hashima Gun, Gifu Prefecture, Japan), Akifumi Tsuzuku, Fumihiro Asano, Teruomi Miyazawa, Hiroshi Handa, Masamichi Mineshita, Yoshihiko Matusno, Takuya Sobajima, Atsunori Masuda, Anri Murakami, Tomoya Kato
PA764
Predictors of pneumothorax after transthoracic lung biopsy: The role of quantitative CT Hassan Chami (Beirut, Lebanon), Hassan Chami, Walid Farraj, Zeinab Abou Yehia, Sanaa Baddour, Peter Sawan, Karim Rebeiz, Rawan Safa, Charbel Saade, Blanche Ghandour, Ali Shamseddine, Deborah Mukherji, Ali Haydar
PA765
Radiological findings of patients with primary ciliary dyskinesia Nagehan Emiralioglu (Ankara, Turkey), Nagehan Emiralioglu, Berna Oguz, Altan Günes, Ebru Yalçin, Deniz Dogru Ersöz, Nural Kiper, Ugur özçelik
PA766
Outcome of intravascular stent in superior vena cava syndrome Naohiko Hamaguchi (Matsuyama, Japan), Naohiko Hamaguchi, Takahide Kato, Mayuko Semba, Mikihiro Kohno, Kotaro Kajiwara, Kensaku Ito, Hideki Makino, Takanori Kanematsu, Hideki Yokoyama
PA767
Primary pulmonary haemosiderosis. Usefulness of MRI with DWI Stevan Ivkovic (Nis, Republic of Serbia), Stevan Ivkovic, Aleksandar Ivkovic, Tamara Milosavljevic, Dusan Ivkovic
PA768
Lung injuries after narcotic overdose. Usefulness of MDCT and MRI Tamara Milosavljevic (Nis, Republic of Serbia), Tamara Milosavljevic, Aleksandar Ivkovic, Stevan Ivkovic
PA769
Interstitial lung disease caused by designer drugs Aleksandar Ivkovic (Nis, Republic of Serbia), Aleksandar Ivkovic, Tamara Milosavljevic, Stevan Ivkovic
PA770
MDCT and MRI findings after antibiotic sub dosage in pneumonia Tamara Milosavljevic (Nis, Republic of Serbia), Tamara Milosavljevic, Aleksandar Ivkovic, Stevan Ivkovic
Hall 14-08
Session 99
12:50 - 14:40
Thematic Poster: Endoscopic ultrasound: an essential tool for interventional pulmonology Chairs : Luis Miguel Seijo Maceiras (Madrid, Spain), Momen Wahidi (Durham, United States of America), Jean-Michel Vergnon (SaintEtienne, France), Chair to be confirmed PA771
Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients Filiz Oezkan (Bochum, Germany), Filiz Oezkan, Amir Khan, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kazuhiro Yasufuku, Takahiro Nakajima, Ruediger Karpf-Wissel, Diana Hartmann, Dirk Theegarten, Lutz Freitag, Kaid Darwiche
PA772
Added value of EUS-B to EBUS for lung cancer staging Laurence M.M.J. Crombag (Amsterdam, Netherlands), Laurence Crombag, Jos Stigt, Christophe Dooms, Kurt Tournoy, Olga Schuurbiers, Daniel Korevaar, Jouke Annema
PA773
EBUS-TBNA in the diagnosis of haematological malignancies; overcoming the challenge Georgia Hardavella (Aghia Paraskevi, Athens, Greece), Georgia Hardavella, Laura Succony, Jim Brown, Ricky Thakrar, Mary Falzon, Vandana Jeebun, Mohammed Munnavar, Sam Janes, Neal Navani
PA774
Efficacy of TB-PCR using EBUS-TBNA samples in patients with intrathoracic granulomatous lymphadenopathy Jung Seop Eom (Busan, Republic of Korea), Jung Seop Eom, Min Ki Lee, Min Ji Kim
57
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA775
Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of malignancy and sarcoidosis Onur Fevzi Erer (Izmir, Turkey), Onur Fevzi Erer, Ceyda Anar, Serhat Erol, Zekiye Aydogdu
PA776
A multimodal image guiding system for navigated endobronchial ultrasound (EBUS): Clinical demonstration Hanne Sorger (Levanger, Norway), Hanne Sorger, Tore Amundsen, Erlend Fagertun Hofstad, Thomas Langø, Hakon Olav Leira
PA777
Validation of a risk stratification model for patients with isolated mediastinal/hilar lymphadenopathy (IMHL) and a negative EBUS Haider Al-Najjar (Doncaster, United Kingdom), Haider Al-Najjar, Matthew Evison, Julie Morris, Julie Martin, Haval Balata, Philip Barber, Richard Booton, Philip Crosbie
PA778
Endobronchial ultrasound elastography type classification in the diagnosis of mediastinal and hilar lymph nodes Takehiro Izumo (Tokyo, Japan), Takehiro Izumo, Yuji Matsumoto, Yoshihisa Hiraishi, Manabu Hayama, Christine Chavez, Shinji Sasada, Takaaki Tsuchida
PA779
Left adrenal gland analysis using the EBUS scope: A feasibility study in lung cancer patients Laurence M.M.J. Crombag (Amsterdam, Netherlands), Laurence Crombag, Peter Bonta, Jouke Annema
PA780
Utility value of endo bronchial ultrasound-trans bronchial needle aspiration (EBUS-TBNA) in isolated tuberculous mediastinal lymphadenopathy Ziaudeen Ansari (Birmingham, United Kingdom), Ziaudeen Ansari, Elizabeth Pudney, Nazim Nathani, Omer Khair, Arvind Rajasekaran
PA781
EBUS-TBNA in sarcoidosis and lymphoma: Exploring the importance of culture on lymph nodes Ping Shi Zhu (Montreal, Canada), Ping Shi Zhu, Thomas Vandemoortele
PA782
Concurrent diagnostic pericardiocentesis and subcarinal mediastinal lymph node aspiration by EBUS TBNA Vishwanath Gella (Hyderabad, India), Vishwanath Gella, Snigdha Ghana, Upendra Srinivas
PA783
EBUS-TBNA: Risk factors for inadequate material Benan Caglayan (Istanbul, Turkey), Benan Caglayan, Sevda Sener Comert, Coskun Dogan, Dilek Ece, Ferhan Karatas, Gamze Celik, Sukran Mutlu, Onder Cetin
PA784
Endobronchial ultrasound-guided transbronchial needle biopsy (EBUS-TBNA) performed in thoracic operating room (OR) resulted in long use of resources Francois Arbib (Echirolles, France), François ARBIB, Anne-Claire Toffart, Michèle Fior-Gozlan, Sylvie Lemee, Amandine Briault, Martine Buchberger, Denis Moro-Sibilot, Jean-François Payen, Christophe Pison
PA785
Comparative yield of cytology/histology during EBUS in patients with mediastinal sarcoidosis Ilya Sivokozov (Moscow, Russian Federation), Ilya Sivokozov, Olga Lovacheva, Irina Shumskaya, Galina Evgushenko, Larisa Lepekha
PA786
Addition of EBUS-TBNA to bronchoscopic biopsies in the diagnosis of sarcoidosis Ping Shi Zhu (Montreal, Canada), Ping Shi Zhu, Thomas Vandemoortele
PA787
Preliminary experience with endobronchial ultrasound-guided transbronchial needle aspiration for sampling of mediastinal lymph nodes Leonello Fuso (Rome, Italy), Leonello Fuso, Francesco Varone, Daniele Magnini, Giulia Angeletti, Andrea Smargiassi, Riccardo Inchingolo
PA788
The underlying causes of granulomatous lymphadenitis detected by EBUS-TBNA Aslihan Gürün Kaya (Ankara, Turkey), Aslihan Gürün Kaya, Aydin çiledag, Fatma çiftçi, Elif Sen, Koray Ceyhan, Akin Kaya, Gökhan çelik, Ismail Savas
PA789
Usefulness of EBUS-TBNA in the diagnostics of stage 1 and 2 sarcoidosis Agata Kalicka (Bydgoszcz, Poland), Agata Kalicka, Cezary Rybacki
Hall 14-09
Session 100
12:50 - 14:40
Thematic Poster: Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Chairs : Daniela Gompelmann (Heidelberg, Germany), Karin Klooster (Groningen, Netherlands), Wolfgang Gesierich (Gauting, Germany), Lars Konge (Virum, Denmark) PA790
Acute radiological abnormalities after bronchial thermoplasty (BT) Julia d'Hooghe (Amsterdam, Netherlands), J.N.S. D’Hooghe, I.A.H. Van den Berk, P.I. Bonta, J.T. Annema
58
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA791
Safety of the application of bronchial thermoplasty with a modified protocol. Experience in our centre Ana Maria Rodrigo Troyano (Barcelona, Spain), Ana Rodrigo-Troyano, Ana Maria Muñoz-Fernández, Virginia Pajares, Cristina Burrel, Vicente Plaza, Alfons Torrego
PA792
Endobronchial valve treatment versus standard medical care in patients with emphysema without interlobar collateral ventilation Karin Klooster (Groningen, Netherlands), Karin Klooster, Nick H.T. Ten Hacken, Jorine E. Hartman, Huib A.M. Kerstjens, Eva M. Van Rikxoort, Dirk-Jan Slebos
PA793
Dislodgement of endobronchial Zephyr valves: An anatomical perspective Hugo Goulart De Oliveira (Porto Alegre, Brazil), Hugo Oliveira, Rafael Rambo, Silvia Oliveira, Amarilio Macedo-Neto
PA794
Endoscopic lung volume reduction (ELVR) in COPD: Improvements in gas transfer capacity correlate with improvements in ventilation and perfusion (VQ) matching Kelvin Hsu (Strathfield, Australia), Kelvin Hsu, Jonathan Williamson, Matthew J. Peters, Alvin J. Ing
PA795
Development of endoscopic valve therapy in patients with severe emphysema Daniela Gompelmann (Heidelberg, Germany), Daniela Gompelmann, Felix J.F. Herth, Nicola Ehlken, Claus Peter Heussel, Hans Hoffmann, Ralf Eberhardt
PA796
Endoscopic lung volume reduction (ELVR) treatment for patients with severe heterogeneous emphysema and bilateral incomplete fissures. Effectiveness and complications of coils´ implantation at 90 days follow up Konstantina Kontogianni (Heidelberg, Germany), Konstantina Kontogianni, Vasiliki Gerovasili, Maren Schuhmann, Daniela Gompelmann, Claus P. Heußel, Hans Hoffmann, Felix F.J. Herth, Ralf Eberhardt
PA797
Endoscopic lung volume reduction (eLVR) with endobronchial valves (EBV) in patients with hypercapnic respiratory failure Franziska Trudzinski (Homburg/Saar, Germany), Franziska Trudzinski, Dominik Ballek, Franziska Kaestner, Robert Bals, Sebastian Fähndrich, Philipp M. Lepper
PA798
Two-year safety of targeted lung denervation in patients with moderate to severe COPD Dirk-Jan Slebos (Groningen, Netherlands), Dirk-Jan Slebos, Karin Klooster, Coenraad Koegelenberg, Johan Theron, Martin Mayse, Chris T. Bolliger
PA799
Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure Arschang Valipour (Vienna, Austria), Arschang Valipour, Christophe Pison, Romain Kessler, Gaetan Deslee
PA800
Preliminary results of study of bronchoscopic hot saline ablation (BHSA) treatment, in emphysematous lung disease David Stav-Struhar (Zerrifin, Israel), David Stav, Isaac Shpirer, Noam Natiff
PA801
Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy Daniela Gompelmann (Heidelberg, Germany), Daniela Gompelmann, Tobias Hofbauer, Vicky Gerovasili, Ralf Eberhardt, Felix J.F. Herth, Hyun-ju Lim, Claus Peter Heussel
PA802
Regional specific gas volume as a potential tool for targeting lobes in endobronchial valve (EBV) treatment Caterina Salito (Milan, Italy), Caterina Salito, Andrea Aliverti
PA803
Endobronchial coils for COPD palliation: A single institution experience Korkut Bostanci (Istanbul, Turkey), Korkut Bostanci, Zeynep Bilgi, Hakan Omercikoglu, Sehnaz Olgun, Davor Stamenovic, Mustafa Yuksel
PA804
Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function Mathias Juech (Lostau, Germany), Mathias Jüch, Hans Jost Achenbach
PA805
Bronchiectasis after bronchial valve implantation Dominik Harzheim (Heidelberg, Germany), Dominik Harzheim, Daniela Gompelmann, Felix Herth, Maren Schuhmann, Ralf Eberhardt
PA806
Factors associated with good response in a cohort of patients with severe emphysema and complete inter-lobar fissures undergoing endo-bronchial valve insertion Bethannie McIntyre (Bristol, United Kingdom), Bethannie McIntyre, Paula Murphy, Tim Batchelor, Saveria Di Gerlando, Nabil Jarad
PA807
Bronchopleural fistula and pneumothorax following lung volume reduction coil treatment in severe emphysema: A case report A k n Gül en (Izmir, Turkey), Askin Gulsen, Fidan Sever, Pelin Girgin, Volkan Karacam
59
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA808
Mid-term follow-up data after endoscopic lung volume reduction with nitinol coils in patients with very severe emphysema Mathias Juech (Lostau, Germany), Mathias Jüch, Hans Jost Achenbach
PA809
Intrabronchial valve treatment in patients with severe heterogeneous emphysema and intact interlobar fissures Arschang Valipour (Vienna, Austria), Arschang Valipour, Sherwin Asadi, Veronika Hutya, Irene Firlinger, Marina Duller, Otto Chris Burghuber
Hall 14-10
Session 101
12:50 - 14:40
Thematic Poster: Interstitial lung diseases I Chairs : Nikolaos Tzanakis (Heraklion, Greece), Sophia E. Schiza (Heraklion, Crete, Greece), Zoe Daniil (Larisa, Greece), Elisabetta Renzoni (London, United Kingdom) PA810
Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation Tomoya Ishii (Kagawa, Japan), Tomoya Ishii, Takuya Inoue, Nobuyuki Kita, Akira Tadokoro, Naoki Watanabe, Nobuhiro Kanaji, Shuji Bandoh
PA811
Prevalence of active smokers among 49 patients affected by interstial lung diseases at two referral centers Paolo Pozzi (Milan, Italy), Paolo Pozzi, Munarini Elena, Luisi Francesca, Biffi Alice, Harari Sergio, Pesci Alberto, Boffi Roberto
PA812
Aerosol delivery of an immunomodulator (interferon- 1b) within mouse lungs Neil R. MacIntyre (Durham, United States of America), Neil MacIntyre, Sanjay Bhardwaj, Rohinton Toddywala
PA813
Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation Makiko Yomota (TOKYO, Japan), Makiko Yomota, Tatsuru Okamura, Yusuke Ohkuma, Yukio Hosomi, Hirotoshi Horio, Kazuteri Ohashi, Tsunekazu Hishima
PA814
Complications in transbrochial cryobiopsy (TCB) Lars Hagmeyer (Haan, Germany), Lars Hagmeyer, Kerstin Richter, Marcel Treml, Christina Priegnitz, Winfried Randerath
PA815
Rituximab for the treatment of chronic hypersensitivity pneumonitis IÑIGO OJANGUREN ARRANZ (Barcelona, Spain), Iñigo Ojanguren, Ana Villar, María Antonia Ramón, María Jesus Cruz, Xavier Muñoz, Ferran Morell
PA816
Distribution of pleural plaques and pulmonary fibrosis due to asbestos exposure: Radiological patterns in asbestosrelated disorders (ARDs) Heiko Michael Knoop (Bochum, Germany), Heiko Knoop, Phil Million, Andreas Weber, Fabian Wolter, Jürgen Behr
PA817
Acute fibrinous and organizing pneumonia: A retrospective study Rita Daniela Gomes Matos (Albergaria-a-Velha, Portugal), Rita Matos Gomes, Eva Padrão, Filipa Soares Pires, Inês Neves, Patrícia Mota, Natália Melo, Susana Guimarães, Conceição Souto Moura, António Morais
PA818
Nasal inspiratory peak flow in sicke cell disease Càssio Da Cunha Ibiapina (Belo Horizonte, Brazil), Cassio Ibiapina, Cristina Alvim, Ana Karine Vieira
PA819
Diffuse pulmonary ossification Jasna Tekavec-Trkanjec (Zagreb, Croatia), Jasna Tekavec-Trkanjec, Tatjana Peroš-Golubicic
PA820
Clinical and radiologic profile of the pseudotumoral silicosis Lamia Berny (Casablanca, Morocco), Lamia Berny, Hanane Benjelloune, Nahid Zaghba, Abdelaziz Bakhatar, Najiba Yassine
PA821
Pulmonary alveolar proteinosis in a cat Viktor Szatmári (Utrecht, Netherlands), Szatmári, Teske, Nikkels, Griese, De Jong, Grinwis, Theegarten, Veraa, Steenbeek, Drent, Bonella
PA822
Clinical, computed tomography, and cytological peculiarities of different variants of exogenic allergic alveolitis (EAA) Natalia Makaryants (Moscow, Russian Federation), Natalia Makaryants, Larisa Lepekha, Evgeniy Shmelev
PA823
The significance of bronchoalveolar or bronchial lavage in ARDS: Validation in 180 patients jumpei hisanaga (kumamoto, Japan), Jumpei Hisanaga, Kazuya Ichikado, Kodai Kawamura, Masakazu Yoshioka
PA824
Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis Tomoyuki Kakugawa (Nagasaki, Japan), Tomoyuki Kakugawa, Kazuhiro Tabata, Hirokazu Yura, Masaomi Tomonaga, Tatsuhiko Harada, Shota Nakashima, Atsuko Hara, Shintaro Hara, Noriho Sakamoto, Yuji Ishimatsu, Junya Fukuoka, Shigeru Kohno
60
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA825
Deficit of alpha-1-antitrypsin: Null allele Maria João Oliveira (Arcozelo - Vila Nova de Gaia, Portugal), Maria João Oliveira, Inês Ladeira, Miguel Guimarães, Ricardo Lima
PA827
Pulmonary aspergilloma (about 76 cases) Khaoula Elatiqi (Casablanca, Morocco), Hanane Benjelloun, Khaoula Elatiqi, Nahid Zaghba, Aziz Bakhatar, Najiba Yassine
PA828
Bronchobiliary fistula (BBF) easily confirmed with urinary dipstick test Jee-Hong Yoo (SEOUL, Republic of Korea), In Kyoung Hwang, Seon Hye Kim, Myung Jae Park, Hong Mo Kang, JeeHong Yoo
PA829
Isolated mosaic pattern due to bronchiolitis in non-transplant patients: Etiology in 60 cases André Bezerra Botelho (Sao Paulo, Brazil), Andre Botelho, Carlos A.C. Pereira, Regina Tibana, Maria Raquel Soares, Flavio Arbex, Lilian Kuranishi, Karen Storrer, Ester Coletta, Rimarcs Ferreira
Hall 14-11
Session 102
12:50 - 14:40
Thematic Poster: Sarcoidosis: clinical Chairs : Demosthenes Bouros (Athens, Greece), Paolo Spagnolo ( Liestal, Switzerland), Dominique Valeyre (Paris, France), Paola Rottoli (Siena, Italy) PA830
Cardiovascular magnetic resonance-guided diagnosis of cardiac sarcoidal affection Carmen Pizarro (Bonn, Germany), Carmen Pizarro, Andreas Goebel, Stefan Pabst, Christian Grohé, Daniel Thomas, Dirk Skowasch
PA831
Benefits of physical training in patients with sarcoidosis Bert Strookappe (Huissen, Netherlands), Bert Strookappe, Marjon Elfferich, Jeff Swigris, Ton Knevel, Marjolein Drent
PA832
A comparison of two scoring methods for the King’s sarcoidosis questionnaire Aish Sinha (Wolverhampton, United Kingdom), Aish Sinha, Sabrina Bajwah, Harry Gosker, Richard Siegert, Daniel Creamer, Genevieve Larkin, Toby Maher, Elisabetta Renzoni, Athol Wells, Irene Higginson, Surinder Birring, Amit Patel
PA833
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Anna Kempisty (Warszawa, Poland), Anna Kempisty, Beata Bialas-Chromiec, Jan Kus
PA834
A comparison of two scoring methods for the King’s brief interstitial lung disease questionnaire Aish Sinha (Wolverhampton, United Kingdom), Aish Sinha, Sabrina Bajwah, Harry Gosker, Richard Siegert, Daniel Creamer, Genevieve Larkin, Toby Maher, Elisabetta Renzoni, Athol Wells, Irene Higginson, Surinder Birring, Amit Patel
PA835
Fatigue in sarcoidosis; effect on quality of life and health status Chris Atkins (Norwich, United Kingdom), Chris Atkins, Daniel Gilbert, Claire Brockwell, Sue Robinson, Andrew Wilson
PA836
Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis Zehra Asuk Yasar (Bolu, Turkey), Zehra Yasar, Erdogan Cetinkaya, Elif Tanriverdio, Aysel Kargi, Sule Gul, Fahrettin Talay, Akif Ozgül
PA837
Optimal use of gas transfer values in detecting pulmonary vascular involvement in sarcoidosis Vasileios Kouranos (Athens, Greece), Vasileios Kouranos, Simon Ward, Maria Kokosi, Joe Jacob, Diego Castillo, Felix Chua, Toby Maher, Andrew Nicholson, David Hansell, Elisabetta Renzoni, Athol Wells
PA838
Steroid treatment effect in pulmonary sarcoidosis (STEPS study) Caroline Broos (Rotterdam, Netherlands), Caroline Broos, Marlies Wijsenbeek, Leon Van den Toorn, Hans In ’t Veen, Roxane Heller, Marco Grootenboers, Monique Wapenaar, Henk Hoogsteden, Mirjam Kool, Bernt Van den Blink
PA839
Comorbid illnesses in South African patients with sarcoidosis Rajen Morar (Johannesburg, South Africa), Rajen Morar, Charles Feldman
PA840
Pulmonary function tests as predictors of mortality in patients with sarcoidosis Vasileios Kouranos (Athens, Greece), Vasileios Kouranos, Aggeliki Rapti, Anastasios Kallianos, Ourania Anagnostopoulou, Ioannis Arapis, George Kaltsakas, Charalampos Kostopoulos, George Tzelepis, Nikolaos Koulouris, Petros Sfikakis, Athol Wells, Elias Gialafos
PA841
Sarcoidosis in Johannesburg, South Africa: A retrospective study Rajen Morar (Johannesburg, South Africa), Rajen Morar, Charles Feldman
PA842
Evaluation of ventricular arrhythmogenesis in patients with sarcoidosis Gülistan Karadeniz (Izmir, Turkey), Fatma Ucsular, Gulistan Karadeniz, Cem Karadeniz, Enver Yalniz, Melike Demir
61
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA843
Methotrexate as a single agent for the treatment of patients with progressive pulmonary sarcoidosis Alexander Vizel (Kazan, Russian Federation), Irina Vizel, Alexander Vizel
PA844
Subcutaneous sarcoidosis: A clinical analysis of nine patients Masaru Ando (Oita, Japan), Masaru Ando, Mari Yamasue, Masataka Kan, Kenji Umiki, Shin-ichi Nureki, Yutaka Hatano, Eishi Miyazaki, Jun-ichi Kadota
PA845
Role of infliximab in managing resistant ventricular arrhythmias in sarcoidosis Shruthi Konda (London, United Kingdom), Shruthi Konda, Felix Chua, Magdi Saba, Ranjit Pagonda, Raminder Aul
PA846
Relationship between radiologic patterns, pulmonary function values and BALF cells in newly diagnosed sarcoidosis Regina Aleksoniene (Vilnius, Lithuania), Regina Aleksoniene, Ingrida Zeleckiene, Mindaugas Mataciunas, Roma Puronaite, Edvardas Danila
PA847
Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis Serge Lebecque (Lyon, France), Serge Lebecque, Toufic Renno, Azzak Bentaher, Marine Ponchon, Alain Calender, JeanFrançois Bernaudin, Dominique Valeyre, Marc Iglarz, Herve Farine, Daniel Strasser, Yves Pacheco
PA848
Polymorphisms of activating FCGR2A and FCGR2C genes in the etiopathogenesis of sarcoidosis Anna Dubaniewicz (Gda sk, Poland), Marlena Typiak, Krzysztof Rebala, Jan Marek Slominski, Zbigniew Jankowski, Anna Dubaniewicz
PA849
Inorganic exposome in pediatric sarcoidosis: The PEDIASARC study Nadia Nathan (Paris, France), Nadia Nathan, Catherine Cavallin, Odile Macchi, Rola Abou Taam, Dominique Valeyre, Veronique Houdouin, Harriet Corvol, Caroline Perisson, Abdellatif Tazi, Xavier Amiot, Ralph Epaud, Anne Houzel, Nassima Hamami, Antoine Deschildre, Jacques De Blic, Annick Clement, Michel Vincent, Paul-André Rosental
Hall 14-12
Session 103
12:50 - 14:40
Thematic Poster: Translational research in respiratory care: new findings Chairs : Aurelie Fabre (Dublin, Ireland), Philipp A. Schnabel (Homburg/Saar, Germany), Helmut H. Popper (Graz, Austria), Nicolas Kahn (Heidelberg, Germany)
PA850
LATE-BREAKING ABSTRACT: Disturbed mitochondrial dynamics and network in diaphragm muscle fibers of mechanically ventilated critically ill patients Marloes van den Berg (Utrecht, Netherlands), Marloes van den Berg, Pleuni E. Hooijman, Albertus Beishuizen, Monique C. de Waard, Armand R.J. Girbes, Angelique Spoelstra - de Man, Ruud Zaremba, Michael W. Lawlor, Ger J.M. Stienen, Koen J. Hartemink, Marinus A. Paul, Roberto Bottinelli, Maria A. Pellegrino, Rob C.I. Wst, Coen A.C. Ottenheijm
PA851
LATE-BREAKING ABSTRACT: Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD Craig Wheelock (Stockholm, Sweden), David Balgoma, Mingxing Yang, Marcus Sjodin, Stuart Snowden, Reza Karimi, Bettina Levanen, Heta Merikallio, Riitta Kaarteenaho, Lena Palmberg, Kjell Larsson, David Erle, Sven-Erik Dahlen, Barbro Dahlen, Magnus Skold, Asa Wheelock, Craig Wheelock
PA852
LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort Chih Hsi Kuo (London, United Kingdom), Scott Chih-Hsi Kuo, Yike Guo, Ioannis Pandis, Stelios Pavlidis, Uruji Hoda, Christos Rossios, Julie Corfield, Ana Sousa, Ratko Djukanovic, Matthew Loza, Fred Baribaud, Peter J. Sterk, Ian M Adcock, Kian-Fan Chung
PA853
Genetic basis of familial spontaneous pneumothorax and lung cysts in an Indian family Suman Paul (Burdwan, India), Suman Paul, Anindita Ray, Bidyut Roy, Susmita Kundu
PA854
Inflammatory gene polymorphisms in asthma and chronic obstructive pulmonary disease in Venezuela Nancy Larocca (Caracas, Venezuela), Nancy Larocca, Dolores Moreno, Jenny Garmendia, Felix Toro, Juan De Sanctis
PA855
Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD Svetlana K. Soodaeva (Moscow, Russian Federation), Svetlana Soodaeva, Nailya Kubysheva, Larisa Postnikova, Marina Boldina, Kubat Rahatbek, Timur Li, Igor Klimanov
PA856
Distinctive role of B-crystallin in COPD pathogenesis of smokers and non-smokers Radostina Cherneva (Sofia, Bulgaria), Radostina Cherneva, Ognaian Daniela, Daniela Petrova, Dimitrina Dimitrova, Dimo Dimov, Tatyana Vlaykova
PA857
The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease Rosa Faner Canet (Barcelona, Spain), Rosa Faner, Alba Gutiérrez-Sacristán, Ady Castro-Acosta, Solene Grosdidier, Jose Luis Lopez-Campos, Francisco Pozo-Rodriguez, Ferran Sanz, Laura Furlong, Alvar Agusti
62
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA858
Endoplasmic reticulum disorganization is present in chronic obstructive pulmonary disease patients Julie Weidner (Lund, Sweden), Julie Weidner, Leif Bjermer, Ellen Tufvesson
PA859
Modulation of symmetric dimethyarginine formation by apelin in human pulmonary endothelial cells Lars Harbaum (Hamburg, Germany), Lars Harbaum, Antonia Glatzel, Hans Klose, Rainer H. Böger, Nicole Lüneburg
PA860
Gene expression changes in human bronchial epithelial cells in response to leukotriene E4 Siiri Altraja (Tartu, Estonia), Siiri Altraja, Mario Mitt, Alan Altraja
PA861
MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD Tanya Tacheva (Stara Zagora, Bulgaria), Tanya Tacheva, Dimo Dimov, Pavlina Chelenkova, Rumena Petkova, Krasimir Dimov, Stoyan Chakarov, Tatyana Vlaykova
PA862
Asthma and diabetes: Possible markers of their co-existence. The possible role of transcription factors GATA-3 and T-bet and negative regulator of transcription SOCS1 in the worsening of asthma Michael Nyoma (St. Petersburg, Russian Federation), Vasily Ivanov, Lada Sorokina, Valeriy Mineev, Mikhail Nyoma, Anna Eremeeva, Ecaterina Rubeko, Snejana Petrova, Vasiliy Trofimov
PA863
Markers of ageing in the limb muscle of patients with COPD Ramzi Lakhdar (Edinburgh, United Kingdom), Ramzi Lakhdar, Ellen Drost, Paul G. Shiels, William MacNee, Roberto Rabinovich
PA864
Identification of extracellular nucleic acids and neutrophil extracellular traps in blood of patients with communityacquired pneumonia Larissa Muravlyova (Karaganda, Kazakhstan), Larissa Muravyova, Vilen Molotov-Luchanskiy, Ryszhan Bakirova, Dmitriy Klyuyev, Lyudmila Demidchik, Yevgenia Kolesnikova
PA865
Metabolic alteration in red blood cells from patients with community-acquired pneumonia Dmitriy Klyuyev (Karaganda, Kazakhstan), Dmitiry Klyuyev, Larissa Muravyova, Vilen Molotov-Luchanskiy, Ryszhan Bakirova, Lyudmila Demidchik, Yevgenia Kolesnikova
PA866
Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency Adriana Ro y (Warsaw, Poland), Adriana Rozy, Katarzyna Duk, Joanna Chorostowska-Wynimko
PA867
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo Beata Pop awska-Wi niewska (Warszawa, Poland), Beata Poplawska-Wisniewska, Jadwiga Popow-Stellmaszyk, Radoslaw Struniawski, Aneta Stepniewska, Emil Wojda, Magdalena Wysocka, Pawel Sliwinski, Malgorzata CzajkowskaMalinowska, Beata Wajda, Dorota Krawiecka, Ewa Jassem, Sabina Janciauskiene, Adam Lesner, Joanna ChorostowskaWynimko
Hall 14-13
Session 104
12:50 - 14:40
Thematic Poster: New insights into lung disease pathogenesis Chairs : Louise Donnelly (London, United Kingdom), Mazen Al-Alawi (Dublin, Ireland), Catherine Greene (Dublin, Ireland), Isis Enlil Fernandez (Munchen, Germany)
PA868
Hyaluronic acid is associated with survival time in stable COPD independently of exacerbation rate, BODE index and adjusted Charlson score Eleni Papakonstantinou (Thessaloniki, Greece), Eleni Papakonstantinou, Ioannis Bonovolias, Michael Roth, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Ioachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte, Daiana Stolz
PA869
Distinct localization of estrogen receptors in lungs of severe COPD patients Juanita H.J. Vernooy (Maastricht, Netherlands), Gonda Konings, Niki Reynaert, Andrea Romano, Emiel Wouters, Juanita Vernooy
PA870
Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Raphael Lhote (Suresnes, France), Raphael Lhote, Tasnime Issoufaly, Christine Therodore, Loic Guillevin, Dominique François, Jean-Emmanuel Kahn, Louis-Jean Couderc, Colas Tcherakian
PA871
Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results Susan Jane Wilson (Southampton, United Kingdom), Susan Wilson, Borislav Dimitrov, Ratko Djukanovic, Jonathan Ward, Ana Sousa, Julie Corfield, Peter Sterk, K. Fan Chung, Brabro Dahlen, Pascal Chanez, Dominick Shaw, Norbert Krug, Thomas Sandstrom, Peter Howarth, UBIOPRED Consortium
63
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA872
Validation of the pitavastatin-induced angiomotin-like protein 1 that controls tight junction stability of lung microvascular endothelial cells via LKB1/AMPK activation Yutaka Nakamura (Morioka, Japan), Rioto Suzuki, Yutaka Nakamura, Tomoki Mizuno, Kazuyuki Abe, Yuka Kaneko, Wataru Shigeeda, Tatsuo Tanita, Kohei Yamauchi
PA873
Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD Kristina Andelid (Göteborg, Sweden), Kristina Andelid, Pernilla Glader, Shigemi Yoshihara, Anders Andersson, Ann Ekberg-Jansson, Anders Lindén
PA874
Transforming growth factor alpha expression in a transgenic mouse model impairs lung and diaphragm mechanics Kimberley Wang (Canning Vale, Australia), Kimberley Wang, Christine Astell, Philip Wijesinghe, Alexander Larcombe, Gavin Pinniger, Brendan Kennedy, Graeme Zosky, David Sampson, Alan James, Timothy Le Cras, Peter Noble
PA875
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Juliy Perelman (Blagoveshchensk, Amur Oblast, Russian Federation), Juliy M. Perelman, Anna G. Prikhodko, Elena V. Ushakova, Victor P. Kolosov
PA876
The effect of interleukin-1 on lung ventilation and hypoxic chemoreception Galina Danilova (Saint Petersburg, Russian Federation), Galina A. Danilova, Nina P. Aleksandrova
PA877
TNF- -induced NF- B activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1 Alexander H Remels (Maastricht, Netherlands), Alexander Remels, Harry Gosker, Koen Verhees, Ramon Langen, Annemie Schols
PA878
A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma Frederic Baribaud (Springhouse, United States of America), Frédéric Baribaud, Huiqing Liu, Patrick Branigan, Daniel Horowitz, Yanqing Chen, Joshua Wertheimer, Joel Tocker, Matthew Loza
PA879
Aspiration, epithelial injury and lung diseases Adil Aldhahrani (Newcastle, United Kingdom), Adil Aldhahrani, Jeffrey Pearson, Christopher Ward
PA880
Macrophage phenotype does not affect protease anti-protease imbalance in COPD Jessica Tilman (London, United Kingdom), Jessica Tilman, Amy Day, Natasha Madge, Peter Barnes, Louise Donnelly
PA881
Role of protein phosphatase 5 (PP5) in mediating corticosteroid insensitivity in airway smooth muscle (ASM) cells in severe asthma Latifa Chachi (Leicester, United Kingdom), Latifa Chachi, Mahnaz Abbasian, Adelina Gavrila, Omar Tliba, Christopher Brightling, Yassine Amrani
PA882
Induced sputum supernatant eicosanoids during oral aspirin challenge of asthmatic patients with and without aspirin hypersensitivity and healthy controls Maria Ignacak (Krakow, Poland), Maria Ignacak, Natalia Celejewska-Wojcik, Krzysztof Wojcik, Aleksandra Cholewa, Kinga Salapa, Krzysztof Oles, Krzysztof Sladek, Jacek Musial, Lucyna Mastalerz
PA883
B-cell activating factor: The architect of lymphoid follicles in severe COPD Francesca Polverino (Brookline, United States of America), Francesca Polverino, Borja Cosio, Maria Laucho-Contreras, Jaime Pons, Amanda Iglesias, Andreas Jahn, Jaume Sauleda, Miguel Divo, Victor Pinto-Plata, Alvar Agusti, Bartolome Celli, Caroline Owen
PA884
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients brahim Koç (Gaziantep, Turkey), Ibrahim Koc, Bulent Gogebakan, Recep Bayraktar, Demet Tasdemir, Ufkun Ozdemir, Ian Adcock, Hasan Bayram
PA885
Bacterial load is associated with neutrophilic sputum in severe asthmatics Chris Newby (Leicester, United Kingdom), Afsaneh Maleki, Chris Newby, Dhananjay Desai, Koirobi Haldar, Amisha Singapuri, Michael Barer, Rod Smallwood, Chris Brightling
PA886
Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment Amr Alderawi (Wolverhampton, United Kingdom), Amr Alderawi, Simon Dunmore, Gaetano Caramori, Andrew Hitchings, Emma Baker, Paul Kirkham
Hall 14-14
Session 105
12:50 - 14:40
Thematic Poster: Airway remodelling: recent developments Chairs : Sukhwinder Singh Sohal (Launceston, Australia), Colin Bingle (Sheffield, United Kingdom), Alen Faiz (Groningen, Netherlands), Chair to be confirmed
64
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA887
Characterisation of lung-resident pericytes in a house dust mite-driven model of asthma Jessica Rowley (London, United Kingdom), Jessica Rowley, Kate Strong, Jill Johnson
PA888
p53 dysfunction increased mitochondrial biogenesis and bronchial smooth muscle cell proliferation in asthma Thomas TRIAN (Bordeaux, France), Thomas Trian, Benoit Allard, Elise Maurat, Isabelle Dupin, Olga Ousova, PierreOlivier Girodet, Roger Marthan, Patrick Berger
PA889
Increased circulating fibrocytes associated with lung function decline in COPD patients with desaturation during 6 minute walk test Chun-Hua Wang (Taipei, Taiwan), Chun-Hua Wang, Tzu-Ting Huang, Han-Pin Kuo
PA890
Lysyl oxidases in idiopathic pulmonary fibrosis: A key participant in collagen I matrix remodelling Gavin Tjin (Sydney, Australia), Gavin Tjin, Annabelle Mahar, Eleanor Kable, Janette Burgess
PA891
Pulmonary fibroblasts are affected by notch ligands in vitro Katharina Heugenhauser (Innsbruck, Austria), Katharina Heugenhauser, Kathrin Watzinger, Christian M. Kaehler
PA892
LSC Abstract – High mobility group box 1 modulates lung innate immunity by promoting wound healing and cytokine release in human bronchial epithelial cells Oluwaseun Ojo (Winnipeg, Canada), Oluwaseun Ojo, Min Hyung Ryu, Gerald Stelmack, Aruni Jha, Jacquie Schwartz, Andrew Halayko
PA893
Effect of nintedanib, pirfenidone, N-acetylcysteine and their combinations on cultured myofibroblast-type cells derived from patients with asbestosis and idiopathic pulmonary fibrosis Anniina Veijola (Oulu, Finland), Anniina Veijola, Riitta Kaarteenaho, Siri Lehtonen
PA894
Transforming growth factor alpha increases extracellular matrix within the airway smooth muscle layer in a transgenic mouse model of airway disease John Elliot (Perth, Australia), John Elliot, Alan James, Kimberley Wang, Alexander Larcombe, Graeme Zosky, Timothy Le Cras, Peter Noble
PA895
A possible role of Krüppel-like factor 5 in small airway wall fibrosis in COPD Hisatoshi Sugiura (Sendai, Japan), Hisatoshi Sugiura, Kyoko Abe, Yuichiro Hashimoto, Akira Koarai, Mitsuhiro Yamada, Tadahisa Numakura, Katsuhiro Onodera, Masakazu Ichinose
PA896
Link between airway inflammation and remodeling: TNF induces airway smooth muscle cell proliferation via an ET1/GMCSF/IL6 network Juergen Knobloch (Bochum, Germany), Juergen Knobloch, Sarah Yanik, Sandra Körber, David Jungck, Erich Stoelben, Andrea Koch
PA897
The critical role of bronchial smooth muscle remodeling in non-severe asthma Pierre-Olivier Girodet (Bordeaux, France), Pierre-Olivier Girodet, Benoit Allard, Matthieu Thumerel, Hugues Begueret, Isabelle Dupin, Olga Ousova, Elise Maurat, Annaig Ozier, Thomas Trian, Roger Marthan, Patrick Berger
PA898
The extracellular matrix deposited by asthmatic airway smooth muscle cells in a resting state reflects a healthy matrix Louise Harkness (Tarrawanna, Australia), Louise Harkness, Anthony Ashton, Janette Burgess
PA899
Airway remodelling in the U-BIOPRED severe asthma cohort Susan Jane Wilson (Southampton, United Kingdom), Susan Wilson, Jonathan Ward, Helen Rigden, Ana Sousa, Julie Corfield, Peter Sterk, K. Fan Chung, Djukanovic Ratko, Brabro Dahlen, Pascal Chanez, Dominick Shaw, Norbert Krug, Thomas Sandstrom, Peter Howarth, U-BIOPRED Consortium
PA900
Different stages of wound repair in differentiated human bronchial epithelial cells show altered microRNA expression Beata Narozna (Poznan, Poland), Beata Narozna, Aleksandra Szczepankiewicz, Peter M. Lackie, John W. Holloway
PA901
Farm dust extract increases the epithelial barrier function of bronchial epithelial cells Luciën van der Vlugt (Alphen aan den Rijn, Netherlands), Luciën E.P.M. Van der Vlugt, Katrien Eger, Gimano D. Amatngalim, Christoph Müller, Franz Bracher, Erika Von Mutius, Hermelijn H. Smits, Pieter S. Hiemstra
PA902
Epithelial to mesenchymal transition in basal progenitor epithelial cells cultured from smokers and COPD patients Jo-Maree Courtney (Blackmans Bay, Australia), Jo-Maree Courtney, Patricia Spafford, Kaitlyn Scolyer, Cameron Hunter, E. Haydn Walters
PA903
Epithelial mesenchymal transition (EMT) in small and large airways of smokers; and relation to airflow obstruction Sukhwinder Singh Sohal (Launceston, Australia), Sukhwinder Singh Sohal, Malik Quasir Mahmood, Shakti Dhar Shukla, Ashutosh A. Hardikar, Wan Danial Noor, H. Konrad Muller, Darryl Knight, Eugene Haydn Walters
65
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA904
Potential role of SPARC, a downstream mediator of TGF-b in chronic airways disease Sharon Wong (Maroubra, Australia), Sharon Wong, Zaridatul Ibrahim, Peter Wark, Maria Sukkar
PA905
Surface-bound TIMP-1 on PMNs promotes pericellular proteolysis: A new culprit in COPD? Francesca Polverino (Brookline, United States of America), Francesca Polverino, Li Zhang, Maria Laucho-Contreras, Caroline Owen
Hall 14-15
Session 106
12:50 - 14:40
Thematic Poster: Translational studies in airway cell biology Chairs : Bernd Schmeck (Marburg, Germany), Julie Laval (Tübingen, Germany), Ann B. Millar (BRISTOL, United Kingdom), Chair to be confirmed
PA906
Particulate matter-induced microparticle generation by human endothelial cells: A novel link between cardiopulmonary diseases and airborne pollutants Tommaso Neri (PISA, Italy), Tommaso Neri, Laura Pergoli, Silvia Petrini, Francesca Faita, Cristina Balia, Valentina Scalise, Mirjam Hoxha, Federica Rota, Roberto Pedrinelli, Pierluigi Paggiaro, Valentina Bollati, Alessandro Celi
PA907
Electrophysiological study of the ENaC function of sheep tracheal epithelium with and without cigarette smoke extract exposure Sotirios Zarogiannis (Larisa, Greece), Sotirios Zarogiannis, Alexandros Grammatikopoulos, Rajesh Jagirdar, Dimitris Magouliotis, Vassiliki Peppa, Zoi Arsenopoulou, Ioannis Makantasis, Paschalis Adam Molyvdas, Konstantinos Gourgoulianis, Chrissi Hatzoglou
PA908
An integrated culture system for in vitro human airway modeling Juan Hou (Vancouver, Canada), Juan Hou, Michael Riedel, Terry Thomas, Allen Eaves, Shron Louis
PA909
Mitochondrial function in three different types of airway epithelial cells Weerawon Thangboonjit (London, United Kingdom), Weerawon Thangboonjit, Peter Barnes, Andrew Durham, Ian Adcock
PA910
CEACAM6-high airway neutrophils and epithelial cells are a feature of severe asthma Aarti Parmar (Leicester, United Kingdom), Aarti Shikotra, David Choy, Salman Siddiqui, Greer Arthur, Deepti Nagarkar, Jia Guiquan, Chandra Ohri, Emma Doran, Claire Butler, Beverley Hargadon, Alexander Abbas, Janet Jackman, Lawren Wu, Liam Heaney, Joe Arron, Peter Bradding
PA911
Effect of whole cigarette smoke exposure and CCSP on MUC5AC mucin production in primary cultures of human bronchial epithelial cells at air-liquid interface of COPD, smokers and control patients Jeremy Charriot (Montpellier, France), Jérémy Charriot, Aurélie Petit, Lucie Knabe, Gamez Anne-Sophie, Isabelle Vachier, Arnaud Bourdin
PA912
Characterisation of a novel 3D model of the airways Tankut G. Guney (London, United Kingdom), Tankut G. Guney, Henry Danahay, Andrew L. Durham, Christos Rossios, Fan Chung, Mark Dowling, Ian Adcock
PA913
Neutrophil elastase contributes to activated human neutrophil-induced rat small airway dysfunction Natasha Madge (Kent, United Kingdom), Natasha Madge, Louise Donnelly, Duncan Rogers
PA914
Characterization of toll-like receptor 7 (TLR7) expression on airway nerves Matthew Drake (Portland, United States of America), Matthew Drake, Katherine Lebold, Emily Blum, Allison Fryer, David Jacoby
PA915
Effect of respiration on primary human alveolar epithelial cells Andreas Stucki (Bern, Switzerland), Andreas O. Stucki, Sean R.R. Hall, Janick D. Stucki, Marcel Felder, Yves Mermoud, Ralph A. Schmid, Thomas Geiser, Olivier T. Guenat
PA916
Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Chao Zhang (HangZhou, China), Chao Zhang, Yan-Ping Wu, Jiao-Fei Cao, Yun Zhao, Zhi-Hua Chen, Hua-Hao Shen
PA917
Seasonal variation in success and ciliation of airway epithelial cells cultured at air-liquid interface; patients samples referred for primary ciliary dyskinesia testing Claire Jackson (Southampton, United Kingdom), Claire Jackson, Janice Coles, James Thompson, Jane Lucas
PA918
Chemotaxis of mesenchymal progenitor cells in the murine lung Kate Strong (London, United Kingdom), Kate Strong, Jess Rowley, Jill Johnson
PA919
Expression and function of a novel membrane-spanning protein, MS4A8B, in the human airways Li Eon Kuek (Melbourne , Australia), Li Eon Kuek, Mark Hulett, Donna Davies, Graham Mackay
66
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA920
PCDH1: Localization and cell-adhesion in airway epithelium in asthma Grissel Faura Tellez (Groningen, Netherlands), Grissel Faura Tellez, Uilke Brouwer, Brigitte Willemse, Jacobien Noordhoek, Irene Hejink, Maaike Vries de, Natalie Smithers, Dirkje Postma, Wim Timens, Laura Wiffen, John Holloway, Peter Lackie, Martijn Nawijn, Gerard Koppelman
PA921
Analysing disease-specific variants of thymic stromal lymphopoietin (TSLP) in asthma Jessica Donaldson (Southampton, United Kingdom), Jessica Donaldson, David Smart, Emily Swindle, Matt Edwards, Peter Howarth, Donna E. Davies
PA922
Differential expression of uPAR in cultured bronchial epithelial cells from asthma patients Sangita Bhatti (Nottingham, United Kingdom), Sangita Bhatti, Michael Portelli, Mariel Slater, Dominick Shaw, Ian Sayers
PA923
Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma Siri Lehtonen (Oulu, Finland), Siri Lehtonen, Henna Karvonen, Elisa Lappi-Blanco, Raija Sormunen, Riitta Kaarteenaho
PA924
Altered airway epithelial cell specification in COPD Sophie Gohy (Tervuren, Belgium), Sophie Gohy, Chantal Fregimilicka, Bruno Detry, Caroline Bouzin, Birgit Weynand, Charles Pilette
PA925
Effects of diesel exhaust on differentiated primary bronchial epithelial cells using in vitro exposure system Maria C Zarcone (Oegstgeest, Netherlands), Maria C. Zarcone, Evert Duistermaat, Annemarie Van Schadewijk, Pieter S. Hiemstra, Ingeborg M. Kooter
Hall 14-16
Session 107
12:50 - 14:40
Thematic Poster: Pulmonary fibrosis: mechanisms of disease Chairs : Gunilla Westergren-Thorsson (Lund, Sweden), Philippe Bonniaud (Dijon, France), Seamas Donnelly (Dublin, Ireland), Eric White (Ann Arbor, United States of America) PA926
C21, a nonpeptide angiotensin II type 2 receptor agonist attenuates lung fibrosis and associated cardiac dysfunction michael katovich (Gainesville, United States of America), Anandharajan Rathinasabapathy, Alana Horowitz, Kelsey Horton, Ulrike Steckelings, Thomas Unger, Colin Sumners, Mohan Raizada, Vinayak Shenoy, Michael Katovich
PA927
Infliximab, an anti-tumor necrosis factor- attenuates bleomycin-induced pulmonary fibrosis in rats Nejat Altintas (SAMSUN, Turkey), Nejat Altintas, Mustafa Erboga, Cevat Aktas
PA928
Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis Keren Borensztajn (Paris, France), Charlène François, Raphaël Borie, Olivier Bardou, Awen Menou, Bruno Crestani, Keren Borensztajn
PA929
KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model Katy Roach (Leicester, United Kingdom), K.M. Roach, P. Bradding
PA930
A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis Mayoko Tsuji (Tokyo, Japan), Maoko Tsuji, Masae Morishia, Kazuhiko Shimizu, Mitsuko Kondo, Jun Tamaoki, Taichi Ezaki
PA931
Altered extracellular matrix in transplanted lungs as a potential marker for chronic rejection Catharina Mueller (Lund, Sweden), Catharina Müller, Annika Andersson-Sjöland, Krister Mogianos, Hans Henrik Schultz, Claus B. Andersen, Martin Iversen, Gunilla Westergren-Thorsson
PA932
Increased levels of glycosaminoglycans in lungs from patients with IPF Oskar Hallgren (Lund, Sweden), Gunilla Westergren-Thorsson, Annika Nybom, Göran Dellgren, Xiao-Hong Zhou, Leif Bjermer, Oskar Hallgren
PA933
BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1 Janette K Burgess (Missenden Road, Australia), Janette Burgess, Lizzie Munk, Jade Jaffar, Judith Black, Brian Oliver
PA934
SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs) Peter Paluch (Prague, Czech Republic), Peter Paluch, Martina Sterclova, Irena Brabcova, Ondrej Viklicky, Martina Vasakova
PA935
mTOR signalling is an essential pathway for TGF- 1 induced collagen synthesis Hannah Woodcock (London, United Kingdom), Hannah Woodcock, Simon Peace, Carmel Nanthakumar, Toby Maher, Paul Mercer, Rachel Chamers
67
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA936
Romidepsin (FK228) target focal adhesion kinase (FAK) expression in lung fibrosis franco conforti (southamtpon, United Kingdom), Franco Conforti, Leanne Wickens, Mark Jones, Paul Skipp, Kate O’Reilly, Donna Davies
PA937
Erythropoietin (EPO) inhibits the immunohistochemical expression of lysyl oxidase (LOX) in bleomycin (BLM)induced pulmonary fibrosis (PF) in rats Drosos Tsavlis (Thessaloniki, Greece), Drosos Tsavlis, Afroditi Papadopoulou, Anastasia Tektonidou, Anna Tzoumaka
PA938
Establishment of alveolar epithelial progenitor cells from the lung with ABCA3 mutations Chiharu Ota (Sendai, Japan), Chiharu Ota, Yukiko Tando, Satoshi Kamata, Yusuke Takei, Mitsuhiro Yamada, Mutsuo Yamaya, Shigeo Kure, Hiroshi Kubo
PA939
HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells Vijay D'Souza (Birmingham, United Kingdom), Vijay D’Souza, Domokos Bartis, Aaron Scott, Fang Gao Smith, David Thickett
PA940
Arginase 1 contributes to fibrogenesis in the lungs of silica-challenge mice Davidson Furtado Dias (Rio de Janeiro, Brazil), Davidson Furtado Dias, Bianca Torres Ciambarella, Vinícius De Frias Carvalho, Marco Aurélio Martins, Patrícia Machado Rodrigues e Silva Martins
PA941
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Faheem Khan (Dublin, Ireland), Faheem Khan, D. White, E.P. Judge, S. Walsh, J. Worrell, E. Cotter, R. Kane, A. Fabre, M.P. Keane, M.W. Butler
PA942
Effects of bone-marrow derived mononuclear cells from silicotic and healthy donors in experimental silicosis Helena Oliveira (Rio de Janeiro, Brazil), Helena Oliveira, Elga Bandeira, Miquéias Lopes-Pacheco, Johnatas Silva, Christina Takyia, Patrícia Rocco, Marcelo Morales
PA943
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model Masato Uji (Osaka, Japan), Masato Uji, Yuko Kureya, Kazuhiro Yamada, Tetsuya Watanabe, Kazuhisa Konishi, Kazuhisa Asai, Tatsuo Nakamura, Kazuto Hirata
PA944
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Luca Tamò (Bern, Switzerland), Luca Tamò, Amiq Gazdhar, Anis Feki, Thomas Geiser
PA945
Effect of low level laser therapy in a model of pulmonary idiopathic fibrosis Nicole Oliveira (São Paulo, Brazil), Nicole Cristine Rigonato-Oliveira, Aurileia Aparecida Brito, Gabriel Moraes, Clariana Soares, Jefferson Comin Aquino-Junior, Luana Beatriz Vitoretti, Rodolfo de Paula Vieira, Ana Paula Ligeiro-Oliveira
Hall 14-17
Session 108
12:50 - 14:40
Thematic Poster: Lung function: exploring the boundaries of the respiratory system Chairs : Liam Welsh (Melbourne, Australia), Karl Sylvester (Streatley, United Kingdom), Tiago Jacinto (Senhora da Hora, Portugal), Monika Franczuk (Warszawa, Poland) PA946
Reference equations for peak nasal inspiratory flow in Portuguese adults Ivânia Gonçalves (Vila Nova de Famalicão, Portugal), Ivânia Gonçalves, Ana Margarida Pereira, Tiago Jacinto, Luís Araújo, Mariana Couto, Ana Sá-Sousa, Helena Pité, Mário Morais-Almeida, João Fonseca
PA947
FEV1 and sRaw in bronchial challenge testing, exchangeable or supplementaFEV1 and sRaw in bronchial challenge testing, exchangeable or supplemental? Florine J.E. van der Horst-van der Vegt (Gravenhage, Netherlands), Florine Van der Horst, Jelmer Vahl, Saar Van Nederveen, Guustaaf Van der Meijden, Harry Heijerman
PA948
Usefulness of respiratory impedance by measuring at functional residual capacity position Toshiyuki OGASA (Kitami City, Hokkaido, Japan), Toshiyuki Ogasa, Shinobu Osanai
PA949
Correlations between fractional exhaled nitric oxide and age and lung function in healthy Thai adults Wilaiwan Khrisanapant (Khon Kaen, Thailand), Wilaiwan Khrisanapant, Tichanon Promsrisuk, Orapin Pasurivong, Watchara Boonsawat, Boonsong Patjanasoontorn, Burabha Pussadhamma, Paitoon Benjapornlert
PA950
Comparison of different inspiratory muscle warm-up protocols Jana Kivastik (Tartu, Estonia), Jana Kivastik, Mati Arend, Jarek Mäestu
PA951
Electromyography activity of the rectus abdominis, internal oblique, and external oblique muscles during forced expiration in healthy adults Kenichi Ito (Habikino-shi,Osaka, Japan), Kenichi Ito, Koji Nonaka, Shinya Ogaya, Jun Horie
68
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA952
Assessment of the Japanese reference value of a new portable instrument for the diffusing capacity of the lungs for carbon monoxide Makiko Nakano (Tokyo, Japan), Makiko Nakano, Satoko Iwasawa, Akiyo Tanaka, Miyuki Hirata, Kazuyuki Omae
PA953
Age-related changes in respiratory fitness in healthy Thais 20-78 years Tichanon Promsrisuk (Khon Kaen , Thailand), Tichanon Promsrisuk, Wilaiwan Khrisanapant, Orapin Pasurivong, Watchara Boonsawat, Boonsong Patjanasoontorn, Burabha Pussadhamma, Paitoon Benjapornlert
PA954
Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Kamola Ubaydullaeva (Tashkent, Uzbekistan), Kamola Ubaydullaeva
PA955
The combination of forced expiratory tracheal noise time and band pass energy divides patients with bronchial obstruction into two clusters Irina Pochekutova (Vladivostok, Primorsky Krai, Russian Federation), Irina Pochekutova, Vladimir Korenbaum, Veronika Malaeva, Anatoly Kostiv, Valentina Kudryavtseva
PA956
The simple way of lung membrane diffusion capacity and alveolar volume evaluation Evgeny V Babarskov (Moscow, Russian Federation), Evgeny Babarskov, Alexander Cherniak, Zaurbek Aisanov, Alexander Chuchalin
PA957
Evaluation of a novel chest wall motion analysis system in cystic fibrosis and healthy volunteers Christopher Golby (Coventry, United Kingdom), Christopher K. Golby, James M. Harte, Edward F. Nash, Theodoros Arvanitis, Babu Naidu
PA958
Development and validation of a low-cost chest wall motion assessment system Christopher Golby (Coventry, United Kingdom), Christopher Golby, Ludovica Pippa, Andrea Aliverti, Theodoros Arvanitis, Babu Naidu
PA959
Do the CPAP auto titration systems (APAP) require calibration? Gianni Prest (IMPERIA, Italy), E. Isnardi, F. Bertolino, G. Prest
PA960
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency James Stockley (Birmingham, United Kingdom), James Stockley, Laura Smith, Brendan Cooper, Robert Stockley, Elizabeth Sapey
PA961
Lung function and respiratory muscle strength in amyotrophic lateral sclerosis Astrid Sandnes (Bergen, Norway), Astrid Sandnes, Tiina Andersen, Maria Vollsæter, Ove Fondenes, Ola Røksund, Thomas Halvorsen, Hege Clemm
PA962
Respiratory function in systemic sclerosis patients Malika Mustafina (Moscow, Russian Federation), Malika Mustafina, Alexandr Cherniak, Galina Nekludova, Olga Koneva, Oksana Desinova
PA963
Diffusion lung capacity changes in Hodgkin lymphoma patients before and after ABVD chemotherapy muhammad Abdullah (lahore, Pakistan), Muhammad Abdullah, Shoaib Alam, Waleed Zafar, Abdul Majid, Ali Saeed Wahla
PA964
The long-term functional changes in COPD patients effected to the ionization radiation Kostiantyn Bazyka (Kiev, Ukraine), Kostiantyn Bazyka, Liudmyla Shvaiko, Viktor Sushko
Hall 14-18
Session 109
12:50 - 14:40
Thematic Poster: Respiratory physiotherapy assessment and techniques in COPD and asthma Chairs : Nidia Aparecida Hernandes (Londrina, Brazil), Heleen Demeyer (Halle, Belgium), Christian Osadnik (Melbourne, Australia), Jordi VILARO CASAMITJANA (Barcelona, Spain) PA965
Breathing exercises for children with asthma Gabriela Chaves (Belo Horizonte, Brazil), Gabriela Chaves, Thalita Macêdo, Diana Freitas, Raquel Britto, Karla Mendonça
PA966
The effects of dyspnea on physical fitness level, daily living activities and anxiety-depression in patients with asthma Manolya Acar (ANKARA, Turkey), Manolya Acar, Neslihan Durutürk, Mustafa Ilgaz Dogrul
PA967
Effects of inspiratory muscle training on respiratory muscle strength, exercise capacity, physical fitness and daily living activities in patients with asthma Neslihan Durutürk (Ankara, Turkey), Neslihan Duruturk, Manolya Acar, Mustafa Ilgaz Dogrul
PA968
Thermal imaging of inspiratory muscle training in patients with asthma- A pilot study Neslihan Durutürk (Ankara, Turkey), Neslihan Duruturk, Nihan Ozunlu Pekyavas, Manolya Acar
69
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA969
Brompton BPAT: A useful tool to assess breathing pattern disorder in asthma? Rebecca Livingston (Borehamwood, United Kingdom), Rebecca Livingston, Lizzie Grillo, Susie Regan, Andy MenziesGow, James Hull
PA970
A comparison of extrapulmonary features in patients with asthma and healthy individuals Hazal Sonbahar (Ankara, Turkey), Hazal Sonbahar, Deniz Inal-Ince, Melda Saglam, Naciye Vardar-Yagli, Ebru CalikKutukcu, Cemile Bozdemir-Ozel, Aslihan Cakmak, Hülya Arikan, Gül Karakaya, Ali Fuat Kalyoncu
PA971
Validity and repeatability of the counting numbers technique from the slow vital capacity in hospitalized individuals Marco Junior (Recife, Brazil), Marco Junior, Anna Escossio, Flávio Andrade, Emilia Costa, Emanuel Sarinho, Angelo Rizzo, Silvia Sarinho
PA972
Peripheral arterial disease in COPD patients Irene TORRES SANCHEZ (Santa Fe (Granada), Spain), Irene Torres-Sánchez, Marie Carmen Valenza, Francisco Manuel Cano Egea, Roberto Cruz-Ramírez, Isabel López-Torres, Irene Cabrera-Martos
PA973
Immediate effects of manual therapy in patients with chronic obstructive pulmonary disease Gül Deniz Yilmaz Yelvar (Ankara, Turkey), Gül Deniz Yilmaz Yelvar, Yasemin çirak, Yasemin Parlak Demir, Murat Dalkilinç, Deniz Kizilirmak, Bülent Bozkurt
PA974
Exercise capacity and muscle strength influences in geriatric individuals with COPD Gül ah Özsoy (Izmir, Turkey), Ismail Ozsoy, Sema Savci, Gulsah Ozsoy, Serap Acar, Sevgi Ozalevli, Atila Akkoclu
PA975
Impact of two factors of combined COPD classification on the peripheral muscle strength and exercise tolerance Júlia Gianjoppe-Santos (São Carlos, Brazil), Julia Gianjoppe-Santos, Marina S. Barusso, Anna Claudia Sentanin, Valéria A. Pires Di Lorenzo
PA976
Reliability of the force platform in patients with COPD: Preliminary results Igor Brito (Londrina, Brazil), Igor Lopes De Brito, Larissa Araújo De Castro, Débora Rafaelli De Carvalho, Rubens Alexandre Da Silva Junior, Vanessa Suziane Probst
PA977
Analysis of different equations to predict quadriceps femoris muscle strength in patients with COPD Aline Nellessen (Londrina, Brazil), Aline Gonçalves Nellessen, Leila Donária, Nidia Aparecida Hernandes, Fabio Pitta
PA978
Do patients with COPD who live alone present better functional status than those who do not? Thaís Paes (Londrina, Brazil), Thaís Paes, Letícia F. Belo, Leila Donária, Aline Nellessen, Karina Furlanetto, Thaís Sant’Anna, Fabio Pitta, Nidia A. Hernandes
PA979
Responsiveness of the Dutch version of the London chest activity of daily living scale (LCADL) in patients with severe COPD Peter Klijn (Hilversum, Netherlands), Monique Legemaat, Anita Beelen, Anton Van Keimpema, Rachel Garrod, Mirella Bergsma, Andrew Stuijfzand, Henk Van Stel, Peter Klijn
PA980
Therapeutic validity and effectiveness of supervised physical exercise in patients with COPD - A systematic review and meta-analysis Martijn Vooijs (Leiden, Netherlands), Martijn Vooijs, Petra Siemonsma, Inge Heus, Jacob Sont, Ton Rövekamp, Nico Van Meeteren
PA981
ATS/ERS criteria for oxygen supplementation and progression of work rate during exercise training sessions in patients with COPD Antenor Rodrigues (Londrina, Brazil), Antenor Rodrigues, Karina Couto Furlaneto, Larissa Siani, Andrea Akemi Morita, Fernanda Morakami, Thais Paes, Gianna W. Bisca, Aline Nellessen, Leila Donaria, Nidia A. Hernandes, Fabio Pitta
PA982
Pressures generated using an improvised PEP device in a COPD and healthy population Daniel Robins (Callaghan, Australia), Daniel Robins, Matthew Egan, Catherine Johnston, Clint Newstead, Jennifer Mackney
PA983
Regional contributions of the ribcage and abdomen in healthy adults and patients with chronic respiratory disease during quiet breathing and speech Rokhsaneh Tehrany (Southampton, United Kingdom), Rokhsaneh Tehrany, Anna Barney, Anne Bruton
PA984
Changes in breathing pattern at comparable levels of ventilation after inspiratory muscle training in COPD patients with inspiratory muscle weakness Noppawan Charususin (Leuven, Belgium), Noppawan Charususin, Daniel Langer, Heleen Demeyer, Marko Topalovic, Marc Decramer, Rik Gosselink
Hall 14-19
Session 110
12:50 - 14:40
Thematic Poster: Safety of and interactions between current treatments for asthma and COPD
70
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Chairs : Paola Rogliani (Rome, Italy), Fabrizio Luppi (Spilamberto, Italy), Dragos Bumbacea (Bucarest, Romania), Maria Gabriela Belvisi (London, United Kingdom) PA985
Safety of tiotropium in patients with cardiac events in the TIOSPIR™ trial Robert Wise (Baltimore, United States of America), Robert Wise, Andy Fowler, Norbert Metzdorf, Helen Dewberry, Achim Mueller, Peter Kowey
PA986
Safety of tiotropium in patients with cardiac events in the UPLIFT® trial Donald Tashkin (Los Angeles, United States of America), Donald Tashkin, Andy Fowler, Norbert Metzdorf, Helen Dewberry, Achim Mueller, Marc Decramer
PA987
Bronchodilator effect of high strength extrafine BDP/formoterol delivered via NEXThaler® in asthmatics Mario Scuri (Parma, Italy), Brian Leaker, Adeep Puri, Mario Scuri, Sara Collarini, Annalisa Piccinno, Elena Carzana, Silvia Geraci, Dave Singh
PA988
Cardiovascular safety of extrafine beclomethasone/formoterol (BDP/FF) delivered via a novel dry powder inhaler (NEXThaler®) in COPD patients Mario Scuri (Parma, Italy), Dave Singh, Giorgia Ciurlia, Annalisa Piccinno, Anna Compagnoni, Maria Bocchi, Mario Scuri
PA989
Overall and cardiovascular safety of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in patients with COPD Jutta Beier (Wiesbaden, Germany), Jutta Beier, Claus Vogelmeier, Robert Mroz, Sergi Pascual, Rosa Maria Segarra, Alejhandra Lei, Gonzalo De Miquel
PA990
Efficacy and safety of QVA149 compared with salmeterol/fluticasone combination (SFC) in Chinese patients with moderate-to-severe COPD: A subgroup analysis from the LANTERN study Nan Shan Zhong (Guangzhou, China), Nanshan Zhong, Changzheng Wang, Xiangdong Zhou, Nuofu Zhang, Francesco Patalano, Michael Humphries, Linda Wang, Donald Banerji
PA991
Safety and effectiveness of indacaterol in Korean COPD patients: A post-marketing surveillance (PMS) study Yeon Oh (Seoul, Republic of Korea), Ho-Kee Yum, Hak-Ryul Kim, Yoon-Soo Chang, Kyeong-Cheol Shin, Yeon-Mok Oh, Song Kim
PA992
Effects of the new ultra-long-acting ² 2-AR agonist indacaterol in chronic treatment alone or in combination with the ² 1-AR blocker metoprolol on cardiac remodelling Luigino Calzetta (Rome, Italy), Luigino Calzetta, Barbara Rinaldi, Maria Donniacuo, Eugenio Martuscelli, Augusto Orlandi, Maria Gabriella Matera
PA993
Searching for synergistic interaction between aclidinium (ACL) and formoterol (FOR): From bench to bedside Luigino Calzetta (Rome, Italy), Luigino Calzetta, Josuel Ora, Paola Rogliani, Maria Gabriella Matera, Mario Cazzola
PA994
Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD Dave Singh (Manchester, United Kingdom), Dave Singh, Anthony D. D’Urzo, James F. Donohue, Ferran Chuecos, Anne Leselbaum, Esther Garcia Gil
PA995
Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on -blockers Eric Derom (Gent, Belgium), Eric Derom, Stephanie Korn, Alan Hamilton, Valeria C. Amatto, Yihua Zhao, François Maltais
PA996
Comparison of protective effect of bronchodilators in COPD Irina Trofimenko (Irkutsk, Irkutsk Oblast, Russian Federation), Irina Trofimenko, Boris Chernyak
PA997
Effects of extra fine formoterol or coarse particle salmeterol on impulse oscillometry (IOS) in corticosteroid treated persistent asthmatics Arvind Deva Manoharan (Dundee, United Kingdom), Arvind Manoharan, Alexander Von Wilamowitz-Moellendorff, Ashley Morrison, Brian Lipworth
PA998
Budesonide augments formoterol-induced bronchodilation of human small airways within minutes Reynold Panettieri (Philadelphia, United States of America), Cynthia Koziol-White, Jie Zhang, Anna Miller-Larsson, Ian Dainty, Reynold Panettieri
PA999
Safety of bi-weekly infusion of A1-PI augmentation therapy in RAPID Niels Seersholm (Copenhagen, Denmark), Niels Seersholm, Robert Sandhaus, Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, James Stocks, Michael Tortorici, Tanja Rosenberg, Oliver Vit, Martin Bexon, Jonathan Edelman, N. Gerard McElvaney
PA1000
The add-on effect of tiotropium bromide to ICS/LABA combination inhaler for the patients with severe uncontrolled asthma Masayuki Hojo (Tokyo, Japan), Masayuki Hojo, Motoyasu Iikura, Haruhito Sugiyama, Toshihiro Shirai
71
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1001
Clinically important deterioration in patients with COPD using umeclidinium/vilanterol, tiotropium or placebo: Pooled data M. Reza Maleki-Yazdi (Toronto, Canada), M. Reza Maleki-Yazdi, Dave Singh, Antonio Anzueto, Lee Tombs, Ian Naya, Stephanie Harris, Ahmar Iqbal
PA1002
Effect of a 10-day oral corticosteroid course on hemostasis and inflammation in patients with stable asthma Christof J. Majoor (Baarn, Netherlands), Christof Majoor, Marlous Sneeboer, Anne De Kievit, Joost Meijers, Tom Van der Poll, Rene Lutter, Pieter Willem Kamphuisen, Elisabeth Bel
PA1003
In vitro analysis of bronchodilators effect on peroxide lipid oxidation Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov, Shamil Farkhutdinov, Valeriy Petriakov
PA1004
Glucose and lactate concentrations in the distal lung are modified by hyperglycaemia and inflammation Annika Åstrand (Mölndal, Sweden), Cecilia Nagorny Holmberg, Cecilia Wingren, Annika åstrand, John Taylor, James Garnett, Emma Baker, Deborah Baines
Hall 14-20
Session 111
12:50 - 14:40
Thematic Poster: New data on established treatments for asthma and COPD Chairs : Fabio L. M. Ricciardolo (Orbassano (Turin), Italy), Fusun Yildiz (Kocaeli, Turkey), Isabelle Vachier (Montpellier, France), Chair to be confirmed
PA1005
QVA149 compared with salmeterol/fluticasone (SFC) on exacerbations and its correlation with baseline blood eosinophils: A pooled analysis of LANTERN and ILLUMINATE Wisia Wedzicha (London, United Kingdom), Jadwiga A. Wedzicha, David Price, Karen Mezzi, Robert Fogel, Donald Banerji
PA1006
Baseline symptom scores and future risk of severe exacerbation: The SPARK study Wisia Wedzicha (London, United Kingdom), Jadwiga A. Wedzicha, Karen Mezzi, Robert Fogel, Donald Banerji
PA1007
The role of determining the levels of collagen type IV in the management of patients with severe chronic obstructive pulmonary disease – Focus on roflumilast Iryna Savelikhina (Ivano-Frankivsk, Ukraine), Mykola Ostrovskyy, Oleksandr Varunkiv, Iryna Savelikhina, Mariana Kulynych-Miskiv
PA1008
Once-daily QVA149 improves dyspnoea and health status compared with tiotropium plus formoterol in patients without ICS use: A post-hoc analysis of the QUANTIFY study Christian Gessner (Leipzig, Germany), Christian Gessner, Wolfgang Schürmann, Karin Förster, Christian Sieder, Simone Hiltl, Roland Buhl, Stephanie Korn
PA1009
Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups Anthony D. D'Urzo (Toronto, Canada), Anthony D’Urzo, Giovanni Bader, Pablo Altman, Pankaj Goyal
PA1010
Glycopyrronium (GLY) and tiotropium (TIO) comparison: Lung function, dyspnea and health status in COPD patients in all GOLD groups Anthony D. D'Urzo (Toronto, Canada), Anthony D’Urzo, Giovanni Bader, Pablo Altman, Pankaj Goyal
PA1011
The effects of inhaler B-2 adrenergic agonists on esophaeal high resolution manometry pressure metrics in asthma patients with inadequate symptom control (Ege University reflux group) Özlem Göksel (Izmir, Turkey), Ozlem Goksel, Rukiye Vardar, Haydar S. Karakus, Yasemin Alev, Esra Yildirim, Munevver Erdinc, Serhat Bor
PA1012
Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Terufumi Shimoda (Fukuoka, Japan), Terufumi Shimoda, Yasushi Obase, Michiyoshi Imaoka, Reiko Kishikawa, Tomoaki Iwanaga
PA1013
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD James F. Donohue (Chapel Hill, United States of America), James F. Donohue, Paul Jones, Christian Bartels, Jessica Marvel, Peter D’Andrea, Donald Banerji, Francesco Patalano, Robert Fogel
PA1014
Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-tosevere COPD: The SPRING study Jose M. MARIN TRIGO (Zaragoza, Spain), Jose Mª Marin, Andreas Clemens, Ricard Casamor, Walter Castellani, Lennart Schaper, Dinesh Saralaya, Anthony Gunstone, Konstantinos Kostikas, Maryam Aalamian-Mattheis, Kai Beeh
72
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1015
Cigarette smoke extract (CSE) promotes acetylcholine (ACh) mediated inflammation and oxidative stress by PEBP1/Raf-mediated MEK and ERK pathway in human bronchial epithelial cells Giusy D Albano (Palermo, Italy), Giusy D. Albano, Anna Bonanno, Loredana Riccobono, Rosalia Gagliardo, Michael Pieper, Mark Gjomarkaj, Mirella Profita
PA1016
Does omalizumab attenuate blood eosinophilia at 52 weeks; a single centre observation Moshfiq Abeer (Hull, United Kingdom), Moshfiq Abeer, Thompson Joanne, Cummings Helena, Watkins Karen, Jaymin Morjaria
PA1017
Cromoglycate: Breathing life into an old asthma drug Sarah Maher (London, United Kingdom), Sarah Maher, Mark Birrell, Katie Baker, Kristof Raemdonck, Sara Bonvini, John Adcock, Michael Wortley, Eric Dubuis, Fisnik Shala, Victoria Jones, Peter Barnes, Rajamannar Thennati, Biswajit Samanta, Dipali Desai, Anil Kumbhani, Maria Belvisi
PA1018
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Tanya Kralimarkova (Sofia, Bulgaria), Tanya Kralimarkova, Maria Staevska, Tsvetelina Lazarova, Diana Hristova, Vasil Dimitrov, Todor Popov
PA1019
Lung function change and exacerbations in patients with COPD in the WISDOM study Henrik Watz (Grosshansdorf, Germany), Henrik Watz, Helgo Magnussen, Anne Kirsten, Kay Tetzlaff, Helen Finnigan, Bernd Disse, Eric Bateman
PA1020
Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma Robert Niven (Manchester, United Kingdom), Robert Niven, Michael Simmonds, Michael Cangelosi, Narinder Shargill, Dominic Tilden, Suzanne Cottrell
PA1021
Effect of inhaled beclomethasone or placebo on brain stem activity in a patient chronically treated with steroids Preliminary report Zygmunt Podolec (Kraków, Poland), Zygmunt Podolec, Marcin Hartel, Daria Panek, Magdalena Podolec-Rubis, Tomasz Banasik
PA1022
Difference in resistance to humidity between commonly used dry powder inhalers Thomas LÖÖf (Mölndal, Sweden), Thomas Lööf, Gunilla Telg, Georgios Stratelis, Jan-Olof Svensson
PA1023
INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms results Andrea Rossi (Verona, Italy), Andrea Rossi, Thys Van der Molen, Ricardo Del Olmo, Alberto Papi, Luis Wehbe, Matthew Quinn, Chengxing Lu, David Young, Ray Cameron, Pablo Altman
Hall 14-21
Session 112
12:50 - 14:40
Thematic Poster: Monitoring airway diseases with lung function tests Chairs : Helgo Magnussen (Grosshansdorf, Germany), Andriana Papaioannou (Vrilissia, Athens, Greece), Ellen Tufvesson (Lund, Sweden), Chair to be confirmed PA1024
LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma Paula Almeida (Salvador, Brazil), Paula C.A. Almeida, Eduardo V. Ponte, Valmar Bião, Adelmir Souza-Machado, Alvaro A. Cruz
PA1025
Use of vitalograph COPD-6 device as point of care screening tool for COPD in resource-limited settings Radhika Banka (Mumbai, India), Radhika Banka, Ujjwal Sharma, Sharmila Lonkar, Mangal Walkar, Getsiyal Pabidha, Jean Bourbeau, Lancelot Pinto
PA1026
Pulmonary function in -thalassaemia major Ching Ching Kate Chan (Hong Kong, Hong Kong), K.C. Chan, H.K. So, C.K. Li, S.C. Ling, C.H. Li, S.Y. Ha, A.M. Li
PA1027
Relationship between small airways bio-markers and airways closure Marcia Soares (Leicester, United Kingdom), Marcia Soares, Ekaterina Migrodskaya, Anna-Carin Olin, Salman Siddiqui
PA1028
COPDGene intra-subject variability of DLco measurements using an ultrasound-based instrument Robert L. Jensen (Salt Lake City, United States of America), Robert Jensen, Barry Make, Elizabeth Regan, Edwin Silverman, James Crapo
PA1029
Assessment of parameters of lung ventilation during 6-minute walk test in patients with COPD Irina Ponomareva (Ryazan, Russian Federation), Irina Ponomareva, Vladimir Abrosimov, Natalia Peregudova
PA1030
Assessing the accuracy of oscillometry in tracking the mean values and the temporal changes in impedance of children Hamed Hanafi (halifax, Canada), Hamed Hanafi, Kamal El-Sankary, Ubong A. Peters, Marwa Al Amer, Dietrich Henzler, Andrew Milne, Jeremy Brown, Geoffrey N. Maksym
73
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA1031
Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance Linnea Jarenbäck (Gantofta, Sweden), Linnea Jarenbäck, Jaro Ankerst, Leif Bjermer, Ellen Tufvesson
PA1032
Health status measurements in alpha-1antitrypsin deficiency (AATD) Stan Ejiofor (Birmingham, United Kingdom), S.I Ejiofor, R.A. Stockley
PA1033
Histamine challenge and bronchodilator tests assessed by the ratio of diaphragm EMG to tidal volume Baiting He (Guangzhou, China), Bai-Ting He, Ning Zhang, Lian Zhou, Jing Wang, John Moxham, Michael I. Polkey, YuanMing Luo
PA1034
Insulin resistance, lung function and exacerbation rate in chronic obstructive lung disease Daniel Carlos Silva Vaz (Porto, Portugal), Daniel Vaz, Manuela Vanzeller, Teresa Shiang
PA1035
Diagnosis of bronchoobstruction in patients with pulmonary tuberculosis associated chronic obstructive pulmonary disease by the forced oscillation technique Elena M Zhukova (Novosibirsk, Russian Federation), Elena Zhukova, Ludmila Vokhminova
PA1036
Do obese asthmatics have a worse bronchodilator response? Hang Siang Wong (Singapore, Singapore), Hang Siang Wong, Hwee Lee Ng, Corrine Kang, Ying Juan Mok, Xue Ning Choo
PA1037
Oscillometry system comparison in phantoms and humans Guy Drapeau (Halifax, Canada), Guy Drapeau, Thomas Schuessler
PA1038
Induced sputum cytology and pulmonary function tests in ex-smoker asthmatic patients controlled with inhaled steroid and long acting beta agonist therapy Bilun Gemicioglu (Istanbul, Turkey), Bilun Gemicioglu, Sermin Borekci, Buket Caliskaner Ozturk, Nail Yilmaz
PA1039
Capnographic measurement as a screening method for respiratory obstructive diseases Tajana Jalusic Gluncic (Zagreb, Croatia), Tajana Jalušic Gluncic, Latinka Basara, Ljiljana Konecki, Slavica Tomic, Miroslav Samaržija, Marko Jakopovic
PA1040
Bronchodilator response in adults 35-70 years old in North-West Russia Elena Andreeva (Arkhangelsk, Arkhangelsk Oblast, Russian Federation), Elena Andreeva, Marina Pokhaznikova, Anatoly Lebedev, Olga Kuznetsova, Jean-Marie Degryse
PA1041
Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations Daniel Carlos Silva Vaz (Porto, Portugal), Daniel Vaz, Manuela Vanzeller, Teresa Shiang
PA1042
Abnormal heart rate variability in patients with bronchiectasis Samia Rached (Sao Paulo, Brazil), Samia Rached, Tatiane Soares Amaral, Kátia De Angelis, Michelle Sartori, Rodrigo Athanazio, Luciana Maria Malosa Sampaio, Anderson Alves de Camargo, Rafael Stelmach, Simone Dal Corso
PA1043
Corelation of MRC gradings within a large single practice primary care COPD cohort in the UK Mukesh Singh (Sutton Coldfield, United Kingdom), Mukesh Singh
Hall 14-22
Session 113
12:50 - 14:40
Thematic Poster: Clinical assessment and monitoring of asthma and COPD Chairs : Stephen James Fowler (Preston, United Kingdom), Georgios Hillas (Ilioupoli, Greece), Nikoletta Rovina (Athens, Greece), Bart Hilvering (Utrecht, Netherlands) PA1044
Clinical and demographic characteristics of Seinäjoki adult asthma study (SAAS) Hannu Kankaanranta (Seinäjoki, Finland), Hannu Kankaanranta, Pinja Ilmarinen, Terhi Kankaanranta, Onni Niemelä, Jussi Haanpää, Leena E. Tuomisto
PA1045
Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Pieter-Paul Hekking (Amsterdam, Netherlands), P.P. Hekking, M. Amelink, R.R. Wener, M.L. Bouvy, E.H. Bel
PA1046
An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome Souvik Barman (Kolkata, India), Souvik Barman, Aloke Gopal Ghoshal, Debdeep Sen, Raja Dhar
PA1047
Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study Malwina Wojtas (Southampton, United Kingdom), Malwina M. Wojtas, Victoria Kim, Nicholas Williams, Kris Ostridge, Ngaire Coombs, Steve Wootton, Tom M. Wilkinson
74
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1048
Outcomes in patients with COPD during a 3 year follow-up Nikolay Yanev (Pleven, Bulgaria), Nikolay Yanev, Nikolay Kyuchukov, Ilia Krachunov, Zlatina Ivanova, Pavlina Nikolova, Plamen Pavlov, Elena Borisova, Tsania Popova, Yavor Ivanov
PA1049
Clinical severity of chronic obstructive pulmonary disease is associated with bone mineral density Esteban Cesar Gabazza Sanabria (Tsu-Mie, Japan), Haruko Saiki, Osamu Hataji, Tadashi Sakaguchi, Esteban C. Gabazza, Yoichi Nishii, Corina D’Alessandro-Gabazza, Tetsu Kobayashi, Osamu Taguchi
PA1050
Predictors of 90 day readmission in hospitalized patients for asthma exacerbation Ana Marçôa (Matosinhos, Portugal), Raquel Marçôa, Rita Linhas, Margarida Dias, Carla Ribeiro, Manuela Vanzeller, Miguel Guimarães, Teresa Shiang
PA1051
Rehospitalizations for an acute exacerbation among patients with COPD Iliya Krachunov (Pleven, Bulgaria), Iliya Krachunov, Nikolay Yanev, Zlatina Ivanova, Nikolay Kyuchukov, Vladislava Angelova, Petkana Hristova, Plamen Pavlov, Pavlina Glogovska, Tsanya Popova, Yavor Ivanov
PA1052
Which are the main determinants of quality-of-life in severe asthma? Federica Novelli (Pisa, Italy), Federica Novelli, Letizia Vergura, Manuela Latorre, Elena Bacci, Silvana Cianchetti, Federico Dente, Antonelli Di Franco, Pierluigi Paggiaro
PA1053
Hospital treatment costs of exacerbations in COPD patients with indications for LTOT Nikolay Kyuchukov (Belene, Bulgaria), Nikolay Kyuchukov, Plamen Pavlov, Pavlina Glogovska, Tsania Popova, Nikolay Yanev, Iliya Krachunov, Zlatina Ivanova, Yavor Ivanov, Petkana Hristova
PA1054
COPD mortality - Is it all COPD? Amarpreet Kaur (London, United Kingdom), Amarpreet Kaur, Jacqueline Creasey, Rumina Mirza, Neelya Kumar, Kanwar Pannu, Dipak Mukherjee
PA1055
Six months follow up of cough-related health status in a large population of patients from the Isala cough clinic Jan Willem K. van den Berg (Zwolle, Netherlands), Leonie Kooistra, Dominique Vaessen, Niels Patberg, Jan Van den Berg
PA1056
Predictors of exacerbations in hospitalised patients with bronchiectasis: A retrospective study in an Asian population Carrie Kah-Lai Leong (Singapore, Singapore), Carrie Kah-Lai Leong, Qiao Li Tan, Jaydeesh Khanna Krishnasamy Balasubramanian, Yuen Li Ng, Thun How Ong, Mariko Siyue Koh, Therese Sophie Lapperre
PA1057
Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis Qiao Li Tan (Singapore, Singapore), Qiao Li Tan, Carrie Kah-Lai Leong, Jaydeesh Khanna Krishnasamy Balasubramanian, Yuen Li Ng, Thun How Ong, Therese Sophie Lapperre, Mariko, Siyue Koh
PA1058
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Jaromir Zatloukal (Olomouc, Czech Republic), Jaromir Zatloukal, Vladimir Koblizek, Marek Plutinsky, Patrice Popelkova, Tomas Dvorak, Petr Safranek, Ondrej Sobotik, Alena Vlachova, Petr Vanik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Pavlina Musilova, Maria Majerciakova, Tomas Vencalek, Eva Kocova, Barbora Novotna, Michal Kopecky, Ondrej Kudela, Katerina Neumannova, Kristian Brat, Eva Volakova, Karel Hejduk, Jan Svancara, Jiri Jarkovsky, Michal Svoboda, Zuzana Zbozinkova
PA1059
Prognosis of new-onset asthma diagnosed at adult age: A systematic review Leena Esteri Tuomisto (Seinajoki, Finland), Leena E. Tuomisto, Pinja Ilmarinen, Hannu Kankaanranta
PA1060
Romanian awareness campaign on the WORLD COPD day Ramona Elena Nedelcu (Bucarest, Romania), Florin Dumitru Mihaltan, Ramona Elena Nedelcu, Amelia Ionescu, Roxana Nemes
PA1061
Patients’ adherence to chronic treatment of pulmonary diseases Claudia Gregoriano (Liestal, Switzerland), Claudia Gregoriano, Simona Henny-Reinalter, Anja Handschin, Anna-Lisa Flamm, Thomas Dieterle, Isabelle Arnet, Kurt E. Hersberger, Jörg D. Leuppi
PA1062
COPD severity analysis according to current evaluation criteria – National survey Yavor Ivanov (Pleven, Bulgaria), Yavor Ivanov, Plamen Pavlov, Pavlina Glogovska, Tsania Popova, Anahid Torossian, Dimitar Kostadinov, Dencho Osmanliev, Diana Petkova, Kosta Kostov, Ognyan Georgiev, Vladimir Hodzhev, Nikolay Kyuchukov, Nikolay Yanev, Petkana Hristova
PA1063
Co morbidity profile in patients with COPD: A prospective study from western part of India Nitin Jain (Jaipur, India), Nitin Jain, Vikram Jain, Nirmal Jain, Mahesh Mishra, Arpit Sharma
Hall 14-23
Session 114
12:50 - 14:40
Thematic Poster: Clinical aspects of asthma: monitoring and mechanisms Chairs : Trudeke G.M. Möller (Capelle aan den Ijssel, Netherlands), Marco Idzko (Freiburg, Germany), Renaud Louis (Liège, Belgium), Arnaud Bourdin (Montpellier, France)
75
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1064
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Siew Hwa Ong (Basel, Switzerland), Gerardo Machnicki, Juzer Lotya, Siew Hwa Ong, Luisa Alvares, Alexandros Sagkriotis, Paul McDwyer, Kristijan H. Kahler, David Price
PA1065
Relationship between specific rhinitis symptom and control status of asthma Hiroyuki Nagase (Tokyo, Japan), Hiroyuki Nagase, Naoya Sugimoto, Yuuta Koizumi, Yusuke Tanaka, Hisanao Yoshihara, Michio Kuramochi, Hidenori Arai, Masao Yamaguchi, Ken Ohta
PA1066
Special characteristics in examination among patients, suffering from bronchial asthma and herpetic infection Nataly Tataurshchikova (Moscow, Russian Federation), Nataly Tataurshchikova
PA1067
Evaluation of lipoxin A4 and nitric oxide as inflammatory mediators in bronchial asthma Abdel Monem Elshabrawi (Suez, Egypt), Fatema El Nokaly, Abd El Monem Elshabrawi, Hala El Mougy, Wafaa Abd El Fatah, Ashraf Behiry
PA1068
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma SRILATA PURU NAIK (Mysore, Karnataka, India), Srilata Puru Naik, P.A. Mahesh, B.S. Jayaraj, M.V.S.S.T. Subbarao, Sareh Raeiszadeh Jahromi
PA1069
Concentration of C-reactive protein (CRP) in elderly asthmatics Karolina Lindner (Wroc aw, Poland), Karolina Lindner, Robert Pawlowicz, Zbigniew Machaj, Bernard Panaszek
PA1070
Identification of IgE reactive proteins from pollen of Lagerstroemia speciosa and spathodea campanulata – Two avenue trees of West Bengal Tanmoy Basak (Kolkata, India), Tanmoy Basak, Naren Pandey, Kashinsath Bhattacharya
PA1071
The allergy profile and accompanying sinonasal pathologies in patients with bronchial asthma Bikemgül Özkara (Ankara, Turkey), Bikemgul Ozkara, Haldun Sevketbeyoglu, Murat Kose, Dilaver Tas, Murat Salihlioglu
PA1072
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients Amaryllis Haccuria (Brussels, Belgium), Amaryllis Haccuria, Vi Doan, Alain Michils, Alain Van Muylem
PA1073
Sputum microbiota in Chinese adults with eosinophilic versus non-eosinophilic asthma Qingling Zhang (Guangzhou, China), Qingling Zhang, Rihuang Qiu, Naijian Li, Zhaowei Yang, Yongfeng Liu, Jing Li, Kian Fan Chung, Nanshan Zhong
PA1074
Infection with HRV-C during acute asthma in adults is associated with increased sputum neutrophils and selfreported severity of symptoms Asger Bjerregård (Frederiksberg, Denmark), Asger Bjerregård, Ingrid Laing, Peter Le Souëf, Siew-Kim Khoo, Vibeke Backer, Markus Fally, Celeste Porsbjerg
PA1075
Most of asthma is diagnosed in adulthood in Finland Hannu Kankaanranta (Seinäjoki, Finland), Hannu Kankaanranta, Leena E. Tuomisto, Pinja Ilmarinen
PA1076
Comparative study of bronchial provocation tests using methacholine or mannitol in bronchial asthma Mayra PARRA PEREZ (Sevilla, Spain), Mayra Parra Pérez, Auxiliadora Romero Falcón, Marta Ferrer Galván, Juan Francisco Medina Gallardo, Francisco Javier Alvarez Gutierrez
PA1077
Systemic inflammation, comorbidities and the outcome of adult-onset asthma Pinja Ilmarinen (Seinäjoki, Finland), Pinja Ilmarinen, Leena E. Tuomisto, Onni Niemelä, Joanna Danielsson, Jussi Haanpää, Hannu Kankaanranta
PA1078
Gamma globulin (Ig) replacement– a potential treatment in uncontrolled asthma associated with humoral immunodeficiency (huID)? Angelica Tiotiu (Vandoeuvre-les-Nancy, France), Angelica Tiotiu, Yves Martinet
PA1079
The western environment has increased hay fever symptoms and IL-10 levels in Chinese immigrants Aarti Saiganesh (Canning Vale, Australia), Aarti Saiganesh, Belinda Hales, Ennee Schultz, Xiaopeng Zhang, Alicia Annamalay, Siew-Kim Khoo, Jack Goldblatt, Peter Le Souef, Guicheng Zhang
PA1080
Allergic versus non allergic asthma: What makes the difference? Ferdaous Yangui (Tunis, Tunisia), Ferdaous Yangui, Maher Abouda, Samia Sellami, Mariem Triki, Rimeh Ayari, Emna Guermazi, Hend Khouani, Mohamed Ridha Charfi
PA1081
Subpopulation structure of blood lymphocytes at patients with lung tuberculosis Olga Berdyugina (Yekaterinburg, Russian Federation), A.V. Ershova, O.V. Berdyugina
76
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1082
Clinical phenotypes in asthmatic population with severe asthma Evangelia Fouka (Thessaloniki, Greece), Evangelia Fouka, Konstantinos Porpodis, Despoina Ioannidou, Kalliopi Domvri, Theodoros Kontakiotis, Konstantinos Zarogoulidis, Despoina Papakosta
PA1083
Periostin: A key contributor to changes in the epithelial phenotype in asthma? Irene Heijink (Groningen, Netherlands), Irene Heijink, Marnix Jonker, Maarten Van den Berge, Dirkje Postma
Hall 14-24
Session 115
12:50 - 14:40
Thematic Poster: Asthma and lung immunology Chairs : René E. Jonkers (Amsterdam, Netherlands), Milena Sokolowska (Bethesda, United States of America), Ronald Dahl (Odense C, Denmark), Chair to be confirmed PA1084
LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma Vibeke Backer (Copenhague, Denmark), Vibeke Backer, Kathrine Baines, Heather Powell, Celeste Porsbjerg, Peter Gibson
PA1085
The role of IL-13, IL-4R cytokine gene variants in atopic and non-atopic asthma Madhavilatha Alasandagutti (Hyderabad, India), Madhavi Latha Alasandagutti, Meenakshi Ponnana, Ramya Shivangala, Lavanya Joshi, Somashekar Sagruthi, Ansari Soheb Sader, Vijaya Lakshmi Valluri, Suman Latha Gaddam
PA1086
Distribution of mast cells and their interactions with nerve in allergic rhinitis Duc Dung Le (Homburg/Saar, Germany), Duc Dung Le, David Schmit, Sebastian Heck, Robert Bal, Bernhard Schick, Basel Al Kadah, Quoc Thai Dinh
PA1087
IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model Xiujuan YAO (Beijing, China), Xiujuan Yao, Wei Wang, Kewu Huang, Chris J. Corrigan, Yong Chang Sun, Sun Ying, Xiujuan Yao
PA1088
Maternal asthma and placental mast cell expression depending on asthma severity, fetal sex and presence of preeclampsia Yulia Dymarskaya (Saint-Petersburg, Russian Federation), Yulia R. Dymarskaya, Olga V. Lavrova, Ludmila B. Zubzhitskaya
PA1089
Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma SANG YEUB LEE (Seoul, Republic of Korea), Sang Yeub Lee, Won Jai Jung, Eun Joo Lee, Kyung Hoon Min, Gyu Young Hur, Seoung Heon Lee, Sung Yong Lee, Je Hyeong Kim, Chol Shin, Jae Jeong Shim, Kwang Ho In, Kyung Ho Kang
PA1090
Screening for alpha1-antitrypsin deficiency at a university hospital Alejandro Raimondi (Buenos Aires, Argentina), Alejandro Raimondi, María Alejandra Grosso, Maria Graciela Beretta, María de los Angeles Zalazar, Federico Zenón, Carlos Marcelo Luna
PA1091
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Arzu Yorgancioglu, Fikret Kurhan, Tugba Goktalay, Aysin Sakar Coskun, Pinar Celik
PA1092
Use of CARAT® and pulmonary function tests to assess asthma control during pregnancy Luis Amaral (Braga, Portugal), Luis Amaral, Carla Martins, Artur Vilela, Alice Coimbra, José Luis Plácido
PA1093
IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma Michela Maria Bellocchia (Turin, Italy), Michela Bellocchia, Monica Boita, Paolo Solidoro, Francesco Coni, Marco Bardessono, Lorena Mercante, Giovanni Rolla, Caterina Bucca
PA1094
Can we predict risk factors for peri- or postoperative complications in asthmatic patients preoperatively? A. Fuat Kalyoncu (Ankara, Turkey), Tuba Erdogan, Ozlem Goksel, Gamze Kirkil, Füsun Yildiz, Bilun Gemicioglu, Eylem Akpinar, Elif Yilmazel Uçar, Eylem Sercan Ozgur, Omur Aydin, Kivilcim Oguzülgen, Gul Karakaya, Ali Fuat Kalyoncu
PA1095
Relation of ghrelin, obestatin levels and ghrelin/obestatin ratio with asthma Deniz Kizilirmak (Ankara, Turkey), Deniz Kizilirmak, Bülent Bozkurt
PA1096
Patients with allergic and eosinophilic asthma in the German severe asthma registry Stephanie Korn (Mainz, Germany), Johannes Holstege, Antje Jahn, Christian Schulz, Karl-Christian Bergmann, Andrea Koch, Rainer Ehmann, Eckard Hamelmann, Roland Buhl, Stephanie Korn
PA1097
Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma whether due to seasonal allergens or to perennial allergens Christian DOMINGO RIBAS (Sabadell (Barcelona), Spain), Christian Domingo, Xavier Pomares, Albert Navarro, Carles Grimau, Ana Sogo, Rosa Mirapeix
77
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1098
No increase in non-specific bronchial hyperreactivy in patients with cypress pollen allergy during the pollen season Denis Charpin (Marseille, France), Denis Charpin, Laurie Pahus, Tunde Sofalvi, Delphine Gras, Marion Gouitaa, Pascal Chanez
PA1099
Are non-cystic fibrosis bronchiectasis a result of primary antibody deficiency? Marina Karakina (Yekaterinburg, Russian Federation), Marina Karakina, Grigory Tsaur, Irina Tuzankina, Eugeny Beltukov
PA1100
Asthma and rhinitis symptom score severity in children on SLIT Ivana Filipovic (Belgrade, Republic of Serbia), Ivana Djuric-Filipovic, Zorica Zivkovic, Djordje Filipovic, Gordana Kostic
PA1101
Headaches and migraine in asthma: The relationship with atopic disorders and parental history Muzaffer Onur Turan (Çanakkale, Turkey), Muzaffer Onur Turan, çigdem çelik Susuz, Pakize Ayse Turan
PA1102
Relation of hemogram parameters with asthma Deniz Kizilirmak (Ankara, Turkey), Bülent Bozkurt, Deniz Kizilirmak
PA1103
Asthma and rhinitis: Clinical and physiological correlation, possible environmental factors Ivano Salimbene (Buccino, Italy), Ivano Salimbene, Dina Filomena Affuso, Ornella Salimbene, Salvatore Marasco, Crescenzo Schettini
Hall 14-25
Session 116
12:50 - 14:40
Thematic Poster: Risk factors and co-morbidities in asthma and COPD Chairs : R. Graham Barr (New York, United States of America), Peymane Adab (Birmingham, United Kingdom), Vanessa Garcia Larsen (London, United Kingdom), Melanie Matheson (Parkville, Australia)
PA1104
Prevalence and impact of Diabetes mellitus (DM) among hospitalized community-acquired pneumonia (CAP) patients Filipe Froes (Lisbon, Portugal), Madalena Martins, Filipe Froes, José M. Boavida, João F. Raposo, Baltazar Nunes, Rogério T. Ribeiro, M. Paula Macedo, Carlos Penha-Gonçalves
PA1105
Body composition and pulmonary function at 18 years old: Findings from a birth cohort in southern Brazil Fernando C Wehrmeister (Pelotas, Brazil), Paula Duarte de Oliveira, Ana Maria Baptista Menezes, Fernando César Wehrmeister, Rogelio Pérez-Padilla, Helen Gonçalves, Maria Cecília Assunção
PA1106
Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis Alexander Mathioudakis (Liverpool, United Kingdom), Alexander G. Mathioudakis, Ioannis Mastoris, Prodromos Kanavidis, Victoria Chatzimavridou-Grigoriadou, Efstathia Evangelopoulou, Georgios A. Mathioudakis, Dave Singh
PA1107
Total dietary antioxidant capacity is associated with lung function volumes in women Lucia Cazzoletti (Verona, Italy), Lucia Cazzoletti, M. Elisabetta Zanolin, Liliya Chamitava, Roberto Bono, Isa Cerveri, Marcello Ferrari, Amelia Grosso, Pietro Pirina, De Marco Roberto
PA1108
Biomarkers of oxidative stress in chronic respiratory diseases M.Elisabetta Zanolin (Verona, Italy), M. Elisabetta Zanolin, Liliya Chamitava, Paolo Degan, Andrea Pasini, Anna FrattaPasini, Morena Nicolis, Mario Olivieri, Angelo Corsico, Pietro Pirina, Roberto Bono, Roberto De Marco
PA1109
The relationship between cigarette smoking intensity and chronic mucus hypersecretion (CMH) at different ages within a nationally representative birth cohort James Allinson (London, United Kingdom), James Allinson, Rebecca Hardy, Gavin Donaldson, Seif Shaheen, Diana Kuh, Jadwiga Wedzicha
PA1110
Contribution of respiratory disease and smoking to in-hospital mortality Neeraj Shah (New Malden, United Kingdom), Neeraj Shah, Dean Jansen, Louise Restrick
PA1111
The interaction between family history of COPD, personal smoking and post-bronchodilator airflow obstruction: A cohort study Jennifer Perret (Melbourne, Australia), Jennifer Perret, Melanie Matheson, David Johns, Adrian Lowe, Caroline Lodge, John Burgess, Bruce Thompson, Christine McDonald, Stephen Morrison, Paul Thomas, Michael Abramson, E. Hadyn Walters, Shyamali Dharmage
PA1112
The effects of current regular smoking on asthma subtypes in the Northern Finnish asthma study Elina Mäkikyrö (Oulu, Finland), Elina Mäkikyrö, Maritta Jaakkola, Jouni Jaakkola
PA1113
Modifiable risk factors for all-cause hospitalization in obstructive lung disease Rosanne Beijers (Maastricht, Netherlands), Rosanne Beijers, Bram Van den Borst, Anne Newman, Sachin Yende, Stephen Kritchevsky, Patricia Cassano, Tamara Harris, Annemie Schols
78
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1114
Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan Motoko Takaoka (Nishinomiya, Japan), Motoko Takaoka, Dan Norbäck
PA1115
Odor annoyance perception and health effects in an Italian general population sample Sandra Baldacci (Pisa, Italy), Sandra Baldacci, Sara Maio, Franca Martini, Patrizia Silvi, Giuseppe Sarno, Sonia Cerrai, Anna Angino, Martina Fresta, Giovanni Viegi
PA1116
The relationship between COPD and periodontitis Adam Usher (Cheltenham, United Kingdom), Adam Usher, Sabrina Parmar, Viren Vithlani, Iain Chapple, Elizabeth Sapey, Robert Stockley
PA1117
Birth weight, lung function testing in school aged children from rural and urban areas Jasmina Jocic-Stojanovic (Belgrade, Republic of Serbia), Jasmina Jocic-Stojanovic, Sofija Cerovic, Vesna Vekovic, Zorica Zivkovic
PA1118
Risk factors for new-onset asthma and early COPD in a cohort of young adults Lisbet Krogh Traulsen (Esbjerg, Denmark), Lisbet Krogh Traulsen, Jesper Bælum, Anders Halling, Trine Thilsing, David Sherson, Torben Sigsgaard, øyvind Omland, Tine Malling, Lars Skadhauge
PA1119
Comorbidities, gender-differences and COPD severity: The French Palomb cohort Chantal Raherison-Semjen (Pessac, France), Chantal Raherison, Emilie Berteaud, Alain Bernady, Julien Casteigt, Yannick Daoudi, Jean-Michel Dupis, Cecilia Nocent-Eijnaini, Laurent Falque, Frédéric Le Guillou, Elodie Blanchard, Helene Jungmann, Laurent Nguyen, Jean Moinard, Anne Prudhomme, Annaig Ozier, Christophe Roy, Marielle Sabatini, Marc Sapene, François Pellet
PA1120
High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Gunnar Einvik (Lørenskog, Norway), Anke Neukamm, Vidar Søyseth, Gunnar Einvik, Nils Henrik Holmedahl, Natalia Kononova, Arne Didrik Høiseth, Angelica Marianne Berg, Torbjørn Omland
PA1121
Prevalence of self-reported heart disease and ischemic ECG changes in COPD and non-COPD Ulf Nilsson (Umeå, Sweden), Ulf Nilsson, Bengt Johansson, Berne Eriksson, Anders Blomberg, Bo Lundbäck, Anne Lindberg
PA1122
The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia Stanislav Kajba (Celje, Slovenia), Stanislav Kajba
PA1123
Chronic obstructive pulmonary disease and comorbidities Marko Jakopovic (Zagreb, Croatia), Irena Sokolovic, Jelena Knezevic, Sanja Popovic-Grle, Andrea Vukic Dugac, Gordana Bubanovic, Mateja Jankovic Makek, Ana Hecimovic, Gzim Redzepi, Miroslav Samarzija, Marko Jakopovic
Hall 14-26
Session 117
12:50 - 14:40
Thematic Poster: Prevalence of respiratory disease Chairs : Bo Lundback (Gothenburg, Sweden), Alessandro Marcon (Verona, Italy), Valerie Siroux (La Tronche, France), Christina Tischer (Neuherberg, Germany) PA1124
Prevalence and incidence of COPD: The Rotterdam study Natalie Terzikhan (Dordrecht, Netherlands), Natalie Terzikhan, Katia M.C. Verhamme, Albert Hofman, Bruno H. Stricker, Guy G. Brusselle, Lies Lahousse
PA1125
Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study Fernando C Wehrmeister (Pelotas, Brazil), Fernando C. Wehrmeister, Ana Maria B. Menezes, Maria Montes de Oca, Carlos Tálamo, Maria Victorina Lopez-Varela, Adriana Muiño, Gonzalo Valdivia, Carmem Lisboa, Jose R. Jardim, Rogelio PerezPadilla
PA1126
Trends in prevalence and inequalities in wheezing and medical diagnosis of asthma during adolescence: The Pelotas 1993 birth cohort, Brazil Ana Maria Menezes (Pelotas, Brazil), Ana Maria B. Menezes, Maria C. Assunção, Helen Gonçalves, Fernando C. Wehrmeister
PA1127
The burden of non-communicable lung disease in urban Malawi Kevin J. Mortimer (Liverpool, United Kingdom), Kevin Mortimer, Hadia Azhar, Jaymini Patel, Sabrina Kapur, Louisa Gnatiuc, Peter Burney, Kourtney Davis, Gilbert Nadeau, Moffat Nyirenda, Stephen Gordon
PA1128
Prevalence and characteristics of chronic airflow obstruction in adult nonsmokers: Results from the BOLD study in Annaba, Algeria cherkaski hamid (annaba, Algeria), Hamid Hacene Cherkaski, Feryal Atoui, Randa Yakoubi, Foued Khalloufi, Rachid Benali, Peter Burney
79
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1129
Prevalence and risk factors of COPD among never-smokers in two areas of Sweden - Occupational exposure to gas, dust or fumes is an important risk factor Stig Hagstad (Gothenburg, Sweden), Stig Hagstad, Helena Backman, Anders Bjerg, Linda Ekerljung, Anne Lindberg, Jan Lötvall, Eva Rönmark, Bo Lundbäck
PA1130
COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study Myriam Denguezli (Sousse, Tunisia), Meriam Denguezli, Hager Daldoul, Anamika Jithoo, Louisa Gnatiuc, Sonia Coton, Sonia Buist, Peter Burney, Imed Harrabi, Zouhair Tabka
PA1131
Prevalence of COPD in vascular diseases Murali Mohan Bangalore Venkataraman (Bangalore, India), BV Muralimohan, Gayatri Ekbote, Syed Zulkharnain Tousheed, Ranganath Ramanjenaya
PA1132
Obstructive diseases - Epidemiology and public awareness of the causes, course and effects. Selected results of the Polish Spirometry Day 2013 and World Spirometry Day 2014 Artur Badyda (Warsaw, Poland), Artur Badyda, Piotr Dabrowiecki
PA1133
A study of the normative values for the CAT questionnaire in the healthy Indian population Lancelot Pinto (Mumbai, India), Radhika Banka, Ujjwal Sharma, Sarika Bhosale, Lalita Angne, Jean Bourbeau, Lancelot Pinto
PA1134
Sex differences in alpha-1-antitrypsin deficiency Sebastian Fähndrich (Homburg/Saar, Germany), Sebastian Faehndrich, Christian Herr, Timm Greulich, Martina Seibert, Philipp M. Lepper, Nikolas Bernhard, Cindy Lützow, Claus Vogelmeier, Robert Bals
PA1135
Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area Ilaria Ferrarotti (Pavia, Italy), Ilaria Ferrarotti, Luciano Corda, Nuccia Gatta, Stefania Ottaviani, Alessia Braghini, Marianna Arici, Giovanna Lanzani, Federica Benini, Angelo Giudo Corsico, Bruno Balbi
PA1136
The change of asthma course during pregnancy Angelo Guido Corsico (Pavia, Italy), Angelo Guido Corsico, Francesca Locatelli, Lucia Cazzoletti, Amelia Grosso, Federica Albicini, Vanessa Ronzoni, Eti Maria Giulia Di Vincenzo, Davide Piloni, Isa Cerveri, Roberto De Marco
PA1137
A population-based study of animal component sensitization, asthma and rhinitis in school children Anders Bjerg (Gothenburg, Sweden), Anders Bjerg, Anna Winberg, Malin Berthold, Magnus Borres, Eva Rönmark
PA1138
Burden of asthma among children in a developing megacity: Childhood asthma study, Pakistan ambreen sahito (karachi, Pakistan), Adeel Ahmed Khan, Sana Tanzil, Tanzil Jamali, Afshan Shahid, Shahla Naeem, Ambreen Sahito, Fraz Anwar Siddiqui, Asaad Ahmed Nafees, Zafar Fatmi
PA1139
Prevalence of chronic cough in a population based survey Neha Kaushik (Wrexham, United Kingdom), Neha Kaushik, Jacky Smith, Mary Linehan, Timothy Frank
PA1140
Allergic disorders in relation to asthma and spastic bronchitis in children Grzegorz Brozek (Katowice, Poland), Grzegorz Brozek, Joshua Lawson, Kamil Baranski, Dawid Szumilas, Jan Zejda
PA1141
Rhinitis and chronic rhinosinusitis in Melbourne, Australia Diogenes Ferreira (Carlton, Australia), Diogenes S. Ferreira, Sonia Kaushik, Shyamali Dharmage, Bruce Thompson, Geza Benke, Michael J. Abramson
PA1142
Prevalence of respiratory symptoms in two general practice populations in Manchester UK Timothy Frank (Manchester, United Kingdom), Timothy Frank, Michelle Hazell, Neha Kaushik, Julie Morris, Mary Linehan
PA1143
Selection bias in epidemiological survey is similar in young adults and the elderly Giuseppe Verlato (Verona, Italy), Giang Nguyen, Giuseppe Verlato, Pierpaolo Marchetti, Roberto Marconcini, Marcello Ferrari, Alesandro Fois, Pietro Pirina, Roberto De Marco
Hall 14-27
Session 118
12:50 - 14:40
Thematic Poster: Occupational disease: clinical cases and series Chairs : Rafael E. de la Hoz (New York, United States of America), Anne Kristin Moller Fell (Skien, Norway), Carl Reynolds (Fareham, United Kingdom), Gennaro D'Amato (Napoli, NA, Italy) PA1144
LATE-BREAKING ABSTRACT: Complicated silicosis in an Australian worker from cutting engineered stone countertops: An embarrassing first for Australia Deborah Yates (Sydney, Australia), Anthony Frankel, Lucinda Blake, Deborah Yates
PA1145
Investigation and diagnosis of occupational asthma to nematodes Johanna Feary (London, United Kingdom), Johanna Feary, Julie Cannon, Jennifer Welch, Michael Tarzi, Paul Cullinan
80
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA1146
A new chemical causing IgE-mediated sensitization and asthma Hille Suojalehto (Helsinki, Finland), Hille Suojalehto, Kirsi Karvala, Katriina Ylinen, Irmeli Lindströn
PA1147
Occupational asthma to ’the miracle tree’ (Moringa oleifera): First description Mathias Poussel (Vandoeuvre-les-Nancy, France), Mathias Poussel, Emmanuelle Penven, Christelle Richard, Magalie Mercy, François Chabot, Christophe Paris
PA1148
A case of occupational asthma occurred in the subway maintenance worker Daeho Kim (Incheon, Republic of Korea), Daeho Kim, Boowook Kim, Kyeongmin Lee, Jeonga Shin
PA1149
Epoxy and delayed asthma David L. Sherson (Vejle, Denmark), Iben Jacobsen, Berit Christensen, Jesper Baelum, Niels Bjerring, Ulla Moeller, David Sherson
PA1150
Occupational asthma as a result of severe asthma Xavier Munoz Gall (Barcelona, Spain), Beatriz Gálvez-Martínez, María-Jesús Cruz, Iñigo Ojanguren, Mónica SánchezOrtíz, Susana Gómez-Ollés, Xavier Muñoz
PA1151
Accidental nitric acid gas exposure and respiratory effects Sehnaz Olgun (Istanbul, Turkey), Sehnaz Olgun Yildizeli, Buket Bayram, Emel Eryuksel, Berrin Ceyhan
PA1152
Short-term respiratory and systemic inflammatory responses to welding exposure Paula Kauppi (Helsinki, Finland), Paula Kauppi, Merja Järvelä, Timo Tuomi, Ritva Luukkonen, Tuula Lindholm, Riina Nieminen, Eeva Moilanen, Timo Hannu
PA1153
Early detection of lung disease in firefighters: A sound frequency analysis Ilina Krishen (Port Huron, United States of America), Ilina Krishen, Mary Lynn Zaremba, Kristin Elliott, Sridhar Reddy
PA1154
Validity of pulmonary functional status including 6 minute walk test in silicosis patients according to ILO classification Deepak UG (Jodhpur, India), Deepak Ug, Vinod Joshi, Gopal Purohit, Kailashchand Agarwal, U. Narendra, Mohan Jayaramu, Naresh Kumar
PA1155
Mobile cardio-respiratory metabolic laboratory as effective tool in early diagnosis of COPD and other chronic noncommunicable diseases (CNCDs) in organized busy groups of employees Zaurbek Aisanov (Moscow, Russian Federation), Sanjita Batyn, Alexander Chuchalin, Zaurbek Aisanov, Alexander Cherniak, Galina Nekludova, Janna Naumenko
PA1156
Pulmonary siderosis as a cause of systemic iron overload Marian J.R. Quanjel (Utrecht, Netherlands), Marian Quanjel, Bart Luijk, Aryan Vink, H. Stigter, Jos Rooijackers
PA1157
Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients Galina P. Orlova (Saint Petersburg, Russian Federation), Galina Orlova, Aleksandra Speranskaya, Ivetta Dvorakovskaya, Andrey Bazhanov
PA1158
Relationship between HRCT findings of Korea asbestosis patients and osteopontin expression Ho Sung Lee ( Cheonan, Republic of Korea), Ho Sung Lee
PA1159
Workplace challenge tests in workers excluded from work with possible occupational asthma Vicky Moore (Birmingham, United Kingdom), Vicky Moore, Gareth Walters, Alastair Robertson, Sherwood Burge
PA1160
Markers of injury and fibrosis in occupational interstitial lung diseases (OILD) Galina P. Orlova (Saint Petersburg, Russian Federation), Galina Orlova, Elena Surkova
PA1161
Glass wool aspiration: An unusual type of occupational pulmonary diseases Sibel Nayci (Mersin, Turkey), Eylem Sercan Ozgur, Oguz Köksel, Sibel Nayci, Rabia Bozdogan Arpaci, Gamze Bozdogan
PA1162
Chemical exposure triggering connective tissue disease with lung involvement Fernando Didier Neto (Sao Paulo, Brazil), Fernando Moacyr Fragoso Didier-Neto, Beatriz Dalcolmo de Almeida Leão, André Nathan Costa, Gustavo Faibischew Prado, Mario Terra-Filho, Ubiratan de Paula Santos
PA1163
Accelerated silicosis: A report of three patients Ubiratan Santos (Sao Paulo, Brazil), Felipe Marques da Costa, Ellen Pierre de Oliveira, Eduardo Algranti, Elizabete Medina Coeli Mendonça, Antônio Fernando Lins de Paiva, Rodrigo Caruso Chate, Mário Terra Filho, Ubiratan De Paula Santos
Hall 14-28
Session 119
12:50 - 14:40
Thematic Poster: Occupational and environmental cohort investigations and population studies Chairs : Vusumuzi Nkosi (Pretoria, South Africa), Else Würtz (Tjele, Denmark), Joachim Muller-Quernheim (Freiburg, Germany), Walter Araùjo Zin (Rio de Janeiro, Brazil)
81
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA1164
Mesothelioma in South African miners 1975-2013 Jill Murray (Johannesburg, South Africa), Jill Murray, Ntombizodwa Ndlovu, Gill Nelson
PA1165
Occupation related lung cancer: Asbestos risk reviewed ayesha amjad (Telford, United Kingdom), Masood Ahmad Khalil, Ayesha Amjad, Kate Garbett, K.S. Srinivasan, H. Moudgil
PA1166
Respiratory symptoms and quality of life in asbestos-related diffuse pleural thickening and pleural plaques Silvie Prazakova (Randwick, Australia), Silvie Prazakova, Alessandra Sandrini, Susan Miles, Paul Thomas, Anthony Johnson, Deborah Yates
PA1167
Mortality among workers exposed to asbestos in mining activities: 1940 - 2010 Ericson Bagatin (Jundiai, Brazil), Ericson Bagatin, Fernando Simões Friestino, Sérgio Roberto De Lucca, Ricardo Cordeiro
PA1168
Respiratory disorders of the producers and users of man made mineral fibres - Comparative study Micaela Margineanu (Iasi, Romania), Micaela Margineanu, Eugenia Danulescu, Felicia Gradinariu, Carmen Liliana Croitoru, Madalina Ipate, Doina Havarneanu
PA1169
Significance of alveolar lavage in assessing the aggressivity of different occupational exposures Felicia Gradinariu (Iasi, Romania), Felicia Gradinariu, Irina Anca Popescu, Carmen Croitoru, Micaela Margineanu, Razvan Danulescu, Madalina Ipate, Ovidiu Petris, Eugenia Danulescu
PA1170
Feasibility of using an electronic screening tool for occupational asthma in primary care Gareth Walters (Solihull, West Midlands, United Kingdom), Gareth Walters, Jon Ayres
PA1171
A new spirometry-based algorithm to predict occupational pulmonary restrictive impairment Sara De Matteis (London, United Kingdom), Sara De Matteis, Amaia Iridoy, Paul Cullinan
PA1172
Chronic obstructive pulmonary disease in never-smoking welders Jordan Minov (Skopje, FYROM (Macedonia)), Jordan Minov, Jovanka Karadzinska-Bislimovska, Kristin Vasilevska, Snezana Risteska-Kuc, Saso Stoleski, Dragan Mijakoski
PA1173
Daytime sleepiness, risk of sleep apnea and accidents in professional drivers David Miedinger (Luzern, Switzerland), David Miedinger, Sandra Isler, Matthias Moritz, Thomas Dieterle, Joerg Leuppi
PA1174
Respiratory effects of laser printer emissions: A controlled exposure study Stefan Karrasch (Neuherberg, Germany), Stefan Karrasch, Rudolf A. Jörres, Myriam Ehret, Britta Herbig, Jeanette Langner, Stefan Seeger, Rudolf Schierl, Dennis Nowak
PA1175
Occupational exposure to metal working fluids aerosol and the relationship with the respiratory symptoms and lung functions among machinists Zailina Hashim (Serdang, Malaysia), Nur Awatif Ahmad, Zailina Hashim
PA1176
Respiratory health in the cotton industry in Pakistan Hanns Moshammer (Wien, Austria), Abdul W. Khan, Hanns Moshammer
PA1177
Work in burnt sugar cane harvesting: Chronic and acute change on inflammatory markers and blood pressure Marceli Rocha Leite (Presidente Prudente, Brazil), Marceli Rocha Leite, Dionei Ramos, Iara Buriola Trevisan, Ana Paula Coelho Figueira Freire, Bruna Spolador de Alencar Silva, Guilherme Yassuyuki Tacao, Renata Marques David, Emmanuel Almeida Burdmann, Ubiratan De Paula Santos
PA1178
Respiratory ill health in the furniture and wood processing industries: A systematic review Ruth Wiggans (Manchester, United Kingdom), Ruth Eleanor Wiggans, Gareth Evans, David Fishwick, Chris Barber
PA1179
Incidence of occupational respiratory diseases in Castilla-La Mancha, Spain Jesus Martinez Moratalla Rovira (Albacete, Spain), Jesús Martínez-Moratalla Rovira, Mª José Zamora López, Máxima Lizán García, Esperanza Mancebo Gilabert, María Martínez-Moratalla De La Prida
PA1180
Respiratory symptoms, lung function tests and airway responsiveness among crop farmers Sasho Stoleski (Skopje, FYROM (Macedonia)), Saso Stoleski, Jovanka Karadzinska-Bislimovska, Jordan Minov, Dragan Mijakoski
PA1181
Interdependence between lung tests, cellular immunity and dose of radiation exposure in COPD patients clean-up workers of Chernobyl NPP accident in remote post accidental period Victor Sushko (Kiev, Ukraine), Viktor Sushko, Kostiantyn Bazyka
PA1182
Lung function, birth weight and tobacco smoke exposure in children from rural and urban areas Vesna Vekovic (Belgrade, Republic of Serbia), Vesna Vekovic, Sofija Verovic, Jasmina Jocic-Stojanovic, Zorica Zivkovic
82
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Hall 14-29
Session 120
12:50 - 14:40
Thematic Poster: Specific populations of smokers (women, adolescents and young adults) Chairs : Elif Dagli (Istanbul, Turkey), Filippos Filippidis (London, United Kingdom), Angela Zacharasiewicz (Vienna, Austria), Paraskevi Katsaounou (Athens, Greece) PA1183
The overestimation on tobacco consumption of peers by teenagers increase when tobacco consumption decrease Marie Dominique Dautzenberg (Paris, France), Marie-Dominique Dautzenberg, Pierre Birkui, Nicole Rieu, Bertrand Dautzenberg
PA1184
Maternal smoking during pregnancy a significant risk factor for women and their children Natalia Astafieva (Saratov, Saratov Oblast, Russian Federation), Natalia Astafieva, Olga Naumova, Inna Gamova, Ekaterina Udovichenko, Irina Perfilova
PA1185
Tobacco use among working adolescents and high school students- Turkey, 2006 and 2013 Ahmet Hakan Gedik (Istanbul, Turkey), Ahmet Hakan Gedik, Erkan Cakir, Ali Ozdemir, Nazli Burcin Karacabey, Nezih Varol, Fazilet Karakoc, Refika Ersu, Bulent Karadag, Elif Dagli
PA1186
Do we need to promote healthy behaviors among medical students? - A cross sectional study Sofia Belo Ravara (Lisboa, Portugal), Sofia Ravara, Daniela Faria, Irma Brito
PA1187
Incidence and social predictors of oral lesions in women with habitual smokeless tobacco use in Karachi, Pakistan Farah Idrees (Karachi, Pakistan), Farah Idrees
PA1188
Comparison of smoking habits among students from medical and non medical universities across Pakistan Saima Akhter (Karachi, Pakistan), Saima Akhter, Usman Ali, Sajeer Bhura, Nadeem Rizvi, Mustufa Khursheed
PA1189
Overlapping causes of starting smoking and substance abuse Mahshid Aryanpur (TEHRAN, Islamic Republic of Iran), Mahshid Aryanpur, Hooman Sharifi, Zahra Hessami, Gholam Reza Heydari, Mohammad Reza Aryan, Ashraf Vaseghnia, Hamid Reza Jamaati
PA1190
The social representation of smoking for female sex workers and their prevalence Ilda Godoy (Botucatu, Brazil), Ligia L. Devóglio, Maria Helena Borgato, Irma Godoy, Ilda De Godoy
PA1191
Prevalence and characteristics of tobacco smoking among female students in Pakistan Hasan Mustafa (Karachi, Pakistan), Saima Akhter, Hasan Mustafa, Usma Ali Warraich, Nadeem Rizvi
PA1192
Comparison of post natal abnormalities and death of infants of smoking and non-smoking women Maria Malik (Karachi, Pakistan), Maria Malik, Ashok Kumar, Nadeem Rizvi
PA1193
Smoking knowledge, attitude and behavior of child labor who live in Tehran during 2013-2014 Mahshid Aryanpur (TEHRAN, Islamic Republic of Iran), Mahshid Aryanpur, Ali Ramezankhani, Hooman Sharifi, Zahra Hessami, Gholam Reza Heydari, Mohammad Reza Aryan, Hamid Reza Jamaati
PA1194
Perceptions of EC tobacco products directive (TPD) cigarette packs and fully standardized Irish cigarette packs: A survey of Irish students Kate Babineau (Dublin, Ireland), Luke Clancy, Kate Babineau, Sheila Keogan
PA1195
Inequalities in smoking prevalence during pregnancy: Comparing results from 53 low and middle income countries Fernando C Wehrmeister (Pelotas, Brazil), Fernando C. Wehrmeister, María Clara Restrepo-Méndez, Giovanny V.A. França, Aluisio J.D. Barros, Cesar G. Victora
PA1196
Smoking behavior of secondary school children in Constanta county Elena Dantes (Constanta, Romania), Elena Dantes, Cristian Oancea, Oana Cristina Arghir, Petronela Ariadna Fildan
PA1197
Factors associated with smoking initiation age in adults Zehra Asuk Yasar (Bolu, Turkey), Zehra Yasar, Aysel Kargi, Fahrettin Talay, Tuncer Tug, Erdogan Cetinkaya
PA1198
Cotinine and trans-3-hydroxycotinine as surrogate markers for ETS exposure in children Peter Fsadni (Birkirkara, Malta), Peter Fsadni, Noel Aquilina, Stephen Montefort
PA1199
The evaluation of the factors that affects the smoking behaviours in a group of high school students in Turkey Melike Demir (Diyarbakir, Turkey), Melike Demir, Gulistan Karadeniz, Fikri Demir, Cem Karadeniz, Halide Kaya, Derya Yenibertiz, Mahsuk Taylan, Velat Sen, Sureyya Yilmaz
PA1200
Modern aspects of evaluation of halth status using acoustic analysis of respiratory sound of teenage smoking Egor Mokin (Samara, Russian Federation), Natalia Mokina, Vasily Pjatin, Egor Mokin
PA1201
Recurrent wheezing in children and smoking exposure Ioana Ciuca (Timis, Romania), Ioana Ciuca, Liviu Pop, Sonia Tanasescu, Gabriela Duta, Monica Marc
83
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Hall 14-30
Session 121
12:50 - 14:40
Thematic Poster: Smoking cessation Chairs : Sofia Belo Ravara confirmed
(Lisboa, Portugal), Philip Tønnesen (Glostrup, Denmark), Michael Toumbis (Athens, Greece), Chair to be
PA1202
Do pulmonary function tests effect short-term smoking cessation rates? Banu Musaffa Salepçi (Istanbul, Turkey), Banu Salepci, Benan Caglayan, Ali Fidan, Elif Torun Parmaksiz, Nesrin Kiral, Sevda Sener Comert, Coskun Dogan, Esma Coskun
PA1203
Online survey of COPD recognition and its determinant factors in the original users of our smoking cessation app Hitoshi Katayama (Toon, Japan), Hitoshi Katayama, Ryoji Ito, Chie Yamamoto, Chizuru Hamada, Ryo Toyozawa, Aki Kato, Seigo Miyoshi, Takafumi Okura, Jitsuo Higaki
PA1204
Evaluation of smoking cessation related press coverage in 2014 Murat GÜner (Istanbul, Turkey), Murat Güner, Elif Dagli, Fusun Yildiz, Osman Elbek, Eza Evrengil
PA1205
Is surgical treatment a motivator factor for smoking cessation? Experience in an anticancer hospital Danai Bisirtzoglou (Athens, Greece), Dimitrios Theofilos, Charalampos Marketos, Danai Bisirtzoglou, Athanasios Zetos, Antigoni Sakelaropoulou, George Politis
PA1206
Smoking cessation for free: First long-term outcomes in three Romanian centres Letitia Trofor (Iasi, Romania), Letitia Trofor, Corina Marginean, Milena Man, Ramona Miron, Elena Barnea, Antigona Carmen Trofor
PA1207
Does short message service (SMS) increase adherence to smoking cessation clinic appointments and quitting smoking? Seda Tural Önür (Istanbul, Turkey), Seda Tural Onur, Mehmet Atilla Uysal, Sinem Iliaz, Ayse Bahadir, Sibel Yurt, Didem Gorgun Hattatoglu, Mediha Gonenc Ortakoylu, Belma Akbaba Bagci
PA1208
Smoke cessation recommendations and prescriptions in hospitalised medical patients Josef Micallef (Birkirkara, Malta), Stephanie Attard, Juanita Casengena Garcia, Kentaro Yamagata, Ramon Casha, Josef Micallef
PA1209
Impacts of pharmacist-led smoking cessation program on patients with chronic diseases in a Thai community hospital Piyawan Kuwalairat (Chumphon, Thailand), Piyawan Kuwalairat, Rarin Sornkate, Sunee Lertsinudom
PA1210
Smoking cessation after first admission in a respiratory unit EVA B. CABRERA CESAR (Granada, Spain), Eva Cabrera Cesar, Maria Carmen Fernandez Aguirre, Nuria Reina Marfil, Lidia Lopez Lopez, Jose Luis Velasco Garrido, Maria Victoria Hidalgo Sanjuan
PA1211
Abstinence, cigarette consumption and health disorders in smokers when quitting and five years later Marinela Raileanu (Bucarest, Romania), Marinela Raileanu
PA1212
Experience of stop smoking national cessation program from Romania, Cluj-Napoca area. Can we help people to quit smoking? Andreea Coman (Cluj-Napoca, Romania), Doina Adina Todea, Andreea Codruta Coman
PA1213
Cigarettes per day and ethnicity in London Patrick T White (London, United Kingdom), Alexander Gilkes, Peter Schofield, Mark Ashworth, Sally Hull, Stevo Durbaba, Patrick White
PA1214
Factors associated with smokers’ will for smoking cessation in Korea AH YOUNG LEEM (Seoul, Republic of Korea), Ah Young Leem, Chang Hoon Han, Chul Min Ahn, Tae-Hoon Jung, Yu-Il Kim, Jae Yeol Kim, Sang Haak Lee, Eun Mi Chun, Kwang-Ha Yoo, Ji Ye Jung
PA1215
Smoking cessations in asthma/COPD patients at one stop service clinic in Tertiary care hospital Panomporn Junla-or (Buriram, Thailand), Visakha Boontod, Panomporn Junla-or, Narin Chindavech, Soralak Prajead, Visagorn Modthong
PA1216
The problem of low rate-smokers: Smoking pattern and cessation outcomes Cristina Chirila (Iasi, Romania), Cristina Chirila, Letitia Trofor, Alexandru Frunza, Andra Maria Albu, Rodica Gherghesanu, Antigona Carmen Trofor
PA1217
Time trend in the smoking cessation program efficacy – A single center experience Branka Bulaji Suboti (Beograd, Republic of Serbia), Branka Bulajic Subotic, Ika Pesic
PA1219
The practical application of clinical guidelines for smoking cessation in adolescents: The final assessment point and the effectiveness of interventions Egor Mokin (Samara, Russian Federation), Natalia Mokina, Vasily Pjatin, Egor Mokin
84
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA1220
Assessing motivation to quit and nicotine dependence in a smoking cessation program- A cross-sectional study Sofia Belo Ravara (Lisboa, Portugal), Sofia Ravara, Mariana Batista, Eva Campos-Pereira, Jose M. Calheiros
Hall 14-31
Session 122
12:50 - 14:40
Thematic Poster: Genetics and environmental factors in phenotypes of asthma and COPD Chairs : Erik Melén (Stockholm, Sweden), Tiziana Patrizia Cremona (Bern, Switzerland), Daan Loth (Rotterdam, Netherlands), Chair to be confirmed
PA1222
LATE-BREAKING ABSTRACT: Genome-wide association studies identify novel loci associated with early postnatal lung function Olga Gorlanova (Aesch, Switzerland), Olga Gorlanova, Jakob Usemann, Philipp Latzin, Anne Schmidt, Sven Michel, Antoaneta Toncheva, Michael Kabesch, Urs Frey
PA1223
Differences in response to Der p1 and bacterial lipopolysaccharide in peripheral blood mononuclear cells from severe and non-severe asthmatics Ewa Pniewska (Lodz, Poland), Ewa Pniewska, Izabela Kuprys-Lipinska, Piotr Kuna, Rafal Pawliczak
PA1224
Genetic variants in NRXN1, CHRNA3, CHRNA5 and CHRNB4 are associated with smoking and increased consumption of cigarettes per day in a Mexican mestizo population Gloria Pérez-Rubio (México, Mexico), Gloria Pérez-Rubio, Martha E. Pérez-Rodríguez, Alejandra Ramírez-Venegas, Raul Sansores, Angel Camarena, Ramcés Falfán-Valencia
PA1225
Gene expression profile of pulmonary inflammation in rat lung induced by nickel oxide nanoparticles following intratracheal instillation Hiroto Izumi (Kitakyushu, Japan), Hiroto Izumi, Yukiko Yoshiura, Taisuke Tomonaga, Byeong-Woo Lee, Takami Okada, Takako Oyabu, Toshihiko Myojo, Manabu Shimada, Masaru Kubo, Kazuhiro Yamamoto, Shinichi Kitajima, Yasuo Morimoto
PA1226
Inactivation of glycogen synthase kinase 3 (GSK-3 ) enhances skeletal muscle oxidative metabolism Alexander H Remels (Maastricht, Netherlands), Alexander Remels, Koen Verhees, Harry Gosker, Annemie Schols, Ramon Langen, Alexander Remels
PA1227
The relationship of vitamin D binding protein polymorphisms with blood vitamin D Level in Korean patients with COPD Youngmok Park (Seoul, Republic of Korea), Youngmok Park, Young Sam Kim, Se Kyu Kim, Yeon-Mok Oh, Sang Do Lee, Ji Ye Jung, KOLD Study
PA1228
Effect of TRPV4 gene polymorphisms on osmotic airway hyperresponsiveness in patients with asthma Denis Naumov (Blagoveshchensk, Amur Oblast, Russian Federation), Denis Naumov, Juliy Perelman, Anna Prikhodko, Victor Kolosov, Vladimir Maksimov, Mikhail Voevoda
PA1229
Genetic influences on lung function decline in AATD Heena Khiroya (Birmingham, United Kingdom), Heena Khiroya, Paul Newby, Ross Edgar, Rob Stockley, Alice Turner
PA1230
Association between genetic polymorphisms of ADAM33 with asthma and its phenotypes Padukudru Anand Mahesh (Mysore, India), Mahesh Padukudru Anand, Sangeetha Visweshwaraiah, Ramachandra Nallur, Jayaraj Biligere, Chaya Sindaghatta, Amrutha Holla
PA1231
Single nucleotide polymorphism and asthma: A study on the genetic basis of asthma Padukudru Anand Mahesh (Mysore, India), Sareh Raeiszadeh Jahromi, P.A. Mahesh, B.S. Jayaraj, Amrutha D. Holla, Sangeetha Vishweswaraiah, Ramachandra B. Nallur
PA1232
Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity Anna Stupnytska (Chernivtsi, Ukraine), Nataliya Gorovenko, Ganna Stupnytska, Svitlana Podolskaya
PA1234
Inflammation-related genes, peripheral blood eosinophil (EOS) and neutrophil (NEU) count, and lung function in adult asthma Simone Accordini (Verona, Italy), Simone Accordini, Lucia Calciano, Cristina Bombieri, Giovanni Malerba, Francesca Belpinati, Marcello Ferrari, Anna Rita Lo Presti, Mario Olivieri, Elisabetta Zanolin, Roberto De Marco
Hall 14-32
Session 123
12:50 - 14:40
Thematic Poster: Management of asthma and other respiratory diseases in primary care Chairs : Anders Ostrem (Oslo, Norway), Ioanna Tsiligianni (Heraklion, Crete, Greece), Tjard Schermer (Nijmegen, Netherlands), Rupert Jones (Milton Combe (DEVON), United Kingdom)
85
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1235
LATE-BREAKING ABSTRACT: The prevalence of night and morning symptoms in primary care COPD patients: How do they relate to COPD health status and disease severity? An UNLOCK study Esther Metting (Groningen, Netherlands), Esther Metting, Ioanna Tsiligianni, Janwillem Kocks, Thys van der Molen, Niels Chavannes
PA1236
Training tool versus instruction leaflet for pMDI use - A controlled group comparative study Michael Welch (San Diego, United States of America), Michael Welch, Alex Greiner, Susan Smith, Nancy Ostrom, Mark Sanders
PA1237
E cigarettes: Knowledge and attitudes in Canadian primary care physicians Alan Kaplan (Richmond Hill, Canada), Alan Kaplan
PA1238
REG study: Real-life, longitudinal ICS adherence patterns in a UK asthma population Alexandra Dima (Amsterdam, Netherlands), Alexandra Dima, Patrick Souverein, Ellen Koster, Alison Chisholm, David Price, Gene Colice
PA1239
Hemoptysis in children: Sometimes scary sometimes petty Ayse Tana Aslan (ANKARA, Turkey), Ayse Aslan, Tugba Sismanlar
PA1240
Pharmacist’s time spending to manage patients with asthma or COPD in an outpatient clinic in Thailand Sirin Phenphinan (Khon Kaen, Thailand), Sunee Lertsinudom, Sirin Phenphinan, Kesarin Choopunyalerd
PA1241
Clinical outcomes and quality of life of asthma patients in Asthma Clinic, Tertiary Care Hospital in Thailand Kesarin Choopunyalerd (Khonkaen, Thailand), Sunee Lertsinudom, Ketsarin Choopanyalert
PA1242
Evaluation of robustness of valved holding chambers (VHCs) following repeated dishwasher cycles in-use Jason Suggett (London, Canada), Jason Suggett, Mark Nagel, Angelica Botero, Jolyon Mitchell
PA1243
Variation in non-elective hospital admission and consequent asthma costs across primary care practice and clinical commissioning group (CCG), Wessex, United Kingdom Lucy Rigge (Westbourne, United Kingdom), Lucy Rigge, Frank Ratcliff, Kate Lippiett, Lynn Josephs, Mike Thomas, Tom Wilkinson
PA1244
Combination therapy versus separate therapy in real-life primary care asthma patients Esther Metting (Groningen, Netherlands), Esther I. Metting, Janwillem W.H. Kocks, Thys Van der Molen
PA1245
Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex David Price (Aberdeen, United Kingdom), David B. Price, Gene Colice, Jonathan Grigg, Richard J. Martin, Theresa W. Guilbert, Elliot Israel, Dirkje S. Postma, Nicolas Roche, Anne Burden, Valerie L. Ashton, Wim Van Aalderen
PA1246
Skilled manpower assistance for management of chronic respiratory diseases (CRDs): Does India really need it? Madhuragauri Shevade (Pune, Maharashtra, India), Madhuragauri Shevade, Komalkirti Apte, Somnath Bondarde, Sapna Madas, Sundeep Salvi
PA1247
The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis Young Min Lee (Busan, Republic of Korea), Young Min Lee
PA1248
Association between alpha 1 antitrypsin and bronchiectasis David Manuel Araújo (Porto, Portugal), David Araújo, Maria Sucena
PA1249
Development and implementation of standard carer training guidelines for the care of long term ventilated patients in the community Alison Armstrong (Newcastle upon Tyne, United Kingdom), Alison Armstrong, Jacqueline Ross, Sue Pieri-Davies
PA1250
Clinical manifestations of GERD in smoking patients Victoria Pidzhimyan (Saint-Petersburg, Russian Federation), Victoria Pidzimyan, Olga Dudina, Vera Yablonskaya, Natalia Shaporova
PA1251
Inhalation therapy with hypertonic saline (3%) – A treatment option for airway disease in children? Markus Koch (Murnau, Germany), Markus Koch, Heribert Mentzel, Rosina Ledermüller
PA1252
Awareness of COPD in primary & secondary health care facilities in Eastern UP, India Anubha Jain (Lucknow, India), Anubha Jain, J.K. Samaria, Shantakumar, Kumar Utsav
PA1253
Study of 793 COPD patients treated by general practitioners (GPs), intensivists (IPs) and pulmonologists (Ps) across India Renu Sorte (Pune, Maharashtra, India), Renu Sorte, Parthssarthy Bhattacharyya, P. Mahesh, Raja Dhar, Suryakant Tripathi, Rajesh Swarnakar, D. Christopher, Mahavir Modi, C. Prasad, Sapna Madas, Sundeep Salvi, Sneha Limaye
86
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Hall 14-33
Session 124
12:50 - 14:40
Thematic Poster: Paediatric respiratory physiology Chairs : Valentina Fainardi (Parma, Italy), Nicole Beydon (Paris, France), Shannon Simpson (Western Australia, Australia), Paul Robinson (Sydney, NSW, Australia), Chair to be confirmed
PA1254
Genetic variants on 6q12 and 11p14 are associated with elevated exhaled nitric oxide and respiratory symptoms during infancy Oliver Fuchs (Munich, Germany), Oliver Fuchs, Olga Gorlanova, Philipp Latzin, Anne Schmidt, Sven Michel, Michael Kabesch, Urs Frey
PA1255
Telomere attrition in peripheral blood mononuclear cells of children with alpha-1 antitrypsin deficiency Francisco Jose Dasi Fernandez (Valencia, Spain), Amparo Escribano, Sara Pastor, Ana Reula, Silvia Castillo, Shirley Camacho, Francisco Sanz, Pilar Codoñer-Franch, Francisco Dasi
PA1256
Structural abnormalities do not explain the reduced exercise capacity in preterm children Christopher O'Dea (Perth, Australia), Christopher O’Dea, Karla Logie, Andrew Wilson, Andrew Maiorana, Jane Pillow, Georgia Banton, Shannon Simpson, Graham Hall
PA1257
Long-term effects of severe acute malnutrition on lung function in children Natasha Lelijveld (London, United Kingdom), Natasha Lelijveld, Jane Kirky, Marko Kerac, Janet Stocks
PA1258
Limitations of forced spirometry in the detection of bronchodilator response in asthmatic children Dorottya Czovek (Brisbane, Australia), Dorottya Czovek, Claire Shackleton, Kate Taylor, Zoltan Gingl, Zoltan Hantos, Peter Sly
PA1259
Home respiratory monitoring in infants born preterm using pulse oximeter plethysmogram analysis Paul Seddon (West Sussex, United Kingdom), Paul Seddon, Sonia Sobowiec Kouman, David Wertheim
PA1260
Thermal imaging method for measurement of respiratory rate Heather Elphick (Sheffield, United Kingdom), Heather Elphick, Abdulkadir Alkali, Ruth Kingshott, Derek Burke, Reza Saatchi
PA1261
Equipment specific reference ranges for the raised volume technique (RVRTC) in infants: A multi-centre collaboration Sooky Lum (London, United Kingdom), Sooky Lum, Vassiliki Bountziouka, Angela Wade, Jane Kirkby, Antonio MorenoGaldo, Olaia SardonPrado, Joerg Mattes, Luis Miguel Borrego, Joanne Miles, Janet Stocks
PA1262
In vitro and in vivo comparison of two multiple breath nitrogen washout devices Lena Raaijmakers (Nijmegen, Netherlands), Lena Raaijmakers, Renee Jensen, Sanja Stanojevic, Peter Merkus, Felix Ratjen
PA1263
Characterisation of leaks during multiple breath washout and their influence on test results Nina Lenherr (Basel, Switzerland), Nina Lenherr, Kerstin Jost, Linn Hornwall, Florian Singer, Sophie Yammine, Philipp Latzin
PA1264
Different indices of inert gas washout measurements define physiological phenotypes Sylvia Nyilas (basel, Switzerland), Sylvia Nyilas, Sophie Yammine, Nitin Kumar, Anne Schlegtendal, Anna Gensmer, Florian Singer, Cordula Koerner-Rettberg, Urs Frey, Carmen Casaulta, Philipp Latzin
PA1265
Ability of lung clearance index to track changes in a routine clinical CF setting Simone Salzmann (Bern, Switzerland), Simone Salzmann, Sophie Yammine, Linn Krüger, Carmen Casaulta, Philipp Latzin
PA1266
The effect of hyperoxia on tidal breathing in preschool children Kathryn Ramsey (Chapel Hill, United States of America), Kathryn Ramsey, Caroline Gallagher, Graham Hall
PA1267
Can Scond and Sacin be estimated from two multiple breath washout tests across childhood? Kate Hardaker (Westmead, Australia), Kate Hardaker, Geshani Jayasuriya, Per Gustafsson, Peter Cooper, Dominic Fitzgerald, Hiran Selvadurai, Paul Robinson
PA1268
LCI and Moment ratios (MR) at different tracer cut-offs in infant multiple-breath-washout measurements Barbara Egger (Basel, Switzerland), Barbara Egger, Sophie Yammine, Anne Schmidt, Urs Frey, Philipp Latzin
PA1269
Peripheral airway abnormalities are common in children post bone marrow transplantation Rathnini Jayasuriya (Sydney, Australia), Geshani Jayasuriya, Greg King, Hiran Selvadurai, Melissa Gabriel, Per Gustaffson, Kate Hardaker, Brendan Kennedy, Steven Keogh, Ida O’Brien, Peter Shaw, Paul Robinson
PA1270
Feasibility of performing pulmonary function testing in cohort studies Krzysztof Kowalik (Mississauga, Canada), Krzysztof Kowalik, Zihang Lu, Wendy Lou, Susan Balkovec, Flora Lau, Per Gustafsson, Malcolm R. Sears, Felix Ratjen, Padmaja Subbarao
87
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA1271
Selecting a spirometry control group for Malawian children Jane Kirkby (London, United Kingdom), Jane Kirkby, Natasha Lelijveld, Sooky Lum, Marko Kerac, Janet Stocks
PA1272
Normal lung function in Angolan children Michele Arigliani (Udine , Italy), Michele Arigliani, Mario C. Canciani, Andrea Magnolato, Philip H. Quanjer
PA1273
Hypoxemia, symptoms and bronchial obstruction in asthmatic children seen in a lung function laboratory Nicole Beydon (Paris, France), Thi Lan Thanh NGuyen, Fatma Lancin, Nicole Beydon
Hall 14-34
Session 125
12:50 - 14:40
Thematic Poster: Paediatric asthma and allergy: asthma management Chairs : Erol Gaillard (Leicester, United Kingdom), Özge Yilmaz (Manisa, Turkey), Giuseppe Gallo (Verona, Italy), Marc van der Schee (Amsterdam, Netherlands) PA1274
Effect of 1 year treatment with inhaled corticosteroids with electronically assessed adherence on height growth in children with asthma Nele Wardenier (Zwolle, Netherlands), Nele Wardenier, Ted Klok, Paul Brand
PA1275
Adherence to inhaled corticosteroids in asthmatic children in Dutch primary care Marjolein Engelkes (Bergschenhoek, Netherlands), Marjolein Engelkes, Hettie Janssens, Johan De Jongste, Miriam Sturkenboom, Katia Verhamme
PA1276
Asthma guidelines need to be followed at primary care level to improve symptom control in children Judy Pitts (Westerville, United States of America), Shahid Sheikh, Judy Pitts, Karen McCoy
PA1277
Following asthma guidelines improves quality of life in children with asthma Judy Pitts (Westerville, United States of America), Shahid Sheikh, Judy Pitts, Nancy Ryan-Wenger, David Stukus, Karen McCoy, Kavitha Kotha
PA1278
Asthmatic children: Parents knowledge is enough? Roseane Caldeira (Montes Claros, Brazil), Roseane Caldeira, Iuri Oliveira
PA1279
Parenting stress related to behavioural problems and disease severity in children with problematic severe asthma Marieke Verkleij (Hilversum, Netherlands), Marieke Verkleij, Erik-Jonas Van de Griendt, Vivian Colland, Nancy Van Loey, Anita Beelen, Rinie Geenen
PA1280
Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study Toshio Katsunuma (Tokyo, Japan), Toshio Katsunuma, Takanobu Maekawa, Ken-ichi Akashi, Takao Fujisawa, Yukihiro Ohya, Koji Hashimoto, Yuichi Adachi, Mari S. Oba, Mayumi Sako, Hidefumi Nakamura, Yasuo Ohashi
PA1281
Inter-observer agreement in clinical assessment of children with acute dyspnea in the emergency department Marieke van der Vegt (Zwolle, Netherlands), Marieke Van der Vegt, Eric De Groot, Paul Brand
PA1282
Study of the small airway and its role in pediatric asthma control assessment Olaia Sardon (San Sebastian, Spain), Olaia Sardon, Garazi Azaldegi, Ane Aldasoro, Paula Corcuera, Jose I. Emparanza, Javier Mintegui, Javier Korta, Eduardo G. Pérez-Yarza
PA1283
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Sanne Kloosterman (Rotterdam, Netherlands), Sanne F. Kloosterman, Harm A.W.M. Tiddens, Joke L. Overweel, Johan C. De Jongste, Hettie M. Janssens
PA1284
Bronchial epithelium is already abnormal in children with severe asthma Ania Carsin (Marseille, France), Ania Carsin, Jean-Christophe Dubus, Julie Mazenq, Céline Garulli, Jacques De Blic, Pascal Chanez, Delphine Gras
PA1285
Assessment of SLIT efficacy in children by FeNO Zorica Živkovi (Beograd, Republic of Serbia), Zorica Zivkovic, Ivana Djuric-Filipovic, Jasmina Jocic-Stojanovic, Vesna Vekovic
PA1286
Magnesium deficiency correction for improvement of children bronchial asthma treatment results Ivan Shishimorov (Volgograd, Russian Federation), Ivan Shishimorov, Vladimir Petrov, Olga Magnitskaya, Aleksey Perminov, Igor Nefedov
PA1287
Validation of a new quality of life instrument for wheezy preschool children Paul Seddon (West Sussex, United Kingdom), Catherine Olden, Liz Symes, Paul Seddon
PA1288
Impact of asthma on health related quality of life of adolescents in a District of Sri Lanka Manjula Danansuriya (Ragama, Sri Lanka), Manjula Danansuriya, Lalini Rajapaksa
88
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1289
Concordance between physician’s assessment of asthma control and quality of life in children Ae Ra Kee (Singapore, Singapore), Ae Ra Kee, Xiaoting Huang, Gwee Yong Xiang, John C. Allen Jr, Soh Yan Tan, Shu Xian Chiang, Ai Huay Teo, Chay Oh Moh, Teoh Oon Hoe, Pugalenthi Arun, Anne Goh, Petrina Wong, Biju Thomas
PA1290
Correlation of financial burden with severity of asthma in children Keya Rani Lahiri (Mumbai, India), Keya Lahiri, Fehmida Najmuddin, Pallavi Gahlowt
PA1291
Inhaled-corticosteroids, body weight and height in children with asthma Guergana Petrova Stoyanova (Sofia, Bulgaria), Guergana Petrova, Vera Papochieva, Snezhina Lazova, Dimitrinka Miteva, Katia Temelkova, Penka Perenovska
PA1292
Knemometry assessment of short-term lower leg growth in children with asthma treated with fluticasone propionate/formoterol combination therapy Ole Wolthers (Randers, Denmark), Ole D. Wolthers, Ainslee Moore, Sabine Mersmann, Sanjeeva Dissanayake
PA1293
Assessment of baseline adrenal function by measurement of long term cortisol levels in scalp hair of asthmatic children using inhaled corticosteroids compared to healthy controls Maria Smit (Gouda, Netherlands), Maria Smit, Ed Van Leer, Gerard Noppe, Yolanda De Rijke, Jurriaan Hoekx, Erica Van den Akker
Hall 14-35
Session 126
12:50 - 14:40
Thematic Poster: Cystic fibrosis: microbiology, immunology and assessment Chairs : Mark Rosenthal (London, United Kingdom), Rishi Pabary (London, United Kingdom), Dominik Hartl (Tübingen, Germany), Chair to be confirmed
PA1294
LATE-BREAKING ABSTRACT: Early following up of gas trapping with computed tomography during normal breathing in infant with Cystic Fibrosis Stefan Matecki (Montpellier, France), magalie Saguitaah, Gauthier Rémi, Cécile Duboibaudry, Laure Couder, Marie Agnes Metges, Muriel Lebourgeois, Phillipe Reix, Francis Amsallem, Nicolas Molinari, Stefan Matecki
PA1295
Alternating inhaled antibiotic therapy in CF: A single center analysis Charlotte Van de Kerkhove (Belsele, Belgium), C. Van de Kerkhove, M. Kicinski, P.C. Goeminne, T.S. Nawrot, L.J. Dupont
PA1296
Antimicrobial susceptibility of pseudomonasaeruginosa in CF patients before and after regular treatment with inhaled tobramycin Guergana Petrova Stoyanova (Sofia, Bulgaria), Guergana Petrova, Tanya Strateva, Penka Perenovska, Dimitrinka Miteva
PA1297
Colonization of bacteria after lung transplantation in cystic fibrosis (CF) patients occurs early but does not impact survival Anna Engell Holm (Copenhagen, Denmark), Anna Engell Holm, Hans Henrik Schutz, Michael Perch, Tacjana Pressler, Jørn Carlsen, Martin Iversen
PA1298
Value of bronchoalveloar lavage (BAL) in management of lung infections in adult cystic fibrosis Parthiban Nadarajan (Dublin, Ireland), Anandan Natarajan, Parthiban Nadarajan, Carla Flanagan, Charles Gallagher, Edward McKone
PA1299
Candidaemia in cystic fibrosis patients with totally implantable venous access devices is associated with invasive procedures and exacerbation frequency Orla O'Carroll (Dublin, Ireland), O. O’Carroll, C. McCarthy, E. O’Brien, T. McEnery, N. McElvaney
PA1300
Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk Miguel Garcia Gonzalez (Westmead, Australia), Miguel Garcia Gonzalez, Karen McKay, Peter Cooper, Hiran Selvadurai, Dominic Fitzgerald, Paul D. Robinson
PA1301
The efficacity of omaluzimab in a case series with allergic bronchopulmonary aspergillosis and cystic fibrosis Virginie LabossiÈre (Montréal, Canada), Virginie Labossière, François Tremblay, Annick Lavoie, Maité Sylviet-Carricart, Céline Bergeron
PA1302
Macrophage morphology in sputum samples from paediatric CF patients Abigail Whitehouse (Romford, United Kingdom), Rina Shah, Abigail Whitehosue, Naseem Mushtaq, Jonathan Grigg
PA1303
Role of polymorphonuclear neutrophils (PMN) in Interleukin-1 (IL-1 ) processing during bacterial lung infection: Relevance to cystic fibrosis (CF) Fanny Magne (Paris, France), Brice Lagrange, Fanny Magne, Laurette Malleret, Yves Pacheco, Gilles Devouassoux, Azzak Bentaher
89
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1304
Differential interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection Aline Schoegler ( Bern, Switzerland), Aline Schoegler, Andrea B. Stokes, Carmen Casaulta, Nicolas Regamey, Michael R. Edwards, Sebastian L. Johnston, Andreas Jung, Alexander Moeller, Thomas Geiser, Marco P. Alves
PA1305
Asymmetric dimethylarginine (ADMA) in exhaled breath condensate (EBC) of children with cystic fibrosis (CF) Francesca Lucca (Treviso, Italy), Francesca Lucca, Mirco Ros, Silvia Carraro, Giuseppe Giordano, Liviana Da Dalt, Eugenio Baraldi
PA1306
Statistical properties of clinical trial outcome measures in pre-school aged children with cystic fibrosis Lidija Turkovic (Perth, Australia), Lidija Turkovic, Tim Rosenow, Marc Padros, Kathryn Ramsey, Stephen Stick
PA1307
How useful is thoracic ultrasound in CF exacerbation? Ioana Ciuca (Timis, Romania), Ioana Ciuca, Monica Marc, Liviu Pop
PA1308
Evaluation of the pulmonary function of patients with cystic fibrosis aged 3-18 year old by using impulse oscillometry and spirometry Zeynep Seda Uyan (Istanbul, Turkey), Ayfer Sakarya Gunes, Zeynep Seda Uyan, Ela Erdem, Yasemin Gokdemir, Bulent Karadag, Fazilet Karakoc, Refika Ersu
PA1309
Physical fitness in cystic fibrosis patients: What is the relation with airway obstruction? Caterina Lambiase (Rome, Italy), Caterina Lambiase, Alessandra Favoriti, Giuseppe Cimino, Paolo Versacci, Alessandra De Luca, Luca Lebone, Desiree Mollicone, Michela Cammarano, Arianna Di Rocco, Giancarlo Tancredi
PA1310
Impact of gastrostomy insertion in CF population on lung function Rania Abusamra (Cambridge, United Kingdom), Rania Abusamra, Leo Thanikkel, Hannah Fox, Robert Ross-Russell
PA1311
Phenotypic characteristics in adult cystic fibrosis (CF) patients carrying 3849+10kbC>T mutation in Russia Maria Usacheva (Yaroslavl, Russian Federation), Stanislav Krasovskiy, Maria Usacheva, Elena Amelina
Hall 14-36
Session 127
12:50 - 14:40
Thematic Poster: Respiratory infections in children Chairs : Heather Elphick (Sheffield, United Kingdom), Jayesh M. Bhatt (Nottingham, United Kingdom), Ahmad Kantar (Bergamo, Italy), Chair to be confirmed PA1312
Infants with viral bronchiolitis demonstrate two distinct patterns of nocturnal oxyhemoglobin desaturation Athanasios G Kaditis (Athens, Greece), Athanasios Kaditis, Polytimi Panaghiotopoulou-Gartagani, Aristea Kalavrou, Anastasia Polytarchou, Dafni Moriki, Aikaterini Stergiou, Georgia Malakasioti, Emmanouel Alexopoulos
PA1313
Respiratory problems in Schimke immuno-osseous dysplasia [SIOD] Hanna Dmenska (Warszawa, Poland), Hanna Dmenska, Edyta Heropolitanska-Pliszka, Barbara Pietrucha, Barbara Piatosa, Wioletta Jarmuzek, Jacek Rubik
PA1314
Age-depended levels of IL-2, IL-4 in children with community acquired pneumonia and wheezing Svetlana Sciuca (Chisinau, Republic of Moldova), Svetlana Sciuca, Liuba Neamtu
PA1315
Primary bronchial airway epithelial cell in vitro responses to common environmental exposures Stephen Turner (Aberdeen, United Kingdom), Steve Turner, Neil McInnes, Matthew Davidson, Alison Scaife, David Miller, Daniella Spiteri, Sean Semple, Tom Engelhardt, Garry Walsh, Graham Devereux
PA1316
Sputum induction for assessment of lower airway infection in preschool children Anja Jochmann (Basel, Switzerland), Anja Jochmann, Karen Robson, Louise Fleming, Luca Artusio, Prasad Nagakumar, Andrew Bush, Sejal Saglani
PA1317
INF-y and Neopterin as a diagnostic markers in recurrent respiratory tract diseases in children Nino Mdivnishvili (Tbilisi, Georgia), Nino Mdivnishvili, Ketevan Barabadze, Nino Adamia
PA1318
Coinfection HIV-TB in children Igor Medvinskiy (Yekaterinburg, Russian Federation), Igor Medvinskiy, Yuriy Chugaev, Sergey Skornyakov, Natalya Kamaeva
PA1319
Acute viral respiratory tract infections and wheezing at follow-up in children < 3 years Antonella Frassanito (Rome, Italy), Antonella Frassanito, Ambra Nicolai, Raffaella Nenna, Giulia Cangiano, Stefano Papasso, Enrica Mancino, Stefania Sirianni, Giulia Faiola, Alessandra Pierangeli, Carolina Scagnolari, Corrado Moretti, Fabio Midulla
PA1320
Is there a correlation between bronchiolitis and urinary tract infection? Fotios Kirvassilis (Oraiokastro, Greece), Fotios Kirvassilis, Elpis Hatziagorou, Alexandra Hatzi, Athina Tsourtsoula, Eleni Tasika, John Tsanakas
90
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Hall 14-37
Session 128
12:50 - 14:40
Thematic Poster: Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma Chairs : Daan Caudri (Rotterdam, Netherlands), Katy Pike (Hampshire, United Kingdom), Stefania La Grutta (Palermo, Italy), Bülent Taner Karadag (Istanbul, Turkey) PA1321
Pediatric long term ventilation: A 15 years experience of one Italian center Marta Unolt (Rome, Italy), Marta Unolt, Martino Pavone, Teresa Salerno, Elisabetta Verrillo, Serena Soldini, Flavia Lombardi, Renato Cutrera
PA1322
Multi-centre retrospective evaluation of respiratory and airway problems in children with sickle cell disease in the UK Morium Akthar (Bromley, United Kingdom), Morium Akthar, Bagashri Malani, Bethany Singh, Atul Gupta
PA1323
Causes of death after lung transplantation in children compared to adults in the United States Don Hayes, Jr. (Columbus, United States of America), Don Hayes, Jr., Joseph Tobias, Patrick McConnell, Mark Galantowicz, Shahid Sheikh, Jeffery Auletta
PA1324
Evaluation of pulmonary functions after hematopoietic stem cell transplantation in children Nilay Ba kizo lu (Istanbul, Turkey), Nilay Bas Ikizoglu, Emine Atag, Gulsun Karasu, Ela Erdem Eralp, Yasemin Gokdemir, Suar Caki Kilic, Refika Ersu, Fazilet Karakoc, Bulent Karadag
PA1325
Study of post-infectious bronchiolitis obliterans in children Nathalia Navi (Niterói, Brazil), Nathalia Navi, Clarissa Laia Franco, Ana Letícia Ferreira Pinto, Caio Cesxar Vasconcellos, Ludmila Santos, Teresa Sarmet, Selma Sias
PA1326
Respiratory and non-respiratory manifestations of enterovirus D68 infection outbreak in children Tita Butenko (Ljubljana, Slovenia), Tita Butenko, Jasna Rodman, Ana Kotnik Pirs, Dusanka Lepej, Marina Praprotnik, Tina Ursic, Miroslav Petrovec, Uros Krivec
PA1327
Epidemiological profile of pacifier use in children at a tertiary hospital and its association with respiratory infections Debora Chong-Silva (Curitiba, Brazil), Cintia Lopes, Debora Chong-Silva
PA1328
Effects of dietary composition on lung function and frequency of wheezing in school-aged children Zahra Aryan (Tehran, Islamic Republic of Iran), Zahra Aryan, Akram Amiri, Akbar Amiri, Roya Kelishadi, Mohammadreza Modaresi, Sahar Shakeri
PA1329
Anthropometric correlates of FeNO in healthy children Kamil Bara ski (Katowice, Poland), Kamil Baranski, Jan Eugeniusz Zejda
PA1330
The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma Kamil Bara ski (Katowice, Poland), Jan Eugeniusz Zejda, Kamil Baranski
PA1331
Respiratory related hospitalizations in premature infants prophylaxed with palivizumab In the Canadian registry of palivizumab (CARESS) Ian Mitchell (Calgary, Canada), Ian Mitchell, Haben Abraha, Abby Li, Bosco Paes, Krista Lanctot
PA1332
Relationship between meteorological conditions and respiratory syncytial virus in a tropical country Ranniery Acuna (Bogota, Colombia), Carlos Rodríguez, Monica Sossa, Ranniery Acuña
PA1333
Bronchiolitis:analysis of 10 consecutive epidemiological seasons Giulia Cangiano (Rome, Italy), Giulia Cangiano, Raffaella Nenna, Antonella Frassanito, Ambra Nicolai, Concetta Schiavariello, Marianna Eleonora Grande, Marianna Ferrara, Sara Ronci, Carolina Scagnolari, Alessandra Pierangeli, Corrado Moretti, Fabio Midulla
PA1334
Quality assessment of acute viral bronchiolitis clinical practice guidelines Carlos E. Rodriguez Martinez (Bogota, Colombia), Carlos E. Rodriguez-Martinez, Mónica P. Sossa-Briceño, Ranniery Acuña-Cordero
PA1335
seasonality of bronchiolitis in hospitalized children Multan, Pakistan tayyba amin (multan, Pakistan), Tayyba Amin, Shahid Iqbal, Imran Saleem
PA1336
Genetic and environmental correlates of asthma among adolescents in Sri Lanka: A case control study Manjula Danansuriya (Ragama, Sri Lanka), Manjula Danansuriya, Lalini Rajapaksa, Anura Weerasinghe, C.H. Katelaris
PA1337
Gender differences in the prevalence and severity of wheezing, rhinitis and eczema in 5- to 8- year old and 12- to 15- year old Maltese children (ISAAC-Malta) Eleanor Gerada (Paola, Malta), Eleanor Gerada, Hugo Agius Muscat, Liberato Camilleri, Stephen Montefort
91
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1338
Decreasing prevalence of wheezing and rhinitis but not eczema in 12- to 15- year old Maltese children over tw o decades (ISAAC-Malta) Eleanor Gerada (Paola, Malta), Eleanor Gerada, Hugo Agius Muscat, Liberato Camilleri, Stephen Montefort
PA1339
Physical activity and frequency of wheezing, and exercise-induced bronchospasm in school-aged children Zahra Aryan (Tehran, Islamic Republic of Iran), Zahra Aryan, Mohammadreza Modaresi, Roya Kelishadi, Akbar Amiri, Akram Amiri
PA1340
Approach of passive smoking by Brazilian pediatricians Debora Chong-Silva (Curitiba, Brazil), Felipe Farias, Fernanda Milaneis, Franccesca Lopes, Natália Campos, Tatiane Soares, Tayane Staniszewski, Debora Carla Chong-Silva
Hall 14-38
Session 129
12:50 - 14:40
Thematic Poster: Paediatric bronchology Chairs : Kostas Priftis (Haidari, Athens, Greece), Deborah Snijders (Ponzano Veneto, Italy), Petr Pohunek (Prague, Czech Republic), Giulia Cangiano (Rome, Italy) PA1341
Effect of low dose propofol and ketamin on emergence in children undergoing flexible bronchoscopy with sevoflurane-remifentanil anaesthesia Özge Yilmaz (Manisa, Turkey), Tulin Ozturk, Arzu Kefi, Ozge Yilmaz, Ismet Topcu, Eralp Cevikkalp, Hasan Yuksel
PA1342
The use of fibreoptic bronchoscopy in the NICU - A single centre experience Jonathan Coutts (Glasgow, United Kingdom), Andrew Maclaren, Elaine Balmer, Jonathan Coutts
PA1343
Clinical follow-up in children with laryngomalacia Tuba Koçkar (Istanbul, Turkey), Tuba Kockar, Hatice Sinav Utku, Mehmet Gündüz, Sedat Oktem
PA1344
Long-term outcomes and quality of life in children with airway obstruction treated by metallic stents Juan L. Anton-Pacheco (Madrid, Spain), Juan L. Antón-Pacheco, Mª Carmen Luna-Paredes, Gloria García-Hernández, Rocio Morante, Antonio Martínez-Gimeno, Carolina Díaz, Mª Isabel Benavent
PA1345
Helical CT scan to diagnose tracheomalacia in children Konstantinos Douros (Athens, Greece), Kostas Douros, Gerasimos Kremmydas, Vasilis Grammeniatis, Marios Papadopoulos, Michael Anthracopoulos, Efi Alexopoulou, Kostas Priftis
PA1346
Dyspnoe due to exercise-induced dysfunctional breathing – Frequent entity in adolescents but poorly understood? Stefanie Benzrath (Bochum, Germany), Stefanie Benzrath, Anne Schlegtendal, Folke Brinkmann, Cordula Körner-Rettberg
PA1347
Subglottic hemangiomas in infants admitted to Alexandria University hospitals: Clinical characteristics, assessment and management Nader Fasseeh (Alexandria, Egypt), Nader Fasseeh, Alaa Gaafar, Basant Ashoush
PA1348
Spanish multicenter study of morbidity and pathogenic role of tracheal bronchus in pediatric patients Marcela Moreno Quintana (Santiago, Chile), Marcela Moreno, Silvia Castillo-Corullón, Estela Pérez-Ruiz, Pedro Mondejar-Lopez, Olga De-la-Serna, Borja Osona, Javier Torres-Borrego, Mikel Santiago-Burruchaga, Oscar Asensio, Anselmo Andres-Martin, Isabel Delgado-Pecellin, Yolanda González-Jiménez, Ana Palmero, Amparo Escribano
PA1349
Therapeutic airway procedures during flexible bronchoscopy in infants and children Uros Krivec (Ljubljana, Slovenia), Uros Krivec, Malena Aldeco, Ana Kotnik Pirs, Igor Fajdiga, Matevz Srpcic, Jelena Berger
PA1350
Diagnosis of the disease of plastic bronchitis in a pediatric bronchoscopy unit Abderrahmane Bouferssaoui (Algiers, Algeria), Abderrahmane Boufersaoui, Leila Smati, Nafissa Keltoum Benhalla, Said Smail, Mourad Baghriche, Fadila Benhassine
PA1351
Flexible bronchoscopy findings in children with protracted bacterial bronchitis E.Nural Kiper (Ankara, Turkey), Nagehan Emiralioglu, Nural Kiper, Ebru Yalçin, Deniz Dogru Ersöz, Ugur özçelik
PA1352
Does physician decision to initiate antibiotics based on bronchoscopy findings correlate with bronchoalveolar lavage (BAL) results? Laura Walker (Hull, United Kingdom), Laura Walker, Alison Scott, Sonal Kansra
PA1353
Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible? Folke Brinkmann (Hannover, Germany), Folke Brinkmann, Mareike Price, Christian Dopfer, Nicoluas Schwerk, Gesine Hansen
PA1354
Investigations of broncho-alveolar lavage in children with asthma, bronchiectasis and cystic fibrosis Guergana Petrova Stoyanova (Sofia, Bulgaria), Guergana Petrova, Penka Perenovska, Vladislav Ulevinov, Tanya Strateva, Nikolay Ulevinov
92
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1355
Bronchoscopic findings in children with congenital heart disease Tuba Koçkar (Istanbul, Turkey), Tuba Kockar, Mehmet Gunduz, Sedat Oktem, Semra Gundogdu, Fatma Gamze Demirel, Ayhan Tastekin, Hacer Kamali
PA1356
Thorax CT-angiography is useful in congenital heart disease with persistent respiratory symptoms in children Tu ba i manlar (Ankara, Turkey), Tugba Sismanlar, Ayse Aslan, Sedef Tunaoglu, Deniz Oguz, Serdar Kula, Betul Derinkuyu, Oznur Boyunaga
PA1357
SP-C deficiency: Three different phenotypes for the same mutation Teresa Salerno (Rome, Italy), Teresa Salerno, Donatella Peca, Laura Menchini, Alessandra Schiavino, Renata Boldrini, Fulvio Esposito, Olivier Danhaive, Renato Cutrera
PA1358
Spontaneous pneumothorax caused by mesenchymal cystic hamartoma in a fifteen year-old girl PERISSON Caroline (paris, France), Caroline Perisson, Sabine Irtan, Annick Clement
PA1359
Study of stridor in children Ludmila Santos (Niterói, Brazil), Ludmila Santos, Nathalia Navi, Ana Letícia Ferreira Pinto, Caio Cesar Vasconcelos, Selma Sias, Omar Abou-Mourad
PA1360
Laryngeal mask airway for ventilation during interventional flexible bronchoscopy in children Chirine Moussa (Ezahra, Tunisia), Anissa Berraies, Chirine Moussa, Besma Hamdi, Alaa Akaad, Saberine Louhaichi, Jamel Ammar, Tahar Mestiri, Agnes Hamzaoui
Room 7.2
Session 130
13:00 - 14:30
Lunchtime session: The evolving marijuana epidemic Experiences in the old and new world Aims : To describe new routes of marijuana use and how these could be toxic in vulnerable populations; and to inform the audience about how to advise patients on the risks and benefits of marijuana use. Tag(s) : Clinical Target audience : Providers of lung health, pulmonary specialists, general practitioners, intensivists, occupational and clinical researchers, and policy and public health specialists. Chairs : Christian Taube (Leiden, Netherlands), Stefan Andreas (Immenhausen, Germany) 13:00
Experiences form the legalisation of marijuana in the US Russell P Bowler (Denver, United States of America)
1361
13:20
Differences between the United States and Europe in cannabis abuse and dependence Speaker to be confirmed
1362
13:40
Effects of inhaled marijuana exposure on lung health Peter Reid (Edinburgh, United Kingdom)
1363
14:00
Panel discussion
1364
Room Elicium 2
Session 131
13:00 - 14:30
Lunchtime session: Treatment of idiopathic pulmonary fibrosis ATS/ERS/JRS/ALAT clinical practice guidelines Aims : To provide the knowledge needed to better understand the published results of several clinical trials that assess the safety and efficacy of various treatment regimens in IPF. The audience will also become aware of the implications of the new evidence-based recommendations for IPF that were generated by a panel of international experts who did not have conflicts of interest. This panel included methodologists who were experienced in reviewing evidence and developing evidence-based guidelines, general pulmonologists, internists and a patient representative. The panel made their recommendations after discussing the evidence in the presence of conflicted experienced IPF experts. By the end of the session, the audience will be able to make a well-informed decision regarding the treatment options for patients with IPF; they will also be able use the new treatment recommendations on the basis of scientific evidence. Moreover, they will have gained an appreciation for the knowns and unknowns associated with each treatment recommendation and the need for further clinical studies/trials on existing and new therapeutic interventions for IPF. Tag(s) : Clinical Target audience : Pulmonologists, clinicians, healthcare providers, respiratory function technologists, clinical investigators, scientists, regulatory agencies, policy makers, patients, healthcare givers, pharmaceutical industries and sponsors. Chairs : Henk C. Hoogsteden (Rotterdam, Netherlands), Fernando J. Martinez (Ann Arbor, United States of America) 13:00
2015 guidelines to treat IPF: an update from the 2011 guidelines - METHODOLOGY Holger Schunemann (Hamilton, Canada)
93
1365
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 13:20
2015 guidelines to treat IPF: an update of the 2011 guidelines - specific treatment recommendations Ganesh Raghu (Seattle, United States of America)
1366
13:50
Insights into the process used to develop the Official 2015 ATS/ERS/JRS/ALAT Clinical Practice Guidelines: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Clinical Practice Guideline Kevin Wilson (Westwood, United States of America)
1367
14:10
Panel discussion
1368
Room 4.2
Session 132
13:00 - 14:30
Championship: 2015 Respiratory Championship Become a champion in respiratory medicine Aims : Could you be a champion in respiratory medicine? This session tests your knowledge of the major fields of respiratory medicine and is an ideal preparation for those wanting to sit the HERMES examination. Target audience : Trainees and specialists in respiratory medicine, and HERMES examination candidates. Chairs : Konrad E. Bloch (Zurich, Switzerland), Thomas Brack (Glarus, Switzerland) Nike Emilia Swietlik (Warsaw, Poland), Slawomir Dudko (Hjørring, Denmark), Speaker to be confirmed
1369
Magic BULLets Rosa Malo de Molina Ruiz (Madrid, Spain), Patricia Sobradillo Ecenarro (Bilbao, Spain), Juan Luis García Rivero (Mompía (Santa Cruz de Bezana)-Cantabria, Spain)
1370
Air Busters Marlies van Dijk (Groningen, Netherlands), Peter Heukels (Rotterdam, Netherlands), Reinier R.L. Wener (Amsterdam, Netherlands)
1371
Léman Cécile Daccord (Lausanne, Switzerland), Lise Lücker (Geneva, Switzerland), Beatrice Duxbury (Geneva, Switzerland)
1372
Room 5.2
Session 133
13:00 - 14:30
Lunchtime session: Asthma-COPD overlap syndrome (ACOS) Joint ERS/NEJM session Aims : Asthma and COPD have long been considered to be distinct entities. However, in the past decade, we have come to realise that there are many patients with features of both. In this session, the science underlying airway obstruction, both reversible and irreversible, will be examined. Thereafter, we will give individual talks on the two major phenotypes in the syndrome, namely, asthma with features of COPD and COPD with features of asthma. Tag(s) : Translational Target audience : This session was developed for scientists who wish to explore the biology of airway obstruction, the clinical researchers who want to study this overlap syndrome, and the practitioners who must diagnose and treat such patients. Chairs : Jeffrey Drazen (Boston, United States of America), Erika von Mutius (Munich, Germany) 13:00
Introduction Jeffrey Drazen (Boston, United States of America)
1373
13:15
Early life origins of obstructive airway diseases Gary P. Anderson (Parkville, Australia)
1374
13:40
Asthma with features of COPD Klaus Friedrich Rabe (Grosshansdorf, Germany)
1375
14:05
COPD with features of asthma Dirkje S. Postma (Groningen, Netherlands)
1376
Room 5.1
Session 134
13:00 - 14:15
Assembly members' meeting: Assembly 10 "Respiratory Infections" Members' Meeting Incl. Groups 10.1 "Respiratory infections" and 10.2 "Tuberculosis" Chairs : Stefano Aliberti (Milan, Italy), Giovanni Sotgiu (Porto Torres, Italy)
94
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Room 4.1
Session 135
13:00 - 14:15
Assembly members' meeting: Assembly 8 "Thoracic surgery and transplantation" Members' Meeting Incl. Groups 8.1 "Thoracic surgery" and 8.2 "Transplantation" Chairs : Dragan R. Subotic (Beograd, Republic of Serbia), Geert Verleden (Leuven, Belgium)
Room Emerald
Session 136
13:00 - 14:15
Assembly members' meeting: Assembly 2 "Respiratory intensive care" Members' Meeting Incl. Groups 2.1 "Acute critical care" and 2.2 "Noninvasive ventilatory support" Chairs : Paolo Navalesi (Vercelli, Italy), Stylianos Orfanos (Athens, Greece)
Room G102-103
Session 137
13:00 - 14:15
Assembly members' meeting: Assembly 11 "Thoracic oncology" Members' Meeting Incl. Groups 11.1 "Lung cancer" and 11.2 "Pleural and mediastinal malignancies" Chairs : Anne-Pascale Meert (Brussels, Belgium), Arnaud Scherpereel (Lille, France)
Room 13.2
Session 139
13:00 - 14:15
Assembly members' meeting: Assembly 4 "Clinical physiology, sleep and pulmonary circulation" Members' Meeting Incl. Groups 4.1 "Clinical respiratory physiology, exercise and functional imaging", 4.2 "Sleep and control of breathing" and 4.3 "Pulmonary circulation and pulmonary vascular disease" Chairs : Maria Bonsignore (Palermo, Italy), Andrea Aliverti (Milan, Italy)
13:15-14:30 INDUSTRY PRACTICAL WORKSHOP Room 7.1
Session 150
SEE PAGE 331 14:45 - 16:45
Year in review: Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea and Ceremony for the ERS Pulmonary Hypertension Research Awards Aims : To provide a complete overview of the recent publications in the different fields. A Ceremony for the ERS Pulmonary Hypertension Research Awards (financially supported by Bayer) will preceed the Year in Review session. Tag(s) : Clinical Target audience : Clinicians. Chairs : Enrico Maria Clini (Pavullo, Italy), Johan Verbraecken (Edegem (Antwerp), Belgium), Atul Malhotra (Calle Guaymas, United States of America) 14:45
Ceremony for the ERS Pulmonary Hypertension Research Awards Frances De Man (Amsterdam, Netherlands), Sébastien Bonnet (Quebec, Canada), Speaker to be confirmed
1409
14:55
Interstitial lung disease Athol Wells (London, United Kingdom)
1410
15:22
Pulmonary embolism Marion Delcroix (Leuven, Belgium)
1411
15:49
Pulmonary hypertension Anton Vonk Noordegraaf (Amsterdam, Netherlands)
1412
16:16
Sleep apnoea Jonathan Jun (Baltimore, United States of America)
1413
Room 7.2
Session 152
14:45 - 16:45
Symposium: Lung transplantation in the year 2015: current indications and results Aims : To give an overview of each disease of the current indications for referral and lung transplantation, and the current results and pitfalls of lung transplantation.
95
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Track(s) : Intensive care Tag(s) : Clinical Target audience : This general session on lung transplantation aims to attract clinicians (pulmonologists and surgeons), who care for transplant patients, especially referring physicians. Chairs : Andrew Fisher (Newcastle, United Kingdom), Claus Neurohr (Munich, Germany) 14:45
Lung transplantation for COPD/emphysema Jens Gottlieb (Hannover, Germany)
1418
15:15
Lung transplantation for pulmonary fibrosis Geert Verleden (Leuven, Belgium)
1419
15:45
Lung transplantation for cystic fibrosis Christian Benden (Zurich, Switzerland)
1420
16:15
Lung transplantation for pulmonary arterial hypertension Paul Corris (Newcastle-upon-Tyne, United Kingdom)
1421
Room Elicium 2
Session 153
14:45 - 16:45
Symposium: Dysfunctional protein quality control in paediatric and adult lung diseases Aims : To review the molecular mechanisms of the cellular stress response to protein damage, describe the evidence for dysfunctional protein quality control pathways in chronic lung diseases, discuss a common pathomechanism for chronic lung diseases and describe innovative targets for the treatment of chronic lung disease. Tag(s) : Basic Target audience : Clinical researchers, clinicians, pharmaceutical industry, and basic life scientists. Chairs : Catherine Greene (Dublin, Ireland), Andreas Guenther (Giessen, Germany) 14:45
Dysfunctional protein quality control in lung diseases William Balch (La Jolla, United States of America)
1422
15:15
Regulation of the proteasome: evaluating the lung proteasome as a new therapeutic target Silke Meiners (Munich, Germany)
1423
15:45
Emerging regulation and functions of autophagy Suzanne Cloonan (Brookline, United States of America)
1424
16:15
The integrated stress response in lung disease Stefan Marciniak (Cambridge, United Kingdom)
1425
Room 4.2
Session 154
14:45 - 16:45
Symposium: Breathlessness during exercise: if not asthma, then what? Aims : To describe the prevalence, (patho)physiology and treatment of exercise-induced asthma, teach how to interpret Exercise-Induced Bronchoconstriction test results, physiotherapeutic assessments and ergometry when evaluating childhood dyspnoea on exertion, describe the other causes of exercise-induced dyspnoea as dysfunctional breathing, vocal cord dysfunction and exercise-induced laryngeal obstruction and provide insight into how to recognise dysfunctional breathing patterns and how to teach diaphragmatic breathing. Track(s) : Physiology Paediatric Tag(s) : Clinical, Healthy Lungs for Life (HLfL) Target audience : Paediatricians, physiotherapists, GPs, allied respiratory professionals, respiratory physicians, and nurses. Chairs : Bart Rottier (Groningen, Netherlands), Mike Thomas (Southampton, United Kingdom) 14:45
Doctor, I am running out of breath Darragh McDonald (Dublin, Ireland)
1426
15:15
Running out of breath: exercise testing Pascale Kippelen (Uxbridge, United Kingdom)
1427
15:45
Exercise-induced shortness of breath: the upper airway Thomas Halvorsen (Bergen, Norway)
1428
16:15
Breathing retraining and reconditioning: a mini course for the MD Carina Hagman (Falun, Sweden)
1429
96
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Room 5.2
Session 155
14:45 - 16:45
Symposium: Thoracic oncology: from fusion genes to treatment Aims : To discuss the different fusion genes, the current diagnostic and treatment practices, and the future challenges and opportunities in advancing outcomes for patients with fusion gene lung cancers. Track(s) : Oncology Tag(s) : Translational Target audience : Clinicians, surgeons, radiation oncologists, and pathologists involved in lung cancer. Chairs : Jacques Cadranel (Paris, France), Jean-Paul Sculier (Brussels, Belgium) 14:45
Fusion genes in thoracic oncology Speaker to be confirmed
1430
15:15
Identification techniques Marcin Skrzypski (Sopot, Poland)
1431
15:45
Drugs that target fusion genes Giulio Metro (Perugia, Italy)
1432
16:15
Management of patients with a tumoural fusion gene Thierry Berghmans (Brussels, Belgium)
1433
Room Elicium 1
Session 156
14:45 - 16:45
Hot topics: How to approach and treat fungal and viral respiratory infections Aims : To discuss the latest information on the epidemiology, diagnosis and treatment of rare infections; to discuss debatable data, especially those in diagnosis; and to stimulate vigilance in the audience that will help to minimise the incidence of these diseases. Track(s) : Infection Tag(s) : Translational Target audience : Clinicians, fellows and scientists. Chairs : Stijn Blot (Ghent, Belgium), Christoph Lange (Borstel, Germany) 14:45
Viral infections in immunosuppressed patients Felix C. Ringshausen (Hannover, Germany)
1434
15:15
MERS-CoV infection Speaker to be confirmed
1435
15:45
Invasive pulmonary aspergillosis in immunosuppressed patients George Dimopoulos (Athens, Greece)
1436
16:15
ERS/ESCMID Clinical Practice Guidelines: Chronic pulmonary aspergillosis David W. Denning (Manchester, United Kingdom)
1437
Room Forum
Session 157
14:45 - 16:45
Oral Presentation: Cystic fibrosis: assessment and treatment Chairs : Ian Balfour-Lynn (London, United Kingdom), Harry G.M. Heijerman (The Hague, Netherlands)
OA1438
Systemic quorum sensing signal molecules are biomarkers for current and future P. aeruginosa infection in cystic fibrosis patients: A longitudinal study Helen Barr (Nottingham, United Kingdom), Helen Barr, Nigel Halliday, Miguel Camara, David Barrett, Paul Williams, Doug Forrester, Daniel Peckham, Kate Williams, Alan Smyth, David Honeybourne, Joanna Whitehouse, Edward Nash, Jane Dewar, Andrew Clayton, Alan Knox, Andrew Fogarty
OA1439
MBW and MRI as sensitive markers of stable CF lung disease and at exacerbation in children and adolescents Mirjam Stahl (Heidelberg, Germany), Mirjam Stahl, Mark Wielpütz, Simon Gräber, Susanne Hämmerling, Olaf Sommerburg, Monika Eichinger, Marcus Mall
OA1440
Temporal progression of fungal microbiota in patients with cystic fibrosis Laura Carrasco Hernandez (Sevilla, Spain), Laura Carrasco Hernández, Cecilía López Ramírez, Esther Quintana Gallego, Isabel Delgado Pecellín, Carmen Calero Acuña, Jose Luis López Campos, Carmen De la Horra Padilla
OA1441
LATE-BREAKING ABSTRACT: Is there a relationship between use of inhaled antibiotics and prevalence of fungal isolates in the respiratory secretions of people with cystic fibrosis? A retrospective data analysis Rosemary Lugg (Somerset, United Kingdom), Rosemary Lugg, Thomas Daniels
97
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 OA1442
A new risk factor predicts ABPA in patients with cystic fibrosis Carsten Schwarz (Berlin, Germany), Anja Thronicke, Claudia Brandt, Carsten Schwarz
OA1443
Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Silvia Gartner (Barcelona, Spain), Silvia Gartner, Antonio Alvarez, Sandra Rovira, Javier De Gracia, Antonio Moreno, Teresa Casals, Paula Fernadez, Eduardo Tizzano, Ines De Mir, Alba Torrent, Elena Garcia Arumi
OA1444
Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy Hartmut Grasemann (Toronto, Canada), Hartmut Grasemann, Tanja Gonska, Julie Avolio, Michelle Klingel, Elizabeth Tullis, Felix Ratjen
OA1445
Long-term tiotropium bromide therapy was retrospectively analyzed in adults with cystic fibrosis Carsten Schwarz (Berlin, Germany), Anja Thronicke, Claudia Brandt, Carsten Schwarz
Room 5.1
Session 158
14:45 - 16:45
Oral Presentation: Latent TB infection and screening Chairs : Christian Wejse (Aarhus, Denmark), Delia Goletti (Roma, Italy) OA1446
The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands Connie G.M. Erkens (The Hague, Netherlands), Connie Erkens, Erika Slump, Maurits Verhagen, Henrieke Schimmel, Gerard De Vries, Susan Van den Hof
OA1447
Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection Hee Jin Kim (Chungwongun, Republic of Korea), Hee Jin Kim, Soo Yeon Oh, Jin Beom Lee, Yeon Sook Seo, Mi Hyeun Kim, Mi Sun Park
OA1448
Infectiousness of tuberculosis patients identified through spot sputum screening compared to patients identified through passive case finding-comparing sputum smear microscopy results Sidse Graff Jensen (Hellerup, Denmark), Sidse Graff Jensen, Nete Wrona Olsen, Niels Seersholm, Torgny Wilcke, Mathias Klok Pedersen, Troels Lillebæk, Axel Kok-Jensen
OA1449
Can asylum seekers be traced! Amanda Middleton (Stoke-on-Trent, United Kingdom), Amanda Middleton, Jane Howie, Tracey Clarke, Martin Allen, Sven Lehm
OA1450
Longitudinal clustering of tuberculosis incidence in Portugal from 2002 to 2012 Pedro Sousa (Lousada, Portugal), Pedro Sousa, Alexandra Oliveira, Rita Gaio, Raquel Duarte
OA1451
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNF -inhibitor treatment Gül Öngen (Istanbul, Turkey), Yesim Ozguler, Gulen Hatemi, Serdal Ugurlu, Emire Seyahi, Melike Melikoglu, Sermin Borekci, Ersan Atahan, Hurrem Gul Ongen, Vedat Hamuryudan
OA1452
Risk factors for active tuberculosis in patients with inflammatory bowel disease: A case-control study Miguel Arias Guillen (Oviedo (Asturias), Spain), Sabino Riestra, Ruth De Francisco, Miguel Arias-Guillén, Cristina Saro, María García-Alvarado, José María Duque, Fernando Muñoz, Lorena Blanco, Olegario Castaño, Isabel Pérez-Martínez, Pablo Martínez-Camblor, Dolores Pérez-Hernández
OA1453
Effect of blood glucose level on the development of tuberculosis based on national health screening program Hee Jin Kim (Chungwongun, Republic of Korea), Hee Jin Kim, Eun-hi Cho, Eun Pyo Lee, Yoon Sung Park, Mi Hyeun Kim
Room 13.1
Session 159
14:45 - 16:45
Oral Presentation: Genetics, genomics and exposures in asthma and COPD Chairs : H. Marike Boezen (Groningen, Netherlands), Torben Sigsgaard (Aarhus, Denmark)
OA1454
LATE-BREAKING ABSTRACT: X chromosome-wide association study revels a member of the IL1R’s family associated with asthma Camila Figueiredo (Salvador, Brazil), Cintia Rodrigues Marques, Gustavo Nunes de Oliveira Costa, Thiago Magalhães da Silva, Pablo Oliveira, Álvaro Augusto Souza da Cruz Filho, Fernando Pires Hartwig, Bernardo Bernardo Horta, Esteban Burchard, Maria Pino-Yanes, Neuza Maria Alcantara-Neves1, Maurício Lima Barreto, Camila Alexandrina Figueiredo
98
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
OA1455
An integrative genomics approach identifies new asthma pathways related to air pollution exposure Anna Gref (Stockholm, Sweden), Anna Gref, Simon Kebede Merid, Olena Gruzieva, Stéphane Ballereau, Allan Becker, Tom Bellander, Anna Bergström, Yohan Bossé, Matteo Bottai, Moira Chan-Yeung, Elaine Fuertes, Despo Ierodakoniou, Ruiwei Jiang, Michael S. Kobor, Michal Korek, Anita L. Kozyrskyj, Ashish Kumar, Nathanael Lemonnier, Elaina MacIntyre, David Nickle, Ma’en Obeidat, Johann Pellet, Marie Standl, Annika Sääf, Cilla Söderhäll, Carla M.T. Tiesler, Maarten Van den Berge, Judith M. Vonk, Hita Vora, Cheng-Jian Xu, Josep M. Antó, Charles Auffray, Michael Brauer, Jean Bousquet, Bert Brunekreef, W. James Gauderman, Joachim Heinrich, Juha Kere, Gerard Koppelman, Dirkje Postma, Christopher Carlsten, Göran Pershagen, Erik Melén
OA1456
Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure Kim De Jong (Groningen, Netherlands), K. De Jong, J.M. Vonk, D.A. Van der Plaat, C.C. Van Diemen, H. Kromhout, R. Vermeulen, C.M. Van Duijn, D.S. Postma, H.M. Boezen
OA1457
Interleukin 33 (IL33) polymorphisms associate with incident adult-onset asthma Taina Lajunen (Oulu, Finland), Taina K. Lajunen, Jouni J.K. Jaakkola, Maritta S. Jaakkola
OA1458
Contact dermatitis and respiratory symptoms in the construction industry: The role of filaggrin gene variants Johan Timmerman (Utrecht, Netherlands), Johan Timmerman, Dick Heederik, Ton Spee, Frits Van Rooy, Esmeralda Krop, Gerard Koppelman, Thomas Rustemeyer, Lidwien Smit
OA1459
Identification of novel genes related to airway obstruction in never-smokers Diana van der Plaat (Groningen, Netherlands), D.A. Van der Plaat, K. De Jong, J.M. Vonk, C.C. Van Diemen, C.M. Van Duijn, L. Lahousse, G.G. Brusselle, D.S. Postma, H.M. Boezen
OA1460
Dysregulation of serum miRNA in chronic obstructive pulmonary disease Woo Jin Kim (Chuncheon, Republic of Korea), Woo Jin Kim, Seok-Ho Hong, Yoonki Hong, Sang Do Lee, Yeon-Mok Oh
Room 2.1
Session 160
14:45 - 16:45
Oral Presentation: Phenotyping asthma with biomarkers Chairs : Stylianos Loukides (Voula, Athens, Greece), Ildikó Horváth (Budapest, Hungary)
OA1461
Characteristics of the frequent exacerbator in U-BIOPRED adult severe asthma cohort Uruj Hoda (St Albans, United Kingdom), Uruj Hoda, Ana Sousa, Julie Corfield, Dominic Shaw, Stephen Fowler, Louise Fleming, Wolfgang Seibold, Per Bakke, Christophe Von Garnier, Ildikó Horváth, Norbert Krug, Barbro Dahlen, Jacek Musial, Pascal Chanez, Paolo Montuschi, Thomas Sandstrom, Peter Howarth, Elisabeth Bel, Aruna Bansal, Ioannis Pandis, Chih-Hsi Kuo, Ratko Djukanovic, Peter Sterk, Graham Roberts, Fan Chung, Fan Chung, U-BIOPRED Study Group
OA1462
Lung microbiome is associated with asthma severity in fungal associated asthma Livingstone Chishimba (Manchester, United Kingdom), Livingstone Chishimba, Robert Niven, Marcin Fraczek, Paul Bowyer, Lucy Smyth, Angela Simpson, David Denning
OA1463
Breathomics can discriminate between anti IgE-treated and non-treated severe asthma adults Paolo Montuschi (Rome, Italy), Giuseppe Santini, Stefano Di Carlo, Alfredo Benso, Nadia Mores, Paul Brinkman, Salvatore Valente, Paolo Montuschi, Francesco Macagno, Gianfranco Politano, Ariane H. Wagener, Aruna T. Bansal, Hugo H. Knobel, Anton J. Vink, Nicholas Rattray, Marco Santonico, Giorgio Pennazza, Yuanyue Wang, Ildiko Horvath, Ratko Djukanovic, Riccardo Polosa, Stephen J. Fowler, Pascal Chanez, Kian F. Chung, Peter J. Sterk, Paolo Montuschi, UBIOPRED Study Group
OA1464
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA Livingstone Chishimba (Manchester, United Kingdom), Livingstone Chishimba, Robert Niven, Marcin Fraczec, Angela Simpson, Paul Bowyer, David Denning
OA1465
Serum transforming growth factor – 1 (TGF- 1) in asthmatics: Association between disease control, severity and duration Aliae AR Mohamed-Hussein (Assiut, Egypt), Neveen Hassan, Aliae Mohamed-Hussein, Ebtssam Mohamed, Omnia Mohamed, Hanan Mohamed, Manal Tammam
OA1466
Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype? Florence Schleich (Liège, Belgium), Florence Schleich, Kirill Bessonov, Jan Dallinga, Virginie Paulus, Monique Henket, Agnes Boots, Agnieszka Smolinska, Emiel Wouters, Frederik-J. Van Schooten, Renaud Louis
OA1467
Matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) as non-invasive biomarkers of remodelling in asthma Aliae AR Mohamed-Hussein (Assiut, Egypt), Neveen Hassan, Aliae Mohamed-Hussein, Ebtssam Mohamed, Omnia Mohamed, Hanan Mohamed, Manal Tammam
OA1468
Can exhaled volatile organic compounds predict asthma exacerbations in children? Edward Dompeling (Maastricht, Netherlands), Dillys Van Vliet, Agnieszka Smolinska, Marieke Van Horck, Quirijn Jöbsis, Philippe Rosias, Jean Muris, Jan Dallinga, Frederik-Jan Van Schooten, Edward Dompeling
99
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Room 4.1
Session 161
14:45 - 16:45
Oral Presentation: Understanding paediatric asthma and allergy: genetics and environment Chairs : Franca Rusconi (Florence, Italy), Bülent Taner Karadag (Istanbul, Turkey) OA1469
Childhood asthma and hay fever are heritable, but specific high-risk genetic variants are not shared between diseases Vilhelmina Ullemar (Stockholm, Sweden), Vilhelmina Ullemar, Patrik Magnusson, Cecilia Lundholm, Anna Zettergren, Erik Melén, Paul Lichtenstein, Catarina Almqvist
OA1470
The influence of traffic-related air pollution (TRAP) on asthma and allergies modified by polymorphisms in GSTT1, GSTM1, GSTP1 and GSTCD Gayan Bowatte (Reservoir, Australia), Gayan Bowatte, Caroline Lodge, Bircan Erbas, Adrian Lowe, Martine Dennekamp, Michael Abramson, Melanie Matheson, Shyamali Dharmage
OA1471
Exposure to siblings in early life modifies the association between CD14 polymorphisms and allergic sensitization in adult life Melisa Lau (Melbourne, Australia), Melisa Lau, Shyamali Dharmage, Aung Win, John Burgess, Adrian Lowe, Caroline Lodge, Jennifer Perret, Jennie Hui, Stephen Morrison, Paul Thomas, Graham Giles, Haydn Walters, Michael Abramson, Melanie Matheson
OA1472
An ecological survey of time trends and associated risk factors for childhood asthma in Aberdeen 1964 – 2014 Stephen Turner (Aberdeen, United Kingdom), Steve Turner, Maxwell S. Barnish, Nara Tagiyeva, Graham Devereux, Lorna Aucott
OA1473
Asthma phenotypes determined by a novel fluctuation based clustering method using a time window of lung function observations Edgar Delgado-Eckert (Leeds, United Kingdom), Edgar Delgado-Eckert, Nitin Kumar, Oliver Fuchs, Juha Pekkanen, JeanCharles Dalphin, Josef Riedler, Roger Lauener, Anne M. Karvonen, Jon Genuneit, Erika Von Mutius, Urs Frey, PASTURE Study Group
OA1474
Sex-specific development of allergic rhinitis among farm children – A cohort study Jon Genuneit (Ulm, Germany), Jon Genuneit
OA1475
Protective factors against childhood asthma in rural China Gary Wong (Shatin, Hong Kong), Katy Wong, Jing Li, Ting Fan Leung, N.S. Zhong, Gary Wong
OA1476
Indoor moisture and mold and respiratory health: A cross-sectional study in Danish schoolchildren Gitte Holst (Aarhus C, Denmark), G. Holst, A. Høst, G. Doekes, H.W. Meyer, A.M. Madsen, T. Sigsgaard
Room Emerald
Session 162
14:45 - 16:45
Oral Presentation: New findings in sleep-disordered breathing in children Chairs : Refika Hamutcu Ersu (Istanbul, Turkey), Maria Pia Villa (Rome, Italy) OA1477
Comparison between adenotonsillectomy and adenoidectomy in the treatment of obstructive sleep apnea in children Yakov Sivan (Tel Aviv, Israel), Keren Armoni Domany, Guy Gut, Elad Dana, Riva Tauman, Bat El Yakir, Yakov Sivan
OA1478
Sleep clinical record in children with sleep disordered breathing Melania Evangelisti (Civita Castellana, Italy), Melania Evangelisti, Jole Rabasco, Nicoletta Pietropaoli, Marilisa Montesano, Maria Pia Villa
OA1479
Central apnoeas in children with obstructive sleep apnoea syndrome: Prevalence and effect of upper airway surgery An Boudewyns (Edegem (Antwerp), Belgium), An Boudewyns, Stijn Verhulst
OA1480
3-D evaluation of the pharyngeal dimensions in OSA children, before and after adenotonsillectomy Silke Weber (Botucatu, Brazil), André Bertoz, Antonio Carlos Marão, Jefferson Barros, Silke Anna Weber
OA1481
The role of nocturnal pulse oximetry in the screening for obstructive sleep apnea in obese children and adolescents Annelies Van Eyck (Wilrijk, Belgium), Annelies Van Eyck, Liesbeth Vanheeswijck, Chinouk Lambrechts, Kim Van Hoorenbeeck, An Boudewyns, Benedicte De Winter, Luc Van Gaal, Wilfried De Backer, Stijn Verhulst
OA1482
Unattended sleep studies in children: Is it worth? Silke Weber (Botucatu, Brazil), Silke Anna Weber, Jefferson Barros, Antonio Carlos Marão, Iury Lima, André Bertoz, Silke Weber
Room E104-106
Session 163
Poster Discussion: New data on established treatments for COPD Chairs : Adam Barczyk (Katowice, Poland), Lena Uller (Lund, Sweden)
100
14:45 - 16:45
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1483
Effect of fluticasone furoate (FF)/vilanterol (VI) compared with VI on acute exacerbations of COPD (AECOPD): A post-hoc analysis by baseline airflow obstruction David Leather (Crewe, United Kingdom), David Leather, Louisa Yates, Amy Newlands
PA1484
Systemic inhibition of p38 MAPK improves lung function and inflammatory markers in moderate-severe COPD Nicholas Clarke (Cambridge, United States of America), Spencer Danto, Grant Langdon, Negin Shojaee, Jared Christensen, Nick Clarke, Lisa Tan, Christelle Perros-Huguet
PA1485
Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency Michael Tortorici (King of Prussia, United States of America), Michael A. Tortorici, Zhenling Yao, James A. Rogers, Oliver Vit, Martin Bexon, Robert Sandhaus, Jonathan Burdon, Eeva Piitulainen, Niels Seersholm, James Stocks, N. Gerard McElvaney, Kenneth R. Chapman, Jonathan Edelman
PA1486
Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency Michael Tortorici (King of Prussia, United States of America), Michael A. Tortorici, Oliver Vit, Martin Bexon, Robert Sandhaus, Jonathan Burdon, Eeva Piitulainen, Niels Seersholm, James Stocks, N. Gerard McElvaney, Kenneth R. Chapman, Jonathan Edelman
PA1487
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Dave Singh (Manchester, United Kingdom), Dave Singh, M. Reza Maleki-Yazdi, Lee Tombs, Ian Naya, Ahmar Iqbal
PA1488
QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study Hanns-Christian Tillmann (Basel, Switzerland), Hanns-Christian Tillmann, Ieuan Jones, Robert Fogel, Donald Banerji
PA1489
Corticosteroids improve lung function and quality of life in subjects with biomass fuel (BMF) smoke exposures induced COPD Kuldeep Mandani (Pune, Maharashtra, India), Kuldeep Mandani, Kanchan Pyasi, Vandana Vincent, Jyoti Londhe, Sapna Madas, Bill Brashier, Sundeep Salvi, Peter Barnes
PA1490
Triple therapy of umeclidinium and inhaled corticosteroid/long-acting ² 2-agonist (ICS/LABA) vs placebo + ICS/LABA in GOLD D patients Edward Kerwin (Medford, United States of America), Edward Kerwin, Thomas Siler, Lee Tombs, Ana R. Sousa, Karen Singletary, Alison Church
PA1491
Implications of under treatment of stable COPD (SAVING study) Antonio Corrado (Firenze, Italy), Antonio Corrado, Andrea Rossi, On Behalf of SAVING/AIPO Study Group
PA1492
Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on -blockers Lorcan McGarvey (Belfast, United Kingdom), Lorcan McGarvey, Roland Buhl, Lawrence Korducki, Valeria C. Amatto, Kay Tetzlaff, Leif Bjermer
PA1493
Effect of umeclidinium/vilanterol (UMEC/VI) on inspiratory capacity/total lung capacity ratio in hyperinflated COPD patients Sally J. Singh (Leicester, United Kingdom), Sally Singh, Francois Maltais, Lee Tombs, Alison Church, Ahmar Iqbal, John H. Riley
PA1494
Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study Vincent Yi-Fong Su (Taipei, Taiwan), Vincent Yi-Fong Su
PA1495
Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study Roberto Walter Dal Negro (Verona, Italy), Roberto W. Dal Negro, Martin Iversen, Peter M.A. Calverly
PA1496
Onset of action of aclidinium (ACL), glycopyrronium (GLY) and tiotropium (TIO): A comparison in COPD patients Paola Rogliani (Rome, Italy), Paola Rogliani, Roberto Lipsi, Josuel Ora, Gabriella Lucà, Luigino Calzetta, Mario Cazzola
PA1497
Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Seil Sagar (Lund, Sweden), Seil Sagar, Mandy Menzel, Leif Bjermer, Lena Uller
PA1498
Investigator-reported vs adjudicated cause of death in the TIOSPIR™ trial Robert Wise (Baltimore, United States of America), Robert Wise, Peter Kowey, George Austen, Andy Lawton, Achim Mueller, Norbert Metzdorf, Andy Fowler, Lorcan McGarvey
PA1499
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity Anthony D. D'Urzo (Toronto, Canada), Anthony D. D’Urzo, Dave Singh, Edward Kerwin, Hassan Lakkis, Ferran Chuecos, Gonzalo De Miquel
101
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1500
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Peter M.A. Calverley (Liverpool, United Kingdom), Peter Calverley, Kay Tetzlaff, Achim Mueller, Norbert Metzdorf, Bernd Disse, Ronald Dahl
Room G102-103
Session 164
14:45 - 16:45
Poster Discussion: Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders Chairs : marcello migliore (catania, Italy), Michel Gonzalez (Lausanne, Switzerland) PA1501
LATE-BREAKING ABSTRACT: Surgical referral and complication rates in the ambulatory management of primary spontaneous pneumothorax: A retrospective analysis Jiyoon Yoon (London, United Kingdom), Jiyoon Yoon, Parthipan Sivakumar, Kevin O’Kane, Liju Ahmed
PA1502
LATE-BREAKING ABSTRACT: Early mobilization optimizing fluid of mediastinal and thoracic tube in the postoperative patients after coronary artery bypass surgery Emilia Nozawa (São Paulo, Brazil), Emilia Nozawa, Vera Regina Moraes Coimbra, Fernanda Carolina Silva G. Cruz, Sara Herculano Souza Silva, Paula Fernanda B.D. França, Filomena Regina Gomes Galas, Ludmilla Abhão Hajjar, Maria Ignêz Zanetti Feltrim
PA1503
Opportunity of videothoracoscopy in diagnostics and treatment of exudative pleurisy Dmitriy Pilkevich (Yekaterinburg, Russian Federation), Dmitriy Pilkevich, Sergey Skornyakov, Marina Lehlyayder, Aleksey Medyakov, Nikita Gorbunov, Dinar Gatautov
PA1504
Early surgical video thoracoscopy in complicated parapneumonic effusion. Retrospective study of 75 cases Herve Le Floch (Clamart, France), Hervé Le Floch, Inès Ngampolo, Frédéric Rivière, Wanda Gaspard, France Charton, Alla Avramenko, Sonia Aguir, Bertrand Grand, Guillaume Boddaert, Marc-Antoine Sanchez, Jacques Margery
PA1505
Late functional effects of lung decortication for stage III pleural empyema Dragan R. Subotic (Beograd, Republic of Serbia), Dragan Subotic, Nikola Atanasijadis, Dejan Moskovljevic, Milan Savic, Zeljko Garabinovic, Vladimir Milenkovic
PA1506
Molecular analysis with nucleic acid-based assays increase pathogen detection of pleural empyema Katarzyna Furrer (Basel, Switzerland), Katarzyna Furrer, Daniel Goldenberger, Reno Frei, Mark Wiese, Maja Weisser, Melanie Toffel, Didier Lardinois
PA1507
Avoidance of surgery in secondary pneumothorax using digital suction device poulomi chatterjee (gurgaon, India), Poulomi Chatterjee, Shaiwal Khandelwal, A.Z. Khan, Pinky Goyal, Bornali Datta
PA1508
Rib fractures: Could we accelerate the healing? Mustafa Calik (Konya, Turkey), Mustafa Calik, Saniye Goknil Calik, Olgun Kadir Aribas, Abdulkerim Kasim Baltaci
PA1509
Tracheostomy, is it really innocent? Mustafa Calik (Konya, Turkey), Mustafa Calik, Saniye Goknil Calik, Mustafa Cihat Avunduk, Olgun Kadir Aribas
PA1510
Surgery of laryngo-tracheal, multifocal and extensive cicatricial stenosis of trachea Otabek Eshonkhodjaev (Tashkent, Uzbekistan), Shukhrat Khudaybergenov, Otabek Eshonkhodjaev, Georgy Pakhomov, Ortikali Irisov, Rustem Hayaliev, Nasretdin Tursunov, Doniyor Abdullaev, Aziz Khasanov
PA1511
The intoduction of a specialised care pathway for patient undergoing pectus surgery Theofano Tikka (Birmingham, United Kingdom), Theofano Tikka, Joanne Webb, Richard Steyn, Ehab Bishay, Maninder Kalkat, Pala Rajesh, Babu Naidu
PA1512
One-institution initial experience with Nuss procedure on eleven patients Marko Kostic (Belgrade, Republic of Serbia), Marko Kostic, Branislav Jovanovic, Nikola Atanasijadis, Marko Popovic, Dragana Asujic
PA1513
Value of different diagnostic procedures in the assessment of the pectus excavatum morphology Marko Kostic (Belgrade, Republic of Serbia), Marko Kostic, Ida Jovanovic, Branislav Jovanovic, Radivoj Brdar, Polina Pavicevic
PA1514
The effect of costal cartilage resection on the chest wall development: Pathological evaluation Mustafa Calik (Konya, Turkey), Mustafa Calik, Saniye Goknil Calik, Mustafa Cihat Avunduk, Olgun Kadir Aribas
PA1515
Single institutional experience with mediastinal mature cystic teratoma: An analysis of 17 cases Osman Haciömeroglu (Istanbul, Turkey), Gulbanu Horzum Ekinci, Osman Haciomeroglu, Levent Alpay, Ayse Ersev, Cuneyt Salturk, Cagatay Tezel, Irfan Yalcinkaya, Adnan Yilmaz
102
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1516
Diagnostic algorithm for teratodermoidal tumors of mediastinum Rustem Hayaliev (Tashkent, Uzbekistan), Georgy Pakhomov, Rustem Hayaliev, Otabek Eshonhodjaev, Abror Makhmudov, Aziz Mustafaev
PA1517
Prognostic value of semiquantitative serum Procalcitonine vs APACHE or SOFA scores in patients with descending necrotizing mediastinitis Francina BolaÑos-Morales (Mexico, Mexico), Francina Bolaños-Morales, Emmanule Peña, Enrique Guzmán-DeAlba, Patricio Santillán-Doherty, Avelina Sotres-Vega, J. Alfredo Santibáñez-Salgado, Jaime Villalba-Caloca
PA1518
Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease Luca Bertolaccini (Negrar Verona, Italy), Luca Bertolaccini, Simona Paiano, Carlo Pomari, Luca Rosario Assante, Andrea Viti, Alberto Terzi
Room G104-105
Session 165
14:45 - 16:45
Poster Discussion: WHO guidelines in TB and clinical practice Chairs : Keertan Dheda (Cape Town, South Africa), Masoud Dara (Copenhagen, Denmark) PA1519
WHO framework on engagement of all health care providers in management of drug-resistant tuberculosis Nhat Linh Nguyen (Geneva , Switzerland), Linh Nguyen, Ernesto Jaramillo, Mukund Uplekar, Fraser Wares
PA1520
Who is responsible for MDR- TB? amitabh das shukla (Allahabad, India), Amitabh Das Shukla, Tariq Mahmood, Alok Chandra, Neha Agrawal
PA1521
Treatment outcomes of new TB cases among children in Russia Vadim Testov (Fryazino, Moscow Region, Russian Federation), Sergey Sterlikov, Vadim Testov, Valentina Aksenova
PA1522
Knowledge about tuberculosis among doctors in primary health care institution in Montenegro Bozidarka Rakocevic (Podgorica, Republic of Montenegro), Bozidarka Rakocevic, Sanja Medenica, Olivera Bojovic, Boban Mugosa, Mirjana Nedovic Vukovic, Anita Grgurevic
PA1523
Active case finding of tuberculosis, Tomsk (Russia) Nina Poliakova (Tomsk, Russian Federation), Nina Poliakova, Askar Yedilbayev, Alexander Barnashov, Nataliya Zemlyanaya
PA1524
The analysis of factors associated with misdiagnosis pneumonia in TB hospital Zhanna Laushkina (Novosibirsk, Russian Federation), Zhanna Laushkina
PA1525
Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva, Anastasia Samoilova, Marina Burakova, Tatev Bagdasaryan, Elena Larionova, Larisa Chernousova
PA1526
Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Shahid Pervaiz (Multan, Pakistan), Shahid Pervaiz, Muhammad Wajaht Tariq, Humayoun Ghulam Murtaza, Muhammad Zubair Shaheen
PA1527
Clinical utility of the Xpert MTB/RIF test in induced sputum Tow Keang Lim (Singapore, Singapore), T.K. Lim, J.S.K. Ng, M.Y. Chew
PA1528
Comparison of GeneXpert MTB/RIF assay in broncho alveolar lavage and gastric lavage samples Ravi Mahat (Kathmandu, Nepal), Ravi Mahat, Madiha Tawfik, Ashok Kumar, Nadeem Rizvi
PA1529
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Shahid Pervaiz (Multan, Pakistan), Shahid Pervaiz, Humayoun Ghulam Murtaza, Muhammad Imran Shahzad, Muhammad Zubair Shaheen
PA1530
The utility of Xpert MTB/RIF performed on bronchial lavages obtained from patients with suspected pulmonary tuberculosis Coenraad Frederik Nicolaas Koegelenberg (Cape Town, South Africa), Coenraad Koegelenberg, Dewald Barnard, Johannes Bruwer, Dante Plekker, Andrew Whitelaw, Jacobus Deetlefs, Elvis Irusen
PA1531
Diagnostic yield of AFB smear, culture, LiPA, GeneXpert: A clinician’s perspective Bhumika Madhav (Navi Mumbai, India), T.K. Jayalakshmi, Aparna Iyer, Bhumika Madhav
PA1532
Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues Alberto Garcia-Basteiro (Maputo, Mozambique), Alberto García-Basteiro, Mamudo Ismail, Carla Carrilho, Esperança Ussene, Paola Castillo, Dercio Chitsungo, Lucilia Lovene, Cesaltina Lorenzoni, Cristina Rodríguez, Jordi Vila, Jaume Ordi, Clara Mendendez, Quique Bassat, Miguel Martínez
103
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1533
Comparative study of gene Xpert MTB/RIF, smear microscopy and TB MGIT culture in diagnosis of tuberculosis in India Kapil Salgia (Mumbai, India), Sunil Narute, Kapil Salgia, Pratibha Singhal, Vipul Kalley
PA1534
Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion varuna jethani (dehradun, India), Varuna Jethani, Girish Sindhwani, Aarti Raghuvanshi, Vinit Mehrotra, Rakhee Khanduri
PA1535
Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium Pierpaolo de Colombani (Copenhagen, Denmark), Pierpaolo De Colombani, Stephane Dupasquier, Giovanni Battista Migliori, Masoud Dara
PA1536
Joint WHO/ERS initiative on e-/m-Health for TB and tobacco control Denis Falzon (Geneva, Switzerland), Dennis Falzon, Mario Raviglione, Douglas Bettcher, Dongbo Fu, Giovannibattista Migliori, Christina Gratziou, Elisabeth H. Bel
Room G106-107
Session 166
14:45 - 16:45
Poster Discussion: Unravelling the mechanisms of symptoms and exercise limitationas in disease Chairs : Luis Puente Maestu (Madrid, Spain), Dennis Jensen (Montreal, Canada)
PA1537
Predicting poor outcome in COPD-heart failure overlap: The role of resting echocardiography and cardiopulmonary exercise testing Jose Alberto Neder Serafini (Kingston, Canada), Maria Clara Alencar, Flavio Arbex, Fred Mancuso, Mayron Oliveira, Luiz Medina, Adriana Mazzuco, Audrey Borghi-Silva, Daniel M. Hirai, Denis O’Donnell, J. Alberto Neder
PA1538
Hyperinflation and its effects on upper and lower extremities exercise in patients with COPD and controls. A longitudinal study Victor Pinto-Plata (Boston, United States of America), Victor Pinto-Plata, Felipe Cortopassi, Miguel Divo, Bartolome Celli
PA1539
Reference equations for incremental shuttle walk test in Spanish population Ane Arbillaga Etxarri (Barcelona, Spain), Elena Gimeno-Santos, Ane Arbillaga-Etxarri, Jordi Vilaró, Ana Balañá, Silvia Córdoba, Juan Carlos Fernández, Beatriz Herrero, Mayte Linares, Eva María Madrid, Patricia Madrid, Daniel Martí, José Méndez, Marian Ramon, Ketty Ruiz, Sonia Souto, Beatriz Valeiro, Marie Carmen Valenza, ángeles Vega-Martinez, Montserrat Vendrell, Judith Garcia-Aymerich
PA1540
Effect of ventilatory inefficiency over exercise capacity in COPD patients with hyperinflation Ivan Caviedes Soto (Lo Barnechea, Chile), Iván Caviedes, Rodrigo Soto
PA1541
Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients Danilo Cortozi Berton (Porto Alegre, Brazil), Danilo C. Berton, álvaro Santos, Bruno Hochhegger, Ivo Bohn Jr, Rodrigo Lima, Vanderleia Breda, Paulo Teixeira
PA1542
Comparison of pulmonary function and diffusion capacity between asthmatic athletes, healthy athletes and nonathlete controls Julie Stang (Oslo, Norway), Julie Stang, Kai-Håkon Carlsen, Trine Stensrud
PA1543
Reference equations for 6-minute walk test in Spanish population Ane Arbillaga Etxarri (Barcelona, Spain), Elena Gimeno-Santos, Ane Arbillaga-Etxarri, Jordi Vilaró, Ana Balañá, Anael Barberán-Garcia, Tamara Del Corral-Núñez, Juan Carlos Fernández, Begoña Jiménez, Asenet López, Daniel López, Gerard Muñoz-Castro, Marian Ramon, Antonio Ríos, Ketty Ruiz, Marta San Miguel, Natalia Sánchez-Cayado, Marie Carmen Valenza, Ana Varas, Carlos Zárate, Judith Garcia-Aymerich
PA1544
The effect of inhaled glucocorticoid on the content of Na+/K+-pumps in human skeletal muscles Søren Jessen (Copenhagen, Denmark), Søren Jessen, Morten Hostrup, Johan Onslev, Torben Clausen, Celeste Porsbjerg
PA1546
Correlation of a decline in aerobic capacity with development of emphysema in patients with COPD Sadatomo Tasaka (Tokyo, Japan), Sadatomo Tasaka, Wakako Yamasawa, Tomoko Betsuyaku, Kazuhiro Yamaguchi
PA1547
Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m Michael Furian (Effretikon, Switzerland), Michael Furian, Sara E. Hartmann, Tsogyal D. Latshang, Deborah Flueck, Philipp M. Scheiwiller, Séverine Mueller-Mottet, Silvia Ulrich, Malcolm Kohler, Marc J. Poulin, Konrad E. Bloch
PA1548
Exercise induced bronchoconstriction is associated with eosinophilic bronchitis in non-asthmatic elite marathon runners Celso Carvalho (Sao Paulo, Brazil), Renata Nakata Teixeira, Rosana Camara Agondi, Milton de Arruda Martins, Celso R.F. Carvalho
104
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1549
Emphysema and the physiological response to incremental exercise in COPD Benjamin Smith (New York, United States of America), Benjamin Smith, Dennis Jensen, Marc Brosseau, Harvey Coxson, Jean Bourbeau
PA1550
Relationship between exercise-related ventilatory variability and dyspnoea in patients with chronic obstructive pulmonary disease: A pilot study Bruno-Pierre Dube (Montreal, Canada), Bruno-Pierre Dubé, Marie-Cécile Niérat, Agnès Bellocq, Christian Straus, Thomas Similowski, Pierantonio Lavaneziana
PA1551
Biking or climbing in COPD patients: The stair test Virginie Jacquemin (Montreal, Canada), Virginie Jacquemin, Andrée-Anne Parent, Alain-Steve Comtois, Marilyn Houle Peloquin, Claude Poirier
PA1552
Mid-thigh cross-sectional area and lower limb muscle function in patients with lung cancer Valerie Coats (Quebec, Canada), Valerie Coats, Fernanda Ribeiro, Lise Tremblay, Brigitte Fortin, François Maltais, Didier Saey
PA1553
Tight coupling between inspiration and expiration after the respiratory compensation point Joost Gerard van den Aardweg (Heemstede, Netherlands), Joost G. Van den Aardweg, Nieskje De Groot
Room 13.2
Session 167
14:45 - 16:45
Poster Discussion: Novelties in noninvasive ventilation Chairs : Ezgi Özyilmaz (Istanbul, Turkey), Lara Pisani (Rome, Italy)
PA1554
Does continuous emailed feedback and use of stickers improve initiation of non-invasive ventilation in acute type II respiratory failure? Justina Ruksenaite (Leicester, United Kingdom), Justina Ruksenaite, Tim Maheswaran, Paul Andrzejowski, Syed-Fayyaz Hussain
PA1555
The use of non-invasive ventilation during fiberoptic bronchoscopy in patients with high risk of orotracheal intubation Maria Laura Vega (Buenos Aires, Argentina), Maria Laura Vega, Sergio Di Yelsi, Juan Manuel Osses, Rosalia Ahumada, Morozovsky Veronica
PA1556
Is there relationship between the parameters of built-in software of home ventilators and efficacy of the domiciliary non invasive ventilation? Raul Hidalgo Carvajal (Toledo, Spain), Raul Hidalgo Carvajal, Marcelino Sanchez Casado, Encarna Lopez-Gabaldon, Jose Ignacio Garcia del Palacio
PA1557
Lack of evidence for mechanical in- and exsufflation – How do we proceed? Ann-Britt Zakrisson (Orebro, Sweden), Ann-Britt Zakrisson, Ylva Nilsagård, Lars Berggren, Margareta Kånåhols, Mia Svantesson-Sandberg, Pernilla östlund
PA1558
Hemodynamic effects of continuous positive airway pressure as assessed by doppler echocardiography Gabrielle Vinhal (Uberlândia, Brazil), Gabrielle Vinhal, Thulio Cunha, Livia Silva, Lucio Araújo, Daniel Melo, Celia Lopes
PA1559
Effects of noninvasive ventilation on heart rate variability after coronary bypass grafting Gabrielle Vinhal (Uberlândia, Brazil), Gabrielle Vinhal, Katrinne Naves, Valdeci Dionisio, Celia Lopes
PA1560
The effect of continuous positive airway pressure titration on blood pressure in obese subjects Culadeeban Ratneswaran (London, United Kingdom), Culadeeban Ratneswaran, Martino Pengo, Sichang Xiao, Johan Bastianpillai, Yuanming Luo, Teck Khong, Joerg Steier
PA1561
Nasal Highflow (NHF) – Quantitation of CO2 wash-out in a lung model Jens Bräunlich (Leipzig, Germany), Jens Bräunlich, Hubert Wirtz
PA1562
Retrospective chart review of impact on intubation rate and safety of high-flow nasal cannula therapy on a general pediatric ward Lieke van Imhoff (Utrecht, Netherlands), Lieke Van Imhoff, Elke Baars, Marije Hennus, Judit Wesseling, Walter Balemans
PA1563
Ventilatory management in COPD-associated obstructive sleep apnea syndrome Marie Netchitaïlo (Rouen, France), Marie Netchitaïlo, Franck Lavergne, Anne-Sophie Bravard, Catherine Tardif, JeanFrançois Muir, Antoine Cuvelier
PA1564
Adherence to long term non-invasive ventilation in children Elaine Chan (London, United Kingdom), Aidan Laverty, Joseph Gannon, Victoria Robinson, Martin Samuels, Francois Abel, Elaine Chan
105
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 PA1565
Indirect comparison between two non-invasive weaning strategies in intubated patients with COPD PeiJun Li (ChengDu, China), PeiJun Li, Ting Wang, ZongAn Liang, FaMing Jiang, Jian Luo, ChaoLi Shi
PA1566
The outcome and predictors of mortality in patients transitioned to invasive mechanical ventilation after noninvasive ventilation failure Andrea Vianello (Mestre, Italy), Andrea Vianello, Emanuela Pipione, Giovanna Arcaro, Sara Zanette, Maddalena Chizzolini, Silvia Iovino, Laura Battistella, Alberto Pavan
PA1567
Management of upper airway obstruction by non-invasive CPAP in neonates with Pierre Robin sequence Alessandro Amaddeo (Trieste, Italy), Alessandro Amaddeo, Veronique Abadie, Veronique Soupre, Christel Chalouhi, Marta Fernandez Bolanos, Sebastien Pierrot, Annick Frapin, Alexandre Lapillone, Adriana Ramirez, Arnaud Picard, Brigitte Fauroux
PA1568
Effect of non-invasive mechanical ventilation on exacerbations in patients with stable COPD: A 4 year cohort study with one year follow-up David Manuel Araújo (Porto, Portugal), David Araújo, Margarida Redondo, Maria Sucena, Tiago Pinto, Miguel Gonçalves, Marta Drummond
PA1569
Long-term non-invasive ventilation in stable COPD patients reduces the rate of hospitalizations for exacerbation Ahmed Boubaya (Nancy, France), Ahmed Boubaya, Kosar Hosseini, Maeva Zysman, Sylvie Chery, Magalie Mercy, Emmanuel Gomez, Anne Guillaumot, Ayman Kheir, Christos Chouaid, Ari Chaouat, François Chabot
PA1570
Obesity hypoventilation syndrome: Predictors of compliance with noninvasive positive pressure ventilation Irina Umarova (Saint Petersburg, Russian Federation), Irina Umarova, Olga Balionis, Alexander Gorelov
PA1571
Longterm mechanical ventilation in ALS – Outcome and perspective. A 12 year national register study of noninvasive and invasive ventilation in Norway Solfrid Indrekvam (Bergen, Norway), Solfrid Indrekvam, Ove Fondenes, Miriam Gjerdevik, Ole-Bjørn Tysnes, Tiina Rekand, Per Bakke
Room E102
Session 168
14:45 - 16:45
Poster Discussion: Lung function: waiting to exhale... Chairs : Felip Burgos (Barcelona, Spain), Waldemar Tomalak (Rabka-Zdroj, Poland) PA1572
Bronchodilator response in healthy never smokers from the SAPALDIA study Pierre-Olivier Bridevaux (Geneva, Switzerland), Pierre-Olivier Bridevaux, Brice Touilloux, Elise Dupuis Lozeron, Christian Schindler, Thierry Rochat, Nicole Probst-Hensch
PA1573
Five FEV1 adjustment methods for grading airway obstruction severity in USA Caucasian patients Olinto Linares (Murray, United States of America), Olinto Linares Perdomo, Matthew Hegewald, Dave Collingridge, Robert L. Jensen, John Hankinson, Alan Morris
PA1574
The effect of adopting new GLI-2012 spirometric reference values on airflow limitation GOLD classification Giuseppe Liistro (Bruxelles, Belgium), Giuseppe Liistro, Eric Marchand, Eric Derom
PA1575
Is the FRC/TLC ratio a valid measure in children with obstructive lung disease? Paul Burns (Glasgow, United Kingdom), Paul D. Burns, Karl P. Sylvester
PA1576
FRC%TLC and RV%TLC to assess effects of lung disease: Comparison to FEV1%FVC Adrian Hugh Kendrick (Bristol, United Kingdom), Adrian Kendrick
PA1577
Accuracy of spirometers used in primary care Matthew Hegewald (Murray, United States of America), Matthew Hegewald, Heather Gallo, Olinto Linares, Robert Jensen, Alan Morris
PA1578
Long-term stability of a portable DLCO instrument Laura Gochicoa-Rangel (Texcoco, Mexico), Laura Gochicoa-Rangel, Rogelio Pérez-Padilla, Luis Torre-Bouscoulet, Juan Carlos Vázquez-García, Mónica Silva-Cerón, Christian Buess, Robert Jensen, Paul Enright
PA1579
Statistical analysis of physiological quality assurance (QA) data Charlotte Earle (Swansea, United Kingdom), Charlotte Earle, Adrian Kendrick
PA1580
Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study Kerry Gove (Southampton, United Kingdom), Kerry Gove, Tom Brown, Hitasha Rupani, Clair Barber, Ramesh Kurukulaaratchy, Anoop Chauhan, Peter Howarth
106
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
PA1581
Selecting a multiple-breath N2 washout device: The search continues Silvia Cornelussen (Maastricht, Netherlands), Kirsten Clermons, Silvia Cornelussen, Lilianne Martin, Paul Bongaerts, Chris Van der Grinten
PA1582
Effects of using a mask vs mouthpiece on the multiple breath inert gas washout technique Sooky Lum (London, United Kingdom), Sooky Lum, Janet Stocks, Wanda Kozlowska, Paul Aurora
PA1583
Development of the ’BreathEasy’ contactless portable respiratory rate monitor (CPRM) Will Daw (Sheffield, United Kingdom), Will Daw, Ruth Kingshott, Alison Scott, Reza Saatchi, Heather Elphick
PA1584
Multi-dimensional modelling of dynamic flows in central airways for normal breathing Minsuok Kim (Kidlington, United Kingdom), Minsuok Kim, Yongmann Chung
PA1585
Capacity of using DPIs during COPD exacerbations Andriana Papaioannou (Vrilissia, Athens, Greece), Andriana Papaioannou, Yiolanda Herodotou, Ioannis Tomos, Giorgos Skylas, Vasileios Seferlis, Effrosyni Manali, Stelios Loukides, Spyros Papiris
PA1586
Inhalation manoeuvre performed by Parkinson’s patients during an off period Marianne Luinstra (Groningen, Netherlands), Marianne Luinstra, Wijnand Rutgers, Hilda Dijkstra, Floris Grasmeijer, Paul Hagedoorn, Jolanda Vogelzang, Henderik Frijlink, Anne De Boer
PA1587
In-vitro emitted dose characteristics of combination budesonide / formoterol tubuhaler using patient inhalation profiles Golshan Bagherisadeghi (Huddersfield, United Kingdom), Golshan Bagherisadeghi, Hassane El Larhrib, Henry Chrystyn
Room D201-202
Session 169
14:45 - 16:45
Poster Discussion: Patient health gains related to the economic effectiveness of disease management programmes Chairs : Otto Chris Burghuber (Vienna, Austria), Ivan Solovic (Vysne Hagy, Slovakia) PA1588
An economic evaluation of a self-management programme for patients with COPD Melina Dritsaki (Coventry, United Kingdom), Melina Dritsaki, Vicki Johnson-Warrington, Sally Singh, Katy Mitchell, Karen Rees
PA1589
Economic effectiveness of integrated care model (ICM) for patients with severe chronic obstructive pulmonary disease (COPD) Ewa Bandurska (Gda sk, Poland), Ewa Bandurska, Iwona Damps-Konstanska, Piotr Popowski, Taduesz Jedrzejczyk, Piotr Janowiak, Katarzyna Swietnicka, Ewa Jassem
PA1590
Predictive value of annual costs on 3-year mortality in COPD Roberto Walter Dal Negro (Verona, Italy), Roberto W. Dal Negro, Luca Bonadiman, Paola Turco
PA1591
Unit costs of Inhaled medicine for asthma and COPD compared to health care expenditure in the second health care sector in Denmark Jens Dollerup (Brøndby, Denmark), Jens Dollerup, Louise Herbild, Ejvind Frausing Hansen
PA1592
Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation Ismail Hanta (Adana, Turkey), Ismail Hanta, Efraim Güzel, Oya Baydar, Sedat Kuleci, Gulsah Seydaoglu
PA1593
Asthma-related healthcare utilization and costs by blood eosinophil levels among adults with persistent asthma Trung Tran (Gaithersburg, United States of America), Trung Tran, Jianbin Mao, Jeffrey McPheeters, Duane Cobenais, Sarowar Golam, Xiao Xu, Rachel Halpern
PA1594
A cross-sectional survey of Maltese patients’ preferences for receiving a cancer diagnosis Joelle Agius (Naxxar, Malta), Joelle Agius (Azzopardi), Ray Zammit
PA1595
Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages? Can Öztürk (Ankara, Turkey), Murat Turk, Fatma Yildirim, Ahmet Selim Yurdakul, Can Ozturk
PA1596
Boyd OODA loop and Wilcoxon rank sum test in diagnostic procedures after major disasters with lung involvement Dusan Ivkovic (Nis, Republic of Serbia), Dusan Ivkovic, Stevan Ivkovic, Tamara Milosavljevic, Aleksandar Ivkovic
PA1597
Direct costs of treating community-acquired pneumonia do not necessarily correlate with clinical severity Vojislav Cupurdija (Kragujevac, Republic of Serbia), Vojislav Cupurdija, Zorica Lazic, Mihajlo Jakovljevic, Marina Petrovic, Slavica Mojsilovic, Ivan Cekerevac, Ljiljana Novkovic, Romana Susa
PA1598
The primary care routine data registry BeoNet: First pilot phase results for COPD research Heidrun Lingner (Hannover, Germany), Heidrun Lingner, Ines Aumann, J. Matthias Von der Schulenburg, Jeanett Radisch, Anna Nickel, Margarethe Wacker, Kreuter Michael, Leidl Reiner, Tobias Welte
107
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015
Room G102-103
Session 170
17:00 - 17:50
Group members' meeting: Group 1.3 Members' Meeting "Imaging" Chairs : Johan Coolen (Leuven, Belgium), Sebastian Ley (Munich, Germany), Aleksandar Grgic (Homburg/Saar, Germany)
Room G104-105
Session 171
17:00 - 17:50
Group members' meeting: Groups 7.3 and 7.4 Members' Meeting "Cystic fibrosis" and "Paediatric respiratory infection and immunology" Chairs : Ian Balfour-Lynn (London, United Kingdom), Kajsa Bohlin (Stockholm, Sweden), Jürg Barben (St. Gallen, Switzerland), Vanessa Craven (Wetherby, United Kingdom)
Room G106-107
Session 172
17:00 - 17:50
Group members' meeting: Group 9.3 Members' Meeting "Nurses" Chairs : Bettina Korn (Dublin, Ireland), Georgia Narsavage (Morgantown, United States of America)
Room E102
Session 173
17:00 - 17:50
Group members' meeting: Group 9.2 Members' Meeting "Physiotherapists" Chairs : Fabio Pitta (LONDRINA/PR, Brazil), Daniel Langer (Leuven, Belgium)
Room E103
Session 174
17:00 - 17:50
Group members' meeting: Group 9.1 Members' Meeting "Respiratory function technologists/scientists" Chairs : Jellien Makonga-Braaksma (Woudenberg, Netherlands), Waldemar Tomalak (Rabka-Zdroj, Poland)
Room G109
Session 175
17:00 - 17:50
Group members' meeting: Group 7.2 and 7.7 Members' Meeting "Paediatric asthma and allergy" and "Paediatric bronchology" Chairs : Marielle Pijnenburg (Rotterdam, Netherlands), Kostas Priftis (Haidari, Athens, Greece), Alexander Möller (Zurich, Switzerland), Deborah Snijders (Ponzano Veneto, Italy)
Room G111
Session 176
17:00 - 17:50
Group members' meeting: Group 3.3 Members' Meeting "Mechanisms of lung injury and repair" Chairs : Martin Kolb (Hamilton, Canada), Melanie Koenigshoff (Munich, Germany)
17:15-19:15 INDUSTRY EVENING SYMPOSIUM
SEE PAGE 331
17:30-19:00 INDUSTRY EVENING MINI SYMPOSIUM
SEE PAGE 331
Room G104-105
Session 190
18:00 - 18:50
Group members' meeting: Group 1.5 Members' Meeting "Diffuse parenchymal lung disease" Chairs : Katerina Antoniou (Heraklion, Greece), Francesco Bonella (Düsseldorf, Germany)
Room G106-107
Session 191
18:00 - 18:50
Group members' meeting: Group 3.1 Members' Meeting "Molecular pathology and functional genomics" Chairs : Marcin Skrzypski (Sopot, Poland), Philippe Bonniaud (Dijon, France), Aurelie Fabre (Dublin, Ireland)
Room E103
Session 192
18:00 - 18:50
Group members' meeting: Groups 6.1 and 6.4 Members' Meeting "Epidemiology" and "Genes and environment"
108
ERS International Congress 2015 DETAILED PROGRAMME SUNDAY 27 SEPTEMBER, 2015 Chairs : Deborah Jarvis (London, United Kingdom), Anne Lindberg (Boden, Sweden), H. Marike Boezen (Groningen, Netherlands), Torben Sigsgaard (Aarhus, Denmark)
Room G109
Session 193
18:00 - 18:50
Group members' meeting: Group 1.1 Members' Meeting "Clinical problems" Chairs : Maurizio Marvisi (Cremona, Italy), Mohankumar Thekkinkattil (Coimbatore, India), Laura Fregonese (London, United Kingdom)
109
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room G106-107
Session 196
07:00 - 08:15
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Challenging clinical cases: CC3 Complications of lung infections Aims : To discuss the two main complications of low respiratory tract infections (abscess and empyema) and to review their current management and treatment indications. Track(s) : Infection Tag(s) : Clinical Target audience : Pulmonologists, respiratory physicians, general practitioners, and trainees Chairs : Michael Tamm (Basel, Switzerland) 07:00
Introduction
1684
07:10
Pulmonary abscess Aran Singanayagam (London, United Kingdom)
1685
07:35
Empyema Francisco Sanz Herrero (Quart de Poblet (Valencia), Spain)
1686
08:00
Discussion
1687
Room E102
Session 197
07:00 - 08:15
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Challenging clinical cases: CC4 Diagnosis of cystic interstitial lung disease Look at the (w)hole lung! Aims : To discuss with the audience the broad spectrum and differential diagnosis of cystic interstitial lung disease Tag(s) : Clinical Target audience : Radiologist, pathologist, Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows, and residents Chairs : Vincent Cottin (Lyon, France) 07:00
Introduction
1688
07:10
Cystic interstitial lung disease - a rare disease? Philipp Markart (Giessen, Germany)
1689
07:35
How to diagnose cystic interstitial lung disease Toby Maher (St. Albans, Hertfordshire, United Kingdom)
1690
08:00
Discussion
1691
Room L001
Session 203
08:00 - 10:20
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Educational skills workshop: EW13 Thoracic ultrasound Aims : To provide hands-on training in transthoracic ultrasound for different indications. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows and residents. Chairs : Nick Maskell (Bristol, United Kingdom) Introduction
1697
Workstation 1: Normal human thoracic cavity Ioannis Psallidas (Oxford, United Kingdom), Fergus Gleeson (Oxford, United Kingdom)
1698
Workstation 2: Pleural effusion and/or pleural thickening Oliver Bintcliffe (Bristol, United Kingdom), Laurence M.M.J. Crombag (Amsterdam, Netherlands)
1699
Workstation 3: Case studies John Wrightson (Oxford, United Kingdom)
1700
110
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Workstation 4: Guided pleural aspiration and lymph node biopsy using models Rahul Bhatnagar (Bristol, United Kingdom), Anthony Edey (Bristol, United Kingdom), Duneesha De Fonseka (Sheffield, United Kingdom)
Room L002
Session 204
1701
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW14 Endoscopic techniques for emphysema, asthma and lung cancer Aims : To show the range of endoscopic options in emphysema, asthma, and lung cancer. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows and residents. Chairs : Arschang Valipour (Vienna, Austria) Introduction
1702
Workstation 1: Endobronchial ultrasound Maren Schuhmann (Heidelberg, Germany)
1703
Workstation 2: Endoscopic lung volume reduction with valves Arschang Valipour (Vienna, Austria)
1704
Workstation 3: Endoscopic lung volume reduction with coils Dirk-Jan Slebos (Groningen, Netherlands)
1705
Workstation 4: Cryobiopsy Sebastian Fernandez Bussy (Santiago, Chile)
1706
Room L001
Session 227
10:40 - 13:00
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Educational skills workshop: EW15 Thoracic ultrasound Aims : To provide hands-on training in transthoracic ultrasound for different indications. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows and residents. Chairs : Nick Maskell (Bristol, United Kingdom) Introduction
1925
Workstation 1: Normal human thoracic cavity Fergus Gleeson (Oxford, United Kingdom), Michael Darby (Bristol, United Kingdom)
1926
Workstation 2: Pleural effusion and/or pleural thickening Oliver Bintcliffe (Bristol, United Kingdom), Jouke T. Annema (Amsterdam, Netherlands)
1927
Workstation 3: Case studies John Wrightson (Oxford, United Kingdom)
1928
Workstation 4: Guided pleural aspiration and lymph node biopsy using models Rahul Bhatnagar (Bristol, United Kingdom), Nick Maskell (Bristol, United Kingdom), Rob Hallifax (Oxford, United Kingdom)
1929
Room L002
Session 228
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW16 Endoscopic techniques for emphysema, asthma and lung cancer Aims : To show the range of endoscopic options in emphysema, asthma, and lung cancer. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows and residents. Chairs : Pallav L Shah (London, United Kingdom)
111
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Introduction
1930
Workstation 1: Endobronchial ultrasound Daniela Gompelmann (Heidelberg, Germany)
1931
Workstation 2: Endoscopic lung volume reduction with valves Ralf Eberhardt (Heidelberg, Germany)
1932
Workstation 3: Endoscopic lung volume reduction with coils Dominik Harzheim (Heidelberg, Germany)
1933
Workstation 4: Cryobiopsy Pallav L Shah (London, United Kingdom)
1934
Room L001
Session 305
14:30 - 16:50
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Educational skills workshop: EW17 Thoracic ultrasound Aims : To provide hands-on training in transthoracic ultrasound for different indications. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows and residents. Chairs : Najib M. Rahman (Oxford, United Kingdom) Introduction
2864
Workstation 1: Normal human thoracic cavity Michael Darby (Bristol, United Kingdom), Anthony Edey (Bristol, United Kingdom)
2865
Workstation 2: Pleural effusion and/or pleural thickening Ioannis Psallidas (Oxford, United Kingdom), Speaker to be confirmed
2866
Workstation 3: Case studies Najib M. Rahman (Oxford, United Kingdom)
2867
Workstation 4: Guided pleural aspiration and lymph node biopsy using models Duneesha De Fonseka (Sheffield, United Kingdom), Oliver Bintcliffe (Bristol, United Kingdom), Rob Hallifax (Oxford, United Kingdom)
2868
Room L002
Session 306
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW18 Endoscopic techniques for emphysema, asthma and lung cancer Aims : To show the range of endoscopic options in emphysema, asthma, and lung cancer. Tag(s) : Clinical Target audience : Pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows and residents. Chairs : Daniela Gompelmann (Heidelberg, Germany) Introduction
2869
Workstation 1: Endobronchial ultrasound Maren Schuhmann (Heidelberg, Germany)
2870
Workstation 2: Endoscopic lung volume reduction with valves Dominik Harzheim (Heidelberg, Germany)
2871
Workstation 3: Endoscopic lung volume reduction with coils Arschang Valipour (Vienna, Austria)
2872
Workstation 4: Cryobiopsy Sebastian Fernandez Bussy (Santiago, Chile)
2873
112
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room L103-104
Session 202
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW29 Chest tube and indwelling catheter placement and management Aims : This workshop is jointly organised by the ERS and CHEST. Participants will be taught techniques that are required to successfully place the indwelling pleural catheters (IPCs) and chest tubes that are needed to drain fluid from the lung. Learners will use models to develop their practical skills. Workstation 1: Case examples will be used to demonstrate how medical professionals can best accommodate the needs of the patient. Workstation 2: This workstation will demonstrate how to correctly insert and regulate IPCs. Workstation 3: This workstation will demonstrate how to correctly manage the insertion of chest tubes to drain fluid from the lungs. Workstation 4: Case examples will illustrate the indications for the use of chest tubes and IPCs. How these indications have been managed will be discussed. Tag(s) : Clinical Target audience : Fellows, residents, pulmonologists and surgeons. Chairs : Felix J.F. Herth (Heidelberg, Germany), Alexander Chen (St Louis, United States of America) Introduction
1692
Workstation 1: Patient management Arnaud Scherpereel (Lille, France)
1693
Workstation 2: Indwelling pleural catheters Stephanie Levine (San Antonio, United States of America)
1694
Workstation 3: Chest tube management Julius P. Janssen (Nijmegen, Netherlands)
1695
Workstation 4: Indications for the use of chest tube and IPCs and how these have been managed. Gerard Silvestri (Charleston, United States of America)
1696
Room L103-104
Session 226
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW30 Chest tube and indwelling catheter placement and management Aims : This workshop is jointly organised by the ERS and CHEST. Participants will be taught techniques that are required to successfully place the indwelling pleural catheters (IPCs) and chest tubes that are needed to drain fluid from the lung. Learners will use models to develop their practical skills. Workstation 1: Case examples will be used to demonstrate how medical professionals can best accommodate the needs of the patient. Workstation 2: This workstation will demonstrate how to correctly insert and regulate IPCs. Workstation 3: This workstation will demonstrate how to correctly manage the insertion of chest tubes to drain fluid from the lungs. Workstation 4: Case examples will illustrate the indications for the use of chest tubes and IPCs. How these indications have been managed will be discussed. Tag(s) : Clinical Target audience : Fellows, residents, pulmonologists and surgeons. Chairs : Arnaud Scherpereel (Lille, France) Introduction
1920
Workstation 1: Patient management Felix J.F. Herth (Heidelberg, Germany)
1921
Workstation 2: Indwelling pleural catheters Alain Tremblay (CALGARY, Canada)
1922
Workstation 3: Chest tube management Momen Wahidi (Durham, United States of America)
1923
Workstation 4: Indications for the use of chest tube and IPCs and how these have been managed. Alexander Chen (St Louis, United States of America)
1924
113
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room L103-104
Session 304
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW31 Chest tube and indwelling catheter placement and management Aims : This workshop is jointly organised by the ERS and CHEST. Participants will be taught techniques that are required to successfully place the indwelling pleural catheters (IPCs) and chest tubes that are needed to drain fluid from the lung. Learners will use models to develop their practical skills. Workstation 1: Case examples will be used to demonstrate how medical professionals can best accommodate the needs of the patient. Workstation 2: This workstation will demonstrate how to correctly insert and regulate IPCs. Workstation 3: This workstation will demonstrate how to correctly manage the insertion of chest tubes to drain fluid from the lungs. Workstation 4: Case examples will illustrate the indications for the use of chest tubes and IPCs. How these indications have been managed will be discussed. Tag(s) : Clinical Target audience : Fellows, residents, pulmonologists and surgeons. Chairs : Alain Tremblay (CALGARY, Canada) Introduction
2859
Workstation 1: Patient management Momen Wahidi (Durham, United States of America)
2860
Workstation 2: Indwelling pleural catheters Stephanie Levine (San Antonio, United States of America)
2861
Workstation 3: Chest tube management Julius P. Janssen (Nijmegen, Netherlands)
2862
Workstation 4: Indications for the use of chest tube and IPCs and how these have been managed. Alexander Chen (St Louis, United States of America)
2863
Room G110
Session 296
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME4 Asthma susceptibility From pathophysiology to personalised medicine Aims : To explain asthma susceptibility by presenting the results of basic science in relation to clinical observations. This will promote the development of personalised therapy on the basis of pathophysiology. Tag(s) : Translational Target audience : Pulmonologists, paediatricians, respiratory therapists, basic scientists, trainees, and anyone with an interest in asthma Chairs : 13:00
Asthma susceptibility: from pathophysiology to personalised medicine Gerard Koppelman (Groningen, Netherlands)
2829
13:30
Interview by a Junior Carmen Veith (Maastricht, Netherlands)
2830
13:40
Discussion
2831
Room G109
Session 295
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME5 Chronic thromboembolic pulmonary hypertension Aims : To review the current knowledge on CTPE: from pathophysiology to clinical presentation and treatment options Tag(s) : Translational Target audience : Pulmonologists, clinical researchers, intensivists, residents, fellows, nurses Chairs : 13:00
Chronic thromboembolic pulmonary hypertension Marion Delcroix (Leuven, Belgium)
2826
13:30
Interview by a Junior Edmund Lau (Connells Point, Australia)
2827
114
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 13:40
Discussion
Room G104-105
2828
Session 294
13:00 - 14:00
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Meet the expert: ME6 Understanding cough Aims : To define why chronic cough remains a clinical challenge; to describe the main causative links; to indicate other possible causes; and to describe possible future treatments. Tag(s) : Clinical Target audience : Pulmonologists, emergency medicine doctors, respiratory physicians, clinical researchers, general practitioners, research fellows, basic scientists, and intensivists. Chairs : 13:00
Understanding cough Alyn Hugh Morice (Cottingham, United Kingdom)
2823
13:30
Interview by a Junior Daan Caudri (Rotterdam, Netherlands)
2824
13:40
Discussion
2825
Room G111
Session 297
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME7 Update on referral guidelines for lung transplantation: what has changed? Aims : To review the current referral criteria for lung transplantation on the basis of an updated report that will soon be published. Tag(s) : Clinical Target audience : Pulmonologists and thoracic surgeons Chairs : 13:00
Update on referral guidelines for lung transplantation: what has changed? Paul Corris (Newcastle-upon-Tyne, United Kingdom)
Room 2.1
2832
Session 194
07:00 - 08:15
How to: Get the most out of literature searches Aims : To discuss what kind of literature efficiently helps to solve clinical dilemmas and how to critically appraise and interpret available studies. Novel types of evidence such as network meta-analysis and benefit-harm assessments will also be discussed. Target audience : Pulmonologists, respiratory therapists, respiratory physicians, general practitioners, intensivists, pathologists, radiologists, thoracic surgeons, otolaryngologist and trainees. Chairs : Milo Puhan (Zurich, Switzerland), Christopher Cates (London, United Kingdom) 07:00
Introduction
1678
07:10
How to find the literature that solves your clinical dilemma Milo Puhan (Zurich, Switzerland)
1679
07:35
How to interpret the literature that solves your practical dilemmas Christopher Cates (London, United Kingdom)
1680
08:00
Discussion
1681
07:00-08:15 INDUSTRY EARLY MORNING SYMPOSIUM Room G102-103
SEE PAGE 331
Session 198
07:30 - 08:20
Group members' meeting: Group 6.2 Members' Meeting "Occupational and environmental health" Chairs : Paul Blanc (San Francisco, United States of America), Paul Cullinan (London, United Kingdom)
115
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room 13.2
Session 199
07:30 - 08:20
Group members' meeting: Groups 7.5 and 7.6 Members' Meeting "Neonatology and paediatric intensive care", "Paediatric respiratory epidemiology" Chairs : Kajsa Bohlin (Stockholm, Sweden), Franca Rusconi (Florence, Italy), Charles Christoph Roehr (Berlin, Germany), Bülent Taner Karadag (Istanbul, Turkey)
Room E103
Session 200
07:30 - 08:20
Group members' meeting: Group 5.3 Members' Meeting "Allergy and immunology" Chairs : Hans Jürgen Heinrich Hoffmann (Aarhus, Denmark), Apostolos Bossios (Gothenburg, Sweden)
Room G109
Session 201
07:30 - 08:20
Group members' meeting: Group 6.3 Members' Meeting "Tobacco, smoking control and health education" Chairs : Paraskevi Katsaounou (Athens, Greece), Thomas Hering (Berlin, Germany)
Room 7.1
Session 205
08:30 - 10:30
Year in review: Tuberculosis: short-course chemotherapy and Ceremony for the ERS Research Award: Innovation in Non-Tuberculous Mycobacteria Science and Medicine Aims : To present the evidence base for improving tuberculosis treatment with current and new drugs, discuss the evidence that suggests a need for shorter-course treatments for tuberculosis, the possible reasons for the problems that may be faced in shortening tuberculosis treatment with reference to the basic science of tuberculosis and present recommendations for future trials. Track(s) : Infection Target audience : Clinicians, clinical trialists, drug development organisations, public health officials, global tuberculosis funders, and basic scientists. Chairs : Jan-Willem Alfenaar (Groningen, Netherlands), Graham H. Bothamley (London, United Kingdom) 08:30
Ceremony for the ERS Research Award: Innovation in Non-Tuberculous Mycobacteria Science and Medicine Rodrigo Andres Floto (Cambridge, United Kingdom), Speaker to be confirmed
1707
08:40
The role of moxifloxacin in treating tuberculosis Stephen Henry Gillespie (St. Andrews, United Kingdom)
1708
09:07
High-dose rifampicin and rifapentine in tuberculosis treatment Amina Jindani (London, United Kingdom)
1709
09:34
Four-month regimens: are they feasible? Christian Lienhardt (Marseille, France)
1710
10:01
Short-course treatment for multidrug-resistant tuberculosis: STREAM trials Sarah Meredith (London, United Kingdom)
1711
Room Auditorium
Session 206
08:30 - 10:30
Symposium: Clinical relevance of exercise stress testing of the right ventricle pulmonary circulation unit Aims : To describe the normal exercise haemodynamics, understand the impact of ventilation on pulmonary haemodynamics in COPD, the impact of extreme sports on the right ventricle and the role of exercise testing on early diagnosis of PAH. Track(s) : Physiology Tag(s) : Clinical, Healthy Lungs for Life (HLfL) Target audience : Clinicians, physiologists, and basic scientists. Chairs : Pierantonio Laveneziana (Paris, France), Anton Vonk Noordegraaf (Amsterdam, Netherlands), Rogério De Souza (Sao Paulo, Brazil) 08:30
ERS Statement: Exercise testing in the evaluation of interventional efficacy Luis Puente Maestu (Madrid, Spain)
1712
08:50
Limits of normal and the methodology Robert Naeije (BRUSSELS, Belgium)
1713
116
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 09:15
Pulmonary haemodynamics and the right ventricle in athletes André La Gerche (Melbourne, Australia)
1714
09:40
Pulmonary haemodynamics during exercise in COPD Bart Boerrigter (Amsterdam, Netherlands)
1715
10:05
Early pulmonary vascular disease in scleroderma Gabor Kovacs (Graz, Austria)
1716
Room 7.2
Session 207
08:30 - 10:30
Symposium: Emerging occupational and environmental lung hazards: from asthma to interstitial disease Aims : To describe emerging exposure-disease relationships, delineate novel pathogenic scenarios for otherwise "idiopathic" conditions, contextualise disease prevention for the practicing pulmonary clinician and expand the differential diagnosis for cases of lung disease with an otherwise unclear aetiology. Track(s) : Epidemiology/Environment Tag(s) : Translational Target audience : Clinicians who encounter lung diseases of unclear aetiology and researchers (including those applied public health) who are investigating disease outbreaks. Chairs : Paul Blanc (San Francisco, United States of America), Paul Cullinan (London, United Kingdom) 08:30
Toxic pneumonitis from nebulised anti-microbials in home humidifiers Yangho Kim (Ulsan, Republic of Korea)
1717
09:00
Bronchiolitis obliterans: a frequently missed occupational or environmental link? Benoit Nemery (Leuven, Belgium)
1718
09:30
Auto-immune complications in pneumoconiois: an underappreciated comorbidity Benjamin Fox (Petach Tikva, Israel)
1719
10:00
Occupational asthma and extrinsic allergic alveolitis: old conditions with many new causes Chris Barber (Sheffield, United Kingdom)
1720
Room Elicium 2
Session 208
08:30 - 10:30
Symposium: How to perform and interpret systematic reviews and meta-analyses Aims : To provide basic knowledge about evidence-based medicine, systematic reviews, meta-analyses, and the Cochrane Collaboration will be described. The reliability of the data provided by meta-analyses will be discussed. The first steps in developing a Cochrane systematic review and meta-analysis will be presented with the aid of high-quality training materials that were generated by the volunteers in the Cochrane Collaboration. We are grateful to the Cochrane Collaboration for allowing us to use these training materials. Track(s) : Oncology Tag(s) : Translational Target audience : All healthcare providers who are interested in evidence-based medicine and how to interpret a common way of summarising data. Chairs : Virginie Westeel (Besançon, France), Thierry Berghmans (Brussels, Belgium) 08:30
Introduction to writing a systematic review: the example of the Cochrane Collaboration Fergus Macbeth (Bristol, United Kingdom)
1721
09:00
Defining a review question and writing a protocol Jaap Trappenburg (Utrecht, Netherlands)
1722
09:30
(Non-)sense to interpret meta-analyses with heterogeneous interventions: the example of nonpharmacological interventions Milo Puhan (Zurich, Switzerland)
1723
10:00
From meta-analyses to network meta-analyses: the Holy Grail for assessing interventions? Ludovic Trinquart (Paris, France)
1724
Room 4.2
Session 209
08:30 - 10:30
Symposium: Mechanisms of virus-driven and host-defence immune responses in acute virusinduced asthma
117
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Aims : To describe the mechanisms by which viruses cause acute asthma. The participants will gain insights into how host immune responses are exploited by the virus, how the host defends itself with its immune responses, and how information about these interactions can be used to develop novel asthma therapies. More specifically, the presentations will describe the effect of viral structure on antiviral host defences, how to differentiate between host immune responses that are exploited by the virus and the immune responses that are crucial for host defence, how genetic variations influence virus-induced asthma exacerbations in children, and how viruses affect the airway microbiome of asthmatics and in turn shape the long-term respiratory outcomes of these patients. Track(s) : Paediatric Infection Tag(s) : Translational Target audience : Clinicians (paediatric and adult), and scientists. Chairs : Gunilla Hedlin (Stockholm, Sweden), Nikolaos G. Papadopoulos (Athens, Greece) 08:30
Interactions between viruses and the immune system in acute asthma James E. Gern (Madison, United States of America)
1725
09:00
Differentiating between virus-driven host immune responses and host defence immune responses Peter Le Souef (Perth, Australia)
1726
09:30
Preschool wheeze: a marker for respiratory problems in adulthood? Alexander John Henderson (Bristol, United Kingdom)
1727
10:00
The effect of viruses on the airway microbiome and how these changes influence long-term respiratory outcome Michael Cox (London, United Kingdom)
1728
Room 5.2
Session 210
08:30 - 10:30
Symposium: Respiratory research in the Netherlands Beyond the Dutch hypothesis Aims : To present the diversity of research topics covered by scientists who are presently active in respiratory research in the Netherlands and who started their careers long after the formulation of the Dutch hypothesis. Tag(s) : Translational Target audience : This session will be of interest to a wide range of basic and clinical scientists. Chairs : Pieter S. Hiemstra (Leiden, Netherlands), Christian Taube (Leiden, Netherlands) 08:30
Patient testimonial Truus Teunissen (Veenendaal, Netherlands)
1729
08:42
Role of muscarinic receptors in airway inflammation and remodelling Reinoud Gosens (Groningen, Netherlands)
1730
09:09
Regulatory B cells in allergy and parasitic infections Hermelijn H. Smits (Leiden, Netherlands)
1731
09:36
Pulmonary rehabilitation in COPD Frits M.E. Franssen (Horn, Netherlands)
1732
10:03
Advanced cell culture techniques and personalised medicine for cystic fibrosis Jeffrey M. Beekman (Utrecht, Netherlands)
1733
Room Elicium 1
Session 211
08:30 - 10:30
Hot topics: Advancing therapies for cystic fibrosis Aims : This session will present insights into the novel therapeutic options for CF and the latest developments in gene and protein therapy. How these therapies can be administered in an individualised fashion will also be discussed. Track(s) : Infection Paediatric Tag(s) : Translational Target audience : Clinicians and basic scientists. Chairs : Margarida D. Amaral (Lisbon, Portugal), Bert Arets (Utrecht, Netherlands) 08:30
Gene therapy of CF Uta Griesenbach (London, United Kingdom)
1734
09:00
Treatment of patients with non-gating mutations with potentiators
1735
118
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 09:30
Individual treatment of cystic fibrosis by using intestinal organoids Florijn Dekkers (Utrecht, Netherlands)
1736
10:00
Personalised therapy for cystic fibrosis: adjusting treatment to the basic defect Luka Clarke (Lisbon, Portugal)
1737
Room Forum
Session 212
08:30 - 10:30
Oral Presentation: Risk assessment and prevention of complications in thoracic surgery Chairs : Dragan R. Subotic (Beograd, Republic of Serbia), Stefano Elia (Naples, Italy) OA1738
The lower pleural covering technique for Birt-Hogg-Dubé syndrome (BHDS) with recurrent pneumothorax Masatoshi Kurihara (Tokyo, Japan), Masatoshi Kurihara, Teruaki Mizobuchi, Hiroki Ebana
OA1739
Cardiopulmonary exercise test to predict perioperative supraventricular tachyarrhythmia after major thoracic surgery: The predictive power of minute ventilation-to-carbon dioxide output (VE/VCO2) Giacomo Cusumano (catania, Italy), Giacomo Cusumano, Riccardo Giuliano, Daniele Lombardo, Alberto Terminella, Salvatore Saita, Salvatore Bellofiore
OA1740
Long-term impact of developing a postoperative pulmonary complications after lung surgery Sebastian Lugg (Bromsgrove, United Kingdom), Sebastian Lugg, Paula Agostini, Theofano Tikka, Kerry Adamas, Amy Kerr, Ehab Bishay, Maninder Kalkat, Richard Steyn, Pala Rajesh, David Thickett, Babu Naidu
OA1741
Short and long term outcomes of pectus surgery Theofano Tikka (Birmingham, United Kingdom), Theofano Tikka, Richard Steyn, Ehab Bishay, Maninder Kalkat, Babu Naidu, Pala Rajesh
OA1742
Video-assisted thoracoscopic surgery (VATS) with nonintubated spontaneous breathing general anesthesia using laryngeal mask (LMA) Georgia Hardavella (Aghia Paraskevi, Athens, Greece), Georgia Hardavella, Nikos Papakonstantinou, Ioannis Karampinis, Antonis Katsipoulakis, Maria Ntassiou, Thodoris Tsoutsouras, Anna Mpairaktari, Nikolaos Anastasiou
OA1743
Preoperative predictive value of 18FDG CT/PET tumor metabolic parameters & SUV lymh nodes/tumor ratio in NSCLC Luca Bertolaccini (Negrar Verona, Italy), Luca Bertolaccini, Giulia Felloni, Matteo Salgarello, Carlo Pomari, Simona Paiano, Luca Rosario Assante, Andrea Viti, Alberto Terzi
OA1744
A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD Anders Bugge (Oslo, Norway), Anders Bugge, May Brit Lund, Cathrine Brunborg, Steinar Solberg, Johny Kongerud
OA1745
EBUS TBNA negative lymph nodes risk stratification model: A tool for multidisciplinary team Luca Bertolaccini (Negrar Verona, Italy), Simona Paiano, Luca Bertolaccini, Carlo Pomari, Luca Rosario Assante, Alberto Terzi
Room 5.1
Session 213
08:30 - 10:30
Oral Presentation: Ring of fire: inflammation and metabolism in sleep-disordered breathing Chairs : Silke Ryan (Dublin, Ireland), Jean-Louis Pepin (Grenoble, France)
OA1746
MicroRNA biomarker profiling for detection of favorable blood pressure responders to CPAP in patients with resistant hypertension and OSA: The HIPARCO-score Fernando Santamaria-Martos (Lleida, Spain), Fernando Santamaria-Martos, Manuel Sánchez-de-la-Torre, Ferran Barbe, Abdelnaby Khalyfa, Alicia Sánchez-de-la-Torre, Monserrat Martinez-Alonso, Miguel ángel Martinez-García, Antonia Barcelo, David Gozal
OA1747
Pharyngeal and systemic inflammation in obstructive sleep apnea (OSA) Jose M. MARIN TRIGO (Zaragoza, Spain), Marta Marin-Oto, Eugenio Vicente, Marta Forner, Pablo Cubero, Ana L. Simon, Jose M. Marin
OA1748
Interaction between body weight obstructive sleep apnea (OSA) on C-reactive protein (CRP) in an otherwise healthy population: The EPIOSA study M TERESA MARTIN DE CARPI (Zaragoza, Spain), M. Teresa Martín Carpi, Santiago J. Carrizo, Marta Andrés, Victoria Gil, Marta Forner, José P. Cubero, Clara Viñado, Dinora Polanco, José M. Marín, Salvador Bello
OA1749
The effect of CPAP withdrawal on exhaled breath in OSA – A randomised controlled trial Esther Irene Schwarz (Zurich, Switzerland), Esther I. Schwarz, Pablo Martinez-Lozano Sinues, Lukas Bregy, Diego Garcia Gomez, Thomas Gaisl, Martin Gaugg, Yvonne Nussbaumer-Ochsner, Nina Strebler, Konrad E. Bloch, John R. Stradling, Renato Zenobi, Malcolm Kohler
119
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
OA1750
The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome Fusun Yildiz (Kocaeli, Turkey), Tugba Onyilmaz, Serap Argun Baris, Hasim Boyaci, Gonca Ornek, Ilknur Basyigit, Fusun Yildiz
OA1751
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Piotr Bielicki (Warsaw, Poland), Piotr Bielicki, Malgorzata Barnas, Kamil Brzoska, Luiza Jonczak, Robert Plywaczewski, Marta Kumor, Tomasz Stepkowski, Ryszarda Chazan, Marcin Kruszewski, Pawel Sliwinski
OA1752
The rs1800629 variant in the TNF- gene is not associated with obstructive sleep apnoea syndrome in a Czech population Martin Pet ek (Olomouc, Czech Republic), Martin Petrek, Jana Petrkova, Veronika Zizkova, Vitezslav Kolek, Milada Hobzova
OA1753
Efficacy of different treatment alternatives por obesity hypoventilation syndrome Juan Fernando Masa Jiménez (Cáceres, Spain), Juan F. Masa, Jaime Corral, Maria L. Alonso, Estrella Ordax, Maria F. Troncoso, Mónica González, Soledad Lopez-Martínez, Jose M. Marin, Sergi Marti, Trinidad Díaz-Cambriles, Eusebi Chiner, Felipe Aizpuru, Carlos Egea
Room 13.1
Session 214
08:30 - 10:30
Oral Presentation: Best abstracts on pulmonary rehabilitation in chronic lung diseases Chairs : Richard Casaburi (Rancho Palos Verdes, United States of America), Martijn A. Spruit (Horn, Netherlands)
OA1754
Physical activity following 12-week supervised exercise training program in patients with idiopathic pulmonary fibrosis Baruch Vainshelboim (Netanya, Israel), Baruch Vainshelboim, Jose Oliveira, Benjamin Fox, Yafit Soreck, Mordechai Kramer
OA1755
Does neuromuscular electrical stimulation of the quadriceps during rehabilitation in COPD outpatients adds a benefit? Catherine Tardif (Bois-Guillaume, France), Catherine Tardif, Anne Laure Roy, Catherine Viacroze, David Debeaumont, Jean Quieffin, Marie Hélène Marques, Claude Dubreuil, Jean François Muir, Dupuis Johan
OA1756
Functional capacity variation after pulmonary rehabilitation in COPD patients – A survival predictor Cláudia Sofia Vaz Guerreiro (Faro, Portugal), Cláudia Guerreiro, Daniela Madama, Fátima Rodrigues
OA1757
Negative pressure ventilation decreases lung function decline, acute exacerbations and hospitalizations in COPD patients with desaturation during 6 minute walk test Te Fang Sheng (Taoyuan, Taiwan), Te-fang Sheng, Hung-Yu Huang, Wen-Ching Joa, Han-Pin Kuo, Chun-Hua Wang
OA1758
Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation Michiel M.J.E.G.W. Vanfleteren (Maastricht, Netherlands), Michiel Vanfleteren, Martijn Spruit, Frits Franssen, Emiel Wouters, Miriam Groenen, Lowie Vanfleteren
OA1759
COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR) Faiza Chowdhury (Sheffield, United Kingdom), Faiza S. Chowdhury, Rachael A. Evans, Jane L. Canavan, Sarah E. Jones, Clare M. Nolan, Amy L. Clark, Samantha S.C. Kon, Derek Bell, Martin R. Cowie, William D.C. Man
OA1760
Metabolic risk factors in patients with advanced COPD and the response to short-term high-intensity pulmonary rehabilitation Nanca Cebron Lipovec (Ljubljana, Slovenia), Nanca Cebron Lipovec, Annemie Schols, Daniel Omersa, Tatjana Kosten, Mitja Lainscak
OA1761
Health status and chronic conditions in patients with COPD and their resident loved ones Nienke Nakken (Horn, Netherlands), N. Nakken, M.A. Spruit, E.H.A. Van den Bogaart, M. Van Vliet, G.J. De Vries, F.L. Custers, J.H. Vercoulen, G.M. Asijee, E.F.M. Wouters, D.J.A. Janssen
Room 2.1
Session 215
08:30 - 10:30
Oral Presentation: Bronchoscopic treatment of emphysema and asthma: what is new? Chairs : Charles-Hugo Marquette (Nice, France), Hervé Dutau (Marseille, France) OA1762
The effect of bronchial thermoplasty on nerve C-fibers and inflammatory cells in patients with severe asthma Nicola Cosimo Facciolongo (Reggio Emilia, Italy), Nicola Facciolongo, Antonino Di Stefano, Vladimiro Pietrini, Federica Bellanova, Roberto Piro, Francesco Menzella, Carla Galeone, Bruno Balbi, Mirco Lusuardi, Luigi Zucchi
120
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
OA1763
Bronchial wall thickness assessed by optical coherence tomography (OCT) before and after bronchial thermoplasty (BT) Julia d'Hooghe (Amsterdam, Netherlands), J.N.S. D’Hooghe, D.M. De Bruin, L. Wijmans, J.T. Annema, P.I. Bonta
OA1764
Distribution of fissure integrity and emphysema measurements by GOLD stages Philippe Raffy (Coralville, United States of America), Philippe Raffy, Youbing Yin, Daniela Gompelmann, Eric Hoffman, Maren Schuhmann, John Newell, Juerg Tschirren, Ralf Eberhardt, Susan Wood, Felix J.F. Herth
OA1765
Regional fissure integrity analysis for improved prediction of endobronchial valve lung volume reduction therapy Youbing Yin (Coralville, United States of America), Y. Yin, P. Raffy, M. Schuhmann, D. Gompelmann, R. Eberhardt, S. Wood, F. Herth
OA1766
CT predictors of VQ perfusion: Application to endobronchial valve lung reduction treatment Maren Schuhmann (Heidelberg, Germany), Maren Schuhmann, Philippe Raffy, Daniela Gompelmann, Youbing Yin, Ralf Eberhardt, Juerg Tschirren, Dominik Harzheim, Felix J.F. Herth
OA1767
Daily physical activity significantly improves after endobronchial valve treatment in patients with emphysema Jorine Hartman (Groningen, Netherlands), Jorine E. Hartman, Karin Klooster, Dirk-Jan Slebos, Nick H.T. Ten Hacken
OA1768
Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR) SANAZ KHALILI TEHRANI (CAMMERAY, Australia), Sanaz Khalili Tehrani, Kelvin Hsu, Jonathan Williamson, Matthew Peters, Alvin Ing
OA1769
QCT analysis of emphysema and air trapping in coil-based lung volume reduction treatment Youbing Yin (Coralville, United States of America), K. Kontogianni, Y. Yin, M. Schuhmann, P. Raffy, R. Eberhardt, D. Gompelmann, F. Herth
Room 4.1
Session 216
08:30 - 10:30
Oral Presentation: Advances in the future treatment of severe asthma Chairs : Mario Cazzola (Rome, Italy), Kian Fan Chung (London, United Kingdom) OA1770
Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma Koustubh Ranade (Potomac, United States of America), Koustubh Ranade, Scott Manetz, Meina Liang, Rozanne (YenWah) Lee, Michael Kuziora, Dewei She, Ed Piper
OA1771
Clinical biomarkers identify T-helper 2 status defined by mucosal CCL26 in the ADEPT-asthma study Matthew Loza (Spring House, United States of America), Matthew Loza, Irina Strambu, Michel Laviolette, David Singh, J. Mark FitzGerald, Stephen Lam, Steven Steven Kelsen, Andreas Eich, Andrea Ludwig-Sengpiel, Geoffrey Chupp, Vibeke Backer, Celeste Porsbjerg, Pierre-Olivier Girodet, Patrick Berger, Richard Leigh, Joel Kline, Mark Dransfield, William Calhoun, Azra Hussaini, Sumita Khatri, Pascal Chanez, Vedrana Susulic, Elliot Barnathan, Kevin Petty, Mark Curran, Anuk Das, Carrie Brodmerkel, Frédéric Baribaud, Philip Silkoff
OA1772
Th2 subsetting of U-BIOPRED asthma subjects based on airway transciptomic profiles Stelios Pavlidis (London, United Kingdom), Stelios Pavlidis, Matthew Loza, Frédéric Baribaud, Chih-Hsi Kuo, Anthony Rowe, Rene Lutter, Uruj Hoda, Christos Rossios, Ana Sousa, Julie Corfield, Ian Adcock, Ratko Djukanovic, Peter Sterk, Fan Chung
OA1773
Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED Christos Rossios (London, United Kingdom), Christos Rossios, Matt Loza, Stelios Pavlidis, Antony Rowe, Ratko Djukanovic, Fred Baribaud, Peter J. Sterk, Kian Fan Chung, Ian M. Adcock, On Behalf of U-BIOPRED Study Group
OA1774
Systemic corticosteroid-associated serum analyte profiles in the U-BIOPRED severe asthma cohort Matthew Loza (Spring House, United States of America), Matthew Loza, Stelios Pavlidis, Anthony Rowe, Ratko Djukanovic, Peter Sterk, Ian Adcock, Frédéric Baribaud, K. Fan Chung
OA1775
Investigating mitochondrial dysfunction in asthma Rebekah Ashmore (London, United Kingdom), Rebekah Ashmore, Andrew Durham, Charalambos Michaeloudes, Christos Rossios, Ian Adcock
OA1776
The effects of clinically relevant reference agents in a mouse model of severe asthma Alan Young (nottingham, United Kingdom), Puneeta Nath, Emma Sadler, Vince Russell, Alan Young
OA1777
Mapping a mouse model of severe asthma to human asthma using gene set variation analysis Kirsty Russell (London, United Kingdom), Kirsty Russell, Stelios Pavlidis, Coen Wiegman, Jeannette Bigler, Navin Rao, Kian Fan Chung, Ian Adcock
Room Emerald
Session 217
Oral Presentation: The multiple faces of host defense
121
08:30 - 10:30
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Chairs : Sinead Weldon (Belfast, United Kingdom), Mark Gjomarkaj (Palermo, Italy) OA1778
LSC Abstract – Cigarette smoke impairs proteasome-dependent MHC I antigen presentation Ilona Keller (Munich, Germany), Ilona Keller, Angela Dann, Oliver Eickelberg, Silke Meiners
OA1779
Loss of bronchial epithelial E-cadherin results in spontaneous airway remodeling and eosinophilic inflammation and exaggerated responses to house-dust mite Martijn Nawijn (Groningen, Netherlands), Martijn Nawijn, Sijranke Post, Laura Hesse, Maaike De Vries, Bart Lambrecht, Tillie Hackett, Irene Heijink
OA1780
Induction of galectin-9 production by viral infection in the lung Shigeki Katoh (Okayama, Japan), Shigeki Katoh, Masaki Ikeda, Hiroki Shimizu, Kiyoyasu Fukushima, Mikio Oka
OA1781
An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection Khondoker Akram (Sheffield, United Kingdom), Khondoker Akram, Nathifa Moyo, Mark Tompkins, Ralph Tripp, Lynne Bingle, James Stewart, Colin Bingle
OA1782
IFN influences bronchial epithelial anti-viral immune responses via inducible epigenetic control of histone methylation of the RIG-I promoter Cosma Mirella Spalluto (Southampton, United Kingdom), C. Mirella Spalluto, Akul Singhania, Christopher H. Woelk, Tilman Sanchez-Elsner, Karl J. Staples, Tom M.A. Wilkinson
OA1783
Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis Sebastian Vencken (Dublin, Ireland), Sebastian Vencken, Irene Oglesby, Raman Agrawal, Kevin Gaughan, Gerry McElvaney, Marcus Mall, Catherine Greene
OA1784
Vitamin D3 deficiency does not result in a breach of pulmonary host defense in mice Julia Niederstrasser (Homburg/Saar, Germany), Julia Niederstraßer, Lisa Wolf, Christian Herr, Christoph Beisswenger, Markus Bischoff, Robert Bals
OA1785
Vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 and killing of non-typeable haemophilus influenzae (NTHi) is reduced after 14 days exposure to TNF- and IL-1 in primary bronchial epithelial cells (PBEC) Jasmijn Schrumpf (Leiden, Netherlands), Jasmijn Schrumpf, Renate Verhoosel, Pieter Hiemstra
Room E104-106
Session 218
08:30 - 10:30
Poster Discussion: Pathogenic mechanisms of lung transplant complications: a focus on CLAD Chairs : Bart Vanaudenaerde (Leuven, Belgium), Claus Neurohr (Munich, Germany)
PA1786
LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab? Simona Soresi (Isleworth, United Kingdom), Neeraj Kohli, Kirsty Habibi-Parker, Haifa Lyster, Anna K. Reed, Martin Carby, Andre R. Simon, Aron F. Popov, Simona Soresi
PA1787
LATE-BREAKING ABSTRACT: Ex vivo pulmonary ultrasound: A new tool for the assessment of marginal organs? Louit Thakuria (London, United Kingdom), Louit Thakuria, Rosalba Romano, Andre Simon, Aron Popov, Fabio De Robertis, Prashant Mohite, Bradley Pates, Timothy Pitt, Mark Griffiths, Simona Soresi, Martin Carby, Anna Reed, Alex Rosenberg
PA1788
LATE-BREAKING ABSTRACT: Lung transplantation in cystic fibrosis patients in Israel: The importance of ethnicity and nutritional status Hagit Levine (Even Yehuda, Israel), Hagit Levine, Dario Prais, Yael Raviv, Victorya Rusanov, Dror Rosengarten, Milton Saute, Moshe Hoshen, Huda Mussaffi, Hannah Blau, Mordechai R. Kramer
PA1789
The role of secondary lymphoid tissue in airway obliteration in a heterotopic trachea transplant model Jana Somers (Leuven, Belgium), Jana Somers, Elly Vandermeulen, Philippe Lemaitre, Hannelore Bellon, David Ruttens, Stijn Verleden, An Martens, Arne Neyrinck, Robin Vos, Geert Verleden, Bart Vanaudenaerde, Dirk Van Raemdonck
PA1790
Serum cytokines patterns in lung transplant recipients Letizia Corinna Morlacchi (Milan, Italy), Letizia Corinna Morlacchi, Valeria Rossetti, Marco Mantero, Mario Nosotti, Paolo Tarsia, Maria Pappalettera, Francesco Blasi
PA1791
System biology (SB) allows the identification of pathogenic micro RNA (miR) in BOS Elena Rossi (Pavia, Italy), Simona Inghilleri, Stefano Di Carlo, Patrizia Morbini, Fiorella Calabrese, Gianfranco Politano, Davide Zampieri, Alfredo Benso, Manuela Agozzino, Emanuela Cova, Federica Meloni, Elena Rossi
122
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA1792
Blood mRNA and miRNA transcriptome to predict chronic lung allograft dysfunction Pierre-Joseph Royer (Nantes, France), Pierre-Joseph Royer, Daniel Baron, Damien Reboulleau, Adrien Tissot, Karine Botturi-Cavailles, Antoine Roux, Martine Reynaud-Gaubert, Romain Kessler, Sacha Mussot, Claire Dromer, Olivier Brugière, Jean-Francois Mornex, Romain Guillemain, Marcel Dahan, Christiane Knoop, Christophe Pison, Angela Koutsokera, Laurent Nicod, Sophie Brouard, Antoine Magnan
PA1793
Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalation Emanuela Cova (Pavia, Italy), Emanuela Cova, Gabriele Ceccarelli, Laura Pandolfi, Manuela Agozzino, Raffaele Allevi, Laura Benedetti, Miriam Colombo, Simona Inghilleri, Sara Magni, Tiberio Oggionni, Davide Prosperi, Maria Gabriella Cusella, Federica Meloni
PA1794
Different expression of CD44variant6 in BAL mesenchymal cells is related to BOS severity Emanuela Cova (Pavia, Italy), Michele Zorzetto, Laura Pandolfi, Simona Inghilleri, Laura Dovizia, Monica Morosini, Angelo Corsico, Davide Piloni, Giulia Stella, Federica Meloni, Emanuela Cova
PA1795
Torque teno virus kinetics after lung transplantation and its association to immunosuppression schemes and to clinical complications Peter Jaksch (VIENNA, Austria), Irene Goerzer, Peter Jaksch, Tamara Seitz, Walter Klepetko, Elisabteh Puchhammer
PA1796
Neurogenic pulmonary edema and right ventricular dysfunction in an animal model of brain death Asmae Belhaj (Brussels, Belgium), Asmae Belhaj, Laurence Dewachter, Céline Dewachter, Myriam Remmelink, Sandrine Rorive, Robert Naeije, Benoit Rondelet
PA1797
Neurogenic pulmonary edema: Effect of corticosteroids Asmae Belhaj (Brussels, Belgium), Asmae Belhaj, Laurence Dewachter, Céline Dewachter, Myriam Remmelink, Sandrine Rorive, Robert Naeije, Benoit Rondelet
PA1798
Airway blood flow changes after lung transplantation Gábor Horváth (Budapest, Hungary), Laura Andrea Toth, Dorottya Filip, Daphna Amitai, Aniko Bohacs, Zoltan Sutto, Veronika Muller, Eliana S. Mendes, Adam Wanner, Gabor Horvath
PA1799
The effect of immunosuppression on airway integrity Hannelore Bellon (Leuven, Belgium), Hannelore Bellon, Elly Vandermeulen, Stijn Verleden, David Ruttens, Hanne Vriens, Hoet Peter, Bart Vanaudenaerde, Robin Vos, Geert Verleden
PA1800
Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort Angela Koutsokera (Lausanne, Switzerland), Angela Koutsokera, Pierre-Joseph Royer, Andreas Fritz, Christian Benden, Adrien Tissot, John-David Aubert, Jean-Philippe Antonietti, Karine Botturi-Cavaillès, Antoine Magnan, Christophe Pison, Laurent P. Nicod
PA1801
Early and late viral infections after lung transplantation Filippo Patrucco (Robbio, Italy), Filippo Patrucco, Massimo Rittà, Daniela Libertucci, Lorena Mercante, Michela Bellocchia, Massimo Boffini, Cristina Costa, Rossana Cavallo, Caterina Bucca, Paolo Solidoro
PA1802
The role of cytomegalovirus in the development of bronchiolitis obliterans syndrome Il'dar Zinnatullin (Saint-Petersburg, Russian Federation), Ildar Zinnatullin, Elena Orlova, Alisa Volkova, Sergey Bondarenko, Andrey Kozlov, Vladimir Vavilov, Olga Slesarchuk, Alexander Kulagin, Ildar Barkhatov, Alexei Chukhlovin, Ludmila Zubarovskaya, Boris Afanasyev
Room G102-103
Session 219
08:30 - 10:30
Poster Discussion: Respiratory disease management in primary care Chairs : Janwillem Kocks (Groningen, Netherlands), Jaime Correia de Sousa (Porto, Portugal) PA1803
LATE-BREAKING ABSTRACT: Impact of the provision of free medications on hospital admissions for asthma in Brazil Talitha Comaru (Barcelona, Spain), Talitha Comaru, Frederico Friedrich, Paulo Pitrez, Leonardo Pinto
PA1804
LATE-BREAKING ABSTRACT: Who benefits most from COPD self-management interventions? An individual patient data meta-analysis Nini Jonkman (Utrecht, Netherlands), Nini Jonkman, Heleen Westland, Jaap Trappenburg, Rolf Groenwold, Erik Bischoff, Jean Bourbeau, Christine Bucknall, David Coultas, Tanja Effing, Michael Epton, Frode Gallefoss, Judith Garcia-Aymerich, Suzanne Lloyd, Evelyn Monninkhof, Huong Nguyen, Job van der Palen, Kathryn Rice, Maria Sedeno, Stephanie Taylor, Thierry Troosters, Nicholas Zwar, Arno Hoes, Marieke Schuurmans
PA1805
Clinically appropriate testing of different valved holding chamber (VHC)-facemask combinations investigating simulated delivered mass to carina Jason Suggett (London, Canada), Jason Suggett, Mark Nagel, Heather Schneider, Jolyon Mitchell
123
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA1806
Pulmonary function and use of health care resources after coronary tomography Frederico Leon Arrabal Fernandes (Sao Paulo, Brazil), Frederico L.A. Fernandes, Moreira Francielle, Janaina Danieli Pessi, Carlos Eduardo Rochite, Regina Maria Carvalho-Pinto, Rafael Stelmach, Alberto Cukier
PA1807
Under-diagnosis, under-treatment and under-counseling of patients of COPD in rural & semi-urban Indian population: If you are not talking to your patient, you are killing him! Mrityunjaya Singh (Varanasi, Uttar Pradesh, India), Mrityunjaya Singh, Sudhir Kumar Agarwal, Manoj Meena, G.N. Srivastava, Ashvendra Singh Chawra
PA1808
How to screen chronic obstructive pulmonary disease in general practice? Ana Luísa Pereira Vieira (Braga, Portugal), Ana Vieira, Joana Lages, Catarina Lacerda, João Cruz, João Cunha
PA1809
Under diagnosis of COPD in primary care setting in Surat, India Kshitij Mandke (Surat, Gujarat, India), Anup Mandke, Kshitij Mandke
PA1810
Inhaler treatment prescription in adults in a primary care setting Salvatore Bucchieri (Palermo, Italy), Salvatore Bucchieri, Fabio Cibella, Piero Alfano, Palma Audino, Mario Raphael Melis, Giuseppina Cuttitta, Snamid Palermo Cooperative Group
PA1811
Impaired health status in primary care COPD patients is underestimated Erik Bischoff (Nijmegen, Netherlands), Erik Bischoff, Laura Elbers-van de Ven, Tjard Schermer, Jan Vercoulen
PA1812
Real life management of chronic obstructive pulmonary disease (COPD) in general practice (GP) in Denmark Anders Løkke (Højbjerg, Denmark), Anders Loekke, Jens Soendergaard, Merete Kjaer Hansen, Soeren Vinther Poulsen, Klaus Roslind, Peter Lange
PA1813
E-learning feedback method to improve spirometry quality and interpretation in primary care - A randomised intervention study Michal Bednarek (Warsaw, Poland), Michal Bednarek, Adam Nowinski, Teresa Rayska, Witold Pobozy, Barbara GebalaJarocka, Marzena Zaluska, Mariola Kumanska, Grzegorz Augustyniak, Dorota Gorecka
PA1814
PAL feasibility test results in the setting of primary health care in Macedonia Biljana Ilievska Poposka (Skopje, FYROM (Macedonia)), Biljana Ilievska Poposka, Maja Zakoska, Stefan Talevski
PA1815
Accuracy of questionnaire with peak flow for diagnosis of airway obstruction and differentiating between asthma and COPD Rahul Kodgule (Pune, India), Rahul Kodgule, Yogesh Thorat, Sundeep Salvi
PA1816
Innovative tools for improving medication adherence in asthma clinic at Srinagarind Hospital Chanee Samosorn (Khonkaen, Thailand), Chanee Samosorn, Pinyo Rattanaphan, Watchara Boonsawat
PA1817
What influences change in health status in COPD in a seven year follow-up? Karin Lisspers (Gagnef, Sweden), Josefin Sundh, Scott Montgomery, Christer Janson, Mary Kämpe, Anna Källander, Björn Ställberg, Karin Lisspers
PA1818
Asthma management in French general practice: Physician-reported medical care and adherence support Alexandra Dima (Amsterdam, Netherlands), Alexandra Lelia Dima, Eric Van Ganse, Helene Le Cloarec, Marijn De Bruin
PA1819
External validation of a decision support system for respiratory primary care patients: A study of diagnostic accuracy Esther Metting (Groningen, Netherlands), Esther Metting, Richard Dekhuizen, Niels Chavannes, Jacqueline MuilwijkKroes, Hans In ’t Veen, Thys Van der Molen
PA1820
Co-morbidities of COPD in primary care Karolina Klester (Barnaul, Russian Federation), Karolina Klester, Elena Klester, Elena Boronina, Galina Ermachkova
Room G104-105
Session 220
08:30 - 10:30
Poster Discussion: Invasive and surgical procedures: the clinical point of view Chairs : Stefano Gasparini (Ancona, Italy), Laureano Molins Lopez-Rodo (Barcelona, Spain) PA1821
Chest tube clamping in spontaneous pneumothorax: 6 hours versus 24 hours – A randomized pilot study Ana Margarida Redondo (Porto, Portugal), Margarida Torres Redondo, Inês Neves, Eva Padrão, Veronica Cardoso, Maria Sucena, Adriana Magalhães
PA1822
Are guidelines of the management of pneumothorax followed? Experience of a Belgian general hospital Richard Frognier (Jodoigne, Belgium), Richard Frognier, Benoît Robaye
PA1823
Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax: A Cochrane review Brian Smith (Adelaide, Australia), Brian Smith, Abel Wakai, Kristin Carson, Ronan O’Sullivan, Aileen McCabe
124
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA1824
Effect of low tidal volume during general anesthesia for urological procedures on lung functions Mohamed Badawy (Luxor, Egypt), Mohamed Badawy, Salah Asieda
PA1825
Bronchological methods of diagnosis and treatment of recurrent papillomatosis of larynx, trachea, bronchi, and lung Valentina Molodtsova (St.Petersburg, Russian Federation), Valentina Molodtsova, Marina Rjabova, Mikhail Ulupov, Mariya Vasiljeva, Aleksandr Prudnikov, Svetlana Starevskaya
PA1826
Success rates of talc slurry pleurodesis - A 2 years review Andreea Alina Ionescu (Penarth, Vale of Glamorgan, United Kingdom), Joy Thomas, Julie Bonsall, Alina Ionescu
PA1827
Identifying false exudates by albumin and protein gradients in patients with heart failure and hepatic hydrothorax Rosa Mirambeaux Villalona (Madrid, Spain), Rosa Mirambeaux Villalona, Paola Arrieta Narvaez, Maria Alejandra Galarza Jimenez, Deisy Barrios Barreto, Esteban Pérez Rodriguez
PA1828
Draining pleural effusions before radiological imaging does not improve diagnostic capability John Corcoran (Oxford, United Kingdom), John Corcoran, Louise Acton, Asia Ahmed, Robert Hallifax, Ioannis Psallidas, John Wrightson, Najib Rahman, Fergus Gleeson
PA1829
Cases of undiagnosed pleural effusion although video-assisted thoracoscopic biopsy Ayse Irem KiliÇ (ISTANBUL, Turkey), Ayse Irem Kiliç, Dilem Anil Tokyay, Fatma Tokgöz Akyil, Aysun Misirlioglu, Emine Aksoy, Mustafa Akyil, Tülin Sevim
PA1830
Pulmonary artery stump thrombosis related to surgical cut procedure Yu Okubo (Kobe, Japan), Yu Okubo, Hiroshi Hamakawa, Kazuhiro Minami, Ichiro Sakanoue, Yutaka Takahashi
PA1831
Recovery of nasal airway and its impact on sleep disordered breathing Irina Morsikyan (Yerevan, Armenia), Irina Morsikyan, Gegham Khandanyan, Mikhail Narimanyan, Artur Shukuryn
PA1832
Surgical risk, functional outcomes, and late survival after lung volume reduction surgery (LVRS): Report of one hundred consecutive surgical cases Mark Ginsburg (New York, United States of America), Mark Ginsburg, Byron Thomashow, William Bulman, Patricia Jellen, Beth Whippo, Joshua Sonett
PA1833
Our cases with pulmonary hydatid cysts Füsun ahin (Istanbul, Turkey), Füsun Sahin, Fulya Omak, Nihat Karadag, Pinar Yildiz
PA1834
Bronchoscopic findings in patients with gastroesophageal reflux (GER) and dry cough Josipa Kokeza (Split, Croatia), Suzana Mladinov, Josipa Kokeza, Vide Popovic, Ivan Gudelj, žarko Ardalic, Kornelija Miše
PA1835
Laparoscopic antireflux surgery as a treatment for chronic cough Jan Koetje (Zwolle, Netherlands), Jan H. Koetje, V.B. Nieuwenhuijs, H.L. Van Westreenen, K.W. Patberg, J.W.K. Van den Berg
PA1836
Clinical and angiographic characteristics of 35 patients with cryptogenic hemoptysis Takahiro Ando (Tokyo, Japan), Takahiro Ando, Masahiro Kawashima, Naoaki Watanabe, Masahiro Ohgiya, Kenichi Okuda, Nobuharu Ohshima, Kimihiko Masuda, Hirotoshi Matsui, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Ken Ohta
Room G106-107
Session 221
08:30 - 10:30
Poster Discussion: Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Chairs : Eric Mortensen (Dallas, United States of America)
PA1837
Influence of prior nonsteroidal anti-inflammatory steroidal drugs (NSAID) on the presentation and evolution of hospitalized community-acquired pneumonia Bruno Philippe (Pontoise, France), Clementine Samain, Gabriel Thabut, Jean-Francois Boitiaux, Stephanie Pham, Francois Senechal, Bruno Philippe
PA1838
Medications associated with the incidence of recurrent pneumonia in Japanese elderly population Tomoko Ishifuji (Nagasaki-shi, Japan), Tomoko Ishifuji, Eiichiro Sando, Norihiro Kaneko, Motoi Suzuki, Makito Yaegashi, Masahiro Aoshima, Koya Ariyoshi, Konosuke Morimoto, Adult Pneumonia Study Group - Japan
PA1839
Could the early administration of antibiotics before admission improve the prognosis of pneumonia? Hiromasa Tachibana (Kurashiki-city, Japan), Hiromasa Tachibana, Tadashi Ishida, Akihiro Ito, Takuya Takaiwa, Yuhei Ito, Machiko Arita, Hroshige Yoshioka
PA1840
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Darina Miteva (Varna, Bulgaria), Darina Miteva, Yordan Radkov, Vanya Kostadinova, Anna Dyakova
125
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA1841
Community-acquired pneumonia--Impacts of diabetes mellitus as a comorbidity: A prospective, observational study Adamadia Liapikou (Athens, Greece), Sotiria Makrodimitri, Anastasia Kosmidou, Ioanna Avgerinou, Panagiotis Petras, Katerina Dimakou, Ioannis Dimitroulis, Michael Toumbis, Adamantia Liapikou
PA1842
Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia Shogo Kumagai (Kurashiki, Japan), Shogo Kumagai, Tadashi Ishida, Hiromasa Tachibana, Yuhei Ito, Akihiro Ito, Toru Hashimoto
PA1843
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Catia Cilloniz Campos (Barcelona, Spain), Catia Cilloniz, Richard Albert, Adamanthia Liapikou, Albert Gabarrus, Ernesto Rangel, Josep Mensa, Antoni Torres
PA1844
Outcome in bacteraemic pneumococcal pneumonia in non-frail elderly patients Leyre Serrano Fernandez (Bilbao (Bizkaia), Spain), Luis Alberto Ruiz, Rafael Zalacain, Alberto Capelastegui, Ainhoa Gomez, Leyre Serrano, Sonia Castro, Marta Garcia, Carmen Jaca, Pedro Pablo España
PA1845
Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia Myoung Kyu Lee (Wonju, Republic of Korea), Myoung Kyu Lee, Sanh-Ha Kim, Suk Joong Yong, Ye-Ryung Jung, WonYeon Lee
PA1846
²Many-armed" CD4: Why it is necessary to count blood CD4 at patient with severe community-acquired pneumonia (CAP)? Kseniia Bielosludtseva (Dniepropetrovsk, Ukraine), Tetyana Pertseva, Tetyana Kireyeva, Kseniia Bielosludtseva
PA1847
Whether there are pharmacoeconomic and other advantages of using procalcitonin-guide antibacterial treatment in patients with severe community-acquired pneumonia in developing countries? Kseniia Bielosludtseva (Dniepropetrovsk, Ukraine), Tetyana Pertseva, Tetyana Kireyeva, Kseniia Bielosludtseva
PA1848
Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification John Wrightson (Oxford, United Kingdom), John Wrightson, John Corcoran, Ioannis Psallidas, Robert Hallifax, Nick Maskell, Najib Rahman
PA1849
Implement "care bundle" and reduce aspiration pneumonia in hospitalised patients Syed Mehdi (Bolton, United Kingdom), Syed B. Mehdi, Peppa Denny, Sarah Simm, Alison Unsworth, Abdul Ashish
PA1850
Bundles for the prevention of ventilator-associated pneumonia in a Brazilian hospital Paulo Magalhães (Santa Cruz, Brazil), Paulo Magalhães, Marina Magalhães, Bárbara Silva, Maria Duarte, Marcos Almeida, Diego Dantas
PA1851
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study Elisa Costantini (Saluggia, Italy), Elisa Costantini, Elias Allara, Filippo Patrucco, Piero Emilio Balbo
PA1852
Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study Isabel Cifuentes Otero (Alcobendas (Madrid), Spain), Angel Gil de Miguel, Ruth Gil-Prieto, Alejandro Alvaro-Meca, Pedro Campuzano, Isabel Cifuentes, Cristina Méndez
PA1853
Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting Maria Jose GALVEZ MEDINA (Madrid, Spain), M.J. Galvez, A. Ramos, A. Delgado-Iribarren, J. Solano, B. Steen
PA1854
Impact of the vaccination campaign on pneumococcal pneumonia after the great East Japan earthquake Daisuke Jingu (Shiogama, Miyagi, Japan), Daisuke Jingu, Takehiro Yajima, Satoshi Ubukata, Makoto Shoji, Hiroshi Watanabe, Hiroshi Takahashi
Room 13.2
Session 222
08:30 - 10:30
Poster Discussion: Neonatal and paediatric intensive care Chairs : Kajsa Bohlin (Stockholm, Sweden), Chair to be confirmed PA1855
Strain-specific susceptibility towards ventilator-induced lung injury in infant rats Francesco Greco (Lucern, Switzerland), Francesco Greco, Susanne Wiegert, Jörg Ersch, Cannizzaro Vincenzo
PA1856
Regional distribution of chest wall displacements in infants during high frequency oscillatory ventilation (HFOV) Emanuela Zannin (Milan, Italy), Martina Perego, Emanuela Zannin, Lara Marconi, Giulia Dognini, Maria Luisa Ventura, Tiziana Fedeli, Paolo Tagliabue, Raffaele Dellaca’
PA1857
Resonance frequency of the respiratory system in premature infants receiving high frequency oscillatory ventilation (HFOV) Emanuela Zannin (Milan, Italy), Lara Marconi, Giulia Dognini, Martina Perego, Paolo Tagliabue, Tiziana Fedeli, Emanuela Zannin, Raffaele Dellaca’, Maria Luisa Ventura
126
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA1858
Small airway hyperresponsiveness is associated with impaired alveolar development in a mouse model of bronchopulmonary dysplasia Jane Bourke (Clayton, Australia), Jane Bourke, Maggie Lam, Simon Royce, Marcel Nold, Claudia Nold
PA1859
Prognostic factors for the outcome of congenital omphalocele Christian Bieli (Basel, Switzerland), Christian Bieli, Selina Krautter, Annina Zweig, Ueli Möhrlen, Andreas Jung, Alexander Möller
PA1860
Carbon dioxide sensitivity and caffeine therapy in the prematurely born infant Thomas Rossor (London, United Kingdom), Thomas Rossor, Gerrard Rafferty, Anne Greenough
PA1861
Airway pressure during nasal high flow and CPAP in neonates Pavel Mazmanyan (Yerevan, Armenia), Pavel Mazmanyan, Mari Darakchyan, Sheng Feng, Stanislav Tatkov
PA1862
Ventilatory responses to hypercarbia in infants of smoking and substance abusing mothers at the high risk age for sudden infant death syndrome Kamal Ali (London, United Kingdom), Kamal Ali, Thomas Rossor, Ravindra Bhat, Kim Wolff, Simon Hannam, Gerrard Rafferty, Anne Greenough
PA1863
Volume targeted versus pressure limited ventilation in term born infants Prashanth Bhat (Greater London, United Kingdom), Prashanth Bhat, Olie Chowdhury, Sandeep Shetty, Simon Hannam, Gerrard Rafferty, Janet Peacock, Anne Greenough
PA1864
Congenital diaphragmatic hernia (CDH) – Influence of fetoscopic tracheal occlusion on outcomes Kamal Ali (London, United Kingdom), Kamal Ali, Perraju Bendapudi, Satamaanasa Polubothu, Gwendolyn Andradi, Mercy Ofuya, Janet Peacock, Ann Hickey, Mark Davenport, Kypros Nicolaides, Anne Greenough
PA1865
Acid and non acid gastro-oesophageal reflux and apnoea in infants Thomas Rossor (London, United Kingdom), Thomas Rossor, Ingran Lingam, Ravindra Bhat, Anne Greenough
PA1866
Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats Xueyu Chen (leiden, Netherlands), Xueyu Chen, Frans Walther, Ruben Van Boxtel, El Houari Laghmani, Rozemarijn Sengers, Gert Folkerts, Edwin Cuppen, Gerry Wagenaar
PA1867
Diffuse pulmonary development disorders- Molecular definable causes of pulmonary hypertension in the mature newborn Meike Hengst (Munich, Germany), Meike Hengst, Nicolaus Schwerk, Jost Wigand Richter, Hans Fuchs, Lars Welzing, Mathias Klemme, Matthias Griese
PA1868
In vitro evaluation of a spacer in a pediatric model of mechanical ventilation Nabile Boukhettala (Tours, France), Nabile Boukhettala, Patrice Diot, Thierry Porée, Laurent Vecellio
PA1869
Humidified high flow nasal cannula (HFFNC) and continuous positive airways pressure (CPAP) in infants with evolving bronchopulmonary dysplasia (BPD) Sandeep Shetty (London, United Kingdom), Sandeep Shetty, Gerrard Rafferty, Anne Greenough
PA1870
Factors associated with prolonged mechanical ventilation in children undergoing cardiac surgery Bárbara Silva (Olinda, Brazil), Taline Ribeiro, Paulo Magalhães, Lívia Andrade, Bárbara Silva, Maria do Carmo Duarte
PA1871
Safety and efficacy of high-flow nasal cannula therapy in preterm infants: A systematic review and meta-analysis Mallinath Chakraborty (Cardiff, United Kingdom), Mallinath Chakraborty, Sarah Kotecha, Roshan Adappa, Nakul Gupta, William Watkins, Sailesh Kotecha
Room E102
Session 223
08:30 - 10:30
Poster Discussion: Molecular pathways of lung injury due to tobacco-related products Chairs : Paraskevi Katsaounou (Athens, Greece), Hiroo Wada (Tokyo, Japan) PA1872
The activity of metalloproteinase and their inhibitors in cerebral arteries in smokers Vera Nevzorova (Vladivostok, Primorsky Krai, Russian Federation), Vera Nevzorova, Elena Gonchar, Nataliya Zacharchuk, Anastasiia Sakovskaia
PA1873
Effect of transcranial direct current stimulation on tobacco consumption: A randomized placebo-controlled trial Aurelie Le Borgne (Toulouse, France), Aurélie Le Borgne-Krams, Rose-Marie Rouquet, Marion Simonetta-Moreau, Claire Thalamas, Gérard Tap, Ivan Berlin, Alain Didier
PA1874
Cotinine level is associated with asthma severity in passive smoker children Shabnbam Eslampanah Nobari (Tehran, Islamic Republic of Iran), Shabnam Eslampanah Nobari, Maryam Hassanzad, Soheila Khalilzade, Mohmmadreza Bolorsaz, Sabere Tashayoe, Seyed Amir Mohajarani, Hooman Sharifi, Aliakbar Velayati
127
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA1875
Effects of secondhand smoking on mucociliary clearance and autonomic nervous systems in Brazilian adults Ana Paula Coelho Figueira Freire (Presidente Prudente, Brazil), Ana Paula Coelho Figueira Freire, Dionei Ramos, Juliana Souza Uzeoto, Bruna Spolador de Alencar Silva, Marceli Rocha Leite, Renata Marques David, Fabiano Francisco de Lima, Iara Buriola Trevisan, Gabriel Santa Brigida, Giovanna Altero Arevalo, Guilherme Yassuyuki Tacao, Francis Lopes Pacagnelli, Giovana Navarro Bertolini, Ercy Mara Cipulo Ramos
PA1876
The impact of smoking on respiratory infections in HIV-infected patients Iosif Marincu (Timisoara, Romania), Iosif Marincu, Emilian Popovici, Stefan Frent, Nicoleta Bertici, Stefan Mihaicuta
PA1877
Comparison of autonomic nervous system activity between smokers and non-smokers under hypoxic conditions Kiril Terziyski (Plovdiv, Bulgaria), Zdravko Taralov, Kiril Terziyski, Peter Dimov, Blagoi Marinov, Stefan Kostianev
PA1878
Mucociliary clearance of smokers after physical effort submaximal and maximal Renata David (Presidente Prudente, Brazil), Renata Marques David, Ercy Mara Cipulo Ramos, Gabriel Faustino Santa Brígida, Guilherme Yassuyuki Tacao, Iara Buriola Trevisan, Ana Paula Coelho Figueira Freire, Juliana Tiyaki Ito, Juliana Uzeloto de Souza, Fabiano Francisco de Lima, Marceli Rocha Leite, Dionei Ramos
PA1879
The influence of smoking on capnometry lung ventilation parameters in chronic obstructive pulmonary disease patients Liudmyla Iashyna (Kiev, Ukraine), Yuriy Feshchenko, Liudmyla Iashyna, Svitlana Opimakh, Victoria Ignatieva, Marina Polianska, Svitlana Moskalenko
PA1880
Comparative study on lung cancer cannabis subjects, not cannabis qassimi loubna (casablanca, Morocco), Wiam El Khattabi, Loubna Qassimi, Hasna Jabri, Hicham Afif
PA1881
Histo-pathological co-relations between smoked and smokeless tobacco in patients with oral cancers in Karachi, Pakistan Aneel Bhagwani (Karachi, Pakistan), Aneel Bhagwani, Shazia Barakzai, Moiz Khan, Naveen Faridi
PA1882
Relation of oxidant-antioxidant status with cardiovascular morbidity in Pan Masala containing tobacco (PMT) users Sanjeeb Shrestha (Dharan, Sunsari, Nepal), Sanjeeb Shrestha
PA1883
Effects of smoking cessation on serum leptin and adiponectin levels Maria Kryfti (Nicosia, Cyprus), Maria Kryfti, Vasilis Galenterides, Katerina Dimakou, Michail Toumbis, Gourgoulianis Konstantinos
PA1884
Effect of smoking on lung function in adult-onset asthma Minna Tommola (Seinäjoki, Finland), Minna Tommola, Pinja Ilmarinen, Leena Tuomisto, Jussi Haanpää, Hannu Kankaanranta
PA1885
The AMPK-TSC1/2-mTOR signaling pathway regulates cigarette smoking-induced inflammation and apoptosis in airway epithelial cells Juan Liu (HangZhou, China), Juan Liu, Wen Li, Songmin Ying, Huahao Shen, Zhihua Chen
PA1886
Correlation between exposure to secondhand smoke load and hemodynamic parameters, lung function and autonomic nervous system Juliana Uzeloto (Anhumas, Brazil), Juliana Souza Uzeloto, Dionei Ramos, Ana Paula Coelho Figueira Freire, Bruna Soplador de Alencar Silva, Marceli Rocha Leite, Renata Marques David, Fabiano Francisco de Lima, Iara Buriola Trevisan, Gabriel Faustino Santa Brígida, Giovanna Altero Arevalo, Guilherme Yassuyuki Tacao, Ercy Mara Cipulo Ramos
PA1887
Smoking increases perioperative risk for coronary surgery Filipe Leite (Coimbra, Portugal), Filipe Leite, Pedro Antunes, Manuel Antunes
Room D201-202
Session 224
08:30 - 10:30
Poster Discussion: Animal studies of asthma and other inflammatory conditions Chairs : Anders Linden (Stockholm, Sweden), Ruby Pawankar (Tokyo, Japan) PA1888
A phosphatidylinositol 3-kinase Inhibitor strongly suppressed pulmonary vascular remodeling in a murine model of allergic vasculitis Kohei Yamauchi (Morioka, Japan), Yuka Oikawa, Nobuhito Sasaki, Miyuki Niisato, Yutaka Nakamura, Kohei Yamauchi
PA1889
NLRP3 inflammasome is activated via phosphoinositide 3-kinase pathway in Aspergillus fumigatus-induced allergic airway inflammation Yong Chul Lee (Jeonju, Republic of Korea), Yong Chul Lee, So Ri Kim, Kyung Bae Lee, Hae Jin Park, Jae Seok Jeong
PA1890
Inflammatory and functional responses after (bio)diesel exhaust exposure in an asthmatic mice model – A comparison between diesel and biodiesel Tirza Timmerman (Groningen, Netherlands), Tirza Timmerman, Ana Julia De Faria Coimbra Lichtenfels, Dolores Ferreira Rivero, Fernanda Arantes Costa, Thais Mauad
128
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA1891
Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model David Schmit (Homburg, Germany), David Schmit, Duc Dung Le, Sebastian Heck, Christoph Beisswenger, Christian Herr, Robert Bals, Quoc Thai Dinh
PA1892
Adoptive Treg transfer to Foxp3-deficient mice prevents bronchus-associated lymphoid tissue formation Jelena Skuljec (Hannover, Germany), Jelena Skuljec, Christine Happle, Anika Lorenz, Gesine Hansen
PA1893
HDM-challenged mice exhibit impaired interferon response to TLR3 ligand in a murine model of viral asthma exacerbation Hamid Akbarshahi (Lund, Sweden), Hamid Akbarshahi, Mandy Menzel, Lena Uller
PA1894
Regulatory B cell development by helminth-derived antigens Hermelijn H. Smits (Leiden, Netherlands), Simone Haeberlein, Lucien E. Van der Vlugt, Nicole N. Driessen, Arifa OzirFazalalikhan, Henrike Veninga, Joke M. Den Haan, Cornelis H. Hokke, Maria Yazdanbakhsh, Hermelijn H. Smits
PA1895
Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function Katja Obieglo (Älvsjö/Stockholm, Sweden), Luciën E.P.M. Van der Vlugt, Katja Obieglo, Arifa Ozir-Fazalalikhan, Tim Sparwasser, Simone Haeberlein, Hermelijn H. Smits
PA1896
TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells Adan Chari Jirmo (Hannover, Germany), Kathleen Daluge, Adan Chari Jirmo, Mandy Busse, Gesine Hansen
PA1897
Pim1 kinase activity preserves airway epithelial integrity upon house dust mite exposure Maaike de Vries (Groningen, Netherlands), Maaike De Vries, Laura Hesse, Maarten Van den Berge, Antoon Van Oosterhout, Irene Heijink, Martijn Nawijn
PA1898
Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape Dimitra Kerdidani (Athens, Greece), Dimitra Kerdidani, Konstantinos Glynos, Sophia Magkouta, Giorgos Kazamias, Vassiliki Karavana, Charis Roussos, Dimitra Rontogianni, Ioannis Kalomenidis, Spyros Zakynthinos, Maria Tsoumakidou
PA1899
B cells in a murine model of allergic asthma and respiratory tolerance Anika Lorenz (Hannover, Germany), Anika Lorenz, Ann-Kathrin Behrendt, Almut Meyer-Bahlburg, Gesine Hansen
PA1900
Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo Sofia Tousa (Athens, Greece), Sofia Tousa, Maria Semitekolou, Ioannis Morianos, Aggelos Banos, Aikaterini Trochoutsou, Tess Brodie, Nikos Poulos, Konstantinos Samitas, Maria Kapasa, Giannis Paraskevopoulos, Mina Gaga, Catherine Hawrylowicz, Federica Sallusto, Georgina Xanthou
PA1901
Tiotropium inhibits airway inflammation and goblet cell metaplasia in a model of relapsing asthma in mice Stan de Kleijn (Leiden, Netherlands), Stan De Kleijn, Yolanda Van Wijck, Veerle Kremer, Hermelijn Smits, Michael Pieper, Pieter Hiemstra, Christian Taube
PA1902
Mouse pathway biology models: Investigating the biology of alternaria alternata induced lung inflammation in the mouse - Role of ILC2 and Th2 cytokines Milenko Cicmil (Boston, United States of America), Michael Caniga, Jie Zhang-Hoover, Adam Hartigan, Alan Byford, Erica Lecese, Robert Faltus, Janice Woodhouse, Malgorzata Gil, Rene De Waal Malefyte, Milenko Cicmil
PA1903
Matrix metalloproteinase-2 is protective in bleomycin-induced pulmonary fibrosis Atsushi Tomaru (Mie, Japan), Atsushi Tomaru, Esteban Gabazza, Tetsu Kobayashi, Hiroyasu Kobayashi, Osamu Taguchi, Takehiro Takagi, Masahiro Oonishi, Kentaro Fujiwara, Corina D’Alessandro Gabazza, Yoshihiro Takahashi, Kentaro Urata
PA1904
IL-37 requires IL18R and SIGIRR to diminish experimental allergic airway inflammation in mice Lars Lunding (Borstel, Germany), Lars Lunding, Sina Webering, Christina Vock, Alexandra Schröder, Diana Raedler, Bianca Schaub, Heinz Fehrenbach, Michael Wegmann
PA1905
Characterization of an acute influenza infection in a murine model of allergic asthma and responses to corticosteroid Boska Hrvacic (Zagreb, Croatia), Boska Hrvacic, Martina Bosnar, Mihailo Banjanac, Ines Glojnaric
Room 7.1
Session 229
10:45 - 12:45
Grand round: Lung cancer: the need for a multidisciplinary approach - an interactive session Aims : To promote a multidisciplinary approach to lung cancer treatment.
129
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Track(s) : Oncology Target audience : Pneumologists, medical oncologist, radiation oncologists, thoracic surgeons, nuclear medicine physicians, radiologists, and pathologists. Chairs : Anne-Pascale Meert (Brussels, Belgium), Prasanta R. Mohapatra (Bhubaneswar, India) 10:45
A case of marginally operable bilateral non-small cell carcinoma Alessandro Brunelli (Leeds, United Kingdom)
1935
11:15
MDT interaction in two comparable NSCLC stage IIIA patients Torsten Gerriet Blum (Berlin, Germany)
1936
11:45
A case study of oligometastatic lung adenocarcinoma Michael Duruisseaux (Grenoble, France)
1937
12:15
Toxicity of SBRT: threat or alarmism? Ursula Nestle (Freiburg, Germany)
1938
Room Auditorium
Session 230
10:45 - 12:45
Symposium: Individualised risk reduction strategies for patients with COPD Aims : To provide an introduction to the clinically important inflammatory phenotypes of COPD, show that the blood eosinophil count is a valid biomarker of risk and risk reduction with inhaled steroids, review the recent findings of studies on inhaled steroid add-on in cohorts that were stratified by baseline blood eosinophil count and detail the factors that associate with a positive response to macrolides. Tag(s) : Translational Target audience : Clinicians, and primary and secondary care physicians. Chairs : Guy Brusselle (Ghent, Belgium), Ian Douglas Pavord (Oxford, United Kingdom) 10:45
Inflammatory phenotypes of COPD Peter Gibson (Newcastle, Australia)
1939
11:15
The blood eosinophil count as a biomarker in COPD Mona Bafadhel (Oxford, United Kingdom)
1940
11:45
The eNose as a predictor of disease severity and treatment response Peter Sterk (Amsterdam, Netherlands)
1941
12:15
Macrolides for COPD: factors associated with treatment success Meilan Han (Ann Arbor, United States of America)
1942
Room 7.2
Session 231
10:45 - 12:45
Symposium: Nutrition in chronic respiratory disease Aims : This session is on the role of diet and nutrients in respiratory health. Its aims are to provide an overview of the ERS statement on COPD and nutrition, and the cost effectiveness of interventions; to describe nutritional assessment methods and the value of nutritional intervention; to review how nutritional interventions improve performance and can serve as adjuncts to pulmonary rehabilitation; to highlight the importance of nutritional support in critical illness; and to describe the impact of diet on the risk of cardiovascular and respiratory disease from an epidemiological perspective. Tag(s) : Clinical Target audience : All clinicians involved in the acute and chronic care of patients with chronic respiratory disease, including those involved in rehabilitation (physician/physiotherapists/nurses and dieticians), and in the ICU. Chairs : Frits M.E. Franssen (Horn, Netherlands), Sally J. Singh (Leicester, United Kingdom) 10:45
State-of-the-art: nutrition in COPD Annemie Schols (Maastricht, Netherlands)
1943
11:15
Can nutrition improve performance in COPD? Michael Steiner (Leicester, United Kingdom)
1944
11:45
Nutrition in critically-ill patients Nicholas Hart (London, United Kingdom)
1945
12:15
Cardiovascular risk and respiratory disease: the influence of diet Raphaëlle Varraso (Villejuif, France)
1946
130
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room Elicium 2
Session 232
10:45 - 12:45
Symposium: Does sleep apnoea impact cognitive function? An ERS/ESRS joint session Aims : To bring together the combined expertise in both the ERS and ESRS in the area of neurocognitive function in relation to sleep, specifically sleep-disordered breathing. The current state of the art in the field, the controversies, and the knowledge deficits will be discussed. At the end of the session, participants will understand the impact of sleep deprivation on neurocognitive function in humans; be aware of the basic methods for evaluating neurocognitive function in humans, including imaging methods; understand the potential impact of sleep-disordered breathing on memory, executive function, and cognitive performance (areas of controversy and uncertainty will be highlighted); and be aware of important trials (and their limitations) in the area of sleep-disordered breathing and its treatment with CPAP. Track(s) : Sleep Tag(s) : Translational Target audience : Physicians from any specialty who deal with sleep disorders and sleep-disordered breathing patients, allied health professionals working in the field of sleep, psychologists, and neurocognitive researchers engaged in the field of sleep. Chairs : Wilfried De Backer (Edegem (Antwerp), Belgium), Walter McNicholas (Dublin, Ireland) 10:45
The effect of sleep deprivation on neurocognitive function in humans: age, chronicity or plasticity? Philippe Peigneux (Brussels, Belgium)
1947
11:15
How we evaluate neurocognitive function: limitations and insights Johanna Schwarz (Stockholm, Sweden)
1948
11:45
The impact of sleep-disordered breathing on the human brain: from children via mice, to adults Mary Morrell (London, United Kingdom)
1949
12:15
The impact of CPAP on neurocognitive function in sleep-disordered breathing: why are the signals so weak? Vincenza Castronovo (Milan, Italy)
1950
Room 4.2
Session 233
10:45 - 12:45
Symposium: When chronic inflammation drives fibrosis: a lesson from lung transplantation Aims : The audience will learn about the inflammatory mechanisms that drive chronic lung allograft dysfunction (CLAD), the role that mesenchymal cells play in the pathogenesis of CLAD, how CLAD is diagnosed, and how CLAD patients are classified into different clinical phenotypes. The current CLAD prevention and treatment strategies in lung recipients will also be described. Tag(s) : Translational Target audience : Clinicians, surgeons, and basic scientists interested in the mechanisms of inflammation and repair and in the diagnosis and management of lung transplant recipients. Chairs : Federica Meloni (Pavia, Italy), Bart Vanaudenaerde (Leuven, Belgium) 10:45
What have we learnt regarding allospecific and aspecific inflammatory mechanisms Laurent-Pierre Nicod (Lausanne, Switzerland)
1951
11:15
The good and the bad of mesenchymal cells in chronic lung allograft dysfunction (CLAD) Vibha N. Lama (Ann Arbor, United States of America)
1952
11:45
Different clinical phenotypes of CLAD: diagnosis and outcomes Geert Verleden (Leuven, Belgium)
1953
12:15
Current and future preventive and treatment strategies in CLAD Andrew Fisher (Newcastle, United Kingdom)
1954
Room 5.2
Session 234
10:45 - 12:45
Symposium: Differentiating COPD exacerbations from pneumonia in COPD patients Aims : To describe the clinical, biological (biomarkers), and physiological approaches that can be used to differentiate between OPD exacerbations from pneumonia in COPD patients. Track(s) : Infection Tag(s) : Clinical Target audience : Clinicians. Chairs : Arturo Humberto Huerta Garcia (Barcelona, Spain), Wisia Wedzicha (London, United Kingdom) 10:45
How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Antoni Torres Marti (Barcelona, Spain)
131
1955
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 11:15
How can I differentiate AECOPD from CAP+COPD patients? John R Hurst (London, United Kingdom)
1956
11:45
Are there new biomarkers that might help to differentiate AECOPD from CAP+COPD? Daiana Stolz (Basel, Switzerland)
1957
12:15
Should we change our antibiotic strategy in AECOPD or CAP+COPD patients? Stefano Aliberti (Milan, Italy)
1958
Room Elicium 1
Session 235
10:45 - 12:45
Hot topics: E-cigarettes: a wolf in sheep's clothing or a sheep in wolf's clothing? Aims : To update physicians, investigators, and health allied professionals about the hot topic of e-cigarettes, describe the safety of ecigarettes and the need for caution when recommending e-cigarette use, present the updated positions of WHO, AHA, FIRS, and ERS in terms of e-cigarette recommendations. Track(s) : Epidemiology/Environment Tag(s) : Healthy Lungs for Life (HLfL) Target audience : Clinicians, nurses, all health professionals (both in pulmonary and non pulmonary discipline) and addiction specialist who would like to be updated with scientific evidences concerning e-cigarettes and the current ERS, FIRS, AHA and WHO positions on e-cigarettes. Chairs : Carlos Andres Jimenez Ruiz (Madrid, Spain), Bo Lundback (Gothenburg, Sweden) 10:45
e-cigarette constituents and particle emission Efthimios Zervas (Patra, Greece)
1959
11:15
The impact of e-cigarettes on the lungs Robert Foronjy (Scarsdale, United States of America)
1960
11:45
Time for e-cigarette regulation Constantine Vardavas (Heraklion, Greece)
1961
12:15
e-cigarettes for smoking cessation Paraskevi Katsaounou (Athens, Greece)
1962
Room Forum
Session 236
10:45 - 12:45
Oral Presentation: Notable abstracts in COPD: variety Chairs : Eric D. Bateman (Cape Town, South Africa), H. Marike Boezen (Groningen, Netherlands)
OA1963
LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study Daiana Stolz (Basel, Switzerland), Daiana Stolz, Jacob Hull Kristensen, Diana Julie Leeming, Morten Asser Karsdal, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm
OA1964
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Daiana Stolz (Basel, Switzerland), Jyotshna Mandal, Michael Roth, Eleni Papakonstantinou, Michael Tamm, Lucas Boeck, Andreas Scherr, Janko Rakic, Renaud Louis, Branislava Milencovic, Wim Boersma, Konstantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Antoni Torres, Tobias Welte, Daiana Stolz
OA1965
Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores Rudolf A Jörres (Munich, Germany), Tanja Schramm, Angelika Kronseder, Frank Biertz, Hans-Ulrich Kauczor, Dennis Nowak, Rudolf Maria Huber, Martina Kerscher, Rudolf A. Jörres
OA1966
Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice Marc Miravitlles (Barcelona, Spain), Marc Miravitlles, Myriam Calle, Juan Luis Rodríguez, Cristina Murio, On Behalf of the FENEPOC Study Group
OA1967
Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension Tatiana Aksenova (Chita, Zabaykalsky Krai, Russian Federation), Tatiana Aksenova, Vladimir Gorbunov, Sergey Lukyanov, Svetlana Tsarenok, Marina Koshkina
OA1968
Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients Marc Miravitlles (Barcelona, Spain), Marc Miravitlles, Esther Garcia Gil, Ferran Chuecos, Rosa Lamarca
132
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
OA1969
Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations Stefano Vezzoli (Parma, Italy), Stefano Vezzoli, Paul Jones, Massimo Corradi, Géraldine Cohuet, Dave Singh, Jørgen Vestbo, Jadwiga Wedzicha, Stefano Petruzelli
OA1970
Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE) Demosthenes Bouros (Athens, Greece), Vassilios Tzilas, Evangelos Bouros, Danae Fourla, Athanasios Zisimopoulos, Nikolaos Papadopoulos, George Koliakos, George Kolios, Ioannis Pneumatikos, Vassilis Aidinis, Agyris Tzouvelekis, Demosthenes Bouros
Room 5.1
Session 237
10:45 - 12:45
Oral Presentation: Paediatric asthma and allergy: epidemiology and risk factors Chairs : Liesbeth Duijts (Rotterdam, Netherlands), Stephen Turner (Aberdeen, United Kingdom)
OA1971
Early life gut microbial alterations in children diagnosed with asthma by three years of age Leah Stiemsma (Vancouver, Canada), Leah Stiemsma, Marie-Claire Arrieta, Pedro Dimitriu, Lisa Thorson, Sophie YuristDoutsch, Boris Kuzeljevic, Diana Lefebvre, Padmaja Subbarao, Piush Mandhane, Allan Becker, Malcolm Sears, Kelly McNagny, Tobias Kollmann, The Child Study Investigators, William Mohn, Brett Finlay, Stuart Turvey
OA1972
Three-dimensional latent class analysis of atopic sensitization in the PASTURE birth cohort Alexander Hose (Munich, Germany), Alexander Hose, Markus Ege, Martin Depner, Charlotte Braun-Fahrländer, Juha Pekkanen, Josef Riedler, Jean-Charles Dalphin, Jon Genuneit, Roger Lauener, Petra Ina Pfefferle, Erika Von Mutius
OA1973
Sensitisation as a predictor of asthma development among wheezing toddlers in secondary healthcare Nienke Boersma (Utrecht, Netherlands), Nienke Boersma, Ruud Meijneke, Johannes Kelder, Walter Balemans
OA1974
Bronchial hyperreactivity in young children is an independent risk factor for later asthma Florian Singer (Zurich, Switzerland), Florian Singer, Valentina Marcaccini, Christina Weingarten, Demet Inci, Shannon J. Simpson, Graham L. Hall, Fritz Horak jr, Alexander Moeller
OA1975
Does breastfeeding protect against childhood eczema? Jingying Wang (Ma'anshan, China), Jingying Wang, Alban Ramette, Maja Jurca, Florian Halbeisen, Caroline Beardsmore, Claudia Kuehni
OA1976
The prevalence of atopy in asthma in a longitudinal birth cohort Louisa Owens (Perth, Australia), Louisa Owens, Peter Le Souef, Ingrid Laing, Guicheng Zhang, Steven Turner, David Mullane, Desmond Cox, Jack Goldblatt
OA1977
An increase in the severity of rhinitis and a reduction in severity of wheezing and eczema in 12- to 15- year old Maltes e children over two decades (ISAAC-Malta) Eleanor Gerada (Paola, Malta), Eleanor Gerada, Hugo Agius Muscat, Liberato Camilleri, Stephen Montefort
OA1978
Allergic comorbidities and lung function in adolescence - Data from the BAMSE cohort Jenny Hallberg (Stockholm, Sweden), Jenny Hallberg, Natalia Ballardini, Anna Bergström, Per Gustafsson, Inger Kull, Gunnar Lilja, Göran Pershagen, Magnus Wickman, Erik Melén
Room 13.1
Session 238
10:45 - 12:45
Oral Presentation: Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease Chairs : Pierantonio Laveneziana (Paris, France), Samuel Verges (Grenoble, France)
OA1979
Heterogeneity of blood flow and metabolism in exercising muscle by near-infrared spectroscopy (NIRS) in COPD patients Zafeiris Louvaris (Agia Paraskevi, Attica, Greece), Zafeiris Louvaris, Ioannis Vogiatzis, Helmut Habazettl, Andreas Asimakos, Harrieth Wagner, Spyros Zakynthinos, Peter Wagner
OA1980
Effect of beta2-adrenergic stimulation on thigh oxygen uptake and lactate accumulation at rest and during exercise Johan Onslev (Copenhagen, Denmark), Johan Onslev, Anders Kalsen, Jens Bangsbo, Vibeke Backer, Morten Hostrup
OA1981
Lung clearance index and exercise capacity among children with CF and non-CF bronchiectasis over a two year period Elpida Hatziagorou (Thessaloniki, Greece), Elpis Hatziagorou, Petrina Vantsi, Vasiliki Avramidou, Asterios Kampouras, Fotios Kirvassilis, Vasiliki Georgopoulou, Maria Karailidou, John Tsanakas
OA1982
Exercise ventilatory inefficiency is an independent predictor of mortality in COPD Abdullah Alharbi (Kingston, Canada), Abdullah Alharbi, Daniel Hirai, Danilo Berton, Nadine Abu-Ghazaleh, Katherine Webb, J. Alberto Neder, Denis O’Donnell
133
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
OA1983
Airway resistance and obesity are independent factors for the occurrence of dynamic hyperinflation in asthmatics Patricia Freitas (Sao Paulo, Brazil), Palmira G. Ferreira, Patricia D. Freitas, Aline G. Silva, Frederico L.A. Fernandes, João M. Salge, Rafael Stelmach, Alberto Cukier, Regina Carvalho-Pinto, Milton A. Martins, Celso R.F. Carvalho
OA1984
Cardiopulmonary exercise testing in the evaluation of dyspnea in the elderly Vanessa Yap (Farmington, United States of America), Vanessa Yap, Debapriya Datta
OA1985
Skeletal muscle oxidative capacity is an independent predictor of physical activity in smokers with and without COPD Alessandra Adami (Torrance, United States of America), Alessandra Adami, Robert Cao, Janos Porszasz, Richard Casaburi, Harry B. Rossiter
OA1986
Is cardiopulmonary exercise test useful to indicate heart failure in patients with COPD? Jose Alberto Neder Serafini (Kingston, Canada), Flavio Arbex, Maria Clara Alencar, Mayron Oliveira, Wladimir Medeiros, Aline Souza, Priscilla Sperandio, Daniel M. Hirai, Denis O’Donnell, J. Alberto Neder
Room 2.1
Session 239
10:45 - 12:45
Oral Presentation: Paediatric pulmonary infections: mechanisms and treatment Chairs : Mark Everard (Perth, Australia), Ahmad Kantar (Bergamo, Italy)
OA1987
LATE-BREAKING ABSTRACT: Symptomatic rhinovirus infections are associated with a lower diversity of the nasopharyngeal microbiota in infants Insa Korten (Bern, Switzerland), Insa Korten, Moana Mika, Meri Gorgievski, Maria Teresa Barbani, Klenja Shkipe, Urs Frey, Markus Hilty, Philipp Latzin
OA1988
Cost-effective management of bronchiolitis in infants: 90% versus 94% oxygen saturation Kathleen Boyd (Glasgow, United Kingdom), Kathleen Boyd, Emma McIntosh, Steff Lewis, Aryelly Rodriguez, Steve Cunningham
OA1989
Effect of recombinant 2- -interferon therapy on virologic and immunologic characteristics by children at early age with acute respiratory viral infections Lidia Kisteneva (Moscow, Russian Federation), Nadezhda Okolysheva, Lidiia Kisteneva, Valentina Malinovskaya, Svyatoslav Cheshik, Elena Ruzhitskaya, Alexey Semenov
OA1990
Trans-placental transmission of the respiratory syncytial virus Mark Everard (Perth, Australia), Angela Fonseca, Abha Chopra, Avram Levy, Paul Noakes, Mark Everard
OA1991
Investigation of the innate antiviral response to respiratory syncytial virus Gemma Saint (Liverpool, United Kingdom), Gemma Saint, Rosalind Smyth, Brian Flanagan, Paul McNamara
OA1992
Ciliary and epithelial abnormalities are features of primary ciliopathies Robert Hirst (Leicester, United Kingdom), Robert Hirst, Andrew Rutman, Gwyneth Williams, Neeta Kulkarni, Chris O’Callaghan
OA1993
Immunofluorescence analysis and diagnosis of primary ciliary dyskinesia with radial spoke defects Niki Tomas Loges (Muenster, Germany), Niki Tomas Loges, Adrien Frommer, Rim Hjeij, Christine Edelbusch, Charlotte Jahnke, Johanna Raidt, Claudius Werner, Julia Wallmeier, Jörg Große-Onnebrink, Heike Olbrich, Sandra Cindríc, Yasin Memari, June Kehelet Marthin, Kim Nielsen, Irael Amirav, Kerem Eitan, David Shoseyov, Karsten Haeffner, Mieke Boon, Martine Jaspers, Heymut Omran
OA1994
Protracted bacterial bronchitis in children: Natural history and risk factors for bronchiectasis Danielle Wurzel (Kelvin Grove, Australia), Danielle Wurzel, Julie Marchant, Stephanie Yerkovich, John Upham, Helen Petsky, Heidi Smith-Vaughan, Brent Masters, Helen Buntain, Anne Chang
Room 4.1
Session 240
10:45 - 12:45
Oral Presentation: Respiratory health across the life course Chairs : Cecilie Svanes (Bergen, Norway), Simone Accordini (Verona, Italy)
OA1995
LATE-BREAKING ABSTRACT: Dietary intake and ventilatory function decline in adults from the European Community Respiratory Health Survey (ECRHS) Vanessa Garcia Larsen (London, United Kingdom), Vanessa Garcia-Larsen, Joachim Heinrich, Ernst Omenaas, Cecilie Svanes, James Potts, Debbie Jarvis, Peter Burney
OA1996
Fetal and infant growth and childhood lung function Herman den Dekker (Rotterdam, Netherlands), Herman Den Dekker, Saskia Schipper, Johan De Jongste, Irwin Reiss, Albert Hofman, Vincent Jaddoe, Liesbeth Duijts
134
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
OA1997
Early determinants of cough in French new-born children: The ELFE cohort Chantal Raherison-Semjen (Pessac, France), Chantal Raherison, Elodie Camiade, Jacques De Blic, Christophe Marguet, Emeline Scherer, Gabriel Reboux, Benedicte Leynaert, Marie-Christine Delmas, Laurence Millon, Marie-Noelle Dufourg, Corinne Bois, Marie-Aline Charles
OA1998
Peak weight velocity in infancy is negatively associated with lung function in adolescence Claudia Flexeder (Neuherberg, Germany), Claudia Flexeder, Elisabeth Thiering, Andrea Von Berg, Dietrich Berdel, Barbara Hoffmann, Sibylle Koletzko, Carl-Peter Bauer, Berthold Koletzko, Joachim Heinrich, Holger Schulz
OA1999
Small airways obstruction is associated with long-term persistence of asthma (EGEA study) Valerie Siroux (La Tronche, France), Valérie Siroux, Anne Boudier, Maïa Dolgopoloff, Sébastien Chanoine, Jean Bousquet, Frederic Gormand, Jocelyne Just, Nicole Le Moual, Rachel Nadif, Christophe Pison, Raphaelle Varraso, Regis Matran, Isabelle Pin
OA2000
Childhood wheeze – A risk factor for COPD? A 50-year cohort study Nargiz Taghiyeva (Aberdeen, United Kingdom), Nara Tagiyeva, Shona Fielding, Graham Devereux, Steve Turner, Graham Douglas
OA2001
Does physical activity affect spirometric indices in lung-healthy adolescents? Results from the GINIplus & LISAplus birth cohorts Maia Smith (Oberschleißheim, Germany), Maia Smith, Andrea Von Berg, Dietrich Berdel, Carl-Peter Bauer, Barbara Hoffman, Sibylle Koletzko, Dennis Nowak, Joachim Heinrich, Holger Schulz
OA2002
15-years mortality in asthma-COPD overlap syndrome (ACOS) elderly population Claudio Sorino (Como, Italy), Claudio Sorino, Claudio Pedone, Stefano Guerra, Nicola Scichilone
Room Emerald
Session 241
10:45 - 12:45
Oral Presentation: Advances in asthma and allergy in animal models Chairs : Christian Taube (Leiden, Netherlands), Apostolos Bossios (Gothenburg, Sweden)
OA2003
A short splice variant of the tumor suppressor gene CYLD induces allergic airway disease in mice and is also expressed in humans Sebastian Reuter (Mainz, Germany), Sebastian Reuter, Hendrik Beckert, Helen Meyer-Martin, Ari Waisman, Roland Buhl, Michael Stassen, Christian Taube
OA2004
Activation of the -catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Hendrik Beckert (Mainz, Germany), Hendrik Beckert, Helen Meyer-Martin, Christian Taube, Roland Buhl, Sebastian Reuter
OA2005
The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models Adan Chari Jirmo (Hannover, Germany), Adan Chari Jirmo, Mandy Busse, Kathleen Dalüge, Christine Happle, Anika Lorenz, Immo Prinz, Gesine Hansen
OA2006
GARP reduces inflammation in a humanized mouse model of allergic airway disease Helen Meyer-Martin (Mainz, Germany), Helen Meyer-Martin, Susanne A. Hahn, Hendrik Beckert, Joachim Maxeiner, Petra Scholtes, Christian Taube, Roland Buhl, Stephanie Korn, Christian Becker, Helmut Jonuleit, Andrea Tüttenberg, Sebastian Reuter
OA2007
IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Lara Ravanetti (Amsterdam, Netherlands), Lara Ravanetti, Annemiek Dijkhuis, Yanaika Sabogal Pineros, Suzanne Bal, Rene Lutter
OA2008
Cytomegalovirus (CMV) modulates the immune responses against inhaled harmless antigens Sebastian Reuter (Mainz, Germany), Sebastian Reuter, Helen Meyer-Martin, Hendrik Beckert, Christian Taube, Roland Buhl, Rafaela Holtappels
OA2009
LSC Abstract – Lack of BMP-6 aggravates pulmonary inflammation in mice after subacute cigarette smoke exposure, but not after chronic exposure Fien Verhamme (Ghent, Belgium), Fien Verhamme, Ken Bracke, Guy Joos, Guy Brusselle
OA2010
LATE-BREAKING ABSTRACT: Identification of a novel lung-resident eosinophil population with immunomodulatory properties in mice Stéfanie Raulier (Liège, Belgium), Stéfanie Raulier, Claire Mesnil, Geneviève Paulissen, Dimitri Pirottin, Thibaut Janss, Christophe Desmet, Thomas Marichal, Fabrice Bureau
Room E104-106
Session 242
Poster Discussion: Work, environment and the epidemiology of asthma Chairs : Christel van Dijk (Utrecht, Netherlands), Nicole Le Moual (Villejuif Cedex, France)
135
10:45 - 12:45
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2011
Self-reported occupational exposure to disinfectants and asthma control in U.S. nurses Nicole Le Moual (Villejuif Cedex, France), Orianne Dumas, Aleta S. Wiley, Raphaelle Varraso, Jan-Paul Zock, Paul K. Henneberger, Frank E. Speizer, Nicole Le Moual, Carlos A. Camargo Jr
PA2012
Increased risk of asthma and rhinitis after exposure to chemicals Christian Schyllert (Karlskrona, Sweden), Christian Schyllert, Linnea Hedman, Martin Andersson, Ulf Hedlund, Bo Lundbäck, Eva Rönmark, Anne Lindberg
PA2013
Cross-sectional study of the risk factors for atopic sensitization, asthma, and bronchial hyperresponsiveness in animal laboratory workers Elcio Vianna (Ribeirão Preto, Brazil), Elcio Vianna, Christian Simoneti, Amanda Freitas, Erica Ferraz, Ericson Bagatin, Marcelo Menezes, Luiza Arruda
PA2014
An exposure-response relation for soluble platinum-salt exposed workers and sensitization Dirk Heederik (Utrecht, Netherlands), Dick Heederik, Jacobs Jose, Frits Van Rooy, Houba Remko
PA2015
Predicting sensitization and allergy in bakery workers participating a surveillance programme Badri Jonaid (Utrecht, Netherlands), Badri Sadat Jonaid, Jos Rooyackers, Dick Heederik
PA2016
Asthma prevalence and pulmonary function tests among flourmill workers in Northern Greece Paschalis Steiropoulos (Alexandroupolis, Greece), Elena Vasileiou, Evangelia Nena, Paschalis Ntolios, Paschalis Steiropoulos, Theodoros C. Constantinidis
PA2017
Comparison of immunology tests for determining sensitisation to mouse proteins in laboratory animal workers Johanna Feary (London, United Kingdom), Johanna Feary, Jennifer Welch, Zoe Lightfoot, Bernadette Fitzgerald, Winston Banya, Paul Cullinan, Meinir Jones
PA2018
Follow-up of wheat and rye sensitization in bakers with occupational asthma Cordula Bittner (Hamburg, Germany), Cordula Bittner, Bettina Simonis, Claus Hoelzel, Volker Harth, Alexandra Preisser
PA2019
Exposure to high endotoxin concentration increases wheezing prevalence among laboratory animal workers Elcio Vianna (Ribeirão Preto, Brazil), Elcio Vianna, Amanda Freitas, Christian Simoneti, Erica Ferraz, Ericson Bagatin, Marcos Borges
PA2020
Acute inhalations in the workplace are associated with new-onset asthma in women Jan-Paul Zock (Utrecht, Netherlands), Jan-Paul Zock, Anne-Elie Carsin, Isabel Urrutia, Silvia Pascual, Sandra Dorado, Mario Olivieri, Jesús Martínez-Moratalla, Nicola Murgia, Bénédicte Leynaert, Maria Mirabelli, Josep M. Antó, Manolis Kogevinas, On Behalf of ECRHS III Partners
PA2021
Acute respiratory effects of magnesia dust in climbing halls Hanns Moshammer (Wien, Austria), Patrik Gebhart, Thomas Mondel, Hanns Moshammer
PA2022
Application of clustering approach to occupational asthma due to isocyanates PAOLA MASON (PADOVA, Italy), Paola Mason, Grazia Barbetta, Maria Cristina Scarpa, Gabriella Guarnieri, Piero Maestrelli
PA2023
Job-task-exposure matrices to assess occupational exposure to disinfectants among U.S. nurses Catherine Quinot (Villejuif, France), C. Quinot, O. Dumas, P.K. Henneberger, R. Varraso, A.S. Wiley, F.E. Speizer, J.P. Zock, C.A. Camargo Jr., N. Le Moual
PA2024
Poor asthma control is associated with low socio-economic status: Results from a nationwide cross sectional study of Danish patients with asthma Anna von Bülow (Lyngby, Denmark), Anna Von Bülow, Margit Kriegbaum, Vibeke Backer, Celeste Porsbjerg
PA2025
Work related symptoms of adult patients with asthma: A multicenter, national, questionnaire based study Dil ad Mungan (Ankara, Turkey), Dilsad Mungan, Ipek Ozmen, Fatma Evyapan, Fusun Topcu, Metin Akgun, Peri Arbak, Yilmaz Bulbul
PA2026
Is occupational asthma really decreasing, or are workers finding referral to specialised centres more difficult? Gareth Walters (Solihull, West Midlands, United Kingdom), Gareth Walters, Amanda Kirkham, Vicky Moore, Alastair Robertson, Sherwood Burge
PA2027
A follow-up study of non-responders in a population-based study on respiratory health in Norway Regine Abrahamsen (Skien, Norway), Regine Abrahamsen, Anne Kristin Møller Fell, Paul Henneberger, Martin Veel Svendsen, Kjell Torèn, Johny Kongerud
PA2028
Is the respiratory health of study participants representative of the entire sample when the participation percentage is low? Paul K. Henneberger (Morgantown, United States of America), Paul Henneberger, Michael Humann, Xiaoming Liang, Aleksandr Stefaniak, Ryan LeBouf, Marcia Stanton, Abbas Virji
136
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room G102-103
Session 243
10:45 - 12:45
Poster Discussion: IPF: clinical aspects Chairs : Venerino Poletti (Forli, Italy), Michael Kreuter (Heidelberg, Germany) PA2029
The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland Nicola Cassidy (Dublin, Ireland), Nicola Cassidy, Denise Dunne, Jim Egan
PA2030
Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Anne-Marie Russell (Holmfirth, West Yorkshire, United Kingdom), Anne-Marie Russell, Tessa Sanderson, Sharon Fleming, Athol Wells, Toby Maher, Paul Cullinan
PA2031
Complications and mortality of tranbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases Claudia Ravaglia (Castelbolognese, Italy), Claudia Ravaglia, Sara Tomassetti, GianLuca Casoni, Carlo Gurioli, Sara Piciucchi, Christian Gurioli, Stefano Sanna, Dubini Alessandra, Poletti Venerino
PA2032
Transbronchial cryobiopsy for the diagnosis of interstitial lung disease (ILD) – The UK experience Theresia Mikolasch (Cambridge, United Kingdom), Theresia Mikolasch, Joanna Porter, Ricky Thakrar, Neal Navani
PA2033
Interim analysis of the EXCITING-ILD registry Michael Kreuter (Heidelberg, Germany), Michael Kreuter, Felix J.F. Herth, Margarethe Wacker, Reiner Leidl, Andreas Hellmann, Michael Pfeifer, Jürgen Behr, Sabine Witt, Dagmar Kauschka, Marcus Mall, Andreas Guenther, Philipp Markart
PA2034
Anti-fibrotic role of inhaled interferon- in idiopathic pulmonary fibrosis Nadia Hasaneen (Stony Brook, United States of America), Nadia Hasaneen, Tuong Vu, Timothy Fusiak, Hussein Foda, Rany Condos, Gerald Smaldone
PA2035
The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea Yong hyun Kim (Bucheon, Gyeonggi-do, Republic of Korea), Yong Hyun Kim, Jun Pyo Myong, Soon Seog Kwon, Kihoon Park
PA2036
Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Fotios Drakopanagiotakis (Giessen, Germany), Fotios Drakopanagiotakis, Franziska Rösner, Carlo Vancheri, Philippe Bonniaud, Athol Wells, Jasmin Wagner, Bruno Crestani, Andreas Guenther
PA2037
Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema Esra Uzaslan (Bursa, Turkey), Ezgi Demirdogen Cetinoglu, Asli Gorek Dilektasli, Nilüfer Aylin Ozturk, Funda Coskun, Ahmet Ursavas, Esra Uzaslan
PA2038
The efficacy of a walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A pilot study Monique Wapenaar-deKorver (Vlaardingen, Netherlands), Maarten Stessel, Monique Wapenaar, Jasmina Huremovic, Elisabeth Bendstrup, Maria Molina, Marlies Wijsenbeek
PA2039
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Wim Wuyts (Rotselaar, Belgium), Wim Wuyts, Benjamin Bondue, Caroline Dahlqvist, Hans Slabbynk, Marc Schlesser, Natacha Gusbin, Marianne Berrens, Paul DeVuyst
PA2040
Does emphysema coexistence with IPF change prognosis? Fatma Tokgöz Aky l (Istanbul, Turkey), Fatma Tokgöz Akyil, Tülin Sevim, Canan Akman, Emine Aksoy, Oguz Aktas, Mustafa Akyil
PA2041
Clinical significance of falling oxygen saturation per walking distance ( SaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF) Hwang In Kyoung (Seoul , Republic of Korea), In Kyoung Hwang, Seon Hye Kim, Myung Jae Park, Hong Mo Kang
PA2042
Idiopathic pulmonary fibrosis: Relationship between patient survival and distance-saturation product Rita Daniela Gomes Matos (Albergaria-a-Velha, Portugal), Rita Matos Gomes, Eva Padrão, Hans Dabó, Luísa Nascimento, Artur Vale, Inês Neves, Patrícia Mota, Natália Melo, António Morais
PA2043
Depression and anxiety in pulmonary fibrosis: A pilot study Claire Vella (Naxxar, Malta), Claire Vella, Jeremy Fleri Soler, Edvyn Andy Wongso, Peter Fsadni, Stephen Montefort
PA2044
Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Miia Kärkkäinen (Kuopio, Finland), Miia Kärkkäinen, Hannu-Pekka Kettunen, Hanna Nurmi, Minna Purokivi, Riitta Kaarteenaho
137
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2045
Do physicians in primary health care recognize pulmonary fibrosis? Minna Purokivi (Kuopio, Finland), Minna Purokivi, Marjukka Myllärniemi, Ulla Hodgson, Eija-Riitta Salomaa, Riitta Kaarteenaho
PA2046
Tuberculosis in patients with idiopathic pulmonary fibrosis Yulia Ilkovich (St.Petersburg, Russian Federation), Lubov Novikova, Yulia Ilkovich, Alexandra Speranskaya
Room G104-105
Session 244
10:45 - 12:45
Poster Discussion: Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Chairs : Jürg Barben (St. Gallen, Switzerland), Jane C. Davies (London, United Kingdom)
PA2047
Exercise improvements in ivacaftor treated G551D cystic fibrosis patients are not solely related to FEV1 and sweat changes Dominic Keating (Melbourne, Australia), Deidre Edgeworth, Dominic Keating, Elyssa Williams, Denise Clark, Brenda Button, Audrey Tierney, Tom Kotsimbos, John Wilson
PA2048
Exercise testing and multiple breath washout as markers of lung disease among patients with cystic fibrosis Elpida Hatziagorou (Thessaloniki, Greece), Elpis Hatziagorou, Asterios Kampouras, Vasiliki Avramidou, Kalliopi Kontouli, Fotios Kirvassilis, Vasiliki Georgopoulou, Maria Karailidou, Athina Tsourtoulas, John Tsanakas
PA2049
Does the lung clearance index track with disease progression in early childhood? Nicole Sonneveld (Rotterdam, Netherlands), Nicole Sonneveld, Sanja Stanojevic, Renee Jensen, Padmaja Subbarao, Felix Ratjen
PA2050
Preschool lung clearance index (LCI) predicts adolescent lung function in cystic fibrosis (CF) Julie Duncan (London, United Kingdom), Julie Duncan, Emma Raywood, Angie Wade, Andy Bush, Janet Stocks, Paul Aurora, On Behalf of The London Cystic Fibrosis Collaboration (LCFC), Funded by the Cystic Fibrosis Trust
PA2051
Comparing two different algorithms of calculating LCI and FRC from N2 MBW in children with CF Christina Kavouridou (Brämhult, Sweden), Christina Kavouridou, Per Gustafsson, Monica Rosberg, Anders Lindblad
PA2052
Ability of the lung clearance index to detect inflammation and infection in preschool children with cystic fibrosis Kathryn Ramsey (Chapel Hill, United States of America), Kathryn Ramsey, Sarath Ranganathan, Jasmine Grdosic, Billy Skoric, Stephen Stick, Graham Hall
PA2053
Immune cell localization in different compartments of human end-stage cystic fibrosis lungs Elise Lammertyn (Leuven, Belgium), Elise J. Lammertyn, Elly Vandermeulen, Hannelore Bellon, John E. McDonough, Ken R. Bracke, Guy G. Brusselle, Erik K. Verbeken, Pieter C. Goeminne, Bart M. Vanaudenaerde, Lieven J. Dupont
PA2054
Allosteric inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) slows airway mucus transport in normal sheep W. M. Abraham (Miami Beach, United States of America), William Abraham, Juan Sabater, Tahir Ahmed
PA2055
Association between lobe specific bronchoalveolar lavage fluid metabolites and structural lung disease in young children with cystic fibrosis Lidija Turkovic (Perth, Australia), Lidija Turkovic, Chalres Esther, Tim Rosenow, Stephen Stick
PA2056
Prediction of CF exacerbations in children by exhaled inflammation markers Edward Dompeling (Maastricht, Netherlands), Marieke Van Horck, Edward Dompeling, Rijn Jobsis
PA2057
Volatile organic compounds emitted by pseudomonas aeruginosa and aspergillus fumigatus mono-cultures and in coculture Anne Neerincx (Nijmegen, Netherlands), Anne H. Neerincx, Brigitte Geurts, Jeroen J. Jansen, Marie-Fleur J. Habets, Johannes A. Booij, Jakko Van Ingen, Johan W. Mouton, Frans J.M. Harren, Leo A.J. Kluijtmans, Ron A. Wevers, Simona M. Cristescu, Peter J.F.M. Merkus
PA2058
Persistence of candida dubliniensis in the lower airways of cystic fibrosis patients Atqah Abdul Wahab (Doha, Qatar), Atqah Abdul Wahab, Husam Salah, Anna Kolecka, Teun Boeckhout, Saad Taj-Aldeen
PA2059
The spectrum of Nocardia lung disease in cystic fibrosis Galit Livnat-Levanon (Haifa, Israel), Galit Livnat, Meir Mei-Zahav, Lea Bentur, Huda Mussaffi, Hannah Blau
PA2060
Histidinylated polylysines: An alternative antibacterial and fluidifying agent in cystic fibrosis.** Virginie HERVE (TOURS, France), Christophe Epinette, Clémence Henry, Eric Morello, Delphine Fouquenet, Thomas Baranek, Lise Vanderlynden, Jérôme Montharu, Francis Gauthier, Mustapha Si-Tahar, Virginie Herve
PA2061
Implementation of supervised physiotherapy in a school environment in children with cystic fibrosis Manjith Narayanan (Leicester, United Kingdom), Naomi Dunmore, Erol Gaillard, Alison Claydon, Manjith Narayanan
138
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2062
What’s the role of stroke volume and cardiac output during exercise in cystic fibrosis? Alessandra Favoriti (Terni, Italy), Alessandra Favoriti, Caterina Lambiase, Giuseppe Cimino, Paolo Versacci, Viviana D’Alù, Federica Montanile, Vittorio Rizzo, Riccardo Lanzano, Francesca Ricupito, Giancarlo Tancredi
PA2063
Diagnostic efficiency of sweat conductivity testing in cystic fibrosis Yasemin Gökdemir (Istanbul, Turkey), Tuncay Seyrekel, Yasemin Gokdemir, Pinar Ozdemir, Fazilet Karakoc, Refika Ersu, Bulent Karadag, Goncagül Haklar
PA2064
CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Borislav Dimitrov (Southampton, United Kingdom), Borislav D. Dimitrov, Mohd Hafiz Hj Jaidi
Room G106-107
Session 245
10:45 - 12:45
Poster Discussion: The challenge of choosing the best physical and functional assessment methods Chairs : Daniel Langer (Leuven, Belgium), Chair to be confirmed PA2065
Clinical significance for ESWT in COPD after a course of pulmonary rehabilitation Jakub Zatloukal (Leicester, United Kingdom), Jakub Zatloukal, Linzy Houchen-Wolloff, Sarah Ward, Sally Singh
PA2066
Comparison of two maximal exercise tests on treadmill in patients with COPD – Preliminary results Fernanda Morakami (Londrina, Brazil), Fernanda Morakami, Antenor Rodrigues, João Brustolin, Fernanda Coimbra, Victoria Escobar, Nidia Aparecida Hernandes, Fabio Pitta
PA2067
Validtiy and usability testing of the Fitbit pedometer in patients with COPD Riany de Sousa Sena (Montreal, Canada), Riany De Sousa Sena, Jean Bourbeau, Pei Zhi Li, Sara Ahmed
PA2068
Does the Glittre test reflect daily activity levels in COPD? Marcelo Velloso (Belo Horizonte, Brazil), Marcelo Velloso, Zoe J. McKeough, Lissa M. Spencer, Jennifer A. Alison
PA2069
Impact of peripheral artery disease on functional capacity in patients with COPD: Results of the COSYCONET study Sarah Wilke (Horn, Netherlands), Sarah Wilke, Robert Bals, Frits Franssen, Annika Karch, Armin Koch, Holger Schulz, Martijn Spruit, Tobias Welte, Emiel Wouters, Rudolf Jörres, Claus Vogelmeier, Henrik Watz
PA2070
Balance status and falls of patients with COPD referred to pulmonary rehabilitation: Preliminary results Larissa Castro (Londrina, Brazil), Larissa Araújo de Castro, Veronica Barbier, Iris Coosemans, Ilse Muylaert, Carlos Marcal Camillo, Noppawan Charussussin, Daniel Langer, Vanessa Suziane Probst, Fabio Pitta, Rik Gosselink, Wim Janssens, Thierry Troosters
PA2071
Psychometric properties of the BESTest and the Berg balance scale in COPD Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Alda Marques, Joana Cruz, Ana Oliveira, Cristina Jácome
PA2072
The determination of cut-off score in 6-minute pegboard and ring test Ismail Ozsoy (Izmir, Turkey), Ismail Ozsoy, Sema Savci, Serap Acar, Duran Ada, Sevgi Ozalevli, Atila Akkoclu
PA2073
Agreement and responsiveness of reference equations for the 6-min walk test in Brazilian patients with COPD Nidia Aparecida Hernandes (Londrina, Brazil), Felipe V.C. Machado, Gianna W. Bisca, Andrea A. Morita, Fabio Pitta, Nidia A. Hernandes
PA2074
Difference in 6MWD between overground and self-paced treadmill walking Wai-Yan Liu (Maastricht, Netherlands), W.Y. Liu, K. Meijer, J.M. Delbressine, E.F.M. Wouters, M.A. Spruit
PA2075
Investigation of clinic measurements of six minute walk test and stair-climbing test in patients with mild COPD Buse Özcan (Izmir, Turkey), Buse Ozcan, Sevgi Ozalevli, Ismail Ozsoy, Aylin Ozgen Alpaydin, Oguz Kilinc
PA2076
Comparison between six minutes walking test and sit-to-stand test in COPD patients Marc Beaumont (Lannion, France), Marc Beaumont, Eliott Boucard, Loic Peran, Romain Pichon, Giuseppe Liistro, Catherine Le Ber-Moy, Gregory Reychler
PA2077
Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension Rengin Demir (Istanbul, Turkey), Rengin Demir, Umit Yasar Sinan, Mehmet Serdar Kucukoglu
PA2078
Which is the best protocol of the sit-to-stand test in patients with COPD? Andrea Morita (Londrina, Brazil), Andrea A. Morita, Gianna W. Bisca, Thais Paes, Karina Furlanetto, Thaís Sant’Anna, Lorena Schneider, Leila Donária, Aline Nellessen, Andreia Travassos, Nidia A. Hernandes, Fabio Pitta, Vanessa S. Probst
PA2079
Reliability and minimal detectable change of the Timed Up & Go test in COPD Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Alda Marques, Joana Cruz, Maria Regêncio, Sara Quina, Ana Oliveira, Cristina Jácome
139
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2080
Comparions between stepper test and step test in COPD patients Gregory Reychler (Bruxelles, Belgium), Gregory Reychler, Eliott Boucard, Loic Peran, Romain Pichon, Thierry Pieters, Catherine Le Ber-Moy, Marc Beaumont
PA2081
Responsiveness of dyspnea, impact of COPD on health status and quality of life on aerobic and resistance training in different intensities – Pilot study Júlia Gianjoppe-Santos (São Carlos, Brazil), Julia Gianjoppe-Santos, Marina S. Barusso, Anna Claudia Sentanin, Jéssica C. Panin, Valéria A. Pires Di Lorenzo
Room 13.2
Session 246
10:45 - 12:45
Poster Discussion: Exhaled biomarkers in children and adults with airways disease Chairs : Konstantinos Kostikas (Karditsa, Greece), Antonio Spanevello (Tradate, Italy) PA2082
Nasal nitric oxide in children with adenoidal hypertrophy and the effect of adenoidectomy Jirina ChlÁdkovÁ (Hradec Kralove, Czech Republic), Jirina Chládková, Tomáš Rybnikár, Marian šenkerík, Jaroslav Chládek
PA2083
Exhaled breath VOCs are associated with nocturnal wakening in asthmatic children Yuanyue Wang (Eindhoven, Netherlands), Yuanyue Wang, Simone Hashimoto, Paul Brinkman, Teunis J. Vink, Hans Weda, Hugo Knobel, Tamara Nijsen, Nicholas J.W. Rattray, Paolo Montuschi, Marco Santonico, Giorgio Pennazza, Arnaldo D’Amico, Louise Fleming, Ana R. Sousa, Clare Murray, Julie Corfield, Hans Bisgaard, Andrew Bush, Wim Van Aalderen, Fan Chung, Dominic Shaw, Ioannis Pandis, Aruna Bansal, Graham Roberts, Peter J. Sterk, Stephen Fowler
PA2084
Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation Maria Vestergaard (Copenhagen, Denmark), Maria Vestergaard, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg
PA2085
Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Ida Mogensen (Enskededalen, Sweden), Ida Mogensen, Kjell Alving, Sven-Erik Dahlen, Bertil Forsberg, Christer Jansson, Andrei Malinovschi
PA2086
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC Olaf Holz (Hannover, Germany), Arne Gaida, Olaf Holz, Shirin Nahidi, Sven Schuchardt, Christoph Nell, Rembert Koczulla, Jens Hohlfeld
PA2087
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Katsuhiro Onodera (sendai, Japan), Katsuhiro Onodera, Hisatoshi Sugiura, Yuichiro Hashimoto, Tadahisa Numakura, Kyoko Abe, Akira Koarai, Mitsuhiro Yamada, Tomoaki Ida, Takaaki Akaike, Masakazu Ichinose
PA2088
Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Ulla Seppala (Solna, Sweden), Ulla Seppala, Lorenzo Sabatelli, Joaquín Sastre, Glenn Crater
PA2089
Exhaled breath temperature as a possible early marker in smokers at risk for COPD (MARKO study) Marina Labor (Osijek, Croatia), Marina Labor, Zarko Vrbica, Ivan Gudelj, Slavica Labor, Iva Juric, Rosanda RosandicPiasevoli, Karla Tudja, Zdenka Mestrovic, Davorka Martinkovic, Davor Plavec
PA2090
Exhaled endogenous particles in a general population sample enriched with asthma subjects Mona Larstad (Gothenburg, Sweden), Mona Lärstad, Ekaterina Mirgorodskaya, Mathias Holm, Hatice Koca, Emilia Viklund, Kjell Torén, Björn Bake, Anna-Carin Olin
PA2091
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Olaf Holz (Hannover, Germany), Arne Gaida, Christoph Nell, Olaf Holz, Sven Schuchardt, Rembert Koczulla, Jens Hohlfeld
PA2092
Longitudinal changes in exhaled breath GC/MS profiles during loss of asthma control by prospective steroid withdrawal Paul Brinkman (Amsterdam, Netherlands), Paul Brinkman, Marianne Van de Pol, Aeilko Zwinderman, Peter Sterk, Niki Fens
PA2093
Influence of age on exhaled breath profile analyzed by an electronic nose in normal subjects Silvano Dragonieri (Bari, Italy), Silvano Dragonieri, Vitaliano Quaranta, Teresa Ranieri, Pierluigi Carratù, Onofrio Resta
PA2094
Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD Josuel Ora (Rome, Italy), Josuel Ora, Luigino Calzetta, Paola Rogliani, Chiara Ciaprini, Rosamaria Capuano, Eugenio Martinelli, Roberto Paolesse, Corrado Di Natale, Mario Cazzola
140
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2095
Study on the origin and collection of exogenous compounds in exhaled breath aerosol particles Göran Ljungkvist (Göteborg, Sweden), Göran Ljungkvist, Olof Beck, Karina Stein, åsa Danielsson, Agneta Agge, Helene Friberg, Emilia Wiklund, Oscar Hammar, Marianne Andersson, Sören Sandqvist, Shahid Ullah
PA2096
EBCpH variability in healthy children Anna Karakatsani (Palio Faliro, Athens, Greece), Anna Karakatsani, Sophia Rodopoulou, Evangelia Samoli, Konstantina Dimakopoulou, Klea Katsouyanni
PA2097
Breath collection related factors may influence electronic nose ability to detect lung cancer András Bikov (Budapest, Hungary), Andras Bikov, Beata Korosi, Laszlo Kunos, Gabriella Zsamboki, Zoltan Sutto, Adam Tarnoki, David Tarnoki, Gyorgy Losonczy, Ildiko Horvath
PA2098
Calv,NO and J’awNO in asthma. A multidimensional approach Raquel Lopez Reyes (Torrent (Valencia), Spain), Raquel Lopez-Reyes, Alberto Garcia-Ortega, Enrique Zaldivar, Miguel Perpiña Tordera
PA2099
Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: An e-nose based study Simone Scarlata (Rome, Italy), Simone Scarlata, Simona Santangelo, Giorgio Pennazza, Marco Santonico, Gilda Giannunzio, Claudio Pedone, Raffaele Antonelli Incalzi
Room E102
Session 247
10:45 - 12:45
Poster Discussion: Pulmonary hypertension: novel clinical insights Chairs : Anton Vonk Noordegraaf (Amsterdam, Netherlands), H. Ardeschir Ghofrani (Giessen, Germany) PA2100
Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Veronique Vorselaars (Nieuwegein, Netherlands), Veronique M.M. Vorselaars, Sebastiaan Velthuis, Marco W.F. Van Gent, Cornelis J.J. Westermann, Repke J. Snijder, Johannes J. Mager, Martijn C. Post
PA2101
Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Tobias Lange (Regensburg, Germany), Tobias Lange, Michael Arzt, Michael Pfeifer
PA2102
Calculation of REVEAL scores for patients with PAH receiving riociguat in the PATENT-2 study Raymond Benza (Pittsburgh, United States of America), Raymond Benza, Adaani Frost, Harrison Farber, Hossein-Ardeschir Ghofrani, Miguel Angel Gómez Sánchez, David Langleben, Stephan Rosenkranz, Dennis Busse, Christian Meier, Sylvia Nikkho, Marius Hoeper
PA2103
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with PAH in PATENT-1 Ioana Preston (Boston, United States of America), Ioana Preston, Nadine Al-Naamani, Stefano Ghio, Hossein-Ardeschir Ghofrani, Paul Hassoun, Sylvia Nikkho, Arno Fritsch, Adam Torbicki
PA2104
Metabolic, cardiovascular and gas exchange abnormalities during activities of daily life in patients with idiopathic pulmonary arterial hypertension Jaquelina Sonoe Ota Arakaki (Sao Paulo, Brazil), Melline Almeida, Roberta Ramos, Eloara Ferreira, Ivan Ivanaga, Gabriela Figliolino, Jose Roberto Jardim, Oliver Nascimento, Luiz Eduardo Nery, Jaquelina Ota-Arakaki
PA2105
An epidemiological study of pulmonary arterial hypertension in Japan Yasunori Kasahara (Chiba, Japan), Yasunori Kasahara, Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi
PA2106
Follow-up of the pulmonary right-to-left shunt with transthoracic contrast echocardiography in patients with hereditary haemorrhagic telangiectasia Veronique Vorselaars (Nieuwegein, Netherlands), Veronique M.M. Vorselaars, Sebas Velthuis, Repke J. Snijder, Cornelis J.J. Westermann, Jan-Albert Vos, Johannes J. Mager, Marco C. Post
PA2107
Apelin improves cardiac output in patients with pulmonary arterial hypertension Lauren Brash (Glasgow, United Kingdom), Lauren Brash, Gareth Barnes, Melanie Brewis, Colin Church, Simon Gibbs, Luke Howard, Martin Johnson, Neil McGlinchey, Joanne Simpson, Colin Stirrat, Stephen Thomson, Geoffrey Watson, David Welsh, Martin Wilkins, David Newby, Andrew Peacock
PA2108
Capillary–hemangiomatosis like lesions in the lungs of sickle cell anemia patients German Rasse (sao paulo, Brazil), German Rasse, Bianca Bergamo de Araujo Paulino, Guilherme Hencklain, Sandra Menosi, Vera Demarchi, Rogerio Souza, Thais Mauad
PA2109
Diagnosis of pulmonary hypertension from MR image based computational models of pulmonary vascular haemodynamics and decision tree analysis Angela Lungu (Sheffield, United Kingdom), Angela Lungu, Andrew Swift, Dave Capener, David Kiely, Rod Hose, Jim Wild
141
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2110
Rationale and study design of the RESPITE trial: Riociguat clinical effects studied in pulmonary arterial hypertension (PAH) patients with insufficient treatment response to PDE-5 inhibitors (PDE-5i) Marius M. Hoeper (Hannover, Germany), Marius Hoeper, Raymond Benza, Gerald Simonneau, James Klinger, David Langleben, Robert Naeije, Paul Corris
PA2111
Pharmacokinetics and safety of concomitant macitentan and hormonal contraceptives Noémie Hurst (Allschwil, Switzerland), Noémie Hurst, Matthias Pellek, Patricia N. Sidharta, Jasper Dingemanse
PA2112
Anxiety and depression are highly prevalent in pulmonary hypertension and might improve with target therapy Gina Somaini (Zurich, Switzerland), Gina Somaini, Elisabeth Hasler, Sévérine Müller-Mottet, Lars Huber, Rudolf Speich, Konrad Bloch, Silvia Ulrich
PA2113
Screening pulmonary hypertension by lung doppler signal: A proof-of-concept study Laurent Godinas (Yvoir, Belgium), Laurent Godinas, Frédéric Lador, Rachel Schatzberger, Majd Zreik, Sven Gunther, Michael Segel, Yoram Palti, Olivier Sitbon, Gérald Simonneau
PA2114
Safety and tolerability of rapid dose-titration of subcutaneous (SC) treprostinil in pulmonary arterial hypertension (PAH) Ekkehard Grünig (Heidelberg, Germany), Ekkehard Grünig, Benjamin Egenlauf, Tobias J. Lange, Ulrich Krüger, Rob Grover, Michelle Pernow, Andrew Traube, Thomas Viethen, Stephan Rosenkranz
PA2115
Pulmonary hypertension in renal dialysis patients - A matter of water Frank Reichenberger (Gauting, Germany), Julia Ortwein, Andreas Feustel, Henning Gall, Christian Tanislav, Werner Seeger, Hossein Ghofani, Frank Reichenberger
PA2116
Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension Gina Somaini (Zurich, Switzerland), Gina Somaini, Adriana Stamm, Sévérine Müller-Mottet, Elisabeth Hasler, Keusch Stephan, Hildenbrand Florian, Rudolf Speich, Michael Furian, Konrad Bloch, Silvia Ulrich
PA2117
Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study Aneta Kacprzak (Warszawa, Poland), Aneta Kacprzak, Monika Szturmowicz, Monika Franczuk, Barbara Burakowska, Marcin Kurzyna, Anna Fijalkowska, Agnieszka Skoczylas, Stefan Wesolowski, Jan Kus, Adam Torbicki
Room D201-202
Session 248
10:45 - 12:45
Poster Discussion: New targets and modalities for the treatment of asthma and COPD Chairs : Gaetano Caramori (Ferrara, Italy), Loes Kistemaker (Groningen, Netherlands)
PA2118
Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Rene van der Merwe (Cambridge, United Kingdom), Gautam Damera, Christopher Brightling, Eugene Bleecker, Dewei She, Rene Van der Merwe, Christine Ward
PA2119
Effect of anti-IL-13 treatment on airway dimensions in severe asthma: Subgroup analysis Christopher E. Brightling (Leicester, United Kingdom), Christopher E. Brightling, Lars H. Nordenmark, Meena Jain, Edward Piper, Dewei She, Martin Braddock, Gene Colice, Göran Tornling
PA2120
Safety and pharmacology of a soluble epoxide hydrolase inhibitor Aili Lazaar (Blue Bell, United States of America), Aili Lazaar, Lucy Yang, Jon Robertson, Navin Goyal, Rebecca Boardley, Ruth Tal-Singer, Joseph Cheriyan, David Newby, Ian Wilkinson, Ruth Mayer
PA2121
Serelaxin is a potent inhibitor of airway contraction and enhances -adrenoceptor-mediated relaxation Jane Bourke (Clayton, Australia), Jane Bourke, Maggie Lam, Maria Jelinic, Laura Parry, Simon Royce, Chrishan Samuel
PA2122
Duvelisib, a PI3K- , inhibitor, in subjects with mild asthma Tess Schmalbach (Cambridge, United States of America), Tess Schmalbach, Rainard Fuhr, Muna Albayaty, Kerstin Allen, Mark Douglas, Joi Dunbar, Justin McLaughlin, Laura Alexander, Charlotte McKee
PA2123
Pharmacokinetics of selective PI3K inhibitors after intratracheal instillation in mice Pawel Gunerka (Lomianki, Poland), Pawel Gunerka, Joanna Hucz-Kalitowska, Pawel Turowski, Marcin Zagozda, Maciej Dziachan, Mariola Sekular, Anna Bujak, Maciej Wieczorek
PA2124
Novel, highly potent and selective JAK3 inhibitor disrupting IL-4/IL-13 signaling in asthma therapy Anna Bujak (Warszawa, Poland), Anna Bujak, Pawel Gunerka, Joanna Lipner, Michal Mroczkiewicz, Bartosz Stypik, Pawel Turowski, Maciej Wieczorek
142
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2125
QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study Veit Erpenbeck (Basel, Switzerland), Veit J. Erpenbeck, Todor A. Popov, S. David Miller, Steven F. Weinstein, Sheldon Spector, Baldur Magnusson, Wande Osuntokun, Paul Goldsmith, Markus Weiss, Jutta Beier
PA2126
iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma Anna-Karin Larsson-Callerfelt (Lund, Sweden), Anna-Karin Larsson-Callerfelt, Maria Weitoft, Leif Bjermer, Ellen Tufvesson, Gunilla Westergren-Thorsson
PA2127
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Chung-Wai Chow (Toronto, Canada), Xiaomin Wang, Sepehr Salehi, Jeremy Soctt, Chung-Wai Chow
PA2128
Dose-FEV1 modeling to support future development of AZD2115, a dual acting bronchodilator for the treatment of COPD Ulrika Wählby Hamren (Mölndal, Sweden), Ulrika Wählby Hamrén, Fredrik öhrn, Ajay Aggarwal
PA2129
Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment Roland Blanqué (Romainville, France), Roland Blanque, Nicolas Desroy, Sonia Dupont, Céline Cottereaux, Alain Monjardet, Emanuelle Wakselman, Wendy Laenen, Vince Russell, Ellen Van der Aar, Reginald Brys, Bertrand Heckmann
PA2130
In-vitro evaluation of a new potent, selective pan-Janus kinase (JAK) inhibitor VR588 Coen Wiegman (London, United Kingdom), Coen Wiegman, Ian Adcock, Alan Rothaul, Mark Main, Frazer Morgan
PA2131
Suppression of cough-reflex sensitivity by electronic cigarette use: Effect of nicotine Peter Dicpinigaitis (New York, United States of America), Peter Dicpinigaitis, Alfredo Lee Chang, Alis Dicpinigaitis
PA2132
Pre-clinical to clinical potency of AZD7624 in LPS induced TNFa response Rikard Pehrson (Mölndal, Sweden), Rikard Pehrson, Tove Hegelund, Sofia Lundin, Patel Naimish, Paul Jansson, Danen Cunoosamy
PA2133
Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways Adelina Gavrila (Leicester, United Kingdom), Adelina Gavrila, Latifa Chachi, Omar Tliba, Christopher Brightling, Yassine Amrani
PA2134
Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group) Ceren Türkcan Kayhan (Izmir, Turkey), Ceren Turkcan Kayhan, Raziye Hilal Senay, Esra Feyzioglu, Fulden Zeynep Ural, Ozlem Goksel, Tuncay Goksel, Suleyman Gulcemal, Munevver Erdinc, Sinan Akgol
PA2135
New nasal spray stimulates ciliary activity in vitro Mieke Boon (Wilsele, Belgium), Mieke Boon, Frans Merkus, Martine Jaspers, Mark Jorissen
Hall 14-01
Session 249
12:50 - 14:40
Thematic Poster: Acute critical care: novelties in critical care Chairs : Federico Longhini (Borgomanero, Italy), Marcus Schultz (Amsterdam, Netherlands), Antonio Artigas (Sabadell (Barcelona), Spain) PA2136
LATE-BREAKING ABSTRACT: The evolution of procalcitonin as a prognostic factor in critically ill patients with sepsis Xubin Huang (Guangzhou, China), Xubin Huang, Jun Zhang, Mian Zeng, Xinyan Huang, Yanzhu Chen
PA2137
ENDOXY – First ISO compliant test of an endothelialized oxygenator model Christian Cornelissen (Aachen, Germany), Christian Cornelissen, Nicole Finocchiaro, Michael Dreher, Stefan Jockenhoevel
PA2138
Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury Laura Chimenti (Barcelona, Spain), Laura Chimenti, Raquel Guillamat, Neus Gomez, Jessica Tijero, LLuis Blanch, Antonio Artigas
PA2139
Healthcare costs utilization and costs of patients hospitalized with acute respiratory distress syndrome (ARDS) in US commercially-insured individuals and Medicare beneficiaries Shih-Yin Chen (Cambridge, United States of America), Ning Wu, John Hanrahan, Jeff Bornstein, Shih-Yin Chen
PA2140
Risk factors for mortality in severe pneumonia patients followed in ICU Begüm Ergan (Izmir, Turkey), Begum Ergan, Recai Ergun
143
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2141
Effects of S-nitroso-N-acetyl-penicillamine (SNAP) on inflammation, apoptosis and iNOS activity in an experimental model of acute lung injury Petra Kosutova (Martin, Slovakia), Petra Kosutova, Daniela Mokra, Hana Pistekova, Pavol Mikolka, Sona Balentova, Lucia Tomcikova, Andrea Calkovska
PA2142
Outcome and prognostic features in respiratory critically-ill patients with hematological malignancies Mohamed Boussarsar (Sousse, Tunisia), Yamina Hamdaoui, Rania Bouneb, Abdelbaki Azouzi, Jihene Ayachi, Ahmed Khedher, Imed Chouchene, Rania Amara, Mohamed Boussarsar
PA2143
Morbi-mortality evaluation in prolonged prone positioning during severe ARDS Franco Appiani (Santiago, Chile), Franco Appiani, Pamela Farias, Felipe Aliaga, Constanza Florestano, Eduardo Tognarelli, Antonio Hernandez
PA2144
Position-dependent distribution of ventilation measured with electrical impedance tomography Christian Karagiannidis (Cologne, Germany), Christian Karagiannidis, Andreas D. Waldmann, Carlos Ferrando Ortolá, Manuel Muñoz Martinez, Anxela Vidal, Arnoldo Santos, Peter L. Róka, Manuel Perez Márquez, Stephan H. Bohm, Fernando Suarez-Spimann
PA2145
The roles of inducible NO synthase and reactive oxygen species on lung injury induced by renal ischemia/reperfusion injury in the isolated perfused rat lung Farzaneh Ketabchi (Shiraz, Islamic Republic of Iran), Farzaneh Ketabchi, Zinab Karimi, Seyed Mostafa Shid Moosavi
PA2146
3D/4D pulmonary ultrasonograpy. Volumetric visualization of the pulmonary parenchyma in the evaluation of critical patients Delgado-Cidranes Ernesto (Madrid, Spain), Delgado-Cidranes Ernesto, Tirado-Conde Gema, Fernandez-Vaquero Miguel Angel, Estrada-Blanco Zuramis
PA2147
N-terminal pro-B-type natriuretic peptide in non-surgical critically ill patents Xubin Huang (Guangzhou, China), Xubin Huang, Jun Zhang, Mian Zeng, Yanzhu Chen
PA2148
Does plasma NGAL help for prediction of acute kidney injury in sepsis patients?: A systematic review and metaanalysis Hye Kyeong Park (goyang-si, Republic of Korea), Hye Kyeong Park, Sollip Kim, Sung-Soon Lee, Hyun-Jung Kim, Hyeong-Sik Ahn, Ji Yang Song, Tae-Hyun Um, Chong-Rae Cho, Hoon Jung, Hyeon-Kyoung Koo, Yun Su Sim, Jae-Uk Song, Joo-Hyun Park
PA2149
Oxidative stress is associated with muscle wasting after aortic surgery Richard Paul (London, United Kingdom), Richard Paul, Mattia Gomarasca, Eleonora D’Angelo, Lisa Barbaro, Gregory Quinlan, Mark Griffiths
PA2150
The "rapid atrial swirl sign" for evaluating central venous catheter tip position is appropriate and time-saving in critical care environments Peter Korsten (Göttingen, Germany), Peter Korsten, Eirini Mavropoulou, Gerhard A. Müller, Daniel Patschan
PA2151
Enoximone as emergency medication for life threatening asthma and suppression of allergic airway inflammation as measured in a house dust mite asthma model Jan Beute (Almere, Netherlands), Jan Beute, Menno Van Nimwegen, Ruud Hendriks, Alex Kleinjan
PA2152
Impact of mechanical ventilation in outcomes of critical care elderly patients: A cohort study Saint Clair Bernardes Neto (Brasilia, Brazil), Saint Clair Gomes Bernardes Neto, Arlley Kennedy Oliveira, Fabio Ferreira Amorim, Graziella França Bernardelli Cipriano, Karla Helena Coelho Vilaca
PA2153
Physician burn-out in Greek intensive care units: A qualitative analysis of associated parameters Afroditi Boutou (Thessaloniki, Greece), Polychronis Voultsos, Maria Koungali, Konstantinos Psaroulis, Afroditi Boutou, Dimitrios Psaroulis
PA2154
Risk of recurrence after surviving severe sepsis: A matched cohort study Hsiu-Nien Shen (Tainan, Taiwan), Hsiu-Nien Shen, Chin-Li Lu, Hsi-Hsing Yang
PA2155
Accuracy of ventilators for intermediate care to deliver tidal volume. A bench study Claude Guérin (Lyon, France), Loredana Baboi, Sarah Guegan, Claude Guérin
Hall 14-02
Session 250
12:50 - 14:40
Thematic Poster: Acute critical care: COPD, muscles and weaning Chairs : Leo M.A. Heunks (Nijmegen, Netherlands), Annalisa Carlucci (San Donato Milanese, Italy), Christian Bruells (Aachen, Germany), Maria Paola Arellano-Maric (La Paz, Bolivia)
144
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2156
LATE-BREAKING ABSTRACT: How patients changed over 15 years: Outcomes and criticality of an Italian respiratory intensive care unit Annia Fleur Schreiber (Turin, Italy), Annia Schreiber, Piero Ceriana, Alberto Malovini, Stefano Nava
PA2157
LATE-BREAKING ABSTRACT: Anti-inflammatory effects of diphenyleneiodonium in lipopolysaccharide-induced acute lung injury in rats Yu Mi Ko (Suwon, Republic of Korea), Yu Mi Ko, Sung-Kyoung Kim, Ki Hoon Park, Hyun Hui Kang, Ju Sang Kim, Sang Haak Lee, So Hyang Song, Jinyoung Yoo, Chi Hong Kim
PA2158
LATE-BREAKING ABSTRACT: Feasibility of low dose anticoagulation protocol during extracorporeal membrane oxygenation SEUNGHYUN LEE (Yangsan, Republic of Korea), Seunghyun Lee, Hye Ju Yeo, Woo Hyun Cho, Yun Seong Kim, Seung Eun Lee, Doosoo Jeon, Seong Hoon Yoon
PA2159
Pulmonary embolism: Diagnosis and mortality in patients with COPD Islam Mejri Ep Ajili (Hammamlif Ben Arous, Tunisia), Takoua Merhabene, Islam Mejri, Amira Jamoussi, Kairallah Belkhouja, Kais Ben Romdhane, Jalila Ben Khlil, Mohamed Besbes
PA2160
Differences in acute response team call triggering with CREWS scoring: A retrospective analysis Mohammad Ahmad (Rochdale, United Kingdom), Mohammad Ahmad, Josephine Mayer, Melanie Pritchard, Jenny Bannon, Hassan Burhan
PA2161
Effect of a ventilation multidisciplinary meeting on respiratory patients’ journey through critical care Abigail Bishopp (Birmingham, United Kingdom), Abigail Bishopp, Natasha Santana-Vaz, Govindan Raghuraman, Biman Chakraborty, Rahul Mukherjee
PA2162
Hydrogen sulphide attenuates lung inflammation caused by resistive breathing Athanasia Pavlidou (Athens, Greece), Athanasia Pavlidou, Constantinos Glynos, Fotis Perlikos, Dimitris Toumpanakis, Zongmin Zhou, Christina Magkou, Andreas Papapetropoulos, Theodoros Vassilakopoulos
PA2163
Analysis of functionality and muscle strength of critical patients and their relation with mechanical ventilation requirement Saint Clair Bernardes Neto (Brasilia, Brazil), Saint Clair Gomes Bernardes Neto, Roberta Fernandes Bomfim, Fernando Beserra de Lim, Fabio Ferreira Amorim, Marcelo De Oliveira Maia, Jose Aires de Araujo Neto
PA2164
Effect of mobilization in critically ill patientes about peripheral muscle strength Shirley Campos (Recife, Brazil), Amina M.S. Lima, Carlos E.S.R. Barros, Adriano F. Vilaça, Raissa F. Correia, Thiago F. Gonçalves, Raquel M.O. Silva, Suellen M. Cardozo, Catarina F.S. Rattes, Helga C.M. Souza, Daniella C. Brandão, Armele F.A. Dornelas, Shirley L. Campos
PA2165
Noninvasive monitoring of carbon dioxide in tracheostomized patients during weaning Friederike Sophie Magnet (Cologne, Germany), Friederike Sophie Magnet, Sarah Schwarz, Wolfram Windisch, Jan Hendrik Storre
PA2166
Influence of weaning methods on the diaphragm after mechanical ventilation Christian Bruells (Aachen, Germany), Christian Brülls, Thomas Breuer, Karen Maes, Christian Bleilevens, Ghislaine Gayan-Ramirez, Gernot Marx, Rolf Rossaint
PA2167
Application of Centers of Disease Control and Prevention (CDC) ventilator associated pneumonia surveillance guidelines to the ’real world’ Aahd Kubbara (Toledo, United States of America), Aahd Kubbara, Abdur Khan, William Barnett, Imad Hariri, Fadi AlReefi, Ahmed Abdelkarim, Shahnaz Rehman, Mohammed Ruzieh, Nawaf Almeshal, Osama Dasa, Nicholas Horen, Faisal Khateeb, Sarah Hensley, Barbara Hahler, Tod Korzec, Mohammed Taleb, Assaly Ragheb, Yusuf Al-Ahwel
PA2168
Does cause of respiratory failure and duration of ventilatory support affect weaning and survival in patients on prolonged mechanical ventilation? Vanessa Yap (Farmington, United States of America), Massa Zantah, Vanessa Yap, Paul Scalise, Debapriya Datta
PA2169
A Comparison of three severity assessment scores: APACHI II SOFA and CURB 65 for predicting inpatient mortality in patients with acute exacerbation of COPD (AECOPD) Saima Akhter (Karachi, Pakistan), Saima Akhter, Usman Ali, Nadeem Rizvi, Quratulain
PA2170
Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations Khaled Wagih (Cairo, Egypt), Adel Saeed, Khaled Wagih, Nasra Huusein
PA2171
Impact of standardized mobilization in mechanically ventilated patients on respiratory muscular strength Shirley Campos (Recife, Brazil), Carlos E.S.R. Barros, Amina M.S. Lima, Adriano F. Vilaça, Raissa F. Correia, Thiago F. Gonçalves, Raquel M.O. Silva, Suellen M. Cardozo, Catarina F.S. Rattes, Helga C.M. Souza, Daniella C. Brandão, Armele F.A. Dornelas, Shirley L. Campos
145
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2172
Outcome and prognostic factors of patients with lung cancer admitted to intensive care unit Yun Su Sim (Seoul, Republic of Korea), Yun Su Sim, Tae Rim Shin, Dong Gyu Kim, Hye Kyeong Park, Jae-Uk Song
Hall 14-03
Session 251
12:50 - 14:40
Thematic Poster: Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Chairs : Lara Pisani (Rome, Italy), Claudia Crimi (Catania, Italy), Antoine Cuvelier (Rouen, France), Antonio M. Esquinas Rodriguez (Murcia, Spain)
PA2173
High-flow nasal cannula heated-humidified (HFNC) oxygen (O2) at 2 litres (lt)/kg/min versus low-flow O2 (up to 2lt/min) in pediatric emergency department (PED) and pediatric ward (PW) in infants with bronchiolitis who need O2 administration: A combined prospective randomized controlled and retrospective study: Preliminary results Kalomoira Kefala (Liège, Belgium), Kalomoira Kefala, Kindja Nyamugabo, Nesrine Farhat, Aurelie Janssen, MarieChristine Seghaye
PA2174
Doppler echocardiographic evaluation of hemodynamic effects of applying bilevel positive airway pressure Gabrielle Vinhal (Uberlândia, Brazil), Gabrielle Vinhal, Bruna Prates, Thulio Cunha, Livia Silva, Lucio Araújo, Daniel Melo, Celia Lopes
PA2175
Effect of NIV on the measurement of ventilatory and metabolic variables Clancy Dennis (Sydney, Australia), C.J. Dennis, C. Menadue, A.R. Harmer, D.J. Barnes, J.A. Alison
PA2176
Noninvasive ventilation after chest wall resection Yordanka Yamakova (Sofia, Bulgaria), Yordanka Yamakova, Rosen Petkov
PA2177
Non-invasive ventilation (NIV) in acute respiratory failure in patients with idiopathic pulmonary fibrosis (IPF) Mohamed Boussarsar (Sousse, Tunisia), Rania Bouneb, Jamila Baroudi, Ahmed Khedher, Jihene Ayachi, Abdelbaki Azouzi, Yamina Hamdouni, Imed Chouchene, Ghada Sboui, Mohamed Boussarsar
PA2178
Non invasive ventilation in acute respiratory failure due to COPD vs non COPD conditions: Effectiveness and failure predictors Jai Kumar Samaria (Varanasi, India), Kumar Utsav, J.K. Samaria
PA2179
Effect of chronic kidney disease on duration of non-invasive ventilation required in acute hypercapnic respiratory failure Abigail Bishopp (Birmingham, United Kingdom), Abigail Bishopp, Nadia Sayeed, Biman Chakraborty, Ben Beauchamp, Amy Oakes, Rahul Mukherjee
PA2180
Factors related with non-invasive ventilation success in chronic obstructive pulmonary disease Fatma Tokgöz Aky l (Istanbul, Turkey), Fatma Tokgöz Akyil, Meltem çoban Agca, Aysun Misirlioglu, Dildar Duman, Tülay Yarkin, Hakan Günen
PA2181
Factors affecting the duration of acute non invasive ventilation required in patients with acute hypercapnic respiratory failure Abigail Bishopp (Birmingham, United Kingdom), Abigail Bishopp, Nadia Sayeed, Biman Chakraborty, Amy Oakes, Ben Beauchamp, Rahul Mukherjee
PA2182
Safety of enteral nutrition in patients with noninvasive ventilation for acute respiratory failure Mariko Kogo (Hyogo prefecture, Japan), Mariko Kogo, Kazuma Nagata, Jiro Ito, Yuki Sato, Shusuke Teraoka, Ryoji Kato, Ryoko Shimizu, Takehiro Otoshi, Daichi Fujimoto, Atsushi Nakagawa, Kojiro Otsuka, Keisuke Tomii
PA2183
Are we using bi-pap correctly? – A retrospective analysis of the use of bi-pap in St.Peter’s Hospital over a 3 month period Hussain Basheer (London, United Kingdom), Hussain Basheer
PA2184
Non-invasive ventilation for treatment of acute and chronic exacerbated respiratory failure: What to expect outside the critical care units? Maria Brandão (Vila Nova de Gaia, Portugal), Maria Esteves Brandão, Joelma Silva, Ricardo Reis, Artur Vale, Bebiana Conde, Abel Afonso
PA2185
Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV Ashok Kumar (Karachi, Pakistan), Ashok Kumar, Ravi Mahat, Nida Hussain, Nadeem Rizvi
PA2186
Outcomes of non-invasive ventilation use in intensive care unit: Results from a five years cohort Saint Clair Bernardes Neto (Brasilia, Brazil), Saint-Clair Gomes Bernardes Neto, Roberta Fernandes Bomfim, Fernando Beserra de Lima, Fabio Ferreira Amorim, Marcelo De Oliveira Maia, Jose Aires de Araujo Neto
146
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2187
Non-invasive vs invasive mechanical ventilation for the management of COPD exacerbation with acute type-2 respiratory failure Md.Mamunur Rashid (Dhaka, Bangladesh), Md. Mamunur Rashid, Asfia Nigar, Md. Rashidul Hassan
PA2188
Evaluation of some predictors for successful weaning from mechanical ventilation Ahmed Alasdoudy (Menouf, Almenoufia, Egypt), Ali Mabrouk, Osama Mansour, Aml Amin, Mahmoud Alhabashy, Ahmed Alasdoudy
PA2189
May the obesity cause a better prognosis for domiciliary NIV prescribed COPD patients? Hilal Alt nöz (Istanbul, Turkey), Hilal Altinoz, Nalan Adiguzel, Cuneyt Salturk, Gokay Gungor, Ozlem Mocin, Huriye Takir, Feyza Kargin, Merih Balci, Zuhal Karakurt
PA2190
A novel collaborative approach in improving management outcomes in patients with motor neurone disease (MND) Helen Umpleby (Tonbridge, United Kingdom), Helen Umpleby, David Oliver, Sandip Banerjee, Lisa Vincent-Smith
PA2191
Improving the efficiency and patient experience using Telemodems for set-up of domiciliary non-invasive ventilation in a district general hospital Nadia Gildeh (Staplehurst, United Kingdom), Nadia Gildeh, Jane Kindred, Sandip Banerjee
PA2192
Compliance to non-invasive continuous positive airway pressure ventilation in children with obstructive sleep apnoea Arun kumar Pugalenthi (Brisbane, Australia), Arun Kumar Pugalenthi, Biju Thomas, Petrina Wong, Anne Goh, Oh Moh Chay, Soh Gin Tan, Mei Lan Lim, Qiao Ling Tan, Teoh Oon Hoe
Hall 14-04
Session 252
12:50 - 14:40
Thematic Poster: Transbronchial and percutaneous approach to peripheral pulmonary lesions Chairs : Mohammed Munavvar (Preston, United Kingdom), Jean-Michel Vergnon (Saint-Etienne, France), Luis Miguel Seijo Maceiras (Madrid, Spain), Chair to be confirmed PA2193
Diagnostic yield of transbronchial criobiopsia in transplant patients and patients with suspected ILD MARGARITA HERRERA MARRERO (Mataró, Spain), Margarita Herrera, Leonor Luque, Mario Culebras, Antonio Alvarez, Alexa Nuñez, Javier De Gracia
PA2194
Complications of transbronchial cryobiopsy in insterticial lung diseases Vanessa LOPEZ RODRIGUEZ (Pamplona (Navarra), Spain), Vanessa López, Xenia López, Sonia Herrero, Jose Cascante, Ana Echegoyen, Jose Elizalde, Javier Hueto
PA2195
Comparative study of confocal laser endomicroscopy using two probes sizes in solitary pulmonary nodules Tidi Hassan (Dublin, Ireland), Tidi Hassan, Christophe Hermant, Mathieu Salaun, Nicolas Piton, Luc Thiberville
PA2196
Complications with endobronchial ultrasound with a guide sheath for peripheral pulmonary lesions Manabu Hayama (Tokyo, Japan), Manabu Hayama, Takehiro Izumo, Yuji Matsumoto, Takaaki Tsuchida, Shinji Sasada, Norio Okamoto
PA2197
Electromagnetic navigation bronchoscopy in the management of peripheral lesions in patients contraindication for transthoracic needle biopsy Noémie Bruel Tronchon (Chevrières, France), Noémie Bruel Tronchon, Michèle Cottier, Marios Froudarakis, Jean Michel Vergnon
PA2198
Factors affecting the transbronchial biopsy for peripheral pulmonary lesions with radial endobronchial ultrasound Yuji Matsumoto (Tokyo, Japan), Yuji Matsumoto, Takehiro Izumo, Takaaki Tsuchida, Shinji Sasada
PA2199
Sonographic characteristics upon endobronchial ultrasonography with a guide sheath (EBUS-GS) are useful for diagnosing pulmonary peripheral lesions Atsushi Kitamura (Tokyo, Japan), Atsushi Kitamura, Hiroshi Nakaoka, Kouhei Okafuji, Yutaka Tomishima, Torahiko Jinta, Naoki Nishimura, Tomohide Tamura, Naohiko Chohnabayashi
PA2200
Utility of virtual bronchoscopic navigation for peripheral pulmonary lesions Kohei Okafuji (Tokyo, Japan), Kohei Okafuji, Atsushi Kitamura, Hiroshi Nakaoka, Ryosuke Tsugitomi, Tomoyuki Tanigawa, Yutaka Tomishima, Torahiko Jinta, Naoki Nishimura, Tomohide Tamura, Naohiko Chonabayashi
PA2201
Diagnostic value of ultrasound guided transthoracic core needle biopsy in mediastinal lesions Rosen Petkov (Sofia, Bulgaria), Rosen Petkov, Tzvetan Minchev, Yordanka Yamakova, Danail Petrov, Emilia Petkova
PA2202
CT-guided percutaneous drainage of lung abscesses: Review of 80 cases. Single center experience Adamadia Liapikou (Athens, Greece), Petros Filippousis, Nektaria Sidiropoulou, Kyriaki Tavernaraki, Adamantia Liapikou, Styliani Arapostathi, Paraskeyi Galani, Loukas Thanos
PA2203
A novel technique for CT-guided transthoracic biopsy of lung lesions with improved accuracy and safety Matthew Koslow (Tel Aviv, Israel), Matthew Koslow, Danny Yaffe, Hassan Haskiya, David Shitrit
147
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2204
Percutaneous ultrasound-guided punctures and biopsies in the diagnosis of peripheral thoracic lesions for pulmonologists Alberto García (Valencia, Spain), Alberto García-Ortega, Andrés Briones, Miguel ángel Martínez, Raquel Martínez-Tomás, Enrique Cases, Sandra Fabregat
PA2205
Ultrasound guided transthoracic biopsy performed by respiratory physicians: Diagnostic yield and complications Christian Laursen (Odense C, Denmark), Christian B. Laursen, Jesper Rømhild Davidsen, Ole Graumann, Niels Christian Hansen
Hall 14-05
Session 253
12:50 - 14:40
Thematic Poster: Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Chairs : Roberto Rabinovich (Edinburgh, United Kingdom), Vasileios Andrianopoulos (Horn, Netherlands), Anja Frei (Zurich, Switzerland), Guido Vagheggini (Volterra, Pisa, Italy) PA2206
The effect of respiratory physiotherapy applied after thorcic surgery on respiratory muscle strength Orçin Telli Atalay (Denizli, Turkey), Orçin Telli Atalay, Harun Taskin, Gökhan Yuncu
PA2207
The relationship between proximal limb and trunk muscle strength and respiratory parameters in chronic obstructive pulmonary disease (COPD) Elvan Keles (Izmir, Turkey), Elvan Keles, Sevgi Ozalevli, Aylin Ozgen Alpaydin
PA2208
The acute and chronic effects of dietry nitrate on exercise tolerance in COPD patients Conor Kerley (Dublin, Ireland), Conor Kerley, Aisling McGown, John Faul, Liam Cormican
PA2209
Determinants of cardio-pulmonary exercise test (CPET) and shuttle walking test (SWT) in COPD patients are different M. L. E. Bartoli (Pisa, Italy), Francesco Costa, Dario Nieri, Maria Laura Bartoli, Sandra Antonelli, Gianna Decusatis, Claudia De Simone, Laura Malagrinò, Sabrina Santerini, Barbara Vagaggini, Pierluigi Paggiaro
PA2210
Effect of pulmonary rehabilitation (PR) on inflammation status in patients with COPD Francesco Gigliotti (Firenze, Italy), Francesco Gigliotti, Claudia Coli, Letizia Lombardelli, Isabella Romagnoli, Federica Logiodice, Barbara Lanini, Ornela Kullolli, Barbara Binazzi, Paola Parronchi, Enrico Maggi, Marie-Pierre Piccinni
PA2211
Aerobic exercise reduces asthma phenotype through inhibition of SOCS-JAK-STAT signaling in airway epithelium Ana Oliveira (São Paulo, Brazil), Ana Roberta Almeida-Oliveira, Jefferson C.J. Aquino-Junior, Manoel C. Oliveira-Junior, Adilson S. Andrade-Sousa, Erasmo A. Neto, Auriléia Aparecida-Brito, Nicole C. Rigonato-Oliveira, Gabriel De Moraes, Ana Paula L. De Oliveira, Rodolfo P. Vieira
PA2212
Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD) Laura Caram (Conchas, São Paulo, Brazil), Laura Caram, Renata Ferrari, Ludimila Nogueira, André Bertani, Thaís Garcia, Carolina Bonfanti, Caroline Knaut, Regina Moretto, Suzana Tanni, Camila Corrêa, Irma Godoy
PA2213
Short and long term effects of a physical activity programa in COPD patients María HernÁndez (Pamplona, Spain), María Hernández, Fabrício Zambom-Ferraresi, María Milagros Antón, Javier Hueto, Jose Cascante, Mikel López, Pilar Cebollero
PA2214
Segmental bioelectrical impedance analysis of lower limb muscle mass in patients with COPD Deniz Dilaver (Romford, United Kingdom), Deniz Dilaver, Jane L. Canavan, Djeya P. Kaliaraju, Claire M. Nolan, Sarah E. Jones, Samantha S.C. Kon, William D.C. Man
PA2215
Effects of pulmonary rehabilitation in COPD patients treated with different pharmacological associations Vittoria Conti (Rome, Italy), Vittoria Conti, Eirini Lemontzi, Aliaksei Kisialiou, Stefano Bonassi, Gregorino Paone, Maurizio Volterrani, Giuseppe Caminiti, Vittorio Cardaci
PA2216
Outcomes of pulmonary rehabilitation for COPD in the elderly: A comparative study Abirami Subramaniam (Dublin, Ireland), Abirami Subramaniam, Padraic McCarthy, Mohamed Elshafi, Bernadette Bowen, Michael Henry
PA2217
Outcomes of pulmonary rehabilitation in hypercapnic COPD patients Ilknur Naz (Izmir, Turkey), Hulya Sahin, Ilknur Naz, Sevcan Guney, Nimet Aksel, Fevziye Tuksavul
PA2218
COPD assessment for symptoms and functional condition in pulmonary rehabilitation János Tamás Varga (Budapest, Hungary), Maria Kerti, Zsuzsanna Balogh, Adrien Halasz, Krisztina Kelemen, Janos Varga
PA2219
Pulmonary rehabilitation in COPD and other chronic lung diseases pek Ozmen (Istanbul, Turkey), Ipek Ozmen, Elif Yildirim, Murat öztürk, özgür Yilmaz, Burhan Yilmaz, Nur Ucgun, Nurgul Yer
148
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2220
Minimal pulmonary rehabilitation program in subjects with COPD Andrzej Obojski (Wroclaw, Poland), Andrzej Obojski, Gabriela Staron, Marcin Zieziula, Robert Pawlowicz
PA2221
Effects of respiratory and callisthenic exercise training on exercise capacity and cuality of life in geriatrics Neslihan Durutürk (Ankara, Turkey), Neslihan Duruturk, Manolya Acar
PA2222
Impact of body mass index (BMI) on outcomes of a specific pulmonary rehabilitation programme (PRP) for chronic obstructive pulmonary disease (COPD) Virginia ALMADANA PACHECO (Sevilla, Spain), Virginia Almadana Pacheco, Natalia Fouz Rosón, Ana Miriam Muñiz Rodríguez, Cristina Benito Bernáldez, Agustín Valido Morales, Teodoro Montemayor Rubio
PA2223
Evaluation of a novel pulmonary rehabilitation programme in Newport, South Wales Patrick Flood-Page (Cardiff, United Kingdom), Patrick Flood-Page, Sam Jones, Linda Naude
PA2224
Determinants of oxyhaemoglobin desaturation and dyspnoea during 6 min walking test in obese and lean COPD patients Roberto Torchio (Venaria Reale, Italy), Claudio Ciacco, Marco Guglielmo, Elena Rindone, Fiorella Pacetti, Mattia Chiesa, Roberto Torchio
PA2225
Are shuttle walk tests on a treadmill and in a corridor with patients with COPD interchangeable? Patricia Lira (Mogi das Cruzes, Brazil), Patricia Lira, Aline Meneses, Mariana Reimberg, Jacqueline Boldorini, Anderson Camargo, Rejane Castro, Simone Corso, Fernanda Lanza
Hall 14-06
Session 254
12:50 - 14:40
Thematic Poster: Clinical exercise physiology in health and disease Chairs : Jose Alberto Neder Serafini (Kingston, Canada), Samuel Verges (Grenoble, France), Paolo Onorati (Alghero, Italy), Gilles Garcia (Le Kremlin Bicètre, France) PA2226
Differences in parasympathetic activity of asthmatic athletes, healthy athletes and non-athlete controls Julie Stang (Oslo, Norway), Julie Stang, Trine Stensrud, Kai-Håkon Carlsen
PA2227
Respiratory muscle endurance after resiratory muscle training in athletes and non-athletes: A systematic review and meta-analysis Lucien Peroni Gualdi (Natal, Brazil), Lucien Peroni Gualdi, Ana Tereza Sales, Guilherme Fregonezi, Andrew Ramsook, Jordan Guenette, Illia Lima, Darlene Reid
PA2228
Qualitative aspects of exertional dyspnea in ILD patients before and after oxygen supplementation Josuel Ora (Rome, Italy), Josuel Ora, Angelo Coppola, Annapina Barrile, Annamaria Salvati, Mario Cazzola, Paola Rogliani
PA2229
Comparative evaluation on the synergism of roflumilast (RFL) and glycopyrronium (Gly) vs ciclesonide (CLS) and Gly on lung volumes and exercise tolerance in severe COPD Josuel Ora (Rome, Italy), Josuel Ora, Roberto Lipsi, Gabriella Lucà, Chiara Ciaprini, Paola Rogliani, Mario Cazzola
PA2230
Effects of 12-week exercise training-related rehabilitation on exertional dyspnoea in patients with idiopathic pulmonary arterial hypertension Pierantonio Laveneziana (Paris, France), Pierantonio Laveneziana, Bruno Degano, Kim Boutet, Xavier Jaïs, Gérald Simonneau, Marc Humbert, Olivier Sitbon, Gilles Garcia
PA2231
Pulmonary function and oxygen uptake in elderly Erlend Hassel (Trondheim, Norway), Erlend Hassel, Dorthe Stensvold, Thomas Halvorsen, Ulrik Wisløff, Arnulf Langhammer, Sigurd Steinshamn
PA2232
Pharmacokinetics of inhaled terbutaline in relation to doping analysis: Impact of exercise and heat Michael Kreiberg (Copenhagen, Denmark), Michael Kreiberg, Vibeke Backer, Victoria Becker, Sebastian Rzeppa, Peter Hemmersbach, Morten Hostrup
PA2233
The value of cardiopulmonary exercise testing in sarcoidosis Evaggelia Fouka (Thessaloniki, Greece), Evaggelia Fouka, Paul Zarogoulidis, Ioannis Kioumis, Georgia Pitsiou, Konstantinos Zarogoulidis, Anastasios Kallianos, Aggeliki Rapti, Georgia Trakada
PA2234
Physiological mechanisms of increased activity-related dyspnea in obesity Dennis Jensen (Montreal, Canada), Kevin Pham, Michele Schaeffer, Ryan Reid, Sara Abdallah, Ross Andersen, Dennis Jensen
PA2235
Right ventricular response during exercise in patients with chronic obstructive pulmonary disease DIEGO AGUSTIN RODRIGUEZ (Barcelona, Spain), Diego A. Rodríguez, Anna Rodo-Pin, Anna Herranz, Antonio Sancho-Muñoz, Joaquim Gea, Jordi Bruguera, Lluis Molina
149
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2236
Climbers usually resident at moderate altitude exhibit less oygen desaturation during rapid ascent to 4559 m Eva Bernardi (Vazzola, Italy), Eva Bernardi, Luca Pomidori, Gaia Mandolesi, Manuela Bartesaghi, Davide Cavallari, Annalisa Cogo
PA2237
Ventilatory analysis during 6MWT gives relevant information about exercise limitation in COPD Eva Bernardi (Vazzola, Italy), Eva Bernardi, Benedetta Stiz, Sergio Angelini, Marco Contoli, Annalisa Cogo
PA2238
6-minute walk distance in young healthy north-African adults aged 16 to 40 years Helmi Ben Saad (Sousse, Tunisia), Mohamed-Kheireddine Bourahli, Mohamed Bougrida, Mehdi Martani, Hacene Mehdioui, Helmi Ben Saad
PA2239
The six minute walk test comparison to a stair climb test Shahzad Ahmad (Mclean, United States of America), Shahzad Ahmad, Anne Whitney Brown, Christopher King, Oksana Shlobin, Nargues Weir, Sydney Stayrook, Steven Nathan
PA2240
Quadriceps muscle contractility and fatigability in cystic fibrosis (CF) patients Samuel Verges (Grenoble, France), Samuel Verges, Mathieu Gruet, Nicolas Decorte, Laurent Mely, Jean-Marc Vallier, Boubou Camara, Sébastien Quetant, Bernard Wuyam
PA2241
Effect of apelin on cardiopulmonary performance during endurance exercise Svyatoslav Kechyn (Margate, United Kingdom), Svyatoslav Kechyn, Gareth Barnes, Akaphot Thongmee, Luke Sebastian Howard
PA2242
Skeletal muscle metabolism in active cystic fibrosis (CF) patients with light/moderate pulmonary dysfunction Samuel Verges (Grenoble, France), Samuel Verges, Nicolas Decorte, Mathieu Gruet, Boubou Camara, Sébastien Quetant, Laurent Mely, Jean-Marc Vallier, Bernard Wuyam
PA2243
Changes in quadriceps mass and function following neuromuscular electrical stimulation (NMES) in COPD: A comparison of responsiveness to training using different measurement modalities Bhavesh Popat (Leicester, United Kingdom), Bhavesh Popat, Lorna Latimer, Michael Steiner, Neil Greening
PA2244
Asthma symptoms, direct and indirect challenge tests in adolescent elite swimmers Kerstin Romberg (Falsterbo, Sweden), Kerstin Romberg, Ellen Tufvesson, Leif Bjermer
Hall 14-07
Session 255
12:50 - 14:40
Thematic Poster: Respiratory muscles and airways function: from physiology to clinical implications Chairs : Antonella Lo Mauro (Milan, Italy), Esther Barreiro Portela (Barcelona, Spain), Eric Derom (Gent, Belgium), Raffaele Dellaca (Milan, Italy)
PA2245
LATE-BREAKING ABSTRACT: Within-breath analysis of respiratory mechanics before and after mannitol challenge Dorottya Czovek (Brisbane, Australia), Dorottya Czovek, Graham Hall, Elisha White, Elysia Hollams, Alan James, Nicholas De Klerk, Patrick Holt, Peter Sly, Zoltan Hantos
PA2246
LATE-BREAKING ABSTRACT: Lung function and the alcohol breath test Susana Cláudia Teixeira de Sousa Varela (Alcochete, Portugal), Susana Sousa, Mafalda Silva, Susana Santos, Claudia Caramujo, Braço-Forte Cristina, Ivone Fernandes, Paula Duarte
PA2247
LATE-BREAKING ABSTRACT: Lung function in survivors of ARDS during the 2009 influenza A H1N1 pandemic: A one year cohort study Rosaura Esperanza Benítez Pérez (México, Mexico), Rosaura Esperanza Benítez Pérez, Julia Sánchez Hernández, Luis Torre Bouscoulet, Laura Gochicoa-Rangel, Mayra Mejía Zarate, Miguelina Jaquez
PA2248
Respiratory muscle strength evaluation in adults with asthma through maximal respiratory pressures measurements Flavia Salame (Manaus, Brazil), Flavia Matos Salame, Maria Angela Fontoura Moreira, Luciana Tesser
PA2249
The effect of normobaric hypoxia on respiratory muscle oxygenation during incremental inspiratory threshold loading (ITL) in healthy adults Nada Basoudan (Vancouver, Canada), Nada Basoudan, Darlene Reid, Jeremy Road, Babak Shadgan, Jordan Guenette
PA2250
Effects of inspiratory muscle training on leg blood flow and exercise tolerance in COPD Danilo Cortozi Berton (Porto Alegre, Brazil), Danilo C. Berton, Marina Castro, Luiz Felipe Fröhlich, Mariah Castilho, Rui Dorneles, Gaspar Chiappa, Marli Knorst, J. Alberto Neder
PA2251
Respiratory work and its components during exercise in interstitial lung disease, COPD and controls Jeferson George Ferreira (São Paulo, Brazil), Jeferson George Ferreira, Letícia Zumpano Cardenas, Marcelo Macchione, Pauliane Santana, Renan Maloni, Mayra Caleffi Pereira, Carlos Roberto R. Carvalho, Pedro Caruso, André Albuquerque
150
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2252
The weakness of the respiratory muscles in the genesis of dyspnea on marfanoid phenotype Maria Vershinina (Omsk, Russian Federation), Maria Vershinina
PA2253
Thoracoabdominal asynchrony decreases chest wall volume and affects respiratory kinematics in COPD Desiderio Cano Porras (Sao Paulo, Brazil), Desiderio C. Porras, Cibele C.B. Marques da Silva, Adriana C. Lunardi, Denise M. Paisani, Rafael Stelmach, Alberto Cukier, Henrique T. Moriya, Celso R.F. Carvalho
PA2254
Respiratory muscle strength, hypoxemia and dyspnea in liver cirrhosis patients Maha Yousif (Minufiya Gavornorate, Egypt), Sameh Ahmed Abdel-bary, Maha Yousif, Hani Ali Hussein
PA2255
Chest wall volumes during constant compared to incremental cycle ergometer tests in chronic obstructive pulmonary disease (COPD) patients: A systematic review and meta-analysis Illia Lima (Natal, Brazil), Illia Lima, Guilherme Fregonezi, Nada Basoudan, Ana Tereza Sales, Darlene Reid
PA2256
Simulation of airway calibre and inflammation interaction by a new model of airway epithelium Cyril Karamaoun (Ixelles, Brussels, Belgium), Cyril Karamaoun, Benoît Haut, Alain Van Muylem
PA2257
Effects of ceramide pathway inhibition on the inflammatory response in lipopolysacharide-triggered lung injury Renata Tiemi Okuro (rio de janeiro, Brazil), Renata Tiemi Okuro, Natália Vasconcelos Casquilho, Mariana Nascimento Machado, Georgia Correa Atella, Samuel Santos Valença, Walter Araújo Zin
PA2258
Characterization of ceramide generation kinetics in a lung injury model induced by lipopolysaccharide Renata Tiemi Okuro (rio de janeiro, Brazil), Renata Tiemi Okuro, Natália Vasconcelos Casquilho, Mariana Nascimento Machado, Taíná Correa Atella, Georgia Correa Atella, Samuel Santos Valença, Walter Araújo Zin
PA2259
The application of infrared thermal imaging in detecting lower extremity deep venous thrombosis FANGGE DENG (Guangzhou, China), Fangge Deng, Qing Tang, Xiufang Deng, Nuofu Zhang, Hua Wu, Nanshan Zhong
PA2260
Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects Nanna Krogh (Copenhagen, Denmark), Nanna Krogh, Vibeke Backer, Sebastian Rzeppa, Peter Hemmersbach, Morten Hostrup
PA2261
Clinical-functional features of osmotic airway hyperresponsiveness in patients with asthma Evgenia Y. Afanaseva (Blagoveshchensk, Amur Oblast, Russian Federation), Evgeniya Y. Afanaseva, Juliy M. Perelman, Anna G. Prikhodko, Leonid G. Nakhamchen, Victor P. Kolosov, Svetlana V. Naryshkina
PA2262
P-wave duration and dispersion during intrathoracic pressure swings Annette Marie Wons (Zurich, Switzerland), Annette Marie Wons, Thomas Gaisl, Valentina Rossi, Christian Schlatzer, Giovanni Camen, Malcolm Kohler
PA2263
Atrial premature beats during the Mueller manoeuvre are a predictor for arrhythmias Thomas Gaisl (Zurich, Switzerland), Thomas Gaisl, Annette Wons, Daniel Bratton, Christian Schlatzer, Esther Schwarz, Noriane Sievi, Christian Clarenbach, Laurent Haegeli, Firat Duru, Malcolm Kohler
Hall 14-08
Session 256
12:50 - 14:40
Thematic Poster: Lung function: new findings and approaches Chairs : Andre Albuquerque (Sao Paulo, Brazil), Bruno Degano (Besançon, France), Caterina Salito (Milan, Italy) PA2264
LATE-BREAKING ABSTRACT: Oxytocin receptor expression but a lack of response to oxytocin in airway tissues Jibriil Ibrahim (Melbourne, Australia), Jibriil Ibrahim, Michelle McIntosh, Robert Bischof
PA2265
LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Anders Christiansen (Middelfart, Denmark), Anders Christiansen, Ingrid L. Titlestad, Jørgen Vestbo
PA2266
Association between sputum cytology and lung function in patients with asthma and COPD Subhabrata Moitra (Krishnagar, Nadia, India), Subhabrata Moitra, Kanchan Pyasi, Vandana Vincent, Rahul Kodgule, Sundeep Salvi
PA2267
Temporal changes in lung function following haemodilution under stable haemodynamic conditions in pigs Gergely Albu (Geneva, Switzerland), Gergely Albu, Cédric Sottas, Magali Walesa, Ferenc Peták, Walid Habre, Mirko Dolci
PA2268
Resting ventilation in patients with asthma compared to healthy controls Marta Gudjonsdottir (Mosfellsbaer, Iceland), Marta Gudjonsdottir, Monique Van Oosten
PA2269
Quantitative chest CT measurements in World Trade Center workers and volunteers Rafael E. de la Hoz (New York, United States of America), Rafael E. De la Hoz, John Doucette, Raúl San José Estepar, Claudia I. Henschke, David F. Yankelevitz, Avi Albeg
151
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2270
Non-contact assessment of acute bronchodilator’ response during tidal breathing in COPD patients using structured light plethysmography (SLP) Pierantonio Laveneziana (Paris, France), Pierantonio Laveneziana, Claudia Llontop, Marie-Cecile Nierat, Agnès Bellocq, Christian Straus, Thomas Similowski
PA2271
Changes in FEV1 after recovery from COPD exacerbation are driven by heterogeneous regional changes in airway caliber and hyperinflation Wim Vos (Heist-op-den-Berg, Belgium), Wim Vos, Cedric Van Holsbeke, Wouter Van Geffen, Huib Kerstjens, Massimo Pistolesi, Omar Usmani, Bita Hajian, Antony Cahn, Jan De Backer, Wilfried De Backer
PA2272
Effects of Ramadan intermittent fasting (RIF) on spirometry in healthy young adults Helmi Ben Saad (Sousse, Tunisia), Imed Latiri, Siwar Sandid, Mohamed Amine Fennani, Souad Amimi, Sonia Rouatbi, Chiraz Maatoug, Makrem Zammit-Chatti, Karim Chamari, Helmi Ben Saad
PA2273
More relaxation by deep inhalation of methacholine than exercise-pretoned airways of asthmatic children Iulia Ioan (Vandoeuvre-les-Nancy, France), Iulia Ioan, Mickael Lescroart, Laurianne Coutier, Claude Bonabel, François Marchal, Cyril Schweitzer, Silvia Varechova
PA2274
Forcede expiratory volume in six second in the spirometric diagnosis of COPD leifu jiang (nanjing, China), Leifu Jiang, Kaisheng Yin, Ping Yan
PA2275
Bronchodilation test estimation using spirometry and electrical impedance analysis in bronchial asthma and COPD patients Vitaly Mishlanov (Perm, Russian Federation), Vitaliy Mishlanov, Tatyana Ustyantzeva, Vladimir Nedugov, Oleg Kalinin, Anastasya Katkova
PA2276
Within-breath resistance and reactance and short-term repeatability in two forced oscillation technique devices Sabine Zimmermann (Glebe, Australia), Sabine Zimmermann, Joanna Lyon, Amy Bertolin, Kanika Jetmalani, Gregory King, Cindy Thamrin
PA2277
Oscillometry changes with body position and correlates with TLC and lung density Ronald Dandurand (Beaconsfield, Canada), Ronald J. Dandurand, Myriam Dandurand, Rafel Bordas, Raúl San José Estépar, Jean Bourbeau, David H. Eidelman
PA2278
Acute effects of air stacking maneuver on chest wall volumes and peak cough flow in healthy subjects Antonio Sarmento (Sousa, Brazil), Antonio Sarmento, Vanessa Resqueti, Illia Lima, Lucien Peroni Gualdi, Guilherme Fregonezi, Andrea Aliverti, Dornelas de Andrade Armele
PA2279
Maximum voluntary ventilation in a Mexican population living at 2240 m above sea level Silvia Cid Juarez (Vera Cruz, Mexico), Silvia Cid Juárez, Luis Torre Bouscolet, Laura Graciela Gochicoa Rangel, Rogelio Pérez Padilla
PA2280
FEV3/FVC ratio in early detection of airway obstruction Cláudia Sofia Vaz Guerreiro (Faro, Portugal), Cláudia Guerreiro, Patrícia Dionísio, Inês Ribeiro, Susana Moreira, João Valença, Dina Escaleira, Cristina Bárbara
PA2281
The effect of duration and number of measurements on respiratory resistance and reactance in airways disease Claude Farah (Five Dock, Australia), Joanna Lyons, Claude Farah, Leigh Seccombe, Gregory King, Cindy Thamrin
PA2282
Effect of Buteyko breathing retraining method on resting ventilation and asthma control in asthma patients Marta Gudjonsdottir (Mosfellsbaer, Iceland), Marta Gudjonsdottir, Monique Van Oosten
PA2283
Characteristics of COPD tidal breathing patterns measured by structured light plethysmography (SLP): An age, gender, BMI matched study Richard W. Iles (Cambridge, United Kingdom), Richard Iles, Shayan Motamedi-Fakhr, Amna Khalid, Rachel Wilson
Hall 14-09
Session 257
12:50 - 14:40
Thematic Poster: Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception Chairs : Matteo Bonini (Roma, RM, Italy), Stefan Matecki (Montpellier, France), Nickolas Koulouris (Athens, Greece), Bruno-Pierre Dube (Montreal, Canada) PA2284
Asthma symptoms, mannitol reactivity and exercise-induced bronchoconstriction in young athletes Kerstin Romberg (Falsterbo, Sweden), Kerstin Romberg, Ellen Tufvesson, Leif Bjermer
PA2285
Mucociliary clearance (MCC) in the trachea in mild-moderate COPD occurs in spirals David Abelson (Mosman, Australia), David Abelson, Clayton Frater, Alice Cottee, Mark Pearson, Lucy Morgan
152
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2286
Lung clearance index (LCI) based on four different alveolar N2 estimates in a large reference population aged 6-86 years Maria Strom (Skövde, Sweden), Maria Strom, Birgitta Houltz, Paul D. Robinson, Anders Lindblad, Kent Green, Kim G. Nielsen, Florian Singer, Per Gustafsson
PA2287
Increase in oxygen uptake to work rate increment ( VO2/ WR) during cardiopulmonary exercise testing: Correlation to COPD severity indicators, including BODE index MAHSA MIRDAMADI (TEHRAN, Islamic Republic of Iran), Besharat Rahimi, Mahsa Mirdamadi, Enayat Safavi, Hamidreza Abtahi, Soheil Peiman
PA2288
Comparison of CF and non CF FRC and LCI values measured with Exhalyzer D and InnocorTM devices Katie Bayfield (London, United Kingdom), Katie Bayfield, Clare Saunders, Eric Alton, Jane Davies
PA2289
Allergies and exercise-induced bronchoconstriction in young soccer players: A screening strategy Valerie Bougault (Ronchin, France), Valerie Bougault, François Drouard, Grégory Dupont, Franck Legall, Benoit Wallaert
PA2290
Cardiorespiratory responses during the 6-minute walk and stepper tests in patients with interstitial lung disease Baptiste CHEHERE (Lille, France), Baptiste Chehere, Valérie Bougault, Alice Gicquello, Benoit Wallaert
PA2291
Cardiorespiratory limitation of the pectus excavatum (PE) and functional changes after surgical correction Ana GOMEZ-BASTERO FERNANDEZ (Sevilla, Spain), Ana Gomez-Bastero, Mario Boyd, Virginia Almadana, Fernando Cozar, Teodoro Montemayor
PA2292
Relationship of pulmonary arterial pressure at high altitude with oxygen saturation and exercise test Akpay Sarybaev (Bishkek, Kyrgyzstan), Almaz Akunov, Abdirashit Maripov, Akpay Sarybaev
PA2293
Normal age-dependant changes in peripheral airway function in the elderly Christopher Htun (St Leonards, Australia), Christopher Htun, Samir Lahzami, Darren Luo, Robin Schoeffel, Gregory King
PA2294
Oxygenation state of the calf muscle during the 6-min walk test in patients with COPD Tomoko Kutsuzawa (Isehara Kanagawa, Japan), Tomoko Kutsuzawa, Daisaku Kurita, Mayumi Ikeuchi
PA2295
Normoxic and hypoxic breathing in unilateral and bilateral model of Parkinson’s disease Kryspin Andrzejewski (Warszawa, Poland), Kryspin Andrzejewski, Krystyna Budzinska, Katarzyna Kaczynska
PA2296
Hypoxic challenge testing in motor neurone disease Emma Crawford (Shropshire, United Kingdom), Emma Crawford, Helen Stone, Ian Cliff, Karen Morrison, Hardev Pall, Naveed Mustfa
PA2297
Analysis of autonomic modulation after an acute session of aerobic exercise at different intensities in patients with moderate and severe COPD Marceli Rocha Leite (Presidente Prudente, Brazil), Marceli Rocha Leite, Ercy Mara Cipulo Ramos, Giovana Navarro Bertolini, Iara Buriola Trevisan, Ana Paula Coelho Figueira Freire, Bruna Spolador de Alencar Silva, Juliana Souza Uzeloto, Giovana Altero Arevalo, Gabriel Faustino Santa Brigida, Renata Marques David, Fabiano Francisco de Lima, Dionei Ramos
PA2298
Impact of xylomethazoline-mediated airway vasoconstriction on exhaled breath tempearture measured by a novel method: A pilot study Peter Dimov (Plovdiv, Bulgaria), Peter Dimov, Zdravko Taralov, Kiril Terziyski, Blagoi Marinov, Stefan Kostianev
PA2299
Cardiopulmonary exercise test as an evaluation tool of respiratory symptoms Pedro Ulisses Cardoso de Brito (Coimbra, Portugal), Pedro Ulisses Brito, Pedro Ramalho, Lígia Fernandes, Joaquim Moita, Cidalia Rodrigues
PA2300
Peak oxygen uptake and breathing pattern in COPD patients – A four year longitudinal study Bente Frisk (Sandsli, Norway), Bente Frisk, Jon A. Hardie, Birgitte Espehaug, Liv I. Strand, Rolf Moe-Nilssen, Tomas M.L. Eagan, Per S. Bakke, Einar Thorsen
PA2301
Small airways in in sedentary and endurance-trained dystrophic (mdx) mice Maria Bonsignore (Palermo, Italy), Francesca Rappa, Maria Bonsignore, Monica Frinchi, Giuseppa Mudò, Natale Belluardo, Francesco Cappello, Giuseppe Morici
PA2302
Utilisation of cardio-pulmonary exercise testing (CPET) to investigate dyspnoea in a respiratory clinic Edward Parkes (Birmingham, United Kingdom), Edward Parkes, Abigail Bishopp, Vicky Moore, Rahul Mukherjee
Hall 14-10
Session 258
12:50 - 14:40
Thematic Poster: Multidimensional analysis of respiratory problems Chairs : Hanneke A.C. Van Helvoort (Nijmegen, Netherlands), Maurice Hayot (Montpellier, France), Capucine Morelot Panzini (Paris, France), Francesca Polverino (Brookline, United States of America)
153
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2303
LATE-BREAKING ABSTRACT: Maximum oxygen uptake (maxVO2) during a 6-minute step test (6-MST) in healthy people: Validation of a low cost exercise test George Chrisoherakis (Gerakas, Greece), Georgios Chrisoherakis, Ilias Karabinos, Nikolaos Papanikolaou, Charalambos Papagoras, Panagiota Kostaki, Anastasios Papadopoulos, Emmanouil Zachariadis
PA2304
LATE-BREAKING ABSTRACT: The value of near infrared spectroscopy in the investigation of peripheral muscle oxygen availability in pulmonary arterial hypertension Marios Panagiotou (Athens, Greece), Marios Panagiotou, Ioannis Vogiatzis, Zafeiris Louvaris, Julien S. Baker, Andrew J. Peacock, Martin K. Johnson
PA2305
LATE-BREAKING ABSTRACT: Functional and clinical correlations of daily physical activity in patients with pulmonary arterial hypertension Marios Panagiotou (Athens, Greece), Marios Panagiotou, Martin K. Johnson, Zafeiris Louvaris, Julien S. Baker, Andrew J. Peacock, Ioannis Vogiatzis
PA2306
LATE-BREAKING ABSTRACT: Deoxyhemoglobin kinetic and performance of respiratory muscles during maximal incremental exercise Ferid Oueslati (Amiens, France), Ferid Oueslati, Zouhair Tabka, Said Ahmaidi
PA2307
LATE-BREAKING ABSTRACT: Reference equations for pulmonary diffusing capacity of CO and NO in adult Caucasians Mathias Munkholm (Copenhagen, Denmark), Mathias Munkholm, Jacob Louis Marott, Lars Bjerre-Kristensen, Flemming Madsen, Ole Find Pedersen, Peter Lange, Børge Nordestgaard, Jann Mortensen
PA2308
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Joo Hun Park (Suwon, Republic of Korea), Joo Hun Park, Seungsoo Sheen, Jae Seung Lee, Yeon-Mok Oh, Ji-Hyun Lee, Kwang Ha Yoo, Ho Il Yoon, Sang-Do Lee
PA2309
Blood pressure response to altitude exposure in patients with COPD Esther Irene Schwarz (Zurich, Switzerland), Esther I. Schwarz, Tsogyal D. Latshang, Michael Furian, Deborah Flück, Sebastian Segitz, Séverine Müller-Mottet, Silvia Ulrich-Somaini, Konrad E. Bloch, Malcolm Kohler
PA2310
Physical activity is an important determinant of arterial stiffness in COPD Noriane Sievi (Zurich, Switzerland), Noriane Sievi, Daniel Franzen, Malcolm Kohler, Christian Clarenbach
PA2311
Pulmonary burden in C57Bl/6 mice infected with plasmodium berghei strains NK65 or ANKA Walter Araùjo Zin (Rio de Janeiro, Brazil), Walter Zin, Gaudio Sena, Giovanna Carvalho, Thamyres Silva, Daniel Silva, Douglas Riva, Patricia Reis, Hugo Faria-Neto
PA2312
LVRS improves endothelial function and blood pressure in patients with COPD: A randomized-controlled trial Christian Clarenbach (Zurich, Switzerland), Christian Clarenbach, Noriane Sievi, Matthias Brock, Didier Schneiter, Walter Weder, Malcolm Kohler
PA2313
Effect of time from last food intake on the respiratory exchange ratio Mehrnaz Asadi Ghrabaghi (Tehran, Islamic Republic of Iran), Hamidreza Abtahi, Mehrnaz Asadi Gharabaghi, Mehdi Azimi
PA2314
Clinical study of n-CPAP elicited change in nasal airflow partitioning as potential cause of mucosal drying David White (Auckland, New Zealand), David White, Jim Bartley, Muhammad Shakeel, Cameron Hughes
PA2315
Identification of MDA associated clusters in exhaled breath samples of patient measurements from GC-IMS spectra Gunther Becher (Bernau, Germany), Gunther Becher, Roman Purkhart, Jörg Schulz, Stephan Heymann, Werner Schüler
PA2316
Assessing dynamic changes in plasma apelin concentration in response to maximal exercise in man Svyatoslav Kechyn (Margate, United Kingdom), Svyatoslav Kechyn, Gareth Barnes, Luke Howard
PA2317
Ventilatory pattern during sequential swallowing in healthy adults Yacine Ouahchi (Tunis, Tunisia), Yacine Ouahchi, Nour Abdelhedi, Meriem Mjid, Sonia Toujani, Nozha Ben Salah, Nadia Mehiri, Béchir Louzir, Jouda Cherif, Majed Beji
PA2318
Effects of combined aerobics and circuit training on lung function and quality of life- Findings from a Nigerian population Ayodele Akinremi (Ibadan, Nigeria), Ayodele Akinremi, Arinola Sanusi, Arionla Sanya
PA2319
Relative accuracy of patients’ interpretation of distance - An assessment of exercise tolerance Helen Davies (Cardiff, United Kingdom), P.P. Kiritharamohan, M.C. Lazarou, H.E. Davies
PA2320
Breathlessness perception in COPD: Relationship with exacerbation frequency Giulia Scioscia (Lucera, Italy), Giulia Scioscia, Isabel Blanco, Ebymar Arismendi, Felip Burgos, Concepción Gistau, Maria Pia Foschino, Alvar Agusti
154
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2321
The cardiopulmonary exercise testing as a predictive tool of sleep apnea syndrome Eleni Karetsi (Larisa, Greece), Vasileios Stavrou, George Vavougios, Chaido Pastaka, Zoe Daniil, Konstantinos Gourgoulianis, Eleni Karetsi
Hall 14-11
Session 259
12:50 - 14:40
Thematic Poster: Inflammation, biomarkers and hypoxia in sleep disordered breathing Chairs : Johan Verbraecken (Edegem (Antwerp), Belgium), Malcolm Kohler (Zurich, Switzerland), Chair to be confirmed PA2322
Is there a relationship between OSAS severity and Nesfatin-1? Elif Yilmazel Uçar (Erzurum, Turkey), Omer Araz, Elif Yilmazel Ucar, Metin Akgun
PA2323
Serum midkine levels in patients with obstructive sleep apnea Hakan Tanriverdi (Zonguldak, Turkey), Hakan Tanriverdi, Firat Uygur, Murat Can, Bülent Altinsoy, Fatma Erboy, Tacettin örnek, Füruzan Köktürk, Meltem Tor, Figen Atalay
PA2324
Severity of obstructive sleep apnea and oxidative stress Ivan Cekerevac (Kragujevac, Republic of Serbia), Ivan Cekerevac, Marina Petrovic, Zorica Lazic, Ljiljana Novkovic, Vojislav Cupurdija
PA2325
Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients Robert Plywaczewski (Warsaw, Poland), Robert Plywaczewski, Anna Czyzak-Gradkowska, Przemyslaw Bielen, Pawel Sliwinski
PA2326
Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients? Juan Alejandro Cascón Hernandez (Paris, France), Juan Cascon, Ramon Fernandez, Gemma Rubinos, Rebeca Alonso, Marta Iscar, Maria Vazquez, Begoña Palomo, Pere Casan
PA2327
Asymmetric dimethylarginine concentration in patients with obstructive sleep apnea Pawe Kici ski (Lublin, Poland), Pawel Kicinski, Andrzej Dybala, Maciej Zakrzewski, Marcin Urbanczuk, Wojciech Myslinski, Jerzy Mosiewicz, Andrzej Jaroszynski
PA2328
Impact of CPAP treatment on pro-BNP in obstructive sleep apnea syndrome Sameh msaad (Sfax, Tunisia), Sameh M’Saad, Malek Grati, Rim Marrakich, Rania Gargouri, Samy Kammoun, Kamel Jamoussi
PA2329
Obstructive sleep apnea and the risk of chronic kidney disease – glomerular filtration rate estimations based on serum cystatin C and creatinine concentrations Adam Nowinski (Warsaw, Poland), Adam Nowinski, Anna Czyzak-Gradkowska, Damian Korzybski, Luiza Jonczak, Przemyslaw Bielen, Robert Plywaczewski, Pawel Sliwinski
PA2330
Heat shock proteins, L-arginine, and asymmetric dimethylarginine levels in patients with obstructive sleep apnea syndrome Erdal n (Elaz g, Turkey), Erdal In, Sinem Nedime Sökücü, Cengiz özdemir, Dilara Kaman
PA2331
Relation of ghrelin, obestatin levels and ghrelin/obestatin ratio with sleep quality Deniz Kizilirmak (Ankara, Turkey), Deniz Kizilirmak, Bülent Bozkurt
PA2332
The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients Milada Hobzová (Olomouc, Czech Republic), Milada Hobzova, Ondrej Ludka, Radka Stepanova, Milan Sova, Eliska Sovova
PA2333
OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial Esther Irene Schwarz (Zurich, Switzerland), Esther I. Schwarz, Michael Furian, Christian Schlatzer, John R. Stradling, Malcolm Kohler, Konrad E. Bloch
PA2334
Breathing and sleep disturbances in lowlanders with COPD travelling to 2590m Tsogyal D. Latshang (Chur, Switzerland), Tsogyal D. Latshang, Michael Furian, Deborah Flueck, Séverine Mueller-Mottet, Batyr Osmonov, René P.M. Tardent, Silvia Ulrich, Malcolm Kohler, Konrad E. Bloch
PA2335
Renin and aldosterone levels in obstructive sleep apnea syndrome patients Dimosthenis Lykouras (Patras, Greece), Dimosthenis Lykouras, Kleanthis Theodoropoulos, Olga Lagiou, Fotios Sampsonas, Michail Lykouras, Agathi Spiropoulou, Apostolos Voulgaridis, Maria Tsiamita, Christodoulos Flordellis, Theodore Alexandrides, Kiriakos Karkoulias, Kostas Spiropoulos
PA2336
Effects of continuous positive airway pressure therapy in patients with severe obstructive sleep apnea and endothelial dysfunction on 24-hour blood pressure profile Fabian Bischof (Regensburg, Germany), Fabian Bischof, József Egresits, Andrea Hetzenecker, Michael Arzt, Richard Schulz, Winfried J. Randerath, Wolfgang Galetke, Stephan Budweiser, Georg Nilius
155
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2337
The effect of CPAP on blood pressure in patients with OSAS and resistant hypertension followed 1 year Oana Claudia Deleanu (Bucarest, Romania), Oana Claudia Deleanu, Andra Elena Malaut, Ana Maria Nebunoiu, Alexandra Roberta Sandu, Miruna Mihaela Micheu, Corina Ioana Oprea, Ion Mierlus Mazilu, Florin Dumitru Mihaltan
Hall 14-12
Session 260
12:50 - 14:40
Thematic Poster: Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Chairs : Athanasios G Kaditis (Athens, Greece), Athanasia Pataka (Panorama Thessaloniki, Greece), Elizabeth Hill (Edinburgh, United Kingdom), Chair to be confirmed PA2338
Association between snoring and wheezing in aged Japanese general population Hiroo Wada (Tokyo, Japan), Hiroo Wada, Katsunori Kondoh, Takeshi Tanigawa
PA2339
Prevalence of physician-diagnosed asthma in patients with suspected obstructive sleep apnea syndrome: A crosssectional analysis of the ESADA database Geraldine Lo Grasso (Palermo, Italy), Geraldine Lo Grasso, Fabio Cibella, Paschalis Steiropoulos, Claudia Gruttad’Auria, Verbraecken Johan, Sliwinski Pawel, Jan Hedner, Ludger Grote, Oreste Marrone, Maria Bonsignore
PA2340
Obstructive sleep apnea syndrome: How are we in Portugal? Paula Maria Gonçalves Pinto (Lisbon, Portugal), Ana Paula Rodrigues, Paula Pinto, Baltazar Nunes, Cristina Bárbara
PA2341
Multimorbidity is a risk factor for obstructive sleep apnea-hypopnea syndrome in ageing Zoe Daniil (Larisa, Greece), Christos Kleisiaris, Evangelos Kritsotakis, Zoe Daniil, Foteini Malli, George Markakis, Ioanna Papathanasiou, Konstantinos Gourgoulianis
PA2342
Prevalence of obstructive sleep apnea syndrome and CPAP adherence in the elderly Chinese population Susanna SS Ng (Hong Kong, Hong Kong), Susanna S.S. Ng, Tat-On Chan, Kin-Wang To, Ken Chan, Jenny Ngai, Fanny Ko, David S.C. Hui
PA2343
Stop-Bang questionnaire in obstructive sleep apnea syndrome: A severity predictor DINORA POLANCO ALONSO (Zaragoza, Spain), Maria Teresa Martin Carpi, Dinora Polanco Alonso, Sara García Marín, Clara Viñado Mañes, Ana Lucia Figueredo Cacacho, Carolina Panadero Paz, Sandra Garcia Saez, José María Marín Trigo, Enrique Chacón Vallés, Salvador Bello Dronda
PA2344
Assessment of end-tidal CO2 during sleep in children with idiopathic epilepsy. Is it associated with seizure control? Maria Gogou (Katerini, Greece), Maria Gogou, Katerina Haidopoulou, Evangelos Pavlou, Efterpi Pavlidou, Maria Hatzistylianou, Maria Eboriadou
PA2345
Sleep disordered breathing in children with congenital heart disease Noor Zehan Abdul Rahim (Kuala Lumpur, Malaysia), Noor Zehan Abdul Rahim, Mark Rosenthal, Anita Simonds, HuiLeng Tan
PA2346
Comparison of blood pressure measured by cuff and calculated from pulse transient time and influence of arousals by cuff inflation on blood pressure level- Pilot study Milan Sova (Olomouc, Czech Republic), Milan Sova, Eliska Sovova, Milada Hobzova, Monika Kamasova, Irena Kuca, Jana Zapletalova, Vitezslav Kolek
PA2347
Differences between patients with overlap syndrome (COPD + OSAS) and patients with OSAS Juan R Fernández-Lahera Martínez (Madrid, Spain), J. Fernández-Lahera, F. Martínez Muñoz, M. Martínez Redondo, I. Artíles, R. Casitas, R. Galera, C. Carpio, I. Fernández, F. García Río, R. Alvarez-Sala
PA2348
Clinical significance of transcutaneous PCO2 in patients with obstructive sleep apnea syndrome Esteban Cesar Gabazza Sanabria (Tsu-Mie, Japan), Tadashi Sakaguchi, Osamu Hataji, Haruko Saiki, Esteban C. Gabazza, Corina D’Alessandro-Gabazz, Yoichi Nishii, Tetsu Kobayashi, Osamu Taguchi
PA2349
Physical activity energy expenditure(PAEE) device for sleep stage analysis Liang-Wen Hang (Taichung, Taiwan), Liang-wen Hang, Shinin-Jye Liang, Yung-Ming Chung, Yu-Hsiang Wang
PA2350
Rosenberg self-esteem evaluation is correlated with insomnia, not with sleep apnea Nikolaos Chavouzis (Thessaloniki, Greece), Nikolaos Chavouzis, Katalin Fekete-Passa, Athanasia Pataka, Georgios Kalamaras, Vasilios Mpagkalas, Georgia Pitsiou, Ioannis Stanopoulos, Theodoros Kontakiotis, Paraskevi Argyropoulou
PA2351
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Marcel Treml (Solingen, Germany), Marcel Treml, Norbert Anduleit, Wiebke Dohrn, Christina Priegnitz, Winfried Randerath
156
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2352
Impact of pulmonary hypertension on reduction of right ventricular longitudinal strain in patients with obstructive sleep apnea syndrome Angelo Canora (Naples, Italy), Angelo Canora, Sabrina Castaldo, Ciro Santoro, Agostino Buonauro, Roberta Esposito, Bruno Trimarco, Alessandro Sanduzzi Zamaparelli, Maurizio Galderisi, Marialuisa Bocchino
PA2353
Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease Alessandra Castrogiovanni (Palermo, Italy), Alessandra Castrogiovanni, Christina Priegnitz, Marcel Treml, Pierpaolo Baiamonte, Claudia Gruttad’Auria, Maria Bonsignore, Winfried Randerath
PA2354
Screening for sleep-disordered breathing in a bariatric population Kate Reed (London, United Kingdom), Kate Reed, Martino Pengo, Joerg Steier
Hall 14-13
Session 261
12:50 - 14:40
Thematic Poster: Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies Chairs : Neil Skjodt (Lethbridge, Canada), Ruzena Tkacova (Kosice, Slovakia), Jan A. Hedner (Goteborg, Sweden), Chair to be confirmed
PA2355
Assessing the role of cerebral autoregulation during intrathoracic pressure changes by near infrared spectroscopy (NIRS) Marco Laures (Suhr, Switzerland), Marco Laures, Nina Bolz, Zhongxing Zhang, Armand Mensen, Christoph Schmidt, Ramin Khatami
PA2356
Is it possible to check whether two measurements was performed on the same patient using pulsoximetric pulse wave signal characteristics? Jakub Radlinski (Rabka-Zdrój, Poland), Jakub Radlinski, Ding Zou, Ludger Grote, Jan Hedner, Waldemar Tomalak
PA2357
Phenotyping comorbidity in obstructive sleep apnea syndrome George Vavougios (Larissa, Greece), George Vavougios, George Natsios, Chaido Pastaka, Sotirios Zarogiannis, Konstantinos Gourgoulianis
PA2358
Are respiratory events and/or arousals during each sleep stage different by upper airway collapsibility? Hideaki Nakayama (Shinjuku-ku, Japan), Hideaki Nakayama, Mika Kobayashi, Mariko Yanagihara, Eiki Ito, Satoru Tsuiki, Satoshi Kasagi, Yasuhiro Setoguchi, Yuuichi Inoue
PA2359
The STOP Bang score: Analysis on anthropomorphic variables Paolo Righini (Turin, Italy), Paolo Righini, Valter Gallo, Giovanni Maria Ferrari, Alessandro Oliva, Roberto Prota
PA2360
Should patients with possible obstructive sleep apnoea (OSA) be screened with overnight pulse oximetry or multichannel sleep studies as a first line diagnostic tool? Alison Butler (Sutton Coldfield, United Kingdom), Alison Butler, Julie Lloyd
PA2361
Symptoms of laryngopharyngeal reflux in patients with obstructive sleep apnea Meriem Mjid (Bab Saadoun/Tunis, Tunisia), Meriem Mjid, Rihab Bey, Sonia Toujani, Yassine Ouahchi, Asma Sebii, Nozha Ben Salah, Abdelmajid Ben Hmida, Bechir Louzir, Nadia Mhiri, Jouda Cherif, Majed Beji
PA2362
The phenotypic and polysomnographic features of REM related obstructive sleep apnea syndrome patients Önder Öztürk (ISPARTA, Turkey), Oguz Celik, Onder Ozturk, Ahmet Akkaya
PA2363
Gender differences in obstructive sleep apnea syndrome En-Ting Chang (Hualien, Taiwan), En-Ting Chang, Hsiu-Mei Wang
PA2364
The phenotypic and polysomnographic features of positional obstructive sleep apnea syndrome patients Önder Öztürk (ISPARTA, Turkey), Seher Karakus, Onder Ozturk, Ahmet Akkaya
PA2365
Phenotypical features of obstructive sleep apneas and hypopneas in children with epilepsy in comparison to healthy children Maria Gogou (Katerini, Greece), Maria Gogou, Katerina Haidopoulou, Evangelos Pavlou, Efterpi Pavlidou, Maria Hatzistylianou, Maria Eboriadou
PA2366
Obstructive sleep apnoea and hypothyroidism othman lamine (Ariana, Tunisia), O. Neffati, H. Zaibi, B. Dhahri, J. Ben Ammar, M.A. Baccar, S. Azzabi, H. Aouina
PA2367
Overnight changes in lung function in patients with obstructive sleep apnoea Fruzsina Martinovszky (Nyíregyháza, Hungary), Fruzsina Martinovszky, Monika Zsolyomi, Adam Tarnoki, David Tarnoki, Gyorgy Losonczy, Laszlo Kunos, Andras Bikov
PA2368
CPAP treatment response in obstructive sleep apnea using the AERScore predictor Alexandru Topirceanu (Timisoara, Romania), Alexandru Topirceanu, Lucretia Udrescu, Stefan Mihaicuta
157
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2369
Polysomnography in Pompe disease Ana Luísa Pereira Vieira (Braga, Portugal), Ana Vieira, Mafalda Ferreira, Joaquim Moita
PA2370
Association between respiratory events and nocturnal gastroesophageal reflux events in patients with coexisting obstructive sleep apnea and gastroesophageal reflux disease Warangkana Tantipornsinchai (Bangkok, Thailand), Warangkana Tantipornsinchai, Nattapong Jaimchariyatam, Sutep Gonlachanvit, Tayard Desudchit
Hall 14-14
Session 262
12:50 - 14:40
Thematic Poster: Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Chairs : Winfried J. Randerath (Solingen, Germany), Maria Bonsignore (Palermo, Italy), Paschalis Steiropoulos (Alexandroupolis, Greece), Jose Maria Montserrat Canal (Barcelona, Spain) PA2371
Effects of CPAP on energy balance in patients with obstructive sleep apnea Ryo Tachikawa (Kyoto, Japan), Ryo Tachikawa, Kaori Ikeda, Takeshi Matsumoto, Satoshi Hamada, Masanori Azuma, Kimihiko Murase, Kiminobu Tanizawa, Morito Inouchi, Toru Oga, Nobuya Inagaki, Michiaki Mishima, Kazuo Chin
PA2372
Prevalence of positional obstructive sleep apnea and patients characteristics using various definitions Rasmus Rude Laub (Copenhagen, Denmark), Rasmus Rude Laub, Kim Lyngby Mikkelsen, Philip Tønnesen
PA2373
Type 2 diabetes and the risk for obstructive sleep apnoea in Nigeria Victor Umoh (Calabar, Nigeria), Victor Umoh, Effiong Akpan, Obeten Ekpo, Mfon Ekwere, Etete Peters, John Ekott
PA2374
Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea Ivana Tomeckova (Presov, Slovakia), Ivana Tomeckova, Miriam Kozarova, Darina Petrasova, Ivana Paranicova, Zuzana Malachovska, Ivan Tkac, Pavol Joppa, Ruzena Tkacova
PA2375
Evaluation of the significance of Epworth sleepiness scale among 687 patients with suspected sleep apnea Rasmus Rude Laub (Copenhagen, Denmark), Rasmus Rude Laub, Kim Lyngby Mikkelsen, Philip Tønnesen
PA2376
Sleep disorder in patients receiving hemodialysis HIND JANAH (CASABLANCA, Morocco), Wiam El Khattabi, Hind Janah, Hasna Jabri, Hicham Afif
PA2377
Gender differences in sleep disordered breathing Eva Lindberg (Uppsala, Sweden), Eva Lindberg, Bryndis Benediktsdottir, Karl A. Franklin, Mathias Holm, Ane Johannessen, Rain Jögi, Thorarinn Gislason, Francisco Gomez Real, Vivi Schlünssen, Christer Janson
PA2378
Hemodynamic response on sleep disordered breathing in obese subjects: Differences between N2 and REM stage Dina Grencho (Lisbon, Portugal), Dina Grencho, Richard Staats, Claudia Pereira, Dina Fernandes, Susana Moreira
PA2379
Obstructive sleep apnea syndrome and cardiometabolic disorders – Is there an association? Andreea Coman (Cluj-Napoca, Romania), Doina Adina Todea, Andreea Codruta Coman
PA2380
Prevalence of nocturia in obstructive sleep apnea syndrom amani ben mansour (tunis , Tunisia), Amani Ben Mansour, Haifa Zaibi, Jihen Ben Ammar, Bassma Dahri, Mohamed Ali Baccar, Saloua Azzabi, Hichem Aouina
PA2381
Catathrenia: A 10 year revision Catarina Carvalho de Oliveira Dias Teixeira, Jose Moutinho Santos
PA2382
Circadian rhythm of melatonin in patients with sleep-disordered breathing Radoslav Bilyukov (Sofia, Bulgaria), Radoslav Bilyukov, Martin Nikolov, Radostina Cherneva, Daniela Petrova, Ognyan Georgiev, Tsanko Mondeshki, Vihra Milanova, Adelina Tsakova, Ventsislava Pencheva
PA2383
Obstructive sleep apnea (OSA) in young and elderly patients – Does age matter? amani ben mansour (tunis , Tunisia), Amani Ben Mansour, Haifa Zaibi, Bassma Dahri, Jihen Ben Ammar, Mohamed Ali Baccar, Saloua Azzabi, Hichem Aouina
PA2384
Severe obstructive sleep apnea syndrome in elderly population: A prospective study of 80 patients Ikbel Khalfallah (Nabeul, Tunisia), Ikbel Khalfallah, Manel Loukil, Imen Ismail, Imed Naceur, Hedia Ghrairi
PA2385
Prevalence of clinical symptoms of sleep apnea hyponea syndrome during pregnancy Sameh msaad (Sfax, Tunisia), Sameh M’Saad, Imene Badri, Jihene Trabelsi, Faten Marouen, Samy Kammoun
PA2386
Spatial QRS-T angle in patients with obstructive sleep apnea – Impact of cardiac and metabolic comorbidities Pawe Kici ski (Lublin, Poland), Pawel Kicinski, Andrzej Dybala, Todd Schlegel, Maciej Zakrzewski, Marcin Urbanczuk, Wojciech Myslinski, Jerzy Mosiewicz, Andrzej Jaroszynski
(Matosinhos, Portugal), Catarina Dias, Liliana Sousa, Lucia Batata, Maria Fatima
158
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2387
Mutual influense of airway hyperresponsiveness and obstructive sleep apnea in patients with asthma Elizaveta Sheludko (Blagoveshchensk, Amur Oblast, Russian Federation), Elizaveta Sheludko, Denis Naumov, Anna Prikhodko, Juliy Perelman, Victor Kolosov
PA2388
Association of sleep-disordered breathing and disturbed cardiac repolarization in patients with ST-segment elevation myocardial infarction Alina Marcinek (Greifswald, Germany), Alina Marcinek, Andrea Hetzenecker, Stefan Buchner, Kurt Debl, Anderas Luchner, Oliver Husser, Okka W. Hamer, Florian Porschenrieder, Claudia Fellner, Malcom Kohler, Lars S. Maier, Michael Pfeifer, Michael Arzt
PA2389
The effect of BPAP therapy on basal metabolism rate in patients with obesity hypoventilation syndrome lknur Basyigit (Kocaeli, Turkey), Gonca Dogru, Hasim Boyaci, Serap Argun Baris, Tugba Onyilmaz, Ilknur Basyigit, Fusun Yildiz
PA2390
Can sleep apnea be a secondary cause of osteoporosis in young people? brahim Hikmet Firat (Ankara, Turkey), Hikmet Firat, Melike Yuceege, Deniz Dulgeroglu, Ali Yalcindag
Hall 14-15
Session 263
12:50 - 14:40
Thematic Poster: To treat or not to treat, and how? Sleep-disordered breathing I Chairs : Wilfried De Backer (Edegem (Antwerp), Belgium), Dirk A.A. Pevernagie (Heeze, Netherlands), Chair to be confirmed PA2391
Continuous positive airway pressure therapy for obstructive sleep apnoea: Do patients who request to have a copy of their letters have better compliance? Katie Chong (London, United Kingdom), Katie Chong, Ian Smith
PA2392
Predictors of titrating pressure using A-CPAP in obstructive sleep apnea Margarida Dias (Vila Nova de Gaia, Portugal), Margarida Dias, Daniela Ferreira, Ana Antunes
PA2393
A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea Susanna SS Ng (Hong Kong, Hong Kong), Susanna S.S. Ng, Ruth S.M. Chan, Jean Woo, Tat-On Chan, Bernice H.K. Cheung, Mandy M.M. Sea, Kin-Wang To, Ken Chan, Jenny Ngai, Wing-Ho Yip, Fanny W.S. Ko, David S.C. Hui
PA2394
Effect of sleep disordered breathing on postural stability Francis Degache (Lausanne, Switzerland), Francis Degache, Yannick Goy, Sopharat Vat, Jose Haba-Rubio, Olivier Contal, Raphael Heinzer
PA2395
PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome Luisa Maria do Nascimento dos Santos (Mirandela, Portugal), Luísa Nascimento, Rita Gomes, Catia Saraiva, Marta Drummond
PA2396
Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome Annia Fleur Schreiber (Turin, Italy), Annia Schreiber, Sara Surbone, Alberto Malovini, Piero Ceriana, Marco Mancini, Nathalie Tedeschi, Giancarlo Piaggi, Annalisa Carlucci
PA2397
Factors determining continuous positive airway pressure (CPAP) compliance in obstructive sleep apnea (OSA) Moussa Riachy (Beirut, Lebanon), Moussa Riachy, Samer Najem, Mirella Iskandar, Jad Choucair, Ihab Ibrahim
PA2398
Comparison between home and hospital set-up for unattended home-based polysomnography: A prospective randomised study Marie Bruyneel (Rhode, Belgium), Marie Bruyneel, Walter Libert, Lieveke Ameye, Vincent Ninane
PA2399
Positional therapy may be a cheap and effective alternative to continuous positive airway pressure in positional obstructive sleep apnoea Deirdre Fitzgerald (Cork, Ireland), Deirdre Fitzgerald, Liam Chawke, Ann O’Mahony, Michelle Balicaco, Terry O’Connor, David Curran
PA2400
Can the OSLER MWT be improved? Christopher Turnbull (Oxford, United Kingdom), Christopher Turnbull, Sonya Craig, Malcolm Kohler, John Stradling
PA2401
Validation of APAP with P-Flex: A novel pressure delivery method Linda Makhlouf (Carquefou, France), Linda Makhlouf, François Codron, François Jounieaux, Catherine Lamblin, JeanMarc Dernis, Marc Bure, François Fortin, Thibaut Gentina
PA2402
Clinical validation of a novel FOT-based APAP device for treatment of obstructive sleep apnea Georg Nilius (Dortmund, Germany), Georg Nilius, Marcel Treml, Christina Priegnitz, Ulrike Domanski, Maik Schröder, Monika Bähr, Dora Triché, Martina Bögel, Christof Schröter, Karin Pietruska, Matthias Schwaibold, Thorsten Piepgras, Joachim H. Ficker, Winfried J. Randerath
159
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2403
REM rebound during CPAP titration as a predictor of chronic CPAP compliance Johan Verbraecken (Edegem (Antwerp), Belgium), Timothy Vranken, Ilse De Volder, Ann Van Gastel, Evert Hamans, Olivier Vanderveken, Paul Van de Heyning, Wilfried De Backer, Johan Verbraecken
PA2404
Inspiratory flow limitation analysis improves ambulatory CPAP titration monitoring Neil Skjodt (Lethbridge, Canada), Samaneh Sarraf, Ronald S. Platt, Neil M. Skjodt
PA2405
The accuracy of BPAP determined apnea-hypopnea index Hatice Uluçoban Dede (Antalya, Turkey), Hatice Uluçoban Dede, Aykut çilli
PA2406
Comparison of the effect of continuous positive airway pressure and mandibular advancement devices on blood pressure in patients with obstructive sleep apnea: A network meta-analysis Daniel Bratton (Zurich, Switzerland), Daniel Bratton, Thomas Gaisl, Annette Marie Wons, Malcolm Kohler
PA2407
Obstructive sleep apnoea and post-operative complications Thilini Basnayake (Victoria, Australia), Thilini Basnayake, Amalia Karahalios, Lynette Reid-Price, David Bramley, Anne Marie Southcott
PA2408
Reductions in body weight and sleep apnea severity in morbidly obese subjects – Which factors contribute to improvements in lung function and blood gases? Anne Marie Gabrielsen (Skien, Norway), Anne Marie Gabrielsen, Jøran Hjelmesæth, May Brit Lund, Jan Magnus Fredheim, Sverre Lehmann, Dag Hofsø
PA2409
Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea Silke Ryan (Dublin, Ireland), Silke Ryan, Audrey Russell, Geraldine Nolan, Walter McNicholas
Hall 14-16
Session 264
12:50 - 14:40
Thematic Poster: To treat or not to treat? Sleep-disordered breathing II Chairs : Renata L. Riha (Edinburgh, United Kingdom), Refika Hamutcu Ersu (Istanbul, Turkey), Maria Pia Villa (Rome, Italy), Juan Fernando Masa Jiménez (Cáceres, Spain) PA2410
Evaluation of lipid profile in patients with obstructive sleep apnea syndrome Taha Tahir Bekci (KONYA, Turkey), Ozgur Ocal, Taha Bekci, Samil Ecirli
PA2411
Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA) Robert Plywaczewski (Warsaw, Poland), Robert Plywaczewski, Anna Czyzak-Gradkowska, Przemyslaw Bielen, Pawel Sliwinski
PA2412
The value of Berlin questionnaire to identify patients at risk for the sleep apnea syndrome in the periodical medical examinations in companies Adriana Arantes (Rio de Janeiro, Brazil), Adriana Arantes, Anne Santanna, Ana Paula Mendonça, Rosângela Cruz, Denise Cortês, Adriana Carvalho, Eduardo Pinto, Fernando Varzim, Marília Santanna, Denise Renzeti, Valéria Pacheco, Roberto Ferreira, Márcio Carvalho, Karla Garcia, Oziel Tardin
PA2413
Patterns of CPAP usage in patients with minimally symptomatic OSA Christopher Turnbull (Oxford, United Kingdom), Christopher Turnbull, Daniel Bratton, Sonya Craig, Malcolm Kohler, John Stradling
PA2414
Short term effects of neck-based treatment and monitoring device for positional obstructive sleep apnea Simone Scarlata (Rome, Italy), Simone Scarlata, Isaura Rossi Bartoli, Simona Santangelo, Gilda Giannunzio, Raffaele Antonelli Incalzi
PA2415
Tri-level ventilation versus CPAP treatment in treatment of complex sleep apnoea syndrome Syed Mehdi (Bolton, United Kingdom), Syed B. Mehdi, Imran Satia, Charlotte Mitchell, Lisa Butler, Claire Goulden, Linda Corner, Salem Madi
PA2416
Impact of a custom-made mandibular repositioning device (MRD) on blood pressure (BP) in obstructive sleep apnea (OSA) patients noncompliant with continuous positive airway pressure (CPAP) Valérie Attali (Paris, France), Valérie Attali, Marie-Pia D’Ortho, Damien Leger, Christelle Monaca, Pierre-Jean Monteyrol, Laurent Morin, Eric Mullens, Bernard Pigearias, Jean-Claude Meurice, Marie-Françoise Vecchierini
PA2417
The application of continuous positive airway pressure in an obstructive sleep apnea syndrome accompanied by subconjunctival hemorrhage secondary to hypertensive episodes: A case report Bikemgül Özkara (Ankara, Turkey), Bikemgul Ozkara, Haldun Sevketbeyoglu, Dilaver Tas, Devrim Deniz
PA2418
Monoblock appliance for treatment of children with sleep disordered breathing Refika Hamutcu Ersu (Istanbul, Turkey), Eser Capan, Refika Ersu, Esen Kiyan, Haydar Yener, Ayse Arman, Hulya Kilicoglu
160
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2419
Polysomnography findings in infants with severe bronchopulmonary dysplasia (BPD) Esther van Mastrigt (Rotterdam, Netherlands), Esther Van Mastrigt, Joel Pichardo, Irwin Reiss, Andre Kroon, Johan De Jongste, Liesbeth Duijts, Koen Joosten, Mariëlle Pijnenburg
PA2420
Sleep disordered breathing and sleep quality in children with bronchiolitis obliterans Zeynep Seda Uyan (Istanbul, Turkey), Zeynep Seda Uyan, Ihsan Turan, Pinar Ay, Erkan Cakir, Ersin Ozturk, Ahmet Hakan Gedik, Yasemin Gokdemir, Ela Erdem, Velat Sen, Bulent Karadag, Fazilet Karakoc, Refika Ersu
PA2421
Oxidative stress in children with OSAS: 8-isoprostane values comparison in urine and exhaled breath condensate (EBC) Maria Chiara Supino (Rome, Italy), Maria Chiara Supino, Susanna Bonafoni, Melania Evangelisti, Mario Barreto, Maria Pia Villa
PA2422
Dietary treatment outcomes of mild obstructive sleep apnea in obese community-dwelling children: The NANOS study Maria Luz Alonso Alvarez (Burgos, Spain), María Luz Alonso-Alvarez, Joaquin Teran-Santos, Estrella Ordax-Carbajo, Monica Gonzalez-Martinez, María Jose Jurado-Luque, Jaime Corral-Peñafiel, Joaquin Duran-Cantolla, Leila KheirandishGozal, David Gozal
PA2423
Sleep-disordered breathing in children with laryngomalacia Maria Luz Alonso Alvarez (Burgos, Spain), María Luz Alonso-Alvarez, Estrella Ordax-Carbajo, Ana Isabel Navazo-Egüia, Pedro Pablo Oyágüez-Ugidos, Fernando Gómez-Sáez, Alicia Mirás-Veiga, Jose Cordero-Guevara, Joaquin Terán-Santos
PA2424
Functional respiratory imaging in obese children and adolescents with obstructive sleep apnea Monique Slaats (Antwerp, Belgium), Monique Slaats, Wim Vos, Cedric Van Holsbeke, Jan De Backer, Kim Van Hoorenbeeck, An Boudewyns, Wilfried De Backer, Stijn Verhulst
PA2425
Correlations between anthropometric and metabolic parameters in children with obstructive sleep apnea syndrome (OSAS) Afroditi Sakellaropoulou (Athens, Greece), Afroditi Sakellaropoulou, Katerina Haidopoulou, Maria Emporiadou, Maria Hatzistilianou
PA2426
Association of asthma and allergic rhinitis with sleep-disordered breathing in childhood Paschalis Steiropoulos (Alexandroupolis, Greece), Evanthia Perikleous, Paschalis Steiropoulos, Evangelia Nena, Maria Iordanidou, Athanasios Chatzimichael, Emmanouil Paraskakis
PA2427
Upper airway stimulation for obstructive sleep apnea: Quality of life outcome after 30 months of follow-up Johan Verbraecken (Edegem (Antwerp), Belgium), Johan Verbraecken, Winfried Randerath, On Behalf of the STAR Trial Investigators
Hall 14-17
Session 265
12:50 - 14:40
Thematic Poster: Pulmonary hypertension: novel insights into the biology of the disease Chairs : Soni Savai Pullamsetti (Bad Nauheim, Germany), Frederic Perros (le Plessis-Robinson, France), Harm Jan H.J. Bogaard (Amsterdam, Netherlands), Laurent Godinas (Yvoir, Belgium) PA2428
LATE-BREAKING ABSTRACT: CFIm25 links alternative polyadenylation to pulmonary hypertension Harry Karmouty-Quintana (Houston, United States of America), Tingting Weng, Ning-Yuan Chen, Michael Blackburn, Eric Wagner, Harry Karmouty Quintana
PA2429
Endothelin-1 contributes to the downregulation of BMP/BMPR2 signaling induced by hypoxia Laurence Dewachter (Brussels, Belgium), Hidekazu Maruyama, Céline Dewachter, Asmae Belhaj, Benoit Rondelet, Myriam Remmelink, Jean-Luc Vachiéry, Robert Naeije, Laurence Dewachter
PA2430
Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats Balram Neupane (Bharatpur, Nepal), Balram Neupane, Djuro Kosanovic, Christina Vroom, Akylbek Sydykov, Hossein Ardeschir Ghofrani, Norbert Weissmann, Friedrich Grimminger, Werner Seeger, Christiane Herden, Ralph Theo Schermuly
PA2431
Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling? Audrey Courboulin (Le plessis-robinson, France), Audrey Courboulin, Guenhaël Sanz, Sandra Breuils-Bonnet, Marceau Quatredeniers, Matthieu Vocelle, Mathilde Lafond, Frédéric Perros, Sébastien Bonnet, Edith Pajot-Augy, Marc Humbert, Sylvia Cohen-Kaminsky
PA2432
Analysis of pulmonary endothelial microparticles, haemodynamics and functional class in pulmonary hypertension Carlos Metz (Homburg / Saar, Germany), Carlos Metz, Heinrike Wilkens, Robert Bals, Ralf Kaiser
PA2433
Hypoxia-induced pulmonary artery fibroblast proliferation and migration is prevented by ASK1 inhibition in an in vitro cellular model of pulmonary hypertension Kathryn Wilson (Glasgow, United Kingdom), Kathryn Wilson, Kornelija Suveizdyt, John Liles, Grant Budas, Andrew Peacock, David Welsh
161
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2434
Monosodium urate crystals stimulate IL-6 production via TAK1 and induce pulmonary vascular dysfunction Laura Moreno (Madrid, Spain), Laura Moreno, Andrea Martínez-Ramas, Bianca Barreira, Rachele Pandolfi, Beatriz De Olaiz Navarro, Daniel Morales-Cano, Raquel Herrero, Jóse ángel Lorente, ángel Cogolludo, Francisco Pérez-Vizcaíno
PA2435
Augmentation of the effects of vasoactive intestinal peptide aerosol on pulmonary hypertension via co-application of a neutral endopeptidase 24.11 inhibitor Hanno Leuchte (Munich, Germany), Hanno Leuchte, Christoph Prechtl, Jens Callegari, Tobias Meis, Shani Haziraj, Dorian Bevec, Juergen Behr
PA2436
IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Yuichi Tamura (Le Plessis-Robinson, France), Yuichi Tamura, Carole Phan, Ly Tu, Raphael Thuillet, Morane Le Hiress, Alice Huertas, Elie Fadel, Gerald Simonneau, Marc Humbert, Christophe Guignabert
PA2437
Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH) Annette Rieg (Aachen, Germany), Annette D. Rieg, Carolin Anker, Julia Krabbe, Rolf Rossaint, Stefan Uhlig, Christian Martin
PA2438
Btk (Bruton’s tyrosine kinase) in B cells is overexpressed in patients with idiopathic pulmonary arterial hypertension Peter Heukels (Rotterdam, Netherlands), Peter Heukels, Jennifer Van Hulst, Laurens Kil, Leon Van den Toorn, Karin Boomars, Rudi Hendriks, Henk Hoogsteden, Bernt Van den Blink, Mirjam Kool
PA2439
Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model Aysun engül (Kocaeli, Turkey), Aysun Sengul, Sertan Arkan, Cigdem Vural, Cuneyt Ozer, Busra Yaprak Bayrak, Aysegul Tas
PA2440
Chemerin potentiates pulmonary artery reactivity to endothelin-1 Aliénor Hanthazi (Braine-l'Alleud, Belgium), Aliénor Hanthazi, Samantha Gomart, Caroline Gaudreau Ménard, Pascale Jespers, Jean-Yves Springael, Robert Naeije, Laurence Dewachter, Kathleen Mc Entee
PA2441
Pulmonary vasoreactivity to leptin in spontaneously hypertensive rats Samantha Gomart (Liège, Belgium), Samantha Gomart, Pascale Jespers, Vadim Shlyonsky, Alienor Hantazi, Caroline Gaudreau Menard, Virginie Van Den Dries, Omer Gurkan Dilek, Robert Naeije, Laurence Dewachter, Kathleen Mc Entee
PA2442
Differential action of beraprost isomers on prostacyclin (IP) receptors and PPAR in pulmonary arteries Lucie Clapp (London, United Kingdom), Lei Shen, Kirby Von Kessler, Peter Laing, Prakash Sista, Lucie Clapp
PA2443
Activation of AMPK inhibits pulmonary arterial remodeling Manxiang Li (Xi'an, China), Dong Han, Yanting Zhu, Lu Liu, Yang Song, Manxiang Li
PA2444
ECFCs from patients with PAH show a disturbed reaction to high fluid flow induced shear stress Josien Smits (Amsterdam, Netherlands), Josien Smits, Harm-Jan Bogaard, Pieter Koolwijk, Anton Vonk Noordegraaf
PA2445
Effect of drugs with pleiotropic properties on tone of pulmonary arteries and bronchi in obstructive lung pathology model Natalia Kuzubova (Saint-Petersburg, Russian Federation), Nataliya Kuzubova, Elena Lebedeva, Anatoliy Fedin, Tatiana Preobrazhenskaya
PA2446
Versican and collagen-III expression in bronchial and pulmonary muscular arteries in COPD patients Raquel Annoni (Sao Paulo, Brazil), Raquel Annoni, Ligia Couceiro, Silvio Barbosa, Tatiana Lancas, Salvatore Battaglia, Marisa Dolhnikoff, Pieter Hiemstra, Peter Sterk, Klaus Rabe, Thais Mauad
Hall 14-18
Session 266
12:50 - 14:40
Thematic Poster: Pulmonary hypertension: the right ventricle and its load Chairs : Frances De Man (Amsterdam, Netherlands), François Potus (Quebec, Canada), Christophe Guignabert (le Plessis-Robinson, France), Chair to be confirmed PA2447
Left ventricular systolic torsion is correlated to right ventricular dilation in pulmonary hypertension patients Bouchra Lamia (Rouen, France), Bouchra Lamia, Luis Carlos Molano, Antoine Cuvelier, Catherine Viacroze, Jean-Francois Muir
PA2448
Right ventricular (RV) morphometric and ventriculo-vascular (VV) coupling patterns in patients with advanced pulmonary arterial hypertension (PAH) undergoing parenteral treprostinil therapy Franz Rischard (Tucson, United States of America), Franz Rischard, Roberto Bernardo, Rebecca Vanderpool, Aiden Abidov, Isaac Jenkins, Marc Simon, Lillian Hansen, Steve Knoper, Hunter Champion
PA2449
Central hemodynamic patterns during recovery from peak exercise Rudolf Oliveira (Sao Paulo, Brazil), Rudolf Oliveira, Manyoo Agarwal, Roza Badreslam, Alexander Opotowsky, Aaron Waxman, David Systrom
162
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2450
Right ventricular REMODELING in idiopathic pulmonary fibrosis with or without pulmonary hypertension Anna Agnese Stanziola (naples, Italy), Anna Agnese Stanziola, Antonello D’Andrea, Maria Martino, Giovanna Caccavo, Enza Di Palma, M. Maglione, M.V. Betancurt Cordito, Eduardo Bossone
PA2451
Wall stress determines systolic and diastolic function – Causes of pulmonary congestion Peter Alter (Marburg, Germany), Peter Alter, Andreas Rembert Koczulla, Christoph Nell, Claus Vogelmeier, Marga Rominger
PA2452
Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension Nuria Chamorro Tort (Barcelona, Spain), Núria Chamorro, Roberto Del Pozo, Jessica García-Lucio, Yolanda Torralba, Isabel Blanco, Manuel López-Meseguer, Jesús Ribas, Diego Rodríguez, Joan Albert Barberà
PA2453
Right ventricular dysfunction in brain death: Effect of corticosteroids Asmae Belhaj (Brussels, Belgium), Asmae Belhaj, Laurence Dewachter, Céline Dewachter, Myriam Remmelink, Sandrine Rorive, Robert Naeije, Benoit Rondelet
PA2454
Myocardial perfusion in patients with pulmonary hypertension of different etiology Tamila Martynyuk (Moscow, Russian Federation), Elvira Valeeva, Tamila Martynyuk, Olga Arkhipova, Galina Ryabykina, Irina Chazova
PA2455
Change of right heart size and function by long-term therapy with riociguat in patients with PAH and CTEPH Benjamin Egenlauf (Heidelberg, Germany), Benjamin Egenlauf, Alberto Marra, Nicola Ehlken, Christine Fischer, Christina Eichstaedt, Christian Nagel, Eduardo Bossone, Antonio Cittadini, Michael Halank, Henning Gall, Karen Olsson, Tobias Lange, Ekkehard Grünig
PA2456
Association of LV torsion with eccentricity in pulmonary hypertension – Insight in interventricular interactions by speckle tracking echocardiography Ralf Kaiser (Saarbrücken, Germany), Ralf Kaiser, Philip Böhmer, Philipp Lepper, Heinrike Wilkens, Robert Bals
PA2457
Improved diagnostic accuracy of MRI in patients with suspected pulmonary hypertension with combined right ventricle and pulmonary artery metrics Andy Swift (Sheffield, United Kingdom), Andrew Swift, Angela Lungu, Henry Walker, Dave Capener, Charlotte Hammerton, Charlie Elliot, Robin Condliffe, David Kiely, Jim Wild
PA2458
Estimation of mPAP with MRI in pulmonary hypertension subgroups: Comparison with echocardiography Andy Swift (Sheffield, United Kingdom), Andrew Swift, Angela Lungu, Henry Walker, Dave Capener, Charlotte Hammerton, Charlie Elliot, Robin Condliffe, David Kiely, Jim Wild
PA2459
A new method for parameter identification in a lumped model of pulmonary circulation Fabijan Luli (Zagreb, Croatia), Fabijan Lulic, Zdravko Virag, Ervin žuljevic, Gordana Pavliša, Miroslav Samaržija
PA2460
Native T1-mapping in precapillary pulmonary hypertension Onno Spruijt (Amsterdam, Netherlands), Onno Spruijt, Loek Vissers, Harm-Jan Bogaard, Mark Hofman, Anton VonkNoordegraaf, Tim Marcus
PA2461
Association of haemodynamic parameters with circulating natriuretic peptides in precapillary pulmonary hypertension Ralf Kaiser (Saarbrücken, Germany), Ralf Kaiser, Katharina Grotemeyer, Philip Böhmer, Philipp Lepper, Robert Bals, Heinrike Wilkens
PA2462
Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance Esther Timmer (Amsterdam, Netherlands), Esther M. Timmer, Nina Rol, Theo J.C. Faes, Harm Jan Bogaard, Anton VonkNoordegraaf, Katrien Grünberg, Nico Westerhof
PA2463
Pulmonary glucose uptake measured by positron emission tomography in pulmonary hypertension Armin Frille (Leipzig, Germany), Armin Frille, Karen Geva Steinhoff, Swen Hesse, Hubert Wirtz, Osama Sabri, HansJuergen Seyfarth
PA2464
Left ventricular-arterial coupling and cardiac remodeling in patients with idiopathic arterial pulmonary hypertension Zaira Dadacheva (Moscow, Russian Federation), Zaira Dadacheva, Anna Belevskaya, Marina Saidova, Tamila Martynyuk, Irina Chazova
PA2465
Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Cathelijne van der Bruggen (Amsterdam, Netherlands), Cathelijne Van der Bruggen, Onno Spruijt, Pia Trip, Frances De Man, Harm Jan Bogaard, Anton Vonk Noordegraaf
PA2466
Myocardial T1 mapping MRI in patients with PH and age-matched healthy volunteers Laura Hutchison (Hope Valley, United Kingdom), Laura Hutchison, Neil Stewart, Paul Hughes, Charlotte Hammerton, Martin Graves, David Kiely, Jim Wild, Andrew Swift
163
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Hall 14-19
Session 267
12:50 - 14:40
Thematic Poster: Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Chairs : Ralf Kaiser (Saarbrücken, Germany), Horst Olschewski (Graz, Austria), John Wort (Hampton, United Kingdom), Chair to be confirmed PA2467
Volumetric capnography to exclude pulmonary embolism at the emergency room Timon Fabius (Enschede, Netherlands), Timon Fabius, Michiel Eijsvogel, Ivo Van der Lee, Marjolein Brusse-Keizer, Frans De Jongh
PA2468
Investigating suspected pulmonary embolism (PE) in pregnancy – Review of practice at Aintree University Hospital Alison Hufton (Barrow in Furness, United Kingdom), Alison Hufton, Paul Albert, Maria Elpida Phitidis, Apollonaris Kwok, Nick Duffy
PA2469
Factors associated with mortality and survival in venous thromboembolism and hidden or concurrent cancer Raquel MORILLO GUERRERO (Azuaga, Spain), Luis Jara-Palomares, Raquel Morillo-Guerrero, Remedios OteroCandelera, Jose Antonio Díaz-Peromingo, Federica Pace, Fatima Del Molino, Marta Saraiva de Sousa, Manuel-Jesus Nuñez-Fernandez, Juan-Carlos Serrano-Casas, Manuel Monreal
PA2470
Hemodynamic profiles in patients with chronic thromboembolic disease before and after pulmonary endarterectomy Coen van Kan (Amsterdam, Netherlands), Coen Van Kan, Mart Van der Plas, Herre Reesink, Reindert Van Steenwijk, Robert Tepaske, Jaap Kloek, Paul Bresser
PA2471
Validation of a prognostic score for pulmonary embolism short-term mortality Foteini Malli (Larisa, Greece), Foteini Malli, George Vavougios, Fotini Bardaka, Konstantinos Gourgoulianis, Zoe Daniil
PA2472
The efficacy of CT in the detection of right ventricular dysfunction in acute pulmonary embolism and comparison with cardiac biomarkers Erdal n (Elaz g, Turkey), Erdal In, Sinem Nedime Sökücü, Cengiz özdemir, Ayse Murat Aydin, Mutlu Kuluöztürk
PA2473
Global fibrinolytic profile in patients with chronic thromboembolic pulmonary hypertension Frédéric Lador (Geneva, Switzerland), Aurélien Lebreton, Alessandro Casini, Frédéric Lador, Philippe De Moerloose, Marguerite Neerman-Arbez
PA2474
The comparison of serum visfatin levels in patients with acute PTE and non-PTE independent of BMI Nuri Tutar (Kayseri, Turkey), Nuri Tutar, Serkan Dogan, Hakan Buyukoglan, Ahmet Sen, Insu Yilmaz, Afra Yildirim, Ali Dogan, Aleyna Yetkin, Fatma sema Oymak, Inci Gulmez, Ramazan Demir
PA2475
The value of revised Geneva scoring system and D-dimer evaluation in the patients with suspicion of pulmonary embolism, admitted to the department of lung diseases Monika Szturmowicz (Warszawa, Poland), Monika Szturmowicz, Aneta Kacprzak, Dorota Wyrostkiewicz, Ewa Jedrych, Katarzyna Lewandowska, Iwona Bartoszuk, Barbara Burakowska, Jaroslaw Kober, Jan Kus
PA2476
Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients AURORA SOLIER LOPEZ (Sevilla, Spain), Aurora Solier Lopez, Raquel Morillo Guerrero, Teresa Elías Hernández, Luis Jara Palomares, Remedios Otero Candelera
PA2477
Pulmonary embolism in children in a tertiary hospital in Bogota Colombia Patricia Panqueva (Bogotá, Colombia), Olga Panqueva, Johana Orozco
PA2478
The cost of pulmonary embolism treatment with different anticoagulation strategies in Turkey pek Kivilcim O uzülgen (Ankara, Turkey), Murat Turk, Yagmur Aldag, Ipek Kivilcim Oguzulgen, Numan Ekim
PA2479
Areas for improvement in PE management; experiences at a district general hospital Oliver Price (Guildford, United Kingdom), Oliver Price, David Lodge, Harpreet Ranu
PA2480
Associated factors with short-term mortality in pulmonary thromboembolism patients Ezgi Demirdö en Çetino lu (BURSA, Turkey), Ezgi Demirdogen Cetinoglu, Asli Gorek Dilektasli, Ozge Aydin Guclu, Guven Ozkaya, Funda Coskun, Ahmet Ursavas, Mehmet Karadag
PA2481
Hughes-Stovin syndrome: A case report Jasna Tekavec-Trkanjec (Zagreb, Croatia), Jasna Tekavec-Trkanjec, Neven Tudoric, Mirjana Vukelic-Markovic, žarko Vrbica
PA2482
Effects of comorbidity in acute pulmonary embolism patients on short-term health issues and hospital costs Sibel Nayci (Mersin, Turkey), Yasin Duman, Eylem Sercan Ozgur, Bahar Tasdelen, Sibel Nayci, Cengiz Ozge, Ahmet Ilvan
PA2483
Correlation between Wells score and echocardiographic parameters in patients with pulmonary embolism Dusanka Obradovic (Novi Sad, Republic of Serbia), Dusanka Obradovic, Biljana Joves Sevic, Uros Batranovic, Rada Tesic
164
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2484
Venous thromboembolism in patients immobilized at home Alberto García (Valencia, Spain), Alberto Garcia-Ortega, Enrique Zaldivar, Raquel Lopez-Reyes, Dolores Nauffal, Manuel Monreal
PA2485
Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea Soo Han Kim (Seoul, Republic of Korea), Soo Han Kim, Jae Seung Lee, Byung Ju Kang, Sang-Do Lee, Jae Won Lee, JongMin Song, Seongsoo Jang
PA2486
Pulmonary embolism in young adults, what particularities? Haifa Zaibi (Tunis, Tunisia), Haifa Zaibi, Sarrz Maazaoui, Jihen Ben Amar, Besma Dhahri, M. Ali Baccar, Salwa Azzebi, Hichem Aouina
Hall 14-20
Session 268
12:50 - 14:40
Thematic Poster: Interventional pulmonology for pleural diseases Chairs : Philippe Astoul (Marseille, France), Marios E. Froudarakis (Alexandroupolis, Greece), Lina Zuccatosta (Torrette, Ancona, Italy), Prashant Nemichand Chhajed (Mumbai, India)
PA2487
Bleeding risk of pleural procedures in patients taking antiplatelet therapy: A multicentric prospective study Laurence Dangers (Paris, France), Laurence Dangers, Gilles Mangiapan, Mikael Alves, Naïke Bigé, Jonathan Messika, Elise Morawiec, Mathilde Neuville, Christophe Cracco, Gaëtan Béduneau, Nicolas Terzi, Isabelle Huet, Xavier Dhalluin, Nathalie Bautin, Jean-Jacques Quiot, Corinne Appere-de Vecchi, Thomas Similowski, Cécile Chenivesse
PA2488
The use of propofol for sedation in medical thoracoscopy Morné Vorster (Durbanville, South Africa), Morné Vorster, Wolfgang Frank, Maurizio Bernasconi, Coenraad Koegelenberg
PA2489
Indwelling pleural catheters: Audit of a new medical service Kirsty Hett (Cardiff, United Kingdom), K.L. Hett, H.E. Davies
PA2490
Idiopathic pleural effusions (IPE) and predictive prognosis MARIA ALEJANDRA GALARZA JIMENEZ (Madrid, Spain), María Alejandra Galarza Jiménez, Esteban Pérez Rodríguez, Deisy Diana Barrios Barreto, Paola Lucía Arrieta Narváez, Rosa Mariela Mirambeaux Villalona, Patricia Castro Acosta
PA2491
Ultrasound assisted medical thoracoscopy amr shoukri (Cairo, Egypt), Amr Shoukri
PA2492
Efficacy and safety of a new pleural device for the ambulatory management of pneumothorax Muhammad Tufail (BRENTWOOD, United Kingdom), Muhammad Tufail, Jonathan Bennett, Rakesh Panchal, Richard Varey, Neil Martin
PA2493
Video-assisted medical thoracoscopic (VAMT) lung biopsy in the diagnosis of diffuse pulmonary infiltrates Tamer Hadidy (Mansoura, Egypt), Tamer El Hadidy, Mohammed Ibrahim, Fatma Moustafa, Amina Abd El-Maksoud
PA2494
Hippocrates quoted ’If an empyema does not rupture, death will occur’. Is single port medical thoracoscopy (S-MT) able ’to make it safely rupture’? Georgia Hardavella (Aghia Paraskevi, Athens, Greece), Georgia Hardavella, Nikos Papakonstantinou, Ioannis Karampinis, Houssein Mumbasa, Shereen Ajab, Mohammed Shafaat, Stavros Malagaris, Gerasimos Papavasileiou, Nikolaos Anastasiou
PA2495
Outcomes of an initiative to improve safety of medical thoracostomy tube insertion Conceicao Santos (Bradbury, Australia), Conceição Santos, Saurabh Gupta, Stephanie Naim, Jonathan Williamson
PA2496
A randomized controlled trial of bronchial occlusion therapies with silicon spigots or fibrin glue against intractable spontaneous pneumothorax Kengo Murata (Tokyo, Japan), Kengo Murata, Yu Sato, Kentaro Sakashita, Miyako Kitazono, Akihiko Wada, Tetsuya Obara, Mikio Takamori
PA2497
Extended indications for local anaesthesia thoracoscopy poulomi chatterjee (gurgaon, India), Poulomi Chatterjee, Shaiwal Khandelwal, Ali Khan, Pinky Goyal, Bornali Datta
PA2498
Thoracoscopy: Diagnostic and therapeutic applications Christine Silva Costa (Leiria, Portugal), Christine Costa, Patrícia Dionísio, Luís Martins, Salvato Feijó, Paula Monteiro, J. Rosal Gonçalves, Cristina Bárbara
PA2499
Pneumothorax size versus chest drain size, does it make a difference? What actually happened Katherine Myall (London, United Kingdom), Katherine Myall, Bethia Bradley, Tudor Toma, Andrew Hearn
PA2500
Role of medical thoracoscopy in multiloculated effusions and empyema: Review of 52 cases Arjun Srinivasan (Coimbatore, India), Arjun Srinivasan, Mahadevan Sivaramakrishnan, Pattabhiraman Vallandramam, Pavan Yadav
165
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2501
Utility of closed pleural biopsy in thoracoscopic era Madhav K. Kale (Pune, India), Madhav Kale, Shoaib Shaikh, Parag Khatavkar
PA2502
Predictor of success in endobronchial occlusion therapy against intractable pneumothoraces Kengo Murata (Tokyo, Japan), Kengo Murata, Yu Sato, Kentaro Sakashita, Miyako Kitazono, Akihiko Wada, Tetsuya Obara, Mikio Takamori
PA2503
Cytology and chest computed tomography findings of pleural effusion in patients with lung cancer Clement Brun (Saint-Etienne, France), Clement Brun, Maxim Sauvage, Cyril Guibert, Blandine Laurent, Georgia Karpathiou, Sophie Bayle, Fabien Forest, Isabelle Court-Fortune, Nathalie Glas, Michelle Cottier, Michel Peoc’h, Marios Froudarakis, Jean-Michel Vergnon
PA2504
Thoracoscopic talc poudrage in pneumothorax Patrícia Alexandra Vieira Dionísio (Oeiras, Portugal), Patrícia Dionísio, Christine Costa, Salvato Feijó, Paula Monteiro, J. Rosal Gonçalves, Cristina Bárbara
PA2505
Thoracoscopic talc Poudrage pleurodesis for malignant effusions Konstantinos Mantzouranis (Athens, Greece), Xanthi Tsiafaki, Konstantinos Mantzouranis, Lefteris Zygouris, Ioannis Gkinis, Filio Kotrogianni
Hall 14-21
Session 269
12:50 - 14:40
Thematic Poster: Surgery and lung cancer: results and complications Chairs : Stefano Elia (Naples, Italy), Marinus Paul (Amsterdam, Netherlands), marcello migliore (catania, Italy), Chair to be confirmed PA2506
Perioperative outcomes of RATS pulmonary lobectomy for lung cancer and tuberculosis in a learning curve setting Peter Yablonsky (Saint Petersburg, Russian Federation), Peter Yablonskii, Grigorii Kudriashov, Sabriddin Nuraliev, Igor Vasilev, Armen Avetisyan, Andrey Kozak, Olga Sokolova
PA2507
Robotic & VATS lobectomy for aspergilloma - Good clinical outcome with early surgical referral Ashish Prakash (Gurgaon, India), Ashish Prakash, Poulomi Chatterjee, Shaiwal Khandelwal, Ali Zamir Khan, Bornali Datta, Pinky Goel, Bandana Mishra
PA2508
The use of one-lung high frequency jet ventilation in minimally invasive operative lung interventions Igor Medvinskiy (Yekaterinburg, Russian Federation), Igor Medvinskiy, Sergey Skornyakov, Dmitriy Eremeev
PA2509
Neutrophil/lymphocyte ratio as a prognostic marker for curative-intent surgery in non-small cell lung cancer Sebastian Lugg (Bromsgrove, United Kingdom), Sebastian Lugg, Tikka Theofano, Amy Kerr, Paula Agostini, Kerry Adamas, Ehab Bishay, Richard Steyn, Maninder Kalkat, Pala Rajesh, David Thickett, Babu Naidu
PA2510
Mode of influence of the type of the chest wall invasion to the outcome of surgical treatment of patients with primary lung cancer Vladimir Milenkovic (Belgrade, Republic of Serbia), Vladimir Milenkovic, Milan Savic, Dejan Moskovljevic, Nikola Atanasijadis, Dragan Subotic
PA2511
Smoking habits of pre-surgery patients Joanne Webb (Birmingham, United Kingdom), Joanne Webb, Amy Kerr, David Thickett, Babu Naidu
PA2512
Survival after lung metastasis resection. Review of 17 years in our centre XENIA ROXANA LOPEZ CONTRERAS (Pamplona (Navarra), Spain), Xenia López Contreras, Vanesa López Rodríguez, Sonia Herrero Martín, Jose Cascante Rodrigo, Pilar Cebollero Rivas, Juan Guelbenzu Zazpe, Javier Hueto Pérez de Heredia
PA2513
Predicted postoperative FEV1, DLCO and VO2 underestimate the postoperative values after lung resection in patients with symptomatic non-cystic fibrosis bronchiectasis Camilla Vallilo (São Paulo, Brazil), Camilla Carlini Vallilo, Ricardo Mingarini Terra, Andre Albuquerque, João Marcos Salge, Alessandro Mariani, Marcia Augusto, Milena Mako Suesada, Paulo Pêgo-Fernandes
PA2514
Microalbuminuria as a predictor of cardiopulmonary complications after thoracic surgery Lucio Cagini (Perugia, Italy), Lucio Cagini, Marco Andolfi, Rossella Potenza, Silvia Ceccarelli, Jacopo Vannucci, Gianpaolo Reboldi, Vito Aldo Peduto, Francesco Puma
PA2515
Prediction of complications after pneumonectomy in patients with pulmonary tuberculosis Larisa Kiryukhina (Saint Petersburg, Russian Federation), Larisa Kiryukhina, Olga Volodich, Armen Avetisyn, Igor Vasilyev, Pavel Gavrilov, Natalia Nefedova, Piotr Yablonskiy
PA2516
Pneumonectomy for lung cancer after induction chemotherapy alone: Is the risk really higher? Milan Savic (belgrade, Republic of Serbia), Milan Savic, Dragan Subotic, Nikola Atanasijadis, Dejan Moskovljevic, Milan Gajic, Vladimir Milenkovic, Marko Popovic
166
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2517
Risk factors for major complications and mortality in children following pneumonectomy (PNE) Veronica S Giubergia (Olivos - Buenos Aires, Argentina), Verónica Giubergia, Forencia Alessandrini, Carolina Barrias, Aixa Reussman, Carlos Giuseppussi, Barrenechea Marcelo, Murtagh Patricia
PA2518
Smoking at the time of curative-intent lung cancer surgery dramatically influences peri-operative complications Sebastian Lugg (Bromsgrove, United Kingdom), Sebastian Lugg, Theofano Tikka, Amy Kerr, Paula Agostini, Kerry Adamas, Ehab Bishay, Richard Steyn, Maninder Kalkat, Pala Rajesh, David Thickett, Babu Naidu
PA2519
Ultrasound assessment of extravascular lung water after thoracic surgery Lucio Cagini (Perugia, Italy), Lucio Cagini, Cecilia Becattini, Maria Giovanna Ranalli, Marco Andolfi, Alessandra Mancuso, Jacopo Vannucci, Giancarlo Agnelli, Francesco Puma
PA2520
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Monika Franczuk (Warszawa, Poland), Monika Franczuk, Piotr Rudzinski, Jerzy Usiekniewicz, Renata Langfort, Jacek Prokopowicz, Tadeusz Orlowski, Stefan Wesolowski
PA2522
Pre-operative peak workload as predictor of post-operative complications in patients undergoing pulmonary resection for lung cancer DIEGO AGUSTIN RODRIGUEZ (Barcelona, Spain), Diego A. Rodríguez, Elena Curto, Anna Rodó-Pin, Clara Martin, Alberto Rodríguez, Joaquim Gea, Rafael Aguiló
PA2523
Interventional management and outcome of lung cancer and cardiac disease. Meta-analytic review Stylianos Michaelides (Athens, Greece), Stylianos Michailidis, George Bablekos, Maria Gioka, Olga Vartzioti, George Ionas, Alexandros Alexopoulos
Hall 14-22
Session 270
12:50 - 14:40
Thematic Poster: Non-inflammatory monitoring of airway diseases Chairs : Silvano Dragonieri (Bari, Italy), Caterina Bucca (Turin, Italy), Eleftherios Zervas (Athens, Greece), Wendy van Beurden (Enschede, Netherlands) PA2524
Shifting respiratory care from lungs to patients: The necessity for patient-focused approach Antonios Kouris (Eindhoven, Netherlands), Antonios Kouris, Charalampos Michailidis, Christos Bergeles
PA2525
Novel water born cooling system enables early mobilization of patients hospitalized for urban heat stress related chronic lung disease progression Christian Witt (Berlin, Germany), Andre Jean Schubert, Nina Omid, Robert Ehrlich, Melissa Jehn, Uta Liebers, Dieter Scherer, Wilfried Endlicher, Christian Witt
PA2526
Factors associated with low-level physical activity in elderly patients with chronic obstructive pulmonary disease Sang Hee Lee (Gunpo, Republic of Korea), Sang Hee Lee, Eun jung Jo, Mi Hyun Kim, Min Ki Lee, Jung Seop Eom, Jeong Ha Mok, Kwangha Lee, Ki Uk Kim
PA2527
Gender differences of echocardiographic characteristics in patients with acute exacerbation of COPD Krishna K Sharma (Jaipur, Rajastahan, India), Krishna K. Sharma, Hemant Chaturvedi, Rudra Dev Pandey, Titiksha Choyal
PA2528
Impact of a mobile health pilot study on asthma rescue inhaler use, control and self-management David Van Sickle (Madison, United States of America), David Van Sickle, Jason Su, Meredith Barrett, Olivier Humblet, Kelly Henderson, Ted Smith
PA2529
Factors related with hospitalizations due to asthma exacerbations ANA GOMEZ LARRAURI (Leioa (Vizcaya), Spain), Ana Gomez Larrauri, Sandra Pedrero Tejada, Amanda Lopez Picado, Sophe Garcia Fuika, Patricia Sobradillo Ecenarro, Paola Carolina Oliva Rodriguez, David Bravo Blanco
PA2530
The appropriateness of Saint George’s respiratory questionnaire in patients with systemic lupus erythematosus and respiratory system involvement Mariana Cebanu (Chisinau, Republic of Moldova), M. Cebanu, V. Sadovici, V. Salaru, M. Mazur
PA2531
Does personality traits and medication adherence affect control of asthma? Ay e Füsun Kalpaklio lu (Ankara, Turkey), A. Fusun Kalpaklioglu, Ayse Baccioglu, Arzu Yorgancioglu, Yavuz Havlucu, Bilun Gemicioglu, Suhail Sheikh, Munevver Erdinc, Ozlem Goksel
PA2532
Sputum microbiology in patients with stabile COPD Vanya Kostadinova (Varna, Bulgaria), Vanya Kostadinova, Yordan Radkov, Temenuga Stoeva, Darina Miteva, Anna Dyakova
PA2533
Aiding paramedics recognition of type two respiratory failure (T2RF) Tanveer Khalid (Greater Manchester, United Kingdom), Tanveer Khalid, Saumitra Baksi
167
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2534
Waist to thigh ratio as a predictor of physical activity in COPD patients Lamprini Tina (Sparta, Greece), Lamprini Tina, NIkolaos Konstas, Panagiotis Andriopoulos
PA2535
The role of specialist nurse led review on reducing emergency asthma admissions in a district general hospital (DGH) Cristina Avram (Manchester, United Kingdom), Cristina Avram, Sandra Dermott, Emma Jones, Imran Aziz
PA2536
Assessment of cough frequency to inhaled mannitol using ambulatory acoustic cough recording Clair Lake (Camperdown, Australia), Clair Lake, Peter Briffa, Phillip Munoz, Keith Wong, John Brannan
PA2537
Phenotypic characterization of asthma-COPD overlap syndrome: Comparison with asthma and COPD Toshiya Inui (Tokyo, Japan), Toshiya Inui, Keitaro Nakamoto, Mitsuru Sada, Shingo Tsuji, Masuo Nakamura, Yasutaka Tanaka, Takashi Koide, Saori Takata, Takuma Yokoyama, Takeshi Saraya, Daisuke Kurai, Haruyuki Ishii, Hiroo Wada, Hajime Takizawa
PA2538
Patient education and its impact on asthma control: A case-control study Selina Dürr (Liestal, Switzerland), Selina Dürr, Jonas Scheuzger, Kurt E. Hersberger, David Miedinger, Prashant N. Chhajed, Andreas Zeller, Jörg D. Leuppi, Claudia Steurer-Stey
PA2539
Monitoring of cough trends in COPD Albertus den Brinker (Eindhoven, Netherlands), Albertus Den Brinker, Peter Hill, Yvette Hayman, Michael Crooks, Alyn Morice
PA2540
Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Rik Loijmans (Amsterdam, Netherlands), Rik J.B. Loymans, Persijn J. Honkoop, Evelien H. Termeer, Helen K. Reddel, Jiska B. Snoeck-Stroband, Willem J. Assendelft, Tjard R. Schermer, Peter J. Sterk, Jacob K. Sont, Gerben Ter Riet
PA2541
Cough is an independent contributor to health-related quality of life impairment in COPD Gaëtan Deslee (Reims, France), Gaëtan Deslee, Pierre-Régis Burgel, Roger Escamilla, Pascal Chanez, Isabelle CourtFortune, Pascale Nesme-Meyer, Grazellia Brinchault-Rabin, Thierry Perez, Gilles Gebrak, Denis Caillaud, Jean Louis Paillasseur, Nicolas Roche
PA2542
Comparison of COPD patients with high and low symptoms from a real-world US survey Barry Make (Denver, United States of America), Barry Make, Tzy-Chyi Yu, Jessica Marvel, Robert Wood, Mark Small, Victoria Higgins
PA2543
Bronchiectasis prevalence and relationship with clinical features in COPD Kristoffer Ostridge (Bournemouth, United Kingdom), Kristoffer Ostridge, Nicholas Williams, Victoria Kim, Malwina Wojtas, Stephen Harden, Emmanuel Aris, Mathieu Peeters, Jeanne-Marie Devaster, Simon Bourne, Tom Wilkinson
Hall 14-23
Session 271
12:50 - 14:40
Thematic Poster: The immunology of allergic airway disease Chairs : Trudeke G.M. Möller (Capelle aan den Ijssel, Netherlands), Christian Taube (Leiden, Netherlands), Anders Linden (Stockholm, Sweden), Gary P. Anderson (Parkville, Australia) PA2544
Macrophage subsets in lung tissue of healthy controls and asthma patients Barbro Melgert (Groningen, Netherlands), Christina Draijer, Carian Boorsma, Patricia Robbe, Machteld Hylkema, Wim Timens, Maarten Van den Berge, Dirkje Postma, Barbro Melgert
PA2545
The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma Nikolaos Lazarinis (Stockholm, Sweden), Nikolaos Lazarinis, Johan Bood, Craig Wheelock, Sven-Erik Dahlén, Barbro Dahlén
PA2546
Characteristics of asthma in U-BIOPRED severe and non-severe cohorts with distinct biomarker profiles Edward Ingenito (Cambridge, United States of America), Edward Ingenito, Jeanette Bigler, Dirk Smith, Anthony Rowe, Fan Chung, Ratko Djukanovic, Ana Sousa, Ian Adcock, Peter Sterk, Ajay Nirula
PA2547
Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Xiujuan YAO (Beijing, China), Xiujuan Yao, Wei Wang, Kewu Huang, Chris J. Corrigan, Yong Chang Sun, Sun Ying, Xiujuan Yao
PA2548
The role of antioxidant enzymes in the pathogenesis of asthma and the formation of the features of its clinical course Ramziddin Kholliev (Samarkand, Uzbekistan), Ramziddin Kholliyev, Musa Khaydarov, Khikmat Turayev, Jamshid Ismailov
PA2549
Hypersensitivity pneumonitis: Clinical spectrum and outcome Chirine Moussa (Ezahra, Tunisia), Chirine Moussa, Besma Hamdi, Anissa Berraies, Alaa Akaad, Saberine Louhaichi, Jamel Ammar, Agnes Hamzaoui
168
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2550
Importance of levels production of Il-4 in the pathogenesis and formation of the phenotype of asthma Gulbahor Fazilova (Samarkand, Uzbekistan), Gulbahor Fazilova
PA2551
IL5 and IL13 modulate trans-compartmental activation and migration of eosinophils Sebastian Reuter (Mainz, Germany), Sebastian Reuter, Helen Meyer-Martin, Hendrik Beckert, Roland Buhl
PA2552
MicroRNA-146a and microRNA-155 expression in induced sputum of allergic asthmatics Carina Malmhäll (Göteborg, Sweden), Carina Malmhäll, Sahar Alawieh, Jan Lötvall, Madeleine Rådinger
PA2553
Intranasal GSK2245035 induces prolonged reductions in nasal responsiveness to allergen Anne Ellis (Kingston, Canada), Anne K. Ellis, Diana Quint, Will Powley, Laurie A. Lee
PA2554
A randomized, placebo-controlled trial using anti-IgE to treat allergic bronchopulmonary aspergillosis Astrid Voskamp (Leiden, Netherlands), Astrid Voskamp, Andrew Gillman, Karen Symons, Alessandra Sandrini, Jennifer Rolland, Robyn O’Hehir
PA2555
Environmental factors in schools determining exercise-induced symptoms in children Iwona Stelmach ( ód , Poland), Iwona Stelmach, Lukasz Cichalewski, Wlodzimierz Stelmach, Daniela Podlecka, Joanna Jerzynska
PA2556
Characterisation of adipose tissue macrophage phenotypes in obese asthma Hashim Periyalil (Fletcher, Australia), Hashim Periyalil, Lisa Wood, Tim Wright, Costa Karihaloo, Peter Gibson
PA2557
CCD contributes for cross-reactivity between food allergen and Bermuda and Timothy pollen allergen in Southern China Wenting Luo (Guangzhou, China), Wenting Luo, Baoqing Sun
PA2558
Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium Irene Heijink (Groningen, Netherlands), Irene Heijink, Marnix Jonker, Dirkje Postma, Maarten Van den Berge
PA2559
Placebo controlled trial of vitamin D supplementation in allergic rhinitis Balakrishnan Menon (Delhi, India), Balakrishnan Menon, Yusuf Dar, Tinu Garg, Harish Bhatia, Charanjeet Kaur
PA2560
Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran Mozhgan Moghtaderi (Shiraz, Islamic Republic of Iran), Mozhgan Moghtaderi, Shirin Farjadian, Zeinab Hosseini
PA2561
Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Claus Kroegel (Jena, Germany), Claus Kroegel, Martin Foerster, Kristin Lerche, Maryam Aalamian-Mattheis, Janett Happe, Anne Moeser, Stephanie Korn
PA2562
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain eva MARTINEZ MORAGON (Valencia, Spain), Eva Martínez Moragón, Fernando Sanchez-Toril Lopez, Miguel Díaz Palacios, Juan José Liñana Santafe, Marta Lleonart Dormuà
PA2563
TNF- , IL-6, IL-10 serum activity in patients with obesity-associated arterial hypertension depend on bronchial obstruction presence Kseniia Sytnyk (Kharkiv, Ukraine), Kseniia Sytnyk, Butov Dmytro
Hall 14-24
Session 272
12:50 - 14:40
Thematic Poster: CAP: prognostic factors in frail patients Chairs : Wim G. Boersma (Alkmaar, Netherlands), Francisco Sanz Herrero (Quart de Poblet (Valencia), Spain), Michael Tamm (Basel, Switzerland) PA2564
Clinical stability predictors and length of stay in adults with community-acquired pneumonia. Prospective cohort Renata Alejandra Baez Saldana (Mexico, Mexico), Renata Báez-Saldaña, Cristobal Guadarrama-Pérez, Alejandro Marín, Araceli Santillán-Martínez, Patricia Castillo-González, Uriel Rumbo-Nava, Teresa Aguirre-Pérez, Rogelio Hernández
PA2565
Factors affecting short and long-term mortality after community-acquired pneumonia Fatma Tokgöz Aky l (Istanbul, Turkey), Fatma Tokgöz Akyil, Armagan Hazar, Murat Yalçinsoy, Aykut çilli, Burcu çelenk, Oguz Kilinç, öznur Kilinç, Abdullah Sayiner, Sezai Tasbakan, Nurdan Köktürk, Aysin Sakar Coskun, Yavuz Havlucu, Ayten Filiz, Ebru çakir Edis
PA2566
Prior antibiotics and outcomes in patients hospitalized with pneumonia Eric Mortensen (Dallas, United States of America), Eric Mortensen, David Rotter, Antonio Anzueto
169
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2567
Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database Nurdan Köktürk (Ankara, Turkey), Ayse Baha, Nurdan Kokturk, Sakine Bahcecioglu, Canan Gunduz, Sezai Tasbakan, Abdullah Sayiner, Aysin Coskun, Feride Durmaz, Aykut Cilli, Burcu Celenk, Oguz Kilinc, Seda Salman, Armagan Hazar, Fatma Tokgoz
PA2568
Decisions about discharge of patients with community-acquired pneumonia from the emergency department Rodolfo Ferrari (Cesena, Italy), Rodolfo Ferrari, Pierluigi Viale, Sara Tedeschi, Daniela Agostinelli, Fabio Tumietto, Mario Cavazza
PA2569
A local perspective on risk factors and short term outcomes in community-acquired pneumonia Caroline Gouder (Kappara, Malta), Caroline Gouder, Donia Gamoudi, Marija Agius, Nadia Gamoudi, David Farrugia, Michael Borg, Josef Micallef
PA2570
Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia Adamadia Liapikou (Athens, Greece), Sotiria Makrodimitri, Adamantia Liapikou, Sofia Rautopoulou, Andreas Anastasopoulos, Nektaria Sidiropoulou, Katerina Dimakou, Michael Toumbis
PA2571
Predictors of 30-day mortality in elderly patients with community acquired pneumonia Xubin Huang (Guangzhou, China), Xubin Huang, Jun Zhang, Xinyan Huang, Mian Zeng, Yanzhu Chen
PA2572
Health care-associated pneumonia and community-acquired pneumonia: A single-center experience Burcu Çelenk Karabo a (A r , Turkey), Burcu Karaboga, Aykut çilli, Rusen Uzun
PA2573
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Elena Klester (Barnaul, Altay Krai, Russian Federation), Elena Klester, Karolina Klester, Igor Babushkin
PA2574
Broad-spectrum antibiotics cannot improve the prognoses of high-risk nursing- and healthcare-associated pneumonia Kenji Umeki (Yufu, Japan), Kenji Umeki, Kohsaku Komiya, Issei Tokimatsu, Masaru Ando, Kazufumi Hiramatsu, Jun-ichi Kadota
PA2575
CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortalityrate settings Qi Guo (Shenzhen, China), Hai-yan Li, Qi Guo, Wei-dong Song, Yi-ping Zhou, Ming Li, Xiao-ke Chen, Hui Liu, Hong-lin Peng, Hai-qiong Yu, Xia Chen, Nian Liu, Zhong-dong Lü, Li-hua Liang, Qing-zhou Zhao, Mei Jiang
PA2576
Legionella score performance under an outbreak of Legionnaires’ disease Ana Cysneiros (Lisbon, Portugal), Ana Cysneiros, Francisca Lopes, Joao Carvalho, Patricia Dionisio, Christine Costa, Bruno Von Amann, Ana Dias, Gustavo Carvalho, Margarida Serrado, Filipe Froes, Cristina Barbara
PA2577
The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia Stine Andersen (Copenhagen, Denmark), Stine Andersen, Gertrud Louise Baunbæk-Knudsen, Andreas Vestergaard Jensen, Pelle Trier Petersen, Pernille Ravn
PA2578
Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia – A prospective study Joana Filipa Clemente Duarte (Entroncamento, Portugal), Joana Duarte, Ana Tavares e Castro, Raquel Silva, Lurdes Correia, Adélia Simão, Armando Carvalho
PA2579
The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia shu yazaki (tokyo, Japan), Shu Yazaki, Torahiko Jinta, Naoki Nishimura, Hiroshi Nakaoka, Kohei Okafuji, Atsushi Kitamura, Yutaka Tomishima, Takeshi Kimura, Naohiko Chohnabayashi
PA2580
Impact of diabetes mellitus on microbiological profiles of patients with community-acquired pneumonia in a central hospital João Henrique Cordeiro da Costa (Baguim do Monte - Gondomar, Portugal), João Cordeiro da Costa, José Almeida, Ana Marques, Angelina Lameirão
Hall 14-25
Session 273
12:50 - 14:40
Thematic Poster: Clinical issues in CAP: microbiological and radiological determinants Chairs : Andres de Roux (Berlin, Germany), Adamadia Liapikou (Athens, Greece), James D. Chalmers (Perth, United Kingdom)
PA2581
LATE-BREAKING ABSTRACT: Differences in S. pneumoniae serotypes distribution causing CAP in hospitalized adults in Spain according to comorbidities by a new urinary antigen detection (UAD) test. The CAPA study Rosario Menendez Villanueva (Valencia, Spain), Rosario Menéndez, Antoni Torres, Pedro Pablo España, Emilio PérezTrallero, José Luis López Hontangas, Francesc Marco, Ana Patricia Martínez de la Fuente, José María Marimón, Alexandra Gimeno, Catia Cilloniz, Ane Uranga, María Ercibengoa, César Balseiro, Cristina Méndez, Isabel Cifuentes
170
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2582
Time to return to work or daily activities under an outbreak of Legionnaires´ disease in Portugal Bruno Miguel Paixão von Amann (Lisbon, Portugal), Bruno Von Amann, Christine Costa, João Carvalho, Francisca Lopes, Patrícia Dionísio, Ana Dias, Ana Cysneiros, Gustavo Carvalho, Margarida Serrado, Filipe Froes, Cristina Bárbara
PA2583
Bacteraemia in outpatient with community-acquired pneumonia Catia Cilloniz Campos (Barcelona, Spain), Catia Cilloniz, Chiara Traverso, Chiara Chiurazzi, Albert Gabarrus, Ernesto Rangel, Francesc Marco, Josep Mensa, Antoni Torres
PA2584
Improvement in culture yield using blood culture bottles in infected pleural fluid Davis Paul (Thrissur, India), Davis Paul Chelangara, Unais Sadakkathulla, Thomas George
PA2585
Accuracy in diagnosis of pneumonia and advancing quality initiative Alexander Youzguin (Southport, United Kingdom), Alexander Youzguin, Aleksandra Rozek
PA2586
Does the grade of a physician influence the likelihood of agreeing with radiologist report? Kanwal Tariq (Hull, United Kingdom), Kanwal Tariq, Julia Harrington, Patrick McDermott, Hassan Burhan, Andrea Collins
PA2587
Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia Francisco Cabello Rueda (Ronda, Spain), Enrique Javier Soto Hurtado, Maria Jesus Gutierrez Fernandez, Maria Dolores Almenara Escribano, Francisco Cabello Rueda, Mariana Zaragoza Rascon, Jose Maria Gonzalez Miret, Alberto Ruiz Cantero
PA2588
Community acquired pneumonia – Coding and advancing quality Kanwal Tariq (Hull, United Kingdom), Patrick McDermott, Kanwal Tariq, Julia Harrington, Hassan Burhan, Andrea Collins
PA2589
Clinical presentation of Legionnaires’ disease during an outbreak: The typical presentation of an atypical pathogen Ana Patrícia Gomes da Rocha Dias (Lisbon, Portugal), Ana Dias, Patrícia Dionísio, Francisca Lopes, Christine Costa, João Carvalho, Gustavo Carvalho, Ana Cysneiros, Bruno Von Amann, Margarida Serrado, Filipe Froes, Cristina Bárbara
PA2590
Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia Burcu Çelenk Karabo a (A r , Turkey), Burcu Karaboga, Aykut çilli
PA2591
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Leyre Serrano Fernandez (Bilbao (Bizkaia), Spain), Leyre Serrano, Rafael Zalacain, Amaia Urrutia, Marta Garcia, Ainhoa Gomez, Sonia Castro, Ruth Diez, Elena Urra, Luis Alberto Ruiz
PA2592
Prevalence of group A -haemolytic streptococcus among children with pharyngitis in Ethiopia Getnet Tesfaw Tadege (Jimma, Ethiopia), Getnet Tesfaw, Gebre Kibru, Demeke Mekonnen, Alemseged Abdissa
PA2593
Disagreement in radiological diagnosis of community acquired pneumonia and its impact on management and mortality: Is the term ’pneumonia’ outdated? Julia Harrington (Liverpool, United Kingdom), Julia Harrington, Kanwal Tariq, Andrea Collins, Hassan Burhan, Patrick McDermott
PA2594
Diagnostic utility of beta defensin 2 and LL-37 for the differenciation between complicated and non-complicated infectious pleural effusions Carlos Antonio AMADO DIAGO (Santander (Cantabria), Spain), Carlos Antonio Amado, Milagros Ruiz de Infante, María del Carmen Fariñas, María Teresa García-Unzueta, Pedro Muñoz, Francisca Santos
PA2595
Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema Alaa Refaat (Kuwait, Kuwait), Alaa Refaat, Nasr Affara, Tark Muhsen, Moataz Salahuddin
PA2596
Community acquired legionella pneumophila pneumonia, clinical characteristics, outcomes and prognostic factors Leyre Serrano Fernandez (Bilbao (Bizkaia), Spain), Sonia Castro, Luis Alberto Ruiz, Ainhoa Gomez, Leyre Serrano, Elena Urra, Lorea Martinez-Indart, Marta Garcia, Beatriz Gomez, Rafael Zalacain
PA2597
Microbiological indicators from sputum of patients with exacerbation of COPD Aigerim Yergaliyeva (Astana, Kazakhstan), Nelya Bisenova, Aigerim Yergalieva
PA2598
Clinical profile and management of empyema thoracis: Identifying the gaps in resource limited setting Deebya Raj Mishra (Dharan, Nepal), Deebya Raj Mishra
PA2599
Coding for pneumonia in hospital: How accurate? Jayanth Bhat (Birmingham, United Kingdom), Jayanth Bhat, Sharon Stanley, Dominic Gair, Naveed Mustfa, Martin Allen
Hall 14-26
Session 274
Thematic Poster: Viral infections: basic research and clinical perspective
171
12:50 - 14:40
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Chairs : Sebastian L. Johnston (London, United Kingdom), Aran Singanayagam (London, United Kingdom), Tobias Welte (Hannover, Germany) PA2600
Human rhinovirus species in children with acute lower respiratory infections in Rabat, Morocco Alicia Annamalay (Subiaco, Australia), Alicia Annamalay, Joelene Bizzintino, Siew-Kim Khoo, Imane Jroundi, Chafiq Mahraoui, Rachid Benmessaoud, Cinta Moraleda, Peter Le Souëf, Quique Bassat
PA2601
LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbations Ernie Wong (London, United Kingdom), Ernie Wong, Michael Edwards, William Cookson, David Jackson, Sebastian Johnston
PA2602
Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae Karl J. Staples (Southampton, United Kingdom), Karl J. Staples, Zoe Pounce, Joshua C. Wallington, C. Mirella Spalluto, Denise Morris, Ben Nicholas, Ratko Djukanovic, Tom M.A. Wilkinson
PA2603
Evidence for cell mediated immune dysfunction in the COPD lung: The role of cytotoxic CD4+ T cells Tom Wilkinson (Southampton, United Kingdom), Karl J. Staples, Richard T. McKendry, C. Mirella Spalluto, Tom M.A. Wilkinson
PA2604
LSC Abstract – Synergistic pro-inflammatory effects of Haemophilus influenzae/RSV co-infections on respiratory epithelial cells Carla Bellinghausen (Maastricht, Netherlands), Carla Bellinghausen, Fahad Gulraiz, Emiel F.M. Wouters, Gernot G.U. Rohde, Frank R. Stassen
PA2605
Smoking alters cellular responses of primary bronchial epithelial cells to rhinovirus infection in an in vitro acute exposure model Maria C Zarcone (Oegstgeest, Netherlands), Maria C. Zarcone, Jasmijn A. Schrumpf, Pieter S. Hiemstra
PA2606
LSC Abstract – A novel immune regulatory function of neutrophils in rhinovirus infections Francesca Tang (Glebe, Australia), Francesca Tang, Phil Hansbro, Janette Burgess, Katherine Baines, Brian Oliver
PA2607
LSC Abstract – Rhinovirus infection induces NRF2 in monocytes but not in epithelial cells, via distinct intracellular pathways Andrew Durham (London, United Kingdom), Andrew L. Durham, Joseph Footitt, Sarah Essilfie-Quaye, Aurica G. Telcian, Patrick Mallia, Kazuhiro Ito, Peter J. Barnes, Sebastian Johnston, Ian M. Adcock
PA2608
Clinical and epidemiological features in H1N1 and H3N2 influenza A virus Ana Lucía Figueredo Cacacho (Zaragoza, Spain), Ana Lucia Figueredo, Elisa Minchole, Carolina Panadero, Dinora Polanco, Clara Viñado, Sandra García, Sara Gomara, Erika Leon, Laura Benedicto, Cristina Aguilar, Salvador Bello
PA2609
Clinical features of influenza virus infection of 2013/2014 season Yuki Iijima (Shimotsuke city, Tochigi prefecture, Japan), Yuki Iijima, Masashi Bando, Masayuki Nakayama, Naoko Mato, Takakiyo Nakaya, Hideaki Yamasawa, Yukihiko Sugiyama
PA2610
The role of viral infection in the progression of community-acquired pneumonia (CAP) Andrey Nikolaev (Saint-Petersburg, Russian Federation), Maxim Pugachev, Mikhail Kharitonov, Vladimir Ivanov, Vladimir Dancev, Yuriy Rudakov, Sergey Kotov, Svetlana Rubova, Mikhail Zhurkin, Andrey Nikolaev
PA2611
Retrospective analysis of viral pneumonia cases due to pandemic H3N2 Coskun Dogan (Istanbul, Turkey), Coskun Dogan, Sevda Sener Comert, Benan Caglayan, Serap Gencer, Elif Torun Parmaksiz, Ali Fidan, Banu Salepci
PA2612
Broccoli sprout homogenates and live attenuated influenza virus: Effect on peripheral blood natural kill cells Loretta Mueller (Basel, Switzerland), Loretta Müller, Terry L. Noah, Ilona Jaspers
PA2613
LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection Nathifa Moyo (Liverpool, United Kingdom), Nathifa Moyo, Gail Leeming, Khondoker Akram, Mark Tompkins, Gail Chapman, Tessa Walsh, Lynne Bingle, Colin Bingle, Ralph Tripp, James Stewart
PA2614
LSC Abstract – Cellular crosstalk between airway epithelial and endothelial cells during viral infections Cornelia Blume (Southampton, United Kingdom), Cornelia Blume, Emily J. Swindle, Riccardo Reale, Jane E. Collins, Timothy M. Millar, Hywel Morgan, Donna E. Davies
PA2615
LSC Abstract – Role For IL-1alpha in viral-induced inflammatory responses in an epithelial-fibroblast co-culture model of the airway mucosa Alison Hill (Southampton, United Kingdom), Alison Hill, Jessica Donaldson, Cornelia Blume, Liku Tezera, Hitasha Rupani, Paddy Dennison, Yvette Thirlwall, Kamran Tariq, Peter Howarth, Chris Grainge, Donna Davies, Emily Swindle
172
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2616
Mapping the cellular source and role of IL-22 in murine lung infections Maximilian Plank (Callaghan, Australia), Maximilian Plank, Gerard Kaiko, Steven Maltby, Hock Tay, Jessica Stewart, Scott Durum, Paul Foster
Hall 14-27
Session 275
12:50 - 14:40
Thematic Poster: Bronchiectasis and NTM infections: clinical and functional characterisation Chairs : Felix C. Ringshausen (Hannover, Germany), Adam Hill (Edinburgh, United Kingdom), Pieter Goeminne (Bornem, Belgium), Anthony De Soyza (Newcastle upon Tyne, United Kingdom)
PA2617
LATE-BREAKING ABSTRACT: Baseline demographic profile of subjects of the phase 3 RESPIRE 1 trial of ciprofloxacin dry powder for inhalation (DPI) in non-cystic fibrosis bronchiectasis (NCFB) Anthony De Soyza (Newcastle upon Tyne, United Kingdom), Anthony De Soyza, Timothy Aksamit, Elisabeth Operschall, Tiemo-Joerg Bandel, Ulrike Krahn, Margarita Criollo, Robert Wilson
PA2618
Prevalence of bronchiectasis in an inpatient respiratory service Paul King (Melbourne, Australia), Philip George, Peter Holmes, Paul King
PA2619
The dilation of bronchi (about 294 case) Lamia Berny (Casablanca, Morocco), Lamia Berny, Hanane Benjelloune, Nahid Zaghba, Abdelaziz Bakhatar, Najiba Yassine
PA2620
Diagnosis and aetiological treatment of bronchiectasis in adult patients Dimitrios Mermigkis (Athens Marousi, Greece), Dimitrios Mermigkis, Agathi Lekkakou, Stavroula Patsilinakou, George Petsinis, Eftixia Kourtelesi, Semiramis Zakaki, Konstantinos Dalamarinis, Xanthi Tsiafaki
PA2621
Impaired neutrophil function in patients with common variable immunodeficiency (CVID) Stuart Elborn (Belfast, United Kingdom), D. Mooney, M.M. Tunney, J.D. Edgar, S. McGrath, L. McIlreavey, E. Johnston, J.S. Elborn
PA2622
Viruses are commonly identified in the exhaled breath of adults with stable bronchiectasis Alicia Mitchell (Naremburn, Australia), Alicia Mitchell, Francesca Tang, Qi Ge, Lucy Morgan, Brian Oliver
PA2623
Bacterial colonization in bronchiectasis patients Kemal Can Tertemiz (Izmir, Turkey), Kemal Can Tertemiz, Aylin Ozgen Alpaydin, Betul Ozdel Ozturk, Volkan Karacam
PA2624
Clinical characteristics of pulmonary nocardiosis in immunocompetent patients Tetsuo Fujita (Chiba, Japan), Tetsuo Fujita, Koichiro Tatsumi
PA2625
Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection Juan Manuel Lebron Ramos (Marbella, Spain), Juan Manuel Lebron Ramos, Luis Fernandez de Rota Garcia, Alicia Padilla Galo, Begoña Tortajada Goitia, Jose Joaquin Cebrian Gallardo, Francisco Rivas Ruiz
PA2626
The use of home intravenous antibiotics in adult non-CF bronchiectasis Louise Anning (Exeter, United Kingdom), Louise Anning, Mhairi McNeill, Alexander Rose, Hilary Mortimer, Nicholas Withers
PA2627
Audit investigating inhaled corticosteroid use in bronchiectasis patients at University Hospital Llandough, Wales Sabena Ali (Bristol, United Kingdom), Sabena Ali, Jamie Duckers, Dawn Lau
PA2628
Sputum neutrophils and functional status in non-cystic fibrosis bronchiectasis (NCFB) is related to microbial colonization Federico Dente (Pisa, Italy), Federico Lorenzo Dente, Marta Bilotta, Manuela Latorre, Letizia Vergura, Silvana Cianchetti, Barbara Vagaggini, Pierluigi Paggiaro
PA2629
Comparison of metabolic and ventilatory demands and perception of effort during activities of daily living in patients with non-cystic fibrosis bronchiectasis and healthy subjects Carina Nunes (Sao Paulo, Brazil), Carina Nunes, Jacqueline Boldorini, Anderson Camargo, Samia Rached, Rodrigo Athanazio, Fernanda Lanza, Alberto Cukier, Rafael Stelmach, Simone Dal Corso
PA2630
Comparison of three methods for preparation of bronchiectasis sputum supernatents for biomarker measurement Wasyla Ibrahim (Glasgow, United Kingdom), Wasyla Ibrahim, Megan Crichton, Alison Dicker, James Chalmers
PA2631
Nontuberculous mycobacteria: Experience in a respiratory departament of a general university hospital Ivis Suarez Lorenzo (Alicante, Spain), Ivis Suárez Lorenzo, Raquel García Sevila, Joan Gil Carbonell, Adelina Gimeno Gascón, Verónica Vilella Tomás, Concepción Martín Serrano, Juan Carlos Rodríguez Díaz
173
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2632
Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study Naoki Nishimura (Chuo City, Tokyo, Japan), Naoki Nishimura, Hiroshi Nakaoka, Torahiko Jinta, Yutaka Tomishima, Kohei Okafuji, Noboru Uchiyama, Naohiko Chohnabayashi
PA2633
Efficacy and safety of kanamycin addition in patients with drug-refractory mycobacterium avium complex lung disease Naoaki Watanabe (Tokyo, Japan), Naoaki Watanabe, Ryota Satou, Nobuharu Ohshima, Masahiro Kawashima, Kazuko Miyakawa, Ayumi Mitsune, Masahiro Ohgiya, Kenichi Okuda, Takahiro Ando, Aika Suzuki, Junko Suzuki, Kimihiko Masuda, Akira Yamane, Atsuhisa Tamura, Hideaki Nagai, Shinobu Akagawa, Hirotoshi Matsui, Nobuyuki Kobayashi, Ken Ohta
PA2634
Positive respiratory samples with mycobacteria non tuberculous and aspergillus fumigatus: Retrospective and multicenter study barras elodie (gauchin-le-gal, France), Elodie Barras, Claire Andrejak, Vincent Jounieaux
PA2635
Development of a quality of life module for nontuberculous mycobacteria (NTM) Alexandra Quittner (Coral Gables, United States of America), Alexandra L. Quittner, Anjana Madan, Estefany Saez-Flores, Kenneth N. Olivier, Kevin Fennelly, Andreas Schmid, Matthias Salathe
Hall 14-28
Session 276
12:50 - 14:40
Thematic Poster: Immunodepression and severe pneumonia Chairs : Carlos Agusti Garcia-Navarro (Barcelona, Spain), Ignacio Martin-Loeches (Dublin, Ireland), Miquel Ferrer Monreal (Barcelona, Spain), Carlos M. Luna (Buenos Aires, Argentina) PA2636
Modified IDSA/ATS minor criteria for severe community-acquired pneumonia best predicted mortality Qi Guo (Shenzhen, China), Qi Guo, Wei-dong Song, Hai-yan Li, Yi-ping Zhou, Ming Li, Xiao-ke Chen, Hui Liu, Hong-lin Peng, Hai-qiong Yu, Xia Chen, Nian Liu, Zhong-dong Lü, Li-hua Liang, Qing-zhou Zhao, Mei Jiang
PA2637
Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis Irina Balatskaya (Barnaul, Russian Federation), Tatiana Martynenko, Irina Balatskaya, Olga Dunaeva, Andrey Momot, Yakov Shoychet
PA2638
Prevalence, characterization and impact of hospital-acquired infections in a pulmonology department Ana Marçôa (Matosinhos, Portugal), Raquel Marçôa, Rita Linhas, Daniel Coutinho, José Carneiro, Ana Gonçalves, Raquel Melo, Carla Ribeiro, Manuela Vanzeller, Nuno Vieira, Margarida Mota, Miguel Guimarães, Teresa Shiang
PA2639
Bugs of the new era: More questions than answers Shyam Krishnan (Jamshedpur, India), Shyam Krishnan, Bhaskar Narayan Chaudhuri, Manasi Ghosh, Santu Samanta, Raja Dhar
PA2640
Persistence of staphylococcus aureus in lower respiratory tract in patients undergoing mechanical ventilation Alicia Lacoma de la Torre (Badalona, Spain), Alicia Lacoma, Meissiner Gomes-Fernandes, Eduard Mesalles, Fernando Arméstar, Raquel Villar, Irma Casas, Sònia Molinos, Montserrat Giménez, Vicente Ausina, Cristina Prat
PA2641
Three years analysis of pulmary infections of mechanically ventilated patiens in adult intensive care unit Arzu Dogru (Istanbul, Turkey), Arzu Dogru, Sibel Devrim, Canan Unlu, Elif Tigen Tukenmez, Melek Gura
PA2642
Ventilator associated pneumonia in a respiratory intensive care unit: What has changed during three years period? Zehra Nur Töreyin (Izmir, Turkey), Zehra Nur Toreyin, Pervin Korkmaz Ekren, Sohret Aydemir, Husnu Pullukcu, Feza Bacakoglu
PA2643
The treatment costs of ventilator associated pneuomonia in intensive care unit Arzu Dogru (Istanbul, Turkey), Arzu Dogru, Sibel Devrim, Canan Unlu, Elif Tukenmez Tigen, Melek Gura
PA2644
Gastroparesis following lung transplantation: Risk factor for pneumonia JORDI RIERA DEL BRIO (Barcelona, Spain), Jordi Riera, Jaume Baldirà, Sergio Ramirez, Cristopher Mazo, Carolina Maldonado, Berta Saez-Gimenez, Irene Bello, Teresa Pont, Jordi Rello
PA2645
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Kseniia Bielosludtseva (Dniepropetrovsk, Ukraine), Kseniia Bielosludtseva
PA2646
Diagnostic yield of bronchoalveolar lavage in hematological malignancies Kemal Can Tertemiz (Izmir, Turkey), Kemal Can Tertemiz, Aylin Ozgen Alpaydin, Seda Salman, Inci Alacacioglu
174
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2647
Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Fikret Kurhan, Timur Pirildar, Tugba Goktalay, Aysin Sakar Coskun, Pinar Celik, Arzu Yorgancioglu
PA2648
The frequency of respiratory infections in patients with chronic hepatitis C treated with pegylated-Interferon Iosif Marincu (Timisoara, Romania), Iosif Marincu, Emilian Popovici, Stefan Mihaicuta, Patricia Poptelecan, Livius Tirnea
PA2649
Pulmonary aspergillous; clinical features and outcomes in a tertiary care hospital Nousheen Iqbal (Karachi, Pakistan), Nousheen Iqbal, Muhammad Irfan, Ali Zubairi, Safia Awan, Javaid Khan
PA2650
Pulmonary aspergilloma Regis Bopaka (Casablanca, Morocco), Regis Gothard Bopaka, Hasna Jabri, Wiam El Khattabi, Hicham Afif
PA2651
Chronic necrotizing aspergillosis, an emerging trend in clinical practice Miguel Lopes (Seixal, Portugal), Miguel Lopes, Fernando Menezes, Jorge Vieira
PA2652
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Midori Sugisaki (Tokyo, Japan), Midori Sugisaki, Eri Hagiwara, Hiroyuki Ito, Norikazu Matsuo, Tomohisa Baba, Shigeru Komatsu, Takashi Ogura
PA2653
Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Nils Hoyer (Copenhagen, Denmark), Nils Hoyer, Jørgen Vestbo
PA2654
Co-infection by pneumocystis jirovecii and histoplasma capsulatum presenting with pulmonary miliary pattern in an HIV positive young male Carlos Andrès Celis Preciado (Bogota, Cundinamarca, Colombia), Javier Lasso, Laura Kattah, Marlon Bustos, Carlos Celis
Hall 14-29
Session 277
12:50 - 14:40
Thematic Poster: Respiratory infections: from basic science to clinical issues Chairs : Antonio R. Anzueto (San Antonio, United States of America), Michael Loebinger (London, United Kingdom), Francesco Blasi (Milan, Italy)
PA2655
LATE-BREAKING ABSTRACT: Oral solithromycin has a favorable profile versus oral moxifloxacin for treatment of adult community-acquired pneumonia (CABP) in elderly patients and those with COPD or asthma David Oldach (Chapel Hill, United States of America), David Oldach, Carlos Luna, Peter Szabo, Ismail Mitha, Cristina Tanaseanu, Alexis Doreski, Carlos Barrera, Anita Das, Kara Keedy, Brian Jamieson, Prabhavathi Fernandes
PA2656
LATE-BREAKING ABSTRACT: Does sputum colour hold the answer? The AERIS study Viktoriya (known as Victoria) Kim (Winchester, United Kingdom), Viktoriya L. Kim, Ngaire A. Coombs, Karl J. Staples, Nicholas P. Williams, Kristoffer Ostridge, Malwina M. Wojtas, Mathieu Peters, Emmanuel Aris, Jeanne-Marie Devaster, Simon C. Bourne, Tom M. Wilkinson
PA2657
LATE-BREAKING ABSTRACT: Bronchial microbiome in severe persistent oral corticosteroid-dependent asthma Laura Millares (Badalona, Spain), Laura Millares, Guadalupe Bermudo, Marian García-Nuñez, Carles Grimau, Natalia Martínez-López, Vicente Pérez-Brocal, Xavier Pomares, Christian Domingo, Eduard Monsó
PA2658
LSC Abstract – Functional metagenomics of respiratoy microbiome in exacerbated COPD Laura Millares (Badalona, Spain), Laura Millares, Rafaela Ferrari, Miguel Gallego, Vicente Pérez-Brocal, Concepción Montón, Xavier Pomares, Marian García-Nuñez, Silvia Capilla, Mateu Espasa, Andres Moya, Eduard Monsó
PA2659
LSC Abstract – Monocyte-derived macrophages upregulate surface MR1 in response to NTHi Joshua Wallington (Southampton, United Kingdom), Joshua Wallington, Richard McKendry, Anthony Williams, Karl J. Staples, Tom Wilkinson
PA2660
LSC Abstract – Extracellular vesicle release by macrophages during infection with non-typeable Haemophilus influenzae Charlotte Volgers (Maastricht , Netherlands), Charlotte Volgers, Birke Benedikter, Paul Savelkoul, Frank Stassen
PA2661
LSC Abstract – The host genetic background impacts on pseudomonas aeruginosa-induced T cell responses and individual susceptibility/resistance to respiratory infection Lorenza Spagnuolo (Milan, Italy), Lorenza Spagnuolo, Maura De Simone, Nicola Lorè, Cristina Cigana, Ida De Fino, Veronica Basso, Anna Mondino, Alessandra Bragonzi
PA2662
Low level laser therapy (830nm) decreases LPS-induced acute respiratory distress syndrome independent of IL-10 release Manoel Carneiro de Oliveira Jr (São Paulo, Brazil), Manoel Carneiro de Oliveira Junior, Auriléia Aparecida Brito, Nicole Cristine Rigonato Oliveira, Ana Roberta Almeida Oliveira, Jeferson Comin Jonco Aquino Junior, Adilson Santos Andrade Souza, Erasmo Assunção Neto, Luis Vicente Franco Oliveira, Ana Paula Ligeiro Oliveira, Rodolfo De Paula Vieira
175
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 PA2663
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant? Shyam Krishnan (Jamshedpur, India), Shyam Krishnan, Tarang Kulkarni, Samim Khan, Raja Dhar
PA2664
Screening for methicilin-resistant staphylococcus aureus colonization: A pulmonology department experience Rita Linhas (Porto, Portugal), Rita Linhas, Raquel Marçoa, Carla Ribeiro, Manuela Vanzeller, Teresa Shiang
PA2665
Staphylococcus aureus and antibiotic susceptibility profiles in respiratory samples from inpatients of a tertiary pneumology center in Romania Stefan Ciprian Gigea (Bucarest, Romania), Adriana Moisoiu, Stefan-Ciprian Gigea, Madalina-Maria Florea, AlexandraMaria Sora, Ionela Erhan, Andrei-Alexandru Muntean, Stefan Dumitrache Rujinski, Dragos-Cosmin Zaharia, Miron Alexandru Bogdan, Mircea-Ioan Popa
PA2666
Clinical implications of agr operon activity in staphylococcus aureus strains isolated from respiratory samples Alicia Lacoma de la Torre (Badalona, Spain), Maisem Laabei, Meissiner Gomes-Fernandes, Alicia Lacoma, Raquel Villar, Tobias A. Jenkins, Vicente Ausina, Cristina Prat
PA2667
Concentrations of immunoglobulin G antibodies against pertussis toxin does not decrease over a long period of time in Japan Yumi Sakakibara (Tokyo, Japan), Yumi Sakakibara, Yoshio Ohtani, Torahiko Jinta, Toshihide Fujie, Yasunari Miyazaki, Naohiko Inase
PA2668
Evolving profile of hydatid cysts about 42 cases Imène Touari (Batna, Algeria), Imene Touari, Meriem Bouali, Asma Ouahchi, Souad Hamoud, Mohamed Redha Selmani, Abdelmadjid Djebbar
PA2669
Complicated hydatid cyst of lung Hamida Kwas (Ariana, Tunisia), Hamida Kwas, Emna Guermazi, Ines Zendah, Amel Khattab, Ibtihel Khouaja, Habib Ghedira
PA2670
LSC Abstract – Chitinase-like protein Chil1 modulates type I interferon response through TLR9-AP3-IRF7 axis during streptococcus pneumoniae lung infection Charles Dela Cruz (New Haven, United States of America), Wei Liu, Chad Marion, Rajvir Singh, Chuan Hua He, Chun Geun Lee, Jack Elias, Charles Dela Cruz
PA2671
Exhaled breath analysis and measurement of respiratory mechanics in calves suffering from enzootic bronchopneumonia (EBP) Carmen Claudia Klein (Gotha, Germany), C.C. Klein, S. Wietstock, A.-K. Dorn, A. Kappe, W.-I. Bock, A. Ahrens
PA2672
LSC Abstract – The inflammatory response to streptococcus pneumoniae is exaggerated by the polysaccharide capsule Jimstan Periselneris (London, United Kingdom), Jimstan Periselneris, Suneeta Chimalapati, Gillian Tomlinson, Catherine Hyams, Alex Dyson, Mahdad Noursadeghi, Jeremy Brown
PA2673
Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells Wajihul Khan (Delhi, India), Wajihul Khan, Raghuram VLN Shrungaram, Shobha Broor, Shama Parveen
Hall 14-30
Session 278
12:50 - 14:40
Thematic Poster: Non-tuberculous mycobacteria and molecular microbiology Chairs : Dirk Wagner (Freiburg, Germany), Berit Lange (Freiburg, Germany), Christian Wejse (Aarhus, Denmark), Chair to be confirmed
PA2674
Chest imaging comparison between non-tuberculous and tuberculosis mycobacteria in sputum acid fast bacilli smear-positive patients Haiqing Chu (Shanghai, China), Haiqing Chu, Bing Li, Lan Zhao, Dongdong Huang, Zhemin Zhang, Jingbo Zhang, Tao Gui, Liyun Xu, Xiwen Sun
PA2675
Clinical evaluation of glycopeptidolipid core antigen IgA antibodies for serodiagnosis of mycobacterium avium complex disease Yoshihiro Kobashi (Kurashiki Okayama, Japan), Yoshihiro Kobashi, Keiji Mouri, Shigeki Kato, Mikio Oka
PA2676
Retrospective investigation of the usefulness of GPL-core antibody for diagnosing MAC-PD in patients who had undergone bronchoscopic examination Yasunari Kishino (Tokyo, Japan), Yasunari Kishino, Tsukasa Ohnishi, Sojiro Kusumoto, Hitomi Furukawa, Yasunori Murata, Shin Ohta, Mayumi Yamamoto, Yoshio Watanabe, Hiroo Ishida, Shintaro Suzuki, Takao Shirai, Akihiko Tanaka, Takuya Yokoe, Hironori Sagara
PA2677
The change in serum Ca 19-9 levels according to treatment responses in pulmonary nontuberculous mycobacterial disease Eunhye Lee (Seoul, Republic of Korea), Eunhye Lee, Ji Young Hong, Young Ae Kang, Ji Eun Park, Eunkyong Goag
176
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2678
Stricter microbiological criteria are useful surrogate in estimating the prevalence of nontuberculous mycobacterial pulmonary disease in Croatia Marko Jakopovic (Zagreb, Croatia), Mateja Jankovic Makek, Ivan Sabol, Jakko Van Ingen, Marko Jakopovic, Ljiljana Zmak, Vera Katalinic-Jankovic, Brigita Ticac, Ljiljana Bulat-Kardum, Gzim Redzepi, Mirna Vranic-Ladavac, Miroslav Samarzija
PA2679
Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease Marko Jakopovic (Zagreb, Croatia), Mateja Jankovic Makeke, Ivan Sabol, Jakko Van Ingen, Marko Jakopovic, Ljiljana Zmak, Andrea Vukic Dugac, Ana Hecimovic, Daniel Sekula, Drazen Strelec, Dina Mihelcic, Miroslav Samarzija
PA2680
Clinical resuts of therapy for non-tuberculous myocardium avium complex -Multicentric retrospective study of 581 patients in Japan Shuichi Yano (Matsue, Japan), Shuichi Yano, Kazunari Tsuyuguchi, Katsuhiro Suzuki, Toumei Ogawa, Katsuo Yamada, Masaji Okada, Norimasa Ito
PA2681
Mediastinal nontuberculous mycobacteria (NTM) – A rare entity Neeraj Shah (New Malden, United Kingdom), Neeraj Shah, Akanksha Malhotra, Felicity Perrin, Marc Lipman, George Santis, Ronan Breen
PA2682
Non tuberculous mycobacteria (NTM) contamination in a hospital water supply network: Association with pulmonary infection in respiratory wards Gregorino Paone (Rome, Italy), Salvatore D’Antonio, Daniela Orazi, Elisabetta Magini, Alfonso Altieri, Mario Giuseppe Alma, Giovanni Puglisi, Isabella Sanguigni, Rita De santis, Gregorino Paone
PA2683
Non-tuberculous mycobacterium incidence & treatment rates in university hospitals of North Midlands (UK) Jayanth Bhat (Birmingham, United Kingdom), Jayanth Bhat, Ashwin Rajhan, Sushil Agarwal, Mandy Middleton, Svenrick Lehm
PA2684
Clinical importance of pulmonary nontuberculous mycobacteria isolated among HIV-positive individuals in Ghana Stephanie Bjerrum (Valby, Denmark), Stephanie Bjerrum, Joseph Oliver Commey, Mercy Jemina Newman, Kennedy Kwasi Addo, Sabine Ruesch-Gerdes, Aase Bengaard Andersen, Isik Somuncu Johansen
PA2685
Pulmonary mycobacterium xenopi infection in Japan Ayako Shiozawa (Shinjyuku, Japan), Ayako Shiozawa, Eriko Morino, Jin Takasaki, Masayuki Hojo, Haruhito Sugiyama
PA2686
Utility of PCR in bronchial aspirate samples for rapid diagnosis of tuberculosis NOEMI MENGUAL MACENLLE (A Coruña, Spain), Noemí Mengual Macenlle, Pilar Sanjuán López, Manuel Lorenzo López Reboiro, Antón Penas Truque, Lidia Méndez Marote, Luis Alejandro Pérez de Llano
PA2687
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Hasnain Javed (Lahore, Pakistan), Hasnain Javed, Nazia Jamil
PA2688
Genotypes of mycobacterium tuberculosis isolates from autopsy material of HIV-positive tuberculosis patients in Russia Anna Vyazovaya (St. Petersburg, Russian Federation), Anna Vyazovaya, Marina Maiskaya, Tatiana Otten, Igor Mokrousov, Olga Narvskaya
PA2689
The distribution of Beijing genotype among mycobacterium tuberculosis strains obtained from patients of different dispensary registration groups from Nizhny Novgorod region of the Russian Federation in 2013-2014 Yulia Alyapkina (Moscow, Russian Federation), Yu S. Alyapkina, E.A. Iljina, L. Yu Vatolina, V. Yu Zhuravlev
PA2690
Evaluation of real-time polymerase chain reaction assay for the diagnosis of mycobacterium tuberculosis complex Adriana Socaci (Timisoara, Romania), Adriana Socaci, Georgeta Gilda Popescu, Constantin Marica
PA2691
Early detection of pulmonary TB in children by STNPCR in blood and urine Juliana Figueirêdo da Costa Lima (Recife, Brazil), Juliana Figueirêdo da Costa Lima, Fabiana Cristina Fulco Santos, Lílian Maria Lapa Montenegro, Gabriela De Moraes Rêgo Guedes, Haiana Charifker Schindler, Aline Santos Peixoto, Marcela Pereira Salazar, Rosana Albuquerque Montenegro
PA2692
Nonspecific microflora in patients associated with pulmonary multidrug-resistant tuberculosis A.O. Hayrapetyan (Abovian, Armenia), L.T. Nikolayan, N.R. Beglaryan, A.O. Hayrapetyan
PA2693
Usefulness of MDCT and MRI in determining of drug-resistant tuberculosis Stevan Ivkovic (Nis, Republic of Serbia), Stevan Ivkovic, Aleksandar Ivkovic, Tamara Milosavljevic, Dusan Ivkovic
Hall 14-31
Session 279
12:50 - 14:40
Thematic Poster: Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
177
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Chairs : Alena Skrahina (Minsk region, Belarus), Raquel Almeida Ferreira Duarte Bessa Melo (Porto, Portugal), Christoph Lange (Borstel, Germany), Chair to be confirmed PA2694
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Bae Soohyun (Daegu, Republic of Korea), SooHyun Bae, YooMi Yeo, KyoungWook Jo, TaeSun Shim
PA2695
Factors influencing sputum smear conversion delay in tuberculosis Soumaya Ben Saad (Bizerte, Tunisia), Islam Mejri, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar
PA2696
Healing predictors when treating MDR-TB Houda Snène (Tunis, Tunisia), Houda Snène, Hafaoua Daghfous, Soumaya Ben Saad, Mouna Ben Khelifa, Sameh Belhadj, Leila Slim, Fatma Tritar
PA2697
Case series of 83 XDR-TB patients in an urban hospital of Gujarat, India; an interim analysis Kumar Utsav (Varanasi, India), Kumar Utsav, Rajesh N. Solanki
PA2698
Improvement of the treatment protocol for newly diagnosed pulmonary tuberculosis, depending on the glutathioneS-transferase gene polymorphism Lilia Todoriko (Chernivtsi, Ukraine), Lilia Todoriko, Igor Semyaniv
PA2699
Failure predictors when treating MDR-TB Houda Snène (Tunis, Tunisia), Houda Snène, Hafaoua Daghfous, Soumaya Ben Saad, Mouna Ben Khelifa, Sameh Belhadj, Leila Slim, Fatma Tritar
PA2700
Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre Olena Oliveira (Porto, Portugal), Olena Oliveira, Anabela Silva, Ana Antunes, Ricardo Reis, Ana Horta, Raquel Duarte
PA2701
Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan Danish Rao (Karachi, Pakistan), Danish Rao, Nisar Rao, Saifullah Baig, Nadeem Ahmed
PA2702
Short term effects of dendritic cell based immunotherapy in multiple and extensively drug resistant pulmonary tuberculosis in Belarus Larisa Litskevich (Minsk, Belarus), Litskevich Larysa, Skrahin Alexander, Shpakovskaya Natalia, Hancharou Andrey, I.V. Romanova, Titov Leonid
PA2703
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Nataliya Zemlyanaya (Tomsk, Russian Federation), Nataliya Zemlyanaya, Irina Gelmanova, Sergey Mishustin, Galina Janova
PA2704
Active pharmacovigilance for multidrug-resistant tuberculosis patients treated with Linezolid, Belarus – 2014-2015 Alena Skrahina (Minsk region, Belarus), Alena Skrahina, Hennadz Hurevich, Dennis Falzon, Liudmila Zhylevich, Valiantsin Rusovich, Masoud Dara, Andrei Dadu, George Sakvarelidze, Svetlana Setkina
PA2705
Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus Parvaneh Baghaei Shiva (Tehran, Islamic Republic of Iran), Parvaneh Baghaei, Payam Tabarsi, Mohammad Reza Masjdei
PA2706
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Karwai Tsang (London, United Kingdom), Karwai Tsang, Ahmed Seedat, Edward Morris, Stella Abiona, Moerida Belton
PA2707
Could side effects of MDR-TB treatment change the outcome of the disease? Houda Snène (Tunis, Tunisia), Houda Snène, Hafaoua Daghfous, Soumaya Ben Saad, Mouna Ben Khelifa, Sameh Belhadj, Leila Slim, Fatma Tritar
PA2708
Side effect profile of 2nd line drugs in multi drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis Bhumika Madhav (Navi Mumbai, India), Bhumika Madhav, Aparna Iyer, T.K. Jayalakshmi
PA2709
The side effects, the outcome and the mortality of anti-tuberculosis treatment in dialyzed patients: A 10-year retrospective analysis Nayuta Saito (Tokyo, Japan), Nayuta Saito, Yugo Kaneko, Yuri Baba, Hironori Kawamoto, Ikumi Fujisaki, Kai Ryu, Sho Watanabe, Tsugumi Horikiri, Aya Seki, Akira Kinoshita, Hiroshi Takeda, Keisuke Saito, Kazuyoshi Kuwano
PA2710
Peripheral neuropathy in XDR-TB patients on second line anti-tubercular therapy Mani Tiwari (Surat, India), Mani Tiwari, Mahendra Patel, Khyati Shamaliya
PA2711
Confirmation of preclinical data on tioureidoiminomethylpyridinium perchlorate in treatment of MDR-TB Anna Starshinova (St-Peterburg, Russian Federation), Maria Pavlova, Tatiana Vinogradova, Anna Starshinova, Piotr Yablonskii, Irina Chernokhaeva, Ludmila Archakova, Nadezda Sapozhnikova
178
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Hall 14-32
Session 280
12:50 - 14:40
Thematic Poster: Epidemiology of TB: deaths, co-morbidities, migration and children Chairs : Enrico Girardi (Rome, Italy), Chair to be confirmed PA2712
Age-specific mortality among tuberculosis-patients in Denmark 1998-2010 Andreas Fløe Nielsen (Aarhus V, Denmark), Andreas Fløe, Ole Hilberg, Christian Wejse, Anders Løkke, Jakob Kjellberg, Rikke Ibsen, Poul Jennum
PA2713
The causes of death among patients with tuberculosis Liljana Simonovska (Skopje, FYROM (Macedonia)), Lijlana Simonovska, Mirjana Trajcevska, Vladimir Mitreski, Iva Simonovska
PA2714
Latent tuberculosis infection and the risk of cancer: A nationwide population-based study Vincent Yi-Fong Su (Taipei, Taiwan), Vincent Yi-Fong Su, Wei-Juin Su
PA2715
Prevalence of pre-XDR-TB, XDR-TB among MDR-TB Patients registered at Ojha Institute of Chest Diseases, Karachi Nisar Ahmed Rao (Karachi, Pakistan), Nisar Rao, Saifullah Baig, Niaz Hussain, Nadeem Ahmed, Danish Rao
PA2716
Risk factor and resistance pattern of MDR TB among suspected cases of Oromia Region Mohammed Suaudi Hassen (Adama, Ethiopia), Mohammed Suaudi Hassen
PA2717
Drug resistance among new TB cases in some Russian regions Vadim Testov (Fryazino, Moscow Region, Russian Federation), Vadim Testov, Vladimir Puzanov, Marina Yakimova, Victor Punga
PA2718
Prevalence of drug resistance in foreign-born TB patients in Germany and among TB patients in the country of origin: Are they similar? The example of Turkey (2005-2010) and Russia (2010-2011) Anne Lallemand (Berlin, Germany), Anne Lallemand, Walter Haas, Barbara Hauer, Lena Fiebig
PA2719
The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010 Ramona Elena Nedelcu (Bucarest, Romania), Ramona Elena Nedelcu, Gilda Popescu, Victor Spinu, Cristina Popa
PA2720
The twin epidemics: HIV / DR-TB co-infection in 2012 Ramona Elena Nedelcu (Bucarest, Romania), Ramona Elena Nedelcu, Victor Spinu, Gilda Popescu
PA2721
Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine Svitlana A. Cherenko (Kiev, Ukraine), Svitlana Cherenko, Nataliia Litvinenko
PA2722
Danish born children with tuberculosis: An epidemiological and genetic investigation of source cases Line Lindebo Holm (Copenhagen, Denmark), Line Lindebo Holm, Erik Svensson, Peter Andersen, Isik Somunco Johansen
PA2723
Diabetes mellitus and pulmonary tuberculosis – Portuguese retrospective cohort João Henrique Cordeiro da Costa (Baguim do Monte - Gondomar, Portugal), João Cordeiro da Costa, Marta Gomes, Raquel Duarte
PA2724
Clinical and epidemiological characteristics of tuberculosis in children after the cancel of massive tuberculin diagnostics and BCG revaccination at the age of 14 Alexander Eismont (Minsk, Belarus), Aleksandr Eismant, Anna Plashchinskaya, Zhanna Krivosheeva
PA2725
Characteristics of non-resident new TB cases in Moscow City, Russia Evgeny Belilovskiy (Moscow, Russian Federation), Elena Bogorodskaya, Sergey Borisov, Evgeny Belilovsky, Piotr Seltsovsky, Ludmila Rybka
PA2726
Prevalence of diabetes mellitus in new tuberculosis cases in Baghdad Mohammad Abdulrazaq (Baghdad, Iraq), Mohammad Abdulrazaq, Abdulla Alfarttoosi
PA2727
Features of pulmonary tuberculosis in migrants Artiom Jucov (Chisinau, Republic of Moldova), Artiom Jucov, Evelina Lesnic
PA2728
HIV and tuberculosis co-infection: A 7 year retrospective cohort study David Manuel Araújo (Porto, Portugal), David Araújo, Leonor Meira, Leonor Almeida, Rita Boaventura, Nuno Osório, Ivo Ferreira, Sara Magalhães, Angélica Ramos, Teresa Carvalho, Fernando Rodrigues, António Castro, João Tiago Guimarães, Margarida Saraiva, Helder Novais Bastos
PA2729
Tuberculosis recurrence Soumaya Ben Saad (Bizerte, Tunisia), Islam Mejri, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar
179
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2730
Seasonaly of pulmonary tuberculosis in Tunisia Jouda Cherif (Tunis, Tunisia), Jouda Cherif, Sonia Toujani, Asma Sebei, Meriem Mjid, Yacine Ouahchi, Nozha Ben Salah, Jalloul Daghfous, Bechir Louzir, Nadia Mehiri, Majed Beji
PA2731
Detection of tuberculous etiology of bronchiectasis in a high burden TB country Oxana Munteanu (Chisihau, Republic of Moldova), Oxana Munteanu, Doina Rusu, Nicoleta Chetrari, Victor Botnaru
Hall 14-33
Session 281
12:50 - 14:40
Thematic Poster: Management of TB: a patient focus Chairs : Marc Lipman (London, United Kingdom), Keertan Dheda (Cape Town, South Africa), Martina Sester (Homburg, Germany), Chair to be confirmed PA2732
Patient and health system delays for tuberculosis patients diagnosed in medical colleges of Puducherry in India Ramesh Chand Chauhan (Puducherry, India), Ramesh Chand Chauhan, Anil Jacob Purty, Zile Singh
PA2733
Predictors of defaulting from treatment among patients with tuberculosis Mohammad Abdulrazaq (Baghdad, Iraq), Mohammad Abdulrazaq, Layth Salihi, Abdulla Alfarttoosi
PA2734
Out-patient MDR-TB care in Moldova Alexandru Buga (Chisinau, Republic of Moldova), Alexandru Buga, Valeriu Crudu, Liliana Domente, Gunta Dravniece, Marina Tadolini, Giovanni Battista Migliori, Davide Manissero
PA2735
MDR TB treatment results of GFATM program implementation in Tomsk, Russia Dmitrii Taran (Moscow, Russian Federation), Dmitrii Taran, Peter Golubchikov
PA2736
Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT) Neus Altet (Barcelona, Spain), Neus Altet, Joan Pau Millet, Jose Maldonado, Israel Molina, Joel Gonzalez, Juanita Soteras
PA2737
A cross-over study to compare the Lung Flute™ to hypertonic saline inhalation about the performance of inducing sputum for the diagnosis of pulmonary tuberculosis Kentaro Sakashita (Tokyo, Japan), Kentaro Sakasihta, Akira Fujita, Mikio Takamori, Tomonari Matsumoto, Eriko Shigeto, Takehumi Saitou, Yasuto Nakatsumi, Taku Nakagawa, Kenji Ogawa, Satoshi Mitarai, Hideo Ogata, Hajime Goto
PA2738
Diagnosis of pulmonary and extra-pulmonary tuberculosis in Paraguay using the electronic nose (ParaNose study) Rosarito Coronel (Asuncion, Paraguay), Rosarito Coronel, Mabel Rodriguez, Marcel Bruins, Jan Willem Gerritsen, Roscio Gomez, Gilberto Chaparro, Domingo Perez, Jan Bart Yntema, Cecile Magis-Escurra
PA2739
Transmission of mycobacterium tuberculosis Ural 163-15 lineage causing multidrug-resistant tuberculosis among hospitalized patients Valeriu Crudu (Chisinau, Republic of Moldova), Valeriu Crudu, Matthias Merker, Christoph Lange, Ecaterina Noroc, Elena Romancenco, Dumitru Chesov, Gunar Günther, Alaxandru Buga, Sofia Alexandru, Stefan Niemann
PA2740
Monitoring of mycobacterium tuberculosis presence on the objects of TB hospital Natalya Eremeeva (Yekaterinburg, Russian Federation), Nataly Eremeeva, Diana Vakhrusheva, Marionella Kravchenko, Vladimir Kanishev, Xenija Belousova, Tatjana Umpeleva
PA2741
Treatment outcome among HIV positive and HIV negative TB patients in Chandigarh, India: A retrospective cohort study Shveta Saini (Panchkula, Haryana, India), Shveta Saini, Mukhmohit Singh
PA2742
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey Aylin Babal k (Istanbul, Turkey), Aylin Babalik, Sinem Koyman, Aysegül Yildirim, Zeki Kiliçaslan
PA2743
Tuberculosis in native and foreign born populations in Portugal Raquel Almeida Ferreira Duarte Bessa Melo (Porto, Portugal), João Paulino, Raquel Duarte, Ana Martins, Miguel Machado, Rita Gaio
PA2744
Aspects of TB endemia in Bucharest Emilia Tabacu (Bucarest, Romania), Emilia Tabacu, Gilda Popescu, Nicoleta Cioran
PA2745
Anti-tuberculosis drug resistance distinctive features -The Republic of Azerbaijan 2012-2013 Irada Akhundova (Baku, Azerbaijan), Irada Akhundova, Elcan Mammedbekov
PA2746
Fifteen years period (2000-2014) of resistant TB forms in Vojvodina (Serbia) Miroslav Ili (Beograd, Republic of Serbia), Miroslav Ilic, Ivan Kopitovic, Marija Vukoja, Vesna Kuruc, Svetlana Kasikovic-Lecic
180
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2747
Drug-resistant tuberculosis in Turkmenistan: Results of the first nationwide survey Andrei Dadu ( Copenhagen, Denmark), Meahry Durdyeva, Svetlana Tomasova, Arax Hovhannesy, Bahtygul Karriyeva, Masoud Dara, Harald Hoffmann, Pierpaolo De Colombani, Matteo Zignol, Andrei Dadu
PA2748
Comparative lentiviral versus adenoviral gene transfer of GM-CSF to bone marrow-derived versus pulmonary macrophages of mice Alena Singpiel (Hannover, Germany), Alena Singpiel, Julia Schneider, Regina Maus, Jennifer Bohling, Friederike BehlerJanbek, Renata Stripecke, Tobias Welte, Ulrich Maus
PA2749
The effectiveness of TB treatment in patients with gastrointestinal tract disorders, depending on the way of administration of anti-TB drugs Mykhailo Kuzhko (Kiev, Ukraine), Mykhailo Kuzhko, Ljubomyr Procyk, Oksana Avramchuk
PA2750
Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB) Igor Motus (Ekaterinburg, Sverdlovsk Oblast, Russian Federation), Igor Motus, Igor Medvinskiy, Elena Kildusheva, Sergey Skornyakov, Glafira Zaletaeva, Anna Tzvirenko, Eugeniy Egorov, Svetlana Krasnoborova
PA2751
C-reactive protein and pulmonary tuberculosis: What correlation with disease severity Hamida Kwas (Ariana, Tunisia), Hamida Kwas, Emna Guermazi, Ines Zendah, Emna Ben Jemia, Amel Khattab, Ibtihel Khouaja, Habib Ghedira
Hall 14-34
Session 282
12:50 - 14:40
Thematic Poster: Case series and clinical conundrums in TB Chairs : Heinke Kunst (London, United Kingdom), Simon Tiberi (London, United Kingdom), Elmira Ibraim (Bucarest, Romania), Lorenzo Guglielmetti (Paris, France) PA2752
Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients Aylin Özgen Alpayd n (Izmir, Turkey), Aylin Ozgen Alpaydin, Mucahit Ozbilgin, Madina Abdulleyeva, Selver Seda Salman, Tufan Egeli, Tarkan Unek, Oguz Kilinc, Vildan Avkan-Oguz
PA2753
Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus Oksana Komissarova (Moscow, Russian Federation), Oksana Komissarova, Olga Konyayeva, Olga Berejnaya, Rizvan Abdullaev, Irina Vasilyeva
PA2754
Tuberculosis in patients receiving treatment of TNF-alpha inhibitors Sermin Börekçi (Istanbul, Turkey), Sermin Borekci, Deniz Demir Yilmaz, Ersan Atahan, Yesim Ozguler, Benan Musellim, Vedat Hamuryudan, Hurrem Gul Ongen
PA2755
Clinical and morphological features of HIV-associated tuberculosis Nkolaj Burinsky (Gomel, Belarus), Nikolaj Burynski, Irina Buynevich, Roman Loginov, Svetlana Goponyako, Elena Demidova
PA2756
Endobronchial tuberculosis Nawal Lakhdar (casablanca, Morocco), Nawal Lakhdar, Hasnae Jabri, Wiam El Khattabi, Hicham Afif
PA2757
Opportunistic infections in patients with lung tuberculosis Alexey Shibanov (Moscow, Russian Federation), Alexey Shibanov, Vladimir Stakhanov, Natalia Karazhas, Maria Kornienko, Maria Kalugina, Tatiyana Rybalkina
PA2758
Capsule endoscopy study on the prevalence of intestinal abnormality in pulmonary tuberculous patients with smearpositive acid-fast bacilli in feces Miwako Saitou (aiduwakamatsu, Japan), Miwako Saitou, Daiki Nemoto, Kennichi Utano, Tomoko Suzuki, Kazutomo Togashi, Katsunao Niitsuma
PA2759
Age as a factor affecting the diagnostic accuracy of TB lymphadenitis Kavita Dave (Milton Keynes, United Kingdom), Kavita Dave, Anita Saigal, Farhan Ullah, Ferduche Miah, Hardeep Kalsi, Robert Sands, Ajitha Jayaratnam
PA2760
Tuberculous empyema: Risk factors and prognosis Soumaya Ben Saad (Bizerte, Tunisia), Bouthaina Melki, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar
PA2761
Primary sternal tuberculosis mimicking anterior chest wall tumor: A case report Ayse Bahadir (Istanbul, Turkey), Bahadir Ayse, Mediha Gönenc Ortaköylü, Levent Cansever, Belma Akbaba, Mehmet Ali Bedirhan
PA2762
Management of pulmonary tuberculosis sequelae Aymen Ayari (Bizerte, Tunisia), Aymen Ayari, Hanene Smadhi, Islam Mejri, Hela Kamoun, Dorra Greb, Iness Akrout, Hela Hassen, Hejar Abdellghaffar, Leila Fkih, M. Lamine Megdiche
181
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2763
Induced sputum or bronchoscopy in smear negative tuberculosis: A randomized study Inge Muylle (Anderlecht, Belgium), Inge Muylle, Marie-Christine Payen, Maria Gabrovska, Peter Rummens, Vincent Ninane
PA2764
Consecutive surgical treatment for bilateral fibro-cavernous pulmonary TB Kirill Vladimirov (St.Petersburg, Russian Federation), Pyotr Yablonskii, Armen Avetisian, Galina Marfina, Grigorii Kudriashov, Kirill Vladimirov, Igor Vasilev, Evgenia Popova
PA2765
Ocular tuberculosis Maria Francisca Teixeira Lopes (Lisbon, Portugal), Francisca Teixeira Lopes, Sara Alfarroba, Ana Dinis, Maria da Conceição Gomes, António Tavares
PA2766
Anterior chest wall tuberculosis in children Ilija Kirovski (Skopje, FYROM (Macedonia)), Ilija Kirovski
PA2767
The effectiveness of polymerase chain reaction in testing the removed portion of lung during surgery Fatima Tashpulatova (Tashkent, Uzbekistan), Mirza Nigmatovich Tillashayhov, Z.A. Sayfiddinov, Z.H. Nuritdinov, Fatima Tashpulatova, Abduvahob Baboev
PA2768
Minimal inhibiting concentration of cationic surfactants against various genotypes of mycobacterium tuberculosis (MBT) Natalya Eremeeva (Yekaterinburg, Russian Federation), Natalya Eremeeva, Diana Vakhruscheva, Marionella Kravchenco
PA2769
Chest xray-may be a useful modality in detection of tuberculosis under national programme bornali Datta (GURGAON, India), Bornali Datta, David Ford, T.C. Tanwar, Poulomi Chatterjee, Pinky Goyal
PA2770
Notified or missed cases? An assessment of successful linkage for referred tuberculosis patients in South India Ramesh Chand Chauhan (Puducherry, India), Ramesh Chand Chauhan, Anil Jacob Purty
PA2771
The correlation between IRF-7 polymorphism (rs3758650) and tuberculosis in Chinese Han people quan wu (chengdu, China), Quan Wu, Can Wu, Yu Wang, Yi Ji, Qian Liu, Qing He
Hall 14-35
Session 283
12:50 - 14:40
Thematic Poster: New developments in medical education, web and internet Chairs : Tiago Manuel Pombo Alfaro
(Coimbra, Portugal), Monica Fletcher (Warwick, United Kingdom), Chair to be confirmed
PA2772
Improving standards of NIV - Simulation training Gemma Probert (Stockton, United Kingdom), Gemma Probert, Nadia Stock, Catherine Popplewell
PA2773
The use of mobile instant messaging technology to communicate audit findings and improve standards Lekshmi Das (Dewsbury, United Kingdom), Lekshmi Das, Kate Williams
PA2774
GOLD and GINA based software tool helps general practitioners to personalize COPD and asthma management Rustem Zulkarneev (Ufa, Republic of Bashkortostan, Russian Federation), Rustem Zulkarneev, Ildar Nugaev
PA2775
Pneumothorax management in Greece: A nationwide survey of respiratory physicians Charalampos Moschos (Athens, Greece), Angeliki A. Loukeri, Evgenia Triantafyllidou, Panagiotis-Dimitrios Spithakis, Zafeiria Barmparessou, Christos F. Kampolis, Charalampos Moschos
PA2776
A new team based non-technical skills educational course to improve the assessment and management of acutely ill respiratory patients Andrew Scott (Galway, Ireland), Andrew Scott, John Garvey, Anthony O’Regan, Dara Byrne
PA2777
Lung function testing: Knowledge of French pulmonology residents Maxime Patout (Rouen, France), Maxime Patout, Benjamin Coiffard, Lucile Sésé, Sylvia Korzeniewski, Valery Bunel, Antoine Luchez, Marie Desseigne, Malo Emery, Elodie Lhuillier, Hélène Salvator, Stephan Matecki, Thierry Perez, Arnaud Chambellan, Anna-Maria De Jesus, Thomas Gille, Catherine Tardif, Agnes-Francoise Pradel, Christian Straus, Luc Thiberville, Alain Didier
PA2778
Educational information events to enhance recruitment to clinical research trials Will Storrar (Winchester, United Kingdom), Will Storrar, Claire Roberts, Samal Gunatilake, Thomas Jones, Thomas Brown, Anoop Chauhan
PA2779
New oral anticoagulants (NOACs) vs. warfarin: Are doctors ready to switch? Manish Gautam (liverpool, United Kingdom), Mahin Ahmed, Manish Gautam
PA2780
Bronchoscopy for anesthesiologists and intensivists: Two years experience with the educational workshops in the Czech Republic Hana Bartáková (Prague, Czech Republic), H. Bartakova, M. Otahal, V. Baca, M. Balik, J. Votruba
182
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2781
RespiraNet Program: The first tele-spirometry service in South Brazil Maria Angela Fontoura Moreira (Porto Alegre, Brazil), Maria ângela Moreira, Igor Gorski Benedetto, Betina Charvet Machado, Marcelo Gonçalves, Luana Schneider, Sabrina Gadenz, Erno Harzheim
PA2782
Completion rates of an online COPD educational resource for nurses Monica Fletcher (Warwick, United Kingdom), Monica Fletcher, Chris Loveridge, Birthe Hellqvist Dahl, Gurpreet Randhawa, Nicholas Blackwell
PA2783
Trainee feedback of a simulation of an acutely ill patient Monique Camilleri (Msida, Malta), Monique Camilleri, Russel Tilney, Gabriella Balzan, Michael Pace Bardon, Josef Micallef, Martin Balzan
PA2784
How confident are medical registrars in performing respiratory orientated procedural skills? Andrew Scott (Galway, Ireland), Andrew Scott, Dara Byrne, John Garvey, Anthony O’Regan
PA2785
The uptake of technology and the SENSOR study Claire Roberts (Southampton, United Kingdom), Anoop Chauhan, Kevin Auton, Ann Dewey, Scott Elliott, Carole Fogg, Sharon Glaysher, Ben Green, Samal Gunatilake, Thomas Jones, Claire Roberts, Stephen Rule, William Storrar
PA2786
Can recursive partitioning empirically derive a pulmonary function test interpretive algorithm Denitza Blagev (Salt Lake City, United States of America), Dave Collingridge, Olinto Linares-Perdomo, Matthew Hegewald, Denitza Blagev
PA2787
AsthmaLife portal: Supporting clinical care and research at the point of care Ann Taite (Kingston, Canada), Ann Taite, Janice Minard, Madonna Ferrone, Chris Licskai, Teresa To, M. Diane Lougheed
PA2788
Adherence to online selfmanagement in patients with COPD or asthma: The role of disease burden Johannes in 't Veen (Bergschenhoek, Netherlands), Johannes In ’t Veen, Bianka Mennema, Anne-Lin Beekhof, Esther Van Noort, Niels Chavannes
PA2789
Development and pilot testing of smartphone based self-management application for adult asthma Jin Han Park (Busan, Republic of Korea), Jin Han Park, Chan Sun Park, Hang Jea Jang
PA2790
Preliminary results of a telemonitoring study: COPD and heart failure patients exhibit great difference in their need of health care Leili Lind (Linköping, Sweden), Leili Lind, Gunnar Carlgren, Jacqueline Mudra, Henrik Synnergren, Niclas Hilding, Daniel Karlsson, Ann-Britt Wiréhn, Hans Lennart Persson
Hall 14-36
Session 284
12:50 - 14:40
Thematic Poster: Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions Chairs : Margareta Emtner (Uppsala, Sweden), Linzy Houchen-Wolloff (Oakham, United Kingdom), Celso Carvalho (Sao Paulo, Brazil), Carlos Augusto Camillo (Leuven, Belgium)
PA2791
COPD assessment test (CAT): Validity and reproducibility in patients with non-cystic fibrosis bronchiectasis Rejane Agnelo Silva de Castro (São Paulo, Brazil), Rejane Agnelo Silva de Castro, Drielly Jesica Milani Zanatta, Samia Zahi Rached, Rodrigo Abensur Athanazio, Anderson Alves de Camargo, Alberto Cukier, Rafael Stelmach, Simone Dal Corso, Fernanda De Cordoba Lanza
PA2792
Is there a correlation between inflammatory status and exercise capacity in patients with bronchiectasis? Preliminary results Anderson Alves de Camargo (São Paulo, Brazil), Anderson Alves de Camargo, Cristiane Helga Yamane de Oliveira, Rodrigo Abensur Athanazio, Samia Zahi Rached, Rodolfo De Paula Vieira, Alberto Cukier, Rafael Stelmach, Simone Dal Corso
PA2793
Physiotherapy adherence and perception in patients with cystic fibrosis: A descriptive study Maria dels Angels Cebria i Iranzo (Valencia, Spain), Maria àngels Cebrià i Iranzo, Tamara Del Corral Núñez-Flores, Nuria Cañas, Mª Teresa Martínez, Candida Froilán, Jordi Vilaró-Casamitjana
PA2794
Effects of bariatric surgery on physical activity in daily life in women Carrie Galvan (RoLandia, Brazil), Carrie C.R. Galvan, Andrea A. Morita, Aline G. Nellessen, Andreia C.T. Costa, Naiara M. Garcia, Valéria A. Tolla, Antonio C. Valezi, Décio S. Barbosa, Fabio Pitta
PA2795
Do preoperative pulmonary functions determine cough effectiveness early after laparoscopic bariatric surgery? Ersin Avc (Izmir, Turkey), Meric Yildirim, Seher özyürek, Ersin Avci, Didem Karadibak, Serhan Derici
PA2796
Movement-evoked pain and fear of dehiscence but not rest pain are related with cough strength after open abdominal surgery Ismail Ozsoy (Izmir, Turkey), Seher özyürek, Meric Yildirim, Ismail özsoy, Ersin Avci, Didem Karadibak
183
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2797
Relationship between physical function ICU test (PFIT) and functional tests in early period after open abdominal surgery Ersin Avc (Izmir, Turkey), Ersin Avci, Didem Karadibak, Sema Savci, Hülya Arikan, Z. Serhan Derici, Tufan Egeli
PA2798
Comparison of pain, respiratory muscle strength and functional tests in early period after upper and lower abdominal surgery Ersin Avc (Izmir, Turkey), Ersin Avci, Didem Karadibak, Sema Savci, Hülya Arikan, Z. Serhan Derici, Tufan Egeli
PA2799
Changes in the physical functions and health-related quality of life of elderly patients with lung cancer undergoing video-assisted thoracoscopic surgery Kunihiko Anami (Kyoto, Japan), Kunihiko Anami, Yoshiyasu Hirayama, Naoki Yamashita, Jun Horie, Kenichi Ito
PA2800
Relationships between orthostatic hypotension and cardiovascular responses to postoperative early mobilization Masatoshi Hanada (nagasaki, Japan), Masatoshi Hanada, Ryo Kozu, Yuichi Tawara, Naoki Mio, Masato Oikawa, Yosuke Morimoto, Yudai Yano, Hideaki Senjyu
PA2801
Comparison of fatigue and Sp02 during shuttle walking test in patients with burn Özden Özkal (Ankara, Turkey), özden özkal, Saadet Ufuk Yurdalan, Mine Seyyah, Ahmet Hakan Acar, Emre Isçi
PA2802
Mucopolysaccharidosis type VI: Assessment of functionality, functional capacity and respiratory muscle strength Paulo Magalhães (Santa Cruz, Brazil), Paulo Magalhães, Bárbara Silva, Lívia Andrade, Maria do Carmo Duarte
PA2803
An exploratory pilot study investigating the effects of oscillations during MI-E for patients with moderate-severe bulbar impairment Rachael Moses (North Shields, United Kingdom), Rachael Moses
PA2804
Investigation of balance deficits in patients with pulmonary arterial hypertension: Preliminary study Buse Özcan (Izmir, Turkey), Buse Ozcan, Serap Acar, Ismail Ozsoy, Sema Savci, Ebru Ozpelit, Can Sevinc, Bahri Akdeniz
PA2805
Factors influence the physical activity in patients with pulmonary arterial hypertension Buse Özcan (Izmir, Turkey), Serap Acar, Sema Savci, Buse Ozcan, Ismail Ozsoy, Ebru Ozpelit, Bahri Akdeniz, Can Sevinc
PA2806
The use of oxygen prescription wristbands significantly improves patient safety on an acute respiratory ward Paul MacDonald (Woking, United Kingdom), Paul MacDonald, Catherine Prodger, Kirsten Thompson, Agnieszka Lewko, Stephanie Harlow, Melanie Irvin-Sellers
PA2807
Human activity profile evaluates functional performance in patients with heart failure? Giane Ribeiro-Samora (Belo Horizonte, Brazil), Giane Ribeiro-Samora, Mariana Hoffman Barbosa, Dayane Montemezzo, Maria Clara Noman Alencar, Danielle Gomes Pereira, Raquel Rodrigues Britto, Verônica Franco Parreira
PA2808
Can diaphragmatic breathing modify chest wall volumes during inspiratory loaded in patients with heart failure? Susan Lage (Belo Horizonte, Brazil), Susan Lage, Mariana Myrrha, Daniella Brandão, Mariana Barbosa, Danielle Pereira, Armele Dornelas de Andrade, Verônica Parreira, Raquel Britto
PA2809
Paediatric paradoxical vocal cord dysfunction: Diagnosis and treatment in a multidisciplinary clinic Nicki Barker (Sheffield, United Kingdom), Nicki Barker, Ravi Thevasagayam, Kelechi Ugonna, Laurie Smith
Room Elicium 2
Session 285
13:00 - 14:30
Lunchtime session: Asthma: emerging risk factors and current management of the patient Joint ERS/Lancet session Aims : To learn about the latest treatments, clinical developments and thinking in the areas of asthma risk, management and treatment. Tag(s) : Clinical Target audience : The session will be most relevant for practicing clinicians, including respiratory physicians and paediatricians, but it will also be relevant for epidemiologists and translational scientists. Chairs : Maria Gabriela Belvisi (London, United Kingdom), Ian Douglas Pavord (Oxford, United Kingdom) 13:00
Known and emerging risk factors for asthma development: is prevention possible? Richard Beasley (Wellington, New Zealand)
2810
13:20
Targeting the interleukin pathway in the treatment of asthma Kian Fan Chung (London, United Kingdom)
2811
13:40
Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank Ian P. Hall (Nottingham, United Kingdom)
2812
184
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
14:00
Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, doubleblind, placebo controlled, phase 2b trial Christopher E. Brightling (Leicester, United Kingdom)
Room 4.2
Session 286
2813
13:00 - 14:30
Lunchtime session: Development and application of new approaches for respiratory disease research Increasing the toolkit Aims : Participants will develop a greater appreciation of the different technological approaches that are available to the respiratory research community and the rationales behind their use. How these approaches can be applied and integrated to improve understanding of respiratory health, disease and drug development will also be discussed. Participants will also benefit from the chance to meet scientists from diverse backgrounds, which could yield new collaborations wherein they can put into practice what they have learnt from the session. Tag(s) : Translational Target audience : Academic researchers of any position (i.e., PhD students, post-doctoral scientists, PIs) from different respiratory disciplines, clinicians, pharmaceutical industry scientists/study directors, technology developers, regulators and funders. Chairs : Philippe Bonniaud (Dijon, France), Anthony Holmes (St Neots, United Kingdom), Iain Kilty (Cambridge, United States of America) 13:00
Optimising disease models for lung diseases and drug development Martin Kolb (Hamilton, Canada)
2814
13:15
From fly to fish, to mouse, to man: lessons from wound healing and cancer Speaker to be confirmed
2815
13:30
Computationally modelling the human lung Merryn Tawhai (Auckland, New Zealand)
2816
13:45
We train rats to save lives Christiaan Mulder (The Hague, Netherlands)
2817
14:05
Panel discussion
2818
Room 5.2
Session 287
13:00 - 14:30
Lunchtime session: Structure-function relationships in the small airways AirPROM EU project Aims : To describe consortium-based approaches to evaluating complex respiratory problems – the sociology of collaboration will also be discussed; to describe the difficulties associated with seeing, measuring, and understanding the processes in the small airways that operate at small-length scales in diseases such as asthma and COPD; to discuss how imaging approaches such as functional hyperpolarised 3He/129Xe imaging can provide new insights into the microstructure of the small airways in asthma and COPD; and to discuss how all of these approaches are being used to develop the first digital models of the small airways. Tag(s) : Translational Target audience : Clinicians, researchers and industry representatives. Chairs : Dirkje S. Postma (Groningen, Netherlands), Scott. S Wagers (Maasmechelen, Belgium) 13:00
What can consortia bring to the small airway problems? Christopher E. Brightling (Leicester, United Kingdom)
2819
13:22
Imaging small airways: why can imaging help us understand the small airways? J.M. Wild (Sheffield, United Kingdom)
2820
13:45
What can computer simulations offer in terms of solving the small airway problems? Rafel Bordas (Oxford, United Kingdom)
2821
14:07
Putting together the puzzle of structure and function in the small airways for the benefit of patients Salman Siddiqui (Leicester, United Kingdom)
2822
Room Forum
Session 288
Assembly members' meeting: Assembly 1 "Clinical" Members' Meeting Chairs : Enrico Maria Clini (Pavullo, Italy), Felix J.F. Herth (Heidelberg, Germany)
185
13:00 - 14:15
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room 5.1
Session 289
13:00 - 14:15
Assembly members' meeting: Assembly 7 "Paediatrics" Members' Meeting Chairs : Fabio Midulla (Rome, Italy), Jonathan Grigg (London, United Kingdom)
Room 13.1
Session 290
13:00 - 14:15
Assembly members' meeting: Assembly 9 Members' Meeting "Allied respiratory professionals" Chairs : Thierry Troosters (Leuven, Belgium), Irene Steenbruggen (Zwolle, Netherlands)
Room 2.1
Session 291
13:00 - 14:15
Assembly members' meeting: Assembly 3 "Cell and molecular biology" Members' Meeting Chairs : Christian M. Kaehler (Innsbruck, Austria), Philipp A. Schnabel (Homburg/Saar, Germany)
Room 4.1
Session 292
13:00 - 14:15
Assembly members' meeting: Assembly 6 "Occupation and epidemiology" Members' Meeting Chairs : Dirk Heederik (Utrecht, Netherlands), Christer Janson (Uppsala, Sweden)
Room Emerald
Session 293
13:00 - 14:15
Assembly members' meeting: Assembly 5 "Airway diseases" Members' Meeting Chairs : Ian M. Adcock (London, United Kingdom), Antonio Spanevello (Tradate, Italy)
13:15-14:30 INDUSTRY PRACTICAL WORKSHOP Room 7.1
SEE PAGE 331
Session 307
14:45 - 16:45
Grand round: Asthma and smoking: dangerous liaisons - an interactive session and Ceremony for the ERS Romain Pauwels Research Award Aims : To provide an update on the effects of smoking on asthma outcomes; review the effects of maternal and passive smoking on childhood asthma; educate the audience with regard to smoking cessation; reinforce the smoking ban in public spaces; and describe the mechanisms underlying the increase in asthma severity due to smoking. Track(s) : Epidemiology/Environment Target audience : This grand round is suitable for a broad range of health professionals, including clinicians and scientists. Clinicians who face difficulties in managing asthma that may be induced by cigarette smoking would benefit in particular, along with clinicians with patients who develop asthma attacks that are provoked by passive smoking; of the latter group, paediatricians who deal with second-hand smoke-exposed children may be especially interested in this grand round. Chairs : Irene Heijink (Groningen, Netherlands), Neil Thomson (Glasgow, United Kingdom) 14:45
Ceremony for the ERS Romain Pauwels Research Award Guy Brusselle (Ghent, Belgium), Sejal Saglani (London, United Kingdom)
2874
14:55
My mother smoked when she was pregnant: why is my asthma bad? Angela Zacharasiewicz (Vienna, Austria)
2875
15:22
Smoking in the asthmatic adult: making things worse Peter J. Barnes (London, United Kingdom)
2876
15:49
The 40-year-old asthmatic who cannot quit smoking Paraskevi Katsaounou (Athens, Greece)
2877
16:16
Treating smoking asthmatics Guy Brusselle (Ghent, Belgium)
2878
Room Auditorium
Session 308
14:45 - 16:45
Symposium: Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC) Aims : To review the results of the latest bronchiectasis clinical trials, compare the pros and cons of oral and inhaled antibiotic therapies in bronchiectasis, describe the emerging scientific techniques that are used to study the airway microbiome and monitor airway inflammation in bronchiectasis, review the evidence for physiotherapy management and emerging airway clearance devices and therapies and describe the activities of the European bronchiectasis network and the opportunities to participate.
186
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 Track(s) : Infection Target audience : This session will be of interest to clinicians, microbiologists, physiotherapists, specialist nurses, and scientists who are interested in non-cystic fibrosis bronchiectasis. Chairs : Pieter Goeminne (Bornem, Belgium), Tobias Welte (Hannover, Germany) 14:45
Understanding the heterogeneity of the disease Stefano Aliberti (Milan, Italy)
2879
15:15
Oral vs. inhaled antibiotic therapy Stuart Elborn (Belfast, United Kingdom)
2880
15:45
Airway clearance techniques in bronchiectasis Eva Polverino (Barcelona, Spain)
2881
16:15
The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network James D. Chalmers (Perth, United Kingdom)
2882
Room 7.2
Session 309
14:45 - 16:45
Symposium: Challenges in non-invasive ventilation (NIV) How it can be improved and what to do next Aims : To describe the causes of NIV failure and how to manage them, detail novel strategies and technologies (ECCO2R, high flow O2) that can be used to deal with NIV failure and present an update on the management of long-term NIV in the paediatric patient. Track(s) : Intensive care Target audience : Pulmonologists, intensivists, respiratory therapists, and nurses. Chairs : Begüm Ergan (Izmir, Turkey), Raffaele Scala (Arezzo, Italy) 14:45
When I understand NIV is failing Arnaud W. Thille (Poitiers, France)
2883
15:15
Prevention of intubation after NIV failure with extracorporeal CO2 removal Stefano Nava (Bologna, Italy)
2884
15:45
Prevention of re-intubation Paolo Navalesi (Vercelli, Italy)
2885
16:15
How children cope with prolonged home NIV Brigitte Fauroux (Paris, France)
2886
Room Elicium 2
Session 310
14:45 - 16:45
Symposium: Cough: a major problem in lung disease Aims : To show the evidence for the clinical burden of cough and how understanding the potential mechanisms may lead to new and effective treatments. At the end of this session, the audience will know how to diagnose chronic cough in lung disease; appreciate the clinical burden of chronic cough in lung disease; understand the current concepts regarding the causes of chronic cough; be aware of the advances in our understanding of the role of nerves in the cough reflex and how this may lead to new drugs; and have insight into the potential novel therapies and their impact on the clinical burden. Tag(s) : Translational Target audience : Pulmonologists, emergency medicine doctors, respiratory physicians, clinical researchers, general practitioners, research fellows, basic scientists, intensivists, nurses, pathologists, and trainees. Chairs : Kian Fan Chung (London, United Kingdom), András Bikov (Budapest, Hungary) 14:45
The diagnosis and clinical burden of chronic cough Akio Niimi (Nagoya, Japan)
2887
15:15
Mechanisms of cough Jaclyn Smith (Manchester, United Kingdom)
2888
15:45
Sensory nerves and the brain in cough Bradley J. Undem (Baltimore, United States of America)
2889
16:15
Future clinical perspectives Lorcan McGarvey (Belfast, United Kingdom)
2890
187
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
Room 4.2
Session 311
14:45 - 16:45
Symposium: Update on respiratory sounds Physiology and pathophysiology of respiratory sounds Aims : This session will present the results from the ERS Task Force on respiratory sounds. The aims of this session are to: describe the physiology and pathophysiology of respiratory sounds; review the current recommendations regarding lung sound nomenclature; examine the challenges that hamper the achievement of observer agreement on lung sounds; and describe the options for objective acoustical analysis of lung sounds. Track(s) : Physiology Paediatric Tag(s) : Clinical Target audience : Clinicians, respiratory specialists and all health professionals who use lung auscultation in their practice. Chairs : Kostas Priftis (Haidari, Athens, Greece), Luis GARCIA-MARCOS ALVAREZ (El Palmar (Murcia), Spain) 14:45
Rales and rhonchi: still acceptable in 2015? Paul L. P. Brand (Zwolle, Netherlands)
2891
15:15
Potential and limitations of respiratory acoustical analyses Hans Pasterkamp (Victoria, Canada)
2892
15:45
Agreeable and contentious respiratory sounds Hasse Melbye (Tromsø, Norway)
2893
16:15
Physiology and clinical relevance of lung sounds Paivi Piirila (Helsinki, Finland)
2894
Room 5.2
Session 312
14:45 - 16:45
Symposium: How to treat brain metastases Aims : To raise awareness among practicing physicians about the therapeutic options for patients with brain metastases. These options go beyond simple cerebral radiation therapy and chemotherapy. The session will provide an overview of the diagnosis and treatment options for brain metastases in lung cancer patients. The strategies for implementing these options in practice will be described from the perspective of the radiologist, the radiation oncologist, and the surgeon. Track(s) : Oncology Tag(s) : Clinical Target audience : Clinicians, surgeons, radiation oncologists, clinical pathologists, palliative care specialists, and nurses. Chairs : Jacques Cadranel (Paris, France), Paul Martin Putora (St. Gallen, Switzerland) 14:45
New modalities for encephalic irradiation Vincent Remouchamps (Namur, Belgium)
2895
15:15
How to prevent and treat brain metastasis in small cell lung carcinoma Delphine Antoni (Strasbourg, France)
2896
15:45
How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis Paul E. Van Schil (Edegem (Antwerp), Belgium)
2897
16:15
How to treat brain metastasis in patients with non-small cell lung carcinoma (NSCLC) and EGFR mutations Anne-Marie Ruppert (Paris, France)
2898
Room Elicium 1
Session 313
14:45 - 16:45
Symposium: Pulmonary hypertension Update from the 2015 ESC/ERS guidelines Aims : To provide a complete update of the new guidelines in pulmonary hypertension, including the underlying evidence. Tag(s) : Clinical Target audience : Clinicians, fellows and scientists. Chairs : Marc Humbert (Paris, France), Anton Vonk Noordegraaf (Amsterdam, Netherlands) 14:45
Diagnosing pulmonary hypertension Adam Torbicki (Warsaw, Poland)
2899
15:15
Treatment of pulmonary hypertension Nazzareno Galiè (Bologna, Italy)
2900
188
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 15:45
Non-medical treatment of pulmonary hypertension Marius M. Hoeper (Hannover, Germany)
2901
16:15
Remaining gaps in our knowledge Gérald Simonneau (Le Kremlin-Bicêtre, France)
2902
Room Forum
Session 314
14:45 - 16:45
Oral Presentation: Clinical problems in acute and chronic lung diseases Chairs : Mohankumar Thekkinkattil (Coimbatore, India), Vincent Cottin (Lyon, France) OA2903
Infliximab in patients with refractory sarcoidosis: Trough concentrations of infiximab Heleen Crommelin (Nieuwegein, Netherlands), Heleen Crommelin, Adriane Vorselaars, Coline Van Moorsel, Vera Deneer, Jan Grutters
OA2904
Hemoptysis in adults: A 5-year study using the French nationwide hospital administrative database Philippe Bonniaud (Dijon, France), Caroline Abdulmalak, Guillaume Beltramo, Marjolaine Georges, Jonathan Cottenet, Catherine Quantin, Philippe Camus, Philippe Bonniaud
OA2905
Thoracic malignancies and pulmonary nodules in patients under evaluation for transcatheter aortic valve implantation (TAVI): Incidence, follow up and possible impact on treatment decision Lars Schmidt (Münster, Germany), Benedikt Vietmeier, Sebastian Bröckling, Gerrit Kaleschke, Dennis Görlich, Christian Schülke, Michael Thrull, Helmut Baumgartner, Wolfgang E. Berdel, Rainer Wiewrodt, Michael Mohr, Lars Henning Schmidt
OA2906
Diagnostic latency and pulmonary morbidity in adult patients with primary immunodeficiency (PID): A single center experience Michael Mohr (Laer, Germany), Michael Thrull, Sebastian Bröckling, Christoph Schliemann, Thorsten Kessler, Bennedikt Vietmeier, Christoph Schülke, Helmut Wittkowski, Wolfgang E. Berdel, Rainer Wiewrodt, Lars-Henning Schmidt, Michael Mohr
OA2907
Respiratory manifestations in hospitalized patients with hematological malignancies Yu Mikami (Tokyo, Japan), Yu Mikami, Daiya Takai, Masafumi Horie, Satoshi Noguchi, Hirotaka Matsuzaki, Kosuke Makita, Hideyuki Takeshima, Yasuhiro Yamauchi, Go Tanaka, Takahide Nagase
OA2908
Lung function in long-term adult survivors of childhood acute lymphoblastic leukemia Ole Myrdal (Rykkinn, Norway), Ole Myrdal, Adriani Kanellopoulos, Jon Runar Christiansen, Ellen Ruud, May-Brit Lund
OA2909
Alexithymia in COPD patients Branislava Milenkovi (Beograd, Republic of Serbia), Branislava Milenkovic, Milan Latas, Jelena Cvejic, Jelena Jankovic
Room 5.1
Session 315
14:45 - 16:45
Oral Presentation: Novel occupational exposures and responses Chairs : David Miedinger (Luzern, Switzerland), Nicola Murgia (Perugia, Italy) OA2910
LATE-BREAKING ABSTRACT: Meta-analysis of the risk of acute mountain sickness from cigarette smoking Denis Vinnikov (Almaty, Kazakhstan), Denis Vinnikov, Paul Blanc, Nurlan Brimkulov, Craig Steinmaus
OA2911
Metalworking fluid-associated respiratory morbidity in a production facility with a cluster of lymphocytic bronchiolitis Kristin Cummings (Morgantown, United States of America), Kristin Cummings, Marcia Stanton, Randy Boylstein, JuHyeong Park, Kathleen Kreiss
OA2912
Risk of exacerbations in COPD and asthma patients living in the neighbourhood of livestock farms Christel van Dijk (Utrecht, Netherlands), Christel Van Dijk, Judith Garcia-Aymerich, Anne-Elie Carsin, Lidwien Smit, Floor Borlée, Dick Heederik, Gé Donker, Joris Yzermans, Jan-Paul Zock
OA2913
Molecular and immunological characterization of wheat allergens responsible for Baker’s asthma Cordula Bittner (Hamburg, Germany), Cordula Bittner, Karsten Frenzel, Horst Muesken, Ulrike Peters, Reinhold Brettschneider
OA2914
Inflammation in induced sputum after aluminum oxide exposure - An experimental chamber study Liv Ingunn Bjoner Sikkeland (Oslo, Norway), Liv Ingunn Sikkeland, Neil Alexis, Rebecca Fry, Per Søstrand, Tor Erik Danielsen, Johny Kongerud
OA2915
Exposure associated respiratory impairments among Indian tea industry workers Subhabrata Moitra (Krishnagar, Nadia, India), Subhabrata Moitra, Saibal Moitra, Prasanta Das, Punam Thapa, Sukumar Debnath, Jayati Das, Swapna Chaudhuri
189
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015 OA2916
Comparison of oxygen uptake and heart rate to assess the physical strain of garbage collectors Alexandra Preisser (Hamburg, Germany), Alexandra Marita Preisser, Linfei Zhou, Marcial Velasco Garrido, Volker Harth
OA2917
Surveillance in talc exposed workers in a chocolate products plant Jos M. Rooijackers (Beuningen, Netherlands), Esther Van Harlingen, Jos Rooijackers, Remko Houba, Ad Vorselaars, Melanie Dubbers, Jan Grutters, Dick Heederik
Room 13.1
Session 316
14:45 - 16:45
Oral Presentation: Monitoring and phenotyping COPD Chairs : Anneke ten Brinke (Molenend, Netherlands), Jose Luis Lopez-Campos Bodineau (Sevilla, Spain) OA2918
Circulating vasoactive intestinal peptide for diagnosis of exacerbation of COPD Jyotshna Mandal (Basel, Switzerland), Jyotshna Mandal, Michael Roth, Luigi Costa, Lucas Boeck, Eleni Papakonstantinou, Michael Tamm, Daiana Stolz
OA2919
Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes Jaromir Zatloukal (Olomouc, Czech Republic), Jaromir Zatloukal, Zdenka Navratilova, Eva Kriegova, Vladimir Koblizek, Vitezslav Kolek, Martin Petrek
OA2920
Malondialdehyde level in chronic obstructive pulmonary disease exacerbations Natalja Voskresenska (Riga, Latvia), Natalja Voskresenska, Julija Voicehovska, Aleksandra Vojcehovska, Grigorijs Orlikovs, Andrejs Skesters
OA2921
Mannose binding lectin - HYPD allele is associated with frequent exacerbation in COPD patients Bijaya Malla (Basel, Switzerland), Bijaya Malla, Jyotshna Mandal, Luigi Costa, Rudi Steffensen, Adrian Egli, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Kostantinos Kostikas, Francesco Blasi, Joachim Aerts, Gernot Rohde, Alicia Lacoma, Lucas Boeck, Janko Rakic, Andreas Scherr, Michael Tamm, Michael Roth, Daiana Stolz
OA2922
Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood Alan Altraja (Tartu, Estonia), Alan Altraja, Argo Aug, Kalle Kilk, Riina Mahlapuu, Siiri Altraja, Ursel Soomets
OA2923
2011 GOLD categories may identify different copd phenotypes M. L. E. Bartoli (Pisa, Italy), Maria Laura Bartoli, Dario Nieri, Sandra Antonelli, Francesco Costa, Gianna Decusatis, Claudia De Simone, Laura Malagrinò, Sabrina Santerini, Barbara Vagaggini, Pierluigi Paggiaro
OA2924
A search for covert precipitating clinical parameters in frequent exacerbators of COPD Ankit BHATIA (lucknow, India), Ankit Bhatia, Surya Kant, Ajay Verma, Prakash Ved, Jain Amita
OA2925
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Marek Plutinsky, Jaromir Zatloukal, Patrice Popelkova, Tomas Dvorak, Petr Safranek, Ondrej Sobotik, Alena Vlachova, Petr Vanik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Pavlina Musilova, Maria Majerciakova, Tomas Vencalek, Eva Kocova, Barbora Novotna, Michal Kopecky, Ondrej Kudela, Katerina Neumannova, Kristian Brat, Eva Volakova, Karel Hejduk, Jan Svancara, Jiri Jarkovsky, Michal Svoboda, Zuzana Zbozinkova
Room 2.1
Session 317
14:45 - 16:45
Oral Presentation: Latest news on miRNAs in pulmonary research Chairs : Marcin Skrzypski (Sopot, Poland) OA2926
Differential microRNA expression in plasma of patients with pulmonary tuberculosis Simone Barry (Bondi Beach, Australia), Simone Barry, Magda Ellis, YuRong Yang, Guangyu Guan, Xiaolin Wang, Warwick Britton, Bernadette Saunders
OA2927
MiR-320d: A novel anti-inflammatory miRNA up regulated by corticosteroids Alen Faiz (Groningen, Netherlands), Alen Faiz, Malte Borggrewe, Dirkje Postma, Katrina Steiling, Avrum Spira, Marc Lenburg, Marnix Jonker, Gerard Koppelman, Pieter Hiemstra, Peter Sterk, Wim Timens, Corry-Anke Brandsma, Maarten Van den Berge, Irene Heijink
OA2928
Biological role of prognostic microRNAs (miRNAs) in squamous lung carcinoma (SCC) cells Martyna Filipska (Gda sk, Poland), Martyna Filipska, Marcin Skrzypski, Jacek Bigda
OA2929
Overexpression of miR-21 in non-small cell lung cancer, positive for Merkel cell polyoma virus ( CPyV) Ismini Lasithiotaki (Samos, Greece), Ismini Lasithiotaki, Eliza Tsitoura, Anastasios Koutsopoulos, Eleni Lagoudaki, Demetrios Spandidos, Nikolaos Siafakas, Giorgos Sourvinos, Katerina Antoniou
190
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
OA2930
Role of exosomal microRNA in driving skeletal muscle wasting in COPD Hannah Burke (Southampton, United Kingdom), Hannah Burke, C. Mirella Spalluto, Doriana Cellura, Karl J. Staples, Tom M.A. Wilkinson
OA2931
microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease Caroline Leuenberger (Zurich, Switzerland), Caroline Leuenberger, Claudio Schuoler, Célia Mignan, Thomas Rechsteiner, Malcolm Kohler, Lars Huber, Matthias Brock
OA2932
Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways Neli Kachamakova-Trojanowska (Krakow, Poland), Neli Kachamakova-Trojanowska, Lukasz Kasper, Agnieszka Jazwa, Alicja Jozkowicz, Marek Sanak, Jozef Dulak, Krzysztof Sladek
OA2933
Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Dan Li (Changchun, China), Lei Song, Dan Li
Room 4.1
Session 318
14:45 - 16:45
Oral Presentation: New observations in respiratory epidemiology Chairs : Giovanni Viegi (Pisa, Italy), Ane Johannessen (Bergen, Norway)
OA2934
LATE-BREAKING ABSTRACT: Blood eosinophils and exacerbations in chronic obstructive pulmonary disease: The copenhagen general population study Signe Vedel Krogh (Herlev, Denmark), Signe Vedel-Krogh, Sune F. Nielsen, Peter Lange, Jørgen Vestbo, Børge G. Nordestgard
OA2935
Linking respiratory and vascular health in Swiss adolescents Julia Dratva (Basel, Switzerland), Julia Dratva, Seraina Caviezel, Emmanuel Schaffner, Robert Bettschart, Nino Künzli, Arno Schmidt-Trucksaess, Daiana Stolz, Elisabeth Zemp, Nicole Probst-Hensch
OA2936
Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study Ann Morgan (Market Harborough, United Kingdom), Ann Morgan, Emily Herriett, Liam Smeeth, Bianca DeStavola, Jennifer Quint
OA2937
Validation of the conceptual model for the dyspnoea-inactivity spiral in patients with COPD Maria Antonia Ramon (Barcelona, Spain), Maria A. Ramon, Anne E. Carsin, Elena Gimeno-Santos, Esther Rodríguez, Jaume Ferrer, Judith Garcia-Aymerich
OA2938
Common airway variants and chronic obstructive pulmonary disease Benjamin Smith (New York, United States of America), Benjamin Smith, Eric Hoffman, Shinjiro Myawaki, John Austin, Kristin Burkhart, Wellington Cardoso, Nadia Hansel, David Jacobs, Joel Kaufman, Ching-Long Lin, Kiang Liu, Dan Rabinowitz, Stephen Rich, Karol Watson, R. Graham Barr
OA2939
Prospective cohort study of cured meat intake and asthma symptom score in the EGEA study Zhen LI (Villejuif, France), Zhen Li, Marta Rava, Annabelle Bédard, Judith Garcia-Aymerich, Bénédicte Leynaert, Christophe Pison, Nicole Le Moual, Isabelle Romieu, Valérie Siroux, Carlos A. Camargo, Rachel Nadif, Raphaëlle Varraso
OA2940
Prospective study of menopause and adult-onset asthma: The E3N French cohort Matulonga Bobette (Paris, France), Bobette Matulonga, Dominique Courbon, Agnès Forrnier, Annabelle Bédard, Sylvie Mesrine, Margaux Sanchez, Gabriel Thabut, Françoise Clavel, Raphaëlle Varraso, Bénédicte Leynaert
OA2941
Change in prevalence of IgE sensitization over 20 years in the European community respiratory health survey cohort Andre Amaral (London, United Kingdom), Andre F.S. Amaral, Roger B. Newson, Josep M. Antó, Isa Cerveri, Thorarin Gislason, Joachim Heinrich, Christer Janson, Nino Kunzli, Benedicte Leynaert, Roberto De Marco, Nicole Probst-Hensch, Cecilie Svanes, Kjell Toren, Serge A. Versteeg, Joost Weyler, Jan-Paul Zock, Peter Burney, Deborah L. Jarvis, On Behalf of ECRHS III Partners
Room Emerald
Session 319
14:45 - 16:45
Oral Presentation: Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles Chairs : Raffaele Dellaca (Milan, Italy), Bruno Degano (Besançon, France) OA2942
Pulmonary consequences of ambient nanoparticles in rats Gergely H. Fodor (Szeged, Hungary), Gergely H. Fodor, Fruzsina Kun-Szabo, Laszlo Tiszlavicz, Orsolya Ivankovitsne Kiss, Jozsef Tolnai, Agnes Filep, Ferenc Petak
191
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
OA2943
Using nanoparticles to detect emphysema Laura Aaltonen (Malmo, Sweden), Hanni Laura Aaltonen, Jonas Jakobsson, Sandra Diaz, Eeva Piitulainen, Jakob Löndahl, Per Wollmer
OA2944
Establishing clinically meaningful cutoffs for %emphysema and %gas trapping in quantitative chest CT scans Richard Casaburi (Rancho Palos Verdes, United States of America), Richard Casaburi, Asli Gorek Dilektasli, Janos Porszasz, William W. Stringer, Surya Bhatt, George Washko, Peter Castaldi, Raul San Jose Estepar, James E. Hansen, For the COPDGene® Investigators
OA2945
Assessment of lung microstructure in ILD with 3He and 129Xe MRI Neil Stewart (Sheffield, United Kingdom), Neil J. Stewart, Graham Norquay, Juan Parra-Robles, Helen Marshall, General Leung, Philip S. Murphy, Rolf F. Schulte, Charlie A. Elliot, Robin Condliffe, Catherine G. Billings, Ian Smith, Paul D. Griffiths, Jan Wolber, Moira K. Whyte, David G. Kiely, Jim M. Wild
OA2946
Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF) Felix Horn (Sheffield, United Kingdom), Felix Horn, Helen Marshall, Salman Siddiqui, Alexander Horsley, Laurie Smith, Ina Aldag, Christopher Brightling, Richard Kay, Christopher Taylor, Juan Parra-Robles, Jim Wild
OA2947
Regional ventilation of patients with hemidiaphragm paralysis by electrical impedance tomography Mayra Caleffi Pereira (Sao Paulo, Brazil), Mayra Caleffi Pereira, Vinicius Torsani, André Apanavicius, Jeferson George Ferreira, Vinicius C. Iamonti, Marcelo Britto Passos Amato, Carlos Roberto Ribeiro de Carvalho, André Luis Pereira de Albuquerque, Pedro Caruso
OA2948
Changes in functional respiratory imaging (FRI) endpoints correlate with changes in patient reported outcomes (PRO) after recovering from acute COPD exacerbation Wim Vos (Heist-op-den-Berg, Belgium), Wim Vos, Cedric Van Holsbeke, Wouter Van Geffen, Huib Kerstjens, Massimo Pistolesi, Omar Usmani, Bita Hajian, Anthony Cahn, Jan De Backer, Wilfried De Backer
OA2949
Regional ventilation in infants quantified by multi-volume high resolution computed tomography (HRCT) and multivolume proton magnetic resonance imaging (MRI) Francesca Pennati (Milan, Italy), Francesca Pennati, Caterina Salito, David Roach, John P. Clancy, Jason Woods, Andrea Aliverti
Room E104-106
Session 320
14:45 - 16:45
Poster Discussion: New data on established treatments for asthma, COPD and bronchiectasis Chairs : Alexander Mathioudakis (Liverpool, United Kingdom), Ian M. Adcock (London, United Kingdom) PA2950
Effects of tiotropium on lung function in current smokers and never smokers with asthma Makoto Yoshida (Fukuoka, Japan), Makoto Yoshida, Tomoaki Iwanaga, Hiromasa Inoue
PA2951
Asthma medication during pregnancy: A cohort study in EFEMERIS database Alain Didier (Toulouse, France), Alain Didier, Anna-belle Beau, Isabelle Lacroix, Caroline Hurault-Delarue, Jean-louis Montastruc, Christine Damase-Michel
PA2952
Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Karin Rosen (South San Francisco, United States of America), Nicola A. Hanania, Benjamin Trzaskoma, Karin Rosén, Volkan Manga, Theodore A. Omachi
PA2953
In vitro comparison of dose accuracy of two budesonide/formoterol dry powder inhalers Jussi Haikarainen (Espoo, Finland), Jussi Haikarainen, Anita Happonen, Tero Löytänä
PA2954
A national database study of the effectiveness of switching real-life asthma patients to fostair Graham Devereux (Aberdeen, United Kingdom), Markus Steiner, Steve Turner, Graham Devereux
PA2955
GLISTEN Study subanalysis: Glycopyrronium differentially improves lung function, health status and rescue medication use when added to salmeterol/fluticasone in COPD severity groups Peter Frith (Daw Park, Australia), Peter Frith, Philip Thompson, Christina Frenzel, Nicol Kurstjens, GLISTEN Study Group
PA2956
Efficacy of fluticasone furoate (FF)/vilanterol (VI) or FF alone in asthma patients with differing eosinophil (eos) levels Ashley Woodcock (Manchester, United Kingdom), Ashley Woodcock, Loretta Jacques, David Leather, Richard Forth
PA2957
The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPD Gary T. Ferguson (Livonia, United States of America), Gary T. Ferguson, Emilio Pizzichini, Matjaž Fležar, Lars Grönke, Lawrence Korducki
192
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2958
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Dave Singh (Manchester, United Kingdom), Dave Singh, Gary T. Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, Roger Abrahams, Olaf Schmidt, Leif Bjermer
PA2959
Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients James Kreindler (Merion Station, United States of America), James Kreindler, Nicholas Locantore, Michael Watkins, Sally Lettis, Ruth Tal-Singer
PA2960
Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD Claus Vogelmeier (Marburg, Germany), Claus Vogelmeier, Pier Luigi Paggiaro, Jordi Dorca, Pawel Sliwinski, Marcel Mallet, Anne-Marie Kirsten, Beatriz Seoane, Rosa Maria Segarra, Anne Leselbaum, Esther Garcia Gil
PA2961
Pharmacokinetic interaction of glycopyrronium bromide pMDI and formoterol pMDI: A randomized, open-label, single-dose, 4-way cross-over study Fabrizia Mariotti (Parma, Italy), Sara Collarini, Anna Compagnoni, Dario Cuomo, Fabrizia Mariotti, Annamaria Muraro, Daniela Acerbi
PA2962
The economical effect of inhaler in patients with early chronic obstructive pulmonary disease Ji Young Yhi (Seoul, Republic of Korea), Ji Young Yhi, Tae-Hyung Kim, Jinkyeong Park, Chin Kook Rhee, Kwang Ha Yoo
PA2963
Influence of inhaled glucocorticosteroids on course of the bronchiectasis Eduard Khodosh (Kharkiv, Ukraine), Eduard Khodosh, Peter Poteiko, Valeriy Krutko, Dmitriy Khoroshun
PA2964
The antiinflammatory and antioxidant effect of tiotropium bromide in subacute cigarette exposure mouse model Aysun engül (Kocaeli, Turkey), Aysun Sengul, Meyrem Ozkan, Ceyla Eraldemir, Leman Huseynova, Doga Ozsoy, Firuzan Akar
PA2965
Once-daily QVA149 improves lung function and health status versus twice-daily salmeterol/fluticasone (SFC) in symptomatic GOLD B and GOLD D COPD patients: LANTERN/ILLUMINATE pooled analysis Claus Vogelmeier (Marburg, Germany), Claus Vogelmeier, Nanshan Zhong, Karen Mezzi, Robert Fogel, Donald Banerji
PA2966
QVA149 is more efficacious than tiotropium and salmeterol/fluticasone combination (SFC) in improving patientreported outcomes and lung function in COPD patients with moderate-to-severe baseline dyspnoea: The IGNITE trials Donald A. Mahler (Lebanon, United States of America), Donald Mahler, Dorothy Keininger, Robert Fogel, Karen Mezzi, Donald Banerji
PA2967
Pharmacokinetic studies for the estimation of bioequivalence of two DPIs containing budesonide and formoterol Katerina Athanassiou (Pikermi, Greece), Katerina Athanassiou, Luigi Silvestro, Simona Rizea Savu
Room G102-103
Session 321
14:45 - 16:45
Poster Discussion: Screening strategies in TB Chairs : Delia Goletti (Roma, Italy), Graham H. Bothamley (London, United Kingdom)
PA2968
A retrospective study of the indications for the use of interferon gamma release assays (IGRA) in a United Kingdom (UK) district general hospital (DGH) tuberculosis (TB) clinic Jennifer Kerks (Telford, United Kingdom), Jennifer Kerks, Callum Gandolfi, Harmesh Moudgil, Thirumalai Naicker, Nawaid Ahmad, Sue George, Koottalai Srinivasan
PA2969
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence Ipek Coskunol (Izmir, Turkey), Ipek Coskunol, Aysegül Baysak, Ayse Dalli, Funda Uluorman, Gerçek Can
PA2970
Tuberculosis screening in patients receiving biological therapy Raquel Almeida Ferreira Duarte Bessa Melo (Porto, Portugal), Sara Ramos, Anabela Nogeira, André Dias, Ana Gonçalves, Ana Rita Gaio, Raquel Duarte
PA2971
Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test? Öner Balbay (Duzce, Turkey), Fatih Alasan, Ege Gulec Balbay, Sengul Cangur, Oner Balbay, Leyla Yilmaz Aydin, Ali Nihat Annakkaya
PA2972
Retrospective study of interferon gamma release assays (IGRAs) done in a district general hospital (DGH) for the screening of patients prior to biological therapies Jennifer Kerks (Telford, United Kingdom), Jennifer Kerks, Callum Gandolfi, Harmesh Moudgil, Thirumalai Naicker, Nawaid Ahmad, Sue George, Koottalai Srinivasan
193
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2973
Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting antiTNF therapy Adriana Petronela Fildan (Constanta, Romania), Ariadna Petronela Fildan, Gheorghita Voicu, Livia Floca, Elis Curtmola, Elena Dantes
PA2974
Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Justina Ruksenaite (Leicester, United Kingdom), Justina Ruksenaite, Thomas Ward, George Tsaknis, Syed-Fayyaz Hussain
PA2975
Tuberculosis contacts screening – Experience of a Portuguese ambulatory center Cátia Sofia Martins Araújo (Massamá, Portugal), Cátia Araújo, João Eusébio, Daniel Duarte, Natália André, Paula Raimundo, António Domingos
PA2976
Risk of developing active TB in children with latent TB infection Natalya Korneva (Saint Petersburg, Russian Federation), Natalia Korneva, Anna Starshinova, Semen Ananiev, Yulia Ovchinnikova, Irina Dovgaluk, Piotr Yablonskii
PA2977
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients Ekrem Cengiz Seyhan (Istanbul, Turkey), Gülsah Günlüoglu, Ekrem Cengiz Seyhan, Zeki Günlüoglu, Nurdan Veske, Sedat Altin, Esra Yazar
PA2978
Low real-world utility of IGRA when screening for LTBI in a low incidence setting James Clemence (London, United Kingdom), James Clemence, Hugo Farne, Harriet Owles, James Wilson, Dean Creer, Douglas Fink
PA2979
Latent mycobacterium tuberculosis infection among type 2 diabetes mellitus patients Olanisun Olufemi Adewole (Ile-Ife, Nigeria), Olanisun Olufemi Adewole, O. Kayode, O. Abe, Harriet Osunkoya, Babatope Kolawole, Rosemary Ikem, Tayo Adewole, Greg Erhabor
PA2980
Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Pedro Oliveira (Vila Nova de Gaia, Portugal), Pedro Mesquita, Marta Gomes, Raquel Duarte
PA2981
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Vera Manina (Saint-Petersburg, Russian Federation), Vera Manina, Anna Starshinova, Alexandr Panteleev, Viacheslav Zhuravlev, Maria Pavlova, Nadezda Sapozhnikova, Piotr Yablonskii, Alena Vasilyeva
PA2982
HIV screening in tuberculosis patients, in the northern region of Portugal Sara Reina (Vila do Conde, Portugal), Sara Reina, Catarina Silva, Ana Maria Correia, Raquel Duarte
PA2983
Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity Mohammed Agha (Cairo, Egypt), Mohammed Agha, Ibraheim El-Mahalawy, Hosam Seleem, Mohamed Helwa
PA2984
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Elmira Gurbanova (Baku, Azerbaijan), Elmira Gurbanova, Rafail Mehdiyev, Kai Blondal, Alan Altraja
PA2985
Active TB in cancer patients: A missed screening opportunity? lynne curry (reading, United Kingdom), Sarah Menzies, Lynne Curry, Christopher Turnbull
Room G104-105
Session 322
14:45 - 16:45
Poster Discussion: Developments in lung cancer diagnosis Chairs : Sam Janes (London, United Kingdom), Ales Rozman (Golnik, Slovenia) PA2986
Determinants of negative predictive value during EBUS-TBNA in diagnosis/staging of lung cancer LUIS ALEJANDRO PADRON FRAYSSE (Sevilla, Spain), Luis Alejandro Padrón Fraysse, Alvaro Donate Salcedo, Beatriz Romero Romero, Lourdes Gómez Izquierdo, Jose Martin Juan
PA2987
Role of transbronchial needle aspiration (TBNA) during endobronchial ultrasonography with guide-sheath (EBUSGS) for peripheral pulmonary lesion (PPL) suspected of lung cancer Ken Arimura (Tokyo, Japan), Ken Arimura
PA2988
EBUS in real life: Primary diagnosis and mediastinal staging Joao Pedro Steinhauser Motta (Rio de Janeiro, Brazil), João Pedro Steinhauser Motta, Franz Stanzel, Axel Kempa, José Roberto Lapa e Silva
194
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA2989
Combined endobronchial and esophageal endosonography for mediastinal staging in lung cancer: Systematic review and meta-analysis Daniel Korevaar (Amsterdam, Netherlands), Daniël Korevaar, Laurence Crombag, Jérémie Cohen, René Spijker, Patrick Bossuyt, Jouke Annema
PA2990
Pulmonolgists ability to review specimens obtained by TBNA - A real life study Achim Rittmeyer (Immenhausen, Germany), Achim Rittmeyer, Tobias Anslinger, Hans-Ulrich Schildhaus, Lutz Welker, Marc Hinterthaner, Birgit Zwerger, Christian Reinhardt, Stefan Andreas
PA2991
Number of procedures and time needed to diagnose lung cancer: Being right the first time Jonathen Venkatachalam (Singapore, Singapore), Akash Verma, Jonathen Venkatachalam, Dessmon Tai, Soon Keng Goh, Ai Ching Kor, Albert Lim, John Abisheganaden
PA2992
Diagnosing lung cancer: Choosing the best for your patient Shuyu Chen (Singapore, Singapore), Shuyu Chen, Jonathen Venkatachalam, Poh Seo Quek, Albert Yick Hou Lim, John Abisheganaden, Akash Verma
PA2993
Fluorescein-aided probe-based confocal laser endomicroscopy (pCLE) for detection of lung cancer Kiyoshi Shibuya (Matsudo, Japan), Kiyoshi Shibuya, Nao Okada, Jouji Horio, Hidemitsu Funabashi, Masahiro Noro
PA2994
Improvement in endoscopic diagnosis of lung cancer by narrow-band imaging (NBI) CARLES GRIMAU CHAPINAL (Sabadell (Barcelona), Spain), Carles Grimau, Guadalupe Bermudo, Luis Urrelo, Miguel Gallego, Eduard Monso
PA2995
Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Raquel Rosa (Lisbon, Portugal), Raquel Rosa, Dionísio Maia, Ana Alves, Telma Lopes, Inês Gonçalves, João Reis, Ivan Bravio, Pedro Baptista, Fernando Martelo, João Cardoso
PA2996
Differentiating incidental lung nodules due to lung cancer from those due to coccidioidomycosis Michael Peterson (Fresno, United States of America), Michael Peterson, Reza Ronagi, Paul Mills
PA2997
Haemoptysis with normal chest x-ray: Do all patients require CT chest and bronchoscopy? Maryam Ahmed (Wolverhampton, United Kingdom), Maryam Ahmed, James Allen, Mohammed Haris, Imran Hussain
PA2998
Early detection of lung cancer in exhaled breath condensate using miRNA markers Francisco Sanz Herrero (Quart de Poblet (Valencia), Spain), Francisco Sanz, Enrique De Casimiro, Carmen María Cortés, Marisa Tárrega, Francisco Dasi, Estrella Fernández
PA2999
Detection of lung cancer using expired breath analysis by ion mobility spectrometry Emma Brodrick (Cardiff, United Kingdom), Emma Brodrick, Antony Davies, Paul Neill, Louise Hanna, E. Williams
PA3000
Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity Rianne de Vries (Amersfoort, Netherlands), R. De Vries, P. Brinkman, S.K. Bootsma, E. Dijkers, F.H.C. De Jongh, P.J. Sterk
PA3001
The role of nitric oxide, reactive nitrogen and oxygen species in lung cancer Alica Bencova (Martin, Slovakia), Alica Bencova, Martina Antosova, Daniela Mokra, Ivan Kocan, Eva Rozborilova
PA3002
Automated target-FISH lung cancer detection (LCD) test of induced sputum Dekel Shlomi (Petah-Tiqwa, Israel), Dekel Shlomi, Alon Ben-Nun, Tal Kaplan, Maya Ilouze, David Simanski, Tiberiu Shulimzon, Naomi Gai-Mor, Lahav Cohen, Nir Golan, Erik Baltaxe, Jair Bar, Amir Onn, Amir Onn, Nir Peled
Room G106-107
Session 323
14:45 - 16:45
Poster Discussion: Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Chairs : Wouter H. van Geffen (Groningen, Netherlands), Maurizio Marvisi (Cremona, Italy)
PA3003
LATE-BREAKING ABSTRACT: No relationship between cardiovascular morbidity and moderate-to-severe exacerbation rates in COPD patients in primary care Paul Jones (London, United Kingdom), Paul Jones, Jadwiga Wedzicha, Alvar Agusti, Marc Decramer, Alice Raillard, Hana Müllerová, Chang-Qing Zhu, Lukasz Adamek
PA3004
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Anna Stupnytska (Chernivtsi, Ukraine), Ganna Stupnytska, Anastasiya Stupnytska, Olga Pritulyak, Olga Nesterovska
PA3005
Correlation between extracellular heat shock protein 72 and clinical parameters including exhaled oxygen level in COPD Balázs Odler (Budapest, Hungary), Balazs Odler, Vivien Somogyi, Gabor Horvath, Veronika Müller
195
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA3006
Continuous indacaterol treatment improves autonomic cardiac regulation in COPD patients Rustem Zulkarneev (Ufa, Republic of Bashkortostan, Russian Federation), Juliana Safina, Naufal Zagidullin, Rustem Zulkarneev, Diana Gareeva, Usman Farhutdinov, Shamil Zagidullin, Julia Aznabaeva
PA3007
Hypercapnea is associated with cardiac arrhythmias in COPD Gunnar Einvik (Lørenskog, Norway), Gunnar Einvik, Rahul Bhatnagar, Nils Henrik Holmedahl, Anke Neukamm, Vidar Søyseth
PA3008
Marfanoid phenotype as a predictor of COPD formation in young patients Anna Khomenya (Omsk, Russian Federation), Anna Khomenya, Maria Vershinina, Galina Nechaeva, Lev Grinberg
PA3009
Association between arterial stiffness and acute exacerbations in patients with chronic obstructive pulmonary disease Esra Uzaslan (Bursa, Turkey), Sinem Ozbay Ozyilmaz, Isa Ozyilmaz, Osman Akin Serdar, Esra Uzaslan
PA3010
The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2 Malika Mustafina (Moscow, Russian Federation), Malika Mustafina, Olga Tsvetkova, Eduard Generozov
PA3011
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Ceylan Ayada (Kütahya, Turkey), Ceylan Ayada, ümran Toru, Osman Genç, Server Sahin, özlem Arik, Ismet Bulut
PA3012
Increased platelet reactivity during acute exacerbations of COPD, irrespective of antiplatelet therapy Mariana Mercedes Munoz Esquerre (Castelldefels (Barcelona), Spain), Mariana Munoz-Esquerre, José Luis Ferreiro, Daniel Huertas, Ana L. Marcano, Marta López-Sánchez, Frederic Manresa, Joan Antoni Gómez-Hospital, Angel R. Cequier, Jordi Dorca, Salud Santos
PA3013
Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial Carmen Pizarro (Bonn, Germany), Carmen Pizarro, Neele Herweg-Steffens, Nikos Werner, Georg Nickenig, Dirk Skowasch
PA3014
Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease Laura Rarmirez Garcia (Madrid, Spain), Laura Ramírez García, Milagros Llanos Flores, Alicia Oliva Ramos, Alicia Cerezo Lajas, Ingrid Frías Benzant, Rodrigo Jiménez García, Valentín Hernández Barrera, Pilar Carrasco Garrido, Ana López de Andrés, Luis Puente Maestu, Javier De Miguel Díez
PA3015
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation sheila zanoria (farmington, United States of America), Sheila Zanoria, Richard ZuWallack, Bibek Singh Pannu
PA3016
Health status predicted mortality in hypercapnic patients with noninvasive ventilation Toru Oga (Kyoto, Japan), Toru Oga, Hiroyuki Taniguchi, Hideo Kita, Tomomasa Tsuboi, Keisuke Tomii, Morihide Ando, Eiji Kojima, Hiromi Tomioka, Yoshio Taguchi, Yusuke Kaji, Ryoji Maekura, Toru Hiraga, Naoki Sakai, Tomoki Kimura, Michiaki Mishima, Kazuo Chin
PA3017
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Hana Muellerova (Uxbridge, Middlesex, United Kingdom), Hana Müllerová, Heather Gelhorn, Hilary Wilson, Victoria Benson, Niklas Karlsson, Shailendra Menjoge, Debora Merrill, Stephen Rennard, Ruth Tal-Singer, Margaret Tabberer, Paul Jones
PA3018
Matrix metalloproteinase, hyaluronic acid and C-reactive protein: Are they really markers of lung obstruction at COPD but not cardiovascular comorbidity? Bogdana Basina (Dnipropetrovsk, Ukraine), Bogdana Basina, Tetyana Pertseva, Lyudmila Konopkina
PA3019
Relationship between COPD characteristics and airway bacterial load measured using 16S qPCR Simon Brill (London, United Kingdom), Simon E. Brill, Phillip James, William O.C. Cookson, Miriam F. Moffatt, Jadwiga A. Wedzicha
PA3020
A novel lung pharmacokinetic model predicts lung exposure and supports dose selection for clinical study of AZD2115, a dual muscarinic receptor antagonist/beta2 adrenoceptor agonist (MABA) Ramon Hendrickx (Gothenburg, Sweden), Ramon Hendrickx, Ann Aurell Holmberg, Ulf Eriksson, Ken Grime
Room 13.2
Session 324
14:45 - 16:45
Poster Discussion: Novel insights into the pathobiology of acute lung injury Chairs : Christian Martin (Aachen, Germany), Wolfgang M. Kuebler (Toronto, Canada)
PA3021
LSC Abstract – Epithelial sodium channel (ENaC) currents and superoxide and hydroxyl formation in influenza H1N1 infected rat primary alveolar type II cells Sotirios Zarogiannis (Larisa, Greece), Sotirios Zarogiannis, James Londino, Lan Chen, Qian Li, Jack Lancaster, James Noah, Diana Noah, Sadis Matalon
196
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA3022
LSC Abstract – Syndecan-1 attenuates lung injury during influenza infection by activating survival signals via c-Met (winner of the LSC 2015 Young Investigator William MacNee Award) Rena Brauer (Los Angeles, United States of America), Rena Brauer, Saundra Y. Schlesinger, Timothy P. Birkland, Lingyin Ge, Ying Huang, John K. McGuire, William C. Parks, Peter Chen
PA3023
Lung inflammation: The role of alveolar macrophages Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov
PA3024
Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism Sanooj Soni (London, United Kingdom), Sanooj Soni, Mariko Yoshida, Samantha Woods, Kieran O’Dea, Michael Wilson, Masao Takata
PA3025
Obesity modulates the alveolar macrophage response Niki Ubags (Maastricht, Netherlands), N.D.J. Ubags, J.H.J. Vernooy, S. Ventrone, S.C Frasch, D.L. Bratton, E.F.M. Wouters, B.T. Suratt
PA3026
Activation of NLRP3 inflammasome is regulated by mitochondrial ROS via PI3K-HIF-VEGF pathway in acute lung injury So Ri Kim (Jeonju, Republic of Korea), So Ri Kim, Yong Chul Lee, Hee Jung Kim, Soon Ha Kim
PA3027
Heparin effect in alveolar cells and macrophages in an acute lung injury model Marta Camprubí (Molins de Rei, Spain), Marta Camprubí-Rimblas, Raquel Guillamat-Prats, Laura Chimenti, Jessica Tijero, Mª Nieves Gómez, Lluís Blanch Blanch, Antonio Artigas
PA3028
Features of rat tracheal epithelium regeneration Igor A. Klimanov (Moscow, Russian Federation), A. Volkova, E. Mubarakshina, A. Gordeeva, A. Temnov, I. Klimanov, S. Soodaeva, V. Novoselov
PA3029
Effect of alveolar type II cells in acute lung injury model Raquel Guillamat-Prats (Barcelona, Spain), Raquel Guillamat-Prats, Ferranda Puig, Raquel Herrero, Anna Serrano-Mollar, Marta Camprubí-Rimblas, Marta Olive-Gadea, Laura Chimenti, Montse Batlle, Jessica Tijero, Maria Nieves Gómez, Lluís Blanch, Antonio Artigas
PA3030
Extracellular ATP is a danger signal activating P2X7 Receptor in a LPS mediated inflammation (ARDS) Sanja Cicko (Freiburg, Germany), Sanja Cicko, Anja Meyer, Nicolas Ehrat, Cemil Korcan Ayata, Andreas Zech, Madelon Hossfeld, Marco Idzko
PA3031
Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPAR jianchun Wang (Chongqing, China), Jianchun Wang, Chuanjiang Lei
PA3032
Association between age-dependent changes in the pulmonary renin angiotensin system and severity of lung injury Laura Schouten (Amsterdam, Netherlands), Laura Schouten, Hendrik Helmerhorst, Gerry Wagenaar, Rene Lutter, Joris Roelofs, Tom Haltenhof, Job Van Woensel, Anton Van Kaam, Albert Bos, Marcus Schultz, Thomas Walter, Roelie Wöstenvan-Asperen
PA3033
SIRT1 contributes to LPS-induced lung injury through interaction with mitochondrial ROS generation Yong Chul Lee (Jeonju, Republic of Korea), Yong Chul Lee, So Ri Kim, Hee Jung Kim, Soon Ha Kim
PA3034
Effects of voluven on lung injury induced by hemorrhagic shock and femoral fracture in rat Farzaneh Ketabchi (Shiraz, Islamic Republic of Iran), Vahid Zangouri, Shahin Khodaei, Farzaneh Ketabchi, Seyed Mostafa Shid Moosavi, Alireza Dehghan, Shahram Payedar
PA3035
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice Hironori Mikumo (Fukuoka, Japan), Hironori Mikumo, Naoki Hamada, Ichiro Inoshima, Saiko Ogata, Yuichi Mizuta, Kunihiro Suzuki, Tetsuya Yokoyama, Yoichi Nakanishi
PA3036
LASSBio 596 improves function, inflammation and apoptosis in lung and liver of mice intoxicated with microcystinLR Giovanna Carvalho (Rio de Janeiro, Brazil), Giovanna Carvalho, Vinicius Oliveira, Maria Diana Gomes, Natalia Casquilho, Raquel Soares, Sandra Azevedo, Lidia Lima, Eliezer Barreiro, Christina Takiya, Walter Zin
PA3037
Glycerol kinase 5 regulates wound healing of airway epithelial cells by mediating aquaglyceroporin 3 and 9 Jian Zhou (Shanghai, China), Jian Zhou, Chunxue Bai
Room E102
Session 325
Poster Discussion: IPF: from bench to bedside Chairs : Martina Vašáková (Prague, Czech Republic), Chair to be confirmed
197
14:45 - 16:45
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA3038
Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc) Jörg Distler (Erlangen, Germany), Jingang Huang, Christian Beyer, Katrin Palumbo-Zerr, Yun Zhang, Stefan-Lutz Wollin, Jörg Distler
PA3039
Expression of miR-185 targets DNA methyltransferase 1 and Cyclin D2 in IPF and lung cancer in BALF cells: Preliminary results Eleni Bibaki (Heraklion, Crete, Greece), Eleni Bibaki, Eliza Tsitoura, Chara Koutoulaki, Eirini Vasarmidi, Evangelia Stamataki, Despina Moraitaki, Nikos Tzanakis, Katerina Antoniou
PA3040
Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis Katrin Esther Hostettler Haack (Basel, Switzerland), Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Qingzhu Sun, Michael Tamm, Christopher Lambers, Michael Roth
PA3041
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblasts in vitro arnaud Mailleux (Paris, France), Audrey Joannes, Joëlle Marchal-Somme, Bruno Crestani, Arnaud Mailleux
PA3042
Real life patient experience of pirfenidone in a regional interstitial lung disease clinic Abirami Subramaniam (Dublin, Ireland), Abirami Subramaniam, Mohamed Elshafi, Loraine Thong, Kate O’Halloran, Bernadette Bowen, Kashif Khan, Desmond Murphy, Barry Plant, Marcus Kennedy, Michael Henry
PA3043
Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Dirk Steffen Koschel (Radebeul, Germany), Lars Lützkendorf, Marcus Vogler, Gert Höffken, Dirk Koschel
PA3044
Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases Claudia Valenzuela (Alcobendas (Madrid), Spain), Claudia Valenzuela, Maria Molina, Fátima Diaz Chantar, Tamara Alonso, Jose Antonio Rodriguez Portal, Maria Jesus Rodriguez Nieto, Rosalia Laporta, María Jesús Linares, Julio Ancochea
PA3045
Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis Paola Faverio (Limbiate, Italy), Paola Faverio, Roberto Ruggiero, Valentina Paolini, Luca Novelli, Federica De Giacomi, Alice Biffi, Elisa Oggionni, Luca Bilucaglia, Alberto Pesci
PA3046
Inhaled PHMG can induce pulmonary fibrosis through mitochondrial ROS generation So Ri Kim (Jeonju, Republic of Korea), So Ri Kim, Yong Chul Lee, Dong Im Kim, Hae Jin Park, Soon Ha Kim
PA3047
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Nour Bacha (Gournay-Sur-Marne, France), Nour Bacha, Adeline Blandinières, Pascale Gaussem, Chantal Boulanger, Jean Marie Renard, Eduardo Anglès-Cano, Dominique Israël-Biet, David Smadja
PA3048
FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice Aurelien Justet (Paris, France), Aurélien Justet, Audrey Joannes, Joelle Marchal-Somme, Valérie Besnard, Philippe Bonniaud, Arnaud Mailleux, Bruno Crestani
PA3049
Role of the nitric oxide-asymmetric dimethylarginine-dimethylarginine dimethylaminohydrolase (NO-ADMADDAH) axis in TGF- mediated epithelial-mesenchymal transition Harpreet Lota (Hounslow, United Kingdom), Harpreet K. Lota, James M. Leiper
PA3050
Etablishing rhesus model of pulmonary fibrosis (PF) for the new drug evaluation Lian Liu (Chengdu, China), Lian Liu, Hao Wang, Hao Wang, Xiaoou Li, Fuqiang Wen
PA3051
Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Ming Liu (Guangzhou, China), Ming Liu
PA3052
Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis Katrin Esther Hostettler Haack (Basel, Switzerland), Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Michael Tamm, Christopher Lambers, Didier Lardinois, Michael Roth
PA3053
Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis Nicolas Kahn (Heidelberg, Germany), Nicolas Kahn, Martin Granzow, Michael Meister, Ralf Eberhardt, Thomas Muley, Eva Baroke, Ute Oltmanns, Felix J.F. Herth, Michael Kreuter
PA3054
Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Xiaoping Long (Essen, Germany), Xiaoping Long, Ulrich Costabel, Xuan He, Thomas E. Wessendorf, Dirk Theegarten, Josune Guzman, Francesco Bonella
198
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA3055
Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis Katrin Esther Hostettler Haack (Basel, Switzerland), Katrin Hostettler, Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, Chistopher Lambers, Michael Tamm, Michael Roth
Room D201-202
Session 326
14:45 - 16:45
Poster Discussion: Best abstracts in chronic care Chairs : Michael Steiner (Leicester, United Kingdom), Roberto Rabinovich (Edinburgh, United Kingdom) PA3056
Effect of weight-loss on the dynamic hyperinflation in obese asthmatics Celso Carvalho (Sao Paulo, Brazil), Aline G. Silva, Patricia D. Freitas, Palmira G. Ferreira, Frederico L.A. Fernandes, João M. Salge, Rafael Stelmach, Alberto Cukier, Milton A. Martins, Celso R.F. Carvalho
PA3057
Effectiveness of an occupational therapy program after AECOPD Marie Carmen Valenza (Granada, Spain), Marie Carmen Valenza, Irene Torres-Sanchez, Concepcion Morales-Garcia, Paz Moreno, Janet Rodriguez, Araceli Ortiz
PA3058
Effectiveness of temporary positive expiratory pressure (T-PEP) at home and at hospital in patients with severe COPD valentina Mascardi (sestri levante, Italy), Valentina Mascardi, Ines Maria Grazia Piroddi, Bruna Grecchi, Antonello Nicolini
PA3059
The effect of frequent use of hypnotics on HRQOL in patients receiving LTOT and/or long-term NIV Tomomasa Tsuboi (Joyo, Japan), Tomomasa Tsuboi, Toru Oga, Takefumi Saito, Shohei Takada, Shuichi Yano, Tetsuro Ohdaira, Yoshiro Mochizuki, Toru Yamanaka, Masahiro Abe, Kensuke Sumi, Kazuo Chin
PA3060
1–year mortality in hospitalized patients with an acute exacerbation of COPD on the pulmonary ward compared to the ICU Wendy van Beurden (Enschede, Netherlands), Wendy Van Beurden, Kirsten Bosscher, Marjolein Brusse-Keizer
PA3061
Clinical characteristics and health status of spontaneous sputum producers in COPD Dionne Braeken (Valkenburg a/d Geul, Netherlands), D.C.W. Braeken, S. Wilke, D.E. Smid, G.G.U. Rohde, J.J.C. Drijkoningen, E.F.M. Wouters, M.A. Spruit, F.M.E. Franssen
PA3062
Comparison of adventitious respiratory sounds between stable COPD and AECOPD Cristina Jácome (Nine, Portugal), Cristina Jácome, Ana Oliveira, Alda Marques
PA3063
Prevalence and characteristics of anxiety and depression in patients with advanced COPD Nicole Toms (Leicester, United Kingdom), Nicole Toms, Neil Greening, Robert Free, Rachael Evans, Michael Steiner
PA3064
Epidemiology of desaturation dips in a cohort of patients under non-invasive ventilation (NIV) Claudio Rabec (Dijon, France), Claire-Marie Monnet, Claudio Rabec, Marjolaine Georges, Clement Foignot, Philippe Camus, Philippe Bonniaud
PA3065
Comparison of effectiveness of two positive expiratory devices in severe COPD patients: Temporary positive expiratory pressure (TPEP) versus oscillatory positive expiratory pressure ( OPEP ) Antonello Nicolini (Sestri Levante GE, Italy), Antonello Nicolini, Valentina Mascardi, Bruna Grecchi
PA3066
Physicians’ knowledge and perceived barriers to pulmonary rehabilitation in Nigeria Ayodele Akinremi (Ibadan, Nigeria), Ayodele Akinremi, Susan Ogwu
PA3067
Benefits of self-management education in COPD exacerbations Annette Overgaard (Skive, Denmark), Jensen Michael Skov, Overgaard Annette, Hougaard Lisbeth, Holm Else
PA3068
Changes over time in body composition assessed by segmental bioelectrical impedance analysis in COPD patients Daniela Gologanu (Bucarest, Romania), Daniela Gologanu, Diana Ionita, Cristina Stanescu, Ana Maria Raceanu, Miron Alexandru Bogdan
PA3069
Self-reported lack of adherence is associated with increased airway hyperresponsivness in asthma Christian Woehlk (Copenhagen, Denmark), Christian Woehlk, Anna Von Bülow, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg
PA3070
Falls, an underestimated risk in COPD Ovidiu Fira-Mladinescu (Timisoara, Romania), Alexandru F. Crisan, Cristian Oancea, Bogdan Timar, Ovidiu FiraMladinescu, Voicu Tudorache
PA3071
Adherence to home mechanical ventilation (HMV) Eric Derom (Gent, Belgium), Jan-Jakob Delanoye, Stef Bouduin, Eric Derom, Guy Joos
PA3072
An integrated care management program (ICMP) for patients with severe COPD; mortality, hazards and causes Elena Valerevna Titova (Trondheim, Norway), Elena Titova, Sigurd Steinshamn, Anne Henriksen
199
ERS International Congress 2015 DETAILED PROGRAMME MONDAY 28 SEPTEMBER, 2015
PA3073
Preliminary outcomes of the CREWS study Phyllis Murphie (Dumfries, United Kingdom), Phyllis Murphie, Margaret Gall, Mary Wilson, Musa Ali, Helen Coles, Stuart Little
Room 13.2
Session 327
17:00 - 17:50
Group members' meeting: Group 1.6 Members' Meeting "General practice and primary care" Chairs : Bjorn Stallberg (Uppsala, Sweden), Hilary Pinnock (Edinburgh, United Kingdom), Janwillem Kocks (Groningen, Netherlands)
Room E103
Session 328
17:00 - 17:50
Group members' meeting: Group 1.4 Members' Meeting "Interventional pulmonology" Chairs : Stefano Gasparini (Ancona, Italy), Jouke T. Annema (Amsterdam, Netherlands), Prashant Nemichand Chhajed (Mumbai, India)
17:15-19:15 INDUSTRY EVENING SYMPOSIUM
SEE PAGE 331
17:30-19:00 INDUSTRY EVENING MINI SYMPOSIUM
SEE PAGE 331
200
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
Room G106-107
Session 349
07:00 - 08:15
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Challenging clinical cases: CC5 Interpretation of pulmonary function testing Aims : To provide the participants with the skills and knowledge necessary for confidently interpreting pulmonary function tests Track(s) : Physiology Tag(s) : Clinical Target audience : Technologists, respiratory physicians, clinical researchers, fellows, and residents. Chairs : Eric Derom (Gent, Belgium) 07:00
Introduction
3187
07:10
The clinical value of trend reports in pulmonary function testing Tiago Jacinto (Senhora da Hora, Portugal)
3188
07:35
The clinical value of bodybox measurements Stefan Walen (Zwolle, Netherlands)
3189
08:00
Discussion
3190
Room E102
Session 350
07:00 - 08:15
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Challenging clinical cases: CC6 Multidisciplinary team discussion in thoracic oncology Aims : To provide physicians (both in training and experienced) with a real-life discussion on thoracic oncology cases by exploring current multidisciplinary discussions in thoracic oncology. How to choose the best strategy(ies) for diagnosing or treating peculiar cases will be presented along with the scientific data in the literature that support each choice. The benchmark decisions that have been taken previously and the scientific foundations for these decisions will also be presented. Finally, a multidisciplinary team discussion as it occurs in daily practice will be simulated: junior members will present case studies that will then be discussed by the participants. In particular, the diagnostic and therapeutic strategies for the cases will be discussed. The outcomes of the discussion will then be compared with what was done in practice. Track(s) : Oncology Tag(s) : Clinical Target audience : All respiratory physicians who manage lung cancer patients. Chairs : Gilbert Massard (Strasbourg, France), Rainer G. Wiewrodt (Münster, Germany) 07:00
Introduction
3191
07:10
A patient with multiple pulmonary nodules Nadeem Anwar (Bolton, United Kingdom)
3192
07:35
A positive post-operative PET Florin Rusu-Cordunean (Iasi, Romania)
3193
08:00
Discussion
3194
Room L001
Session 352
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW19 Motivational interviewing for smoking cessation in COPD smokers Aims : To review the different strategies used to increase the motivation of COPD smokers to quit smoking. Track(s) : Epidemiology/Environment Tag(s) : Clinical Target audience : Pulmonologists, nurses, thoracic surgeons, fellows and residents. Chairs : Paraskevi Katsaounou (Athens, Greece) Introduction
3199
Workstation 1: Different theories of motivation Lynne Johnston (Newcastle, United Kingdom)
3200
201
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Workstation 2: How to measure motivation Speaker to be confirmed
3201
Workstation 3: The different phases of motivational interviewing Dimos Fotopoulos (Rethymnon, Greece)
3202
Workstation 4: The roles spirometry and lung age play in increasing the motivation of COPD patients Carlos Andres Jimenez Ruiz (Madrid, Spain)
3203
Room L002
Session 353
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW20 Respiratory sampling techniques Aims : Sampling the airways is a useful way of accessing “the core” of lung diseases. Since the different techniques that are used to sample the airways can yield interesting immunological, inflammatory, and clinical data, this workshop aims to provide practical skills for both clinical and research purposes. The workshop does not require previous experience in this field. The workstations will be organised to be interactive and to provide all the required skills needed to perform the techniques. Tag(s) : Translational Target audience : Researchers, respiratory physicians interested in biological research, biologists, pulmonologists, pathologists, technicians. Chairs : Philipp A. Schnabel (Homburg/Saar, Germany) 08:00
Introduction
3204
08:05
Workstation 1: Clinical cytology – rapid onsite evaluation (ROSE) Matthias Wiebel (Heidelberg, Germany)
3205
08:40
Workstation 2: Histology Erik Thunnissen (Amsterdam, Netherlands)
3206
09:15
Workstation 3: Sputum collection Patrizia Pignatti (Pavia, Italy)
3207
09:50
Workstation 4: Analysis of BAL fluids Christian M. Kaehler (Innsbruck, Austria)
3208
Room L001
Session 376
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW21 Motivational interviewing for smoking cessation in COPD smokers Aims : To review the different strategies used to increase the motivation of COPD smokers to quit smoking. Track(s) : Epidemiology/Environment Tag(s) : Clinical Target audience : Pulmonologists, nurses, thoracic surgeons, fellows and residents. Chairs : Sofia Belo Ravara
(Lisboa, Portugal)
10:40
Introduction
3432
10:45
Workstation 1: Different theories of motivation Sotiria Schoretsaniti (Athens, Greece)
3433
11:20
Workstation 2: How to measure motivation Gian Paolo Guelfi (Genoa, Italy)
3434
11:55
Workstation 3: The different phases of motivational interviewing Speaker to be confirmed
3435
12:30
Workstation 4: The roles spirometry and lung age play in increasing the motivation of COPD patients Paraskevi Katsaounou (Athens, Greece)
3436
Room L002
Session 377
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW22 Respiratory sampling techniques
202
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Aims : Sampling the airways is a useful way of accessing “the core” of lung diseases. Since the different techniques that are used to sample the airways can yield interesting immunological, inflammatory, and clinical data, this workshop aims to provide practical skills for both clinical and research purposes. The workshop does not require previous experience in this field. The workstations will be organised to be interactive and to provide all the required skills needed to perform the techniques. Tag(s) : Translational Target audience : Researchers, respiratory physicians interested in biological research, biologists, pulmonologists, pathologists, technicians. Chairs : Antonio Spanevello (Tradate, Italy) Introduction
3437
Workstation 1: Clinical cytology Eva Schmutz (Heidelberg, Germany)
3438
Workstation 2: Histology Helmut H. Popper (Graz, Austria)
3439
Workstation 3: Sputum collection Antonio Spanevello (Tradate, Italy)
3440
Workstation 4: Analysis of BAL fluids Ulrich Costabel (Essen, Germany)
3441
Room L001
Session 449
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW23 Motivational interviewing for smoking cessation in COPD smokers Aims : To review the different strategies used to increase the motivation of COPD smokers to quit smoking. Track(s) : Epidemiology/Environment Tag(s) : Clinical Target audience : Pulmonologists, nurses, thoracic surgeons, fellows and residents. Chairs : Philip Tønnesen (Glostrup, Denmark) Introduction
4419
Workstation 1: Different theories of motivation Lynne Johnston (Newcastle, United Kingdom)
4420
Workstation 2: How to measure motivation Gian Paolo Guelfi (Genoa, Italy)
4421
Workstation 3: The different phases of motivational interviewing Dimos Fotopoulos (Rethymnon, Greece)
4422
Workstation 4: The roles spirometry and lung age play in increasing the motivation of COPD patients Carlos Andres Jimenez Ruiz (Madrid, Spain)
4423
Room L002
Session 450
14:30 - 16:50
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW24 Respiratory sampling techniques Aims : Sampling the airways is a useful way of accessing “the core” of lung diseases. Since the different techniques that are used to sample the airways can yield interesting immunological, inflammatory, and clinical data, this workshop aims to provide practical skills for both clinical and research purposes. The workshop does not require previous experience in this field. The workstations will be organised to be interactive and to provide all the required skills needed to perform the techniques. Tag(s) : Translational Target audience : Researchers, respiratory physicians interested in biological research, biologists, pulmonologists, pathologists, technicians. Chairs : Christian M. Kaehler (Innsbruck, Austria) Introduction
4424
Workstation 1: Clinical cytology Matthias Wiebel (Heidelberg, Germany)
4425
203
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Workstation 2: Histology Erik Thunnissen (Amsterdam, Netherlands)
4426
Workstation 3: Sputum collection Patrizia Pignatti (Pavia, Italy)
4427
Workstation 4: Analysis of BAL fluids Christian M. Kaehler (Innsbruck, Austria)
4428
Room G110
Session 443
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME8 Effect of air travel and altitude in patients with respiratory conditions Focussing on COPD Aims : To review current air travel guidelines for COPD patients, the use of pre-flight tests and the availability of in-flight oxygen Tag(s) : Clinical Target audience : Pulmonologists, nurses, and respiratory technologists. Chairs : 13:00
Effect of air travel and altitude in patients with respiratory conditions Konrad E. Bloch (Zurich, Switzerland)
4403
13:40
Case presentation: participants - to submit your cases please contact
[email protected]
4404
Room G104-105
Session 441
13:00 - 14:00
This course is fully booked. Please contact
[email protected] to be added to the waiting list.
Meet the expert: ME9 Management of non-tuberculous mycobacterial (NTM) infections Aims : To provide updated information on the management of NTM disease. Track(s) : Infection Target audience : Pulmonologists, intensivists, emergency medicine doctors, nurses, respiratory physicians, and clinical researchers. Chairs : 13:00
Management of nontuberculous mycobacterial infections Christoph Lange (Borstel, Germany)
Room G109
Session 442
4401
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME10 Paediatric lung function tests reference values Aims : To review the key points regarding the use of appropriate reference values for lung function testing in children and their correct interpretation. The session will focus on both spirometry and the reference values for lung function techniques in preschool children. Track(s) : Paediatric Tag(s) : Clinical Target audience : Caretakers who use lung function testing to manage paediatric patients, paediatric pulmonologists, paediatric nurses, and paediatric lung function technicians. Chairs : 13:00
Paediatric lung function tests reference values: appropriateness and interpretation Sanja Stanojevic (Toronto, Canada)
Room G111
Session 444
4402
13:00 - 14:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Meet the expert: ME11 Research methodology and data analysis Aims : To review the different methodological procedures in scientific studies and to explain the statistical procedures that can be used to analyse the data of scientific studies. Tag(s) : Translational Target audience : Pulmonologists, thoracic surgeons, nurses, paediatricians, and clinical researchers. Chairs :
204
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 13:00
Research methodology and data analysis H. Marike Boezen (Groningen, Netherlands)
Room Auditorium
4405
Session 355
08:30 - 10:30
Session: Live pulmonary endoscopy Lung cancer Aims : In a pulmonary practice, the diagnostic work-up of patients with suspected lung cancer is important and involves a large number of patients. Endosonography (EBUS and EUS) is an important tool for mediastinal staging. The techniques that will be demonstrated are bronchoscopy, TBNA, EBUS, EUS (B), EUS, and radial EBUS. Track(s) : Oncology Tag(s) : Clinical Target audience : General pulmonologists and residents Chairs : Felix J.F. Herth (Heidelberg, Germany), Christophe Dooms (Leuven, Belgium) 08:30
Live pulmonary endoscopy: welcome and opening remarks Marcel Levi (Amsterdam, Netherlands)
3213
08:30
Patient advocate (AMC) Olga C.J. Schuurbiers (Nijmegen, Netherlands), Erik H.F.M. van der Heijden (Nijmegen, Netherlands)
3214
08:35
Opening lecture: Endoscopic techniques for the diagnosis and staging of lung cancer Felix J.F. Herth (Heidelberg, Germany)
3215
08:50
EBUS and EUB-B Jouke T. Annema (Amsterdam, Netherlands), Bin Hwangbo (Goyang, Republic of Korea)
3216
08:50
EUS-FNA (linear) Artur Szlubowski (Krakow, Poland), Paul Frost Clementsen (Copenhagen, Denmark)
3217
08:50
Bronchoscopy with TBNA (and cryobiopsy) Stefano Gasparini (Ancona, Italy), Semra Bilaceroglu (Izmir, Turkey)
3218
08:50
EBUS (radial) Ralf Eberhardt (Heidelberg, Germany), Maren Schuhmann (Heidelberg, Germany)
3219
08:50
EBUS-TBNA (linear) Pallav L Shah (London, United Kingdom), Laurence M.M.J. Crombag (Amsterdam, Netherlands)
3220
10:05
Lung cancer: live procedure question and answer session Felix J.F. Herth (Heidelberg, Germany), Christophe Dooms (Leuven, Belgium)
3221
10:15
Concluding lecture: Position of endoscopy in lung cancer staging algorithms Christophe Dooms (Leuven, Belgium)
3222
Room Auditorium
Session 379
10:45 - 12:45
Session: Live pulmonary endoscopy Interstitial and pleural diseases Aims : Interstitial lung diseases constitute a significant part of the workload of pulmonologists. Sarcoidosis is the most prevalent interstitial lung disease and tissue confirmation is often needed. Novel endoscopic techniques that yield peripheral lung tissue are available. The techniques that will be demonstrated are bronchoscopy with BAL, TBNA and TBLB, cryobiopsies, EBUS, and EUS (B). Malignant and infectious/inflammatory diseases are often associated with pleural diseases. Thoracoscopy is the standard technique for diagnosing pleural diseases. The techniques that will be demonstrated are flexible and rigid thoracoscopy. Tag(s) : Clinical Chairs : Venerino Poletti (Forli, Italy), Najib M. Rahman (Oxford, United Kingdom) 10:45
Opening lecture: Endoscopy for sarcoidosis and ILD Venerino Poletti (Forli, Italy)
3446
10:45
Patient advocate (AMC) Erik H.F.M. van der Heijden (Nijmegen, Netherlands), Olga C.J. Schuurbiers (Nijmegen, Netherlands)
3447
11:00
Bronchocopy, BAL, TBLB, and cryobiopsy Juergen Hetzel (Dusslingen, Germany), Johannes M.A. Daniels (Amsterdam, Netherlands)
3448
205
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 11:00
EBUS-TBNA Rocco Trisolini (Bologna, Italy), Stefano Gasparini (Ancona, Italy)
3449
11:00
EUS-B Masahide Oki (Nagoya, Japan), Jouke T. Annema (Amsterdam, Netherlands)
3450
11:00
Rigid thoracoscopy Julius P. Janssen (Nijmegen, Netherlands), Marios E. Froudarakis (Alexandroupolis, Greece)
3451
11:00
Flexible thoracoscopy Ales Rozman (Golnik, Slovenia), Mohammed Munavvar (Preston, United Kingdom)
3452
12:20
Interstitial and pleural diseases: live procedure question and answer session Venerino Poletti (Forli, Italy), Najib M. Rahman (Oxford, United Kingdom)
3453
12:30
Concluding lecture: Role of thoracoscopy in pleural diseases Najib M. Rahman (Oxford, United Kingdom)
3454
Room Auditorium
Session 436
13:00 - 14:30
Session: Live pulmonary endoscopy Emphysema and severe asthma Aims : Endoscopic lung volume reduction (ELVR) for severe emphysema and bronchial thermoplasty for severe asthma are new treatment possibilities for patients with obstructive lung diseases. The techniques that will be demonstrated are endobronchial valve Chartis measurements, endobronchial coils, and bronchial thermoplasty. Tag(s) : Clinical Target audience : General pulmonologists and residents. Chairs : Pallav L Shah (London, United Kingdom), Arschang Valipour (Vienna, Austria) 13:00
Opening lecture: endoscopic therapies for emphysema and asthma Arschang Valipour (Vienna, Austria)
4379
13:00
Patient advocate (AMC) Therese Lapperre (Singapore, Singapore)
4380
13:00
Patient advocate (UMCG) Nicolaas H.T. ten Hacken (Groningen, Netherlands)
4381
13:15
Endobronchial coils Dirk-Jan Slebos (Groningen, Netherlands), Frank Sciurba (Pittsburgh, United States of America)
4382
13:15
Bronchial thermoplasty Gerard P. Cox (Hamilton, Canada), Peter I. Bonta (Amsterdam, Netherlands)
4383
13:15
Endobronchial valves and Chartis measurement Dirk-Jan Slebos (Groningen, Netherlands), Frank Sciurba (Pittsburgh, United States of America)
4384
14:00
Emphysema and severe asthma: question and answer session Arschang Valipour (Vienna, Austria), Pallav L Shah (London, United Kingdom)
4385
14:15
Concluding lecture: Which patient should I refer for ELVR/BT? Pallav L Shah (London, United Kingdom)
4386
Room Auditorium
Session 452
14:45 - 16:45
Session: Live pulmonary endoscopy Transthoracic ultrasound Aims : Transthoracic ultrasound is a helpful tool for investigating clinical problems such as suspected pleural fluid, white hemithorax, atelectasis, empyema, and diaphragm function problems. This session will demonstrate some of the most common investigations that are performed with transthoracic ultrasound. Tag(s) : Clinical Target audience : General pulmonologists and residents. Chairs : Fergus Gleeson (Oxford, United Kingdom), Chair to be confirmed 14:45
Transthoracic ultrasound: technical aspects and artefacts Fergus Gleeson (Oxford, United Kingdom)
206
4433
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 14:45
Patient advocate (AMC) Therese Lapperre (Singapore, Singapore), Inge van den Berk (Amsterdam, Netherlands)
4434
15:00
White hemi thorax Jouke T. Annema (Amsterdam, Netherlands)
4435
15:00
Pleural effusion Najib M. Rahman (Oxford, United Kingdom), Laurence M.M.J. Crombag (Amsterdam, Netherlands)
4436
15:00
Empyema Ioannis Psallidas (Oxford, United Kingdom)
4437
15:00
Peripherally located lung tumour Najib M. Rahman (Oxford, United Kingdom), Laurence M.M.J. Crombag (Amsterdam, Netherlands)
4438
15:00
Mesothelioma Ioannis Psallidas (Oxford, United Kingdom), John Wrightson (Oxford, United Kingdom)
4439
16:20
Transthoracic ultrasound: question and answer session Fergus Gleeson (Oxford, United Kingdom), Speaker to be confirmed
4440
16:30
Transthoracic ultrasound in clinical practice Speaker to be confirmed
4441
Room 2.1
Session 346
07:00 - 08:15
How to: Review articles and abstracts Aims : To establish a best practice guide to assessing critical aspects of scientific papers such as ethics, originality and structure and to evaluate different approaches to giving constructive and valuable feedback. Target audience : Pulmonologists, respiratory therapists, respiratory physicians, intensivists, pathologists, radiologists, basic scientists and clinical researchers. Chairs : Wisia Wedzicha (London, United Kingdom) 07:00
Introduction
3174
07:10
How to assess central aspects of a scientific paper (ethics, originality, structure) Marcos I. Restrepo (San Antonio, United States of America)
3175
07:35
How to give constructive feedback Marc Humbert (Paris, France)
3176
08:00
Discussion
3177
Room Emerald
Session 347
07:00 - 08:15
How to: Work with the EU funding system Aims : To gain an understanding of the funding system of the EU, especially Horizon 2020, and how to facilitate positive outcomes from grant applications. Target audience : Pulmonologists, respiratory therapists, respiratory physicians, general practitioners, intensivists, basic scientists, clinical researchers, research fellows, pathologists, radiologists, and trainees. Chairs : Martina Sester (Homburg, Germany) 07:00
Introduction
3178
07:10
How to identify available types of funding Daniela Maria Cirillo (Milan, Italy)
3179
07:35
How to get your funding application accepted Matthias Griese (Munich, Germany)
3180
08:00
Discussion
3181
07:00-08:15 INDUSTRY EARLY MORNING SYMPOSIUM
207
SEE PAGE 331
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
Room 7.1
Session 354
08:30 - 10:30
Year in review: In paediatrics From airways to sleep disorders Aims : To update the audience in four topics in paediatric respiratory medicine. The most recent and significant literature and developments relating to these topics will be highlighted. Track(s) : Paediatric Tag(s) : Clinical Target audience : Paediatricians and other clinically active clinicians, GPs, and health professionals. Chairs : Jonathan Grigg (London, United Kingdom), Fabio Midulla (Rome, Italy) 08:30
The paediatric airways Ernst Eber (Graz, Austria)
3209
09:00
Paediatric respiratory infection Mark Everard (Perth, Australia)
3210
09:30
Asthma in childhood Fernando Maria De Benedictis (Ancona, Italy)
3211
10:00
Sleep-disordered breathing in childhood Refika Hamutcu Ersu (Istanbul, Turkey)
3212
Room 7.2
Session 356
08:30 - 10:30
Symposium: Basics in physiology Aims : To describe the main principles underlying gas exchange, blood perfusion, and pulmonary haemodynamics. Track(s) : Physiology Tag(s) : Basic Target audience : Clinicians, physiologists, and basic scientists. Chairs : Robert Naeije (BRUSSELS, Belgium), Anton Vonk Noordegraaf (Amsterdam, Netherlands) 08:30
Control of ventilation Jerome Dempsey (Madison, United States of America)
3223
09:00
Pulmonary haemodynamics and the right ventricle Nico Westerhof (Amsterdam, Netherlands)
3224
09:30
Exercise testing Susan Ward (Crickhowell, United Kingdom)
3225
10:00
Gas exchange: general principles and compensatory mechanisms John Michael B. Hughes (London, United Kingdom)
3226
Room Elicium 2
Session 357
08:30 - 10:30
Symposium: Non-small cell lung cancer (NSCLC): sequence, timing, and modality of multi-line therapies Aims : Most lung cancer patients must undergo a second-line therapy. A substantial number will also undergo third, fourth, and further lines of therapy. While first-line therapies are well supported by scientific evidence, there are far fewer well-designed clinical trials that support the use of second-line and especially further line therapies. Moreover, there are little data available that helps the clinician to reliably select the sequence, timing, and modality of multi-line therapies. This symposium focuses on various aspects of multi-line therapies in clinical practice in terms of treatment response, symptom control, and quality of life. Track(s) : Oncology Tag(s) : Translational Target audience : Researchers who are interested in medical oncology, clinical scientists, clinicians with an interest in the molecular basis of thoracic malignancies, and all specialists involved in the diagnostic and therapeutic management of lung cancer. Chairs : Nicolas Schönfeld (Berlin, Germany), Fernando Gamarra (Straubing, Germany) 08:30
Radiation therapy in oligometastatic lung cancer: upfront or on demand?
3227
09:00
The art of maintaining a clinical meaningful response: number of treatment cycles and when to use maintenance therapy rather than instituting early next line therapy
3228
208
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 09:30
Tyrosine kinase inhibitors beyond progression: never, intercalating or forever? Rainer G. Wiewrodt (Münster, Germany)
3229
10:00
Combating acquired resistance: are rebiopsies needed for guiding multi-line therapies? Pascale Tomasini (Marseille, France)
3230
Room 4.2
Session 358
08:30 - 10:30
Symposium: Lung cancer screening: how to implement a comprehensive preventive approach Aims : To describe and present the techniques and potential algorithms, based on the available evidence, and tentatively discuss the implementation of these algorithms. Track(s) : Oncology Tag(s) : Clinical Target audience : Clinicians, pulmonologists, surgeons, oncologists, GPs, residents, and fellows. Chairs : Mina Gaga (Athens, Greece), Cornelia Schaefer-Prokop (Amersfoort, Netherlands) 08:30
Patient's perspective Cilia Linssen (Haarlem, Netherlands)
3231
08:42
Lung cancer: the global burden of the disease Jean-Paul Sculier (Brussels, Belgium)
3232
09:09
Current evidence from lung cancer-screening trials that include computed tomography Matthias Prokop (Nijmegen, Netherlands)
3233
09:36
Diagnostic approaches to lesions found during CT screening Nicolas Kahn (Heidelberg, Germany)
3234
10:03
Lung cancer screening: the critical review Hans Hoffmann (Heidelberg, Germany)
3235
Room 5.2
Session 359
08:30 - 10:30
Symposium: ERS Task Forces and Guidelines: procedures, methodology and publication including publication in ERJ, ERR, and ERJ Open Research Aims : To provide insights into the ERS procedures and methodology that are used to develop guidelines and consensus statements, illustrate the role of journals (in particular those within the ERS portfolio) in publishing this information and update the audience regarding the major recent task forces/guidelines in pulmonary hypertension, field walking tests in chronic respiratory disease, idiopathic pulmonary fibrosis, and bronchiolitis obliterans syndrome. Tag(s) : Clinical Target audience : Respiratory clinicians, nurses, educators, and students. Chairs : Anh Tuan Dinh-Xuan (Paris, France), Marc Humbert (Paris, France) 08:30
ERS Statement: Diagnosis and treatment of primary spontaneous pneumothorax Jean-Marie Tschopp (Crans-Montana, Switzerland)
3236
08:54
ERS/ATS Technical Standard: Field walking tests in chronic respiratory disease Sally J. Singh (Leicester, United Kingdom)
3237
09:18
ERS Statement: Idiopathic pulmonary fibrosis Katerina Antoniou (Heraklion, Greece)
3238
09:42
ERS/ISHLT/ATS Clinical Practice Guidelines: Diagnosis and management of bronchiolitis obliterans syndrome Allan Glanville (Sydney, Australia)
3239
10:06
ATS/ERS Statement: Interstitial Pneumonia with Autoimmune Features Vincent Cottin (Lyon, France)
3240
Room Elicium 1
Session 360
08:30 - 10:30
Symposium: Microbial impacts at different human ages Our microbiota and respiratory disease Aims : This session will present the importance and implications of the microbiome; how changes to the gut microbiome influence the lung; and how different types of host-microbe interactions may shape human health at different ages.
209
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Track(s) : Infection Tag(s) : Basic Target audience : General clinicians, basic researchers and epidemiologists. Chairs : Sejal Saglani (London, United Kingdom), Holger Garn (Marburg, Germany) 08:30
Implications of host-microbe interactions early in life for the development of respiratory disease Marie-Claire Arrieta (Vancouver, Canada)
3241
09:00
The characteristics and function of the microbiota in old age Yvone Huang (Ann Arbor, United States of America)
3242
09:30
Implications of the microbiome and mycobiome in cystic fibrosis Gaudenz Hafen (Belmont-sur-Lausanne, Switzerland)
3243
10:00
Host-microbe interactions in lung transplantation Eric Bernasconi (Lausanne, Switzerland)
3244
Room Forum
Session 361
08:30 - 10:30
Oral Presentation: Prognostic factors in pneumonia: from clinical observations to experimental models Chairs : Carlos M. Luna (Buenos Aires, Argentina), Eva Polverino (Barcelona, Spain)
OA3245
Streptococcus pneumoniae infection is an independent cause of cardiac rhythm alteration in community-acquired pneumonia Francisco Sanz Herrero (Quart de Poblet (Valencia), Spain), Francisco Sanz, Marcos Restrepo, Estrella Fernández-Fabrellas, Eusebi Chiner, María Luisa Briones, María Carmen Aguar, Rubén Lera, ángela Cervera, José Blanquer
OA3246
Distinguishing features of pneumonia and exacerbations in COPD Nicholas Williams (Romsey, United Kingdom), Nicholas Williams, Karl J. Staples, Kris Ostridge, Victoria Kim, Malwina M. Wojtas, Stephen Harden, Emmanuel Aris, Mathieu Peeters, Jeanne-Marie Devaster, Simon Bourne, Tom Wilkinson
OA3247
Biomarkers for oxidative stress in patients with community-acquired pneumonia Vilen Molotov-Luchanskiy (Karaganda, Kazakhstan), Vilen Molotov-Luchanskiy, Larissa Muravyova, Ryszhan Bakirova, Dmitriy Klyuyev, Lyudmila Demidchik, Yevgenia Kolesnikova
OA3248
Exhaled breath: Non-invasive diagnosis of ventilator-associated pneumonia Rianne Fijten (Elsloo LB, Netherlands), Rianne Fijten, Ronny Schnabel, Agnieszka Smolinska, Jan Dallinga, Marie-Louise Boumans, Ellen Stobberingh, Agnes Boots, Paul Roekaerts, Dennis Bergmans, Frederik-Jan Van Schooten
OA3249
Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies Simone Scarlata (Rome, Italy), Simone Scarlata, Ombretta Annibali, Simona Santangelo, Francesca Chiodi, Silvia Ferraro, Anna Zito, Maria Cristina Tirindelli, Giuseppe Avvisati, Raffaele Antonelli Incalzi
OA3250
Respiratory function as predictor for pneumonia in individuals with spinal cord injury? Anja Raab (Luzern, Switzerland), Anja Raab, Franz Michel, Claudio Perret, Maria T.E. Hopman, Gabi Müller
OA3251
Characterization of pulmonary function and mechanics in a novel model of pneumococcal pneumonia Rosanel Amaro Rodriguez (Barcelona, Spain), Rosanel Amaro, Gianluigi Li Bassi, Elisabet Aguilera-Xiol, Chiara Chiurazzi, Chiara Travierso, Montserrat Rigol, Laia Fernandez, Anna Motos, Marcus Schultz, Marco Carbonara, Joan Daniel Marti, María Adela Saco, Taitha Comaru, Jacobo Sellarés, José Ramirez, Francesc Marco, Antoni Torres
Room 5.1
Session 362
08:30 - 10:30
Oral Presentation: Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Chairs : Paul Kirkham (Wolverhampton, United Kingdom), Reinoud Gosens (Groningen, Netherlands)
OA3252
TRPV4 and activation of airway sensory nerves: The role of ATP Sara Bonvini (London, United Kingdom), Sara Bonvini, Mark Birrell, Megan Grace, Sarah Maher, John Adcock, Michael Wortley, Eric Dubuis, Yee-Man Ching, Anthony Ford, Fisnik Shala, Montserrat Miralpiex, Gema Tarrason, Jaclyn Smith, Maria Belvisi
OA3253
Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM) Sara Bonvini (London, United Kingdom), Sara Bonvini, Mark Birrell, Eric Dubuis, John Adcock, Victoria Jones, Pauline Flajolet, Sepideh Poushpas, Mengqi Wang, S. Mark Duffy, Peter Bradding, Kevin Langley, Maria Belvisi
210
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA3254
Beneficial effects of menthol are mediated via a TRPM8-independent mechanism Sarah Maher (London, United Kingdom), Sarah Maher, Mark Birrell, Sara Bonvini, Michael Wortley, Eric Dubuis, Fisnik Shala, Victoria Jones, Pauline Flajolet, Yulia Negreskul, Zelie Britton, Lana Hebib, Maria Belvisi
OA3255
Effectiveness of 15-deoxy-delta-12-14-prostaglandin J2 on established asthma pathological changes triggered by house dust mite in mice Diego Coutinho (Rio de Janeiro, Brazil), Diego De Sa Coutinho, Edna Alves dos Anjos Valotta, Patricia Machado Rodrigues e Silva, Marco Aurelio Martins
OA3256
Discovery of PRS-060, an inhalable CD123/IL4Ra/TH2 blocking anti-asthmatic anticalin protein re-engineered from endogenous lipocalin-1 Gary P. Anderson (Parkville, Australia), Gary P. Anderson, Andreas Hohlbaum, Kristian Jensen, Alexandra Bähre, Hendrik Gille
OA3257
MUC4 overexpression correlates corticoid resistance in chronic rhinosinusitis with nasal polyps Sonia Contreras (Valencia, Spain), Sonia Contreras, Adela Serrano, Lucia Díaz, Beatriz Ballester, Pilar Bañuls, Javier Milara
OA3258
CompEx – A novel composite asthma exacerbation endpoint Anne Fuhlbrigge (Boston, United States of America), Anne Fuhlbrigge, Thomas Bengtsson, Stefan Peterson, Alexandra Jauhiainen, Malin Fageras
OA3259
Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS) David Price (Aberdeen, United Kingdom), David Price, Daniela Van Eickels, Matthias Binek, Mona Khalid, Ron M.C. Herings, Jetty Overbeek, Richard Dekhuijzen, Thys Van der Molen, Wim Van Aalderen, Gene Colice, Theresa Guilbert, Eliot Israel, Richard Martin, Dirkje Postma, Nicolas Roche, Vicky Thomas, Cristiana Miglio
Room 13.1
Session 363
08:30 - 10:30
Oral Presentation: Acute critical care: news from the ICU Chairs : Antonio Artigas (Sabadell (Barcelona), Spain), Sabrine Hemmes (Amsterdam, Netherlands)
OA3260
LATE-BREAKING ABSTRACT: Automated oxygen titration in patients with acute respiratory distress at the emergency department. An international randomized controlled study. PHRC national 2010 freeO2 hypox #08-12 Erwan L'Her (Brest, France), Erwan L’Her, Erwan L’Her, Patricia Dias, Maellenn Gouillou, Nicolas Paleiron, Patrick Archambault, Pierre-Alexandre Bouchard, Francois Lellouche
OA3261
Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia Nousheen Iqbal (Karachi, Pakistan), Nousheen Iqbal, Muhammad Irfan, Javaid A. Khan, Safia Awan
OA3262
Is restricted transfusion approach in the ICU appropriate also for COPD exacerbations? Begüm Ergan (Izmir, Turkey), Begum Ergan, Recai Ergun
OA3263
Effectiveness of a biofeedback intervention toward weaning the difficult-to-wean MV patients CHING-I LI (Taipei, Taiwan), Ching-I. Li, Yu-Ju Chen, I-Chen Lin, Shing-Shan Guo
OA3264
Diaphragm ultrasound as a novel guide of weaning from invasive ventilation Gamal Agmy (Assiut, Egypt), Gamal Agmy, Samiaa Hamdy, Sherin Farghally
OA3265
Neuromuscular electrical stimulation in mechanically ventilated polytrauma patients: A strategy to minimize musculoskeletal dysfunction Luciana Vieira (Brasilia, Brazil), Luciana Vieira, Gerson Cipriano Jr, Paulo Eugenio Silva, Vinicius Silva, Priscilla Melo, Joao Durigan, Larissa Vieira, Natalia Lucilia, Andre Xavier, Hedian Gomes
OA3266
ICU-acquired pneumonia and PaO2/FIO2 value accuracy: A new paradigm? Telma Chantal Almeida Sequeira (Carnaxide, Portugal), Telma Sequeira, Chiara Chiurazzi, Miquel Ferrer, Chiara Travierso, Mariano Rinaudo, Gianluigi Li Bassi, Antoni Torres
OA3267
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial Antoni Torres Marti (Barcelona, Spain), Antoni Torres, Oriol Sibila, Miquel Ferrer, Rosario Mendendez, Josep Mensa, Albert Gabarrus, Jacobo Sellares, Marcos Restrepo, Antonio Anzueto, Nichael Niederman, Carlos Agusti, Eva Polverino
Room 2.1
Session 364
Oral Presentation: Predictors of lung transplant complications Chairs : Geert Verleden (Leuven, Belgium), Andrew Fisher (Newcastle, United Kingdom)
211
08:30 - 10:30
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA3268
LATE-BREAKING ABSTRACT: Prospective randomised pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in patients after primary lung transplantation (LuTX) Clemens Aigner (Vienna, Austria), Clemens Aigner, Alexis Slama, Maximilian Barta, Andreas Mitterbauer, György Lang, Shahrokh Taghavi, Jose Matilla, Roman Ullrich, Katharina Krenn, Peter Jaksch, Klaus Markstaller, Walter Klepetko
OA3269
Alveolar macrophages and pulmonary microbiota are interconnected indicators of lung ecology post-transplantation Eric Bernasconi (Lausanne, Switzerland), Eric Bernasconi, Angela Koutsokera, Celine Pattaroni, Berutto Carine, Boubou Camara, Benjamin J. Marsland, Christian Benden, Christophe Pison, John-David Aubert, Laurent P. Nicod, SysCLAD FP7 Consortium
OA3270
The impact of long-term air pollution and traffic on outcome after lung transplantation in Europe David Ruttens (Leuven, Belgium), David Ruttens, Stijn Verleden, Esmee Bijnens, Ellen Winckelmans, Jens Gottlieb, Gregor Warnecke, Federica Meloni, Monica Morosini, Davide Piloni, Wim Van der Bij, Erik Verschuuren, Gerhard Weinreich, Markus Kamler, Urte Sommerwerck, Antonio Roman, Susana Gomez-Olles, Cristina Berastegui, Christian Benden, Are Holm, Martin Iversen, Hans-Henrik Schultz, Bart Luijk, Erik-Jan Oudijk, Diane Van Kessel, Johanna Kwakkel-van-Erp, Peter Jaksch, Walter Klepetko, Nikolaus Kneidinger, Claus Neurohr, Paul Corris, Andy Fisher, Gerard Meachery, Jim Lordan, Elly Vandermeulen, Hannelore Bellon, Barbara Hoffmann, Kees De Hoogh, Danielle Vienneau, Gerard Hoek, Benoit Nemery, Geert Verleden, Robin Vos, Tim Nawrot, Bart Vanaudenaerde
OA3271
A multi-omics data integration approach to identify a predictive molecular signature of CLAD Johann Pellet (Lyon, France), Johann Pellet, Diane Lefaudeux, Pierre-Joseph Royer, Angela Koutsokera, Sandrine Bourgoin-Voillard, Markus Schmitt, Candice Trocme, Johanna Claustre, Andreas Fritz, Michel Seve, Antoine Magnan, Christophe Pison, Laurent Nicod, Charles Auffray, On Behalf of the SysCLAD Consortium
OA3272
Role of 18F-FDG PET in Restrictive Allograft Syndrome after lung transplantation Robin Vos (Lummen, Belgium), Robin Vos, Stijn Verleden, Elly Vandermeulen, David Ruttens, Hannelore Bellon, Jonas Yserbyt, Lieven Dupont, Dirk Van Raemdonck, Olivier Gheysens, Nathalie De Raedt, Geert Verleden, Bart Vanaudenaerde
OA3273
HNP and CCSP protein levels are differentially regulated in BAL from patients with obstructive and restrictive chronic allograft dysfunctions Natalia Smirnova (München, Germany), Natalia Smirnova, Claus Neurohr, Oliver Eickelberg, Jürgen Behr, Nikolaus Kneidinger
OA3274
Determining factors for bronchial healing in lung transplantation Anne Olland (Strasbourg, France), Anne Olland, Jospeh Seitlinger, Sandrine Hirschi, Jérémie Reeb, Stéphane Renaud, Olivier Collange, Anne Roche, Matthieu Zappatera, Nicola Santelmo, Tristan Degot, Pierre-Emmanuel Falcoz, Romain Kessler, Gilbert Massard
OA3275
A mechanistic study on the effect of azithromycin on T helper-17 cells Elly Vandermeulen (Leuven, Belgium), Elly Vandermeulen, Jana Somers, Hannelore Bellon, Stijn Verleden, David Ruttens, Philippe Lemaître, Robin Vos, Geert Verleden, Bart Vanaudenaerde
Room 4.1
Session 365
08:30 - 10:30
Oral Presentation: Tele-rehabilitation in chronic lung diseases Chairs : Nicolino Ambrosino (Volterra, Italy), Thierry Troosters (Leuven, Belgium)
OA3276
Short-term telemonitoring program after hospital discharge for COPD exacerbation: Greek pilot of the renewing health multicenter randomized trial Eirini Stafyla (Larissa, Greece), Theodora Kerenidi, Eirini Stafyla, George Dafoulas, Haralabos Giannakakos, Maria Pinaka, Eleni Karetsi, Panagiotis Stafylas, Kiriaki Theodorou, Petros Pexlivanoglou, Fenia Mavrodi, Vasileios Aletras, Konstantinos Gourgoulianis
OA3277
Telemonitoring of cycle home exercise in patients with COPD Karl-Josef Franke (Hagen, Germany), Karl-Josef Franke, Ulrike Domanski, Maik Schroeder, Volker Jansen, Georg Nilius
OA3278
Wearable smart technology for monitoring COPD with co-morbidities – Patients’ perceptions Reem Kayyali (Kingston-upon-Thames, United Kingdom), Reem Kayyali, Roshan Siva, Evangelos Kaimakamis, Martijn A. Spruit, Anouk Vaes, John Chang, Richard Costello, Nikki Davies, Nada Philip, Barbara Pierscionek, Eleni Perantoni, Rita Paradiso, Andreas Raptopoulos, Shereen Nabhani-Gebara
OA3279
Long-term exercise maintenance in COPD via telerehabilitation: Effects from a 2-year pilot study Paolo Zanaboni (Tromsø, Norway), Paolo Zanaboni, Linda Aarøen Lien, Hanne Hoaas, Audhild Hjalmarsen, Richard Wootton
OA3280
Use of the medical device NOWOX® to identify patterns of oxygen use in patients participating to the COPD management European trial (COMET) Joelle Texereau (Paris, France), Jeanne Pigassou, Romain Kessler, Peter Haidl, Pere Casan, Silvia Tognella, Jose Luis Viejo, Dieter Koehler, Roberto Dal Negro, Jean Bourbeau, Joelle Texereau
212
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA3281
An auto-titrating intelligent oxygen therapy (iO2T) system in COPD patients: A randomised cross-over trial Mohammad Moghal (London, United Kingdom), Mohammad Moghal, Rishi Goburdhun, Nicholas Hopkinson, William Man, Mary Morrell, Robert Dickinson, Anita Simonds
OA3282
Machine learning for COPD exacerbation prediction Cristobal Esteban Gonzelez (Bilbao (Bizkaia), Spain), Cristóbal Esteban, Javier Moraza, Cristóbal Esteban, Fernando Sancho, Myriam Aburto, Amaia Aramburu, Begona Goiria, Amaia Garcia-Loizaga, Alberto Capelastegui
OA3283
Home-based telerehabilitation program using real-time monitoring and interactive exercise for patient with lung cancer: A feasibility study Valerie Coats (Quebec, Canada), Valerie Coats, Hélène Moffet, Sébastien Simard, Lise Tremblay, Lynda Fradette, François Maltais, Didier Saey
Room Emerald
Session 366
08:30 - 10:30
Oral Presentation: Diagnosing and management of COPD in primary care Chairs : Bjorn Stallberg (Uppsala, Sweden), Mike Thomas (Southampton, United Kingdom)
OA3284
LATE-BREAKING ABSTRACT: A novel approach for identifying patients with undiagnosed clinically-significant COPD David Mannino (Lexington, United States of America), Fernando Martinez, David M. Mannino, Nancy K. Leidy, Karen G. Malley, Elizabeth D. Bacci, R. Graham Barr, Russ P. Bowler, Meilan K. Han, Julia F. Houfek, Barry J. Make, Catherine A. Meldrum, Stephen Rennard, Byron M. Thomashow, John W. Walsh, Barbara P. Yawn
OA3285
TargetCOPD: A pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care Rachel Jordan (Birmingham, United Kingdom), Rachel Jordan, Peymane Adab, Alice Sitch, Alexandra Encoson, Sue Jowett, Deirdre Blissett, Jen Marsh, Richard Riley, Martin Miller, Brendan Cooper, Alice Turner, Jon Ayres, K.K. Cheng, Kate Jolly, Rob Stockley, Sheila Greenfield, Stan Siebert, Amanda Daley, David Fitzmaurice
OA3286
Does registration of performance indicators improve health outcomes in COPD? Melinde Boland (Rotterdam, Netherlands), Melinde Boland, Apostolos Tsiachristas, Niels Chavannes, Maureen Rutten-van Mölken
OA3287
Effectiveness of a physical exercise training programme COPD in primary care: A randomized controlled trial Annemieke Fastenau (Maastricht, Netherlands), Annemieke Fastenau, Onno Van Schayck, Bjorn Winkens, Rik Gosselink, Jean Muris
OA3288
COPD over diagnosis in the UK Halima Buni (Birmingham, United Kingdom), Halima Buni, Rachel Jordan, Peymane Adab, Alexandra Enocson, Kar Keung Cheng
OA3289
Cardiovascular status of patients with a severe form of COPD Barbora Novotná (Hradec Kralove, Czech Republic), Barbora Novotna, Vladimir Koblizek, Michal Svoboda, Jan Svancara, Karel Hejduk, Jiri Jarkovsky, Michal Kopecky, Rudolf Praus, Zuzana Zbozinkova, Marek Putinsky, Jaromir Zatloukal, Patricie Popelkova, Tomas Dvorak, Petr Safranek, Ondrej Sobotik, Alena Vlachova, Petr Vanik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Pavlina Musilova, Maria Majerciakova, Tomas Vencalek, Eva Kocova, Onderj Kudela, Katerina Neumannova, Kristian Brat, Eva Volakova, Frantisek Salajka
OA3290
Application of the COMCOLD comorbidity index to a UK primary care COPD cohort Mukesh Singh (Sutton Coldfield, United Kingdom), Mukesh Singh
OA3291
COPD readmissions in an urban environment: Health service factors Timothy Harries (London, United Kingdom), Timothy Harries, Katherine Jackson, Patrick White
Room E104-106
Session 367
08:30 - 10:30
Poster Discussion: Rehabilitation, exercise, hospitalisation and COPD Chairs : Christian Osadnik (Melbourne, Australia), Rachael A Evans (Leicestershire, United Kingdom)
PA3292
Tele-coaching to promote physical activity in patients with COPD: Evaluation by patients Heleen Demeyer (Halle, Belgium), Heleen Demeyer, Zafeiris Louvaris, Anja Frei, Corina De Jong, Matthias Loeckx, Gilbert Buesching, Sara Buttery, Maarten Spruyt, Rebecca Tanner, Noah Rubio, Elena Gimeno-Santos, Nick Hopkinson, Roberto Rabinovich, Michael Polkey, Judith Garcia-Aymerich, Iannis Vogiatzis, Thierry Troosters
PA3293
Relationship between multidimensional disease severity and activities of daily living in patients with chronic obstructive pulmonary disease Deniz Inal Ince (ANKARA, Turkey), Ebru Calik-Kutukcu, Hulya Arikan, Melda Saglam, Naciye Vardar-Yagli, Deniz InalInce, Cigdem Oksuz, Sema Savci, Tulin Duger, Lutfi Coplu, Abdülsamet Sandal
213
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3294
The effects of walking prescription to promote physical activity in chronic obstructive pulmonary disease Shakila Perumal (Dublin, Ireland), Shakila Devi Perumal
PA3295
Lack of understanding of COPD is associated with a higher physical activity level Rafaella Xavier (São Paulo, Brazil), Aline Costa Lopes, Rafaella Fagundes Xavier, Carolina Caporali, Adriana Claudia Lunardi, Regina Maria de Carvalho Pinto, Alberto Cukier, Celso Ricardo Fernandes De Carvalho
PA3296
Effects of exercise training in water and on land in patients with COPD Josiane Felcar (Londrina, Brazil), Josiane Marques Felcar, Vanessa Suziane Probst, Débora Rafaelli De Carvalho, Myriam Fernanda Merli, Rafael B. Mesquita, Laís S. Vidotto, Laís Regina Garcia, Fabio Pitta
PA3297
Effect of high-intensity physical training on balance of patients with COPD submitted to exercise in water and on land Débora Carvalho (Marilândia do Sul, Brazil), Débora Rafaelli De Carvalho, Larissa Araújo De Castro, Igor Lopes De Brito, Mayara Manzoni Marques Da Silva, Roberta Dos Santos, Josiane Marques Felcar, Rubens Alexandre Silva Jr., Fabio Pitta, Vanessa Suziane Probst
PA3298
Bipedal postural control in severe COPD patients with bronchitic and emphysematic phenotype Kate ina Neumannová (Olomouc, Czech Republic), Katerina Neumannova, Vladimir Koblizek, Nicolas Vuillerme, Zdenek Svoboda, Vratislav Sedlak, Jaromir Zatloukal, Marek Plutinsky
PA3299
Oxygen uptake, ventilation and symptoms during whole body vibration training in patients with severe COPD Rainer Gloeckl (Schoenau am Koenigssee, Germany), Rainer Gloeckl, Petra Richter, Sandra Winterkamp, Klaus Kenn
PA3300
Is the whole body vibration able to improve functional capacity in patients with COPD? A meta-analysis Armele Dornelas de Andrade (Recife, Brazil), Adriane Cardim, Sóstynis Albuquerque, Maira Pessoa, Jasiel Frutuoso, Patricia Marinho, Armele Dornelas de Andrade
PA3301
Effect of upper extremity strength training on respiratory and peripheral muscle strength, arm exercise capacity, activities of daily living and occupational performance in patients with chronic obstructive pulmonary disease Ebru Çalik Kütükcü (Ankara, Turkey), Hulya Arikan, Ebru Calik-Kutukcu, Melda Saglam, Naciye Vardar-Yagli, Cigdem Oksuz, Deniz Inal-Ince, Tulin Duger, Sema Savci, Lutfi Coplu
PA3302
Acute effects of pursed-lips breathing on chest wall volumes and diaphragm mobility in COPD patients - Cross over study Vanessa Resqueti Fregonezi (Natal- Rio Grande do Norte, Brazil), Vanessa Resqueti, Marcelly Florenço de Barros, Adriane Borba Cardim, Rosália Maria Pinheiro Souza, Shirley Lima Campos, Guilherme Fregonezi, Armele de Fátima Dornelas de Andrade
PA3303
Periodized resistence training in COPD: Effects on mucociliary clearance and dyspnea Gabriel Brígida (Presidente Prudente, Brazil), Fabiano Lima, Dionei Ramos, Bruna Silva, Giovanna Arévalo, Ana Paula Freire, Juliana Uzeloto, Fernanda Rodrigues, Iara Trevisan, Gabriel Santa Brigida, Marceli Leite, Ercy Ramos
PA3304
The late impact of hospitalization on the daily life physical activity level in patients of COPD Rafaella Xavier (São Paulo, Brazil), Rafaella Fagundes Xavier, Aline Costa Lopes, Carolina Caporali, Adriana Claudia Lunardi, Ercy Mara Cipulo Ramos, Rafael Stelmach, Celso Ricardo Fernandes De Carvalho
PA3305
The impact of hospitalization for non-respiratory causes in the functionality of patients with COPD Patricia Lavoura (São Paulo, Brazil), Patricia Lavoura, Debora Meira, Deise Silva, José Curiati, Arnaldo Lichtenstein, Celso Carvalho, Clarice Tanaka
PA3306
Impact of exacerbation of COPD on anxiety and depression symptoms and dyspnea in the activities of daily living Júlia Gianjoppe-Santos (São Carlos, Brazil), Julia Gianjoppe-Santos, Anna Claudia Sentanin, Marina S. Barusso, Fabíola P.G. Rizzatti, Mauricio Jamami, Valéria A. Pires Di Lorenzo
PA3307
Changes in cognitive status during acute exacerbation of COPD Marie Carmen Valenza (Granada, Spain), Isabel Torres, Marie Carmen Valenza, Irene Torres-Sanchez, Irene CabreraMartos, Adelina Martin-Salvador
PA3308
Changes in cognitive status across clinical stages in COPD Marie Carmen Valenza (Granada, Spain), Isabel Lopez-Torres, Marie Carmen Valenza, Silvia Merlos-Navarro, Irene Torres-Sanchez, Irene Cabrera-Martos
Room G102-103
Session 368
Poster Discussion: Sarcoidosis: pathogenesis Chairs : Paola Rottoli (Siena, Italy), Michael Kreuter (Heidelberg, Germany)
214
08:30 - 10:30
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3309
iNKT cells are inversely related to -glucan in BALF and granuloma formation in patients with sarcoidosis Marjeta Tercelj-Zorman (Ljubljana, Slovenia), Marjeta Tercelj, Barbara Salobir, Matija Rijavec, Izidor Kern, Ragnar Rylander, Peter Korosec
PA3310
Inhibited IL-17A ameliorates sarcoid-like granulomatosis in mice Dingyuan Jiang (Beijing, China), Dingyuan Jiang, Jing Geng, Zheng Liu, Min Zhu, Xiaofen Zheng, Huaping Dai
PA3311
Peripheral blood leukocyte immune responses are distinctly altered in sarcoidosis Simon Fraser (Hull, United Kingdom), Simon Fraser, Laura Sadofsky, Simon Hart
PA3312
Significant changes in monocyte subsets during infliximab therapy in severe sarcoidosis Daniëlle Hijdra (Nieuwegein, Netherlands), Adriane Vorselaars, Daniëlle Hijdra, Heleen Crommelin, Coline Van Moorsel, Jan Grutters
PA3313
Repeated boost with propionibacterium acnes induce pulmonary fibrosis following sarcoidosis in C57BL/6 mice Dingyuan Jiang (Beijing, China), Dingyuan Jiang, Xiaoxi Huang, Jing Geng, Shuhong Li, Chen Wang, Huaping Dai
PA3314
Specific activation of non-classical Th1 cells in pulmonary sarcoidosis Caroline Broos (Rotterdam, Netherlands), Caroline Broos, Menno Van Nimwegen, Hans In ’t Veen, Jouke Annema, Roxane Heller, Henk Hoogsteden, Rudi Hendriks, Bernt Van den Blink, Mirjam Kool
PA3315
Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Anna Kempisty (Warszawa, Poland), Anna Kempisty, Beata Bialas-Chromiec, Dagmara Borkowska, Jan Kus
PA3316
Is the BTNL2 genotype associated with specific HLA-DRB1 and DRB3/4/5 alleles in Danish sarcoidosis patients? Nils Milman (Virum, Denmark), Nils Milman, Thomas van Overeem Hansen, Michael Skov Jemsem
PA3317
Lipidomics in sarcoidosis Sabina Kostorz (Tarnowskie Góry, Poland), Dariusz Jastrzebski, Beata Toczylowska, Sabina Kostorz, Elzbieta Zieminska, Karolina Zieleznik, Dariusz Ziora, Jerzy Kozielski
PA3318
Atopy in sarcoidosis a good prognostic sign? Paul Minnis (Bangor, United Kingdom), Paul Minnis, Peter Riddel, David O’Dwyer, Paul Byrne, Seamas C. Donnelly
PA3319
Serum and bronchoalveolar exosomal miRNAs in pulmonary sarcoidosis Zdenka Navrátilová (Olomouc, Czech Republic), Zdenka Navratilova, Eva Novosadova, Dagmar Smitalova, Amit Kishore, Vitezsla Kolek, Martin Petrek
PA3320
Scalp hair cortisol: A promising new biomarker for psychological wellbeing in patients with sarcoidosis? Mirjam van Manen (Rotterdam, Netherlands), M.J.G. Van Manen, V.L. Wester, L.M. Van den Toorn, B. Van den Blink, Y.B. De Rijke, K.Y. Dorst, E.F.C. Van Rossum, M.S. Wijsenbeek
PA3321
Determination of a single nucleotide polymorphism (SNP) of the TNFalpha-R1 region (TNFRSF1A) in patients with lung sarcoidosis: Preliminary results Francesco Bonella (Düsseldorf, Germany), Francesco Bonella, Hung Tran, Dirk Theegarten, Josune Guzman, Ulrich Costabel
PA3322
Leptin, inflammatory biomarkers and body composition in patients with sarcoidosis Elzbieta Puscinska (Warszawa, Poland), Elzbieta Puscinska, Michal Bednarek, Anna Goljan-Geremek, Joanna Chorostowska-Wynimko, Ada Rozy, Paulina Jagus, Pawel Sliwinski, Dorota Górecka
PA3323
Comparative role of serum cathepsin S concentrations for differential diagnosis of sarcoidosis from other lung diseases Etsuro Yamaguchi (Nagakute, Aichi, Japan), Masaki Nishimura, Etsuro Yamaguchi, Nobuhiro Asai, Hiroyuki Tanaka, Ayumu Takahashi, Kenji Baba, Akihito Kubo
PA3324
The effect of exercise on serum amyloid a levels in patients with sarcoidosis: A preliminary report George Vavougios (Larissa, Greece), George Vavougios, Periklis Panagis, Eleni Karetsi, Ioannis Papanikolaou, Fotini Bardaka, Panagiotis Maragozidis, Vasileios Stavrous, Konstantinos Gourgoulianis, Zoe Daniil
PA3325
Proinflammatory cytokine gene polymorphisms in the prediction of clinical course in sarcoidosis patients Tatjana Radjenovic Petkovic (Nis, Republic of Serbia), Tatjana Radjenovic Petkovic, Tatjana Pejcic, Desa Nastasijevic Borovac, Ivana Stankovic, Tatjana Jevtovic Stoimenov
PA3326
Different biopsy techniques for confirmation of sarcoidosis: The game for the best diagnostic yield is still open Thomas Wessendorf (Essen, Germany), Thomas Wessendorf, Francesco Bonella, Dirk Theegarten, Kaid Darwiche, Marta Cuyás Cortadellas, Eda Börner, Ulrich Costabel
215
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
Room G104-105
Session 369
08:30 - 10:30
Poster Discussion: TB treatment: new drugs and drug resistance Chairs : Christoph Lange (Borstel, Germany), Raquel Almeida Ferreira Duarte Bessa Melo (Porto, Portugal) PA3327
Minimal inhibitory concentrations (MICs) of mefloquine: in vitro activity against MDR- and nonMDR-Tb strains David Krieger (Berlin, Germany), David Krieger, Silvan Vesenbeckh, Nicolas Schönfeld, Gudrun Bettermann, Holger Rüssmann, Harald Mauch, Torsten Bauer
PA3328
Efficacy of moxifloxacin in TB resistant to isoniazid Mykhailo Kuzhko (Kiev, Ukraine), Mykhailo Kuzhko, Ljubomyr Procyk, Leonid Grechanyk, Nataliia Gulchuk, Oksana Avramchuk, Mykola Gumeniuk
PA3329
Neuroleptic drugs as potential adjuvants in the treatment of MDR-TB: Minimal inhibitory concentrations (MICs) of different phenothiazines against M. tuberculosis Silvan Vesenbeckh (Berlin, Germany), Silvan Vesenbeckh, David Krieger, Gudrun Bettermann, Nicolas Schönfeld, Holger Rüssmann, Harald Mauch, Torsten Bauer
PA3330
Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China Shenjie Tang (Shanghai, China), Shenjie Tang, Lan Yao, Xiaohui Hao
PA3331
Minimum inhibitory concentrations (MIC) determination of TB drugs and broad-spectrum antibiotics in M.tuberculosis with M/X/TDR Sergejj Aleksandrovich Popov (Moscow, Russian Federation), Sergey Popov, Aleksey Kuzmin, Tamara Sabgayda, Nataly Vedenina
PA3332
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Florian von Groote-Bidlingmaier (Cape Town, South Africa), Sadiyya Sheik, Sweetness Siwendu, Melissa Mitchell, Andreas Henri Diacon, Florian Von Groote-Bidlingmaier
PA3333
Rifampicin-resistant TB on Gene Xpert: What is the best empiric combination treatment while awaiting cultures? Lancelot Pinto (Mumbai, India), Ujjwal Sharma, Chaitali Nikam, Radhika Banka, Camilla Rodrigues, Lancelot Pinto
PA3334
Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB) Myungsun Lee (Seoul, Republic of Korea), Myungsun Lee, Namsoo Rhu, Ji Yeon Lee, Joonsung Joh, Youngran Kim, Ina Jeong
PA3335
Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Svitlana A. Cherenko (Kiev, Ukraine), Svitlana Cherenko, Nataliia Litvinenko
PA3336
Administration of linezolid, bedaquiline and imipenem in treatment of patients with extensively drug-resistant tuberculosis Diljara Esmedlyaeva (St.Petersburg, Russian Federation), L.T. Nikolayan, L.M. Yeghiazaryan, A.O. Hayrapetyan, N.R. Beglaryan, V.R. Poghosyan
PA3337
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Yana Batyrshina (Novosibirsk, Russian Federation), Yana Batyrshina
PA3338
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva, Anastasia Samoilova, Svetlana Moiseeva, Natalia Kuzmina, Natalia Musatova
PA3339
Cost-effectiveness of treating MDR-TB by adding delamanid to background regimens in Germany Roland Diel (Hamburg, Germany), Roland Diel, Norbert Hittel, Tom Schaberg
PA3340
Electronic nose as a surrogate marker of response to treatment of pulmonary tuberculosis (ELNOSUR study) Rosarito Coronel (Asuncion, Paraguay), Rosarito Coronel, Sandra Gonzalez, Cecile Magis-Escurra
PA3341
Evaluation of optimal regimens for treatment of rifampicin resistant-tuberculosis: Multicenter, randomized controlled study in China Shenjie Tang (Shanghai, China), Shenjie Tang, Lan Yao, Xiaohui Hao, Yidian Liu
PA3342
Should MRI be used to determine the duration of treatment in spinal tuberculosis? Emily McGhee (Hertfordshire, United Kingdom), Emily McGhee, Kolera Chengappa, Ronan Breen, Jonathan Lucas, Heather Milburn
216
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3343
An incidence of the ethambutol-induced optic neuropathy and the usefulness of periodic visual acuity test – A questionnaire survey in Japan masataka matsumoto (miki, Japan), Masataka Matsumoto, Toshiyasu Sakurai, Kimihide Tada, Akihiko Ikeda, Tatsuo Kato, Takashi Yoshiyama, Riyo Fujiyama, Fumiaki Nakamura
PA3344
Influence of mycobacterium tuberculosis strains on recurrence of tuberculosis in Hanoi, Vietnam Nguyen Hang (Hanoi, Vietnam), Nguyen T.L. Hang, Shinji Maeda, Takayuki Wada, Pham H. Thuong, Nguyen V. Hung, Vu C. Cuong, Nguyen P. Hoang, Shinsaku Sakurada, Minako Hijikata, Ikumi Matsushita, Luu T. Lien, Naoto Keicho
Room G106-107
Session 370
08:30 - 10:30
Poster Discussion: Monitoring and phenotyping COPD Chairs : Petros Bakakos (Athens, Greece), Chair to be confirmed PA3345
The association of vitamine D deficiency and skeletal muscle dysfunction in COPD Hyun Jung Jin (Daegu, Republic of Korea), Hyun Jung Jin, Kwan Ho Lee, Jin Hong Chung, Kyeong-Cheol Shin, Dong Won Lee
PA3346
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index Lucas Boeck (Basel, Switzerland), Lucas Boeck, Kostantinos Kostikas, Francesco Blasi, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Renaud Louis, Joachim Aerts, Tobias Welte, Antoni Torres, Gernot Rohde, Janko Rakic, Andreas Scherr, Michael Koller, Michael Tamm, Daiana Stolz
PA3347
Survivin in patients with chronic obstructive pulmonary disease Apostolos Bossios (Gothenburg, Sweden), Apostolos Bossios, Linda Ekerljung, Minna Turkkila, Carina Malmhäll, Malin Erlandsson, Sofia Töyra Silfverswärd, Bo Lundbäck, Maria Bokarewa
PA3348
Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) Abdel Monem Elshabrawi (Suez, Egypt), Hussien Abo-Alyazid, Ezzat Rezk, Abd Elmonem Elshabrawi, Kamel Hasan, Mokhles Ibrahim, Mahmoud Sayed, Ibrahim Abo- Elfetouh
PA3349
Validation of a four point sputum colour chart in chronic obstructive pulmonary disease Mark McKane (Dundee, United Kingdom), Mark McKane, Megan Crichton, Alison Dicker, James Chalmers
PA3350
The potential value of FRAX index and bone turnover markers to identify osteoporosis in COPD patients Pilar Rivera Ortega (Barcelona, Spain), Pilar Rivera-Ortega, Jessica González-Gutiérrez, Patricia Restituto, Nerea Varo, Amparo Calleja, Macarena Rodríguez, Ana B. Alcaide, Arantza Campo, Javier J. Zulueta, Juan P. De Torres
PA3351
Blood eosinophils as a biomarker in alpha 1 anti trypsin deficiency Safia Zaffarullah (London, United Kingdom), Safia Zaffarullah, Alice M. Turner, Robert Stockley, Diane Griffiths, Ross Edgar
PA3352
Telehome monitoring (THM) in COPD: A new model of evaluating nocturnal oxygen desaturation Maurizio Moretti (Modena, Italy), Anna Porcu, Sara Balestracci, Francesco Costa, Maurizio Morertti
PA3353
Nocturnal desaturation in COPD patients; is OSA screening the answer? Akanksha Das (Navi Mumbai, India), Akanksha Das, T.K. Jayalakshmi, Aparna Iyer, Bhumika Madhav, Pragati Agarwal, Amit Nagpal
PA3354
Lung clearance index is increased in patients with COPD Sebastian Fähndrich (Homburg/Saar, Germany), Sebastian Faehndrich, Martina Seibert, Philipp M. Lepper, Heinrike Wilkens, Stefan Wagenpfeil, Robert Bals
PA3355
A network-based approach to defining phenotypes in COPD Lucretia Udrescu (Timisoara, Romania), Lucretia Udrescu, Mihai Udrescu, Alexandru Topîrceanu, Stefan Mihaicuta
PA3356
A liquid chromatography MS/MS metabolomics study of COPD patients Barbora Novotná (Hradec Kralove, Czech Republic), Barbora Novotna, Mohammed Abdel-Hamid, Vladimir Koblizek, Jiri Jarkovsky, Karel Hejduk, Vit Rehacek, Josef Bis, Frantisek Salajka
PA3357
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease Panagiota Tzani (Parma, Italy), Roberta Pisi, Marina Aiello, Andrea Zanini, Panagiota Tzani, Davide Paleari, Emilio Marangio, Antonio Spanevello, Gabriele Nicolini, Alfredo Chetta
PA3358
Impulse oscillation respiratory reactance and airway reversibility in chronic obstructive pulmonary disease Yasushi Yamamoto (Asahikawa, Japan), Yasushi Yamamoto, Shinobu Osanai, Yoshihiro Kazebayashi, Noriko Hirai, Shunsuke Okumura, Takaaki Sasaki, Yoshinobu Ohsaki
217
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3359
The influence of statin supplementation on inflammatory markers in patients with chronic obstructive pulmonary disease Mradul Daga (New Delhi, India), Mradul Daga, Ankit Chhoda, Naushad Ahmad Khan, Govind Mawari
PA3360
Significance of neutrophil to lymphocyte ratio in patients of chronic obstructive pulmonary diseases: A prospective study at tertiary care centre in India Deepak Shah (Varanasi, India), D.K. Shah, J.K. Mishra
PA3361
Asthma control in preschool wheezing children Paula Pinto (Lisbon, Portugal), Paula Leiria-Pinto, Pedro Martins, Elena Finelli, Joana Belo, João Marques, Isabel Peralta, Miguel Paiva, Sara Prates, Nuno Neuparth
PA3362
Stable state fibrinogen is additive to MR-proADM as a predictor of mortality in COPD patients Maaike Telgen (Enschede, Netherlands), Maaike Zuur-Telgen, Paul Van der Valk, Bram Zuur, Job Van der Palen, Huib Kerstjens, Marjolein Brusse-Keizer
Room 13.2
Session 371
08:30 - 10:30
Poster Discussion: Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine Chairs : Raphael Heinzer (Lausanne, Switzerland), Jose Maria Montserrat Canal (Barcelona, Spain)
PA3363
Relation between carotid intima-media thickness, serum paraoxonase levels and severity of obstructive sleep apnea syndrome Esma Sevil Akkurt (ANKARA, Turkey), Esma Sevil Akkurt, Serife Savas Bozbas, Serpil Eroglu, Emre Ozcalik, Fusun Oner Eyuboglu
PA3364
Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study Jose M. MARIN TRIGO (Zaragoza, Spain), José M. Marín, M. Teresa Martín Carpi, Santiago J. Carrizo, Marta Andrés, Victoria Gil, Marta Forner, José P. Cubero, Clara Viñado, Dinora Polanco, Salvador Bello
PA3365
OSA complication score as novel reference to assess systemic inflammation in sleep apnoea Aleksandra Piechuta (Warszawa, Poland), Aleksandra Piechuta, Iwona Osinska, Piotr Bielicki, Tomasz Skirecki, Joanna Domagala-Kulawik
PA3366
Identification of subjects with high probability of sleep-disordered breathing in a non-sleepy general population: The NoSAS score Helena Marti-Soler (Lausanne, Switzerland), Helena Marti-Soler, José Haba-Rubio, Raphaël Heinzer
PA3367
Voice analysis in patients with obstructive sleep apnea syndrome Sinziana Lovin (Iasi, Romania), Sinziana Lovin, Corneliu Botez, Traian Mihaescu
PA3368
Can questionnaires improve the screening value of oximetry for assessing sleep apnea syndrome? Athanasia Pataka (Panorama Thessaloniki, Greece), Athanasia Pataka, Euphemia Daskalopoulou, George Kalamaras, Nikolaos Chavouzis, Katalin Fekete Passa, Paraskevi Argyropoulou
PA3369
Usefulness of linear discriminant analysis of overnight oximetry from respiratory polygraphy at home to assist in the diagnosis of pediatric obstructive sleep apnea hypopnea syndrome ANDREA CRESPO SEDANO (Valladolid, Spain), Andrea Crespo, Félix Del Campo, Roberto Hornero, Daniel álvarez, Joaquin Terán, Maria Luz Alonso
PA3370
Adenotonsillectomy revisited: Outcomes and differences in 100 children with adenotonsillectomy Katharina Heschl (Kreuzlingen, Switzerland), Katharina Heschl, Bernhard Rinderer, Benedikt Gerber, Marc Kengelbacher, Degenhard Schwub, Bernd Erkert, Christoph Stüssi, Peter Salfeld
PA3371
Incident cardiovascular events in severely obese patients treated with continous positive airway pressure (CPAP)/non invasive ventilation (NIV): A 5.5-year follow-up Anna Maria Marotta (Palermo, Italy), Anna Maria Marotta, Jean Christian Borel, Louis Marie Galerneau, Renaud Tamisier, Emilia Mazzuca, Laura Serafino Agrusa, Maria Rosaria Bonsignore, Jean Louis Pepin
PA3372
Current automatic CPAP devices exhibit different response when tested with an improved simulator of OSA patient Ramón Farré Ventura (Barcelona, Spain), Valentina Isetta, Raquel Santano, Josep M. Montserrat, Daniel Navajas, Ramon Farre
PA3373
The role of functional respiratory imaging in the prediction of treatment outcome with fixed mandibular advancement in OSA patients Wim Vos (Heist-op-den-Berg, Belgium), Wim Vos, Olivier M. Vanderveken, Jan De Backer, Kristien Wouters, Wilfried De Backer, Marijke Dieltjens, Marc Braem
218
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3374
Sleep variables and neuromuscular electrical stimulation on the masticatory muscles in adults with cerebral palsy: A novel therapy approach Luis Vicente Oliveira (Sao Paulo, Brazil), Lilian Giannasi, Israel Santos, Jessica Urbano, Rodolfo Vieira, José Amorim, Luis Oliveira, Claudia Oliveira, Monica Gomes
PA3375
The role of compliance with positive airway pressure use on blood pressure in patients with obstructive sleep apnea: Is longer use a key-factor? Izolde Bouloukaki (Crete, Greece), Izolde Bouloukaki, Charalampos Mermigkis, Irini Lambiri, Katerina Giannadaki, Nikolaos Tzanakis, Eleni Mauroudi, Dimitris Georgopoulos, Sophia Schiza
PA3376
A bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnea: A multicenter randomized controlled trial Jose Maria Montserrat Canal (Barcelona, Spain), Valentina Isetta, Miguel A. Negrín, Carmen Monasterio, Juan F. Masa, Nuria Feu, Ainhoa álvarez, Francisco Campos-Rodriguez, Concepción Ruiz, Jorge Abad, Ramon Farré, Marina Galdeano, Patricia Lloberes, Cristina Embid, Mónica De la Peña, Javier Puertas, Mireia Dalmases, Josep M. Montserrat
PA3377
Telemedicine sleep clinic review - Patient acceptability survey Phyllis Murphie (Dumfries, United Kingdom), Phyllis Murphie, Bernie Mills, Stuart Little
PA3378
New method for evaluation of CPAP AHI measurement accuracy Loc Le Xuan (Boulogne-Billancourt, France), Loc Le Xuan, Bernard Fleury, Philippe Salamitou
PA3379
Contactless monitoring for sleep disordered-breathing, respiratory and cardiac co-morbidity in an elderly independent living cohort Gary Baker (Armidale, Australia), Gary Baker, Mark Norman, Mohan Karunanithi, Colin Sullivan
PA3380
Sonographic measurement of lateral parapharyngeal wall thickness and severity of childhood obstructive sleep apnoea Albert Li (SHATIN, Hong Kong), Albert M. Li, Chun T. Au, Kate Chan, Kin H. Liu, Winnie Chu
Room E102
Session 372
08:30 - 10:30
Poster Discussion: Epidemiological studies of asthma and allergy Chairs : Josep Maria Anto Boque (Barcelona, Spain), Jon Genuneit (Ulm, Germany) PA3381
Early respiratory infections and development of asthma in the first 27 years of life Aino Rantala (Oulu, Finland), Aino K. Rantala, Maritta S. Jaakkola, Elina M.S. Paaso, Timo T. Hugg, Jouni J.K. Jaakkola
PA3382
Elevated exhaled nitric oxide in combination with wheeze history in adolescence predicts persistent wheeze in adulthood Andrei Malinovschi (Uppsala, Sweden), Andrei Malinovschi, Christer Janson, Pia Kalm-Stephens, Lennart Nordvall, Kjell Alving
PA3383
Determinants of new-onset and persistence of adult asthma in Denmark Lars Skadhauge (Esbjerg, Denmark), Lars Rauff Skadhauge, Jesper Rømhild Davidsen, øyvind Omland, Vivi Schlünssen, David Sherson, Torben Sigsgaard, Trine Thilsing, Jesper Bælum
PA3384
Evolution and risk factors for active asthma in adults participating in EGEA and ECRHS-France cohorts Isabelle Pin (Grenoble Cedex, France), Isabelle Pin, Joris Giai, Anne Boudier, Jean Bousquet, Frédéric Gormand, Jocelyne Just, Raphaelle Varraso, Catherine Neukirch, Pascal Demoly, Chantal Raherison, Benedicte Leynaert, Valérie Siroux
PA3385
Characteristics and prognosis of never smokers with asthma in the general population Yunus Çolak (Helsingør, Denmark), Yunus çolak, Shoaib Afzal, Børge Nordestgaard, Peter Lange
PA3386
High incidence and low remission of allergic sensitization from the age of 8 to 12 years Joakim Bunne (Piteå, Sweden), Joakim Bunne, Helena Moberg, Linnéa Hedman, Anders Bjerg, Martin Andersson, Bo Lundbäck, Eva Rönmark
PA3387
Polysensitization and comorbidities of asthma and rhinitis in adults in the EGEA study Emilie Costa burte (Villejuif, France), Emilie Burte, Jean Bousquet, Valérie Siroux, Bénédicte Jacquemin, Rachel Nadif
PA3388
Relation of inhalant allergen-specific immunoglobulin E and lung function in adolescents Agnes Luzak (Neuherberg, Germany), Agnes Luzak, Claudia Flexeder, Andrea Von Berg, Dietrich Berdel, Claudia Klümper, Sibylle Koletzko, Carl-Peter Bauer, Joachim Heinrich, Dennis Nowak, Holger Schulz
PA3389
Allergies, asthma and the risk of pancreatic cancer: A population-based case-control study in Ireland MIGUEL SANTIBAÑEZ (SANTANDER, Spain), Miguel Santibañez, Michael O’Rorke, Eamonn O’Leary, Marianna De Camargo Cancela, Liam Murray, Linda Sharp, On Behalf of the PanCAM Study Group
219
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3390
Blood neutrophil pattern is associated with poor asthma control in adults from the EGEA study Rachel Nadif (Villejuif, France), Rachel Nadif, Valerie Siroux, Anne Boudier, Nicole Le Moual, Jocelyne Just, Frederic Gormand, Christophe Pison, Regis Matran, Isabelle Pin
PA3391
Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Trung Tran (Gaithersburg, United States of America), T. Tran, M. Schatz, W. Chen, Q. Li, D. Khatry, R. Zeiger
PA3392
The influence of age, region and season on asthma admissions in NHS England for the years 2000-2014 Leo Thanikkel (Bishops Stortford, United Kingdom), Leo Thanikkel, Jonathan Hope, Joan Lasenby, Richard Iles
PA3393
To spray or not to spray? The association of household cleaning agents and disinfectants with asthma in young adults – Results from a cross-sectional analysis in Germany Tobias Weinmann (München, Germany), Tobias Weinmann, Jessica Gerlich, Sabine Heinrich, Dennis Nowak, Erika Von Mutius, Christian Vogelberg, Diana Roller, Jon Genuneit, Saba Al-Khadra, Stefanie Lanzinger, Tina Lohse, Irina Motoc, Viola Walter, Gudrun Weinmayr, Katja Radon
PA3394
Predictors of headache in urban and rural setting from respiratory questionnaires in children aged 10-15 Martin Balzan (Tal Qroqq, Malta), Martin Balzan, Fabio Cibella, Christopher Zammit, Silvia Ruggieri, David Bilocca, Remo Minardi, Gaspare Drago, Giuseppina Cuttita, Stephen Montefort, Giovanni Viegi
PA3395
Asthma is associated with lower quality of life among teenaged girls but not boys Linnea Hedman (Lulea, Sweden), Linnea Hedman, Caroline Stridsman, Sven-Arne Jansson, Helena Backman, Britt-Marie Eklund, Martin Andersson, Eva Rönmark
PA3396
Adolescents with asthma - Everyday life at school Caroline Stridsman (Luleå, Sweden), Caroline Stridsman, Elisabeth Dahlberg, Karin Zandren, Eva Rönmark, Linnea Hedman
PA3397
Health-related quality of life in adults with asthma and rhinitis Sven-Arne Jansson (Holmsund, Sweden), Sven-Arne Jansson, Mai Leander, Linnea Hedman, Malin Axelsson, Caroline Stridsman, Eva Rönmark
PA3398
Depression and anxiety symptoms in asthmatics: Associations with health-related quality of life Mai Leander (Uppsala, Sweden), Mai Leander, Anna Rask-Andersen, Erik Lampa, Karl A. Franklin, Thorarinn Gislason, Mathias Holm, Anna Oudin, Cecilie Svanes, Christer Janson
Room D201-202
Session 373
08:30 - 10:30
Poster Discussion: Indoor air and ambient pollution Chairs : Paul Peeters (Maastricht, Netherlands), Emel Kurt (Eskisehir, Turkey) PA3399
Outdoor PM2.5 lChemical composition in 3 areas with urban/rural difference in prevalence of respiratory diseases Fabio Cibella (Palermo, Italy), Fabio Cibella, Martin Balzan, Cinzia Perrino, Gianluca Scaccianoce, David Bilocca, Christopher Zammit, Gaspare Drago, Silvia Ruggieri, Silvia Canepari, Remo Minardi, Stephen Montefort, Giovanni Viegi
PA3400
A retrospective cross-sectional study of traffic-related air pollution and asthma prevalence among young adults in Israel Shlomo Moshe (Holon, Israel), Shlomo Moshe, Nili Greenberg, Jeremy A. Sarnat, Brent A. Johnson, Yinon Rudich
PA3401
Determination of assessment of air pollutants on mortality and morbidity in Greek cities Efthimios Zervas (Patra, Greece), Marina Ntanopoulou, Aris Bloutsos, Efthimios Zervas
PA3402
Developing indoor air questionnaire for primary school pupils: Test-retest repeatability of self- and parent -administered questionnaires Jussi Lampi (Kuopio, Finland), Jussi Lampi, Sari Ung-Lanki, Juha Pekkanen
PA3403
Indoor environment, endotoxin and (1,3)- -glucan in offices – Associations with asthma, respiratory symptoms and rhinitis among office workers in Malaysia Jamal H. Hashim (Kuala Lumpur, Malaysia), Fang Lee Lim, Zailina Hashim, Leslie Thien Lung Than, Salmiah Md Said, Jamal Hisham Hashim, Dan Norback
PA3404
Adult asthma, allergy and eczema in Stockholm (3HE-study)-associations with energy use, building characteristics and home environment factors Dan Norback (Uppsala, Sweden), Dan Norbäck, Erik Lampa, Karin Engvall
PA3405
Chronic effects of air pollution on lung function after lung transplant (SysCLAD) Valerie Siroux (La Tronche, France), Valérie Siroux, Meriem Benmerad, Rémy Slama, Karine Botturi, Johanna Claustre, Antoine Roux, Carine Gomez, Romain Kessler, Olivier Brugière, Jean-François Mornex, Sacha Mussot, Marcel Dahan, Véronique Boussaud, Isabelle Danner-Boucher, Claire Dromer, Christiane Knoop, Laure Malherbe, Frederik Meleux, Laurent Nicod, Antoine Magnan, Christophe Pison
220
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3406
Preschool children’s asthma and allergic symptoms in Chongqing, China, associated with parental health: Reporting bias or shared home environment Juan Wang (Uppsala, Sweden), Juan Wang, Baizhan Li, Wei Yu, Qin Yang, Han Wang, Jan Sundell, Dan Norback
PA3407
Traffic related elements in tree barks and pollen abortion rates are effective to assess the effects of air pollution exposure on human health Luis Fernando Amato-Lourenco (Osasco, Brazil), Luis F. Amato-Lourenco, Bruna Vieira, Douglas Rene Silva, Paulo Hilário Nascimento Saldiva, Regiani Carvalho-Oliveira
PA3408
Respiratory efficiency and incidence of selected pulmonary diseases depending on exposure to ambient particulate matter (PM10) Artur Badyda (Warsaw, Poland), Artur Badyda, Piotr Dabrowiecki, Piotr Oskar Czechowski, Grzegorz Majewski, Anna Gayer, Dominika Mucha, Lukasz Adamkiewicz
PA3409
Environmental black carbon exposure in Singapore school children Dyan Zhang (Singapore, Singapore), Dyan Zhewei Zhang, Jonathan Grigg, Saji George, Oon Hoe Teoh, Oh Moh Chay, Arun Pugalenthi, Anne Goh, Petrina Wong, Biju Thomas
PA3410
Citizen science based symptom scores of allergic rhinitis to validate the grass pollen hay fever forecast Letty de Weger (Leiden, Netherlands), Letty A. De Weger, H. Bas Hofstee, Arnold J.H. Van Vliet, Pieter S. Hiemstra, Jacob K. Sont
PA3411
Effects of urban ozone pollution on hospitalizations for exacerbation of chronic obstructive pulmonary disease Diana Krmpotic (Zagreb, Croatia), Diana Krmpotic, Vesna Luzar-Stiffler, Predrag Herzog
PA3412
Differences in association between endotoxin and asthma and wheeze with environmental exposures Peter S. Thorne (Iowa City, United States of America), Peter Thorne, Angelico Mendy, Darryl Zeldin, Paivi Salo
PA3413
Biomass fuel use is a risk for pulmonary tuberculosis: Case control study ambreen sahito (karachi, Pakistan), Ambreen Sahito, Asaad Ahmed Nafees, Unaib Rabbani, Ambreen Kazi, Zafar Fatmi
PA3414
Nasal symptoms of cane cutters exposed to sugarcane burning Iara Buriola Trevisan (Tupi Paulista, Brazil), Iara Buriola Trevisan, Ercy Mara Cipulo Ramos, Marceli Rocha Leite, Gabriel Faustino Santa Brigida, Renata Marques David, Ana Paula Coelho Figueira Freire, Juliana Souza Uzeloto, Bruna Spolador de Alencar Silva, Giovanna Altero Arevalo, Guilherme Yassuyuki Tacao, Fabiano Francisco de Lima, Dionei Ramos
PA3415
Short term impact of air pollution on asthma and COPD in Tirana during 1 year period Milda Nanushi (Tirana, Albania), Milda Nanushi, Agron Deliu, Hasan Hafizi, Jolanda Nikolla, Luljata Cakerri
Room 7.1
Session 378
10:45 - 12:45
Hot topics: Antibiotic resistance in respiratory infections Aims : At the end of this hot topic session, the audience will better understand the common mechanisms of antibiotic resistance and the impact of the resistome on daily clinical practice; be up to date regarding the epidemiology and risk factors for multidrug-resistant bacteria in both acute and chronic respiratory infections; be aware of useful tools that raise suspicion of a MDR respiratory infection both in the community and in the hospital; understand the role of new and old antibiotics in the management of respiratory infections caused by multidrug-resistant bacteria in light of the most recently published literature; appreciate the principles of antibiotic stewardship; and be conversant with the current recommendations of public health organisations that aim to reduce antibiotic resistance in respiratory infections. Track(s) : Infection Tag(s) : Translational Target audience : Hospitalists (including those working in the ICU), general practitioners, microbiologists, public health stakeholders, and scientists interested in antimicrobial resistance. Chairs : Francesco Blasi (Milan, Italy), Felix C. Ringshausen (Hannover, Germany) 10:45
The resistome and other mechanisms of antibiotic resistance Georgina Cox (Hamilton, Canada)
3442
11:15
How resistance is changing the etiology of acute and chronic respiratory infections? Tobias Welte (Hannover, Germany)
3443
11:45
New (or old?) drugs for bad bugs Rosario Menendez Villanueva (Valencia, Spain)
3444
12:15
Antibiotic stewardship and priorities of interventions in public health Danilo Lo Fo Wong (Copenhagen, Denmark)
3445
221
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
Room 7.2
Session 380
10:45 - 12:45
Symposium: Fingerprinting severe asthma Experience from the UBIOPRED project Aims : The UBIOPRED project (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) aims to increase our understanding of the different types of severe asthma by defining biomarkers for severe asthma. For this, a large cohort and a multi-omics approach is being employed. The resulting huge database can be used to stratify patients according to phenotypes or clusters; identify individual biomarkers of disease by using readily accessible samples; define single molecular fingerprints by using 'omics technologies; and integrate clinical, biomarker, and 'omics approaches to obtain individualised disease signatures or handprints. Tag(s) : Translational Target audience : Clinicians, scientists, clinical scientists, cell and molecular biologists, and translational researchers. Chairs : Sally Wenzel (Pittsburgh, United States of America), Craig Wheelock (Stockholm, Sweden) 10:45
Introduction to the UBIOPRED project Peter Sterk (Amsterdam, Netherlands)
3455
10:50
Defining the clinical clusters of severe asthma within UBIOPRED Marijke Amelink (Amsterdam, Netherlands)
3456
11:15
Biomarker profiling of asthma phenotypes Paul Skipp (Southampton, United Kingdom)
3457
11:40
Integrating fingerprints: molecular phenotyping of severe asthma Bertrand De Meulder (Lyon, France)
3458
12:05
Severe asthma in children Louise Fleming (London, United Kingdom)
3459
12:30
Patient's testimonial Breda Flood (Gorey, Ireland)
3460
Room Elicium 2
Session 381
10:45 - 12:45
Symposium: Resistance to therapy in lung cancer Aims : To describe the main mechanisms of resistance to the drugs that are currently being used to treat lung cancer, present the theoretical strategies to overcome resistance and new drug developments and discuss the clinical implications of drug resistance along with recommendations for planning therapy. Track(s) : Oncology Tag(s) : Clinical Target audience : Clinicians who are treating lung cancer patients or are interested in new developments in thoracic oncology, pathologists, and researchers in the field of lung cancer. Chairs : Fernando Gamarra (Straubing, Germany), Nicolas Reynoird (La Tronche, France) 10:45
Resistance to chemotherapy in lung cancer Thierry Berghmans (Brussels, Belgium)
3461
11:15
Mechanisms of EGFR-TKI resistance and new treatment strategies Nicolas Girard (Bron, France)
3462
11:45
Crizotinib resistance in lung cancer Speaker to be confirmed
3463
12:15
The clinical point of view: strategies for overcoming resistance in lung cancer treatment Rudolf M. Huber (Munich, Germany)
3464
Room 4.2
Session 382
10:45 - 12:45
Symposium: Obstructive sleep apnoea, obesity, and weight loss Aims : To provide an update on the strategies that make it easier for patients with obstructive sleep apnoea (OSA) to lose weight, the metabolic features of OSA in morbidly obese patients, what to expect in OSA patients after bariatric surgery and the recent experimental studies on the role of hypoxia in obese adipose tissue, with special focus on their clinical implications. Track(s) : Sleep Tag(s) : Translational Target audience : Clinicians who are interested in sleep-disordered breathing and respiratory problems in obese patients.
222
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Chairs : Walter McNicholas (Dublin, Ireland), Eva Lindberg (Uppsala, Sweden), Geraldo Lorenzi Filho (Sao Paulo, Brazil) 10:45
Hypoxia and metabolism: why is it difficult for OSA patients to lose weight? Anne-Laure Borel (Grenoble, France)
3465
11:12
OSA in morbidly obese patients: is it different? Neus Salord Oleo (Barcelona, Spain)
3466
11:38
Lifestyle interventions in mild and severe OSA patients Nico De Vries (Amsterdam, Netherlands)
3467
12:04
Controversies on the role of hypoxia in adipose tissue: insights from recent experimental studies Maria Bonsignore (Palermo, Italy)
3468
12:30
Patient's testimonial Dan Smyth (Dundalk, Ireland)
3469
Room 5.2
Session 383
10:45 - 12:45
Symposium: New insights in immunology and molecular pathways of tobacco smoke Aims : To update pulmonologists and researchers regarding smoking-related inflammation, genes that relate to addiction and lung cancer and the crosslinks between COPD and lung cancer. Track(s) : Epidemiology/Environment Tag(s) : Healthy Lungs for Life (HLfL) Target audience : Investigators and clinicians. Chairs : Ian M. Adcock (London, United Kingdom), Jean-Paul Sculier (Brussels, Belgium) 10:45
Nicotine at the crossroads of smoking addiction and lung cancer Georgios Stathopoulos (Rio, Patras, Greece)
3470
11:15
Tumourigenic aspects of nicotine
3471
11:45
Molecular pathways of tobacco smoke Constantinos Glynos (Athens, Greece)
3472
12:15
Mechanistic links between COPD and lung cancer Guy Brusselle (Ghent, Belgium)
3473
Room Elicium 1
Session 384
10:45 - 12:45
Oral Presentation: Latest developments in clinical studies in acute and chronic lung diseases Chairs : Jan C. Grutters (Nieuwegein, Netherlands), Chair to be confirmed OA3474
LATE-BREAKING ABSTRACT: Predicting CTEPH after acute pulmonary embolism Erik Klok (Leiden, Netherlands), F.A. Klok, O. Dzikowska-Diduch, M. Kostrubiec, H.W. Vliegen, P. Pruszczyk, G. Hasenfuss, M.V. Huisman, S. Konstantinides, M. Lankeit
OA3475
LATE-BREAKING ABSTRACT: Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results Martin Cowie (London, United Kingdom), Martin Cowie, Holger Woehrle, Karl Wegscheider, Christiane Angermann, Marie-Pia d’Ortho, Erland Erdmann, Patrick Levy, Anita Simonds, Virend Somers, Faiz Zannad, Helmut Teschler
OA3476
LATE-BREAKING ABSTRACT: Study to understand mortality and morbidIty in COPD (SUMMIT) Jørgen Vestbo (Manchester, United Kingdom), Jorgen Vestbo, Julie Anderson, Robert D. Brook, Peter Calverley, Bart Celli, Courtney Crim, Fernando Martinez, Julie Yates, David Newby
OA3477
LATE-BREAKING ABSTRACT: Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in idiopathic pulmonary fibrosis (IPF): PANORAMA Juergen Behr (München, Germany), Jrgen Behr, Elisabeth Bendstrup, Bruno Crestani, Andreas Gnther, Horst Olschewski, Magnus Skld, Athol Wells, Wim Wuyts, Dirk Koschel, Michael Kreuter, Benoit Wallaert, Helen Tang, Jrgen Beck, Carlo Albera
OA3478
LATE-BREAKING ABSTRACT: Antiacid therapy and progression free survival in idiopathic pulmonary fibrosis (IPF) Michael Kreuter (Heidelberg, Germany), Michael Kreuter, Wim Wuyts, Elisabetta Renzoni, Dirk Koschel, Toby M. Maher, Martin Kolb, Derek Weycker, Klaus-Uwe Kirchgaessler, Felix J.F. Herth, Ulrich Costabel
223
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA3479
LATE-BREAKING ABSTRACT: Detrimental effects of medically indicated oral anticoagulation on survival in idiopathic pulmonary fibrosis (IPF) Michael Kreuter (Heidelberg, Germany), Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler, Toby M. Maher
OA3480
LATE-BREAKING ABSTRACT: Lung function in patients with primary ciliary dyskinesia (PCD): A multinational study Florian Halbeisen (Bern, Switzerland), Florian Halbeisen, Myrofora Goutaki, Elisabeth Maurer, Mieke Boon, Carmen Casaulta, Annick Clement, Suzanne Crowley, Eric G. Haarman, Bulent Karadag, Cordula Koerner-Rettberg, Henryk Mazurek, Lucy Morgan, Kim G. Nielsen, Francesca Santamaria, Nicolaus Schwerk, Panayiotis Yiallouros, Philipp Latzin, Jane S. Lucas, Claudia E. Kuehni
OA3481
LATE-BREAKING ABSTRACT: Chr17q21 modifies environmental effects on respiratory infections in infancy and effects on asthma Georg Loss (La Jolla, United States of America), Georg Loss, Martin Depner, Caroline Roduit, Jon Genuneit, Anne Karvonen, Anne Hyvärinen, Roger Lauener, Petra Pfefferle, Michael Kabesch, Juha Pekkanen, Jean-Charles Dalphin, Josef Riedler, Charlotte Braun-Fahrländer, Erika von Mutius, Markus Ege, The PASTURE Study Group
Room Forum
Session 385
10:45 - 12:45
Oral Presentation: Science and biomarkers in TB Chairs : Daniela Maria Cirillo (Milan, Italy), Chair to be confirmed OA3482
Dual-specificity phosphatase 14 gene polymorphism in Vietnamese patients with pulmonary tuberculosis Naoto Keicho (Tokyo, Japan), Minako Hijikata, Ikumi Matsushita, Nguyen T.L. Hang, Pham H. Thuong, Shinsaku Sakurada, Vu C. Cuong, Luu T. Lien, Naoto Keicho
OA3483
Cellular and humoral immune response in non HIV infected tuberculous patients in Upper Egypt Maha Ghanem (Assiut, Egypt), Maha K. Ghanem, Nour Eldin H.M. Imam, Hebat Allah Rashed, Azza Ezz ElDin
OA3484
Mycobactericide activity in genetically related tuberculosis contacts Javier JUAN GARCIA (León, Spain), Javier Juan García, Sara Raposo García, Silvia García García, Piedad Rivas López, Jose Manuel Guerra Laso, Teresa Nebreda Mayoral, Cristina Díez Tascón, Octavio Miguel Rivero Lezcano, Javier Juan García
OA3485
Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis Massimo Amicosante (Rome, Italy), Carmela Gallo, Alessia Del Duca, Monica Losi, Alba Grifoni, Roberta Bernardini, Alfonso Altieri, Gregorino Paone, Maurizio Mattei, Cesare Saltini, Massimo Amicosante
OA3486
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Delia Goletti (Roma, Italy), Elisa Petruccioli, Linda Petrone, Teresa Chiacchio, Valentina Vanini, Fabrizio Palmieri, Gina Gualano, Gilda Cuzzi, Assunta Navarra, Enrico Girardi, Delia Goletti
OA3487
CD27 expression as a new tool to distinguish active tuberculosis from latent infection Elisa Petruccioli (Rome, Italy), Elisa Petruccioli, Linda Petrone, Valentina Vanini, Fabrizio Palmieri, Gina Gualano, Gilda Cuzzi, Delia Goletti
OA3488
Highly specific differentiation of mycobacterium avium subspec. paratuberculosis (MAP) in comparison to other mycobacteria using GC IMS-spectral analysis from headspace Gunther Becher (Bernau, Germany), Gunther Becher, Roman Purkhart, Werner Schüler, Heike Köhler, Petra Reinhold
OA3489
Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Allison Wolf (New York, United States of America), Allison Wolf, Max O’Donnell, Paras Jain, Vanisha Munsamy, Farina Karim, Michelle Larsen, Alexander Pym, William R. Jacobs
Room 5.1
Session 386
10:45 - 12:45
Oral Presentation: Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Chairs : Philipp A. Schnabel (Homburg/Saar, Germany), Nicolas Kahn (Heidelberg, Germany)
OA3490
The first U-BIOPRED sputum handprint of severe asthma Diane Lefaudeux (Lyon, France), Diane Lefaudeux, Bertrand De Meulder, Matthew J. Loza, Marek Sanak, Ana R. Sousa, Julie Corfield, Frédéric Baribaud, Dominic E. Shaw, Ildiko Horvath, Jacek Musial, Pascal Chanez, Norbert Krug, Paolo Montuschi, Per S. Bakke, Florian Singer, Stephen J. Fowler, Sven-Erik Dahlén, Thomas Sandström, Peter J. Sterk, Ratko Djukanovic, Kian Fan Chung, Ian M. Adcock, Charles Auffray, The U-BIOPRED Study Group
224
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 OA3491
LSC Abstract – Toll-like receptor 10: Expression and functional role in LPS mediated inflammation Yadu Balachandran (Saskatoon, SK, Canada), Yadu Balachandran, Baljit Singh
OA3492
Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA Kenneth Bolger (Kilkenny, Ireland), Kenneth Bolger, Anthony Bosco, Pat Holt, Conor Burke
OA3493
Telomere-associated gene network in lung adenocarcinoma Lilit Nersisyan (Yerevan, Armenia), Lilit Nersisyan, Anna Hakobyan, Arsen Arakelyan
OA3494
Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta glucocorticoid receptor signaling axis Ramon Langen (Maastricht, Netherlands), Ramon Langen, Koen Verhees, Marco Kelders, Chiel De Theije, Annemie Schols
OA3495
INTS12 knockdown leads to perturbation of genes and pathways of relevance to airway biology Abdul Kader Kheirallah (Nottingham, United Kingdom), Abdul Kader Kheirallah, Ian Sayers, Ian Hall
OA3496
SMAD3 regulation contributes to lung vascular remodeling in pulmonary arterial hypertension Diana Zabini (Toronto, Canada), Diana Zabini, Andras Kapus, Wolfgang Kuebler
OA3497
The properties of pulmonary surfactant after 30-day space flight and simulated microgravity Daniil Kazarin (Izhevsk, Russian Federation), Daniil Kazarin, Irina Bryndina, Natalia Vasilieva
Room 13.1
Session 387
10:45 - 12:45
Oral Presentation: New findings in paediatric respiratory physiology Chairs : Enrico Lombardi (Florence, Italy), Graham Hall (West Perth, Australia)
OA3498
LATE-BREAKING ABSTRACT: Measurement of respiratory system mechanics via laryngeal mask airway in children Zoltán Hantos (Szeged, Hungary), Zoltán Hantos, Anoop Ramgolam, Gergely Makan, Dorottya Czovek, Zoltán Gingl, Graham Hall, Britta Regli-Von Ungern Sternberg
OA3499
New reference equations for interpreting results from the raised volume technique (RVRTC) in infants Sooky Lum (London, United Kingdom), Sooky Lum, Vassiliki Bountziouka, Angela Wade, Jane Kirkby, Ines De Mir, Joerg Mattes, Paula Corcuera-Elosegui, Luis Miguel Borrego, Simon Lee, Janet Stocks
OA3500
Longitudinal infant lung function measures in unsedated infants Diane Gray (Cape Town, South Africa), Diane Gray, Lauren Willemse, Ane Visagie, Peter D. Sly, Graham L. Hall, Heather J. Zar
OA3501
Changes in breathing pattern upon 100% oxygen during N2MBW in children Kerstin Jost (Basel, Switzerland), Kerstin Jost, Nina Lenherr, Florian Singer, Sven M. Schulzke, Urs P. Frey, Philipp Latzin, Sophie Yammine
OA3502
Lung clearance Index changes over time among patients with cystic fibrosis Elpida Hatziagorou (Thessaloniki, Greece), Elpis Hatziagorou, Vasiliki Avramidou, Asterios Kampouras, Fotios Kirvasilis, Petrina Vantsi, Maria Karailidou, John Tsanakas
OA3503
Longitudinal lung function in school-age children born very preterm Shannon Simpson (Western Australia, Australia), Shannon Simpson, Karla Logie, Maureen Verheggen, Christopher O’Dea, Andrew Wilson, Jane Pillow, Graham Hall
OA3504
Classification of flow-dependent changes in mechanical impedance in healthy newborns Bence Radics (Szeged, Hungary), Bence Radics, Zita Gyurkovits, Zoltán Gingl, Gergely Makan, Balázs Maár, Hajnalka Orvos, Peter D. Sly, Zoltán Hantos
OA3505
Lung function in school age children with chronic lung disease of prematurity Ephraim Bar-Yishay (Beer-Sheva, Israel), Ephraim Bar-Yishay, Elena Matyashchuk, Dario Prais, Hannah Blau, Eytan Kaplan
Room 2.1
Session 388
10:45 - 12:45
Oral Presentation: IPF pathogenesis Chairs : Bruno Crestani (Paris, France), Katerina Antoniou (Heraklion, Greece) OA3506
LSC Abstract – Changes in the respiratory microbiome during acute exacerbations of Idiopathic Pulmonary Fibrosis Philip Molyneaux (London, United Kingdom), Philip Molyneaux, William Cookson, Miriam Moffatt, Dong Soon Kim, Toby Maher
225
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA3507
LSC Abstract – Toll-like receptor 4 (TLR4) in idiopathic pulmonary fibrosis (IPF) Simone Ebener (Bern, Switzerland), Simone Ebener, Stephan Christian Schäfer, Bruno Crestani, Thomas Geiser, Manuela Funke
OA3508
Functional analysis of the ABCA3-transporter with fluorescent labeled phosphatidylcholine Stefanie Höppner (Munich, Germany), Stefanie Höppner, Thomas Wittmann, Ulrike Schindlbeck, Susanna Kinting, Adriano Torrano, Christoph Bräuchle, Ralf Zarbock, Matthias Griese
OA3509
The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid Annette van der Vis ( Nieuwegein, Netherlands), Joanne Van der Vis, Reinier Snetselaar, Karin Kazemier, Jan Grutters, Coline Van Moorsel
OA3510
Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis Shinichiro Ohshimo (Hiroshima, Japan), Shinichiro Ohshimo, Chihiro Yamaoka, Yasush Horimasu, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Francesco Bonella, Josune Guzman, Ulrich Costabel, Nobuoki Kohno
OA3511
RNA-seq analysis does not substantiate a causative link between herpes virus infection and IPF Joseph Lasky (New Orleans, United States of America), Quiyan Yin, Michael Strong, Erik Flemington, Joseph Lasky
OA3512
Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE) Andriana Papaioannou (Vrilissia, Athens, Greece), Andriana Papaioannou, Konstantinos Kostikas, Georgia Papadaki, Aneza Roussou, Aris Spathis, Argyro Mazioti, Ioannis Tomos, Effrosyni Manali, Stelios Loukides, Petros Karakitsos, Spyros Papiris, Filia Diamantea
OA3513
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis EIRINI VASARMIDI (Heraklion, Crete, Greece), Eirini Vasarmidi, Eliza Tsitoura, Stella Sarantoulaki, Chara Koutoulaki, Irini Charalambous, George Margaritopoulos, Nikolaos Siafakas, Katerina Antoniou
Room 4.1
Session 389
10:45 - 12:45
Oral Presentation: The multiple facets of stem and progenitor cells in lung health and disease Chairs : Eric White (Ann Arbor, United States of America), Gunilla Westergren-Thorsson (Lund, Sweden) OA3514
Airway epithelial progenitors regenerate the distal lung Dimitra Zazara (Patras, Greece), Dimitra E. Zazara, Magda Spella, Anastasios D. Giannou, Ioannis Lilis, Malamati Vreka, Georgios T. Stathopoulos
OA3515
LSC Abstract – Murine bone marrow-derived mesenchymal stem cells exert anti-viral and barrier-protective properties in influenza virus infection Lina Jankauskaite (Giessen, Germany), Lina Jankauskaite, Carole Schmoldt, Juergen Lohmeyer, Susanne Herold
OA3516
Lung-derived mesenchymal stromal cells are tissue specific and display an altered gene expression in BOS patients Sara Rolandsson Enes (Lund, Sweden), Sara Rolandsson, Annika Andersson Sjöland, Lennart Hansson, Ingrid Skog, Hillevi Larsson, Leif Bjermer, Stefan Scheding, Gunilla Westergren-Thorsson
OA3517
Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling Olivier Bernard (Bobigny, France), Olivier Bernard, Florence Jeny, Elisabetta Dondy, Yurdagül Uzunhan, Shalini Sivarajah, Valérie Vanneaux, Jérôme Larghero, Hilario Nunès, Carole Planès, Nicolas Dard
OA3518
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Winifred Broekman (Leiden, Netherlands), Winifred Broekman, Jan Stolk, Thais Mauad, Jaap Jan Zwaginga, Wim E. Fibbe, Jaap Oostendorp, Ingeborg Bajema, Michel I.M. Versteegh, Christian Taube, Pieter S. Hiemstra
OA3519
Effect of MSC treatment on LPS-induced inflammation, emphysema and atherosclerosis in E3L mice Padmini Khedoe (Den Haag, Netherlands), Padmini Khedoe, Stan De Kleijn, Annemarie Van Schadewijk, Bram Van der Linden, Lianne Van der Wee-Pals, Annemarie Van Oeveren-Rietdijk, Jaap Plomp, Hetty De Boer, Melissa Van Pel, Patrick Rensen, Jimmy Berbée, Pieter Hiemstra
OA3520
Mesenchymal stem cell-conditioned medium induces neutrophils apoptosis via inhibition of NF-kB pathway and increases endogenous pulmonary stem cells in endotoxin-induced acute lung injury Vincent Yi-Fong Su (Taipei, Taiwan), Vincent Yi-Fong Su, Kuang-Yao Yang
226
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA3521
Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway Patrick Berger (Bordeaux, France), Isabelle Dupin, Benoît Allard, Annaïg Ozier, Elise Maurat, Olga Ousova, Thomas Trian, Hoang-Nam Bui, Claire Dromer, Olivier Guisset, Elodie Blanchard, Gilles Hibert, Frédérique Vargas, Roger Marthan, Pierre-Olivier Girodet, Patrick Berger
Room Emerald
Session 390
10:45 - 12:45
Oral Presentation: Pulmonary hypertension: new pathophysiological insights Chairs : Robert Naeije (BRUSSELS, Belgium), Harm Jan H.J. Bogaard (Amsterdam, Netherlands) OA3522
Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension Pia Trip (Amsterdam, Netherlands), Pia Trip, Silvia Rain, Louis Handoko, Cathelijne Van der Bruggen, Harm Jan Bogaard, Tim Marcus, Anco Boonstra, Nico Westerhof, Anton Vonk Noordegraaf, Frances De Man
OA3523
Prognostic value of MRI in pulmonary arterial hypertension: Early and late predictors Andy Swift (Sheffield, United Kingdom), Andrew Swift, Dave Capener, Rothman Alex, Elliot Charlie, Condliffe Robin, Wild Jim, Kiely David
OA3524
Increased right ventricular diastolic stiffness and reduced ejection fraction in pulmonary hypertension Toshitaka Nakaya (Sapporo, Japan), Toshitaka Nakaya, Ichizo Tsujino, Takahiro Sato, Noriko Oyama-Manabe, Hiroshi Ohira, Masaharu Nishimura
OA3525
Exercise capacity after pulmonary endoarterectomy and its determinants Rita Di Domenica (Pavia, Italy), Rita Di Domenica, Mariachiara Mennitti, Arianna Viscardi, Maurizio Pin, Valentina Grazioli, Antonio Sciortino, Catherine Klersy, Andrea Maria D’Armini, Federica Meloni, Angelo Guido Corsico, Isa Cerveri
OA3526
Pressure-flow relationship during exercise predicts transplant-free survival in patients with pre-capillary pulmonary hypertension Elisabeth Domenica Hasler (Uster, Switzerland), Elisabeth Domenica Hasler, Séverine Müller-Mottet, Gina Somaini, Stéphanie Saxer, Rudolf Speich, Marco Maggiorini, Lars Huber, Konrad E. Bloch, Silvia Ulrich
OA3527
Overnight rostral fluid shift in group 1 pulmonary arterial hypertension Sven GÜnther (Le Kremlin Bicêtre, France), Sven Günther, Georges Chebly, Marc Humbert, Isabelle Arnulf, Thomas Similowski, Stefania Redolfi
OA3528
Exercise-induced immune response in patients with idiopathic pulmonary arterial hypertension Lars Harbaum (Hamburg, Germany), Lars Harbaum, Emilia Renk, Sara Yousef, Nicole Lüneburg, Tim Oqueka, Hans J. Baumann, Djordje Atanackovic, Rainer H. Böger, Carsten Bokemeyer, Hans F.E. Klose
OA3529
Clinical and haemodynamic predictors of abnormal pulmonary vascular response at exercise Edmund Lau (Connells Point, Australia), Edmund Lau, Laurent Godinas, David Montani, Andrei Seferian, Xavier Jais, Laurent Savale, Oliver Sitbon, Gerald Simonneau, Marc Humbert, Denis Chemla, Philippe Herve
Room E104-106
Session 391
10:45 - 12:45
Poster Discussion: Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Chairs : Vanessa Suziane Probst (Londrina, Brazil), Jordi VILARO CASAMITJANA (Barcelona, Spain)
PA3530
Exercise training in patients with interstitial lung disease (ILD): Can reponders be distinguished from nonresponders Veronica Barbier (Leuven, Belgium), Veronica Barbier, Carlos A. Camillo, Heleen Demeyer, Wim Janssens, Wim Wuyts, Thierry Troosters
PA3531
Physiological responses to functional exercise capacity in interstitial lung disease patients with acute exacerbations Meral Bosnak Güçlü (Ankara, Turkey), Zeynep Pelin Ugras, Burcu Camcioglu, Meral Bosnak Güçlü, Müserrefe Nur Karadalli, Nurdan Köktürk, Haluk Türktas
PA3532
Inspiratory and peripheral muscle weakness in hospitalized patients with decompensated heart failure Karen Kimoto (Sao Bernardo do Campo, Brazil), Karen Kimoto, Igor Moraes, Samantha Grams, Marcos Brandmuller Fernandes, Wellington Yamaguti
PA3533
Influence of early resistance exercise after coronary artery bypass grafting Daniel Borges (São Luis, Brazil), Nayana Ximenes, Vinícius Nina, Daniel Borges, Reijane Lima, Mayara Silva, Luan Silva, Thiago Baldez, Marina Costa
227
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3534
A comparison of three methods for improving expiratory cough flow and lung volume in children with neuromuscular diseases Akshat Kapur (Glasgow, United Kingdom), Akshat Kapur, Michael Seear, Maggie McIlwaine, Hilda Perry, Melissa Richmond, Cassandra Yoon, Kathryn Selby
PA3535
Impact of expiratory muscle training in paraplegic subjects Roland Hotton (Limal, Belgium), Julien Klepper, Charline Icart, Thomas Mettay, Roland Hotton
PA3536
The effects of supervised and home-based breathing exercises on functional outcomes in patients with fibromyalgia syndrome Onur Aydogdu (Istanbul, Turkey), Onur Aydogdu, Zübeyir Sari, ömer Aydin, Ufuk Yurdalan
PA3537
Effect of positive airway pressure added to conventional chest physiotherapy in resolution of pleural effusion after drainage: A randomised controlled trial Adriana C. Lunardi (Santo André/ SP, Brazil), Elinaldo Santos, João Silva Junior, Fernanda Melo, Marcus Assis Filho, Marcela Vidal, Juliana Silva, Marcia Novais, Franklin Barbosa, Islla Marreiros, Débora Palheta, Adriana Lunardi
PA3538
Implementation of inspiratory muscle training to wean off from mechanical ventilation in ICU Jean Christophe Villiot-Danger (Briançon, France), Tristan Bonnevie, Jean-Christophe Villiot-Danger, Francis-Edouard Gravier, Johan Dupuis, Guillaume Prieur, Clément Médrinal
PA3539
Effects of pulmonary rehabilitation during hematopoietic stem cell transplantation Meral Bosnak Güçlü (Ankara, Turkey), Zeynep Aribas, Meral Bosnak-Güçlü, Gülsah Bargi, Deniz Inal Ince, Zeynep Arzu Yegin, Sahika Zeynep Aki, Gülsan Sucak
PA3540
Physical activity has a protective effect against postoperative pulmonary complications after abdominal surgery Adriana C. Lunardi (Santo André/ SP, Brazil), Fernando Wegner, Daniel Souza, Luciana Chiavegato, Adriana Lunardi
PA3541
Lung expansion techniques on thoracoabdominal mechanics in patients underwent to open abdominal and laparoscopic surgeries Adriana C. Lunardi (Santo André/ SP, Brazil), Adriana Lunardi, Cibele Marques da Silva, Desiderio Cano, Denise Paisani, Celso R.F. Carvalho
PA3542
Breathing exercises by flow-oriented incentive spirometry in postoperative bariatric surgery Eli Maria Pazzianotto-Forti (Capivari, Brazil), Eli Maria Pazzianotto-Forti, Carolina Moraes da Costa, Daniela Merino, Maura Rocha, Irineu Rasera-Júnior
PA3543
Influence of thoracic and abdominal surgery on cough power, lung function, and vocal function Kazuyuki Tabira (Nara, Japan), Kazuyuki Tabira, Shigeharu Koh, Tomoya Akakabe, Hiromi Inoue, Naomi Miyamoto, Shinichi Arizono
PA3544
Early mobilization in the postoperative patients submitted to cardiac surgery – A systematic review Luciana Chiavegato (São Paulo, Brazil), Priscila Ramos, Natália Ricci, Erika Suster, Denise Paisani, Luciana Chiavegato
PA3545
Regional contributions of the ribcage and abdomen before and after a six week pulmonary rehabilitation programme Rokhsaneh Tehrany (Southampton, United Kingdom), Rokhsaneh Tehrany, Anne Bruton, Anna Barney
PA3546
Physical deterioration during hospitalization in patients with community-acquired pneumonia Irene TORRES SANCHEZ (Santa Fe (Granada), Spain), Adelina Martín-Salvador, Irene Torres-Sánchez, Ana FulgencioDelgado, Marie Carmen Valenza, Irene Cabrera-Martos, Isabel López-Torres
PA3547
Impact of hospitalization in the functionality and quality of life of adults and elderlies Débora Martins Meira (São Paulo , Brazil), Débora Meira, Patricia Lavoura, Deise Ferreira, José Antonio Curiati, Arnaldo Lichtenstein, Celso Carvalho, Clarice Tanaka
Room G102-103
Session 392
10:45 - 12:45
Poster Discussion: Best abstracts in physical activity in chronic lung diseases Chairs : Henrik Watz (Grosshansdorf, Germany), Nicolino Ambrosino (Volterra, Italy) PA3548
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Anja Frei (Zurich, Switzerland), Anja Frei, Tsung Yu, Sarah Crook, Patrick Muggenstrum, Gerben Ter Riet, Milo A. Puhan
PA3549
Physical activity after discharge following chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF) exacerbations Katherine Gross (West Hartford, United States of America), Katherine Gross, Thomas Waring, Harsh Chawla, Chinthaka Bulathsinghala, Richard Soucier, Richard ZuWallack
228
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3550
The role of sustained physical inactivity in the progression of exercise intolerance and muscle depletion in COPD Benjamin Waschki (Hamburg, Germany), Benjamin Waschki, Anne Kirsten, Olaf Holz, Kai-Christian Müller, Miriam Schaper, Anna-Lena Sack, Thorsten Meyer, Klaus Rabe, Helgo Magnussen, Henrik Watz
PA3551
Development of a new performance scale to assess activities of daily living in COPD patients Gabriel Ricardo Garcia (CITY BELL, Argentina), Gabriel Garcia, Miguel A. Bergna, Viridiana Pistorio, Roberto Ravinovich
PA3552
Change in physical activity level following COPD exacerbation Paul Andrzejowski (Sheffield, United Kingdom), Paul Andrzejowski, Neil Greening, Matthew Richardson, Theresa HarveyDunstan, Linzy Houchen-Wolloff, Emma Chaplin, Tim Maheswaran, Justina Ruksenaite, Fayyaz Hussain, Sally Singh
PA3553
Self-report vs. pedometer steps in COPD: Are they similar? Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Joana Cruz, Dina Brooks, Alda Marques
PA3554
Physical activity is closely associated with short physical performance battery score in elderly COPD Masahiro IWAKURA (Akita, Japan), Masahiro Iwakura, Atsuyoshi Kawagoshi, Kazuki Okura, Yoshino Terui, Mizuki Sato, Masahiro Satake, Keiyu Sugawara, Hitomi Takahashi, Takeshi Kashiwagura, Takanobu Shioya
PA3555
Validity and usability of low-cost accelerometers for internet-based self-monitoring of physical activity in patients with COPD Martijn Vooijs (Leiden, Netherlands), Martijn Vooijs, Laurence Alpay, Jiska Snoeck-Stroband, Thijs Beerthuizen, Petra Siemonsma, Jannie Abbink, Jaap Sont, Ton Rövekamp
PA3556
Physical activity and the use of COPD medication Milla Katajisto (Helsinki, Finland), Milla Katajisto, Jukka Koskela, Ari Lindqvist, Maritta Kilpeläinen, Tarja Laitinen
PA3557
Walking and cycling in patients with asthma and COPD Rob Van Lummel (The Hague, Netherlands), Rob C. van Lummel, Siete C. Frouws, Alex J. van ’t Hul, Jaap H. van Dieën, Johannes C.C.M. in ’t Veen
PA3558
Sit to stand performance and physical activity levels in COPD Sarah Jones (Berkshire, United Kingdom), Sarah E. Jones, Jane L. Canavan, Claire M. Nolan, Samantha S.C. Kon, Matthew Maddocks, Michael I. Polkey, William D.C. Man
PA3559
Four-meter gait speed is useful to detect daily activity level in chronic respiratory diseases Chieko Yoshida (Kumamoto, Japan), Chieko Yoshida, Hideharu Ideguchi, Aiko Masunaga, Keisuke Kojima, Susumu Hirosako, Hidenori Ichiyasu, Kazuiko Fujii, Hirotsugu Kohrogi
PA3560
Patients with asthma moderate and severe presents reduced moderate levels of physical activity, less aerobic conditioning and poorly control of the asthma Ronaldo Aparecido da Silva (Sao Paulo, Brazil), Ronaldo Aparecido da Silva, Patrícia Gonçalves Leite Rocco, Alberto Cukier, Rafael Stelmach, Milton de Arruda Martins, Celso Ricardo Fernandes Carvalho
PA3561
Physiological determinants of rehabilitative-induced improvement in daily physical activity in patients with COPD Eleni Kortianou (Athens, Alimos, Greece), Eleni Kortianou, Zafeiris Louvaris, Stavroula Spetsioti, Maroula Vasilopoulou, Nikolaos Chynkiamis, Nikolaos Anastasopoulos, Giorgos Kaltsakas, Nikos G. Koulouris, Ioannis Vogiatzis
PA3562
Determinants of physical activity in patients with COPD: A longitudinal study Tsung Yu (Zurich, Switzerland), Tsung Yu, Anja Frei, Ter Riet Gerben, Milo Puhan
PA3563
Effects of low-intensity exercise and home-based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with COPD Atsuyoshi Kawagoshi (Akita city, Japan), Atsuyoshi Kawagoshi, Noritaka Kiyokawa, Masahiro Iwakura, Kazuki Okura, Keiyu Sugawara, Hitomi Takahashi, Shunichi Sakata, Masahiro Satake, Takanobu Shioya
PA3564
Engaging technology for encouraging physical activity in COPD patients: A first user test Chevone Barretto (Cambridge, United Kingdom), Chevone M. Barretto, Marian K.J. Dekker, Rita Priori, Charalampos Xanthopoulakis, Emiel F.M. Wouters, Mareike Klee, Martijn Spruit, Privender Saini
PA3565
Cycling detection with a single activity monitor Siete Frouws (Den Haag, Netherlands), Siete C. Frouws, Alex J. van ’t Hul, Johannes C.C.M. in ’t Veen, Jaap H. van Dieën, Rob C. van Lummel
Room G104-105
Session 393
Poster Discussion: New models for treating airway diseases Chairs : Irfan Rahman (Rochester, United States of America), Irene Heijink (Groningen, Netherlands)
229
10:45 - 12:45
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3566
Andrographolide restores steroid sensitivity to block LPS/IFN- -induced IL-27 and airway hyperresponsiveness in mice Wupeng Liao (Singapore, Singapore), Wupeng Liao, Wan Shun Daniel Tan, Wai-Shiu Fred Wong
PA3567
Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-achip Remi Villenave (Boston, United States of America), Remi Villenave, Kambez Benam, Carolina Lucchesi, Antonio Varone, Thomas Ferrante, Cedric Hubeau, Hyun-Hee Lee, Michael Salmon, Steve Alves, James Weaver, Geraldine Hamilton, Tony Bahinski, Donald Ingber
PA3568
Effects of LTRA on T cell-induced bronchoconstriction in the mice Akio Mori (Sagamihara, Kanagawa, Japan), Akio Mori, Satoshi Kouyama, Miyako Yamaguchi, Y.O. Iijima, Akemi Ohtomo-Abe, Takayuki Ohtomo, Natsumi Saito, Arisa Kinoshita, Kentaro Watarai, Chihiro Mitsui, Chiyako Oshikata, Kiyoshi Sekiya, Takahiro Tsuburai, Mamoru Ohtomo, Yuma Fukutomi, Masami Taniguchi, Osamu Kaminuma
PA3569
Effect of roflumilast on airway remodeling in a murine model of chronic asthma Hyoung Kyu Yoon (Seoul, Republic of Korea), Sei Won Kim, Chin Kook Rhee, Jin Woo Kim, Sook Young Lee, Joong Hyun Ahn, Hyoung Kyu Yoon
PA3570
Cell therapy by adipose stromal cells affect tracheal responsiveness and inflammatory responses in guinea pigs model of COPD Mohammad Hossein Boskabady (Mashhad, Islamic Republic of Iran), Mohammad Hossein Boskabady, Azadeh Feizpour, Ahmad Ghorbani
PA3571
Lung absorption half-life of inhaled drugs can be predicted with rat lung slices Erica Bäckström (Mölndal, Sweden), Erica Bäckström, Anders Lundqvist, Elin Boger, Margareta Hammarlund-Udenaes, Markus Fridén
PA3572
Effect of simvastatin on steroid-resistence in human epithelial cultured cells: A preliminary study Luigino Calzetta (Rome, Italy), Luigino Calzetta, Barbara Rinaldi, Giuseppe Gritti, Maria Donniacuo, Giovanna Donnarumma, Maria Gabriella Matera
PA3573
Antioxidant effects of bisphosphonates in smoking- induced lung injury in rat model Celalettin Korkmaz (KONYA, Turkey), Celalettin Korkmaz, Durdu Mehmet Yavsan, Soner Demirbas, Pembe Oltulu, Ibrahim Kilinç, Mehmet Uyar, Mehmet Gok, Kursat Uzun
PA3574
Organic components of diesel exhaust particles (DEP) activate airway sensory nerves via transient receptor potential ankrin-1 (TRPA1) ion channels Ryan Robinson (London, United Kingdom), Ryan Robinson, Michael Wortley, Eric Dubuis, Shu Chen, Sheng Hu, Sara Bonvini, Sarah Maher, John Adcock, Ian Mudway, Alexandra Porter, Terry Tetley, Mark Birrell, Maria Belvisi
PA3575
Proteome profiling reveals candidate mediators of TGF- -induced glucocorticoid resistance Meina Li (Parkville, Australia), Meina Li, Christine Keenan, Yuxiu Xia, Alastair Stewart
PA3576
Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model Aysun engül (Kocaeli, Turkey), Meyrem Ozkan, Aysun Sengul, Ceyla Eraldemir, Leman Huseynova, Firuzan Akar
PA3577
Effects of anti-IL-1 , anti-IL-1 , anti-IL-18 and anti-IL-1RI antibodies on combined smoke and virus-induced airway inflammation in mice Hannes Bucher (Biberach an der Riss, Germany), Hannes Bucher, Martina Keck, Michel Przibilla, David Lamb, David Wyatt, Mareike Wittenbrink, Klaus Fuchs, Birgit Jung, Klaus J. Erb, Daniel Peter
PA3578
Tissue distribution of inhalation drugs in rat lung slices Erica Bäckström (Mölndal, Sweden), Erica Bäckström, Anders Lundqvist, Elin Boger, Petter Svanberg, Pär Ewing, Margareta Hammarlund-Udenaes, Markus Fridén
PA3579
Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Lucie Knabe (Montpellier, France), Lucie Knabe, Jennifer Bonini, Jessica Varilh, Petit Aurélie, Isabelle Vachier, Pascal Chanez, Magali Taulan, Arnaud Bourdin
PA3580
Direct relationship between inhibition of leukotriene release in lung and free plasma concentration of a LTC4 synthase inhibitor in a rat model Linda Swedin (Mölndal, Sweden), Linda Swedin, Eva Lamm Bergström, Theresa Andreasson, Magnus Munck af Rosenschöld, Britta Bonn, Andy Davis
PA3581
A human-like ex vivo preclinical model for aerosol deposition studies Sophie PERINEL Ragey (Cellieu, France), Sophie Perinel Ragey, Jérémie Pourchez, Lara Leclerc, John Avet, Marc Durand, Nathalie Prevot, Michèle Cottier, Jean Michel Vergnon
230
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3582
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Andreas Kuttler (Basel, Switzerland), Andreas Kuttler, Thomas Dimke
PA3583
Novel oral voltage-gated sodium channel (Nav) inhibitors inhibit capsaicin induced cough in conscious guinea pigs Monica Aparici Virgili (Sant Feliu de Llobregat, Spain), Jorge De Alba, Monica Aparici, Joan Antoni Fernández-Blanco, Silvia Fonquerna, Laia Sole, Israel Ramos, Marisa Vinyals, Sonia Sentellas, James Duffy, Gary Clark, Damian Bell, Montserrat Miralpeix
Room G106-107
Session 394
10:45 - 12:45
Poster Discussion: Co-existing diseases and asthma Chairs : Cesar Picado (Barcelona, Spain), Vibeke Backer (Copenhague, Denmark)
PA3584
Treatment of concomitant obstructive sleep apnea/hypopnea syndrome in patients with persistent poorly controlled bronchial asthma - Real opportunity to improve asthma control Liudmyla Iashyna (Kiev, Ukraine), Liudmyla Iashyna, Yurii Feshchenko, Maryna Polianska, Viktoria Ignatieva, Inna Zvol, Svitlana Moskalenko, Natalia Kramarska, Svitlana Opimakh, Iryna Chumak, Natalia Diachenko, Ksenia Nazarenko
PA3585
The method of evaluation of -receptor’s activity changes Olga Agapova (Lubertsy Moscow region, Russian Federation), Olga Agapova, Kirill Zykov, Yuri Skoblov, Valery Masenko, Irina Chazova
PA3586
The use of ambulatory blood pressure monitoring in patients with bronchial asthma and hypertension Marina Zakharova (Simferopol, Ukraine), Marina Zakharova, Natalia Zhukova, Olga Krjuchkova
PA3587
The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction Olga Kharevich (Minsk, Belarus), Kharevich Olga, Lapteva Irina, Lapteva Elena, Koroleva Elena, Shpakouskaya Natalia, Kovalenko Dmitry, Dzusmikeeva Marina
PA3588
Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA) Manuela Latorre (Pisa, Italy), Manuela Latorre, Veronica Seccia, Chiara Baldini, Letizia Vergura, Federica Novelli, Marias Laura Bartoli, Silvana Cianchetti, Elena Bacci, Federico Dente, Antonella Di Franco, Pierluigi Paggiaro
PA3589
Comorbidity and some issues of cardiovascular disorders in disabled asthma patients Svitlana S Panina (Dniepropetrovsk, Ukraine), Anatoliy Ipatov, Svitlana Panina, Nataliia Sanina, Nataliia Gondulenko, Svitlana Panina
PA3590
Low vitamin D level and adult-onset bronchial asthma: Is there a link? Mariia Goremykina (Samara, Russian Federation), Marya Goremykina, Vitalii Kypaev
PA3591
Outpatients with asthma and irreversible airflow limitation - Some clinical characteristics Zlatina Ivanova (Pleven, Bulgaria), Zlatina Ivanova, Iliya Krachunov, Nikolay Kyuchukov, Nikolay Yanev, Pavlina Glogovska, Plamen Pavlov, Tsania Popova, Yavor Ivanov
PA3592
The impact of ethnicity on patients presenting with acute asthma exacerbation: The experiences of an inner city district general hospital Adam Ainley (London, United Kingdom), Adam Ainley, Tara Maisel, Anna Seeley
PA3593
Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids Howraman Meteran (Copenhagen, Denmark), Howraman Meteran, Christian Grabow Westergaard, Vibeke Backer
PA3594
Continuity study of the bone mineral density reduction in long term use of inhaled corticosteroids Zoran Stojanovski (Skopje, FYROM (Macedonia)), Zoran Stojanovski, Trajce Nicevski, Jordan Minov
PA3595
Clinical features of asthma complicated with eosinophilic otitis media and the effect of treatment with the anti-IgE monoclonal antibody omalizumub Etsuko Tagaya (Tokyo, Japan), Etsuko Tagaya, Ayako Kubo, Hiroko Sekine, Rie Misobuchi, Katsunori Ochiai, Kiyoshi Takeyama, Mitsuko Kondo, Kazuo Isono, Jun Tamaoki
PA3596
Importance of meanplatelet volume, platelet distribution width and red blood cell distribution width in asthmatic subjects brahim Koç (Gaziantep, Turkey), Ibrahim Koc, Yusuf Dogan, Serdar Dogan
PA3597
Respiratory complaints with the syndrome Dunbar simulate asthma Ludmila F Kovaleva (Saint-Petersburg, Russian Federation), Ludmila Kovaleva, Aleksei Gichkin, Vitaly Perley, Anatoly Ignashev, Maria Petrova, Elena Privalova, Nadezhda Jakovleva, Olga Titova
PA3598
Severe sleep apnea syndrome associated with chronic cough without daytime sleepiness Naoko Yokohori (Chiba, Japan), Naoko Yokohori, Mizue Hasegawa, Akitoshi Sato, Hideki Katsura
231
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3599
Allergic and non-allergic rhinitis in children Vamekh Kherkheulidze (Tbilisi, Georgia), Maia Kherkheulidze, Nani Kavlashvili, Eka Kandelaki, Vamekh Kherkheuldize, Nino Adamia
PA3600
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Muzaffer Onur Turan (Çanakkale, Turkey), Onur Turan, Turgay Kasan, Pakize Ayse Turan, Arzu Mirici
PA3601
Precision of bronchoprovocation testing in the diagnosis of exercise-induced laryngeal obstruction Emil Schwarz Walsted (Frederiksberg, Denmark), Emil Schwarz Walsted, James Hull, Asger Sverrild, Celeste Porsbjerg, Vibeke Backer
Room 13.2
Session 395
10:45 - 12:45
Poster Discussion: Modulating the immune system in COPD and asthma Chairs : Gary P. Anderson (Parkville, Australia), Jonas Erjefalt (Lund, Sweden) PA3602
Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy Jing Li (Guangzhou, China), Mulin Feng, Zhaowei Yang, Jing Li
PA3603
IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways Anna James (Stockholm, Sweden), Martijn Manson, Anna James, Jesper Säfholm, Mamdoh Al-Ameri, Per Bergman, AnnCharlotte Orre, Sven-Erik Dahlén, Mikael Adner
PA3604
Tiotropium Respimat® add-on therapy in children with symptomatic asthma Christian Vogelberg (Dresden, Germany), Christian Vogelberg, Petra Moroni-Zentgraf, Migle LeonaviciuteKlimantaviciene, Ralf Sigmund, Eckard Hamelmann, Michael Engel, Stanley Szefler
PA3605
IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD Abraham Roos (Hamilton, Canada), Abraham Roos, Sanjay Sethi, Leif Bjermer, Christopher Stevenson, Jonas Erjefalt, Martin Stampfli
PA3606
Efficacy of tiotropium Respimat® in adults with moderate asthma, by baseline LTRA use Ronald Dahl (Odense C, Denmark), Ronald Dahl, Thomas Casale, Eugene Bleecker, Emilio Pizzichini, Michael Engel, Petra Moroni-Zentgraf, Louis Bour, Huib Kerstjens
PA3607
Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations Zied Moatemri (Ariana, Tunisia), Zied Moatemri, Nidhal Belloumi, Salsabil Dabboussi, Samira Mhamdi, Abir Hedhli, Chiraz Aichaouia, Mohsen Khadraoui, Rezaik Cheikh
PA3608
Saccharomyces cerevisiae UFMG 905 modulates cytokine production in the cecum and inhibits lung inflammation Marcos Borges (Ribeirao Preto, Brazil), Marcos C. Borges, Vanessa M.B. Fonseca, Camila M. Sandy, Flaviano S. Martins, Elcio O. Vianna
PA3609
BioPhysical bronchodilator: A new class of respiratory drug John Dennis (Calgary, Canada), John Dennis, Richard Leigh, Tamer ElMays, Francis Green
PA3610
Aspergillus fumigatus sensitization in COPD and smokers Stéphanie Everaerts (Leuven, Belgium), Stephanie Everaerts, Erna Van Hoeyveld, Kristina Vermeersch, Lieven Dupont, Bart Vanaudenaerde, Xavier Bossuyt, Katrien Lagrou, Wim Janssens
PA3611
The utility of HLA-DQB302 as a genetic marker to predict the effect of aspirin desensitization on lung function of patients with aspirin exacerbated respiratory disease Zahra Aryan (Tehran, Islamic Republic of Iran), Zahra Aryan, Hossein Esmaeilzadeh, Ali Akbar Amirzargar, Mohammad Nabavi
PA3612
Differentiate late-onset asthma and COPD by CD4+ T memory cells in peripheral blood Zhihong Chen (Shanghai, China), Zhihong Chen, Kan Xu, Xinjun Tang, Zhihui Min, Xiangdog Wang
PA3613
Periostin and TSLP: New markers useful in diagnosis of obstructive lung disease Patrycja Nejman-Gryz (Warsaw, Poland), Patrycja Nejman-Gryz, Katarzyna Górska, Magdalena Paplinska-Goryca, Malgorzata Proboszcz
PA3614
Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD Paul Stoll (Rostock, Germany), Paul Stoll, Anne Baehker, Martin Ulrich, Kai Bratke, Katharina Garbe, J. Christian Virchow, Marek Lommatzsch
PA3615
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Jasper Geerdink (Nijmegen, Netherlands), Jasper Geerdink, Sami Simons, Rebecca Pike, Jadwiga Wedzicha, Hans Stauss, Yvonne Heijdra, John Hurst
232
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3616
Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD Ma gorzata Proboszcz (Kielce, Poland), Malgorzata Proboszcz, Katarzyna Górska, Magdalena Paplinska-Goryca, Patrycja Nejman-Gryz
PA3617
Increased circulating alveolar epithelial microparticles in COPD patients Toru Takahashi (Montreal, Canada), Toru Takahashi, Mitsuhiro Yamada, Seiichi Kobayashi, Tomonori Makiguchi, Chiharu Ota, Hiroshi Kubo
PA3618
Risk factors for frequent exacerbations in (ex)smoking and never-smoking adult-onset asthma patients Guus Westerhof (Amsterdam, Netherlands), Guus Westerhof, Christa De Groot, Marijke Amelink, Selma De Nijs, Els Weersink, Anneke Ten Brinke, Elisabeth Bel
PA3619
Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency Charanjeet Kaur (New Delhi, India), Charanjeet Kaur, Balakrishnan Menon, Mohammad Yusuf Dar, Harsh Vardhan
Room E102
Session 396
10:45 - 12:45
Poster Discussion: Paediatric pulmonary infections Chairs : Jayesh M. Bhatt (Nottingham, United Kingdom), Kostas Priftis (Haidari, Athens, Greece)
PA3620
LATE-BREAKING ABSTRACT: Sphingolipids in tracheal aspirates of prematurely born infants with and without BPD Esther van Mastrigt (Rotterdam, Netherlands), Esther van Mastrigt, Salome Zweekhorst, Bas Bol, Jeroen Tibboel, Joost van Rosmalen, Andre Kroon, Johan de Jongste, Irwin Reiss, Martin Post, Marielle Pijnenburg
PA3621
How dangerous are respiratory tract infections with enterovirus D68? Jasna Rodman (Ljubljana, Slovenia), Jasna Rodman, Tita Butenko, Ana Kotnik Pirš, Dušanka Lepej, Marina Praprotnik, Tina Uršic, Miroslav Petrovec, Uroš Krivec
PA3622
Metapneumovirus infection vs. metapneumovirus and RSV coinfection. Is there a difference? Kenneth Escobar (Quetzaltenango, Guatemala), Kenneth Escobar, Astrid Godinez, Estuardo Funes Merida, Fabiola Moscoso
PA3623
Detection of Hemophilus Influenzae in children with respiratory syncytial virus and rhinovirus lower respiratory tract infection Patricia Diaz Amor (Santiago, Chile), Patricia Diaz, Henry Reynolds, Guillermo Zepeda, Aldo Gaggero, Mabel Rivas, Paola Uasapud, Ricardo Pinto, Maria Lina Boza
PA3624
Persistence of respiratory syncytial virus replication in lung dendritic cells Mark Everard (Perth, Australia), Angela Fonseca, Naomi Scott, Deborah Strickland, Mark Everard
PA3625
Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations Candice Bjornson (Calgary, Canada), Candice Bjornson, Parco Chan, Abby Li, Bosco Paes, Krista Lanctot, Ian Mitchell
PA3626
Working with families: Lessons from a Canadian registry of palivizumab use Ian Mitchell (Calgary, Canada), Ian Mitchell, Parco Chan, Abby Li, Hao Yi, Bosco Paes, Krista Lanctot
PA3627
Up-regulation of serum periostin and squamous cell carcinoma antigen levels in respiratory syncytial virus bronchitis of infants Hiroaki Nakamura (Tokyo, Japan), Hiroaki Nakamura, Kenichi Akashi, Masako Watanabe, Shoichiro Ohta, Junya Ono, Yoshinori Azuma, Takashi Sekine, Kenji Izuhara, Toshio Katsunuma
PA3628
Ubiquitination of DDX21 in airway epithelial cells infected with respiratory syncytial virus Dorota Chudek (Lublin, Poland), Dorota Chudek, Rachel Corkhill, Rob Beynon, Paul McNamara, Brian Flanagan
PA3629
RSV-RNA load in infants hospitalized for bronchiolitis and recurrent wheezing at 36 months follow-up Raffaella Nenna (Rome, Italy), Raffaella Nenna, Ambra Nicolai, Antonella Frassanito, Giulia Cangiano, Concetta Schiavariello, Marianna Eleonora Grande, Marianna Ferrara, Carolina Scagnolari, Alessandra Pierangeli, Corrado Moretti, Fabio Midulla
PA3630
Presentation and diagnostic delay in ataxia telangiectasia (A-T) Jayesh M. Bhatt (Nottingham, United Kingdom), Rebecca Devaney, Sara Pasalodos, Mohnish Suri, Andrew Bush, Jayesh Bhatt
PA3631
Characteristics and outcomes of pulmonary hydatid disease in children: About 70 cases Chirine Moussa (Ezahra, Tunisia), Anissa Berraies, Chirine Moussa, Besma Hamdi, Ala Aqqad, Saberine Louhaichi, Jamel Ammar, Tarek Kilani, Agnes Hamzaoui
233
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3632
Swallow aspiration and respiratory symptoms in normally developing children Alison Kelly (London, United Kingdom), Stacey Zimmels, Alison Kelly, Louise Fleming
PA3633
Cathelicidin (LL-37) ve human 2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis Ahmet Hakan Gedik (Istanbul, Turkey), Ahmet Hakan Gedik, Erkan Cakir, Bilge Gultepe, Tarik Umutoglu, Hayrettin Daskaya
PA3634
Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children Chih-Yung Chiu (Keelung, Taiwan), Chih-Yung Chiu, Kin-Sun Wong, Shen-Hao Lai, Jen-Kun Chen, Jing-Long Huang
PA3635
Can blood or urine IP-10 discriminate between active and no active tuberculosis in children? Linda Petrone (Rome, Italy), Linda Petrone, Angela Cannas, Francesco Aloi, Martin Nsubuga, Joseph Sserumkuma, Ritah Angella Nazziwa, Levan Jugheli, Tedson Lukindo, Enrico Girardi, Klaus Reither, Delia Goletti
PA3636
Clinical characteristics of chlamydia trachomatis respiratory tract infections in young infants in South Korea Yong-Han Sun (Inchon, Republic of Korea), Yonghan Sun
Room D201-202
Session 397
10:45 - 12:45
Poster Discussion: Paediatric asthma and allergy: lung function and biomarkers Chairs : Silvia Carraro (Padova, Italy), Florian Singer (Zurich, Switzerland)
PA3637
Changes in inspiratory resistance after exercise challenge relate to subclinical airways inflammation in adolescents without FEV1-fall Andrei Malinovschi (Uppsala, Sweden), Henrik Johansson, Pasquale Pompilio, Margareta Emtner, Raffaele Dellaca, Andrei Malinovschi
PA3638
Airway inflammation and hyperresponsiveness study in skier children determined by induced sputum and mannitol test Gerardo Vizmanos-Lamotte (PAL, Andorra), Gerardo Vizmanos-Lamotte, Elisa Canturri Gispert, Lluís Alvarez Castillo, Carola Ribó Campa, Monique Henket, María Jesús Cruz, Renaud Louis, Antonio Moreno-Galdó
PA3639
Spirometry and multiple breath nitrogen washout (MBNW) before and after cold dry air challenge (CACh) in children and adolescents with asthma Andreas Pfleger (HARTBERG, Austria), Andreas Pfleger, Michael Steinbacher, Gerold Schwantzer, Elisabeth Weinhandl, Ernst Eber
PA3640
Addressing current gaps in the clinical utility of lung clearance index (LCI) in school aged children with asthma Reinoud De Leeuw (Rotterdam, Netherlands), Reinoud De Leeuw, Sam Irving, Sejal Saglani
PA3641
Structured light plethysmography: New method to evaluate expiratory flow limitation in asthmatic children Michele Ghezzi (Verona, Italy), Michele Ghezzi, Laura Tenero, Michele Piazza, Alessandro Bodini, Giorgio Piacentini
PA3642
Changes in respiratory function following bronchodilator in acute paediatric asthma measured using structured light plethysmography Hamza Hmeidi (Stoke on Trent, United Kingdom), Hamza Hmeidi, Ed Chadwick, Warren Lenney, Francis Gilchrist, Rachel Wilson, Shayan Motamedi-Fakr, Richard Iles, John Alexander
PA3643
Non-invasive, non-contact measurement of tidal breathing parameters in children aged 3-17 years using structured light plethysmography (SLP) Hamza Hmeidi (Stoke on Trent, United Kingdom), Hamza Hmeidi, Ed Chadwick, Warren Lenney, Francis Gilchrist, John Alexander, Rachel Wilson, Shayan Motamedi-Fakr, Richard Iles
PA3644
Different equations in preschool wheezing children Paula Pinto (Lisbon, Portugal), Paula Leiria-Pinto, Pedro Martins, Isabel Peralta, Sara Serranho, Nuno Neuparth
PA3645
Relevance of FEF25–75% and FEF75% measurements in lung function evaluation of preschool and young school-age children Fabrícia Carolino (Porto, Portugal), Fabrícia Carolino, Carla Martins, Artur Vilela, Mário Miranda, José Luís Plácido
PA3646
Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint: Results of the PACMAN2 study Susanne Vijverberg (Utrecht, Netherlands), Susanne Vijverberg, Paul Brinkman, Jan Raaijmakers, Kors Van der Ent, Peter Sterk, Anke-Hilse Maitland- van der Zee, Leo Koenderman
PA3647
Fractional exhaled nitric oxide during acute viral bronchiolitis and future asthma at the age of four years guy gut (Shefayim, Israel), Guy Gut, Keren Armoni-Domany, Musa Hindiyeh, Ella Mendelson, Yakov Sivan
234
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3648
Exhaled nitric oxide in pediatric athletes admitted to a sports medicine department Radu Diaconu (Craiova, Romania), Radu Diaconu, Ligia Stanescu, Carmen Diaconu, Carmen Niculescu
PA3649
Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels Mary Glukhova (Moscow, Russian Federation), Mary Glukhova, Natalya Geppe, Svetlana Soodaeva, Natalya Kolosova
PA3650
Expression of inflammatory markers in sputum cells and cytokine production by different asthma phenotypes in children Alla Nakonechna (Neston, United Kingdom), Alla Nakonechna, Yurij Antipkin, Tatiana Umanets, Vladimir Lapshyn, Tamara Zadorozhnaja, Olga Pustovalova
PA3651
Serum zinc level in asthmatic and healthy school children Aseel Zeidan (Doha, Qatar), Aseel Zeidan, Atqah AbdulWahab, Tony Avades, Prem Chandra
PA3652
Serum and exhaled condensate leptin levels in asthmatic and obese children: A pilot study Laura Tenero (Verona, Italy), Laura Tenero, Alessandro Bodini, Laura Zanoni, Michele Piazza, Giorgio Piacentini
PA3653
Usefulness of periostin as a biomarker of pediatric asthma Takashi Inoue (Kanagawa, Japan), Takashi Inoue, Kenichi Akashi, Suzuki Ryohei, Masako Watanabe, Kenji Izuhara, Shoichito Ohta, Junya Ono, Noriyuki Yanagida, Sakura Sato, Motohiro Ebisawa, Shuuichi Ashizuka, Toshio Katsunuma
PA3654
Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma Mohanna Mahmoud Alavi (Stockholm, Sweden), Mohanna Mahmoud Alavi, Björn Nordlund, Sara Thunberg, Hans Grönlund, Joakim Lundahl, Gunilla Hedlin, Anders Lindén, Jon Konradsen
Hall 14-01
Session 398
12:50 - 14:40
Thematic Poster: Different data in COPD Chairs : Tiziana Patrizia Cremona (Bern, Switzerland), Claus Vogelmeier (Marburg, Germany), Job van Boven (Groningen, Netherlands), Chair to be confirmed PA3655
Human herpesvirus type 8 in patients with chronic obstructive pulmonary disease Cheng-Chuan Su (Chiayi County, Taiwan), Cheng-Chuan Su, Shih-Ming Tsao, Chun-Liang Lai, Ming-Nan Lin, Jen-Pi Tsai
PA3656
Flow-mediated dilation of the brachial artery and endothelial dysfunction in different COPD phenotypes Andrea Vukic Dugac (Zagreb, Croatia), Andrea Vukic Dugac, Alen Ruzic, Sanja Popovic-Grle, Ana Hecimovic, Mateja Jankovic Makek, Miroslav Samarzija, Marko Jakopovic
PA3657
Evaluation of arrhythmia frequency in patients with COPD Akinori Ebihara (Tokyo, Japan), Akinori Ebihara, Asuka Nagai, Naoko Imamura, Tokuzen Iwamoto, Ichiro Kuwahira
PA3658
Maximal walking as a risk factor of impairment of platelet aggregation in COPD subjects Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Katerina Neumannova, Ilona Fatorova, Doris Vokurkova, Vratislav Sedlak, Jan Svancara, Michal Svoboda, David Prazak, Barbora Koblizkova, Barbora Novotna, Zdenek Svoboda
PA3659
Bullous Emphysema with predominant apical involvement as a pathognomonic feature of Cannabis lung Narendrababu Rampura Chinnappa (Swansea, United Kingdom), Narendra Babu Rampura Chinnappa, Kasia Zalewska, Damian John Mckeon
PA3660
COPD and pneumonia Burcu Arpinar Yigitbas (Istanbul, Turkey), Burcu Arpinar Yigitbas, Sibel Yurt, Baris Seker, Celal Satici, Ayse Filiz Kosar
PA3661
Audit 2014: Standard of inpatient care during exacerbation of COPD in Territory Care Hospital, Pakistan Saima Akhter (Karachi, Pakistan), Saima Akhter, Nadeem Rizvi
PA3662
Early phenotypes of chronic obstructive pulmonary disease (COPD) Gulchekhra Tashmetova (Tashkent, Uzbekistan), Gulchekhra Tashmetova
PA3663
Variability in clinical practice for chronic obstructive pulmonary disease in outpatient clinics Maria ABAD ARRANZ (Sevilla, Spain), María Abad Arranz, Carmen Calero Acuña, Fernando Romero Valero, Antonio Hidalgo Molina, Ruth Ayerbe Garcia, Ricardo Ismael Aguilar Perez-Grovas, Francisco Garcia Gil, Laura Caballero Ballesteros, Francisco Casas Maldonado, Maria Sánchez Palop, Alejandro Segado Soriano, Dolores Pérez Tejero, José Calvo Bonachera, Bárbara Hernández Sierra, Adolfo Doménech del Rio, Macarena Arroyo Valera, Francisco Gonzalez Vargas, Juan José Cruz Rueda, José Luis López-Campos Bodineau
PA3664
COPD and BMI at primary level Dejan Aleksovski (Skopje, FYROM (Macedonia)), Dejan Aleksovski, Zoran Stojanovski, Ivana Babalj Veljanovski
235
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3665
The relationship between dyspnea and detection of depression in COPD patients (pts) Yuliia Huba (Dnipropetrovsk, Ukraine), Tetyana Pertseva, Lyudmila Konopkina, Yuliia Huba
PA3666
Relation betweeen vitamin D levels and clinical properties of COPD patients Derya Kocakaya (Istanbul, Turkey), Derya Kocakaya, Ozan Kocakaya, Berrin Bagci Ceyhan
PA3667
Estimation of tiotropium efficacy at the COPD patients with group D Anna V Demchuk (Vinnytsia, Ukraine), Yuriy Mostovoy, Tetyana Konstantynovych, Anna Demchuk
PA3668
Different response of lung tissue to intravenous acetylated opium Maria Sanzharovskaya (Tomsk, Tomsk Oblast, Russian Federation), Maria Sanzharovskaya, Mikhail Bragin, Ekaterina Budankova, Elena Ustyuzhanina, Evgeniy Kuzin, Anna Fisenko, Galina Chernyavskaya, Georgy Chernogoryuk
PA3669
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Ceylan Ayada (Kütahya, Turkey), Ceylan Ayada, ümran Toru, Osman Genç, Server Sahin, özlem Arik, Ismet Bulut
PA3670
Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients Zoran Stojanovski (Skopje, FYROM (Macedonia)), Zoran Stojanovski, Goran Andonovski, Miralem Jukic, Olgica Kuzarevska-Blazevska
PA3671
Delay in diagnosis of COPD leading to poor prognosis of disease Imen Bachouch (Ariana, Tunisia), Imen Bachouch, Rana Fessi, Fatma Chermiti, Sofia Taktak, Amel Chtourou, Souraya Fenniche
PA3672
Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Olga Shtepa (Dnipropetrovsk, Ukraine), Olga Shtepa, Tetyana Pertseva, Tetyana Kireyeva
PA3673
Effectiveness of vaccination of patients with combination of COPD and coronary heart disease (CHD) Galina Ignatova (Chelyabinsk, Chelyabinsk Oblast, Russian Federation), Galina Ignatova, Vladimir Antonov, Olga Rodionova
PA3674
Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD Kateryna Gashynova (Dniepropetrovsk, Ukraine), Kateryna Gashynova, Kateryna Bogatska
Hall 14-02
Session 399
12:50 - 14:40
Thematic Poster: Acute and chronic lung diseases: good clinical practice Chairs : Dario Olivieri (Parma, Italy), Maurizio Marvisi (Cremona, Italy), Philippe Camus (Dijon, France), Laureano Molins Lopez-Rodo (Barcelona, Spain) PA3675
A case of recurrent pneumonia due to Arnold Chiari malformation Ezgi Demirdö en Çetino lu (BURSA, Turkey), Ezgi Demirdogen Cetinoglu, özge Aydin Guclu, Asli Gorek Dilektasli, Ahmet Ursavas, Mehmet Karadag
PA3676
Delayed Birt-Hogg-Dube syndrome diagnosis in the absence of telltale skin lesions Rolf Wolters (Houten, Netherlands), Rolf Wolters, Joost Van Gorp, Floris Sanders, Cees Perre, Gijs Limonard
PA3677
Transudative chylothorax in a patient with pulmonary hypertension Sedat Kuleci (Adana, Turkey), Sedat Kuleci, Oya Baydar, Efraim Güzel, Ismail Hanta
PA3678
An atypical presentation of granulomatosis with polyangiitis (GPA) with pituitary involvement Badar Ganaie (Walsall, United Kingdom), Muhammad Badar Ganaie, Ajit Thomas
PA3679
Phrenic nerve palsy secondary to Parsonage-Turner syndrome: A case series Tom McEnery (Dublin, Ireland), Thomas McEnery, Aisling McGowan, John Faul, Conor Burke, Ronan Walsh, Liam Cormican
PA3680
Validation of SleepMinder as non-contact device for sleep-disordered breathing and periodic limb movement Gerhard Weinreich (Essen, Germany), Gerhard Weinreich, Sarah Terjung, Yi Wang, Stefanie Werther, Alberto Zaffaroni, Helmut Teschler
PA3681
Hypoxic? Don’t "pop" to the shops Rob Hallifax (Oxford, United Kingdom), Rob Hallifax, Tina O’Hara, Amulya Misra
PA3682
Intrathoracic mass as an initial presentation of follicular carcinoma of thyroid: A rare entity Ashwini Mishra (Lucknow, India), Ashwini Mishra, Surya Kant, Anand Srivastava, Ajay Verma, Nuzhat Hussain, Rahul Kumar, Karthik Nagaraju
236
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3683
Granulomatous lymphadenitis: Experience of a portuguese oncologic institute Madalena Sofia Antunes Reis (Paúl-Covilhã, Portugal), Madalena Reis, Paulo Mota, Jorge Dionísio, José Duro da Costa
PA3684
Association of pulmonary and cardiac manifestations in patients with primary antiphospholipid syndrome: A review of the Serbian national cohort study Milica Kontic (Belgrade, Republic of Serbia), Milica Kontic, Ljudmila Stojanovich, Aleksandra Djokovic
PA3685
Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis Tasnime Issoufaly (Paris, France), Tasnime Issoufaly, Raphaël Lhote, Louis-Jean Couderc, Leila Zemoura, Colas Tcherakian
PA3686
Pulmonary manifestations in patients with IgG4-related disease at a tertiary care institute Lancelot Pinto (Mumbai, India), Radhika Banka, G.C. Yathish, C. Balakrishnan, Rohini Samant, Lancelot Pinto
PA3687
Vitamin D concentration and patient reported outcomes in sarcoidosis Branislav Gvozdenovic (Belgrade, Republic of Serbia), Branislav S. Gvozdenovic, Violeta Vucinic, Mira Vukovic, Mihailo Stjepanovic
PA3688
A case of Ehlers-Danlos syndrome with hemoptysis Yasemin Ates (Istanbul, Turkey), Yasemin Ates, Zuleyha Bingol, Turhan Ece
PA3689
Red cell distribution width (RDW) as a biomarker of disease severity in ILD patients Rahul Katyal (Chandigarh, India), Rahul Katyal, Ashok Janmeja, Vivek Ku
PA3690
Cardiac sarcoidosis detected by magnetic resonance imaging – Preliminary report of prospective study Magdalena Martusewicz-Boros (Warsaw, Poland), M. Martusewicz-Boros, E. Wiatr, D. Piotrowska-Kownacka, J. Fijolek, D. Gawryluk, J. Grudny, K. Modrzewska, U. Nowicka, M. Polaczek, E. Radzikowska, J. Szopinski, J. Winek, J. Zaleska, J. Zych, K. Roszkowski-Sliz
PA3691
Are there any predictors of MTX response in progressive pulmonary sarcoidosis? Anna Goljan Geremek (Warsaw, Poland), Anna Goljan Geremek, Michal Bednarek, Urszula Demkow, Elzbieta Puscinska, Adam Nowinski, Dorota Gorecka
PA3692
Sarcoidosis: Changed phenotype and worsening of the course by overtime Metin Basaranoglu (Istanbul, Turkey), Sevtap Sipahi, Metin Basaranoglu, Mert Bal, Tuncer Karayel
PA3693
Chemical injury: Reality or myth? mehrnaz mozaffarian (Tehran, Islamic Republic of Iran), Mehrnaz Mozaffarian, Ali Panahi, Majid Malekmohammad, Hamidreza Jamaati
PA3694
Takayasu arteritis with endobronchial involvement Dildar Duman (istanbul, Turkey), Meltem çoban Agca, Dildar Duman, Fatma Merve Tepetam, Fatma Tokgöz, Ayçim Sen, Hakan Günen, Tülay Yarkin
Hall 14-03
Session 400
12:50 - 14:40
Thematic Poster: Latest insights into chronic care Chairs : Claudio Ferdinando Donner (Borgomanero, Italy), Heleen Demeyer (Halle, Belgium), Chris Burtin (Diepenbeek, Belgium), William Man (Harefield, United Kingdom) PA3695
IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK Nazia Chaudhuri (Sheffield, United Kingdom), Annette Duck, Lucy Pigram, Deeba Ahmed, Nazia Chaudhuri
PA3696
Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation Dionne Smid (Horn, Netherlands), Dionne Smid, Frits Franssen, Sarah Wilke, Jean Muris, Gernot Rohde, Paul Jones, Emiel Wouters, Martijn Spruit
PA3697
Tracheostomized (TCS) patients: Is it possible to manage noninvasively tracheobronchial secretions? Francesco D'Abrosca (Veruno, Italy), Francesco D’Abrosca, Ilaria Prince, Stefano Belli, Claudia Carai, Michela Moroso, Davide Vallese, Elisa Spada, Sergio Zaccaria, Bruno Balbi
PA3698
Benefits of a reservoir nasal cannula (Oxymizer®) vs. a conventional nasal cannula during exercise in hypoxemic patients with pulmonary fibrosis Inga Heinzelmann (Schonau am Konigssee, Germany), Inga Heinzelmann, Rainer Gloeckl, Laura Wiegand, Max Matthaei, Klaus Kenn
PA3699
Improving Advance Care Planning in a respiratory inpatient setting using the SPICT tool Thomas Charlton (Brighton, United Kingdom), Thomas Charlton, Sarah Khosravi, Stephen Bass, Louise Mason, Katharine Hurt
237
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3700
Determination of lesion specific reference equations for respiratory function in individuals with spinal cord injury Anja Raab (Luzern, Switzerland), Anja M. Raab, Sonja De Groot, Marcel W.M. Post, David J. Berlowitz, Jacinthe Adriaansen, Franz Michel, Maria T.E. Hopman, Gabi Müller
PA3701
Pulmonary function and respiratory muscular strength in end-stage renal disease patients under hemodialysis Aline Danaga (Avaré, Brazil), Aline Danaga, Israel Santos, Caroline Gonçalves, Jéssica Tomei, Luis Vicente Oliveira
PA3702
Clinical trial of ghrelin for weight loosing patients with chronic respiratory failure Nobuhiro Matsumoto (Miyazaki, Japan), Nobuhiro Matsumoto, Keisuke Miki, Hironobu Tsubouchi, Akihiro Sakamoto, Yasuji Arimura, Shigehisa Yanagi, Hirotoshi Iiboshi, Makoto Yoshida, Ryosuke Souma, Hiroshi Ishimoto, Yoshifumi Yamamoto, Kazuhiro Yatera, Masanori Yoshikawa, Hironori Sagara, Tomoaki Iwanaga, Hiroshi Mukae, Ryoji Maekura, Hiroshi Kimura, Masamitsu Nakazato, Kenji Kangawa
PA3703
The feasibility, efficacy and safety of a multidisciplinary care pathway for in-patient treatment of acute exacerbation of bronchiectasis Lim Ki Hui (Singapore, Singapore), Lim Ki Hui, Jonathen Venkatachalam, Ruth Chang Rui Ying, Kuan Sen Tee, John Abisheganaden, Albert Lim Yick Hou
PA3704
Evaluation of water immersion level on respiratory function of tetraplegic patients undergoing hydrotherapy Helène Prigent (Garches, France), Leire Santisteban, Caroline Hugeron, Michele Lejaille, Isabelle Vaugier, Florian Kunst, Line Falaize, Frederic Lofaso, Helene Prigent
PA3705
A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations IRENE CASELLES GONZALEZ (orihuela, Spain), Irene Caselles Gonzalez, Rubén Andújar Espinosa, Chushao Hu, Beatriz Galvez Martínez, Carlos Federico álvarez Miranda, Olga Meca Birlanga, Miguel Reyes Cotes, Andrés Carrillo Alcaraz, Juan Miguel Sánchez Nieto
PA3706
Experiences and quality of life (QOL) after admission to an intensive care unit (ICU) due to an acute exacerbation in chronic obstructive pulmonary disease (COPD) Wendy van Beurden (Enschede, Netherlands), Marloes Mijnster, Wanda Hagmolen of ten Have, Marcel Pieterse, Christina Bode, Wendy Van Beurden
PA3707
Investigation of sarcopenia in Japanese COPD patients SHINTARO SUZUKI (Tokyo, Japan), Shintaro Suzuki, Hironori Sagara
PA3708
Applying positive pressure in airway in two moments: Post-anesthetic recovery and 1st postoperative day Eli Maria Pazzianotto-Forti (Capivari, Brazil), Eli Maria Pazzianotto-Forti, Patrícia Brigatto, Letícia Baltieri, Carolina Moraes, Maura Rocha, Irineu Rasera-Júnior
PA3709
Neutrophilia is associated with the persistent parenchymal changes after acute lung injury Yangjin Jegal (Ulsan, Republic of Korea), Yangjin Jegal, Kwang Won Seo, Seung Won Ra, Taehoon Lee, Jong-Joon Ahn
PA3710
Pulmonary rehabilitation program survey in Japan in 2014 Soh Imamura (Narasino-shi, Japan), Soh Imamura, Hikaru Ashida, Hiroshi Matsuo, Mariko Takeuchi, Akari Miyano, Teppei Shiono, Katsuya Onitsuka, Naohiro Usuki, Izumi Komaba, Hideki Katsura
PA3711
Minimal equipment for aerobic training in COPD: A systematic review Jennifer Alison (Killara NSW, Australia), Jennifer Alison, Sonia Cheng, Zoe McKeough
PA3712
Comparison among different instruments to evaluate the clinical control in asthmatic patients submitted to aerobic training Ronaldo Aparecido da Silva (Sao Paulo, Brazil), Ronaldo Aparecido da Silva, Patrícia Duarte De Freitas, Patrícia Gonçalves Leite Rocco, Milene Saccomani, Aline Grandi, Karen Brandão Evaristo, Andrezza Franaç-Pinto, Felipe Augusto Rodrigues Mendes, Palmira Galnush Ferreira, Alberto Cukier, Rafael Stelmach, Milton Arruda Martins, Celso Ricardo Fernandes De Carvalho
PA3713
Baseline determinants of 1-minute sit-to-stand test performance in COPD patients Sarah Crook (Zurich, Switzerland), Sarah Crook, Anja Frei, Tsung Yu, Gerben Ter Riet, Milo Puhan
PA3714
Predictors of dropout from a supervised pulmonary rehabilitation programme Naoyuki Yoshida (Kiyose-shi, Tokyo, Japan), Naoyuki Yoshida, Takashi Yoshiyama, Satoshi Takao, Kazumasa Yamane, Daisuke Tamon, Natsuki Hoshino, Juri Fukuda, Yoko Kuwahara, Etsuko Asai, Hajime Goto
Hall 14-04
Session 401
12:50 - 14:40
Thematic Poster: Latest insights into the management of chronic respiratory diseases Chairs : Jean Bourbeau (Montreal, Canada), Carolyn Rochester (New Haven, United States of America), Eleni Kortianou (Athens, Alimos, Greece), Isabelle Vivodtzev (Echirolles, France)
238
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3715
Decannulation of tracheostomized patients Daniela Alves (Castelo Branco, Portugal), Daniela Alves, Inês Faria, Carvalheira Santos, Rosa Silva, Cristina Bárbara
PA3716
Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus Larisa Litskevich (Minsk, Belarus), Litskevich Larysa, Skrahin Alexandr, Hurevich Henadz, Novicova Maria, Shpakovskaya Natalia
PA3717
Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report Piotr Janowiak (Gda sk, Poland), Piotr Janowiak, Iwona Damps-Konstanska, Malgorzata Krajnik, Zygmunt Podolec, Ewa Jassem
PA3718
Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Laura Caram (Conchas, São Paulo, Brazil), Laura Caram, Letícia Coneglian, Renata Ferrari, Marcia Faganello, Liana Coelho, Suzana Tanni, Irma Godoy
PA3719
Olfactory stimulation of TRPM8 agonist lessen the perception of dyspnea induced by constant load exercise in neversmokers Masashi Kanezaki (himeji, Japan), Masashi Kanezaki
PA3720
SPACE for COPD: Experiences of using a web based rehabilitation programme Stacey Hewitt (Leicester, United Kingdom), Stacey Hewitt, Emma Chaplin, Christopher Brough, Sally Boyce, Nicky Hudson, Sally Singh, Lindsay Apps
PA3721
Evidence of benefit from home tele-rehabilitation on chronic dyspnea and quality of life in patients with COPD Maroula Vasilopoulou (Athens, Thrakomakedones, Greece), Maroula Vasilopoulou, Andriana I. Papaioannou, Georgios Kaltsakas, Sofianna A. Gennimata, Anastasios F. Palamidas, Chrysoula Feridou, Nikolaos Chynkiamis, Theodora Vasilogiannakopoulou, Stavroula Spetsioti, Zafeiris Louvaris, Otilia Kocsis, Stylianos Pantelopoulos, Nikolaos G. Koulouris, Ioannis Vogiatzis
PA3722
Exercise perspectives & rehabilitation: Challenges in severe asthma Lindsay Apps (Leicester, United Kingdom), Lindsay Apps, Stacey Hewitt, Ruth Green, Peter Bradding, Anna Murphy, Neil Martin, Sally Singh, Nicky Hudson, Rachael Evans
PA3723
Do anxiety and depression affect different outcomes of pulmonary rehabilitation? Latinka Basara (Zagreb, Croatia), Latinka Basara, Tajana Jalušic Gluncic, Olivera Maletic, Dubravka Pelicaric, Sanja Popovic Grle, Marko Jakopovic, Miroslav Samaržija
PA3724
The effect of an outpatient pulmonary rehabilitation program on exercise tolerance and asthma control in obese asthma patients Yasemin Turk (Rotterdam, Netherlands), Y. Türk, A. Van Huisstede, F.M.E Franssen, P.S. Hiemstra, A. Rudolphus, C. Taube, G.J. Braunstahl
PA3725
Psychological comorbidities in patients with COPD: Which changes can be observed after 3, 6, 9 and 12 months of an inpatient pulmonary rehabilitation (PR)? Birgit Schwaighofer (Bad Reichenhall, Germany), Birgit Schwaighofer, Danijel Jelusic, Michael Wittmann, Michael Schuler, Konrad Schultz
PA3726
Impact of comorbidities on outcome of pulmonary rehabilitation in patients with COPD Nashwa Abdel Wahab (Alexandria, Egypt), Maged Fayed, Sahar Murad, Nashwa Abdel Wahab, Rasha Daabis, Gihan Younis
PA3727
Social role of children and adolescents with chronic respiratory disease, phenomenological analysis Maria Gomez (Bogotá, Colombia), Maria Victoria Gomez Marentes, Samanta Cruz, Angie Velasquez, Doris Valencia, Maria Ines Mantilla Pastrana
PA3728
Technology depended children with chronic respiratory problems. Do they benefit from home care? Fotios Kirvassilis (Oraiokastro, Greece), Fotios Kirvassilis, Elianna Chrysochou, Elpis Hatziagorou, John Tsanakass
PA3729
Exercise training added to usual care in pulmonary hypertension: A systematic review Carlos Andrès Celis Preciado (Bogota, Cundinamarca, Colombia), Carlos Celis, Milena García, Claudio Villaquirán
PA3730
Measurement of vital capacity in amyotrophic lateral sclerosis – Forced and slowly performed Tiina Andersen (Bergen, Norway), Tiina Andersen, Astrid Sandnes, Maria Vollsæter, Thomas Halvorsen, Ove Fondenes, Ola Røksund
PA3731
Admission pattern, referral rate and scope of physiotherapy services in a Nigerian intensive care unit Ayodele Akinremi (Ibadan, Nigeria), Ayodele Akinremi, Kayinsola Akinkuade
239
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3732
Preoperative screening with respiratory failure risk index reduces postoperative pulmonary complications in esophagectomy patients Satoshi Hokari (Niigata City, Japan), Satoshi Hokari, Yasuyoshi Ohshima, Kenjiro Shima, Rika Moriya, Toshiyuki Koya, Hiroshi Kagamu, Hiroki Tsukada, Toshinori Takada, Toshiaki Kikuchi
PA3733
Quality of life in the PLATINO study 6 to 9 years later Cristiane Pradella (São Paulo, Brazil), Cristiane O. Pradella, Mariana R. Gazzotti, Graciane L. Moreira, Beatriz M. Manzano, Maria Montes de Oca, Maria V. Lopes, Ana Maria B. Menezes, Adriana Muiño, Carmen Lisboa, Gonzalo Valdivia, Rogelio Perez-Padilla, Oliver A. Nascimento, José R. Jardim
PA3734
Multimodal therapeutic program during hospitalization in obese COPD patients Irene TORRES SANCHEZ (Santa Fe (Granada), Spain), Irene Torres-Sánchez, Irene Cabrera-Martos, Juan José CruzRueda, Isabel López-Torres, Jeanette Rodríguez-Torres, Marie Carmen Valenza
Hall 14-05
Session 402
12:50 - 14:40
Thematic Poster: A more functional view of chest pathology Chairs : Firdaus Mohamed Hoesein (Utrecht, Netherlands), Aleksandar Grgic (Homburg/Saar, Germany), Jan De Backer (Kontich, Belgium), Heinrike Wilkens (Homburg/Saar, Germany)
PA3735
LATE-BREAKING ABSTRACT: Tomoscintigraphic comparison of lung deposition with a vibrating-mesh and a jet nebulizer Jonathan Dugernier (Brussels, Belgium), Jonathan Dugernier, Gregory Reychler, Virginie Depoortere, Jean Roeseler, JeanBernard Michotte, Pierre-Francois Laterre, Francois Jamar, Michel Hesse
PA3736
LATE-BREAKING ABSTRACT: A new, easy to use computed tomography based scoring system for sinus disease in cystic fibrosis: Validated with acceptable inter- and intra-rater reliability Shahid Sheikh (Columbus, United States of America), Shahid Sheikh, Brian Handly, Nancy Ryan-Wenger, Steve Kirkby, Chandar Ramanathan, Karen McCoy, Don Hayes, Jr., Meredith Lind
PA3737
LATE-BREAKING ABSTRACT: Comparative studies on bronchuswall-thickness by histologic and computed tomographic measurements of porcine lungs Christoph Brochhausen (Mainz, Germany), Christoph Brochhausen, Christine Schmitt, Volker H. Schmitt, David Hollemann, Oliver Weinheimer, Andreas Mamilos, Hinrich B. Winther, Amelie Amelie Elsäßer, C. James Kirkpatrick
PA3738
LATE-BREAKING ABSTRACT: The relationship between crackle characteristics and regional ventilation/perfusion ratio measured by SPECT/CT Surussawadi Bennett (Khon Kaen, Thailand), Surussawadi Bennett, Michael Bennett, Tom Havelock, Anna Barney, Peter Howarth, Anne Bruton
PA3739
Coronary artery calcification, epicardial fat burden, and cardiovascular events in COPD Thomas Gaisl (Zurich, Switzerland), Thomas Gaisl, Christian Schlatzer, Esther Schwarz, Mathias Possner, Julia Stehli, Noriane Sievi, Christian Clarenbach, Damini Dey, Piotr Piotr, Philipp Kaufmann, Malcolm Kohler
PA3740
The right ventricular sizes, function and quality of life in patients with very severe COPD Vasiliy Pyankov (Kirov, Russian Federation), Vasily Pyankov, Yulia Chuyasova
PA3741
Lung structure and function relation in systemic sclerosis: Application of lung densitometry Maarten K. Ninaber (Leiden, Netherlands), Maarten Ninaber, Jan Stolk, Jasper Smit, Els Bakker, Berend Stoel
PA3742
Pulmonary artery diameter but not diameter ratio is indicative of pulmonary hypertension in systemic sclerosis M. Els Bakker (Leiden, Netherlands), Els Bakker, Maarten Ninaber, Jan Stolk, Lucia Kroft, Anne Schouffoer, Berend Stoel
PA3743
Pulmonary artery dilation and increased lung density in systemic sclerosis M. Els Bakker (Leiden, Netherlands), Els Bakker, Maarten Ninaber, Jan Stolk, Lucia Kroft, Anne Schouffoer, Berend Stoel
PA3744
Dynamic CT in diagnostics of tracheomalacia Ondrej Kudela (Trutnov, Czech Republic), Ondrej Kudela, Eva Kocova, Vratislav Sedlak, Vladimir Koblizek, Barbora Novotna, Martin Balzek
PA3745
Characteristics and outcomes of patients who undergo multiple computer tomographic pulmonary angiograms (CTPAs) for suspected pulmonary embolism (PE) Abigail Sharpe (Middlesbrough, United Kingdom), Abigail Sharpe, Richard Hartley, George Antunes
PA3746
Evaluation of acute pulmonary embolism by sixty-four slice multidetector CT angiography: Correlation between obstruction index, right ventricular dysfunction and clinical presentation Ali Abdelazeem Hasan (Assiut, Egypt), Noha Attia, Gehan Seifeldein, Ali Hasan, Abdelkarim Hasan
240
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3747
Ratio of pulmonary arterial to aortic diameter and right to left ventricular diameter associate with poor outcome in medically-treated chronic thromboembolic pulmonary hypertension ryogo ema (Chiba, Japan), Ryogo Ema, Toshihiko Sugiura, Naoko Kawata, Rintaro Nishimura, Takayuki Jujo, Ayako Shigeta, Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi
PA3748
Longitudinal micro-CT of preclinical models of lung disease provides biomarkers of disease and therapy that reveal compensatory changes in lung volume Greetje Vande Velde (Leuven, Belgium), Greetje Vande Velde, Jennifer Poelmans, Ellen De Langhe, Amy Hillen, Jeroen Vanoirbeek, Uwe Himmelreich, Rik Lories
PA3749
Tricuspid deceleration time predicts right atrial pressure in patients with suspected pulmonary hypertension: Preliminary experience with cardiac magnetic resonance imaging Andy Swift (Sheffield, United Kingdom), Megan Johnson, William Hunt, Hammerton Charlotte, Dave Capener, Elliot Charlie, Condliffe Robin, Kiely David, Wild Jim, Swift Andrew
PA3750
Progressive TLC loss after unilateral lung transplantation in IPF: Functional respiratory imaging differentiates between transplanted and native lung Francisca Ferreira (Kontich, Belgium), Francisca Ferreira, Veronique Verplancke, Wim Vos, Cedric Van Holsbeke, Jan De Backer, Wilfried De Backer, Peter Van Hal 99m
PA3751
Tc isonitrils scintigraphic study of pulmonary TB evolution Stefan Bilha (Suceava, Romania), Stefan Bilha, Neli Claudia Bilha, Irena Cristina Grierosu, Cipriana Stefanescu
PA3752
Multi nuclear 3D multiple breath washout imaging with hyperpolarised 3He and 129Xe MRI Felix Horn (Sheffield, United Kingdom), Felix Horn, Madhwesha Rao, Neil Stewart, Helen Marshall, Juan Parra-Robles, Jim Wild
PA3753
Lobar variation of emphysema impacts lung function Kristoffer Ostridge (Bournemouth, United Kingdom), Kristoffer Ostridge, Nicholas Williams, Victoria Kim, Malwina Wojtas, Michael Bennett, Stephen Harden, Emmanuel Aris, Mathieu Peeters, Jeanne-Marie Devaster, Simon Bourne, Tom Wilkinson
PA3754
Bone density is associated with emphysema and air trapping on CT in smokers Esther Pompe (Utrecht, Netherlands), Esther Pompe, Pim De Jong, Eva Van Rikxoort, Leticia Gallardo Estrella, Werner De Jong, Rozemarijn Vliegenthart, Matthijs Oudkerk, Carlijn Van der Aalst, Bram Van Ginneken, Jan-Willem Lammers, Firdaus Mohamed Hoesein
Hall 14-06
Session 403
12:50 - 14:40
Thematic Poster: Pulmonary hypertension in lung disease Chairs : Luke Howard (London, United Kingdom), Shiro Mizuno (Ishikawa, Japan), Gabor Kovacs (Graz, Austria), Joan Albert Barbera (Barcelona, Spain) PA3755
Prediction of pulmonary hypertension using chest-computed tomography in patients with pulmonary sarcoidosis Marloes Huitema (Utrecht, Netherlands), Marloes Huitema, Spee Marcela, Boerman Sanne, Veerle Vorselaars, Snijder Repke, Hendrik Van Es, Jan Grutters, Martijn Post
PA3756
Right and left ventricular function in lowlanders with COPD travelling to moderate altitude Silvia Ulrich (Zurich, Switzerland), Mona Lichtblau, Tsogyal Latshang, Michael Furian, Séverine Müller-Mottet, Silke Kueest, Deobrah Flueck, Batyr Osmonov, Malcolm Kohler, Felix Tanner, Ekkehard Gruenig, Konrad E. Bloch, Silvia Ulrich
PA3757
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea Pierluigi Carratù (Bari, Italy), Pierluigi Carratù, Valentina Ventura, Mauro Maniscalco, Silvano Dragonieri, Simona Berardi, Roberto Ria, Vitaliano Quaranta, Angelo Vacca, Marco Ciccone, Barbara Phillips, Onofrio Resta
PA3758
Hepatopulmonary syndrome in non-cirrhotic patients with chronic viral hepatitis mahmoud elhabashy (minofeyia, Egypt), Mahmoud Elhabashy, Ahmed Khamis, Waleed Shehab, Mohamed Shaban, Abdallah Essa, Mahmoud Kamel
PA3759
A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism Tatiana Shuginova (st.petersburg, Russian Federation), Natalia Shaporova, Tatiana Shuginova, Vera Chernobrivtseva
PA3760
Risk of malignant arrhythmia in highlanders with high altitude pulmonary hypertension during wakefulness and sleep Sayaka Stefanie Aeschbacher (Zurich, Switzerland), Sayaka S. Aeschbacher, Michael Furian, Tsogyal D. Latshang, Silvia Ulrich, Talant Sooronbaev, Erkin Mirrakhimov, Almaz Aldashev, Konrad E. Bloch
241
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3761
Time course of pulmonary artery pressure and clinical characteristics in Kyrgyz highlanders Talantbek Sooronbaev (Bishkek, Kyrgyzstan), Talant Sooronbaev, Batyr Osmonov, Michael Furian, Sayaka S. Aeschbacher, Tsogyal D. Latshang, Silvia Ulrich, Almaz Aldashev, Konrad E. Bloch
PA3762
Evolution of pulmonary blood volume under anticoagulant therapy after a first symptomatic pulmonary embolism Laurent Bertoletti (St Priest En Jarez, France), Laurent Bertoletti, Nathalie Prevot, Sandrine Accassat, Céline Chapelle, Nathalie Glas, Stéphanie Chomette-Ballereau, Frédéric Costes
PA3763
The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension Sergey Avdeev (Moscow, Russian Federation), Sergey Avdeev, Viliya Gaynitdinova
PA3764
Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension? Herve Guenard (Bordeaux, France), Hervé Guénard, Claire Dromer, Delphine Bourlier, Christian Kays
PA3765
Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Laura Price (London, United Kingdom), Laura Price, Aleksander Kempny, Kostantinos Dimopoulos, Raphael Alonso, Lisa Parfitt, Carl Harries, Martin Carby, Andre Simon, Athol Wells, John Wort, Anna Reed
PA3766
Long-term improvement of pulmonary haemodynamics and exercise capacity in patients with pulmonary hypertension and hypoventilation following NIPPV and influence of NIPPV adherence Matthias Held (Wurzburg, Germany), Matthias Held, Katharina Schuh, Sabine Karl, Johanna Walthelm, Stefan Baron, Christine Roth, Berthold Jany
PA3767
Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Junichi Nakamura (sapporo-shi Hokkaido, Japan), Junichi Nakamura, Ichizo Tsuzino, Takahiro Sato, Hiroshi Ohira, Satoshi Itaya, Chisa Takashina-Goto, Taku Watanabe, Masaru Suzuki, Satoshi Konno, Masaharu Nishimura
PA3768
Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases Ekaterina Nikolaeva (Moscow, Russian Federation), Ekaterina Nikolaeva, Ildar Kurmukov, Natalia Yudkina, Alexander Volkov
PA3769
Endotelialny dysfunction at patients with COPD and coronary heart disease Irina Demko (Krasnoyarsk, Krasnoyarsk Krai, Russian Federation), Irina Demko, Angelina Kraposhina, Irina Soloveva, Marina Mamaeva, Natalia Gordeeva, Elena Sobko, Alla Salmina
PA3770
Rating predominance of pulmonary hypertension, lung hyperinflation and left ventricular dysfunction in patients with moderate and severe COPD in Belarus Larisa Litskevich (Minsk, Belarus), Larysa Litskevich, Alena Skrahina, Irina Dovnar, Irina Lantuchova, Galina Novskaya
PA3771
Structural alterations and endothelial activation in pulmonary and bronchial vessels of asthmatics Thais Mauad (Sao Paulo, Brazil), Thais Mauad, Renata Calciolari Rossi e Silva, Raquel Annoni, Diogenes Seraphin Ferreira, Luiz Feranado Ferraz da Silva
PA3772
D-dimer testing in patients with acute exacerbation of COPD and suspected pulmonary embolism Charalampos Moschos (Athens, Greece), Christos F. Kampolis, Charalampos Moschos, Angeliki A. Loukeri, PanagiotisDimitrios Spithakis, Eustratios Stratos, Dimosthenis Papapetrou, Alexia Alexikou, Aikaterini Tzagkaraki, Prokopis Kythreotis, Dimitrios Veldekis
PA3773
Educating cardiologists on COPD management to improve CVD outcomes Mohit Bhutani (Edmonton, Canada), Mohit Bhutani, Jafna Cox
Hall 14-07
Session 404
12:50 - 14:40
Thematic Poster: Pulmonary hypertension: management Chairs : Horst Olschewski (Graz, Austria), Robin Condliffe (Sheffield, United Kingdom), Paul Corris (Newcastle-upon-Tyne, United Kingdom), Olivier Sitbon (Le Kremlin Bicêtre, France) PA3774
Predicting survival in hospitalized pulmonary hypertension patients Nathaniel Steiger (Chicago, United States of America), Nathaniel Steiger, Vasiliki Thomeas, Mardi Gomberg-Maitland
PA3775
Initial dual oral combination therapy for pulmonary arterial hypertension (PAH) in daily practice Caroline SATTLER (Le Kremlin-Bicetre, France), Caroline Sattler, Bourlier Delphine, Laurent Bertoletti, Laurent Savale, Caroline O’Connell, Xavier Jaïs, David Montani, Marc Humbert, Gérald Simonneau, Olivier Sitbon
PA3776
Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity Beatriz Gsrcia Aranda (London, United Kingdom), Beatriz Garcia-Aranda, Aleksander Kempny, Marina Revilla-Martinez, Carl Harries, Lisa Parfitt, Rafael Alonso-Gonzalez, Laura Price, Konstatinos Dimopoulos, John Wort
242
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3777
Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH) George Calcaianu (Bucharest, Romania), George Calcaianu, Ari Chaouat, Matthieu Canuet, Romain Kessler
PA3778
Prognostic value of predicted 6MWD in PAH Rogério De Souza (Sao Paulo, Brazil), Francisca Gavilanes, Jose Leonidas Alves-Jr, Luis Felipe Prada, Caio Fernandes, Patricia Vitorio, Luciana Morinaga, Susana Hoette, Carlos Jardim, Rogerio Souza
PA3779
Patient perspectives on exercise training in pulmonary arterial hypertension (PAH) Alison MacKenzie (Glasgow, United Kingdom), Alison MacKenzie, Martin Johnson
PA3780
Cardiopulmonary comorbidities are associated with hemodynamics in pulmonary arterial hypertension Philipp Douschan (Graz, Austria), Philipp Douschan, Kovacs Gabor, Vasile Foris, Andrea Olschewski, Horst Olschewski
PA3781
Transitioning sildenafil to taladafil in PAH patients is safe Fabienne Goncalves (Oporto, Portugal), Fabienne Gonçalves, Ana Gomes, Célia Cruz, Inês Furtado, Margarida Vicente, Luísa Carvalho, Mário Santos, Abílio Reis
PA3782
Accuracy of impedance cardiography to measure cardiac output at rest in pulmonary hypertension Elise Noel-Savina (cugnaux, France), Elise Noel-Savina, Laurent Tetu, Grégoire Prévot, Marion Dupuis, Fabien Pillard, Daniel Rivière, Alain Didier
PA3783
Lack correlation between FVC/DLC index and pulmonary hypertension in non sclerodermic patients Donato Lacedonia (Molfetta, Italy), Donato Lacedonia, Michele Correale, Giovanna Elisiana Carpagnano, Giuseppe Antonio Palmiotti, Maria M. Lo Storto, Piergiuseppe Bonfitto, Matteo Di Biase, Maria Pia Foschino Barbaro
PA3784
PAAT and RVET versus RVSP to predict pulmonary hypertension Alex Balekian (Bandol, France), Vivian Mo, Brian Bellucci, Joshua Fisher, Alex Balekian
PA3785
Prognostic value of systolic pulmonary artery pressure change at exercise in pulmonary arterial hypertension Faure Morgane (Saint-Priest, France), Morgane Faure, Ari Chaouat, Emmanuel Gomez, Magalie Mercy, Anne Guillaumot, François Chabot
PA3786
Adherence to pulmonary arterial hypertension targeted therapies Duncan Grady (Cambridge, United Kingdom), Duncan Grady, Marjorie Weiss, Joanna Pepke-Zaba
PA3787
Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension Karen Olsson (Hannover, Germany), Karen M. Olsson, Anika K. Frank, Marius M. Hoeper, Tobias Welte, Bitter Thomas
PA3788
Variation in mortality from pulmonary hypertension by aetiology Nesrin Mogulkoc ( ZM R, Turkey), Nesrin Mogulkoc, Tarik Simsek, Sanem Nalbantgil, Meral Kayikcioglu, Yasemin Kabasakal, Hakan Kultursay
PA3789
Rare case of extensive systemic to pulmonary arteriovenous malformation presenting with recurrent headaches shumail zargar (New Delhi, India), Shumail Bashir, Deepak Rosha
PA3790
Right heart catheterisation – for respiratory physicians? Shruthi Konda (London, United Kingdom), Shruthi Konda, Srividya Narayan, Praveen Molanguri, Brendan Madden
PA3791
Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients Neil Hamilton (sheffield, United Kingdom), Neil Hamilton, Michaela Sellars, Mark Graves, Iain Armstrong, Athanasios Charalampopolous, David Kiely, Charlie Elliot, Robin Condliffe
PA3792
Simple, non-invasive methods to assess severity of pulmonary hypertension Maria Simakova (St. Petersburg, Russian Federation), Maria Simakova, Aigun Kazimli, Anton Rygkov, Alexander Naimushin, Olga Moiseeva
Hall 14-08
Session 405
12:50 - 14:40
Thematic Poster: Connective tissue disorders Chairs : Carlo Albera (Turin, Italy), Spyridon Papiris (Athens, Greece), Claudia Valenzuela (Alcobendas (Madrid), Spain), Athol Wells (London, United Kingdom) PA3793
Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis Jin Woo Song (Seoul, Republic of Korea), Jin Woo Song, Joon Seon Song, Eun Jin Chae
PA3794
Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis Robert Vassallo (Rochester, United States of America), Lei Wang, Paula Walters, Asha Nair, Jin Jen, Andrew Limper, Eric Matteson, Diane Grill, Robert Vassallo
243
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3795
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Ana María López Vázquez (Valencia, Spain), Ana María López Vázquez, Beatriz Soria Navarro, Carles Fabregat Franco, Sherlyne Jaimes Díaz, Cristina Sabater Abad, Mercedes Ramón Capilla, Gustavo Juan Samper, Estrella FernandezFabrellas, Juana Rodriguez Delgado, Araceli Carbonell Moncho
PA3796
Radiologic pattern as a survival predictor in the rheumatoid artritis intersticial lung disease Alexa Nuñez (Barcelona, Spain), Alexa Nuñez, Iñigo Ojanguren, Xavier Muñoz, M.J. Cruz, Ferran Morell, Ana Villar
PA3797
Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Hanna Nurmi (Kuopio, Finland), Hanna Nurmi, Miia Kärkkäinen, Riitta Kaarteenaho, Minna Purokivi
PA3798
Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD? Maki Noyama (Kurashiki, Japan), Maki Noyama, Machiko Arita, Tadashi Ishida
PA3799
What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis! Daniel Antunes Silva Pereira (Sao Paulo, Brazil), Daniel Antunes Silva Pereira, Olivia Meira Dias, Mariana Sponholz Araujo, Leticia Kawano-Dourado, Carolina Salim Freitas, Alexandre De Melo Kawassaki, Bruno Gratziou, Carlos R.R. Carvalho, Ronaldo Adib Kairalla
PA3800
Interstitial lung disease in a single center inception cohort of early rheumatoid arthritis patients Charlotte Hyldgaard (Åbyhøj, Denmark), Charlotte Hyldgaard, Mette Axelsen, Frank Andersen, Trine Bay Laurberg, Jesper Blegvad, Torkell Ellingsen
PA3801
Predicting progression of RA-ILD using anti-CCP Paul Minnis (Bangor, United Kingdom), Paul Minnis, Karol Henry, Brigid Clark, Michael P. Keane
PA3802
Characterization of interstitial pneumonia associated with clinical amyopathic dermatomyositis mari yamasue (Yufu-city, Japan), Mari Yamasue, Masaru Ando, Ryo-ichi Ushijima, Jun-ichi Kadota
PA3803
Serum KL-6 as a biomarker to assess response to azathioprine in connective tissue disease associated lung disease (CTD-ILD) Eda Boerner (Haan, Germany), Eda B. Boerner, Thomas E. Wessendorf, Shinichiro Ohshimo, Ulrich Costabel, Francesco Bonella
PA3804
Recurrence predictive factors of cryptogenic organizing pneumonia Yoshihiko Taniguchi (Sakai city, Osaka, Japan), Yoshihiko Taniguchi, Chikatoshi Sugimoto, Toru Arai, Taisuke Tsuji, Kazunobu Tachibana, Masanori Akira, Masanori Kitaichi, Seiji Hayashi, Yoshikazu Inoue
PA3805
Gastro-oesophageal dismotility measurements in scleroderma-associated interstitial lung disease: Correlation with respiratory and reflux symptoms Angelo De Lauretis (Mantova, Italy), Angelo De Lauretis, Dina Visca, Simon Ward, Claudia Clayman, Charles Murray, Ong Voon, Christopher Denton, Gisela Lindahl, Carmel Stock, Alfredo Chetta, Marina Aiello, Veronica Alfieri, Michael Kreuter, Wim Wuyts, Toby Maher, Athol U. Wells, Elisabetta Renzoni
PA3806
Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe Joanna Wo niak (Bydgoszcz, Poland), Joanna Wozniak, Tomasz Wandtke, Piotr Kopinski, Joanna Chorostowska, Agata Gizycka, Cezary Rybacki, Iwona Patyk, Blazej Przybyslawski, Andrzej Redziak
PA3807
A multicenter evaluation of a new periostin detection kit for idiopathic pulmonary fibrosis Kenji Izuhara (Saga, Japan), Kenji Izuhara, Shoichiro Ohta, Masaki Okamoto, Noriho Sakamoto, Koichiro Takahashi, Hiroshi Yamamoto, Hisako Kushima, Keiichi Akasaka, Kiminori Fujimoto, Junya Ono
PA3808
Childhood interstitial lung disease: A diagnostic challenge Tu ba i manlar (Ankara, Turkey), Tugba Sismanlar, Ayse Aslan, Matthias Griese
PA3809
The RANKL-OPG balance in pulmonary fibrosis Barbro Melgert (Groningen, Netherlands), Carian Boorsma, Christina Draijer, Robbert Cool, Corry-Anke Brandsma, George Nossent, Peter Heukels, Bernt Van den Blink, David Brass, Wim Timens, Barbro Melgert
PA3810
Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD) Stan Ejiofor (Birmingham, United Kingdom), S.I Ejiofor, R.A. Stockley
PA3811
The ratio AGE/RAGE is increased in idiopathic pulmonary fibrosis Carlos Esteban Machahua Huamani (L'Hospitalet de Llobregat, Spain), Carlos Machahua, Ana Montes-Worboys, Roger Llatjós, Ignacio Escobar, Lurdes Planas, Jordi Dorca, Maria Molina-Molina, Vanesa Vicens-Zygmunt
Hall 14-09
Session 406
Thematic Poster: IIPs: orphan
244
12:50 - 14:40
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Chairs : George Margaritopoulos (Kavala, Greece), Aikaterini D. Samara (Athens, Greece), Carlo Vancheri (Catania, Italy), Wim Wuyts (Rotselaar, Belgium) PA3812
Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)? Ilaria Campo (Pavia, Italy), Ilaria Campo, Michele Zorzetto, Francesco Bonella, Francesca Mariani, Elena Paracchini, Simona Ferrari, Francesca Datturi, Federica Meloni, Maurizio Luisetti
PA3813
The large airway lesions of lymphangioleiomyomatosis: Pathological and radiological analysis Yuki Ko (Iizuka, Japan), Yuki Ko, Kazunori Tobino, Kuniaki Seyama, Toyohiro Hirai, Masatoshi Kurihara, Takeshi Johkoh, Noriyuki Tomiyama, Toshio Kumasaka, Kazuhisa Takahashi
PA3814
Serum angiotensin-converting enzyme activity in lymphangioleiomyomatosis Yoshikazu Inoue (Osaka, Japan), Yoshikazu Inoue, Masaki Hirose, Toru Arai, Chikatoshi Sugimoto, Akiko Matsumuro, Tomomi Homma, Yoshinobu Matsuda, Aya Hirooka, Naoko Takeuchi, Yumiko Sasaki, Kazunobu Tachibana, Seiji Hayashi, Masanori Akira, Masanori Kitaichi
PA3815
Pleuroparenchymal fibroelastosis (PPFE) – Resembling features in patients with malignancies Eva Baroke (Heidelberg, Germany), Eva Baroke, Claus Peter Heussel, Arne Warth, Ute Oltmanns, Karin Palmowski, Nicolas Kahn, Felix Herth, Michael Kreuter
PA3816
Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume? Elena Paracchini (Pavia, Italy), Francesca Mariani, Elena Paracchini, Ilaria Campo, Zamir Kadija, Carmine Tinelli, Maria Chiara Mennitti, Antonio Ciuffreda, Giuseppe Rodi, Maurizio Luisetti
PA3817
Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Oana Claudia Deleanu (Bucarest, Romania), Oana Claudia Deleanu, Ana-Maria Nebunoiu, Carolina Tarasova, Ruxandra Ulmeanu, Florin Dumitru Mihaltan
PA3818
Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Marina Yu. Kameneva (Saint Petersburg, Russian Federation), Marina Kameneva, Ivetta Dvorakovskaya, Artem Tishkov, Olga Baranova, Olga Yurieva, Vasiliy Trofimov
PA3819
Analysis of 9 adult patients with idiopathic pulmonary hemosiderosis Mehmet AYDO AN (Etlik - Ankara, Turkey), Seyfettin Gümüs, ömer Deniz, Mehmet Aydogan, Bülent Karaman, Fatih örs, Ergun Tozkoparan, Hayati Bilgiç
PA3820
The utilitiy of FENO for the diagnosis of hypersensitivity pneumonitis IÑIGO OJANGUREN ARRANZ (Barcelona, Spain), Iñigo Ojanguren, Xavier Muñoz, Ana Villar, Ferran Morell, María Jesus Cruz
PA3821
Specific IgG antibodies in chronic hypersensitivity pneumonitis Dirk Steffen Koschel (Radebeul, Germany), Jan Holfert, Bärbel Wiedemann, Gert Höffken, Dirk Koschel
PA3822
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Paolo Cameli (Certaldo, Italy), Paolo Cameli, Elena Bargagli, David Bennett, Rosa Metella Refini, Paola Rottoli
PA3823
Metabolic syndrome in interstitial lung diseases Aydanur Ekici (Kirikkale, Turkey), Aydanur Ekici, Emel Bulcun, Mehmet Ekici, Pinar Yildiz, Tulay Karakoc, Dilay Cimen
PA3824
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Su-Ying Low (Singapore, Singapore), Su-Ying Low
PA3825
The clinical significance of 24hr continuous monitoring of SpO2 during daily life in the patients with interstitial pneumonia Mitsuko Kondo (Tokyo, Japan), Mitsuko Kondo, Ken Arimura, Kiyoshi Takeyama, Etsuko Tagaya, Jun Tamaoki
PA3826
Variation in mortality from interstitial lung disease by diagnosis Nesrin Mogulkoc ( ZM R, Turkey), Nesrin Mogulkoc, Tarik Simsek, Imren Nesil, Yasemin Kabasakal, Selen Bayraktaroglu, Ali Veral, Aysegul Ergonul, Kutsal Turhan
PA3827
Sporadic idiopathic non-specific interstitial pneumonia in monozygotic twin sisters Marta CuyÁs Cortadellas (Essen, Germany), Marta Cuyás Cortadellas, Filiz Oezkan, Ulrich Costabel, Thomas Wessendorf, Dirk Theegarten, Kaid Darwiche, Francesco Bonella
PA3828
Prevalence of obstructive sleep apneas in patients with idiopathic interstitial pneumonia Gabriela Tabaj (capital federal, Argentina), Gabriela Tabaj, Daniela Visentini, Patricia Malamud, Cecilia Gonzalez Ginestet, Glenda Ernst, Gabriela Rando, Georgina Gramblicka, Eduardo Giugno
PA3829
Diagnostic value of transbronchial cryobiopsy compared to surgical lung biopsy Lars Hagmeyer (Haan, Germany), Lars Hagmeyer, Kerstin Richter, Marcel Treml, Christina Priegnitz, Winfried Randerath
245
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3830
Hypoxic challenge test applied to children previously diagnosed with hypersensitivity pneumonitis Yagmur Sisman (Copenhagen, Denmark), Yagmur Sisman, Frederik Buchvald, Anne Katrine Blyme, Birgitte Hanel, Jann Mortensen, Kim G. Nielsen
PA3831
Role of HGF in the healthy and injured lung Clemens Ruppert (Giessen, Germany), Clemens Ruppert, Ingrid Henneke, Martina Korfei, Werner Seeger, Andreas Günther
Hall 14-10
Session 407
12:50 - 14:40
Thematic Poster: Interstitial lung diseases II Chairs : Martina Vašáková (Prague, Czech Republic), Claudia Ravaglia (Castelbolognese, Italy), Nikolaos M. Siafakas (Heraklion, Crete, Greece), Luca Richeldi (Southampton, United Kingdom) PA3832
Low fruit intake and exercise are associated with COPD in the USA Tatsiana Beiko (Charleston, United States of America), Tatsiana Beiko, Suchit Kumbhare, Luca Paoletti, Charlie Strange
PA3833
An insight of lung cysts with filamin A mutation E.Nural Kiper (Ankara, Turkey), Nagehan Emiralioglu, Nural Kiper, Nicolaus Schwerk, Güzin Cinel, Ebru Yalçin, Deniz Dogru Ersöz, Ugur özçelik
PA3834
Clinical characteristics and outcomes of pleural empyema in Southern Tunisia Rahma Gargouri (Sfax, Tunisia), Nadia Moussa, Rahma Gargouri, Wajdi Ketata, Ghassen Trigui, Sameh Msaed, Ilhem Yangui, Sami Kammoun
PA3835
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease? Fatma Tokgöz Aky l (Istanbul, Turkey), Fatma Tokgöz Akyil, Tülin Sevim, Hakan Kiral, Emine Aksoy, Mustafa Vayvada, Mustafa Akyil, Dilem Anil Tokyay, Volkan Baysungur
PA3836
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA masakiyo yatomi (maebashi, Japan), Masakiyo Yatomi, Takeshi Hisada, Yasuhiko Koga, Akihiro Ono, Yosuke Kamide, Haruka Aoki, Tsurumaki Hiroaki, Kaori Seki, Noriaki Sunaga, Kyoichi Kaira, Tamotsu Ishizuka, Kunio Dobashi, Masanobu Yamada, Fumikazu Okajima
PA3837
Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Nikolas Manitsopoulos (Athens, Greece), Nikolaos Manitsopoulos, Anastasia Kotanidou, Christina Magkou, Ioanna Ninou, Xia Tian, Vassilis Aidinis, Ralph Schermuly, Stylianos Orfanos
PA3838
Role of Wnt-1, Wnt-3 and MMP-7 in fibrotic response in extrinsic allergic alveolitis and idiopathic pulmonary fibrosis Martina Sterclova (Praha, Czech Republic), Martina Sterclova, Peter Paluch, Katharina Heinzelmann, Isis Fernandez, Oliver Eickelberg, Martina Vasakova
PA3839
Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE) Kaïs Ahmad (Lyon, France), Kais Ahmad, Delphine Gamondes, Jean-François Cordier, Vincent Cottin
PA3840
Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis Julien Guiot (Liège, Belgium), Julien Guiot, Monique Henket, Jean-Louis Corhay, Renaud Louis
PA3841
Ultrasound in the assessment of interstitial lung diseases: Correlation with high-resolution computed tomography and lung functions Sevda Sener Comert (Istanbul, Turkey), Sevda Sener Cömert, Benan çaglayan, Coskun Dogan, Elif Parmaksiz, Ali Fidan, Banu Salepçi, Nesrin Kiral
PA3842
Sleep quality among patients with idiopathic pulmonary fibrosis Paschalis Steiropoulos (Alexandroupolis, Greece), Paschalis Ntolios, Theodoros Karampitsakos, Maria Karailidou, Maria Xanthoudaki, Evangelia Nena, Despoina Kotakidou, Stavros Anevlavis, Marios Froudarakis, Demosthenes Bouros, Paschalis Steiropoulos
PA3843
Which are the interstitial lung diseases where core needle biopsy has diagnostic utility? Maria João Oliveira (Arcozelo - Vila Nova de Gaia, Portugal), Maria João Oliveira, Tiago Pereira, Sergio Campainha, Sofia Neves
PA3844
Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Vanessa Maria Ferreira dos Santos (Ovar, Portugal), Vanessa Santos, Eva Padrão, Inês Neves, Natália Melo, Patrícia Mota, Rui Cunha, José Pereira, António Morais
246
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3845
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Paul Minnis (Bangor, United Kingdom), Paul Minnis, Rosemary Kane, Rachel Anglin, Sinead Walsh, Julie Worrel, Faheem Khan, Robert V. Lumsden, Sharon Whitty, Michael P. Keane
PA3846
The effect of nintedanib compared to pirfenidone on proliferation of lung fibroblasts from patients with IPF Lutz Wollin (Biberach Riss, Germany), Jennifer Schuett, Angela Ostermann, Lutz Wollin
PA3847
Characterization of diphtheria toxin-induced engraftment and depletion of dendritic cell subsets in the lungs of chimeric zDC+/DTR mice Meritxell Tort Tarrés (Hannover, Germany), Meritxell Tort Tarrés, Sarah Knippenberg, Franziska Aschenbrenner, Regina Maus, Tobias Welte, Ulrich Maus
PA3848
Neuroendocrine cell hyperplasia in children with idiopathic interstitial pneumonia Nagehan Emiralioglu (Ankara, Turkey), Nagehan Emiralioglu, Diclehan Orhan, Nural Kiper, Güzin Cinel, Ebru Yalçin, Deniz Dogru Ersöz, Ugur özçelik
PA3849
Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis Yubiao Guo (Guangzhou, Guangdong Province, China), YuBiao Guo, Yifeng Luo, Daiyin Cao, Jingyu Chen
PA3850
Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF) Piotr Kopinski (Bydgoszcz, Poland), Piotr Kopinski, Joanna Chorostowska, Grzegorz Przybylski, Andrzej Dyczek, Ewelina Wedrowska, Marek Jankowski, Adam Szpechcinski, Agata Gizycka, Joanna Golinska
Hall 14-11
Session 408
12:50 - 14:40
Thematic Poster: Management of COPD and other respiratory diseases in primary care Chairs : Mark L. Levy (London, United Kingdom), Arnulf Langhammer (Levanger, Norway), Alan Kaplan (Richmond Hill, Canada), Rachel Jordan (Birmingham, United Kingdom) PA3851
LATE-BREAKING ABSTRACT: COPD patient preferences for using technology to communicate with physicians Laura Khurana (Boston, United States of America), Laura Khurana, Sarah Tressel Gary, Antonio V. Otero, Chris Hall, Susan M. Dallabrida
PA3852
LATE-BREAKING ABSTRACT: Observational study on effectiveness of the combination of antitussives and NASAIDs in patients with URTI related cough Alessandro Zanasi (Bologna, Italy), Alessandro Zanasi, Luigi Lanata, Federico Saibene, Francesco De Blasio
PA3853
Prospective study on emergency care pneumologic in Bab El Oued University Hospital Souad Souilah (Alger, Algeria), Souad Souilah, Nesrine Dermech, Rabah Amrane, Aziza Fissah
PA3854
Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study Eirini Mitsiki (Athens, Greece), Eirini Mitsiki, Kosmas Kazanas, Panagiotis Hatziapostolou
PA3855
Evalation of smoking prevelance in Turkey after tobacco control strategies Davut Baltaci (Duzce, Turkey), Leyla Yilmaz Aydin, Davut Baltaci, Ali Nihat Annakkaya, Feyza Sariguzel, Fatih Alasan, Usame Velioglu, Handan Ankarali
PA3856
Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Carlos Cabrera Lopez (Las Palmas de G.C., Spain), Carlos Cabrera-Lopez, Ciro Casanova-Macario, Yolanda MartínBlázquez, Virgina Mirabal-Sánchez, María del Carmen Sánchez-Pérez, Felisa álvarez-Rodríguez, Gabriel Julia-Serda, Pedro Cabrera-Navarro, Miguel Angel García-Bello, José Maria Marín-Trigo, Juan Pablo De Torres-Tajes, Miguel Divo, Bartolomé Celli
PA3857
Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of COPD Hooman Sharifi (Tehran, Islamic Republic of Iran), Hooman Sharifi, Mohammad Reza Masjedi, Habib Emami, Mostafa Ghanei, Sonia Buist
PA3858
Learning to care: Using machine learning to improve prediction of COPD admissions Hilary Pinnock (Edinburgh, United Kingdom), Hilary Pinnock, Felix Agakov, Peter Orchard, Anna Agakova, Mary Paterson, Lucy McCloughan, Chris Burton, Stuart Anderson, Brian McKinstry
PA3859
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics Vincent Mak (Elstree, United Kingdom), Vincent Mak, Grainne D’Ancona, Rishi Rampersad, Azhar Saleem, Jas Khambh
247
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3860
Changes in use and quality of spirometry in primary care in Navarra (Spain) after an improvement plan López Vanessa (Pamplona, Spain), López Vanessa, Hueto Javier, Nuin Marian, Malon Mar, Mari Puig Guillermina, Bermejo M. Carmen, Zagaceta Jorge, Cebollero Pilar
PA3861
Hospital resource use for COPD patients varies by both clinical commissioning group and primary care practices across nine CCGs in the United Kingdom Lucy Rigge (Westbourne, United Kingdom), Lucy Rigge, Frank Ratcliff, Kate Lippiett, Lynn Josephs, Mike Thomas, Tom Wilkinson
PA3862
Effects of a self-management program for patients with COPD or chronic heart failure (CHF) on self-efficacy related to exercise and fatigue – The SAFS study Kersti Theander (Karlstad, Sweden), Kersti Theander, Mats Arne, Mikael Hasselgren, Karin Lisspers, Björn Ställberg, AnnBritt Zakrisson
PA3863
The prevalence of airflow limitation in North-West Russia according to different cut-off values Elena Andreeva (Arkhangelsk, Arkhangelsk Oblast, Russian Federation), Elena Andreeva, Marina Pokhaznikova, Anatoly Lebedev, Olga Kuznetsova, Jean-Marie Degryse
PA3864
What are the most common respiratory diseases encountered in clinical practice? Results of a pilot study in 737 Indian patients Madhuragauri Shevade (Pune, Maharashtra, India), Madhuragauri Shevade, Komalkirti Apte, Sushma Jadhav, Sapna Madas, Sundeep Salvi
PA3865
The sensitivity and positive predictive value of GP two-week wait referrals for lung cancer Mihir Sanghvi (Watford, United Kingdom), Mihir Sanghvi, Ali Mohammed
PA3866
Diagnosis of alpha 1 antitrypsin deficiency in primary care Miriam Barrecheguren Fernandez (Barcelona, Spain), Miriam Barrecheguren, Mónica Monteagudo, Carles Llor, Eulalia Borrell, Cristina Esquinas, Jaume Ferrer, Marc Miravitlles
PA3867
GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort: Disease management in primary care: Descriptive data Nebal Abu Hussein (Basel, Switzerland), Nebal Abu Hussein, Pascal Urwyler, P.O Bridevaux, P.N Chhajed, J.W. Fitting, Thomas Geiser, Ladina Joos Zellweger, Melcom Kohler, Sabrina Maier, David Miedinger, Salome Schafroth Török, Robert Thurnheer, Michael Tamm, Joerg Daniel Leuppi
Hall 14-12
Session 409
12:50 - 14:40
Thematic Poster: Systemic and airway biomarkers Chairs : Sinead Weldon (Belfast, United Kingdom), Anirban Sinha (Amsterdam, Netherlands), Clifford Taggart (Belfast, United Kingdom), Mazen Al-Alawi (Dublin, Ireland) PA3868
TSLP as biomarker in asthma patients Sabina Skrgat (Golnik, Slovenia), Sabina Skrgat, Mateja Marc Malovrh, Irena Sarc, Mira Silar, Vladimir Dimitric, Peter Korosec
PA3869
Link between vitamin D and IL33 and sST2 in children with asthma Chirine Moussa (Ezahra, Tunisia), Anissa Berraies, Saberine Louhaichi, Besma Hamdi, Alaa Aqqad, Chirine Moussa, Jamel Ammar, Kamel Hamzaoui, Agnes Hamzaoui
PA3870
Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis Kiyoshi Takeyama (Tokyo, Japan), Kiyoshi Takeyama, Mitsuko Kondo, Tomohiro Akaba, Jun Tamaoki
PA3871
Surfactant protein D as additional marker in diagnostics of asthma and its combination with gastroesophageal reflux disease with pulmonary manifestations Svetlana Lyamina (Moscow, Russian Federation), Svetlana Lyamina, Sergey Kalish, Georgy Yurenev, Igor Maev, Igor Malyshev
PA3872
Myeloperoxidase of bronchial leucocytes as a biomarker of osmotic bronchial hyperresponsiveness in asthmatics Juliy Perelman (Blagoveshchensk, Amur Oblast, Russian Federation), Juliy M. Perelman, Aleksey B. Pirogov, Anna G. Prikhodko, Sergey V. Zinoviev, Victor P. Kolosov, Tatiana A. Maltseva
PA3873
Exosomal messenger RNAs in the airway are potential biomarkers for acute lung injury in mice Sotaro Shikano (Itabashi-ku,Tokyo, Japan), Sotaro Shikano, Toshio Inoue, Shuichiro Maruoka, Yasuhiro Gon, Kazumichi Kuroda, Kenji Yamagishi, Kaori Soda, Eriko Tsuboi, Ikuko Takeshita, Shu Hashimoto
PA3874
Pepsin as a reliable biomarker for reflux aspiration: A novel method for detection Angela Hackett (Liverpool, United Kingdom), Angela Hackett, Rebecca Miller, Brian Flanagan, Rob Beynon, Paul McNamara
248
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3875
Dynamics of the inflammatory process by determining the IL-6 content in bronchoalveolar fluid in chronic bronchitis and chronic bronchitis complicated by secondary bronchiectasis Tetiana Bondarenko (Ivano-Frankivsk, Ukraine), Mykola Ostrovskyy, Tetiana Bondarenko, Oleksandr Varunkiv
PA3876
Cleaved SLPI as a marker for exacerbation in cystic fibrosis Matthew Twigg (Belfast, United Kingdom), Matthew Twigg, Simon Brockbank, Philip Lowry, Peter FitzGerald, Sinéad Weldon, Clifford Taggart
PA3877
Familial and sporadic IPF: A proteomic comparison ELENA BARGAGLI (Siena, Italy), Elena Bargagli, Alfonso Carleo, Claudia Landi, Rosa Maria Refini, Giuseppe Cillis, Luca Bini, Paola Rottoli
PA3878
QuantiFERON value in the diagnosis of tuberculous pleurisy Rachida Yahiaoui (Barcelona, Spain), Rachida Yahiaoui, Fatih Meçabih, N. Ramdani, Rabah Amrane, Aziza Fissah, Rabiha Baba-Ahmad
PA3879
Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Donato Lacedonia (Molfetta, Italy), Donato Lacedonia, Grazia Pia Palladino, Chiara Porro, Giovanna E. Carpagnano, Teresa Trotta, Luigi D. Zoppo, Valerio Saliani, Maria Pia Foschino Barbaro
PA3880
Periostin in lower airway samples and serum, a novel asthma marker? Katarzyna Górska (Warsaw, Poland), Katarzyna Górska, Patrycja Nejman-Gryz, Piotr Korczynski, Monika ProchorecSobieszek, Rafal Krenke
PA3881
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD Wai Yee James (London, United Kingdom), Wai Yee James, Claire Greiller, Beverley MacLaughlin, Neil Barnes, Raj Rajakulasingam, Angshu Bhowmik, Aklak Choudhury, David Simcock, Chris Corrigan, Chris Griffiths, David Jolliffe, Adrian Martineau
PA3882
Characterizations and potential functions of protein arginine methyltransferase 1 in primary lung structural cells Qingzhu Sun (Basel, Switzerland), Qingzhu Sun, Daiana Stolz, Michael Tamm, Shemin Lu, Michael Roth
PA3883
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma jim Jia (south San Francisco, United States of America), Guiquan Jia, Ashley Morando, Janet Jackman, Nirav Bhakta, John V. Fahy, Prescott G. Woodruff, Kelly Loyet, Tangsheng Yi, Joseph R. Arron
PA3884
Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics Gilles Devouassoux (Pierre Bénite, France), Gilles Devouassoux, Maud Gaillot Drevon, Veronique Barbalat, Raphaelle Barnoud, Mojgan Devouassoux Shisheboran, Alexandre Pachot, Bruno Mougin, Sandra Zaouche, Christian Dubreuil, Yves Pacheco
PA3885
MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients Solveig Tangedal (Bergen, Norway), Solveig Tangedal, Marianne Aanerud, Louise J.P. Persson, Per S. Bakke, Tomas M.L. Eagan
PA3886
The use of immunohistochemical stains to identify Langerhans cells in pulmonary histiocytosis Hollie Bancroft (Birmingham , United Kingdom), Hollie Bancroft, Roy Stewart, Babu Naidu, Simon Trotter
PA3887
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Magdalena Paplinska-Goryca (Warsaw, Poland), Magdalena Paplinska-Goryca, Patrycja Nejman-Gryz, Katarzyna Górska, Katarzyna Bialek-Gosk, Joanna Hermanowicz-Salamon
Hall 14-13
Session 410
12:50 - 14:40
Thematic Poster: Therapeutic approaches in inflammatory lung disease Chairs : Terry Tetley (London, United Kingdom), Alen Faiz (Groningen, Netherlands), Catherine Greene (Dublin, Ireland), Yuichi Tamura (Le Plessis-Robinson, France)
PA3888
LATE-BREAKING ABSTRACT: Host defence peptide prodrugs are respirable when delivered by vibrating mesh nebuliser Eanna Forde (Mayo, Ireland), Eanna Forde, Hilary Humphreys, Catherine Greene, Deirdre Fitzgerald-Hughes, Louise Sweeney, Ronan MacLoughlin, Marc Devocelle
PA3889
Changes in epithelial barrier components E-cadherin, Beta-catenin, EGR with steroid treatment in murine model of asthma Hasan Yüksel (Manisa, Turkey), Hasan Yuksel, Ozge Yilmaz, Meral Karaman, Fatih Firinci, Ahmet Turkeli, Esra Toprak Kanik, Sevinc Inan
249
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3890
Antioxidant efficiency in the treatment of asthma exacerbations Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov, Shamil Farkhutdinov
PA3891
Effect of epigenetic probes on IL-1B and polyIC treated normal human epithelial cells Peter Brook (London, United Kingdom), Peter Brook, Andrew Durham, Ian Adcock
PA3892
No shunting towards LTB4 when blocking LTC4s in vitro Pernilla Glader (Mölndal, Sweden), Pernilla Glader, Swedin Linda, Wissing Britt-Marie, Göransson Melker, Davis Andy
PA3893
Treprostinil effectively inhibits PDGF and TGF-ß1 induced extracellular matrix composition by IPF fibroblasts Christopher Lambers (Vienna, Austria), Christopher Lambers, Zhoa Feng, Peter Jaksch, Walter Klepetko, Michael Roth
PA3894
Carbocysteine reverses the effects of cigarette smoke and improves the effects of beclomethasone on the histone deacetylases in bronchial epithelial cells Elisabetta Pace (Palermo, Italy), Elisabetta Pace, Serena Di Vincenzo, Maria Ferraro, Chiara Cipollina, Maria Rosaria Bonsignore, Federico Saibene, Luigi Lanata, Mark Gjomarkaj
PA3895
Immunoregulatory effects of ceftaroline in airway epithelial cells and in immunocompetent cells Elisabetta Pace (Palermo, Italy), Elisabetta Pace, Maria Ferraro, Andreina Bruno, Liboria Siena, Serena Di Vincenzo, Mark Gjomarkaj
PA3896
The electrophilic 17-oxo-docosahexaenoic acid (17-oxo-DHA) enhances the anti-inflammatory potency of fluticasone propionate Chiara Cipollina (Palermo, Italy), Chiara Cipollina, Serena Di Vincenzo, Caterina Di Sano, Mark Gjomarkaj, Elisabetta Pace
PA3897
Anti-inflammatory effects of aerobic exercise in a murine model of asthma: Role of leukotrienes pathway Ricardo Custódio (Sao Paulo, Brazil), Ricardo Wesley Alberca-Custodio, Flavia Regina Greiffo, Manoel Carneiro OliveiraJunior, Adilson Santos Andrade-Sousa, Fernanda Magalhães Arantes-Costa, Angela Batista Gomes Santos, Nilsa Regina Damaceno-Rodrigues, Hugo Caire Castro-Faria-Neto, Sonia Jancar, Asghar Abbasi, Hinnak Northoff, Marco Idzko, Ana Paula Ligeiro Oliveira, Rodolfo P. Vieira
PA3898
Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice Dominika wierczy ska-Machura (Lodz, Poland), Dominika Swierczynska-Machura, Ewa Nowakowska-Swirta, Joanna Piasecka-Zelga, Radoslaw Swiercz, Jolanta Gromadzinska, Wojciech Wasowicz, Jolanta Walusiak-Skorupa, Cezary Palczynski
PA3899
Glucagon inhibits airway hyperreactivity and lung inflammation in a murine model of acute lung injury Daniella Insuela (Rio de Janeiro, Brazil), Daniella Insuela, Patricia Silva, Marco Aurélio Martins, Vinicius Carvalho
PA3900
Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Ceri Davies (London, United Kingdom), Ceri Davies, Jo Ann Rhodes, Peter Barnes, Louise Donnelly
PA3901
Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells Elisabetta Pace (Palermo, Italy), Maria Ferraro, Mark Gjomarkaj, Liboria Siena, Serena Di Vincenzo, Elisabetta Pace
PA3902
Identifying a therapeutic target for ablating new blood vessel formation in patients with asthma Qi Ge (Sydney, Australia), Qi Ge, Janette Burgess, Anthony Ashton
PA3903
Investigating the role of cathepsin S in the pathogenesis of cystic fibrosis-like lung disease Ryan Brown (Belfast, United Kingdom), Ryan Brown, Donna Small, Anthony Abladey, Leslie Holsinger, Robert Booth, Chris Scott, Stuart Elborn, Marcus Mall, Sinéad Weldon, Cliff Taggart
PA3904
Demonstration of anti-inflammatory properties of an inhaled p38 inhibitor AZD7624 Danen Cunoosamy (Mölndal, Sweden), Danen Cunoosamy, Katerina Pardali, Naimish Patel, Jansson Paul
PA3905
Combination therapy of ICSs/LABAs plus montelucastin patients with severe asthma Zlatica Goseva (Skopje, FYROM (Macedonia)), Zlatica Goseva, Angelko Gjorcev, Elena Jovanovska Janeva
PA3906
Bcl-2 antagonist ABT-737 attenuates corticosteroid-insensitive neutrophilic airway inflammation Bao-ping Tian (Hangzhou , China), Bao-ping Tian, Li-xia Xia, Fen Lan, Ping-li Wang, Zheng-qiang Bao, Zhi-Hua Chen, Song-min Ying, Hua-Hao Shen
Hall 14-14
Session 411
12:50 - 14:40
Thematic Poster: Inflammation and remodelling in lung disease Chairs : Agnes Boots (Maastricht, Netherlands), Ali Oender Yildirim (Neuherberg, Germany), Malgorzata Wygrecka (Giessen, Germany), Christian Martin (Aachen, Germany)
250
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3907
LATE-BREAKING ABSTRACT: Tissue-resident epithelial stem/progenitor cells in pulmonary epithelial repair Takeshi Kawasaki (Chiba, Japan), Takeshi Kawasaki, Rintaro Nishimura, Ayumi Sekine, Rika Suda, Takashi Urushibara, Toshio Suzuki, Shin Takayanagi, Jiro Terada, Seiichiro Sakao, Koichiro Tatsumi
PA3908
LATE-BREAKING ABSTRACT: The metalloproteinase ADAM8 promotes acute and chronic lung inflammation Daniela Dreymueller (Aachen, Germany), Daniela Dreymueller, Jessica Pruessmeyer, Julian Schumacher, Joerg W. Bartsch, Andreas Ludwig
PA3909
Electrospray as a novel and efficient technique for targeted gene delivery Paulius Ruzgys (Bern, Switzerland), Paulius Ruzgys, Stephan Boehringer, Saulius šatkauskas, David Hradetzky, Amiq Gazdhar, Thomas Geiser
PA3910
New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung Elena Lopez Rodriguez (Hannover, Germany), Carolin Laukamp, Alberto Hidalgo, Antonio Cruz, Jesus Perez-Gil, Matthias Ochs, Lars Knudsen, Elena Lopez-Rodriguez
PA3911
Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle Ronaldo Aparecido da Silva (Sao Paulo, Brazil), Ronaldo Aparecido Silva, Francine Maria Almeida, Clarice Rosa Olivo, Beatriz Mangueira Saraiva-Romanholo, Adenir Perini, Milton Arruda Martins, Celso Ricardo Fernandes Carvalho
PA3912
Influence of exercise on the nitric oxide metabolism in young smokers Svetlana K. Soodaeva (Moscow, Russian Federation), Elena Zaprudnova, Svetlana Soodaeva, Igor Klimanov, Timur Li, Nataliya Popova, Mary Glukhova, Lidiya Nikitina
PA3913
Respiratory NO metabolism in skiers and biathlonists with exercise-induced bronchospasm Lidiya Nikitina (Khanty-Mansi Autonomous Okrug, Russian Federation), Lidiya Nikitina, Svetlana Soodaeva, Fedor Petrovsky, Yulia Petrovskaya, Valentina Kotlyarova, Alexandr Chuchalin, Igor Klimanov, Timur Li
PA3914
Glucose transport in the strenuously contracting diaphragm Ioanna Sigala (Athens, Greece), Ioanna Sigala, Maria Makropoulou, Vasiliki Karavana, Panayiotis Zacharatos, Tatiana Michailidou, Stamatios Theocharis, Theodoros Vassilakopoulos
PA3915
Prooxidant-antioxidant balance in mustard airway disease with different severity Rasoul Aliannejad (Tehran, Islamic Republic of Iran), Daryoush Hamidi Alamdari, B. Fatemeh Nobakht M. Gh., Afsaneh Arefi Oskouie, Mostafa Rezaei-Tavirani, Alireza Akbarzadeh Baghban, Rasoul Aliannejad
PA3916
Association of free radical formation, severity of disease and degree of systemic inflammation in patients with bronchial asthma Vanya Ilieva-Fartunova (Stara Zagora, Bulgaria), Vanya Ilieva-Fartunova, Vanya Tsoneva, Galina Nikolova, Antoaneta Zheleva, Atanas Koychev, Veselina Gadjeva
PA3917
Inhalation of chlorine causes lung inflammation and airway hyperresponsiveness in a rat model of chemical-induced lung injury Sofia Jonasson (Umeå, Sweden), Elisabeth Wigenstam, Linda Elfsmark, Bo Koch, Sofia Jonasson
PA3918
The differential effect of inspiratory, expiratory and combined resistive loading on healthy rat lung Konstantinos Loverdos (Athens, Greece), Konstantinos Loverdos, Dimitrios Toumpanakis, Eleni Litsiou, Vassiliki Karavana, Constantinos Glynos, Christina Magkou, Stamatios Theocharis, Theodoros Vassilakopoulos
PA3919
Protective effects of tiotropium bromide on the morphological remodeling of the bronchi on the neocollagenesis processes in patients with moderate COPD during exacerbation Mariana Kulynych-Miskiv (Galych, Ukraine), Mariana Kulynych-Miskiv, Mykola Ostrovskyy, Oleksandr Varunkiv, Iryna Savelikhina, Olena Deltsova, Vasyl Miskiv, Sergiy Gerashchenko
PA3920
Modulation of cytotoxic effects of histones by osteopontin Gopinath Kasetty (Lund, Sweden), Gopinath Kasetty, Ravi Kiran Varma Bhongir, Matthias Morgelin, Arne Egesten
PA3921
Expression of estrogen receptors and estrogen metabolism genes in lungs of COPD patients Juanita H.J. Vernooy (Maastricht, Netherlands), Gonda Konings, Niki Reynaert, Andrea Romano, Ken Bracke, Guy Brusselle, Emiel Wouters, Juanita Vernooy
PA3922
Altered expression of CuZn-SOD and thioredoxin correlate with the histopathological features in small airways of patients with severe COPD Beata Olejnicka (, Sweden), Daniel Popa, Gustaf Lejonberg, Jonas Erjefält, Beata Olejnicka
PA3923
Cytotoxic activity and oxidative DNA damage in smoking asthmatics versus COPD patients Nikolaos Soulitzis (Heraklion, Crete, Greece), Nikolaos Soulitzis, Eirini Neofytou, Nikoletta Rovina, Eleftherios Zervas, Dimitra Papandrinopoulou, Nikolaos Siafakas
251
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3924
Eucalyptol reduced inflammation and oxidative stress on mouse lungs exposed to long and short-term cigarette smoke Emanuel Feitosa (Rio de Janeiro, Brazil), Emanuel Kennedy-Feitosa, Luis Cristovao Porto, Martina Schmidt, Renata Okuro, Walter Araujo Zin, Lycia Brito-Gitirana, Samuel Santos Valenca
PA3925
Serum metabolomic analysis of mustard airway diseases by nuclear magnetic resonance spectrometry: A pilot study Rasoul Aliannejad (Tehran, Islamic Republic of Iran), B. Fatemeh Nobakht M. Gh., Rasoul Aliannejad, Salman Taheri, Mostafa Rezaei-Tavirani, Fariba Fathi, Afsaneh Arefi Oskouie
PA3926
La simvastatina no inhibe la inflamación producida por las células pulmonares Cecilia López Ramírez (Sevilla, Spain), Cecilia López Ramírez, Laura Carrasco Hernández, Elena Arellano Orden, Carmen Calero Acuña, Eduardo Márquez Martín, José Luis López Campos
Hall 14-15
Session 412
12:50 - 14:40
Thematic Poster: Novel strategies for the management of asthma, COPD and airway infections Chairs : Mark Perry (London, United Kingdom), Fabrizio Luppi (Spilamberto, Italy), Ken Bracke (Ghent, Belgium)
PA3927
Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs) David Price (Aberdeen, United Kingdom), Henry Chrystyn, Sinthia Bosnic-Anticevich, Nicolas Roche, Mathieu Molimard, John Haughney, Federico Lavorini, Dawn Shan, Erika Sims, Anne Burden, Valerie L. Ashton, John Efthimiou, Marek Ferkl, David B. Price
PA3928
Predictors of good inhaler technique in asthma and COPD Kyra Camilleri (Attard, Malta), Kyra Camilleri, Martin Balzan, Michael Pace Bardon, Emma Schembri, Michael Sullivan, Simon Mifsud, Darlene Muscat, Rachelle Asciaq, Stephen Montefort
PA3929
A 2 year programme to improve inhaler technique for adult patients with asthma and chronic obstructive pulmonary disease in a Welsh university health board John Amit Benjamin (Pontyclun, United Kingdom), John Amit Benjamin, Rhian Williams, Kathleen Bruce, Owain Jones, Lorna Philips
PA3930
Is simulation based training in inhaler technique of health care professionals more effective than written information?: A randomised controlled study Xavier Valan Selvaraj Fernando (Llanelli, United Kingdom), Xavier Valan S. Fernando, Anoop Prakash, Anetha Sabanathan, Graham Fent, Victoria Thorley Dickinson, Frank Edenborough, Jack Kastelik, Alan Rigby, Makani Purva, Jaymin Morjaria
PA3931
Relationship between the ability to learn dry-powder inhaler use and the cognitive functions in patients with COPD F KRET KANAT (KONYA, Turkey), Baykal Tulek, Nart Bedin Atalay, Ercan Kurtipek, Gulfem Yildirim, Fikret Kanat, Mecit Suerdem
PA3932
A new clinically relevant method of calculating adherence Imran Sulaiman (Dublin 8, Ireland), Imran Sulaiman, Jansen Seheult, Isabelle Killane, Elaine MacHale, Richard Reilly, Richard Costello
PA3933
Optimal adherence with inhaled corticosteroids is related to better health status Kirsten Koehorst-ter Huurne (Enschede, Netherlands), Kirsten Koehorst-ter Huurne, Sharina Kort, Kris Movig, Paul VanderValk, Job Van der Palen, Marjolein Brusse-Keizer
PA3934
How many adolescents are actually included in randomised trials primarily in adults with asthma? An analysis of recent trial reports Kaylea Clark (Liverpool, United Kingdom), Kaylea Clark, Olivia Annal, Paul Mcnamara, Ian Sinha
PA3935
Identification of molecular pathways in distinct asthma phenotypes identified in ADEPT Carl Manthey (Radnor, United States of America), Carl Manthey, Vy Hoang, Michael Macoritto, Matthew Loza, Fréedéric Baribaud, Joel Tocker
PA3936
A new investigational use only automated immunoassay for periostin Nicolette Jeanblanc (North Chicago, United States of America), Nicolette Jeanblanc, Scott Manetz, Rozanne (Yen-Wah) Lee, Meina Liang, Partha Choudhury, Reena Varkey, Ethan Grant, Melissa Parker, Katie Streicher, Lydia Greenlees, Maria Datwyler, Gerard Davis, Koustubh Ranade
PA3937
GOLD and phenotypes: The new Czech COPD guidelines Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Jan Chlumsky, Vladimir Zindr, Jana Kocianova, Jaromir Zatloukal, Katerina Neumannova, Jakub Zatloukal, Vratislav Sedlak, Jaroslav Zak, Karel Hejduk, Barbora Novotna
252
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3938
Implementation of COPD phenotypes in real life Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Jan Zigmond, Ladislav Pecen, Jan Chlumsky, Barbora Novotna, Viktor Kasak, Jaromir Zatloukal, Martin Blazek, Ales Tichopad
PA3939
Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients Andrzej Bargiel (Ostrow Wielkopolski, Poland), Andrzej Bargiel, Andrzej Obojski
PA3940
Eligibility of patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy David Michael George Halpin (Exeter Devon, United Kingdom), David Halpin, David B. Price, Marjan Kerkhof
PA3941
The effects of bronchodilators in patients with tuberculosis-destroyed lung and chronic airflow obstruction Jung Seop Eom (Busan, Republic of Korea), Jung Seop Eom, Hye Yun Park, Min Ki Lee, Min Ji Kim
PA3942
Comparison between anticholinergic and beta-2 agonist treatments by using pletismography and impulse oscillometry Francesco Bini (Pavia, Italy), Francesco Bini, Giorgio De Bernardi, Noemi Grassi, Adriano Vaghi
PA3943
Biopharmaceutical and chemical compatibility of the combination of salbutamol hemisuccinate and methatropium iodide Tatiana Molostova (Moscow, Russian Federation), Tatiana Molostova, Alexander Chuchalin, Sofia Skachilova, Elena Shilova, Yuriy Kalinin, Tamerlan Balaev, Irina Badygina, Alexander Solovyev
PA3944
Speech and language therapy for chronic cough and vocal cord dysfunction: Patient satisfaction with therapy given face-to-face and via videocalls Jemma Haines (Wilmslow, United Kingdom), Jemma Haines, Aashish Vyas, Claire Slinger, Siobhan Lillie, Stephen J. Fowler
PA3945
A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC) David E. Griffith (Tyler, United States of America), David Griffith, Patrick Flume, Kevin Winthrop, Rachel Thomson, Dirk Wagner, Jakko Van Ingen, Liza Micioni, John P. McGinnis II, Carlos Fernandez, Gina Eagle
PA3946
The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis Ludmila Balanetchi (Chisinau, Republic of Moldova), Svetlana Sciuca, Ludmila Balanetchi
Hall 14-16
Session 413
12:50 - 14:40
Thematic Poster: Novel treatments for cough, asthma, COPD and bronchiectasis Chairs : Omar Usmani (London, United Kingdom), Reinoud Gosens (Groningen, Netherlands), Maria Luisa Bocchino (Naples, Italy), Tania Maes (Gent, Belgium)
PA3947
Anti-tussive effects of FAAH inhibition: The role of endocannabinoids and downstream signalling pathways in the inhibition of vagal sensory nerve activation Michael Wortley (London, United Kingdom), Michael Wortley, John Adcock, Eric Dubuis, Sarah Maher, Sara Bonvini, Mark Birrell, Maria Belvisi
PA3948
Pharmacological profile of a novel, potent and oral TRPA1 antagonist. Characterization in a preclinical model of induced cough Monica Aparici Virgili (Sant Feliu de Llobregat, Spain), Gema Tarrasón, Irene Jover, Carla Carcasona, Joan Antoni Fernández-Blanco, Peter Eichhorn, Amadeu Gavaldà, Jorge De Alba, Richard Roberts, Montserrat Miralpeix, Mònica Aparici
PA3949
Reliability and validity of a Turkish version of Leicester cough questionnaire Yavuz Havlucu (Manisa, Turkey), Nazmiye Akis Gonen, Yavuz Havlucu, Arzu Yorgancioglu, Tugba Goktalay, Aysin Sakar Coskun, Pinar Celik
PA3950
Prediction of human lung PK for AZD7624, an inhaled P38 inhibitor for the treatment of COPD Sara Asimus (Mölndal, Sweden), Mats Någård, Rikard Pehrson, Sara Asimus, Tove Hegelund, Paul Jansson, Naimish Patel
PA3951
Nociceptin modulates the inflammatory immune microenvironment in a conventional murine model of asthma GIUSEPPE Spaziano (NAPLES, Italy), Giuseppe Spaziano, Maria Matteis, Rosalinda Sorrentino, Fiorentina Roviezzo, Giuseppe Cirino, Aldo Pinto, Francesco Rossi, Gioia Tartaglione, Manuela Sgambato, Bruno D’Agostino
PA3952
BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model Ariana Corrêa Florencio (São Paulo, Brazil), Ariana Florencio, Fernanda Magalhães Arantes-Costa, Robson Santos de Almeida, Thayse Regina Brüggemann, Sérgio D. Sasaki, Milton A. Martins, Iolanda F.L.C. Tibério, Fernanda D.T.Q.S. Lopes, Edna A. Leick
253
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3953
Atorvastatin lowers inflammatory sputum mediators in smokers with asthma Catherine Charron (London, United Kingdom), Catherine Charron, Rekha Chaudhuri, Mark Spears, Kazuhiro Ito, Charles McSharry, Neil Thomson
PA3954
Decoy chemokine neutraligands with anti-asthmatic activity Dayana Abboud (Illkirch, France), Dayana Abboud, François Daubeuf, Quoc tuan Do, Valérie Utard, Pascal Villa, Jacques Haiech, Dominique Bonnet, Marcel Hibert, Philippe Bernard, Jean-Luc Galzi, Nelly Frossard
PA3955
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Francesco Bini (Pavia, Italy), Francesco Bini, Roberto Ruggiero, Noemi Grassi, Giorgio De Benernardi, Adriano Vaghi
PA3956
Evaluation of methotrexate in the treatment of severe asthma Anita Molard (Strasbourg, France), François Hervy, Gairard-Dory Anne-Cécile, Anita Molard, Carine Metz-Favre, Cindy Barnig, Bénédicte Gourieux, Frédéric De Blay
PA3957
Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Anselm Morell (Valencia, Spain), Anselm Morell, Javier Milara, Lucia Díaz, Beatriz Ballester, Teresa Peiró, Sonia Gonzalez, Pilar Bañuls, Julio Cortijo
PA3958
Bronchodilator activity of the combination of salbutamol hemisuccinate and methatropium iodide compared with monotherapy in preclinical studies Tatiana Molostova (Moscow, Russian Federation), Tatiana Molostova, Alexander Chuchalin, Sofia Skachilova, Elena Shilova, Yuriy Kalinin, Tamerlan Balaev, Irina Badygina, Alexander Solovyev
PA3959
Evaluation of vitamin D in asthma: Its effect on inflammatory markers and clinical profile Gaki Nima (Delhi, India), Gaki Nima, Balakrishnan Menon, Santosh Jha
PA3960
The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea Domenico Spina (London, United Kingdom), Radhakrishnan Venkatasamy, Clive Page, Domenico Spina
PA3961
Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation Michela Maria Bellocchia (Turin, Italy), Michela Bellocchia, Monica Boita, Filippo Patrucco, Cinzia Ferrero, Giulia Verri, Daniela Libertucci, Francesco Coni, Giuseppe Tabbia, Alessio Mattei, Caterina Bucca
PA3962
The efficacy of lung volume reduction coil practice to type-2 respiratory insufficiency in severe COPD cases Fidan Sever (Izmir , Turkey), Fidan Sever, Askin Gulsen, Ayse Pelin Girgin, Necdet Batuhan Tamci, Hatice Yilmaz
PA3963
Additive effect of targeted lung denervation plus drug in patients with COPD Coenraad Frederik Nicolaas Koegelenberg (Cape Town, South Africa), Coenraad Koegelenberg, Johan Theron, Dirk-Jan Slebos, Karin Klooster, Martin Mayse, Chris T. Bolliger
PA3964
Response to subcutaneous octreotide in a cohort of patients with bronchorrhoea Helen Fowles (Hull, United Kingdom), Helen Fowles, Alyn Morice, Yvette Hayman, Kayleigh Arnell
PA3965
Mucus-normalizing activity of a fixed thyme and primula extract combination: Reduction of LPS-induced goblet cell metaplasia and mucin production in vivo Martin Lehner (Neumarkt, Germany), Jan Seibel, Martin D. Lehner, Jutta Haunschild
Hall 14-17
Session 414
12:50 - 14:40
Thematic Poster: Non-exhaled biomarkers in the assessment of airways disease Chairs : Florence Schleich (Liège, Belgium), Fabio L. M. Ricciardolo (Orbassano (Turin), Italy), Todor Popov (Sofia, Bulgaria), AnnaCarin Olin (Gothenburg, Sweden) PA3966
Can cys-LT, PG-D2, PG-E2, IL-5 and ADAM33 levels and their correlation with pulmonary function be discriminative in asthma, COPD and ACOS? Bilun Gemicioglu (Istanbul, Turkey), Gulfidan Cakmak, Bilun Gemicioglu, Yasemin Erdogan Doventas, Macit Koldas
PA3967
Can blood eosinophils predict sputum eosinophils in stable COPD? Netsanet Negewo (Newcastle, Australia), Netsanet Negewo, Vanessa McDonald, Katherine Baines, Peter Wark, Jodie Simpson, Paul Jones, Peter Gibson
PA3968
Oxidative stress and biomarkers in patients with bronchial asthma Keitaro Nakamoto (Tokyo, Japan), Keitaro Nakamoto, Hiroo Wada, Shingo Tsuji, Mitsuru Sada, Toshiya Inui, Masuo Nakamura, Kojiro Honda, Yasutaka Tanaka, Takashi Koide, Saori Takata, Masato Watanabe, Takuma Yokoyama, Takeshi Saraya, Daisuke Kurai, Haruyuki Ishii, Hajime Takizawa
254
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA3969
Rheumatoid factor as the new predictive marker of reduced lung function: A cross-sectional study Jae-Uk Song (Seoul , Republic of Korea), Jae-Uk Song, Joong Kyong Ahn, Hye Kyeong Park, Yun Su Sim
PA3970
Serum levels of RAAS components in COPD Ümran Toru (Kütahya, Turkey), ümran Toru, Ceylan Ayada, Osman Genç, Server Sahin, özlem Arik, Ismet Bulut
PA3971
Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis? Hanine Al Kayal (Machghara, West Bekaa, Lebanon), Hanine Al Kayal, Hassan Abu Bass, Ahmad El Sabbah, Wiam Ramadan, Hassan Khachfe, Khalil Al Kwatly, Wissam H. Joumaa
PA3972
Investigation the role of pentraxin-3 in the innate immune system in patients with COPD Mona Bafadhel (Oxford, United Kingdom), Madiha Dilpazir, Samantha Thulborn, Christopher Brightling, Mona Bafadhel
PA3973
Short-term stability of the mature elastin degradation biomarker plasma desmosine and influence of smoking on plasma desmosine levels Michiel T.H. Spanbroek (Wijchen, Netherlands), Michiel Spanbroek, Jody Van den Ouweland, Twan Beijers, Henny Van Daal, Richard Dekhuijzen, Rob Janssen
PA3974
Metabolic syndrome in patients with COPD and their association with systemic inflammation Jain Nirmal Kumar (Jaipur, India), Nirmal Kumar Jain, Nitin Jain, Arpit Sharma
PA3975
Exploring the volatome of different cancer cell lines Pierre-Hugues Stefanuto (Liège, Belgium), Pierre-Hugues Stefanuto, Romain Pesesse, Virginie Bertrand, Marie-Claire Depauw-Gillet, Jean-François Focant
PA3976
eTRIKS IT platfroms for large-scale biomedical research Ioannis Pandis (London, United Kingdom), I. Pandis, Y. Guo, F. Guitton, X. Yang, K. Sun, S. Wang, N. Jullian, A.R. Sousa, A.T. Bansal, J. Corfield, S. Pavlidis, P.P. Hekking, L.J. Fleming, D. Shaw, G. Roberts, N. Fitch, J.H. Riley, S.S. Wagers, A. Rowe, I.M. Adcock, K.F. Chung, C. Auffray, P.J. Sterk, The U-BIOPRED Study Group
PA3977
Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease Juan R Fernández-Lahera Martínez (Madrid, Spain), J. Fernández-Lahera, D. Romera, A. Gómez Mendieta, A. Martínez Verdasco, J. Fernández-Bujarrabal, A. Santiago, S. Alcolea, Y. Martínez-Abad, C. Prados, C. Villasante, R. Alvarez-Sala
PA3978
A cross-sectional study on association between stable COPD & metabolic syndrome (Syndrome X) ANGSHUMAN MUKHERJEE (Kolkata, India), Angshuman Mukherjee, Samim Khan, Sumitra Basuthakur, Raja Dhar
PA3979
Neutrophils and spirometry changes in COPD patients treated with roflumilast Konstantinos Porpodis (Thessaloniki, Greece), Kalliopi Domvri, Konstantinos Porpodis, Antonis Papaioannou, Paul Zarogoulidis, Dimitrios Dimitrios Petridis, Olga Hatzizisi, Alexandra Liaka, Violeta Kikidaki, Sofia Lampaki, Ioannis Organtzis, Konstantinos Zarogoulidis
PA3980
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Celeste M. Porsbjerg (Copenhagen, Denmark), Celeste Porsbjerg, Asger Sverrild, Vibeke Backer
PA3981
Utility of BAP-65 score in assessing the severity and predicting the outcome in acute exacerbation of COPD, in a tertiary care hospital in South India Kapali Siva K (Chennai, India), Kapali Siva Kumaraguru, Gayathri Anur Ramakrishnan
PA3982
Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids namrata saxena (Mumbai, India), Namrata Kewalramani, Sujeet Rajan, Sanjeet Marik
PA3983
Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD Nejat Altintas (SAMSUN, Turkey), Aziz Gumus, Nejat Altintas, Halit Cinarka, Aynur Kirbas, Muge Haziroglu, Mevlut Karatas, Unal Sahin
PA3984
Evaluation of mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease Gülistan Karadeniz (Izmir, Turkey), Gülistan Karadeniz, Serir Aktogu, Onur Fevzi Erer, Serpil Bulaç Kir, Sibel Doruk, Melike Demir
PA3985
Higher BODE Index in COPD patients correlated with higher number of comorbidities Mohit Bhatia (Ghaziabad, India), Mohit Bhatia, J.K. Samaria, Ashvendra Singh Chawra
Hall 14-18
Session 415
12:50 - 14:40
Thematic Poster: Exhaled biomarkers in monitoring airways disease Chairs : Paolo Montuschi (Rome, Italy), András Bikov (Budapest, Hungary), Marieann Hogman (Gavle, Sweden), Giovanna Elisiana Carpagnano (Foggia, Italy)
255
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA3986
LATE-BREAKING ABSTRACT: Extended NO analysis is useful to modify anti-inflammatory treatment in asthmatic children with intermediate FENO50 Alexandra Thornadtsson (Gävle, Sweden), Alexandra Thornadtsson, Marieann Högman, Anne Neerincx, Frans Harren, Peter Merkus, Simona Cristescu
PA3987
LATE-BREAKING ABSTRACT: Breathe free: Open source development of a breath sampler by a consortium of breath researchers Kitchen Simon (Cambridge, United Kingdom), Simon Kitchen, Alasdair Edge, Rob Smith, Paul Thomas, Stephen Fowler, Salman Siddiqui, Marc van der Schee
PA3988
LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort Diana Julie Leeming (Herlev, Denmark), Diana Julie Leeming, Inger Byrjalsen, Jannie M.B. Sand, Asger Bihlet, Ruth TalSinger, Bruce E. Miller, Morten A. Karsdal, Jørgen Vestbo
PA3989
LATE-BREAKING ABSTRACT: Biomarkers of extracellular matrix turnover predict mortality in the ECLIPSE COPD cohort Jannie Marie Bülow Sand (Herlev, Denmark), Jannie M.B. Sand, Diana Julie Leeming, Inger Byrjalsen, Asger Bihlet, Ruth Tal-Singer, Bruce E. Miller, Morten A. Karsdal, Jørgen Vestbo
PA3990
LATE-BREAKING ABSTRACT: Lung function assessed by home forced oscillation and self reported symptoms during COPD exacerbations Pasquale Pio Pompilio (Milan, Italy), Pasquale Pio Pompilio, Roberta Macis, Valentina Isetta, Giulia Munaro, Paul Walker, Angelo Paolo Castellani, Mireia Dalmase, Jo Middlemass, A. Niroshan Siriwardena, Paolo Zanaboni, Ruth Sepper, Kaiu Prikk, Andrei Malinovschi, Christer Janson, Dorjan Marušiç, Tatjana Dolgan, Raffaele L. Dellaca’, Peter M.A. Calverley, Roberto Rosso
PA3991
The influence of smoking on the temperature of the exhaled air in patients with chronic lung diseases Irina Khelimskaia (khabarovsk, Russian Federation), Irina Khelimskaia, Valentina Bondar, Veronika Nikulina
PA3992
Monitoring of ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection Petr Kuban (Brno, Czech Republic), Petr Kuban, Michal Gregus, Frantisek Foret, Jana Skrickova, Dagmar Kindlova, Martina Doubkova, Eva Pokojova, Marek Plutinsky, Ilona Binkova, Zdenek Merta
PA3993
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Gareth Hynes (Oxford, United Kingdom), Gareth Hynes, Christopher Brightling, Mona Bafadhel
PA3994
Temporal stability of feno measurement in COPD Bernardino Alcazar Navarrete (Cájar, Spain), Bernardino Alcázar Navarrete, Pedro J. Romero Palacios, Francisca Castellano Miñán, Oliverio Ruiz Rodriguez, Andres Ruiz Sancho
PA3995
Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites Igor A. Klimanov (Moscow, Russian Federation), Igor Klimanov, Svetlana Soodaeva, Mary Glukhova, Lidiya Nikitina, Timur Li, Nataliya Popova
PA3996
Unbiased clustering of severe asthma patients based on exhaled breath profiles Paul Brinkman (Amsterdam, Netherlands), Paul Brinkman, Pieter-Paul Hekking, Simone Hashimoto, Yuanyue Wang, Anton Vink, Hans Weda, Hugo Knobel, Tamara Nijsen, Nicholas Rattray, Pascal Chanez, Massimo Caruso, Ildikó Horváth, Paolo Montuschi, Ratko Djukanovic, Fan Chung, Marco Santonico, Giorgio Pennazza, Arnaldo D’Amico, Stephen Fowler, Peter Sterk, U-BIOPRED Study Group
PA3997
Additive contribution of exhaled nitric oxide and sputum eosinophils to airway responsiveness Andrei Malinovschi (Uppsala, Sweden), Andrei Malinovschi, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg
PA3998
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Svetlana Tsyplenkova (Moscow, Russian Federation), Svetlana Tsyplenkova, Yuriy Mizernitskyi, Ludmila Sokolova, Elena Sorokina
PA3999
Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS) Charles Knoery (Glasgow, United Kingdom), Charles Knoery, Ben Brockway, Jan Cowan, Emma Cox, Robin Taylor
PA4000
Effect of cigarette smoke exposure on exhaled nitric oxide and its relation to asthma and hay feverin adult NHANES subjects Tiago Jacinto (Senhora da Hora, Portugal), Tiago Jacinto, Andrei Malinovchi, Christer Janson, João Fonseca, Kjell Alving
PA4001
Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels Oleksandr Varunkiv (Ivano-Frankivsk, Ukraine), Mykola Ostrovskyy, Oleksandr Varunkiv, Mariana Kulynych-Miskiv, Iryna Savelikhina
256
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA4002
Longitudinal variability of nasal nitric oxide measurements during winter Holger Dressel (Zurich, Switzerland), Fabio Barresi, David Imo, Marion Maggi, Holger Dressel
PA4003
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD Nejat Altintas (SAMSUN, Turkey), Murat Aydin, Nejat Altintas, Levent Mutlu, Bulent Bilir, Musatfa Oran, Feti Tukubas, Birol Topcu
PA4004
Exhaled fungal microbiome in asthma: Possible association with severity and control Giovanna Elisiana Carpagnano (Foggia, Italy), Giovanna E. Carpagnano, Donato Lacedonia, Grazia Cotugno, Annarita Depalo, Giuseppe Antonio Palmiotti, Ernesto Giuffreda, Maria Pia Foschino Barbaro
PA4005
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population Manish Sharma (Mathura, India), Manish Sharma, R.P. Ilangho
Hall 14-19
Session 416
12:50 - 14:40
Thematic Poster: Immune aspects of asthma and other airway diseases Chairs : Apostolos Bossios (Gothenburg, Sweden), Jonas Erjefalt (Lund, Sweden), Gennaro D'Amato (Napoli, NA, Italy), Chair to be confirmed PA4006
Helicobacter pylori lysate affects the tolerant state of human monocyte-derived dendritic cells Yolanda van Wijck (Leiden, Netherlands), Yolanda Van Wijck, Alwin Van der Ham, Maria Yazdanbakhsh, Pieter Hiemstra, Anne Müller, Hermelijn Smits, Christian Taube
PA4007
Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness Utako Fujii (Okahama, Japan), Utako Fujii, Arihiko Kanehiro, Hiroki Kakuta, Akihiko Taniguchi, Daisuke Morichika, Genyo Ikeda, Genyo Ikeda, Hikari Nakayama, Koichi Waseda, Etsuko Murakami, Nobuaki Miyahara, Mikio Kataoka, Mitsune Tanimoto
PA4008
Applying the 3Rs to asthma research Anthony Holmes (St Neots, United Kingdom), Anthony Holmes
PA4009
The effect of different PV extracts in the treatment of asthma in an animal model andiamira balestra (ribeirao preto, Brazil), Andiamira Balestra, Camila Sandy, Ana Maria Pereira, Fabio Carmona, Marcos Borges
PA4010
The role of lL-17 in the OVA-LPS driven model of lung inflammation Maria Rehnberg (Molndal, Sweden), Maria Rehnberg, Marie Ramnegård, Nina Krutrök, Linda Yrlid, Johan Jirholt
PA4011
Effect of verapamil on vascular endothelial growth factor production in immunocompetent cells Fatemeh Hajighasemi (Tehran, Islamic Republic of Iran), Fatemeh Hajighasemi, Abbas Mirshafiey
PA4012
Fraction of exhaled nitric oxide (FeNo) norms in healthy elderly Tunisian subjects Ines Sfaxi (Sousse, Tunisia), Ines Sfaxi, Helmi Ben Saad, Sonia Rouatbi
PA4013
APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma Robert Niven (Manchester, United Kingdom), Rob Niven
PA4014
Complex alterations of lung dendritic cell subsets across distinct asthma phenotypes Michiko Mori (Lund, Sweden), Michiko Mori, Cecilia Andersson, Anders Bergqvist, Hans Jürgen Hoffmann, Leif Bjermer, Jonas Erjefält
PA4015
The prevalence and evaluation of premenstrual asthma, comparing premenstrual symptoms with asthmatic and healthy women Dane Ediger (BURSA, Turkey), Dane Ediger, Dilek Bahcetepe
PA4016
Coagulation activity increases with disease severity in patients with asthma Marlous Sneeboer (Amsterdam, Netherlands), Marlous Sneeboer, Christof Majoor, Anne De Kievit, Joost Meijers, Rene Lutter, Tom Van der Poll, Pieter-Willem Kamphuisen, Peter Sterk, Elisabeth Bel
PA4017
Lung function impairment in adult asthma increases the risk of systemic inflammation Celeste M. Porsbjerg (Copenhagen, Denmark), Celeste Porsbjerg, Asger Sverrild, Katherine Baines, Peter Gibson, Vibeke Backer
PA4018
High doses of sublingual tablets of house dust mite allergen extracts: Lung function assessment in a phase I study in adults with mite-associated allergic asthma Robert K. Zeldin (Garches, France), Robert K. Zeldin, Martine Le Gall, Patricia Rodriguez, Yann Amistani, Pascal Demoly
257
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4019
The clinical and biological response to allergen-specific immunotherapy with basophil activation test (BAT) in the atopic diseases Anna Agnese Stanziola (naples, Italy), Anna Agnese Stanziola, Giovanna Caccavo, Maurizia Lanza, Sara Carputo, Maria Martino, Francesca Simioli, Maria D’Amato, Francesco Perna
PA4020
Comorbidity of allergic rhinitis and asthma to birch allergen in an environmental exposure chamber Victoria Nelson (Mississauga, Canada), Victoria Nelson, Peter Couroux, Tara Sadoway, Piyush Patel, Anne Marie Salapatek
PA4021
Analysis of the characteristics of patients presenting with exacerbation of asthma to emergency care units in Japan Hiroyoshi Watanabe (Koshigaya, Japan), Hiroyoshi Watanabe, Kumiya Sugiyama, Hideyuki Satoh, Shunsuke Suka, Hajime Arifuku, Tomoshige Wakayama, Shingo Tokita, Yasutsugu Fukushima
PA4022
New indication of the conventional treatment for asthma: chronic idiopathic urticaria Ebru Özdemir (Ankara, Turkey), Ebru özdemir, Esra Karabiber, Gül Karakaya, A. Fuat Kalyoncu
PA4023
Tolerance of ultra-rush immunotherapy in children ZOUARI AMIRA (tunis, Tunisia), Sellami Amira, Moetamri Zied, Mhamdi Samira, Dabboussi Selsabil, Aichaouia Chiraz, Khadhraoui Mohsen, Echikh Rzaiek
PA4024
Barriers to adherence to asthma medication Rahma Gargouri (Sfax, Tunisia), Nadia Moussa, Rahma Gargouri, Najla Bahloul, Sourour Abid, Karim Wajdi Rekik, Hajer Ayadi, Sami Kammoun
PA4025
Sensitization to moulds in patients with newly diagnosed allergic asthma Silviya Novakova (Plovdiv, Bulgaria), Silviya Novakova, Mateva Nonka, Plamena Novakova, Manuela Yoncheva
Hall 14-20
Session 417
12:50 - 14:40
Thematic Poster: Immune mechanisms in the human lung Chairs : Hans Jürgen Heinrich Hoffmann (Aarhus, Denmark), Thais Mauad (Sao Paulo, Brazil), Ronald Dahl (Odense C, Denmark), Ruby Pawankar (Tokyo, Japan) PA4026
Should patients with mild asthma be excluded from allergic rhinitis drug trials? Anne Marie Salapatek (Mississauga, Canada), Anne Marie Salapatek, Peter Couroux, Victoria Nelson, Piyush Patel
PA4027
RNA-Seq transcriptome profiling of genes regulated by vitamin D in an asthma model Rachel Foong (West Perth, Australia), Rachel Foong, Anthony Bosco, Shelley Gorman, Prue Hart, Graeme Zosky
PA4028
Dual role of M2 macrophages in asthma Barbro Melgert (Groningen, Netherlands), Christina Draijer, Patricia Robbe, Carian Boorsma, Machteld Hylkema, Barbro Melgert
PA4029
IL-13 in a mouse model of chemical-induced airway hyperresponsiveness Fien Devos (Leuven, Belgium), Fien Devos, Lore Pollaris, Benoit Nemery, Tomoaki Hoshino, Jan Ceuppens, Peter Hoet, Jeroen Vanoirbeek
PA4030
Characterization of an endogenous Th17-cell generation during sensitization in the murine lung Melanie Albrecht (Hannover, Germany), Melanie Albrecht, Sandra Lingner, Matthias Lochner, Anna-Maria Dittrich
PA4031
The immunomodulatory activity of protein S protects against allergic airway inflammation Yoshinori Takahashi (Tsu shi, Japan), Yoshinori Takahashi, Kentaro Urata, Atsushi Tomaru, Kentaro Fujiwara, Masahiro Onishi, Takehiro Takagi, Hiroyasu Kobayashi, Corina D’Alessandro-Gabazza, Esteban Gabazza, Osamu Taguchi, Tetsu Kobayashi
PA4032
Eotaxin-3 exerts innate host defense activities that are modulated by mast cell proteases Anele Gela (Lund, Sweden), Anele Gela, Gopinath Kasetty, Sandra Jovic, Maria Ekoff, Gunnar Nilsson, Sven Kjellstrom, James Pease, Arne Egesten
PA4033
Airway hyperresponsiveness in patients treated with omalizumab Pasquale Capano (Agropoli, Italy), Pasquale Capano, Diomira Magliacane
PA4034
The content of natural killer cells in the blood of patients with asthma in combination with depression Zhanna Antanovich (Minsk, Belarus), Zhanna Antanovich, Natalia Goncharova
PA4035
First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device John Dennis (Calgary, Canada), John Dennis, Andy Clark, Ian McAffer, Stefan Dalberg, Francis Green
258
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4036
Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity Mayra PARRA PEREZ (Sevilla, Spain), Mayra Parra Perez, Auxiliadora Romero Falcon, Marta Ferrer Galvan, Juan Francisco Medina Gallardo, Francisco Javier Alvarez Gutierrez
PA4037
Bronchodilators in school children with asthma and normal FEV1 Borislav A. Kamenov (Nis, Republic of Serbia), Svetlana Kamenov, Aleksandar Kamenov, Borislav Kamenov, Snezana Cekic
PA4038
Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data Jing Yang (Beijing, China), Jing Yang, Michael Humphries, Shuang Ren, Linda Wang, Abhijit Pethe, Ioannis Kottakis
PA4039
Chronic granulomatous disease diagnosed in adulthood- Report of 2 Cases Ayse Irem KiliÇ (ISTANBUL, Turkey), Ayse Irem Kiliç, Dilem Anil Tokyay, Yasemin Bodur, Emine Aksoy, Oguz Aktas, Fatma Tokgöz Akyil, Tülin Sevim
PA4040
Osteopontin binds and modulate the antibacterial action of eosinophil-recruiting chemokines during allergic inflammation Anele Gela (Lund, Sweden), Anele Gela, Gopinath Kasetty, Anders Bergqvist, Jonas Erjefält, Matthias Mörgelin, Arne Egesten
PA4041
Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment Joanna Hermanowicz-Salamon (Warszawa, Poland), Joanna Hermanowicz-Salamon, Patrycja Nejman-Gryz, Renata Rubinsztajn, Magdalena Paplinska-Goryca, Ryszarda Chazan
PA4042
24-h efficacy and pharmacokinetics of tiotropium Respimat® 5 g in patients with asthma Roland Buhl (Mainz, Germany), Roland Buhl, Kai-Michael Beeh, Wolfgang Timmer, Piet Cornelissen, Ralf Sigmund, Ashish Sharma, Michael Engel, Petra Moroni-Zentgraf, Ronald Dahl
PA4043
Matrix metalloproteinase levels of bronchial mucosa and the correlation with clinical parameters in clinically stable bronchiectasis Ying-ying Gu (Guangzhou, China), Wei-jie Guan, Ying-ying Gu, Gui-hong Liu, Yong-hua Gao, Rong-chang Chen, Nanshan Zhong
PA4044
PI3K inhibition confer efficacy in experimental models of allergic airway inflammation Sandra Rodrigo Blomqvist (Mölndal, Sweden), Sandra Rodrigo Blomqvist, Rikard Pehrson, Karin Björhall, Susanne Arlbrandt, Britta Bonn, Matthew Perry, Mohib Uddin, Neil Holden, Matt Thomas, Kostantinos Karabelas
PA4045
Hospital-based multicenter study in Turkey: The atopic effect on the progress of viral pneumonia Demet Can (Izmir, Turkey), Semiha Bahceci, Demet Can, Saniye Girit, Ferhat çatal, Velat Sen, Sevgi Pekcan, Hasan Yüksel, Aysen Bingöl, Ilknur Bostanci, Duygu Erge, Refika Ersu
Hall 14-21
Session 418
12:50 - 14:40
Thematic Poster: Treatment and control of respiratory disease Chairs : Anne Lindberg (Boden, Sweden), Lucia Cazzoletti (Verona, Italy), Christer Janson (Uppsala, Sweden), Bo Lundback (Gothenburg, Sweden)
PA4046
LATE-BREAKING ABSTRACT: One-year assessment of asthma control and quality of life in Europe: The liaison study (international cross-sectional and longitudinal assessment on asthma control) Eleonora Ingrassia (Parma, Italy), Eleonora Ingrassia, Gabriele Nicolini, Daniele Guastalla, Fulvio Braido, Guy Brusselle, David Price, Nicolas Roche, Joan B. Soriano, Heinrich Worth
PA4047
LATE-BREAKING ABSTRACT: Stability of blood eosinophil count in COPD patients in the UK clinical practice research datalink Sarah Landis (Uxbridge, United Kingdom), Sarah Landis, Robert Suruki, Nicolas Galwey
PA4048
LATE-BREAKING ABSTRACT: The urban-rural gradient in asthma: A population-based cohort study in Northern Europe Signe Timm (Aarhus C, Denmark), Signe Timm, Cecilie Svanes, Christer Janson, Torben Sigsgaard, Ane Johannesen, Thorarinn Gislason, Rain Jogi, Ernst Omenaas, Bertil Forsberg, Kjell Torén, Mathias Holm, Vivi Schlünssen
PA4049
Factors associated with patient perspective outcomes in a cohort of asthmatics Muriel M Delvaux (Liege, Belgium), Muriel Delvaux, Florence Schleich, Virginie Paulus, Monique Henket, Renaud Louis
PA4050
The adherence to inhaled drugs in COPD patients: Effect on survival Valeria Belleudi (Rome, Italy), Valeria Belleudi, Nera Agabiti, Mirko Di Martino, Silvia Cascini, Ursula Kirchmayer, Riccardo Pistelli, Giulio Formoso, Danilo Fusco, Marina Davoli
259
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4051
Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD Gulshan Sharma (Galveston, United States of America), Gulshan Sharma, Wei Zhang, Yong-Fang Kuo
PA4052
Drug treatment in a German real-life COPD cohort (DACCORD) Heinrich Worth (Furth, Germany), Heinrich Worth, Roland Buhl, Carl-Peter Criée, Peter Kardos, Claus Vogelmeier
PA4053
COPD guideline adherence in hospital- and population-recruited COPD patients Bahareh Jouleh (Bergen, Norway), Bahareh Jouleh, Amund Gulsvik, Tomas Eagan, Rune Grønseth
PA4054
Discordant symptom severity in COPD: The PHAROAH study Mark Orme (Loughborough, United Kingdom), Mark Orme, Dale Esliger, Mike Morgan, Sally Singh, Michael Steiner, Andrew Kingsnorth, Lauren Sherar
PA4055
Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Tomas Mikal Eagan (Bergen, Norway), Tomas M.L. Eagan, Jon A. Hardie, åsne Jul-Larsen, Per S. Bakke, Rebecca J. Cox
PA4056
The relationship between pneumococcal antibody response patterns and asthma status Young J Juhn (Rochester, United States of America), Rohit Divekar, Chung Il Wi, Miguel Park, Roshini Abraham, Young Juhn
PA4057
Prevalence of switching from brand to generic asthma medications Marjolein Engelkes (Bergschenhoek, Netherlands), Marjolein Engelkes, Nico Van Blijderveen, Katia Verhamme, Jetty Overbeek, Josine Kuiper, Ron Herings, Miriam Sturkenboom, Johan De Jongste, Hettie Janssens
PA4058
Effect of not appropriate treatment in severe/not controlled asthma: The AGAVE study Sara Maio (Pisa, Italy), Sara Maio, Sandra Baldacci, Franca Martini, Patrizia Silvi, Giuseppe Sarno, Sonia Cerrai, Anna Angino, Anna Paola Pala, Giovanni Viegi
PA4059
Effectiveness of montelukast on asthma control in infants: A claims data study Manon Belhassen (Lyon, France), Belhassen Manon, Ginoux Marine, Laigle Valérie, Chanut-Vogel Céline, Lamezec Liliane, De Blic Jacques, Brouard Jacques, Fauroux Brigitte, De Pouvourville Gérard, Laforest Laurent, Van Ganse Eric, Belhassen Manon
PA4060
Tracing asthma by drug utilization in young adults Jesper Bælum (Odense C, Denmark), Jesper Baelum, David Sherson, Trine Thilsing, Lars Rauff Skadhauge, Lisbet Krogh Traulsen, øyvind Omland, Jesper Rømhild Davidsen, Torben Sigsgaard, Vivi Schlünssen
PA4061
Estimating severe asthma prevalence in austria using nationwide prescription data Daniel Doberer (Wien, Austria), Riad Ghanem, Berthold Reichardt, Michael Wolzt, Daniel Doberer
PA4062
Asthma therapeutic management in the elderly: Pharmacoepidemiological approach in the E3N cohort Sebastien Chanoine (La Tronche, France), Sebastien Chanoine, Margaux Sanchez, Pierrick Bedouch, Françoise ClavelChapelon, Raphaelle Varraso, Isabelle Pin, Valerie Siroux
PA4063
Do we treat mycoplasma pneumoniae infections differently during an epidemic? Jasna Rodman (Ljubljana, Slovenia), Jasna Rodman, Tatjana Mrvic, Darja Keše, Rok Kogoj
Hall 14-22
Session 419
12:50 - 14:40
Thematic Poster: Asthma and COPD: overlap and exacerbations Chairs : Per Sigvald Bakke (Bergen, Norway), James Allinson (London, United Kingdom), Peter Lange (Hvidovre, Denmark), Simone Accordini (Verona, Italy)
PA4064
The prevalence of asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS) in a Northern Italy general population sample Marco Caminati (Verona, Italy), Massimo Guerriero, Marco Caminati, Simona Paiano, Luigi Assante, Gianenrico Senna, Carlo Pomari
PA4065
LATE-BREAKING ABSTRACT: The burden of asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) in urban China Bo Ding (Mölndal, Sweden), Bo Ding, Marco DiBonaventura, Jonas Roman, Niklas Karlsson, Xia Ling
PA4066
Evaluation of asthma/COPD overlap within the ECLIPSE study Tara Rheault (Research Triangle Park, United States of America), Tara Rheault, Wurst Keele, Lisa Edwards, Ruth TalSinger, Alvar Agusti, Jørgen Vestbo
PA4067
Validation of the recording of acute exacerbations of COPD in the clinical practice research datalink: Phase 1 results Kieran Rothnie (London, United Kingdom), Kieran Rothnie, Hana Mullerova, John Hurst, Liam Smeeth, Kourtney Davis, Sara Thomas, Jennifer Quint
260
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4068
Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort Eric van Ganse (Lyon, France), Eric Van Ganse, Laurent Laforest, Hélène Le Cloarec, Alexandra Dima, And the ASTROLAB Group
PA4069
Predictors of exacerbation frequency in chronic obstructive pulmonary disease Juan Luis García Rivero (Mompía (Santa Cruz de Bezana)-Cantabria, Spain), Miguel Santibañez, Roberto Garrastazu, Juan Luis Garcia-Rivero, Mario Ruiz, Sandra Arenal, Jose Helguera, Cristina Bonnardeaux, Carlos Leon, Javier Llorca
PA4070
Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study Bernardino Alcazar Navarrete (Cájar, Spain), Bernardino Alcazar Navarrete, Pilar De Lucas, Joan B. Soriano, Alonso Fernandez-Nistal, Antonia Fuster, Jose Miguel Rodríguez González-Moro, Aurelio Arnedillo, Patricia Garcia Sidro, María José Espinosa de los Monteros
PA4071
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Carolina Vitale (Frattamaggiore, Italy), Manuela Pitassi, Carolina Vitale, Maria D’Amato, Anna Stanziola, Mauro Mormile, Antonio Molino
PA4072
Lower rate of COPD exacerbations in patients with COPD and concurrent lung carcinoma – Data from the Bergmannsheil cohort David Jungck (Bochum, Germany), David Jungck, Ihab Abutayyem, Helena Wassiljew, Susanne Blum, Inga Isbruch, Jürgen Knobloch, Andrea Koch
PA4073
COPD exacerbations occur more frequently in women – Data from the Bergmannsheil cohort David Jungck (Bochum, Germany), David Jungck, Helena Wassiljew, Ihab Abutayyem, Susanne Blum, Inga Isbruch, Jürgen Knobloch, Andrea Koch
PA4074
Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems Suresh Babu (Southampton, United Kingdom), Suresh Babu, Elizabeth Pink, Karen Watkins, Helena Cummings, Joanne L. Thompson, Jaymin Morjaria
PA4075
Vitamin D status in COPD patients admitted for exacerbation Evgeni Mekov (Sofia, Bulgaria), Evgeni Mekov, Yanina Slavova, Adelina Tsakova, Marianka Genova, Dimitar Kostadinov, Delcho Minchev, Dora Marinova, Maya Tafradjiiska
PA4076
Relationship of cold frequency and virus detection to exacerbations in COPD patients Neil Johnston (Dundas, Canada), Neil Johnston, Marita Olsson, Staffan Edsbacker, Maria Gerhardsson de Verdier, Per Gustafson, Christopher McCrae, Andrew McIvor
PA4077
Differences in COPD: Smokers versus non smokers Carlos Cabrera Lopez (Las Palmas de G.C., Spain), Carlos Cabrera Lopez, Ciro Casanova Macario, Fernando León Marrero, Gabriel Juliá Serdá, Pedro Cabrera Navarro, Miguel Angel García Bello, Juan Pablo De Torres Tajes, Jose María Marín Trigo, Miguel Divo, Bartolomé Celli
PA4078
The clinical significance of laryngopharyngeal reflux in patients with chronic obstructive pulmonary disease Deog Kyeom Kim (Seoul, Republic of Korea), Doh Young Lee, Young Ho Jung, Sung Soo Park, Hee Soon Chung, Eunyoung Heo, Deog Kyeom Kim
PA4079
Definition of nocturnal gastroesophageal reflux for studies on airway diseases Össur Ingi Emilsson (Uppsala, Sweden), össur Ingi Emilsson, Sigurdur Júlíusson, Sören Berg, Einar Stefán Björnsson, Bryndís Benediktsdóttir, Christer Janson, Thórarinn Gíslason
PA4080
Gastro-oesophageal reflux disease and exacerbations of COPD in a cohort of 2,135 COPD patients Victoria Benson (Uxbridge, United Kingdom), Victoria Benson, Hana Müllerová, Jørgen Vestbo, Jadwiga Wedzicha, Anant Patel, John Hurst
PA4081
Seasonal variation in cryptogenic hemoptysis hospitalizations in Tunisia Sonia Toujani Chekki (Tunis, Tunisia), Asma Sebei, Sonia Toujani, Meriem Mjid, Rihab Bey, Nozha Ben Salah, Yacine Ouhachi, Jalloul Daghfous, Bechir Louzir, Nadia Mehiri, Jouda Cherif, Majed Beji
PA4082
LATE-BREAKING ABSTRACT: Multinational, database cohort study to assess severe exacerbation rate in asthma Marjolein Engelkes (Bergschenhoek, Netherlands), Marjolein Engelkes, Maria de Ridder, Elisabeth Svensson, Klara Berensci, Daniel Prieto-Alhambra, Francesco Lapi, Carlo Giaquinto, Gino Picelli, Nada Boudiaf, Frank Albers, Sarah Cockle, Eric Bradford, Robert Suruki, Peter Rijnbeek, Miriam Sturkenboom, Katia Verhamme
PA4083
LATE-BREAKING ABSTRACT: Multinational, database cohort study to assess all-cause mortality following severe asthma exacerbations Katia MC Verhamme (Rotterdam, Netherlands), Marjolein Engelkes, Maria de Ridder, Elisabeth Svensson, Klara Berensci, Daiel Prieto-Alhambra, Francesco Lapi, Carlo Giaquinto, Gino Picelli, Nada Boudiaf, Frank Albers, Sarah Cockle, Eric Bradford, Robert Suruki, Peter Rijnbeek, Miriam Sturkenboom, Katia Verhamme
261
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
Hall 14-23
Session 420
12:50 - 14:40
Thematic Poster: Occupational and environmental exposure assessment and biomarkers Chairs : Kevin Lamote (Gent, Belgium), Elizabeth Fireman (Tel-Aviv, Israel), Subhabrata Moitra (Krishnagar, Nadia, India), Chair to be confirmed PA4084
LATE-BREAKING ABSTRACT: The urban-rural gradient of allergic asthma in adults Grethe Elholm (Hammel, Denmark), Grethe Elholm, Allan Linneberg, Lise Lotte Husemoen, Øyvind Omland, Pernille Milvang Grønager, Torben Sigsgaard, Vivi Schlünssen
PA4085
LATE-BREAKING ABSTRACT: Bacterial microbiota of mattress dust and nasal samples, farming exposure, and childhood asthma Martin Depner (Munich, Germany), Lena Birzele, Martin Depner, Markus Johannes Ege, Marion Engel, Christoph Bernau, Elisabeth Horak, Charlotte Braun-Fahrlaender, Jon Genuneit, Hanna Danielewicz, Dick Heederik, Erika von Mutius, Antje Legatzki
PA4086
LATE-BREAKING ABSTRACT: The association between serum vitamin D deficiency and allergic symptom in pregnant women Kumiko Kanatani (Kyoto, Japan), Kumiko Kanatani, Yuichi Adachi, Kei Hamazaki, Hidekuni Inadera, Kazunari Onishi, Youichi Kurozawa, Takeo Nakayama
PA4087
LATE-BREAKING ABSTRACT: The differential pattern of deposition of nano-ranged particles in the airways of exposed workers Elizabeth Fireman (Tel-Aviv, Israel), Elizabeth Fireman, Rinat Aldehaid, Moshe Stark, Yehuda Schwarz, Amir Bar Shai
PA4088
Lung retention of nonfibrous mineral particles in subjects free of occupational exposure Jean-Claude Pairon (Créteil, France), Hélène Attali, Karine Beugnon, Perrrine Boudet, Patrick Brochard, Pascal Andujar, Laurent Martinon, Sophie Lanone, Jean-Claude Pairon
PA4089
The potential of a low-cost particle counter to quantify airborne particulate matter in a laboratory animal facility Meinir Jones (London, United Kingdom), Meinir Jones, Sean Semple, Susie Schofield, Johanna Feary, Paul Cullinan
PA4090
Reduction personal exposure to black carbon during commuting in London - A feasibility study Lee Koh (London, United Kingdom), Lee Koh, Abigail Whitehouse, Jonathan Grigg
PA4091
Counting asbestos bodies in bronchoalveolar lavage: A retrospective analysis and literature review Valerie Nuyts (Leuven, Belgium), Valerie Nuyts, Hadewijch Vanhooren, Kristiaan Nackaerts, Benoit Nemery de Bellevaux
PA4092
Biomarkers of oxidative-stress and inflammation in exhaled breath of hospital cleaners Piera Boschetto (Ferrara, Italy), Enrico Casimirri, Mariarita Stendardo, Melissa Bonci, Roberta Andreoli, Barbara Bottazzi, Roberto Leone, Mischela Schito, Alberto Papi, Marco Contoli, Massimo Corradi, Piera Boschetto
PA4093
Chemical fingerprint of outdoor PM2.5 in Malta Martin Balzan (Tal Qroqq, Malta), Martin Balzan, Fabio Cibella, Christopher Zammit, David Bilocca, Cinzia Perrino, Silvia Canepari, Gianluca Scaccianoce, Stephen Montefort, Giovanni Viegi
PA4094
Indoor pollutions and the prevalence of respiratory symptoms among highlanders in Kyrgyzstan Talantbek Sooronbaev (Bishkek, Kyrgyzstan), Talantbek Sooronbaev, Beraki Ghezai, Sian Williams, Meerim Almatalieva, Mamed Mademilov, Niels Chavannes
PA4095
Emission of toxic chemicals from traditional cigarette and e-cigarette side-stream smoke Constantinos Sioutas (Los Angeles, United States of America), Arian Saffari, Nancy Daher, Ario Ruprecht, Cinzia De Marco, Paolo Pozzi, Roberto Boffi, Samera Hamad, Martin Shafer, James Schauer, Dane Westerdahl, Constantinos Sioutas
PA4096
Uptake of inhaled polychlorinated biphenyls (PCBs) in a human longitudinal cohort study and animal inhalation studies Peter S. Thorne (Iowa City, United States of America), Peter Thorne, Matt Ampleman, Xin Hu, Andrea Adamcakova-Dodd, Keri Hornbuckle
PA4097
Decrease in lung function in relation to increasing BDE exposure in teenagers Gavin ten Tusscher (Hoorn NH, Netherlands), Gavin Ten Tusscher, Marike Leijs, Janna Koppe, Kees Olie, Pim De Voogt, Wim Van Aalderen
PA4098
Organic dust toxic syndrome caused by occupational exposure to shrimpshell powder Randi Bertelsen (Bergen, Norway), Randi Bertelsen, øistein Svanes, Bjørg Eli Hollund, Anne Mette Madsen, Torben Sigsgaard, Tor Aasen, Cecilie Svanes
262
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4099
Determining Mus m 1 personal exposure in laboratory animal workers where mice are housed in individually ventilated cages Jennifer Canizales (London, United Kingdom), Jennifer Canizales, Meinir Jones, Sean Semple, Zoe Lightfoot, Johanna Feary, Paul Cullinan
PA4100
N-acetylhexosaminidase to assess exposure to fungi Ragnar Rylander (Lerum, Sweden), Ragnar Rylander
PA4101
Aeromycoflora over rice field and their allergenic effect on farmers of N24 Parganas, West Bengal, India Mouli Saha (Santiniketan, Bolpur, India), Mouli Saha, Kashinath Bhattacharya
PA4102
The exhaled carbon monoxide levels, respiratory function tests and the blood oxidative stress levels of the petrol station workers Ay e Nur Soytürk (Kars, Turkey), Ayse Nur Soytürk, Aysegül Karalezli, Canan Hasanoglu
Hall 14-24
Session 421
12:50 - 14:40
Thematic Poster: Occupational and environmental effects: in vitro and animal models Chairs : Loretta Mueller (Basel, Switzerland), Kristin Cummings (Morgantown, United States of America), David Mannino (Lexington, United States of America), Chair to be confirmed
PA4103
Different toxicity of combustion particles on human lung A549 cells: A comparison between diesel exhaust and wood smoke Yuduo Zheng (Aarhus, Denmark), Yuduo Zheng, Jing Wang, Miriam Gerlofs-Nijland, Jakob Bønløkke, Christiane Beer, Torben Sigsgaard
PA4104
Effect of gasoline exhaust emission on bronchial epithelial cells and natural killer cells Roth Michèle (Dornach, Switzerland), Michèle Roth, Selina Steiner, Christoph Bisig, Pierre Comte, Jan Czerwinski, Barbara Rothen-Rutishauser, Philipp Latzin, Loretta Müller
PA4105
Toxicological responses of normal human bronchial epithelium (NHBE) model exposed to settled dust samples from moisture damaged and reference schools Kati Huttunen (Cardiff, United Kingdom), Kati Huttunen, Anna Julia Wlodarczyk, Zoë Prytherch, Tim Jones, Jenni Tirkkonen, Martin Täubel, Juha Pekkanen, Dick Heederik, Jan-Paul Zock, Anne Hyvärinen, Maija-Riitta Hirvonen, Ralf Zimmermann, Kelly BéruBé
PA4106
Receptors for adhesion molecules are induced on monocytes exposed to PM10 Ernesto Alfaro-Moreno (Södertälje, Sweden), Ernesto Alfaro-Moreno, Angelica Montiel-Davalos, Guillermina Hernandez, Rebeca Lopez-Marure, Raul Quintana-Belmares, Vesna Munic Kos, Karin Cederbrant
PA4107
Effect of engineered nanoparticles on natural killer cells in vitro Loretta Mueller (Basel, Switzerland), Loretta Müller, Selina Steiner, Laura Rodriguez-Lorenzo, Alke Petri-Fink, Barkara Rothen-Rutishauser, Philipp Latzin
PA4108
Silver nanoparticles of 20nm in diameter increase epithelial sodium channel (ENaC) currents in isolated sheep pleura Zoi Arsenopoulou (Larissa, Greece), Zoi Arsenopoulou, Paschalis Adam Molyvdas, Konstantinos Gourgoulianis, Sotirios Zarogiannis, Chrissi Hatzoglou
PA4109
Graphene compounds modulate autophagy combined with PU.1 change in the macrophages Jong-Wook Shin (Seoul, Republic of Korea), Jong Wook Shin, In Won Park, Jae Woo Jung, Jae Cheol Choi, Jae Yeol Kim, Byoung Whui Choi, Kyung Soon Choi, Soo Young Kim
PA4110
Emodin mitigates diesel exhaust particles-induced increase in airway resistance, inflammation and oxidative stress in mice Abderrahim Nemmar (Al ain, United Arab Emirates), Abderrahim Nemmar, Suhail Al-Salam, Priya Yuvaraju, Sumaya Beegam, Badreldin H. Ali
PA4111
Effects of acute hypochlorite exposure in OVA-sensitized and challenged mice Isabella Santos de Genaro (Sao Paulo, Brazil), Isabella S. de Genaro, Francine M. de Almeida, Deborah Hizume, Henrique T. Moriya, Bruna N. Cordeiro, João Carlos G. Cruz, Renan B. Lopes, Rodolfo P. Vieira, Ronaldo A. Silva, Milton A. Martins, Fernanda M. Arantes-Costa, Beatriz M. Saraiva-Romanholo
PA4112
Standardization of a murine model of asthma due to soybean inhalation Daniel Alvarez-Simon (Barcelona, Spain), Daniel álvarez-Simón, Susana Gómez-Ollés, Xavier Muñoz, María-Dolores Untoria, Marta Ollé-Monge, María-Jesús Cruz
PA4113
Comparison of two murine models of acute and chronic hypersensitivity pneumonitis due to pigeon serum exposure Mª JESUS CRUZ CARMONA (Barcelona, Spain), Mónica Sánchez-Ortiz, María-Jesús Cruz, María-Dolores Untoria, Ana Villar, Ferran Morell, Marta Ollé-Monge, Xavier Muñoz
263
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4114
Effects of hydrogen sulfide on ozone-induced features of chronic obstructive pulmonary disease Feng Li (Shanghai, China), Feng Li, Pengyu Zhang, Min Zhang, Li Liang, Xiaoyuan Sun, Aihua Bao, Min Li, Yueqin Tang, Jicheng Gong, Jim (Junfeng) Zhang, Ian Adcock, Kian Fan Chung, Xin Zhou
PA4115
Oxidative DNA damage in rat lung after exposure to cerium oxide nanoparticles Kazuaki Kawai (Kitakyushu, Japan), Kazuaki Kawai, Yun-Shan Li, Yuya Kawasaki, Yasuo Morimoto
PA4116
Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study Takako OYABU (Kitakyushu, Japan), Takako Oyabu, Yasuo Morimoto, Manabu Shimada, Masaru Kubo, B.W. Lee, Takami Okada, Hiroto Izumi, Yukiko Yoshiura, Toshihiko Myojo
PA4117
Gold nanoparticles translocate from the lung into the blood in man and accumulate at sites of vascular inflammation in apolipoproteinE knockout mice Jennifer Raftis (edinburgh, United Kingdom), Jennifer Raftis, Mark Miller, Jeremy Langrish, Petra Krystek, Colin Campbell, Ken Donaldon, Flemming Cassee, David Newby, Nicholas Mills, Rodger Duffin
PA4118
Pulmonary toxicity of cerium oxide nanoparticle following intratracheal instillation and inhalation of nanoparticles Yasuo Morimoto (Kitakyushu, Japan), Yasuo Morimoto, Hiroto Izumi, Yukiko Yoshiura, Taisuke Tomonaga, Takako Oyabu, Toshihiko Myojo, Manabu Shimada, Masaru Kubo, Kazuhiro Yamamoto, Shinichi Kitajima
PA4119
Enhanced interleukin-18 expression in rodent models of quartz induced fibrosis Paul Peeters (Maastricht, Netherlands), Paul Peeters, Damien Vanberlo, Niki Reynaert, Emiel Wouters, Catrin Albrecht, Roel Schins
PA4120
Effects of air pollution on inflammation of respiratory system: Differences between male and female kelly yoshizaki (São Paulo, Brazil), Kelly Yoshizaki, Adriana Lino-dos-Santos-Franco, Jôse Mára Brito, Thaís Moraes Nascimento Santos, Pérola Vasconcelos, Thaís Mauad, Paulo Hilário Nascimento Saldiva, Mariangela Macchione
PA4121
Chlorpyrifos, but not diazinon, potentiates airway hyperreactivity in sensitized guinea pigs Becky Proskocil (Portland, United States of America), Becky Proskocil, Donald Bruun, Pamela Lein, David Jacoby, Allison Fryer
Hall 14-25
Session 422
12:50 - 14:40
Thematic Poster: E-cigarette, sisha and waterpipe Chairs : Constantine Vardavas (Heraklion, Greece), Bertrand Dautzenberg (Paris, France), Filippos Filippidis (London, United Kingdom), Constantinos Glynos (Athens, Greece) PA4122
Comparison of knowledge attitude and practice of shisha use among medical students and pharmacy students Ashok Kumar (Karachi, Pakistan), Ashok Kumar, Salman Baig, Ammara Raif
PA4123
The effect of smoking on lung function and respiratory symptoms in population of 25-40 years who worked in state administration Jagoda Stojkovic (Skopje, FYROM (Macedonia)), Jagoda Stojkovic, Biserka Kaeva, Gencijana Stevcevska, Smiljko Jovanovski, Irina Angelovska
PA4124
Evaluation of Iranian general population attitudes towards tobacco taxes Mahshid Aryanpur (TEHRAN, Islamic Republic of Iran), Mahshid Aryanpur, Hooman Sharifi, Zahra Hessami, Gholam Reza Heydari, Mohammad Reza Aryan, Ashraf Vaseghnia, Hamid Reza Jamaati
PA4125
Characterization of medical doctor’s smoking habits in a central hospital Rafaela Campanha (Lisbon, Portugal), Rafaela Campanha, Inês Ribeiro, Cristina Matos, Fernando Nogueira
PA4126
Comparison of knowledge attitude and practice of cigarette smoking and water pipe use among physicians and surgeons of Pakistan Ashok Kumar (Karachi, Pakistan), Ashok Kumar, Sadhana Notani, Ravi Mahat, Nida Hussain, Nadeem Rizvi
PA4127
Evaluation of water pipe tobacco smoking among Iranian professional athletes Zahra Hessami (Tehran, Islamic Republic of Iran), Zahra Hessami, Hooman Sharifi, Gholamreza Heydari, Jamaati Hamidreza
PA4128
Factors associated with E-cigarette use among Irish teenagers Kate Babineau (Dublin, Ireland), Kate Babineau, Luke Clancy, Sheila Keogan
PA4129
Urinary cotinine and lipid profile as risk factors of cardiovascular morbidity in pan masala containing tobacco (PMT) users Sanjeeb Shrestha (Dharan, Sunsari, Nepal), Sanjeeb Shrestha
PA4130
E-cigarettes: Views of healthcare professionals Nwaorima Kamalu (Bristol, United Kingdom), Nwaorima Kamalu, Bandipalyam Prathibha
264
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4131
What are characteristics of exclusive e-cigarettes users compared to dual tobacco and e-cigarettes users in middle school? Bertrand Dautzenberg (Paris, France), Bertrand Dautzenberg, Nicole Rieu, Pierre Birkui, Marie-Dominique Dautzenberg
PA4132
Cigarette and e-cigarette use: A series of 146 patients seen in a respiratory functional exploration department Jean-Charles Glerant (Bron, France), Ghislaine Plasencia, Jean-Charles Glerant, Philippe Imamdad, Ségolène Turquier
PA4133
Doses of nicotine used in e-cigarette in the 1 million puffs study Bertrand Dautzenberg (Paris, France), Bertrand Dautzenberg
PA4134
Shisha (waterpipe) use in medical students of a developing country MARYAM HASSAN (Karachi, Pakistan), Maryam Hassan, Nousheen Iqbal, Muhammad Irfan, Javaid Khan
PA4135
Shisha-smoking: Knowledge and prevalence among high school students Helmy Haja Mydin (Kuala Lumpur, Malaysia), Helmy Haja Mydin, Farizah Mohd Hairi, Fatihah Mohd Amin, Amer Amer Nordin
PA4136
Is electronic-cigarette a tobacco industry discovery? Elif Dagli (Istanbul, Turkey), Elif Dagli, Fusun Yildiz, Murat Guner
PA4137
Knowledge of electronic cigarettes: A survey of national health service (NHS) employees at a large UK district general hospital Aoife Lillis (Lytham St Annes, United Kingdom), Aoife Lillis, Claire Jones, Tarek Saba
PA4138
Assesment of the level of use and knowledge of adolescents about electronic cigarette – A pilot study in Cluj-Napoca Area, Romania Andreea Coman (Cluj-Napoca, Romania), Doina Adina Todea, Andreea Codruta Coman
Hall 14-26
Session 423
12:50 - 14:40
Thematic Poster: Respiratory physiology in children: technical and clinical aspects Chairs : Paul Aurora (London, United Kingdom), Paul Seddon (West Sussex, United Kingdom), Claudia Calogero (Massarosa, Italy) PA4139
Respiratory function, scoliosis and arthrodesis in Duchenne muscular dystrophy Lauriane Coutier (Vandoeuvre Les Nancy, France), Laurianne Coutier, Laurence Mainard-Simard, Jean-Louis Tassin, Vincent Laugel, Brigitte Estournet, Cyril Schweitzer
PA4140
Spontaneous breathing pattern in children with spinal muscle atrophy (SMA) Antonella Lo Mauro (Milan, Italy), Antonella LoMauro, Chiara Mastella, Giovanni Baranello, Andrea Aliverti
PA4141
Scoliosis and spinal fusion (SF) correlate with spirometry but not with breathing pattern at rest in Duchenne muscular dystrophy (DMD) Antonella Lo Mauro (Milan, Italy), Antonella LoMauro, Marianna Romei, Sandra Gandossini, Nereo Bresolin, Maria Grazia D’Angelo, Andrea Aliverti
PA4142
Determinants of the tension-time index of the inspiratory muscles in healthy children Theodore Dassios (London, United Kingdom), Theodore Dassios, Aggeliki Vervenioti, Gabriel Dimitriou
PA4143
Impact of sedation on interpretation of longitudinal lung function growth Diane Gray (Cape Town, South Africa), Diane Gray, Lauren Willemse, Ane Visagie, Peter Sly, Heather J. Zar, Graham L. Hall
PA4144
Variability of spirometry in healthy preschool children Luciano Enrique Busi (Trelew, Argentina), Luciano Enrique Busi, Peter David Sly, Ricardo Daniel Tourres
PA4145
Lung growth by lung carbon monoxide diffusing capacity, in healthy children residing at 2240 m above sea level Laura Gochicoa-Rangel (Texcoco, Mexico), Laura Gochicoa-Rangel, Uri Mora-Romero, Rogelio Pérez-Padilla, Gabriela Cantú-González, Luis Rodríguez-Moreno, Selene Guerrero-Zúñiga, Mónica Silva-Cerón, Rosario Fernández-Plata, Luis Torre-Bouscoulet
PA4146
A standardized tool to assess quality of MBW tracings Renee Jensen (Toronto, Canada), Renee Jensen, Sanja Stanojevic, Michelle Klingel, Felix Ratjen
PA4147
Time between multiple breath nitrogen washout (MBNW) tests: Is duration of washout enough across childhood? Kate Hardaker (Westmead, Australia), Kate Hardaker, Geshani Jayasuriya, Per Gustafsson, Peter Cooper, Dominic Fitzgerald, Hiran Selvadurai, Paul Robinson
265
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4148
Validation of commercial devices for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in school-aged children Emma Raywood (London, United Kingdom), Emma Raywood, Julie Duncan, Angie Wade, Janet Stocks, Andy Bush, Paul Aurora, On Behalf of The London Cystic Fibrosis Collaboration (LCFC), Funded by Action Medical Research for Children, The Henry Smith Charity
PA4149
Underestimation of lung clearance index values in infants with cystic fibrosis due to software analysis algorithms Pinelopi Anagnostopoulou (Bern, Switzerland), Pinelopi Anagnostopoulou, Sophie Yammine, Anne Schmidt, Insa Korten, Elisabeth Kieninger, Ines Mack, Daniel Trachsel, Gaudenz Hafen, Alexander Moeller, Carmen Casaulta, Philipp Latzin
PA4150
Usability of a hand-held device to determine nasal nitric oxide in clinical routine Andreas Jung (Zurich, Switzerland), Andreas Jung, Michael Bigger, Christian Bieli, Alexander Möller
PA4151
Respiratory and neurobehavioural characteristics of a murine model of congenital myotonic dystrophy type 1 Helène Prigent (Garches, France), Helene Prigent, Maud Ringot, Nelina Ramanantsoa, Lise Michel, Thomas Bourgeois, Boris Matrot, Genevieve Gourdon, Jorge Gallego
PA4152
Inter-reviewer agreement of a standardized MBW quality control tool Renee Jensen (Toronto, Canada), Renee Jensen, Sanja Stanojevic, Maria Ester Pizarro, Michelle Klingel, Felix Ratjen
PA4153
Cardiac and pulmonary abnormalities in children with chronic kidney diseases undergoing hemodialysis Eman Sobh (Al-Mahalla Al-Kobra, Egypt), Eman Sobh, Manal Abd Elsalam, Soma Aabd Allah, Fadila Mamdouh, Rehab Hamdy
PA4154
Development of lung function in infancy in ’healthy’ preterm infants Ines Mir Messa (Barcelona, Spain), Ines De Mir, Olaia Sardon, Paula Corcuera, Manuel Sanchez Solís, Araceli Caballero, A.F. Hoo, Virginia Pérez, Eduardo González Perez-Yarza, Antonio Moreno-Galdó
PA4155
A pilot study of respiratory and nutritional outcomes of moderate/late preterm birth Katy Pike (Hampshire, United Kingdom), Katharine C. Pike, Philippa Crowley, Jessica Taylor, Michael P.W. Grocott, Sandy Jack, Alan Jackson, Alison Leaf, Jane S.A. Lucas
PA4156
Gaz exchange, nasal nitric oxyde levels and lung function tests in children with primary ciliary dyskinesia Guillaume Thouvenin (Paris, France), Guillaume Thouvenin, Aline Tamalet, Harriet Corvol, Annick Clement, Estelle Escudier, Nicole Beydon
PA4157
Evaluation of the LEOSound-Monitor® for standardized detection of wheezing and chough in childhood Volker Gross (Giessen, Germany), Volker Gross, Christof Urban, Andreas Weissflog, Ulrich Koehler, Michael Scholtes, Keywan Sohrabi, Sebastian Kerzel
PA4158
Polymorphisms of ADRB2 gene and airway resistance in children with bronchopulmonary dysplasia Evgenii Furman (Perm, Perm Krai, Russian Federation), Elena Zhdanovich, Evgeny Furman, Mariya Ponomareva, Irina Koryukina
Hall 14-27
Session 424
12:50 - 14:40
Thematic Poster: Monitoring sleep-disordered breathing in children and adults Chairs : Athanasios G Kaditis (Athens, Greece), Richard Staats (Murches, Portugal), Nicole Beydon (Paris, France), Valentina Fainardi (Parma, Italy)
PA4159
LATE-BREAKING ABSTRACT: Effects of air stacking versus glossopharyngeal breathing on maximum insufflation capacity in children and adolescents with neuromuscular disease Rodrigo Hernan Torres Castro (Santiago, Chile), Rodrigo Torres-Castro, Jordi Vilaró, Roberto Vera-Uribe, Luis Vasconcellos, Homero Puppo
PA4160
Evaluation of nasal resistance in children with sleep disordered breathing Jole Rabasco (Rome, Italy), Francesco Quagliarella, Jole Rabasco, Melania Evangelisti, Marilisa Montesano, Marco Del pozzo, Maria Pia Villa
PA4161
Sleep disordered breathing in children: Is it less in rural areas? Ela Erdem Eralp (Istanbul, Turkey), Ersoy Civelek, Ela Erdem, Bulent Karadag, Fazilet Karakoc, Can Naci Kocabas, Refika Ersu
PA4162
Functional respiratory imaging in children with Down syndrome and OSA Monique Slaats (Antwerp, Belgium), Monique Slaats, Wim Vos, Cedric Van Holsbeke, Marek Wojciechowski, Jan De Backer, Dieter Loterman, An Boudewyns, Wilfried De Backer, Stijn Verhulst
266
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4163
Is there a link between a unique body position during sleep in children with Down syndrome and obstructive sleep apnoea? Mieke Maris (Zwijndrecht, Belgium), Mieke Maris, An Boudewyns, Marek Wojciechowski, Paul Van de Heyning, Stijn Verhulst
PA4164
Apparent life –Threatening events may predispose to sleep disordered breathing in preschool age Jole Rabasco (Rome, Italy), Jole Rabasco, Alessandro Vigo, Melania Evangelisti, Silvia Noce, Marilisa Montesano, Maria Pia Villa
PA4165
Sleep studies in infants with apparent life threatening event Joaquin TerÁn-Santos (Burgos, Spain), Joaquin Terán-Santos, María José Mora-Simón, Estrella Ordax-Carbajo, Ana Isabel Navazo-Egüia, Gregorio De La Mata, Isabel Del Blanco, María García-Gonzalez, Esteban Gómez-Sanchez, María Luz Alonso-Alvarez
PA4166
Oxygen saturation, periodic breathing and apnea during sleep in infants 1 to 4 months old living at 2,560 meters above sea level Santiago Ucros (Bogota, Colombia), Santiago Ucrós, Claudia Granados, Karem Parejo, Fernando Guillén, Fausto Ortega, Sonia Restrepo, Fabián Gil, Miriam Guillén
PA4167
Adenotonsillar tissue size in prematurely-born children with snoring: An MRI study Athanasios G Kaditis (Athens, Greece), Georgia Papaioannou, Evangelia Manopoulou, Marina Tsaoussoglou, Polytimi Panaghiotopoulou-Gartagani, George Chrousos, Athanasios Kaditis
PA4168
Sleep-disordered breathing and adipokine secretion in obese children and adolescents Annelies Van Eyck (Wilrijk, Belgium), Annelies Van Eyck, Kim Van Hoorenbeeck, Benedicte De Winter, Luc Van Gaal, Wilfried De Backer, Stijn Verhulst
PA4169
Serum leukotriene B4 levels, tonsillar hypertrophy and obstructive sleep-disordered breathing in childhood Athanasios G Kaditis (Athens, Greece), Emmanouel Alexopoulos, George Haritos, Christina Befani, George Mousailidis, Vassilis Lachanas, Panagiotis Liakos, Konstantinos Gourgoulianis, Athanasios Kaditis
PA4170
Sleep architecture and type 2 diabetes mellitus: Where’s the link? Ana Araújo (Aveiro, Portugal), Ana Araújo, Luís Rodrigues, Jorge Henriques, Gilberto Teixeira, Pedro Ferreira, Carla Valente, Alcina Saraiva, Lília Andrade
PA4171
Resting energy expenditure among patients with obstructive sleep apnea syndrome: The impact of a single CPAP application Katalin Passa-Fekete (Thessaloniki, Greece), Katalin Fekete, Afroditi Boutou, Georgia Pitsiou, Nikolaos Chavouzis, Athanasia Pataka, Ioanna Ahanasiou, George Ilonidis, Theodoros Kontakiotis, Paraskevi Argyropoulou, Ioannis Kioumis
PA4172
Serum levels of adipokines in obstructive sleep apnea Züleyha Kaya Bingöl (Istanbul, Turkey), Zuleyha Bingol, Ekrem Bilal Karaayvaz, Aysegul Telci, Ahmet Kaya Bilge, Gulfer Okumus, Esen Kiyan
PA4173
Emerging aplications: Screening OSA by modified pictorial Epsworth sleepiness scale in Indian Azmat Karim (Delhi, India), Azmat Karim, Vijay Kumar Arora, Mohan Bandhu Gupta
PA4174
Overlap: Asthma and sleep apnea syndrome Antonella Marotta (Limatola, BN, Italy), Giuseppe Fiorentino, Anna Annunziata, Gianfranco Scotto di Frega, Rosa Cauteruccio, Antonella Marotta, Anna Michela Gaeta, Maria Antonietta Mazza, Maria Cardone
PA4175
Prevalence of overlap syndrome and its correlation with severity of obstructive sleep apnea syndrome Sarra Maazaoui (Tunis, Tunisia), Sarra Maazaoui, Haifa Zaibi, Jihen Ben Amar, Besma Dhahri, Salwa Azzebi, M. Ali Baccar, Hichem Aouina
PA4176
Profile of patients with obstructive sleep apnoea referred to a sleep clinic in Sri Lanka Chandimani Undugodage (Colombo, Sri Lanka), Chandimani Undugodage, Gnanapriya Daminda, Manjula Danansuriya, Ashan Kalugamage
PA4177
Sleep disordered breathing in patients with glycogenosis type II Gianfranco Scotto di Frega (Naples, Italy), Anna Annunziata, Giuseppe Fiorentino, Gianfranco Scotto di Frega, Antonella Marotta, Rosa Cauteruccio, Anna Michela Gaeta, Maria Antonietta Mazza, Maria Cardone
PA4178
Obstructive sleep apnoea and nocturnal arrhythmias in patients with ischaemic heart disease Silin Kuang (Singapore, Singapore), Silin Kuang, See Meng Khoo
Hall 14-28
Session 425
Thematic Poster: More paediatric asthma and allergy
267
12:50 - 14:40
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Chairs : Angela Zacharasiewicz (Vienna, Austria), Marc van der Schee (Amsterdam, Netherlands), Sejal Saglani (London, United Kingdom), Erol Gaillard (Leicester, United Kingdom)
PA4179
LATE-BREAKING ABSTRACT: Rhinovirus species and specific antibody response in preschool children with acute wheeze Katarina Stenberg Hammar (Stockholm, Sweden), Katarina Stenberg-Hammar, Katarzyna Niespodziana, Cilla Söderhäll, Anna James, Jon R. Konradsen, Erik Melén, Marianne van Hage, Rudolf Valenta, Gunilla Hedlin
PA4180
Wheeze presentations to emergency department exponentially decline with increasing age Stephen Oo (Perth, Australia), Stephen Oo, Skarin Dmitry, Ta Ta, Bizzintino Joelene, Laing Ingrid, Borland Meredith, Le Souef Peter
PA4181
Asthma and allergy from infancy into school age – The allergic march revisited Emma Goksor (Molnlycke, Sweden), Emma Goksör, Petra Loid, Bernt Alm, Per Möllborg, Rolf Pettersson, Laslo Erdes, Nils åberg, Göran Wennergren
PA4182
Follow-up of infants hospitalized for bronchiolitis. Clinical factors that determine their evolution Guillermo Zepeda Flores (Santiago, Chile), Guillermo Zepeda, Patricia Díaz, Ricardo Pinto, Aldo Gaggero, Paola Uasapud
PA4183
Prevalence of allergic diseases in schoolchildren in Oran town, Algeria Abdelmajid Snouber (Oran, Algeria), Malika Metahri, Abdelmajid Snouber, Souad Kebbati, Bellahouel Bencharef, Malika Guermaz
PA4184
Effect of Asian dust on pediatric asthma in Korea Yoon-Sung Park (Incheon, Republic of Korea), Yoon-Sung Park, Jeong Hee Kim, Hae Ji Jang, Yoon-Hee Tae, Dae Hyun Lim
PA4185
Nationality and asthma: The role of familar atopy and lifestyle Emilija Vlashki (SKOPJE, FYROM (Macedonia)), Emilija Vlashki, Katerina Stavric, Milica Kimovska, Lidija Seckova, Sultana Asani, Teuta Jakupi
PA4186
Prolonged bronchodilator responsiveness after preschool virus-induced wheezing episodes may predict asthma persistence Sotirios Fouzas (Patras, Greece), Eleni Skylogianni, Kostas Bolis, Michael Anthracopoulos, Sotirios Fouzas
PA4187
Risk for asthma is associated with higher BMI, but not with obesity? Ivana Banic (Zagreb, Croatia), Ivana Banic, Sandra Bulat Lokas, Jelena Zivkovic, Iva Mrkic Kobal, Marcel Lipej, Davor Plavec, Mirjana Turkalj
PA4188
Hospitalization rate as a measure of the outpatient management quality in children with asthma Minca Mramor (Ljubljana, Slovenia), Minca Mramor, Tjaša Kljajic, Malena Aldeco, Ana Kotnik Pirš, Dušanka Lepej, Marina Praprotnik, Uroš Krivec
PA4189
Relationship between childhood asthma severity and mother’s general education Snezana Radic (Belgrade, Republic of Serbia), Snezana Radic, Branislava Milenkovic, Branislav Gvozdenovic, Zorica Zivkovic, Milka Micic, Spomenka Smiljanic, Olivera Calovic
PA4190
Level of physical activity in asthmatic in an extremely arid area in the Brazilian Northeast Marco Junior (Recife, Brazil), Marco Junior, Emilia Costa, Emanuel Sarinho, Angelo Rizzo, Silvia Sarinho
PA4191
Are acute exacerbation blood eosinophil numbers associated with clinical pattern of preschool wheeze? Karl Holden (Leicester, United Kingdom), Karl Holden, Damian Roland, Kathryn Staley, Erol Gaillard
PA4192
Are raised blood eosinophils during acute wheeze associated with exacerbation frequency in preschool children? Karl Holden (Leicester, United Kingdom), Karl Holden, Damian Roland, Kathryn Staley, Erol Gaillard
PA4193
Nutritional status measured by bioelectrical impedance in asthmatic children Eliza Wasilewska (Gda sk, Poland), Eliza Wasilewska, Aurelia Ziólkowska, Sylwia Malgorzewicz, Ewa Jassem
PA4194
The role of vasoactive intestinal peptide in regulation of bronchial tone in children with asthma during the period of exacerbation Olga Semernik (Rostov-on-Don, Russian Federation), Olga Semernik, Alexander Lebedenko
PA4195
Hyperactivity of the IL33-ST2 axis during postnatal alveolarization increases susceptibility to allergic airway inflammation by enhancing migration and skewing of CD11b+ dendritic cells Ismé de Kleer (Rotterdam, Netherlands), Ismé De Kleer, Mirjam Kool, Harald Braun, Hamida Hammad, Rudi Hendriks, Bart Lambrecht
PA4196
Relationship between epithelial TGF-ß1 expression and number of myofibroblasts in bronchial mucosa of children with chronic respiratory diseases Lenka Honkova (Prague, Czech Republic), Lenka Honková, Katarina Beránková, Jirí Uhlík, Petra šimunková, Petr Pohunek
268
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA4197
YKL-40 levels in cord blood – Associations with respiratory symptoms and asthma in children? Jakob Usemann (Basel, Switzerland), Jakob Usemann, Urs Frey, Ines Mack, Anne Schmidt, Dominik Hartel, Philipp Latzin
PA4198
Altered expression of histamine receptor 4 and MAPK kinase in childhood asthma Aleksandra Szczepankiewicz (Poznan, Poland), Aleksandra Szczepankiewicz, Paulina Sobkowiak, Aleksandra Hoffmann, Beata Narozna, Anna Breborowicz
Hall 14-29
Session 426
12:50 - 14:40
Thematic Poster: Respiratory physiotherapy: outcomes in disease and health Chairs : Deniz Inal Ince (ANKARA, Turkey), Guilherme Augusto de Freitas Fregonezi (Barcelona, Spain), Rachael A Evans (Leicestershire, United Kingdom), Carlos Augusto Camillo (Leuven, Belgium) PA4199
Swallowing function during high-flow nasal cannula therapy masaki oomagari (Hamamatsu, Japan), Masaki Oomagari, Ichiro Fujishima, Norimasa Katagiri, Shinichi Arizono, Koji Watanabe, Tomohisa Ohno, Hiroshi Maeda, Motoki Moriwaki, Mariko Fujimori, Shohei Ohgi
PA4200
Reliability of phonation maximum time and capacity in slow vital healthy subjects Marco Junior (Recife, Brazil), Marco Junior, Emilia Costa, Flávio Andrade, Rodrigo Araújo, Angelo Rizzo, Emanuel Sarinho, Silvia Sarinho
PA4201
Pain assessment before and after three chest physiotherapy techniques in hospitalized neonates Mariana Hoffman Barbosa (Belo Horizonte, Brazil), Mariana Hoffman, Tricia Oliveira, Dayane Montemezzo, Gabriela Lopes, Flávia Rocha, Tanti Sant’Ana, Verônica Parreira
PA4202
Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis Gerard MUÑOZ CASTRO (Girona, Spain), Gerard Muñoz, Javier De Gracia, Antoni Alvarez, Gladis Sabater, Saioa Eizaguirre, Enric Boyer, Montserrat Vendrell
PA4203
Inhaled hypertonic saline as an adjunct to respiratory physiotherapy in UK paediatric lung transplant patients Emma Shkurka (London, United Kingdom), Emma Shkurka, Helen Spencer, Hafez Ahmed
PA4204
Role of bronchus morphology on mucus mobilization during chest physiotherapy Benjamin Mauroy (Nice, France), Benjamin Mauroy, Christian Fausser, Dominique Pelca, Jacques Merckx, Patrice Flaud
PA4205
Are crackles age dependent? Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Ana Oliveira, José Aparício, Alda Marques
PA4206
Respiratory auscultation: (dis)agreement between health professionals Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Ana Machado, Ana Oliveira, José Aparício, Alda Marques
PA4207
Respiratory clinicians’ views of motivational interviewing (MI) for enhancing engagement and adherence as part of pulmonary rehabilitation (PR) Robert Shannon (Southampton, United Kingdom), Robert Shannon, Maggie Donovan-Hall, Anne Bruton
PA4208
Learning motivational interviewing (MI) for use in pulmonary rehabilitation (PR) Robert Shannon (Southampton, United Kingdom), Robert Shannon, Anne Bruton, Maggie Donovan-Hall
PA4209
Goal setting in rehabilitation for people with COPD: Respiratory physiotherapists’ perspectives Rachael Summers (southampton, United Kingdom), Rachael Summers, Claire Ballinger, Anne Bruton, Rachel Garrod, Miranda Leontowitsch
PA4210
Assessment of inpatient’s satisfaction with physiotherapy care in a public hospital Luciana Chiavegato (São Paulo, Brazil), Daniela Gimenes de Paula, Nathália Toledo Pacheco, Flavia Medeiros, Luciola Costa, Luciana Chiavegato
PA4211
Unsupported upper limb exercise test: Reliability and learning effect Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Alda Marques, Ana Oliveira, Cristina Jácome, Joana Cruz
PA4212
Impact of immersion at different levels on respiratory function in healthy subjects Roland Hotton (Limal, Belgium), Sandra Peignot, Thomas Mettay, Roland Hotton
PA4213
Effects of position on tidal volume changes from manual breathing assist techniques Takako Tanaka (Nagasaki, Japan), Takako Tanaka, Hideaki Senjyu, Chika Kitagawa, Masaharu Asai, Ryo Kozu
PA4214
Assessment of inspiratory pressures: Comparison between the maximum static and the nasal sniff in young healthy Natália Pinto (Brasilia, Brazil), Natália Lucília Pinto, Paula Lorranny Marques, Graziella França Bernardelli, Sergio Ricardo Mateus
269
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4215
Sustained maximal inspiratory pressure as a measure to inspiratory muscle function Mariana Hoffman Barbosa (Belo Horizonte, Brazil), Mariana Hoffman, Dayane Montemezzo, Sabrina Lima, Danielle Gomes, Natália Oliveira, Raquel Britto, Giane Ribeiro-Samora
PA4216
The stability of breathing pattern components over time in different body positions Fatimah AL Shaikh (southampton, United Kingdom), Fatimah Al-Shaikh, Anne Bruton, Anna Barney
PA4217
Comparison of breathing pattern and thoracoabdominal motion of healthy elderly Letícia Gabriel (Belo Horizonte, Brazil), Letícia Gabriel, Mariana Hoffman, Liliane Mendes, Giane Samora, Catarina Rattes, Armele Dornelas, Raquel Britto, Verônica Parreira
PA4218
Influence of posture, gender and sex on breathing pattern and thoracoabdominal motion during quiet breathing in healthy subjects Liliane Mendes (Belo Horizonte, Brazil), Liliane Souza Mendes, Mariana Hoffman Barbosa, Letícia Silva Gabriel, Giane Ribeiro-Samora, Guilherme Freitas Fregonezi, Armèle Dornelas Andrade, Raquel Rodrigues Britto, Verônica Franco Parreira
Hall 14-30
Session 427
12:50 - 14:40
Thematic Poster: Quality management in lung cancer Track(s) : Oncology Chairs : Torsten Gerriet Blum (Berlin, Germany), Georgia Hardavella (Aghia Paraskevi, Athens, Greece), Chair to be confirmed PA4219
Novel survey tool used to assess priorities of lung cancer patients and carers Mathew Peters (Concord, Australia), Matthew Peters, Aoife McNamara, Win Boerckel, Albert Van Eijk, Jesme Fox
PA4220
Lung cancer consultation letter to patient - Do you feel informed and cared? Syed Mehdi (Bolton, United Kingdom), Syed B. Mehdi, Ram Sundar, Neil Bayman
PA4221
Reducing the rate of emergency presentation in lung cancer Michelle Huxley (Crewe, United Kingdom), Michelle Huxley, Sue Stubbs, Catherine Mills, Duncan Fullerton, Syed M.H. Kazmi
PA4222
Epithelial growth factor receptor (EGFR) mutation status and the treatment of non-small cell lung cancer (NSCLC): A population based quality assurance analysis Niels-Christian Gerner Hansen (Odense C, Denmark), Niels-Chr. G. Hansen, Christian B. Laursen, Karin H. Hansen, Karen E. Olsen
PA4223
Effect of incidental FDG findings at extrapulmonary locations on duration of diagnosis and time to treatment in patients staged for lung cancer: Retrospective analysis Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Pinar Celik, Fikret Kurhan, Tugba Goktalay, Aysin Sakar Coskun, Arzu Yorgancioglu
PA4224
Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013 Matthew Evison (Manchester, United Kingdom), Haval Balata, Evison Matthew, Julie Morris, Haider Al-Najjar, Phil Barber, Philip Crosbie, Richard Booton
PA4225
European mapping of EGFR mutation test and EGFR tyrosine kinase inhibitors availability in thoracic oncology Carbonnaux Mélodie (LYON, France), Mélodie Carbonnaux, Pierre-Jean Souquet, Arnaud Scherpereel, Sébastien Couraud
PA4226
Low histological confirmation rate in a District General Hospital (DGH)– exploring the reasons why Michelle Huxley (Crewe, United Kingdom), Michelle Huxley, Sue Stubbs, Syed M.H. Kazmi
PA4227
Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays? Michelle Huxley (Crewe, United Kingdom), Michelle Huxley, Sue Stubbs, Lynn Thomas, Gerhard Bockeler, Duncan Fullerton, Syed M.H. Kazmi
PA4228
Lung cancer and socioeconomic status: Differences in demographics, stage, treatment and mortality in a lung cancer centre Eve Denton (Mornington, Australia), Eve Denton, Matthew Conron, David Hart, Gavin Wright, Rory Wolfe, Prue Russell
PA4229
Population’s understanding and degree of participation of a screening lung cancer programme María Sánchez-Carpintero Abad (Orkoien (Navarra), Spain), María Sánchez-Carpintero Abad, Leticia García Rodriguez, Marta López Cañadas, Franisco Roig Vázquez
PA4230
Improving survival for NSCLC patients in the national lung cancer audit Ian Woolhouse (Birmingham, United Kingdom), Paul Beckett, Ian Woolhouse, Mick Peake, Laila Tata, Aamir Khakwani
270
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4231
Defining a standard set of patient-centered outcomes for patients with lung cancer Jan van Meerbeeck (Ghent, Belgium), Jan P. Van Meerbeeck, Kimberley S. Mak, Annelotte Van Bommel, Caleb Stowell, Mick Peake
PA4232
Follow -up results, malignancy rates and malignancy determinants of the pulmonary nodules that evaluated in multidisciplinary thoracic oncology tumour board Özge Öztürk (Ankara, Turkey), özge öztürk, Ahmet Ugur Demir, Ziya Toros Selçuk
PA4233
Lung cancer, has it changed in the last ten years? David BRAVO BLANCO (Llodio, Spain), David Bravo Blanco, Olatz Llaguno Ochandiano, Igor Murga Arizabaleta, Ester Marijuán Gómez, Laura Tomás López, Jose Luis Lobo Beristain, Patricia Sobradillo Ecenarro
PA4234
Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Haval Balata (Manchester, United Kingdom), Haval Balata, Matthew Evison, Julie Morris, Haider Al-Najjar, Phil Barber, Philip Crosbie, Richard Booton
PA4235
Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines? Haval Balata (Manchester, United Kingdom), Haval Balata, Matthew Evison, Haider Al-Najjar, Phil Barber, Richard Booton, Philip Crosbie
Hall 14-31
Session 428
12:50 - 14:40
Thematic Poster: Lung cancer: prognostic factors and features of oncogene-driven tumours Track(s) : Oncology Chairs : Nadja Triller (Ljutomer, Slovenia), Charlotte Leduc (Strasbourg, France), Etienne Giroux Leprieur (Paris, France), Ilona Rousalova (Prague, Czech Republic) PA4236
Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC) Rainer G. Wiewrodt (Münster, Germany), Arik Bernard Schulze, Lars Henning Schmidt, Andreas Kuemmel, Lara Baie, Christoph Albers, Andreas Faldum, Dennis Görlich, Rainer Wiewrodt
PA4237
MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma Yasushi Horimasu (Hiroshima, Japan), Yasushi Horimasu, Nobuhisa Ishikawa, Sonosuke Tanaka, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Noboru Hattori, Hironobu Hamada, Nobuoki Kohno
PA4238
PIWI proteins as prognostic markers in non small cell lung cancer Jorge Moisés Lafuente (Barcelona, Spain), Jorge Moisés, Alfons Navarro, Rut Tejero, Nuria Viñolas, Anna Cordeiro, Ramón M. Marrades, Dolors Fuster, Oriol Caritg, Carmen Muñoz, Laureano Molins, Josep Ramírez, Mariano Monzó
PA4239
Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Florent Baty (St. Gallen, Switzerland), Florent Baty, Martin Brutsche
PA4240
Significance of expression of TGF- in pulmonary metastasis in non-small cell lung cancer tissues Marina Petrovic (Kragujevac, Republic of Serbia), Marina Petrovic, Vladimir Jurišic, Ivan Cekerevac, Zorica Lazic, Gordana Kostic, Goran Davidovic
PA4241
Exploring the neutrophil/lymphocyte and platelet/lymphocyte ratios as biomarkers for lung cancer development Pablo SANCHEZ SALCEDO (Orkoien (Navarra), Spain), Pablo Sanchez-Salcedo, Jessica Gonzalez, Diego MartinezUrbistondo, Juan Berto, Pilar Rivera, Esmeralda Lopez-Zalduendo, Ana Belen Alcaide, Arantzazu Campo, Juan Pablo De Torres, Javier Zulueta
PA4242
A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of earlystage non-small cell lung cancer Lee Soyeon (Daegu, Republic of Korea), So Yeon Lee, Seung Soo Yoo, Mi Jung Hong, Hye Won Seo, Yong Dae Lee, Keum Ju Choi, Jin Eun Choi, Hyo Gyoung Kang, Yangki Seok, Eung Bae Lee, Kyung Min Shin, Ji Yun Jeong, Won Kee Lee, Shin Yup Lee, Jaehee Lee, Seung Ick Cha, Chang Ho Kim, Young Tae Kim, Sanghoon Jheon, Jae Yong Park
PA4243
p16(ink4) expression and spirometry tests have similar survival outcomes values in non-small-cell lung cancer patients Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Rifat Sejdinovic, Edin Jusufovic, Dragan Keser, Besim Prnjavorac, Ljiljana Sejdinovic, Azra Okanovic
PA4244
The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer Lars Schmidt (Münster, Germany), Lars Henning Schmidt, Andreas Kümmel, Dennis Görlich, Michael Mohr, Sebastian Bröckling, Inga Grünewald, Eva Wardelmann, Anne Schultheis, Jan-Henrik Mikesch, Benedikt Vietmeier, Carsten MüllerTidow, Alessandro Marra, Christoph Schliemann, Wofgang E. Berdel, Wolfgang Hartmann, Wiewrodt Rainer
271
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4245
Are serum leptin levels a prognostic factor in advanced lung cancer? Ceyda Anar (Izmir, Turkey), Ceyda Anar, Derya Deniz, Serhat Erol, Yasemin Ozdogan, Melike Yuksel Yavuz, Ufuk Yilmaz, Huseyin Halilcolar
PA4246
Serum osteopontin as a prognostic marker in patients with lung cancer Vasiliki Petta (Athens, Greece), Vasiliki Petta, Stelios Loukides, Konstantinos Kostikas, Georgios Papatheodorou, Kyriaki Cholidou, Yiannis Tomos, Spyridon Papiris, Nikolaos Koulouris, Petros Bakakos
PA4247
Does bronchial location of lung cancer influence overall survival? Christophe Paris (Nancy, France), Christophe Paris, Patrice Avogbe, Jean-Michel Vignaud, Amandine Luc, Emmanuelle Penven, Isabelle Thaon
PA4248
Prognostic factors for stage IV lung adenocarcinoma patients receiving retreatment with EGFR-TKI Chia-yu Kuo (Tainan, Taiwan), Chia-Yu Kuo, Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, Jui-Ying Lee, Shah-Hwa Chou, Ta-Chih Liu, Ming-Shyan Huang, Inn-Wen Chong
PA4249
EGFR mutation in non-small cell lung cancer(NSCLC) in South Croatia Suzana Mladinov (Split, Croatia), Suzana Mladinov, Ivan Skopljanac, Veljka Ivcevic, Sendi Kuret, Meri Glavina Durdov, Kornelija Miše
PA4250
The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma Chung-Jen Huang (New Taipei city, Taiwan), Chung-Jen Huang, Wen-Hui Ku
PA4251
ALK/EML4 translocation in non-squamous NSCLC and their predictors Margarida Dias (Vila Nova de Gaia, Portugal), Margarida Dias, Rita Linhas, Ana Antunes, Sérgio Campainha, Sara Conde, Ana Barroso
PA4252
Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Clotilde Fournier (marseille, France), Clotilde Fournier de Lesquen, Laurent Greillier, Pascale Tomasini, Helene Barazzutti, Frederic Fina, Fabrice Barlesi
PA4253
Lung cancer patients harbouring epidermal growth factor receptor mutation Catarina Carvalho de Oliveira Dias (Matosinhos, Portugal), Catarina Dias, David Araujo, Adriana Magalhaes, Henrique Queiroga, Venceslau Espanhol, Jose Machado, Conceiçao Moura, Agostinho Marques, Gabriela Fernandes
PA4254
RT-PCR expression of EML4-ALK oncogene in Bulgarian patients with non-small cell lung cancers Dora Marinova (Sofia, Bulgaria), Dora Marinova, Darina Kachakova, Yanina Slavova, Gergana Stancheva, Atanaska Mitkova, Radka Kaneva, Dimitar Kostadinov, Vanyo Mitev
PA4255
Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival Shivalingaswamy Salimath (Davangere, India), Shivalingaswamy Salimath, B.S. Jayaraj, P.A. Mahesh
Hall 14-32
Session 429
12:50 - 14:40
Thematic Poster: Cell biology of lung cancer and new biomarkers Track(s) : Oncology Chairs : Sebastian Ott (Bern, Switzerland), Iwona Osinska (Warszawa, Poland), Yury Ragulin (Obninsk, Kaluga Oblast, Russian Federation), Chair to be confirmed PA4256
SMYD3 links lysine methylation of MAP3K2 to ras-driven lung cancer Nicolas Reynoird (La Tronche, France), Nicolas Reynoird, Pawel Mazur, Julien Sage, Or Gozani
PA4257
Involvement of adamalysin proteases in modulations of tumor microenvironment and premetastatic niches Kim Donati (Liège, Belgium), Kim Donati, Sandrine Bekaert, Christelle Sépult, Agnès Noël, Natacha Rocks, Didier Cataldo
PA4258
Macrophages promote urethane-induced lung adenocarcinoma Ioannis Lilis (Rio, Patras, Greece), Ioannis Lilis, Malamati Vreka, Magda Spella, Ioanna Giopanou, Antonia Marazioti, Georgios Stathopoulos
PA4259
RBM5 regulates EGFR involving in cancerous transformation of cigarette smoke-induced BEAS-2B cells Jie Zhang (Changchun, China), Jie Zhang, Xuejiao Lv, Yuqiu Hao, Zhenzhong Su, Junyao Li, Yanwei Du
PA4260
The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines Armin Frille (Leipzig, Germany), Armin Frille, Katharina Leithner, Andelko Hrzenjak, Andrea Olschewski, Horst Olschewski, Christoph Wohlkoenig
272
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4261
Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC) Tomasz Wandtke (Bydgoszcz, Poland), Tomasz Wandtke, Joanna Wozniak, Piotr Kopinski, Joanna ChorostowskaWynimko, Teresa Iwaniec, Andrzej Dyczek
PA4262
Antitumor efficacy of the double suicide genesin lung cancer cells Cheng Shen (Chengdu, China), Cheng Shen, Guowei Che
PA4263
Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells Hak-Ryul Kim (Iksan, Jeonbuk, Republic of Korea), Hak-Ryul Kim, Kyung-Hwa Cho, Ki-Eun Hwang, Eun-Taik Jeong
PA4264
A requirement for IKKa in lung adenocarcinoma Malamati Vreka (Patras, Greece), Malamati Vreka, Ioannis Lilis, Maria Papageorgopoulou, Antonia Marazioti, Anastasios Giannou, Theodora Agalioti, Magda Spella, Georgios Stathopoulos
PA4265
Comparative analysis of cisplatin treatment in in vitro 3D lung microtissue and monolayer cell cultures Edit Kiss (Pécs, Hungary), Edit Kiss, Monika Avdicevic, David Ernszt, Judit E. Pongracz
PA4266
Ghrelin ameliorates cancer cachexia associated with the development of lung adenocarcinoma in mice Hironobu Tsubouchi (Kiyotake, Miyazaki prefecture, Japan), Hironobu Tsubouchi, Shigehisa Yanagi, Ayako Miura, Nobuhiro Matsumoto, Masamitsu Nakazato
PA4267
The markers of oxidative stress in patient with lung cancer Martina Antosova (Martin, Slovakia), Martina Antosova, Alica Bencova, Pavol Mikolka, Petra Kosutova, Daniela Mokrá, Eva Rozborilová
PA4268
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Nataliya Kulagina (Moscow, Russian Federation), Nataliya Kulagina, Vasiliy Pokrovsky, Alexander Averyanov, Alexey Nikitin, Dmitriy Sazonov, Nikolay Urazovsky
PA4269
Expression of interleukin-18 and interleukin-18 receptor mRNA in lung tissue samples from non small lung cancer Charoula Eleni Giannakopoulou (Athens, Greece), Charoula Eleni Giannakopoulou, Irene Papadopoulou, Grigorios Stratakos, George Kaltsakas, Fotis Vlastos, Rodoula Trigidou, Nikolaos Koulouris
PA4270
Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer Chris Wendt (Minneapolis, United States of America), Brian Sandri, Andrew Limper, Pratik Jagtap, Svetlana Avdulov, Mark Peterson, Ping Yang, Ola Larsson, Carl Murie, Peter Bitterman, Tim Griffin, LeeAnn Higgins, Todd Markowski, Chris Wendt
PA4271
Changes in lymphocyte subgroups of non-small cell lung cancer patients during chemotherapy Qian Wang (Beijing, China), Qian Wang, Lei Yang, Yang Ge, Dong Yan, Guosheng Feng, Guangyu An, Yingmin Ma
PA4272
Serum and bronchial aspiration fluid HE-4 levels in lung cancer Elif Yilmazel Uçar (Erzurum, Turkey), Elif Yilmazel Ucar, Alev Lazoglu Ozkaya, Omer Araz, Metin Akgun, Mehmet Meral, Hasan Kaynar, Leyla Saglam, Hulya Aksoy, Fatih Akcay
PA4273
Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD Darja Svirina (Riga, Latvia), Darja Svirina, Sergejs Isajevs, Gunta Strazda, Ints Silins, Immanuels Taivans
PA4274
The association of cyclooxygenase 2 single-nucleotide polymorphisms with susceptibility to and severity of non-small cell lung cancer Chuen-Ming Shih (Taichung, Taiwan), Yao-Ling Lee, Chuen-Ming Shih
PA4275
Analysis of FOXP3 expression in the lymph nodes of patients with lung adenocarcinoma- The pilot study Iwona Osinska (Warszawa, Poland), Iwona Osinska, Juliusz Pankowski, Monika Pasieka-Lis, Dominika Wolosz, Joanna Domagala-Kulawik
Hall 14-33
Session 430
12:50 - 14:40
Thematic Poster: Diagnosis and therapy of lung cancer Track(s) : Oncology Chairs : Paul Martin Putora (St. Gallen, Switzerland), Konstantinos Zarogoulidis (Thessaloniki, Greece), Ales Rozman (Golnik, Slovenia), Nicolas Girard (Bron, France)
PA4276
LATE-BREAKING ABSTRACT: Novel rapid screening assay for HER2 duplicated insertion mutation by EprobePCR method Yoshiaki Takase (Gunma Pref., Japan), Yoshiaki Takase, Kimihiro Shimizu, Jun Atsumi, Yasuaki Enokida, Kai Obayashi, Yoichi Ohtaki, Toshiteru Nagashima, Tatsuo Ichihara, Yasumasa Kimura, Kengo Usui, Yasumasa Mitani, Izumi Takeyoshi
273
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4277
Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria Sara Isabel Vicente Antunes (Madrid, Spain), M.T. Pérez Warnisher, S. Vicente Antunes, E. Cabezas, G. Gallardo, A. Alcazar, P. Rodriguez, L. Seijo
PA4278
Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers Cátia Susana de Sousa Saraiva Barroca (Lisbon, Portugal), Catia Saraiva, Jorge Dionísio, Paula Ferreira, Dina Matias, Paulo Mota, Ambrus Szanthó, Duro Costa, Teresa Almodovar
PA4279
Serum platelet, MPV, PCT and PDW values, neutrophil to lymphocyte and platelet to lymphocyte ratios in lung cancer diagnosis Füsun ahin (Istanbul, Turkey), Füsun Sahin, Pinar Yildiz
PA4280
Change in cardiorespiratory fitness after lung resection is not related to the amount of lung tissue removed Elisabeth Edvardsen (Oslo, Norway), Elisabeth Edvardsen, Sigmund A. Anderssen, Fredrik Borchsenius, Ole H. Skjønsberg
PA4281
Predicted versus observed pulmonary function and peak oxygen uptake after lung cancer surgery Elisabeth Edvardsen (Oslo, Norway), Elisabeth Edvardsen, Sigmund A. Anderssen, Fredrik Borchsenius, Ole H. Skjønsberg
PA4282
Surgical treatmment non-small cell lung cancer in the elderly patients Aleksey Reshetov (Saint-Petersburg, Russian Federation), Aleksey Resahetov, Aleksey Elkin, Igor Lvov, Olga Shtepa, Dmitriy Kovalenko, Vadim Mosiagin, Vladimir Nevelskiy
PA4283
Surgical treatment outcomes on early-stages of non-small-cell lung cancer Islam Mejri Ep Ajili (Hammamlif Ben Arous, Tunisia), Fekih Leila, Islam Mejri, Aymen Ayari, Hanène Smadhi, Hela Kammoun, Hela Hassène, Dorra Greb, Hajer Abdelghaffar, Ines Akrout, Mohamed Lamine Megdiche
PA4284
Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer Robert Smyth (Kerry, Ireland), Robert Smyth, Judith Lyons, Claire Comerford, Barry O’Connell
PA4285
Narrow band imaging (NBI) bronchoscopy in detection and characterization of X-ray negative bronchial lesions Alena Strunina (Yaroslavl, Yaroslavl Region, Russian Federation), Alena Strunina, Roman Kuvaev, Sergey Kashin, Natalya Smirnova, Alexandr Nadezhin
PA4286
Autofluorescence bronchoscopy usefulness in endoscopic bronchial stump follow up Núria TOLEDO PONS (Palma de Mallorca, Spain), Núria Toledo Pons, Elisabetta Nervo, Vanina Pardini, Francisco de Borja Cosío, Federico Fiorentino, Alberto Alonso Fernandez, Ernest Sala Llinas, Jaume Sauleda Roig
PA4287
Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma Huri Ozkan Y lmaz (ORDU, Turkey), Huri Ozkan Yilmaz, Attila Saygi, Adnan Yilmaz, Dida Marasli, Yeliz Duzgun, Hulya Koksal
PA4288
Non-small cell lung cancer: Are M1a and M1b the same stage? Margarida Dias (Vila Nova de Gaia, Portugal), Margarida Dias, Daniel Coutinho, Rita Linhas, Sérgio Campainha, Sara Conde, Ana Antunes, Ana Barroso
PA4289
Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC) Ghassen Soussi (Boumhal, Tunisia), Ghassen Soussi, Hajer Racil, Saoussen Bacha, Sana Cheikh Rouhou, Asma Zidi, Aïda Ayadi, Nawel Chaouch, Abdellatif Chabbou
PA4290
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Seung Jun Lee (Jinju, Republic of Korea), Seung Jun Lee, Sujin Lim, Jung Wan You, Yu Ji Cho, Yi Yeong Jeong, Ho Cheol Kim, Jong Deog Lee
PA4291
Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer Pavlos Zarogoulidis (Thessaloniki, Greece), Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kaid Darwiche, Lutz Freitag, Konstantinos Zarogoulidis, Lonny Yarmus, J. Francis Turner, Robert Browning, Joshua Stopek, Harald Rittger, Thomas Vogl
PA4292
TTF 1- expression and pemetrexed based chemotherapy. A retrospective analysis Claus Steppert (Bayreuth, Germany), Claus Steppert, Hannah Foerster, Rumo Leistner, Jens Krugmann
PA4293
Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung Kunihiko Yoshimura (Tokyo, Japan), Kunihiko Yoshimura, Miho Ejima
PA4294
Prognostic factors in non-small cell lung cancer othman lamine (Ariana, Tunisia), O. Neffati, L. Fekih, H. Kammoun, A. Ayari, I. Mejri, H. Smadhi, I. Akrout, H. Abdelghaffar, D. Greb, H. Hassene, M.L. Megdiche
274
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4295
Metabolomic profiles in lung cancer subjects and healthy controls. Influence of smoking tobacco exposure Ricardo Ismael Aguilar Perez Grovas (Huelva, Spain), Ricardo Aguilar Perez-Grovas, Eva Vázquez Gandullo, Belén Callejón Leblic, Macarena González Fernández, Jesús Grávalos Guzmán, Tamara García Barrera, José Luis Sánchez Ramos, José Antonio Maldonado Pérez, María Pilar Muñoz Zara, José Luis Gómez Ariza, Antonio Pereira Vega
Hall 14-34
Session 431
12:50 - 14:40
Thematic Poster: Thoracic oncology around the world: rare cases and local features Track(s) : Oncology Chairs : Dragana M. Jovanovi (Beograd, Republic of Serbia), Mauro Zamboni (Rio de Janeiro, Brazil), Laura Succony (Hertfordshire, United Kingdom), Florin Rusu-Cordunean (Iasi, Romania) PA4296
Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients Christelle Clement-Duchene (Neuves-Maisons, France), Christelle Clément-Duchêne, Guillaume Gauchotte, Yves Martinet, Jean-Michel Vignaud, Christophe Paris
PA4297
Multifocal cavitary lung adenocarcinoma: Clinical, radiologic and pathologic features Wenhui Chen (Beijing, China), Wenhui Chen, Yuhui Zhang, Xueli Zhang, Lei Zhang, Ping Wei, Huaping Dai
PA4298
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Stephanie Hobbins (West Midlands, United Kingdom), Stephanie Hobbins, Paul Beckett, Michael Peake, Ian Woolhouse
PA4299
The bronchial carcinoid tumor. Experience in our hospital XENIA ROXANA LOPEZ CONTRERAS (Pamplona (Navarra), Spain), Xenia López Contreras, Vanesa López Rodríguez, Sonia Herrero Martín, Pilar Cebollero Rivas, Jose Cascante Rodrigo, Angel Panizo, Javier Hueto Pérez de Heredia
PA4300
Pulmonary artery sarcoma. Complex problems with a rare tumor Igor Motus (Ekaterinburg, Sverdlovsk Oblast, Russian Federation), Igor Motus, Vladimir Parshin, Yrii Belov, Alexander Chernyavsky, Anton Neretin
PA4301
A rare diagnosis after pediatric tuberculosis screening Nadia Nathan (Paris, France), Nadia Nathan, Marie Wislez, Nathalie Lambert, Benjamin Diallo, Hubert Ducou le Pointe, Aurore Coulomb l’Hermine, Annick Clement
PA4302
Rare localization of NUT midline carcinoma revealed by pneumonia and pleural effusion in a 13 years old patient: A case report Jessica Taytard (Gradignan, France), Jessica Taytard, Filomena Pierro, Harriet Corvol, Aurore Coulomb-l’Hermine, Annick Clement
PA4303
Sclerosing hemangioma of the lung: An analysis of 8 cases Adnan Yilmaz (Istanbul, Turkey), Gulbanu Horzum Ekinci, Osman Haciomeroglu, Ayse Ersev, Levent Alpay, Ayçim Sen, Pinar Atagun Guney, Adnan Yilmaz
PA4304
Cancer-associated retinopathy in a 66 years-old woman with small-cell lung cancer Mathilde Jeanvoine (Rouen, France), Mathilde Jeanvoine, Mathieu Salaün, Florian Guisier, Julie Gueudry, Suzanna Bota, Luc Thiberville
PA4305
Sclerosing hemangioma of the lung: Report of 4 cases Tatyana Novitskaya (Saint-Petersburg, Russian Federation), I.V. Dvorakovskaya, T.A. Novitskaya, F.M. Mazitova, I.N. Chuprov, S.A. Vinnichuk
PA4306
Adenoid cystic carcinoma of the trachea and bronchus: Prognostic factors and patterns of recurrence Mian Xie (Guangzhou, China), Mian Xie, Xiaosong Ben, Jinjun Zhang, Jinhui Hou, Shenhai Wei, Yinyin Gu
PA4307
Rare primary pulmonary tumors Meriem Mjid (Bab Saadoun/Tunis, Tunisia), Meriem Mjid, Hana Blibech, Sonia Toujani, Rihab Bey, Nozha Ben Salah, Yassine Ouahchi, Bechir Louzir, Nadia Mhiri, Jouda Cherif, Majed Beji
PA4308
Clinicopathological characteristics and treatment outcomes of pulmonary carcinosarcoma in eight patients Adnan Yilmaz (Istanbul, Turkey), Gulbanu Horzum Ekinci, Osman Haciomeroglu, Serda Kanbur Metin, Ayse Ersev, Pinar Atagun Guney, çagatay Tezel, Adnan Yilmaz
PA4309
Epidemiological and clinical profile of lung cancer in Algiers Samir Dourmane (Alger, Algeria), Samir Dourmane, Merzak Gharnaout
PA4310
Survival in lung cancer: Associated factors in Tunisian patients melki boutheina (TUNIS, Tunisia), Boutheina Melki, Samira Aouadi, Houda Gahrsalli, Dorra Bejar, Soumaya Laabidi, Sonia Maâlej, Leila Douik el Gharbi
275
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4311
General characteristics and therapeutic options in lung cancer in Turkey Tevfik Özlü (TRABZON, Turkey), Tevfik Ozlu, Yilmaz Bulbul, Sibel Arinc, Berna A. Ozyurek, Hulya Gunbatar, Aysegul Senturk, Ayse Bahadir, Melike Ozcelik, Ufuk Yilmaz, Makbule Ozlem Akbay, Leyla Saglam, Talat Kilic, Gamze Kirkil, Neslihan Ozcelik, Dursun Tatar, Serap Argun Baris, Mehmet Yavsan, Hatice Selimoglu Sen, Serdar Berk, Murat Acat, Gulfidan Cakmak, Perran Fulden Yumuk, Yavuz Selim Intepe, Umran Toru, Sibel O. Ayik, Ilknur Basyigit, Sibel Ozkurt, Levent Cem Mutlu, Zehra Asuk Yasar, Hidir Esme, Muharrem Erol, Ozlem Oruc, Yurdanur Erdogan, Selvi Asker, Arife Ulas, Serhat Erol, Bugra Kerget, Ahmet Emin Erbaycu, Turgut Teke, Mehmet Besiroglu, Huseyin Can, Fahrettin Talay
PA4312
Smoking patterns after lung cancer diagnosis: A pulmonology department experience Rita Linhas (Porto, Portugal), Rita Linhas, Margarida Dias, Sérgio Campainha, Ana Antunes, Sara Conde, Ana Barroso
PA4313
Lung cancer in never smokers. A survival analysis in a radon prone area María Luisa Torres Duran (Vigo (Pontevedra), Spain), María Torres-Duran, Alberto Ruano-Ravina, Isaura Parente-Lamelas, Virginia Leiro-Fernandez, Jose Abal-Arca, Carmen Montero-Martínez, Carolina Pena-Alvarez, Olalla Castro-Anon, Antonio Golpe-Gomez, Cristina Martinez, Roxyris Guzman-Taveras, Maria Jose Mejuto-Martí, Marta Nuñez-Fernández, Alberto Fernandez-Villar, Juan Miguel Barros-Dios
PA4314
Oncologic emergencies in patients monitored for lung cancer in the Bab-El-Oued University Hospital Souad Souilah (Alger, Algeria), Souad Souilah, Sihem Khodja, Nesrine Dermech, Nassima Djami, Rabah Amrane, Aziza Fissah
PA4315
Smoking and lung cancer: Data from a single center in Greece Mina Gaga (Athens, Greece), Clementine Bostantzoglou, Iris Vlachantoni, Konstantinos Samitas, Theoplasti Grigoratou, Erasmia Economidou, Eleftherios Zervas, Lykourgos Kolilekas, Mina Gaga
Hall 14-35
Session 432
12:50 - 14:40
Thematic Poster: Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Track(s) : Oncology Chairs : Sotirios Zarogiannis (Larisa, Greece), Bogdan Dragos Grigoriu (Iasi, Romania), Chair to be confirmed PA4317
Malignant pleural mesothelioma: Current status and future projections in Turkey A. Salih Emri (Ankara, Turkey), Ozge Yavuz, Salih Emri
PA4318
Solitary fibrous tumors of the pleura a rare entity Kalliopi Athanassiadi (Athens, Greece), Kalliopi Athanassiadi, Dimitrios Soufleris, Irini Mavromati, Maria Mis, Stylianos Benakis, Theodore Argyrakos, Eleni Papagianni
PA4319
Solitary fibrous tumour of the pleural: Two malignant cases Sarah Bigeni (Gozo, Malta), Sarah Bigeni, Joseph Galea, Cynthia Farrugia Jones
PA4320
A case of a 3 thymoma arising from a "giant" mediastinal thymolipoma Georgia Karpathiou (Ioannina, Greece), Violaine Yvorel, Fabien Forest, Georgia Karpathiou, Marie-Laure Stachowicz, Olivier Tiffet, Abdulrazzaq Sulaiman, Eric Parietti, Michel Péoc’h
PA4321
Differential diagnosis of space-occupying lesions of the posterior mediastinum Georgy Pakhomov (Tashkent, Uzbekistan), Georgy Pakhomov, Rustem Hayaliev, Otabek Eshonkhodjaev, Abror Makhmudov, Aziz Mustafaev
PA4322
Thymic epithelial tumors: 10 years’ experience of a Portuguese oncologic institute Madalena Sofia Antunes Reis (Paúl-Covilhã, Portugal), Madalena Reis, Teresa Almodôvar, José Duro da Costa
PA4323
Spontaneous pneumomediastinum: A 10 years’ experience of a pulmonology ward Patrícia Alexandra Vieira Dionísio (Oeiras, Portugal), Patrícia Dionísio, Luís Martins, Susana Moreira, Alda Manique, Isabel Correia, Cristina Bárbara
PA4324
Malignant mesothelioma, are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio prognostic indicator parameters as reliable? Seda Tural Önür (Istanbul, Turkey), Seda Tural Onur, Sinem Sokucu, Levent Dalar, Kaan Kara, Songul Buyukkale, Sedat Altin
PA4325
Thoracentesis in the bilateral pleural effusion. Should we puncture both sides? Prospective study Lucia Ferreiro Fernandez (Santiago de Compostela, Spain), Lucía Ferreiro, María Esther San José, Francisco Gude, Adriana Lama, Juan Suárez-Antelo, Antonio Golpe, María Elena Toubes, Francico Javier González Barcala, José Manuel álvarez Dobaño, Luis Valdés
PA4326
PET and endobronchial ultrasound. SUV value of mediastinal lymph nodes suspicious for malignancy Juan Berto Botella (Pamplona (Navarra), Spain), Juan Bertó Botella, Esmeralda López Zalduendo, Jessica Gonzalez Gutierrez, Pablo Sánchez Salcedo, Pilar Rivera, Arantxa Campo, Ana Belen Alcaide, Juan Pablo De Torres, Diego Martínez Urbistondo, Javier Zulueta
276
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA4327
Diagnostic values of inflammation biomarkers in pleural effusions (PE) Regina Hasa (Tirana, Albania), Regina Hasa, Perlat Kapisyzi, Hasan Hafizi, Roland Hasa, Eritjan Tashi
PA4328
Validation of the LENT score in Japanese sample: The impact of EGFR-TKI Tamaki Takahashi (Kyoto, Japan), Tamaki Takahashi, Daisuke Naito, Yusuke Wakatsuki, Yuko Yamamoto, Yoko Hamakawa, Kazuki Shima, Yuichi Chihara, Kenichi Takahashi, Hiromichi Katakura, Naoki Sakai
PA4329
A rare cause of cavitary lesion in the lung: Richter’s transformation Fatma Bodur Yildirim (Ankara, Turkey), Fatma Yildirim, Iskender Kara, Sedat Yildiz, Nalan Akyürek, Kadir Acar, Melda Türkoglu, Gülbin Aygencel
PA4330
Medical thoracoscopic versus ultrasound guided transthoracic pleural needle biopsy in diagnosis of pleural lesions Gehan Abo El-Magd (Tanta, Egypt), Ali M. Abdella, Gehan H. AboEl-Magd, Khaled A. Dewan, Dina A. Elgohary
PA4331
Recurrent pleural effusion – An unusual diagnosis: A case report Vinit Niranjane (Nagpur, India), Vinit Niranjane, Mitesh Dave
PA4332
Case report: Primary pleural lymphoma presenting as a multiloculated lymphocytic exudative effusion in a lady Jennifer Guan (Singapore, Singapore), Jennifer Huey Chen Guan, Mark Chih Hsiang Tien, Chuen Peng Lee, Kim Hoong Yap, John Abisheganaden
PA4333
Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy Ben Vlies (Liverpool, United Kingdom), Ben Vlies, Keir Pickard, Apollo Kwok, Biswajit Chakrabarti, Victoria Tippett, Seamus Grundy
PA4334
Malignant mesothelioma in University Lung Clinic Sarajevo during 1998-2013 Aida Ustamujic (Sarajevo, Bosnia and Herzegovina), Aida Ustamujic, Vesna Cukic, Irma Sladic, Vladimir Lovre, Dina Dizdarevic-špago, Sadika Genjac
PA4335
What outcome after pleurodesis in malignant pleural effusion in lung cancer? Hanene Smadhi (Ariana, Tunisia), Hanen Smadhi, Aymen Ayari, Hela Kammoun, Islam Mejri, Hazem Zribi, Dorra Greb, Ines Akrout, Hela Hassan, Hajer Abdelghaffar, Leila Fekih, MLamine Megdiche
Hall 14-36
Session 433
12:50 - 14:40
Thematic Poster: Malignant pleural effusions and mesothelioma Track(s) : Oncology Chairs : Dragos Bumbacea (Bucarest, Romania), Nick Maskell (Bristol, United Kingdom), Marios E. Froudarakis (Alexandroupolis, Greece), Chair to be confirmed PA4336
LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions Hui Li Zhu (Shanghai, China), Huili Zhu, Hongqing Li, Zhonghao Tang, Haiyan Ge, Shilei Cui
PA4337
Thoracoscopic management of malignant plural effusion, Assiut University Hospital, Egypt Lamia Shaaban (Assiut, Egypt), Lamia Shaaban, Amany Omar, Raafat Elsokary, Mohamed Brakat, Fouzy Frahat
PA4338
Comparison of 1 liter vs. 1.5 liter thoracentesis in the management of malignant pleural effusion Khatereh Mousavi -Fatemi (Tehran, Islamic Republic of Iran), Khatereh Mousavi-Fatemi, Besharat Rahimi, Abbas Rahimi Foroushani, Hamidreza Abtahi, Seyyed Farshad Allameh, Soheil Peyman
PA4339
Discordant exudates and their impact on Light’s criteria accuracy to diagnose exudate effusions. The value of clinical presentation Lucia Ferreiro Fernandez (Santiago de Compostela, Spain), Lucía Ferreiro, John T. Huggins, Rolando Sánchez Sánchez, Carlos E. Kummerfeldt, Luis Valdés, Steven A. Sahn
PA4340
Drain, pain and no gain: Pitfalls when inserting intercostal chest drain (ICD) Hussein Chreif (London, United Kingdom), Hussein Chreif, Hamid Aminy-Raouf, Burhan Khan
PA4341
Efficacy of talc slurry pleurodesis in malignant pleural effusions Pedro Ricardo da Silva Santos (Figueira da Foz, Portugal), Pedro Silva Santos, Maria Alcide Marques, Hugo Monteiro, Fátima Fradinho
PA4342
Patient-related outcome measurements in pleural diseases Ioannis Psallidas (Oxford, United Kingdom), Ioannis Psallidas, Talwar Ambika, John P. Corcoran, Eleanor K. Mishra, Rob J. Hallifax, John Wrightson, Najib M. Rahman
PA4343
Effect of smoking on experimental malignant pleural effusion Sophia Magkouta (Athens, Greece), Sophia Magkouta, Konstantinos Glynos, Apostolis Pappas, Andreas Papapetropoulos, Ioannis Kalomenidis
277
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4344
Explore opportunity for a "pleural procedure clinic" and review of pleural services Muhammad Yousaf (Warrington, United Kingdom), Muhammad Yousaf, Erandi Barker, Joanna Heaton, Shameen Oliveira, Joanna Gallagher
PA4345
Malignant pleural effusion (MPE) as debut of cancer Ismael Ali Garcia (Madrid, Spain), Ismael Ali García, Beatriz Morales Chacón, Nuria Abad Santamaría, Maria Teresa Río Ramirez, María Isabel Verdugo Cartas, Raquel Pérez Rojo, Eva De Santiago Delgado, Yolanda Martínez Abad, Bárbara Steen, Mercedes Izquierdo Patrón, Rosario Melchor Iñiguez, José Ignacio De Granda Orive, María Beatriz Arias Arcos, Victoria Villena Garrido
PA4346
Clinical nurse specialist led image guided pleural interventions – Is it safe? Farinaz Noorzad (London, United Kingdom), Farinaz Noorzad, Liju Ahmed
PA4347
Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy Michael Mcgettrick (Glasgow, United Kingdom), Michael McGettrick, Selina Tsim, Kevin G. Blyth
PA4348
Volume quantification of malignant pleural mesothelioma Thomas Bronsveld (Hengelo, Netherlands), Thomas Bronsveld, Emanuel Citgez, Robin Bruggink, Onno Mennes, Frans De Jongh, Marjolein Brusse-Keizer, Hugo Schouwink
PA4349
Hypertonicity increases apparent water permeability in benign mesothelial cells but differentially regulates it in epithelioid mesothelioma cells depending on the osmotic agent Evgeniy Solenov (Novosibirsk, Russian Federation), Evgeniy Solenov, Lubov Katkova, Galina Baturina, Vassiliki Peppa, Chrissi Hatzoglou, Konstantinos Gourgoulianis, Sotirios Zarogiannis
PA4350
Effects of hyper and hypo osmotic stress on pleural mesothelial cell adhesion and migration Vasiliki Georgia Peppa (Larissa, Greece), Vassiliki Peppa, Evgeniy Solenov, Lubov Katkova, Galina Baturina, Paschalis Adam Molyvdas, Konstantinos Gourgoulianis, Chrissi Hatzoglou, Sotirios Zarogiannis
PA4351
The role of aquaporin-1 (AQP1) and amiloride sensitive epithelial sodium (ENaC) in cell adhesion of mesothelioma cells is cell and extracellular matrix type dependent Sotirios Zarogiannis (Larisa, Greece), Rajesh Jagirdar, Eleni Apostolidou, Paschalis Adam Molyvdas, Konstantinos Gourgoulianis, Chrissi Hatzoglou, Sotirios Zarogiannis
PA4352
Survival analysis of pleural malignant mesothelioma (MM) at a single Institution in Liguria, Italy Annamaria Carletti (Sarzana ISP), Italy), Anna Maria Carletti, Lucia Benfatto, Vanna Balestracci, Pier Aldo Canessa
PA4353
Predictive parameters of survival in malignant pleural effusion Paola Lucia Arrieta Narvaez (Madrid, Spain), Paola Lucía Arrieta Narváez, Esteban Pérez Rodríguez, Rosa Mariela Mirambeaux Villalona, Deisy Diana Barrios Barreto, Patricia Castro Acosta, Eva Mañas Baena
PA4354
LSC Abstract – A requirement for mast cells in malignant pleural effusion Anastasios Giannou (Patras, Greece), Anastasios D. Giannou, Antonia Marazioti, Magda Spella, Hara Apostolopoulou, Nikolaos I. Kanellakis, Ioannis Psallidas, Malamati Vreka, Dimitra E. Zazara, Ioannis Lilis, Theodora Agalioti, Georgios T. Stathopoulos
Hall 14-37
Session 434
12:50 - 14:40
Thematic Poster: Emerging strategies for airway disease treatments Chairs : Xin Yao ( Nanjing, China), Chair to be confirmed
PA4355
LATE-BREAKING ABSTRACT: Protective effects of surfactant protein D (SP-D) treatment in 1,3-ß-glucanmodulated allergic inflammation Grith Sorensen (Odense, Denmark), Dalia Fakih, Bartosz Pilecki, Anders Schlosser, Christine Jepsen, Laura Thomsen, Jens Madsen, Howard Clark, Kenneth Barfod, Soren Hansen, Niels Marcussen, Rania Jounblat, Soulaima Chamat, Uffe Holmskov, Grith Sorensen
PA4356
LATE-BREAKING ABSTRACT: T-cell membrane organization as a potential new target in asthma Gilles Dufour (Wanze, Belgium), Gilles Dufour, Natacha Rocks, Audrey Duyckaerts, Catherine Gerard, Andreia Giro dos Santos, Fabienne Perin, Marie-Paule Mingeot-Leclercq, Brigitte Evrard, Didier Cataldo
PA4357
LATE-BREAKING ABSTRACT: Aspergillus fumigatus specific IgE, but not total IgE or A. fumigatus specific IgG is associated with evidence of lung damage in asthma Kerry Woolnough (Lichfield, United Kingdom), Kerry Woolnough, Catherine Pashley, Andrew Wardlaw
PA4358
LATE-BREAKING ABSTRACT: IgE sensitisation to A. fumigatus is associated with fixed airflow obstruction independent of atopic status Kerry Woolnough (Lichfield, United Kingdom), Kerry Woolnough, Catherine Pashley, Andrew Wardlaw
278
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4359
LATE-BREAKING ABSTRACT: Prevention of COPD exacerbation by lysozyme: A double-blind, randomized, placebo-controlled study Masakazu Ichinose (Sendai, Japan), Masakazu Ichinose, Yoshinosuke Fukuchi, Koichiro Tatsumi, Hiromasa Inoue, Toshihisa Arai, Kai Shibata, Hideaki Miyagishi, Yukinori Sakata
PA4360
LATE-BREAKING ABSTRACT: miR-877 and its target protein HDAC6 are involved in airway inflammation Yongyao Cui (Shanghai, China), Haozhong Lu, Jianrong Xu, Zhihua Yu, Juan Li, Yu Qiu, Wenhui Zhang, Yongyao Cui
PA4361
LATE-BREAKING ABSTRACT: Safety, pharmacokinetic and pharmacodynamic profile of RV1162, a narrow spectrum kinase inhibitor, in healthy subjects and COPD patients Paul Russell (London, United Kingdom), Paul Russell, Chris Stevenson, Catherine Charron, Charlie Brindley, Dave Singh
PA4362
LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Peter M.A. Calverley (Liverpool, United Kingdom), Peter Calverley, Christoph Hallmann, Norbert Metzdorf, Lars Grnke, Achim Mueller, David Halpin
PA4363
LATE-BREAKING ABSTRACT: PT003, a novel co-suspension MDI glycopyrronium/formoterol fixed-dose combination is superior to monocomponents in patients with COPD Klaus Friedrich Rabe (Grosshansdorf, Germany), Klaus Rabe, Fernando Martinez, Roberto Rodriguez-Roisin, Leonardo M. Fabbri, Gary T. Ferguson, Paul Jones, Stephen Rennard, Michael Golden, Patrick Darken, Chad Orevillo, Tracy Fischer, Colin Reisner
PA4364
LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma Fang Cai (South San Francisco, United States of America), Fang Cai, David F. Choy, Jochen Brumm, Cecile Holweg, Alyssa Morimoto, Joseph R. Arron, John Matthews, Heleen Scheerens
PA4365
LATE-BREAKING ABSTRACT: A Phase 1b study of PUR0200, a novel tiotropium formulation, in COPD patients David Hava (Lexington, United States of America), David Hava, Katie Kane, Fred Reid, Arjun Ravi, Jo Collier, Tess Schmalbach, Dave Singh
PA4366
LATE-BREAKING ABSTRACT: ENERGITO: Efficacy and safety of once-daily combined tiotropium + olodaterol versus twice-daily combined fluticasone propionate + salmeterol Kai Michael Beeh (Wiesbaden, Germany), Kai-Michael Beeh, Eric Derom, Jose Echave-Sustaeta, Lars Groenke, Alan Hamilton, Dongmei Zhai, Leif Bjermer
PA4367
LATE-BREAKING ABSTRACT: Novel inhaled ROR/c inhibitor for potential treatment of COPD Srinivasa Honnegowda (Navi Mumbai, India), Srinivasa Honnegowda, Abraham Thomas, Sachin Chaudhari, Sanjib Das, Daisy Shah, Malini Bajpai, Indrani Sarkar, Abhay Kulkarni, Girish Gudi, Satyawan Jadhav, Neelima Khairatkar-Joshi
PA4368
LATE-BREAKING ABSTRACT: Morin attenuates ovalbumin-induced airway inflammation by modulating oxidative stress-responsive MAPK signaling Xiaoning Zeng (Nanjing, China), Xiaoning Zeng, Yuan Ma, Mao Huang
PA4369
LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors John Upham (Brisbane, Australia), John Upham, Megan Landgraf, Camilla Xi
PA4370
LATE-BREAKING ABSTRACT: The effects of NKT cells on the different degrees of severity bronchial asthma in mice Chuangli Hao (Suzhou, China), Fanfan Chi, Chuangli Hao
PA4371
LATE-BREAKING ABSTRACT: Triptolide modulates the CD4+ T cells balance in an allergic asthmatic mouse model Ningfei Ji (Nanjing, China), Ningfei Ji, Wenjing Wang, Mingshun Zhang, Mao Huang
PA4372
LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma Zhijun Jie (Shanghai, China), Yanchao He, Wei Sun, Jindong Shi, Xiao Su, Zhijun Jie
PA4373
LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity Abeer Kassem (Alexandria, Egypt), Dalal El Giziry, Nermin Zakaria, Abeer Kassem, Mona Abdellatif
PA4374
LATE-BREAKING ABSTRACT: Inhibition of MAP3K19 - A novel therapeutic approach for treatment of IPF Stefen Boehme (San Diego, United States of America), Stefen Boehme, Tai Wei Ly, Kevin Bacon
279
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
Room 7.1
Session 435
13:00 - 14:30
Lunchtime session: e/mHealth, TB and tobacco control followed by the launch of the ERS/WHO strategic document on e/mHealth for TB Aims : To launch the WHO/ERS strategic document on e/mHealth and TB/tobacco control; to describe the activities that have been put in place and supported by the WHO/ERS joint agreement since 2014; and to discuss the state-of-the-evidence for e/mHealth and TB/tobacco control and the efforts being put in place to improve it. Track(s) : Infection Tag(s) : Clinical Target audience : Experts in public health and health promotion, TB specialists, pulmonologists and primary care clinicians. Chairs : Giovanni Battista Migliori (Varese, Italy), Mario C. Raviglione (Geneva, Switzerland) 13:00
The WHO/ERS strategic document on e/mHealth and TB/tobacco control Denis Falzon (Geneva, Switzerland)
4375
13:25
Making mHealth more effective for patients and their carers Caroline Free (London, United Kingdom)
4376
13:50
Information, diagnostics and laboratories Claudia Denkinger (Geneva, Switzerland)
4377
14:15
Ceremony for the launch of the WHO/ERS strategic document on e/mHealth for tuberculosis
4378
Room 4.2
Session 437
13:00 - 14:30
Lunchtime session: Interplay of myeloid and epithelial cells in infectious diseases Highlights from the 2015 Lung Science Conference Aims : To discuss the complex mechanisms by which environmental particles and infectious agents (bacteria and viruses) cause disease and the innate immune mechanisms by which epithelial cells, macrophages and neutrophils protect from disease. Tag(s) : Translational Target audience : Clinicians, clinical scientists, scientists and allied health care workers with an interest in environmental particles and infectious diseases exposure. Chairs : Bruno Crestani (Paris, France), Dominik Hartl (Tübingen, Germany), Jean-Michel Sallenave (Paris, France) 13:00
Epithelial regulation of airway macrophages in health and disease Tracy Hussell (Manchester, United Kingdom)
4387
13:30
Macrophage-released TNF-related apoptosis-inducing ligand (TRAIL) impairs alveolar fluid clearance in influenza A virus infection Christin Becker (Giessen, Germany)
4388
14:00
Exposure to nanoparticles modulates lung infections Ignacio Garcia-Verdugo (Paris, France)
4389
Room 5.2
Session 438
13:00 - 14:30
Lunchtime session: Advances in pneumonia management, COPD therapy and lung nodule evaluation Joint ERS/JAMA session Aims : The audience will learn about the usefulness of systemic corticosteroid therapy for severe community-acquired pneumonia; the risks and benefits of treating older patients with COPD with combined long-acting bronchodilators and inhaled corticosteroid therapy versus long-acting bronchodilator alone; and the roles and limitations of FDG-PET scanning for evaluating pulmonary nodules that are suspicious for lung cancer. Tag(s) : Clinical Target audience : Clinicians and clinical researchers. Chairs : George O'Connor (Boston, United States of America), Guy Brusselle (Ghent, Belgium) 13:00
Systemic corticosteroid for treating severe community-acquired pneumonia Antoni Torres Marti (Barcelona, Spain)
4390
13:30
Inhaled corticosteroid combined with long-acting bronchodilator versus long-acting bronchodilator alone for older patients with COPD Peter M.A. Calverley (Liverpool, United Kingdom)
4391
280
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 14:00
The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer Eric Grogan (Nashville, United States of America)
Room Elicium 1
Session 439
4392
13:00 - 14:30
Lunchtime session: Evolution of medical journals Perspectives from the ERS and ATS Aims : To describe how medical journals are evolving and the new initiatives in the field. Target audience : Clinicians, scientists, other healthcare professionals and anyone involved in medical publications. Chairs : Oliver Eickelberg (Munich, Germany), Wisia Wedzicha (London, United Kingdom) 13:00
Advantages of “journal families”: experience from ATS Wisia Wedzicha (London, United Kingdom)
4393
13:20
Publications in critical care Laurent Brochard (Toronto, Canada)
4394
13:40
Respiratory highlights in AJRCCM Fernando J. Martinez (Ann Arbor, United States of America)
4395
14:00
Involving early-career researchers in editorial work Alexander Mackay (London, United Kingdom)
4396
Room G102-103
Session 440
13:00 - 14:00
Patient forum: ELF/ERS session: Improving adherence and outcomes in pulmonary rehabilitation Aims : This forum will explore how professionals can improve their healthcare outcomes by incorporating the patient's experience. This session will discuss the barriers that can arise when referring patients to enrol and complete a programme of pulmonary rehabilitation in primary and tertiary care settings. This interactive session, which will be led by a patient and a professional, will demonstrate how open professional-patient dialogue can help improve the practical problems experienced by patients receiving treatment.
Target audience : Pulmonologists, respiratory therapists, respiratory physicians, clinical researchers, general practitioners, research fellows, basic scientists, paediatricians, nurses, trainees and allied health professionals. Chairs : Frits M.E. Franssen (Horn, Netherlands), Dan Smyth (Dundalk, Ireland) 13:00
Barriers to and facilitators of pulmonary rehabilitation Martijn A. Spruit (Horn, Netherlands)
4397
13:15
Pulmonary rehabilitation in the primary care setting Frederik van Gemert (Harlingen, Netherlands), Cornelis Van Hecken (Amsterdam, Netherlands)
4398
13:30
Pulmonary rehabilitation in the tertiary care setting Frits M.E. Franssen (Horn, Netherlands), Speaker to be confirmed
4399
13:45
Discussion and closing Dan Smyth (Dundalk, Ireland)
4400
13:15-14:30 INDUSTRY PRACTICAL WORKSHOP Room 7.1
Session 451
SEE PAGE 331 14:45 - 16:45
Hot topics: Pandemics and emerging infections PREPARE FP7 EU-funded project Aims : This session will provide an update on global planning; the management of existing pandemics and the evolving lessons that have been learnt; and how to facilitate care and promote public health messages in future major infectious disease outbreaks and pandemics. Track(s) : Infection Tag(s) : Translational Target audience : Respiratory physicians, intensivists, microbiologists, allied health professionals, scientists, primary care and public health teams. Chairs : Gernot G.U. Rohde (Maastricht, Netherlands), Anita Simonds (London, United Kingdom)
281
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 14:45
Global capacity and responses to pandemics Randall N. Hyer (Stevensville, United States of America)
4429
15:15
Ebola: progress with vaccines Sarah Gilbert (Oxford, United Kingdom)
4430
15:45
Translational medicine lessons from H1N1 Pasi Penttinen (Stockholm, Sweden)
4431
16:15
Behaviour change and communication in pandemics: key elements Speaker to be confirmed
4432
Room 7.2
Session 453
14:45 - 16:45
Symposium: Sleep-disordered breathing Beyond OSAS Aims : To provide up-to-date insights into sleep and obstructive sleep apnoea syndrome (OSAS) in the intensive care unit (ICU); ventilatory treatment in obesity hypoventilation syndrome (OHS) (the results of a recent randomised controlled trial will be presented); perioperative sleep disturbances; and sleep-related disorders in the paediatric setting that require evaluation and ventilatory treatment. Track(s) : Sleep Tag(s) : Clinical Target audience : Pulmonologists, intensivists, sleep physicians respiratory therapists, paediatricians, and surgeons. Chairs : Stylianos Orfanos (Athens, Greece), Wilfried De Backer (Edegem (Antwerp), Belgium) 14:45
Sleep disturbances in critically ill patients Francesco Fanfulla (Pavia, Italy)
4442
15:15
OSAS in the perioperative period Cesare Gregoretti (Turin, Italy)
4443
15:45
Efficacy of CPAP and NIV in long term treatment of OHS: the results of the Spanish multicentre randomised trial "Pickwicks" Juan Fernando Masa Jiménez (Cáceres, Spain)
4444
16:15
CPAP/NIV in paediatric patients with sleep disturbances Brigitte Fauroux (Paris, France)
4445
Room Elicium 2
Session 454
14:45 - 16:45
Symposium: Stop immune tolerance in lung cancer! Aims : To update oncologists, pulmonologists, and thoracic surgeons regarding the new lung cancer treatment options as well as immunologists, pathologists, and researchers on the immune mechanisms in lung cancer, new research directions, and the methods that are used in practice to evaluate the anti-cancer responses and immune status of cancer patients. Track(s) : Oncology Tag(s) : Translational Target audience : Oncologists, pulmonologists, thoracic surgeons, immunologists, pathologists, and researchers who are interested in the practical applications of immunotherapy and evaluation of immune status before treatment. Chairs : Philipp A. Schnabel (Homburg/Saar, Germany), Arnaud Scherpereel (Lille, France) 14:45
How to define the immune status of lung cancer patient Joanna Domagala-Kulawik (Warsaw, Poland)
4446
15:15
Reversing the suppression of T-cells: the role of monoclonal antibodies Joachim Aerts (Rotterdam, Netherlands)
4447
15:45
A novel approach to anti-cancer vaccines Thomas Wehler (Homburg/Saar, Germany), Speaker to be confirmed
4448
16:15
Chemotherapy triggered crosstalk between tumor and immune cells Yuting Ma (Paris, France)
4449
Room 4.2
Session 455
Symposium: The next generation of lung function tests Looking into a breath: exhaled biomarkers
282
14:45 - 16:45
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Aims : To provide an overview of the development and possibilities of breath analysis tests, the new technologies that are available (monitoring VOCs in asthma and COPD during the daily lung function routine), the roles that FeNO and exhaled breath temperature play among the other lung function tests and how these new techniques will be integrated practically into the existing technology. Track(s) : Physiology Tag(s) : Clinical Target audience : Clinicians, nurses, respiratory function technologists, scientists, and physiologists. Chairs : Peter Sterk (Amsterdam, Netherlands), Waldemar Tomalak (Rabka-Zdroj, Poland) 14:45
Origin and development of measuring exhaled breath Stephen James Fowler (Preston, United Kingdom)
4450
15:15
When will exhaled biomarkers influence diagnosis and follow-up of patients with respiratory disease? Ildikó Horváth (Budapest, Hungary)
4451
15:45
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Niki Fens (Amsterdam, Netherlands)
4452
16:15
Back to the future: integrating breath analysis in lung function equipment Paolo Paredi (London, United Kingdom)
4453
Room 5.2
Session 456
14:45 - 16:45
Session: Healthy lungs for life Why taking the active option is essential for lung health Aims : To describe the concerns and issues faced by patients who find physical activity difficult and how these issues can be addressed, review the current evidence on the direct links between physical activity and lung health, describe the public health problem that is physical inactivity and its impact and discuss how taking the active option can be promoted in areas where air quality is problematic. Track(s) : Epidemiology/Environment Tag(s) : Healthy Lungs for Life (HLfL) Target audience : All healthcare professionals who are interested in the link between physical activity and lung health, especially those who must advise their patients about the importance of physical activity in general and encourage their patients with respiratory conditions to become active. Chairs : Thierry Troosters (Leuven, Belgium), Dan Smyth (Dundalk, Ireland) 14:45
Why taking the active option is essential for lung health Matthew Cullen (Dublin, Ireland)
4454
15:00
The interaction between physical activity and lung health: the Copenhagen experience Judith Garcia Aymerich (Barcelona, Spain)
4455
15:25
Is physical inactivity as bad as smoking? Speaker to be confirmed
4456
15:50
Is physical inactivity as bad as smoking? Henriette Smit (Utrecht, Netherlands)
4457
16:15
How healthy is physical activity when there is no clean air to breathe? Patrick De Boever (Antwerp, Belgium)
4458
Room Elicium 1
Session 457
14:45 - 16:45
Hot topics: Regenerative medicine of the lung: opportunities and threats Aims : Chronic lung diseases, including COPD, IPF and others, are characterized by loss of lung function. This loss associates with a defective tissue repair response that results in tissue destruction and/or remodelling. The defective tissue repair cannot be modified by current pharmacological or non-pharmacological treatment. To develop therapies that restore normal tissue repair in the lung, it is necessary to gain insights into the mechanisms that regulate repair and the origins of the defective tissue repair response in disease. In this symposium, the mechanisms of tissue repair in and outside the lung, including stem cell activation and renewal, will be discussed. Moreover, therapeutic possibilities that are based on stem and progenitor cell transplantation and activation will be discussed. These therapeutic possibilities include bioscaffolds that can facilitate tissue growth and repair. At the end of the symposium, the audience will understand: the mechanisms behind tissue repair and the role of endogenous stem and progenitor cell populations in repair; how stem and progenitor cells (e.g., iPS cells and macrophage progenitors) can be used for therapeutic purposes in the lung; and how bioscaffolds can facilitate tissue repair, either alone or in combination with exogenous stem or progenitor cell transplantation.
283
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 Tag(s) : Basic Target audience : This session will be of interest to basic scientists, and clinicians and everyone who has an interest in regenerative medicine of the lung. Chairs : Melanie Koenigshoff (Munich, Germany), Reinoud Gosens (Groningen, Netherlands) 14:45
Alveolar progenitor cells: Ready for endogenous lung regeneration
4459
15:15
Modelling human lung development and disease using pluripotent stem cells Hans-Willem Snoeck (New York, United States of America)
4460
15:45
The lung-from-the-lab approach: recent advances in tissue-engineering scaffolds Darcy Wagner (Munich, Germany)
4461
16:15
Pulmonary transplantation of macrophage progenitors: a novel therapeutic opportunity? Gesine Hansen (Hannover, Germany)
4462
Room Forum
Session 458
14:45 - 16:45
Oral Presentation: Novel mechanisms and treatments in allergy and asthma Chairs : Lena Uller (Lund, Sweden), Hans Jürgen Heinrich Hoffmann (Aarhus, Denmark) OA4463
Many obese individuals experience wheezing, rather than asthma. A Mendelian randomization study of 86,019 adults Yunus Çolak (Helsingør, Denmark), Yunus çolak, Shoaib Afzal, Peter Lange, Børge Nordestgaard
OA4464
First clinical trial of a new IgE-adsorber in allergic asthma Christian Lupinek (Vienna, Austria), Christian Lupinek, Kurt Derfler, Silvia Lee, Thomas Prikoszovich, Oliver Movadat, Eva Wollmann, Ventzislav Petkov, Volker Schoder, Rene Cervenka, Thomas Plaichner, Gottfried Stegfellner, Hans Huber, Rainer Henning, Justyna Kozik-Jaromin, Adelheid Gauly, Hans Peter Leinenbach, Ingrid Uhlenbusch-Koerwer, Rudolf Valenta
OA4465
Prostaglandin E2 prevents mast cell dependent bronchoconstrictrion via the EP2 receptor in human small airways Jesper Säfholm (Stockholm, Sweden), Jesper Säfholm, Martijn Manson, Johan Bood, Ingrid Delin, Ann-Charlotta Orre, Per Bergman, Mamdoh Al-Ameri, Sven-Erik Dahlén, Mikael Adner
OA4466
Innate lymphoid cells are proportionally higher in children with atopy Chris Grime (London, United Kingdom), Christopher Grime, Prasad Nagakumar, Hue-ling Tan, Mark Rosenthal, Sejal Saglani, Clare Lloyd
OA4467
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response Deimante Hoppenot (Utena, Lithuania), Deimante Hoppenot, Kestutis Malakauskas, Simona Lavinskiene, Raimundas Sakalauskas
OA4468
The dynamic change of IL-25 and its receptor expression during allergen challenge in asthmatic subjects Wei Tang (Shanghai , China), Wei Tang, Steven Smith, Paul O’Byrne, Roma Sehmi
OA4469
Changes in pollen sensitization over last twenty years in Tunisia Ferdaous Yangui (Tunis, Tunisia), Ferdaous Yangui, Hend Khouani, Maher Abouda, Rimeh Ayayri, Mariem Triki, Samia Sellami, Emna Guermazi, Mohamed Ridha Charfi
OA4470
Eosinophils attenuate parainfluenza virus infection through nitric oxide Matthew Drake (Portland, United States of America), Matthew Drake, Elizabeth Bivins-Smith, Becky Proskocil, Zhenying Nie, Jamie Lee, Nancy Lee, Allison Fryer, David Jacoby
Room 5.1
Session 459
14:45 - 16:45
Oral Presentation: Acute critical care: mechanical ventilation: how to limit the damage Chairs : Marcus Schultz (Amsterdam, Netherlands), Chair to be confirmed OA4471
LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-?B pathway Jie Chen (Beijing, China), Jie Chen, Liangan Chen
OA4472
Assessing regional PEEP-related airway opening and dilatation in ARDS patients Tom Schepens (Kontich, Belgium), Tom Schepens, Cedric Van Holsbeke, Wim Vos, Jan De Backer, Paul Parizel, Wilfired De Backer, Jean-Jacques Rouby, Phillipe G. Jorens
284
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA4473
Risk factors and prognostic impact of patient-ventilator asynchrony in mechanically ventilated patients. A prospective study Camille Rolland (paris, France), Camille Rolland-Debord, Côme Bureau, Marc Clavel, Sebastien Perbet, Nicolas Terzi, Achille Kouatchet, Thomas Similowski, Alexandre Demoule
OA4474
Effects of veno-venous extracorporeal CO2 removal on pulmonary hypertension in an ARDS model Julien Guiot (Liège, Belgium), Philippe Morimont, Julien Guiot, Thomas Desaive, Jean-Olivier Defraigne, Bernard Lambermont
OA4475
Measurements of regional strain and time constants in ex-vivo animal models at different PEEP levels using functional respiratory imaging (FRI) Francisca Ferreira (Kontich, Belgium), Francisca Ferreira, W.R. Henderson, Cedric Van Holsbeke, Wim Vos, Jan De Backer, Yannick Molgat-Seon, Miranda Kirby, Paolo Dominelli, Donald Griesdale, MyPinder Sekhon, Harvey Coxson, John Mayo, William Sheel
OA4476
Risk factors and prognostic impact of decreased breathing variability in mechanically ventilated patients. A prospective study Camille Rolland (paris, France), Camille Rolland-Debord, Côme Bureau, Marc Clavel, Sebastien Perbet, Nicolas Terzi, Achille Kouatchet, Thomas Similowski, Alexandre Demoule
OA4477
Risk factor and prognosis of ventilator-associated event Jae Kyeom Sim (Seoul, Republic of Korea), Jae Kyeom Sim, Jee Youn Oh, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Kyung Ho Kang
OA4478
Assisted ventilation in patients with acute respiratory distress syndrome: Lung-distending pressure and patientventilator Interaction Jonne Doorduin (Nijmegen, Netherlands), Jonne Doorduin, Christer Sinderby, Jennifer Beck, Johannes Van der Hoeven, Leo Heunks
Room 13.1
Session 460
14:45 - 16:45
Oral Presentation: Any news from the asthma field? Chairs : Gilles Garcia (Le Kremlin Bicètre, France), Florence Schleich (Liège, Belgium) OA4479
What is important to people with asthma: Maximising research impact? Sarah Masefield (Sheffield, United Kingdom), Sarah Masefield, Leanne Metcalf, Pippa Powell, Erika Kennington, Carine Lewis, Samantha Walker
OA4480
The role of dysfunctional breathing in asthma control Sandra Veidal (Copenhagen, Denmark), Sandra Veidal, Asger Sverrild, Vibeke Backer, Celeste Porsbjerg
OA4481
Detecting specific clusters of asthma and COPD patients using fluctuation based clustering of daily lung function recordings in the BIOAIR study Delphine Girard (Bern, Switzerland), Delphine Girard, Edgar Delgado, Maciej Kupczyk, Sven-Erik Dahlén, Urs Frey, On Behalf of the BIOAIR and ChAMP Consortia
OA4482
The use and abuse of steroids in asthma action plans Tow Keang Lim (Singapore, Singapore), T.K. Lim, Nora Said, C.C. Gan, S.Y. Lee
OA4483
Impact of alexithymia on asthma managment Samira Aouadi (Arina, Tunisia), Samira Aouadi, Dorra Bejar, Houda Gahrsalli, Islem Bel Haj Khalifa, Manel Guermani, Faten Ellouze, Sonia Maâlej, Leila Douik el Gharbi
OA4484
Yield of a mannitol bronchial provocation test (BPT) for the diagnosis of asthma in a real-life study Jose Anibal Diaz Tantalean (Barcelona, Spain), José Aníbal Díaz-Tantaleán, Alexa Nuñez-Dubón, Iñigo Ojanguren, María Jesús Cruz, Xavier Muñoz
OA4485
Epidemiology of clinical trials in respiratory diseases in Europe and Italy Roberta Bodini (Verona, Italy), Roberta Bodini, Pierachille Santus, Fabiano Di Marco, Stefano Aliberti, Stefano Centanni, Francesco Blasi, Andrea Rizzi, Giuseppe Recchia
OA4486
Role of changes of airway patency and lung inflation in predicting the asthma control achievement Ilin Andrei (Blagoveschensk, Russian Federation), Andrey V. Il’in, Juliy M. Perelman, Anna G. Prikhodko, Anatoliy V. Lenshin, Victor P. Kolosov
Room 2.1
Session 461
14:45 - 16:45
Oral Presentation: New frontiers in the management of interstitial and orphan lung diseases Chairs : Philippe Camus (Dijon, France), Alfredo Chetta (Parma, Italy)
285
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA4487
LATE-BREAKING ABSTRACT: The heterogeneity of systemic inflammation in bronchiectasis John R Hurst (London, United Kingdom), A. Saleh, J. Chalmers, A. de Soyza, T. Fardon, S. Koustas, J. Scott, J. Simpson, J. Brown, J. Hurst
OA4488
Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Vincent Cottin (Lyon, France), Vincent Cottin, David M. Hansell, Nicola Sverzellati, Derek Weycker, Katerina M. Antoniou, Mark Atwood, Gerry Oster, Frank Weber, Klaus-Uwe Kirchgaessler, Harold R. Collard, Athol U. Wells
OA4489
Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)–The LOTUSS study Dinesh Khanna (Ann Arbor, United States of America), Dinesh Khanna, Carlo Albera, Aryeh Fischer, James Seibold, Ganesh Raghu, Nader Khalidi, Lorinda Chung, Elena Schiopu, Dan Chen, Eduard Gorina
OA4490
Effect of pirfenidone on treatment-emergent (TE) all-cause mortality (ACM) in patients with idiopathic pulmonary fibrosis (IPF): Pooled data analysis from ASCEND and CAPACITY Steven Nathan (Falls Church, United States of America), Steven D. Nathan, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Ian Glaspole, Marilyn K. Glassberg, David Kardatzke, Talmadge E. King Jr., Klaus-Uwe Kirchgaessler, Lisa H. Lancaster, David J. Lederer, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Paul W. Noble
OA4491
Benefit of continued pirfenidone treatment following hospitalisation within the first 6 months of therapy—Ad hoc analysis from three phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF) Steven Nathan (Falls Church, United States of America), Steven Nathan, Carlo Albera, Williamson Bradford, Ulrich Costabel, Roland Du Bois, Elizabeth Fagan, Robert Fishman, Ian Glaspole, Marilyn Glassberg, Kenneth Glasscock, Lisa Lancaster, David Lederer, Zhengning Lin, Carlos Pereira, Jeffrey Swigris, Dominique Valeyre, Paul Noble, Athol Wells
OA4492
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Beatriz Lara, Esther Rodriguez, Pietro Pirina, Ignacio Blanco, Marc Miravitlles
OA4493
Health-related quality of life in patients with alpha-1 antitrypsin deficiency Ana Margarida Redondo (Porto, Portugal), Margarida Torres Redondo, Elsa Campoa, Sandra Saganha, Maria Sucena
OA4494
Clinical characteristics and follow up in adult patients with primary ciliary dyskinesia Justine Frija-Masson (Paris, France), Justine Frija-Masson, Laurence Bassinet, Isabelle Honore, Nadine Desmazes-Dufeu, Bruno Housset, André Coste, Estelle Escudier, Pierre-Régis Burgel, Bernard Maître
Room 4.1
Session 462
14:45 - 16:45
Oral Presentation: Treatment of IPF Chairs : Athol Wells (London, United Kingdom), Luca Richeldi (Southampton, United Kingdom) OA4495
Interim analysis of nintedanib in an open-label extension of the INPULSIS® trials (INPULSIS®-ON) Bruno Crestani (Paris, France), Bruno Crestani, Takashi Ogura, Katy Pelling, Carl Coeck, Manuel Quaresma, Michael Kreuter, Mitchell Kaye
OA4496
LSC Abstract – Inhibition of oxygen sensing HIF prolyl hydroxylases in humans presents a novel therapeutic target for the fibrotic lung Benjamin Scally (Edinburgh, United Kingdom), Benjamin Scally, Andreas Alber, Sarah Howie, Nik Hirani
OA4497
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Minoru Inomata (Tokyo, Japan), Minoru Inomata, Yukiko Miura, Nariaki Kokuho, Hiroki Hayashi, Takahito Nei, Koichiro Kamio, Kazue Fujita, Yoshinobu Saito, Akihiko Gemma, Takefumi Saito, Arata Azuma
OA4498
Effect of baseline corticosteroid medication on reduction in FVC decline with nintedanib Vincent Cottin (Lyon, France), Vincent Cottin, Huiping Li, Fabrizio Luppi, Florence Le Maulf, Rozsa Schlenker-Herceg, Susanne Stowasser, Roland M. Du Bois
OA4499
Effect of baseline FVC on lung function decline with nintedanib in patients with IPF Toby Maher (St. Albans, Hertfordshire, United Kingdom), Toby M. Maher, Kevin R. Flaherty, Paul W. Noble, Carlo Vancheri, Wim A. Wuyts, Toshio Kimura, Christoph Hallmann, Susanne Stowasser, Luca Richeldi
OA4500
Pirfenidone post-authorization safety registry (PASSPORT) update Vincent Cottin (Lyon, France), Vincent Cottin, Toby M. Maher, Arata Azuma, Lesley Groves, Philip Hormel, Magnus Sköld, Sara Tomassetti, Dirk Koschel
OA4501
Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Lisa Nicol (Tillicoultry, United Kingdom), Lisa Nicol, Pauline McFarlane, Catriona Graham, David McAllister, William Wallace, Gareth Stewart, Sarah Howie, John Murchison, Nik Hirani
286
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
OA4502
Effect of anti-acid medication on reduction in FVC decline with nintedanib Ganesh Raghu (Seattle, United States of America), Ganesh Raghu, Bruno Crestani, Zelie Bailes, Rozsa Schlenker-Herceg, Ulrich Costabel
Room E104-106
Session 463
14:45 - 16:45
Poster Discussion: Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Chairs : Claudia Kuehni (Bern, Switzerland), Franca Rusconi (Florence, Italy) PA4503
Indoor room nitric oxide and alveolar nitric oxide in the Southern California children’s health study Sandrah Eckel (Los Angeles, United States of America), Sandrah Eckel, Zilu Zhang, Edward Rappaport, Rima Habre, William Linn, Kiros Berhane, Bastain Theresa, Zhang Yue, Gilliland Frank
PA4504
The association of particulate matter air pollution with exercise-induced bronchospasm Mohammadreza Modaresi (Tehran, Islamic Republic of Iran), Mohammadreza Modaresi, Roya Kelishadi, Akram Amiri, Akbar Amiri, Zahra Aryan, Babak Amra, Jamal Faghihinia
PA4505
Air pollution and bronchiolitis from 2004 to 2014 in Rome Melania Evangelisti (Civita Castellana, Italy), Melania Evangelisti, Giulia Cangiano, Raffaella Nenna, Ambra Nicolai, Antonella Frassanito, Stefano Papasso, Claudia Alessandroni, Chiara Di Mario, Valeria Zambonini, Greta Di Mattia, Corrado Moretto, Fabio Midulla
PA4506
Traffic proximity and lung function. A case-control study in asthmatic children Mauro Ferrante (Palermo, Italy), Ferrante Mauro, Ranzi Andrea, Tommaso Giulia, Lauriola Paolo, De Cantis Stefano, Cilluffo Giovanna, Antona Roberta, Ferrante Giuliana, Malizia Velia, Montalbano Laura, La Grutta Stefania
PA4507
Relationships between school indoor toluene and respiratory symptoms in Italian children Marzia Simoni (Pisa, Italy), Marzia Simoni, Sandra Baldacci, Mario Canciani, Carlo Pini, Luigia Maria Brunetti, Luciana Indinnimeo, Paolo Carrer, Annibale Biggeri, Piersante Sestini, Giovanni Viegi, Sara Maio, Sonia Cerrai, Giuseppe Sarno
PA4508
Lung function and respiratory symptoms in children from an electronic waste recycling area in China Xiang Zeng (Groningen, Netherlands), Xiang Zeng, Xijin Xu, H. Marike Boezen, Judith M. Vonk, Xinye Zhou, Fangfang Lu, Xia Huo
PA4509
Lower probability of FEV1 improvement in asthmatic children exposed to passive smoke Giovanna Cilluffo (Palermo, Italy), Giovanna Cilluffo, Salvatore Fasola, Laura Montalbano, Velia Malizia, Giuliana Ferrante, Roberta Antona, Stefania La Grutta
PA4510
Indoor air pollution and tobacco smoke exposure in an African birth cohort study Aneesa Vanker (Cape Town, South Africa), Aneesa Vanker, Whitney Barnett, Polite M. Nduru, Kirsty Brittain, Robert P. Gie, Heather J. Zar
PA4511
Predicting asthma exacerbations in children – A real life observational study Stephen Turner (Aberdeen, United Kingdom), Steve Turner, Annie Burden, Mike Thomas, Clare Murray, David Price
PA4512
Causal relationships between infections and asthma throughout childhood: A path analysis approach Alban Ramette (Bern, Switzerland), Alban Ramette, Ben Spycher, Caroline Beardsmore, Claudia Kuehni
PA4513
Systematic review of childhood asthma prediction models Mariona Pinart (Barcelona, Spain), Mariona Pinart, Henriette A. Smit, Thomas Keil, Jean Bousquet, Josep M. Antó, Karin C. Lødrup-Carlsen
PA4514
VAS and PAQLQ association with level of asthma control by using C-ACT Laura Montalbano (Palermo, Italy), Laura Montalbano, Giovanna Cilluffo, Velia Malizia, Giuliana Ferrante, Roberta Antona, Stefania La Grutta
PA4515
Asthma control, severity and lung function impairment through network analysis in children Antonino Abbruzzo (Sciacca, Italy), Antonio Abbruzzo, Giovanna Cilluffo, Laura Montalbano, Velia Malizia, Giuliana Ferrante, Roberta Antona, Stefania La Grutta
PA4516
Diagnostic accuracy of nasal nitric oxide measurement for establishing diagnosis of primary ciliary dyskinesia: A systematic review and meta-analysis Panayiotis Kouis (Nicosia, Cyprus), Panayiotis Kouis, Stefania Papatheodorou, Panayiotis Yiallouros
PA4517
The accuracy of nasal nitric oxide testing in PCD diagnostics is population specific Samuel Collins (Christchurch, United Kingdom), Samuel Collins, Laura Behan, Hazel Evans, Patricia Goggin, Amanda-Lea Harris, Claire Jackson, Samantha Packham, Woolf Walker, Jane Lucas
287
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4518
Lung function of patients with primary ciliary dyskinesia: A systematic review Myrofora Goutaki (Bern, Switzerland), Myrofora Goutaki, Anu Jose, Bettina Meier, Elisabeth Maurer, Florian Halbeisen, Philipp Latzin, Claudia Kuehni
PA4519
Primary ciliary dyskinesia: Diagnostic and phenotypic features in an Italian population Deborah Snijders (Ponzano Veneto, Italy), Deborah Snijders, Massimo Pifferi, Giovanni A. Rossi, Angelo Barbato, Gruppo PCD-Italia
PA4520
Diagnosing primary ciliary dyskinesia; the patient perspective Laura Behan (Cork, Ireland), Laura Behan, Audrey Dunn Galvin, Sarah Masefield, Fiona Copeland, Michele Manion, Bernhard Rindlisbacher, Beatrice Redfern, Jane S. Lucas
Room G102-103
Session 464
14:45 - 16:45
Poster Discussion: Biomarkers in TB: immunology and physiology Chairs : Lorenzo Guglielmetti (Paris, France), Marc Lipman (London, United Kingdom) PA4521
Significance of interferon gamma-inducible chemokines in pleural effusions Yun-jung Jung (Suwon, Republic of Korea), Yun Jung Jung, Wou Young Chung, Keu Sung Lee, Seung Soo Sheen, Joo Hun Park, Kwang Joo Park
PA4522
Nitric oxide activity in tuberculous pleuritis Rachida Yahiaoui (Barcelona, Spain), Rachida Yahiaoui, Houda Belguendouz, Chafika Touil, Djamal Messaouadéne, Rabah Amrane, Aziza Fissah
PA4523
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs Yoshihiro Kobashi (Kurashiki Okayama, Japan), Yoshihiro Kobashi, Keiji Mouri, Shigeki Kato, Mikio Oka
PA4524
Effectiveness of tuberculosis detection using a skin test with allergen recombinant (CFP-10-ESAT-6) in children Ludmila Slogotskaya (Moscow, Russian Federation), L. Slogotskaya, E. Bogorodskaya, O. Sentchichina, D. Ivanova, G. Nikitina, V. Litvinov, P. Seltsovsky, D. Kudlay, N. Nikolenko, S. Borisov
PA4525
Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children Zhanna Kryvasheyeva (Minsk, Belarus), Zhanna Kryvasheyeva, Natalya Morozkina, Natalya Emeljanova, Andrey Astrovko, Irina Babchenok
PA4526
Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection CHIU-PING KUO (Taipei, Taiwan), Chiu-Ping Kuo, Yen-Ta Lu, Rong-Luh Lin
PA4527
System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction) Diljara Esmedlyaeva (St.Petersburg, Russian Federation), Diljara Esmedlyaeva, Olga Titarenko, Marina Dyakova, Maria Pavlova, Viacheslav Zhuravlev
PA4528
High diagnostic accuracy of immunodiagnosis in sputum smear/PCR-negative pulmonary tuberculosis Claudia Jafari (Hamburg, Germany), Claudia Jafari, Martin Ernst, Christoph Lange, Barbara Kalsdorf
PA4529
Acute phase reaction in pulmonary tuberculosis during treatment Mirjana Trajcevska (Skopje, FYROM (Macedonia)), Mirjana Trajcevska, Aleksandar Sandevski, Ljiljana Simonovska
PA4530
Can platelet count and mean platelet volume be used as a differiantial marker betweeen tuberculosis and sarcoidosis? Dildar Duman (istanbul, Turkey), Dildar Duman, Meltem çoban Agca, Fatma Merve Tepetam, Murat Yalçinsoy, Emine Nur Koç, Esra Bülbül, özgecan Karahan, Tülin Kuyucu
PA4531
State of the colon microbial population in patients with pulmonary tuberculosis depending on the culture sensitivity spectrum Lilia Todoriko (Chernivtsi, Ukraine), Lilia Todoriko, Olena Pidverbetska, Oleg Pidverbetskiy
PA4532
Radiologic profile of treated pulmonary tuberculosis patients and their correlation with modified medical research council scale and spirometry Arpit Sharma (Jaipur, India), Arpit Sharma, Vikram Jain, Mahesh Mishra, Pritha Nayyar, Nitin Jain
PA4533
The temporal pattern of coughing in tuberculosis compared to other diseases Richard Turner (London, United Kingdom), Richard Turner, Sergio Matos, Surinder Birring, Graham Bothamley
PA4534
Influence of the association of smoking, COPD and rpulmonary tuberculosis on diffusion lung capacity Larisa Kiryukhina (Saint Petersburg, Russian Federation), Larisa Kiryukhina, Olga Volodich, Pavel Gavrilov, Maria Pavlova, Liudmila Archakova, Natalia Nefedova, Elena Aganezova, Elmira Zilber, Piotr Yablonskiy
288
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA4535
Smoking as a risk factor which activates IL-2 gene polymorphism in patients with MDR-TB Dmytro Butov (Kharkiv, Ukraine), Dmytro Butov, Mykhaylo Kuzhko, Nataly Makeeva, Tetyana Butova
PA4536
The influence of genotype allele HLA-DRB1* on the development of generalized forms of tuberculosis among children Anna Starshinova (St-Peterburg, Russian Federation), Anna Starshinova, Natalya Korneva, Irina Dovgaluk, Maria Pavlova, Irina Pavlova, Ludmila Bubnova
PA4537
Assessing gender differences among tuberculosis suspects and patients in Guinea-Bissau Frauke Rudolf (Valby, Denmark), Frauke Rudolf, Antonio Mateus Mendes, Cecilie Blenstrup Pantsche, Armando Sifna, Morreira Sargento Mendes, Victor Gomes, Christian Wejse
Room G104-105
Session 465
14:45 - 16:45
Poster Discussion: Outcomes of lung transplantation Chairs : Martin Iversen (København, Denmark), Anne Olland (Strasbourg, France) PA4538
Return to work after lung-transplantation – A cross-sectional single-center study Hendrik Suhling (Hannover, Germany), Hendrik Suhling, Christine Knuth, Axel Haverich, Tobias Welte, Jens Gottlieb
PA4539
Evaluation of bone mineral density in lung transplantation candidates with end stage lung disease Merih Kalamanoglu Balci (Istanbul, Turkey), Merih Kalamanoglu Balci, Belma Erdogan, Hayat Hatipoglu
PA4540
Psychological criteria for contraindication in lung transplant candidates: 5 years survey Andre Nathan Costa (Sao Paulo, Brazil), Andre Nathan Costa, Elaine Hojaij, Bellkis Romano, Priscila Camargo, Rafael Carraro, Jose Eduardo Afonso Junior, Silvia Campos, Liliane Mello, Marcos Samano, Ricardo Teixeira
PA4541
Azathioprine discontinuation and medium and long term outcomes after lung transplantation Valeria Rossetti (Milano, Italy), Valeria Rossetti, Letizia Corinna Morlacchi, Paolo Tarsia, Maria Pappalettera, Alice D’Adda, Davide Tosi, Francesco Blasi
PA4542
Primary graft dysfunction after lung transplantation: Medium and long term outcomes Letizia Corinna Morlacchi (Milan, Italy), Valeria Rossetti, Letizia Corinna Morlacchi, Maria Pappalettera, Paolo Tarsia, Alessandro Palleschi, Mario Nosotti, Francesco Blasi
PA4543
Anti-reflux surgery for gastroesophageal reflux disease after lung transplantation: Benefit for lung function, acute rejections and respiratory infections Abdul Monem Hamid (Puteaux, France), Am Hamid, A. Roux, O. Boche, J. Leport, M. Stern, S. De Miranda, D. Grenet, L. Azuar-Beaumont, B. Douvry, D. Usturoi, E. Cuquemelle, E. Sage, A. Chapelier, C. Picard
PA4544
Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation FATIMA DIAZ CHANTAR (Ronda (Malaga), Spain), Fátima Díaz-Chantar, Jose Antonio Rodríguez-Portal, Rocío Parody, Oriana López, Nancy Rodríguez
PA4545
Predictive value of donor age for recipient lung function and CLAD-free survival after lung transplantation Henrik Auråen (Oslo, Norway), Henrik Auråen, Arnt Fiane, Odd Geiran, øystein Bjørtuft, Inga Leuckfeld, Are Martin Holm
PA4546
Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation in the United States Don Hayes, Jr. (Columbus, United States of America), Don Hayes, Jr., Stephen Kirkby, Bryan Whitson, Sylvester Black, Shahid Sheikh, Joseph Tobias, Heidi Mansour, Benjamin Kopp
PA4547
Scandiatransplant priority for urgency in lung transplantation – A 5 year multicentre experience Hans Henrik Schultz (Valby, Denmark), Hans Henrik Schultz, Are Martin Holm, Geerdt C. Riise, Göran Dellgren, Ingrid Skog, Karl Lemstrøm, Martin Iversen
PA4548
Lung transplantation in alpha 1 antitrypsin deficiency Helen Stone (Stoke on Trent, United Kingdom), Helen Stone, Ross Edgar, Richard Thompson, Rob Stockley
PA4549
Lung transplantation for Non- Cystic fibrosis bronchiectasis: A single centre retrospective analysis of 34 patients Jessica Rademacher (Hannover, Germany), Jessica Rademacher, Hendrik Suhling, Jan Fuge, Tobias Welte, Jens Gottlieb, Felix C. Ringshausen
PA4550
Prolonged mechanical ventilation negatively affects survival and functional outcome in lung transplant recipients Carine Gomez (Marseille, France), Carine Gomez, Christophe Doddoli, Bérengère Coltey, Nadine Dufeu, Anderson Dieudonné Loundou, Fabienne Bregeon, Marc Leone, Pascal-Alexandre Thomas, Laurent Papazian, Martine ReynaudGaubert
289
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4551
Evaluation of anastomotic diameter in lung transplant: Comparing bronchofibroscopy with multiplanar reconstructed thoracic computed tomography Tiago Soares Oliveira e Sá (Lisboa, Portugal), Tiago Sá, Vânia Caldeira, Dionísio Maia, Raquel Rosa, Ricardo Coelho, Sofia Santos, Alexandra Borba, Nicole Murinello, Rita Gerardo, Ana Alves, Natalie Antunes, Luísa Semedo, João Cardoso
PA4552
Lung transplantation following endoscopic lung volume reduction Thomas Fuehner (Hannover, Germany), Thomas Fuehner, Carolina Clajus, Mark Greer, Igor Tudorache, Tobias Welte, Jens Gottlieb
PA4553
Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study RIGAUD Matthieu (Sete, France), Matthieu Rigaud, Claire Dromer
PA4554
Isolation of stenotrophomonas maltophilia in lung transplant recipients: effects of treatment on prevalence and outcome Patrick Hofmann (Kaltbrunn, Switzerland), Patrick Hofmann, Michael Hombach, Macé Schuurmans, Urs Bürgi, Bruno Isenring, Nicolas Müller, Malcolm Kohler, Christian Benden, Lars Huber
PA4555
Carbapenem-resistant Klebsiella pneumoniae in lung transplant recipients: A case series Priscila Camargo (São Paulo, Brazil), Priscila Cilene León Bueno Camargo, Silvia Vidal Campos, Felipe Xavier Melo, Ricardo Henrique de Oliveira Braga Teixeira, Paulo Manuel Pêgo-Fernandes
Room G106-107
Session 466
14:45 - 16:45
Poster Discussion: Pulmonary circulation: the story of fresh and old clots Chairs : Marion Delcroix (Leuven, Belgium), Marc Humbert (Paris, France)
PA4556
Transthoracic echocardiography does not improve sPESI scale value in low risk pulmonary thromboembolism patients ANA GOMEZ LARRAURI (Leioa (Vizcaya), Spain), Ana Gomez-Larrauri, Jose Luis Lobo Beristain, Agustina RivasGuerrero, J. Trujillo Santos, M. Monreal, A. Skride, O. Sanz, I. Cañas, L. MAZZOLAI
PA4557
Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension Yaoita Nobuhiro (Sendai, Japan), Nobuhiro Yaoita, Taijyu Satoh, Kimio Satoh, Koichiro Sugimura, Shunsuke Tatebe, Tatsuo Aoki, Masanobu Miura, Yoshihiro Fukumoto, Hisanori Horiuchi, Hiroaki Shimokawa
PA4558
Additive effects of balloon pulmonary angioplasty and the following cardiac rehabilitation on exercise capacity and quality of life Shigefumi Fukui (Suita, Japan), Shigefumi Fukui, Takeshi Ogo, Yoichi Goto, Jin Ueda, Akihiro Tsuji, Reon Kumasaka, Tetsuo Arakawa, Michio Nakanishi, Hiroshi Takaki, Norifumi Nakanishi
PA4559
Percutaneous transluminal pulmonary angioplasty improves biventricular cardiac functions in patients with chronic thromboembolic pulmonary hypertension - A cardiac magnetic resonance studyHaruka Sato (Sendai, Japan), Haruka Sato, Hideki Ota, Koichiro Sugimura, Tatsuo Aoki, Shunsuke Tatebe, Masanobu Miura, Saori Yamamoto, Hironobu Yaoita, Kimio Satoh, Hiroaki Shimokawa
PA4560
Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study Marius M. Hoeper (Hannover, Germany), Marius Hoeper, Hossein-Ardeschir Ghofrani, Michael Halank, F. Joachim Meyer, Gerd Stähler, Jürgen Behr, Ralf Ewert, Monique Fletcher, Pablo Colorado, Sylvia Nikkho, Janethe de Oliveira Pena, Friedrich Grimminger
PA4561
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with CTEPH in the CHEST-1 study Ioana Preston (Boston, United States of America), Ioana Preston, Nadine Al-Naamani, Adam Torbicki, Hossein-Ardeschir Ghofrani, Paul Hassoun, Sylvia Nikkho, Arno Fritsch, Stefano Ghio
PA4562
Importance of computerized tomographic pulmonary angiography findings to predict mortality and cardiac comorbidity Sehnaz Olgun (Istanbul, Turkey), Cagatay Cimsit, Sehnaz Olgun Yildizeli, Emel Eryuksel, Canan Cimsit, Berrin Ceyhan
PA4563
Pulmonary embolism in Spain: Differences between men and women Alicia Oliva Ramos (Rivas-Vaciamadrid, Spain), Alicia Oliva Ramos, Milagros Llanos Flores, Ingrid Frías Benzant, Laura Ramirez García, Rodrigo Jiménez García, Pilar Carrasco Garrido, Valentín Hernandez Barrera, Luis Puente Maestu, Ana Lopez de Andrés, Javier De Miguel Díez
PA4564
Accuracy of inflammatory markers to distinguish between pneumonia and pulmonary embolism in acute settings Livingstone Chishimba (Manchester, United Kingdom), Livingstone Chishimba, Fahad Iqbal, Williams John, Sushil Agarwal, Kasule Alice, Joynson Andrea, Imran Hussain
290
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA4565
Assessing patients for suitability for outpatient management of pulmonary embolism; A retrospective analysis Adeel Ashraf (Blackburn, United Kingdom), Adeel Ashraf, Mohammed Paracha, Qurat Malik, Sahira Isaji, Sean Lee
PA4566
Effects of percutaneous transluminal pulmonary angioplasty on respiratory functions in patients with chronic thromboembolic pulmonary hypertension Tatsuo Aoki (Sendai, Japan), Tatsuo Aoki, Koichiro Sugimura, Kotaro Nochioka, Shunsuke Tatebe, Masanobu Miura, Nobuhiro Yaoita, Haruka Sato, Kimio Satoh, Hiroaki Shimokawa
PA4567
Oral and inhaled corticosteroid use has a time-dependent association with recurrent pulmonary embolism Marlous Sneeboer (Amsterdam, Netherlands), Marlous Sneeboer, Barbara Hutten, Christof Majoor, Pieter-Willem Kamphuisen, Elisabeth Bel
PA4568
Cardiac remodeling and left ventricular-arterial coupling in patients with chronic thromboembolic pulmonary hypertension Anna Belevskaya (Moscow, Russian Federation), Anna Belevskaya, Zaira Dadacheva, Marina Saidova, Tamila Martynyuk, Irina Chazova
PA4569
Relationship between computerized tomographic pulmonary angiography findings with clinical indices and scoring parametres in pulmonary embolism Sehnaz Olgun (Istanbul, Turkey), Sehnaz Olgun Yildizeli, Cagatay Cimsit, Emel Eryuksel, Canan Cimsit, Berrin Ceyhan
PA4570
Quantitative evaluation of ventilation-perfusion heterogeneity in precapillary pulmonary hypertension with SPECT scintigraphy Tripura Sharma (Sydney, NSW, Australia), Kaipa Tripura Sharma, Edmund Lau, Tamera Corte, David Celermajer, Dale Bailey, Elizabeth Bailey, Geoff Schembri
PA4571
Clinical profile and mortality of patients with pulmonary embolism and cancer AROLQUI GONZALEZ CASTILLO (Valencia, Spain), Arolqui González Castillo, Sonia Cepeda Madrigal, Ildefonso Furest Carrasco, Ignacio Inchaurraga álvarez, Eva María Martínez Moragón
PA4572
Benefit of using an age-adjusted D-dimer cut-off Javier Berraondo Fraile (Valencia, Spain), Javier Berraondo-Fraile, Ana Lopez-Vazquez, Ana Bediaga-Collado, Izumi Konishi, Gustavo Juan-Samper, Estrella Fernandez-Fabrellas, Mercedes Ramon-Capilla
PA4573
Can pulmonary arterial CT obstruction index rate predict right ventricular dilatation in pulmonary embolism? Canan Eren Dagli (ORDU, Turkey), Berna Botan Yildirim, Aydin Kurt, Aysegul Karalezli, Canan Eren Dagli, Hatice Canan Hasanoglu
Room 13.2
Session 467
14:45 - 16:45
Poster Discussion: Clinical assessment in asthma and COPD Chairs : Jose Luis Lopez-Campos Bodineau (Sevilla, Spain), Marco Contoli (Ferrara, Italy) PA4574
Physiological and biological predictors of length of stay and recovery in adults with acute asthma Thomas Jones (Portsmouth, United Kingdom), Thomas Jones, Jonathon Owen, Thomas Brown, Scott Elliott, Samal Gunatilake, Heena Mistry, William Storrar, Sumita Kerley, Dominic Reynish, Sal Matti, Jan Shute, Anoop Chauhan
PA4575
Predictors of exacerbations in asthma Andriana Papaioannou (Vrilissia, Athens, Greece), Andriana Papaioannou, Konstantinos Kostikas, Anastasia Papaporfuriou, Elissavet Konstantellou, Georgios Hillas, Nikolaos Koulouris, Spyridon Papiris, Petros Bakakos, Stelios Loukides
PA4576
A 12-year prognosis of adult-onset asthma: Seinajoki adult-onset asthma study Leena Esteri Tuomisto (Seinajoki, Finland), Leena Tuomisto, Pinja Ilmarinen, Onni Niemela, Jussi Haanpaa, Terhi Kankaanranta, Hannu Kankaanranta
PA4577
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore pei yee tiew (singapore, Singapore), Pei Yee Tiew, Mariko Siyue Koh, Thun How Ong, Chian Min Loo, Therese Sophie Lapperre
PA4578
Role of gastro-oesophageal reflux in severe asthma: Experience from the Wessex severe asthma cohort Kamran Tariq (Eastleigh, United Kingdom), Kamran Tariq, Clair Barber, Kerry Gove, Hitasha Rupani, Tom Brown, Ramesh Kurukulaaratchy, Anoop Chauhan, Ratko Djukanovic, Peter Howarth
PA4579
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Nikolay Yanev (Pleven, Bulgaria), Nikolay Yanev, Nikolay Kyuchukov, Ilia Krachunov, Zlatina Ivanova, Pavlina Nikolova, Plamen Pavlov, Elena Borisova, Tsania Popova, Yavor Ivanov
PA4580
Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adults Keitaro Omori (Hiroshima, Japan), Keitaro Omori, Hiroshi Iwamoto, Noboru Hattori, Takashi Yamane, Taku Nakashima, Yoshinori Haruta, Akihito Yokoyama, Nobuoki Kohno
291
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015 PA4581
High incidence of oesophageal dysmotility in unexplained respiratory symptoms Jennifer Burke (East Yorkshire, United Kingdom), Jennifer Burke, Warren Jackson, Shoaib Faruqi, Alyn Morice
PA4582
Effect of obesity and metabolic syndrome in patients with bronchial asthma Mandeep Singh (Delhi, India), Mandeep Singh, Raj Kumar, Shailendra Gaur, Rajendra Prasad
PA4583
Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD Felipe Villar Alvarez (Madrid, Spain), Felipe Villar, Alba Naya, Pilar Carballosa, Diana Sánchez, María José Checa, Sandra Pelicano, Itziar Fernández, Germán Peces-Barba
PA4584
Characterization of asthma exacerbations in outpatients – National survey Yavor Ivanov (Pleven, Bulgaria), Yavor Ivanov, Plamen Pavlov, Pavlina Glogovska, Tsania Popova, Anahid Torossian, Dimitar Kostadinov, Dencho Osmanliev, Diana Petkova, Kosta Kostov, Ognyan Georgiev, Vladimir Hodzhev, Nikolay Kyuchukov, Nikolay Yanev, Petkana Hristova
PA4585
Validation of five non-invasive respiratory rate monitors in patients with COPD in a laboratory setting Noah Rubio (Edinburgh , United Kingdom), Noah Rubio, Richard Parker, Hilary Pinnock, Christopher Weir, Janet Hanley, Lucy McClougham, William MacNee, Brian McKinstry, Roberto Rabinovich
PA4586
Infection associated phenotype of asthma: Results of a difficult asthma clinic service improvement project Sushiladevi Natarajan (Leicester, United Kingdom), Sushiladevi Natarajan, Robert Free, Andrew Wardlaw, Salman Siddiqui
PA4587
Sleep quality in patients with asthma and COPD Marija Kojicic Vukoja (Sremska Kamenica, Republic of Serbia), Marija Vukoja, Ivan Kopitovic, Dragana Milicic, Dragana Dabovic, Olivera Maksimovic, Miroslav Ilic
PA4588
Depressive symptomatology in COPD patients Lamprini Tina (Sparta, Greece), Lamprini Tina, NIkolaos Konstas, Panagiotis Andriopoulos
PA4589
The predictors for COPD exacerbations using remote patient monitoring Worawan Sirichana (Bangkok, Thailand), Worawan Sirichana, Xiaoyan Wang, Michael Taylor, Igor Barjaktarevic, Christopher B. Cooper
PA4590
Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation Ali Abdelazeem Hasan (Assiut, Egypt), Samiaa Hamdy, Ali Hasan, Ghada Abd-Elrahman, Soheir Mustafa, Lobna Abde Wahed, Hanan Sharaf El-Deen, Mohammed Zedan
PA4591
Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD Pawan Gupta (Delhi, India), Pawan Gupta, Sunil Chhabra
Room E102
Session 468
14:45 - 16:45
Poster Discussion: New insights into exercise and muscle performance Chairs : Michael Steiner (Leicester, United Kingdom), Ioannis Vogiatzis (Athens, Greece) PA4592
Comparison of 2- versus 6-minute walking test in patients with severe COPD Rainer Gloeckl (Schoenau am Koenigssee, Germany), Rainer Gloeckl, Inga Heinzelmann, Sebastian Teschler, Klaus Kenn
PA4593
Responsiveness of the short physical performance battery (SPPB) in severely dyspnoeic patients with COPD Deborah Carrington (Middlesex, United Kingdom), Deborah Carrington, Sarah Jones, Jane Canavan, Claire Nolan, Samantha Kon, Michael Polkey, William Man
PA4594
Compartments distribution of body composition in patients with chronic obstructive pulmonary disease Jose Roberto De Brito Jardim (Sao Paulo, Brazil), José Roberto Jardim, Carolina Rocco, Mariana Gazzotti, Cristiane Pradela, Elias Porto, Oliver Nascimento, Mariana Adas, Cynthia Brandão, Marise Lazaretti
PA4595
Reliability and validity of the modified stair climb power test in COPD Sarah Jones (Berkshire, United Kingdom), Sarah E. Jones, Jane L. Canavan, Claire M. Nolan, Matthew Maddocks, Samantha S.C. Kon, Michael I. Polkey, William D.-C. Man
PA4596
The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments Hirohisa Kano (Ogaki, Japan), Hirohisa Kano, Akira Shiraki, Joe Shindoh, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi, Sho Hori
PA4597
Can diagnostic staff (DS) or patients predict whether the 6-minute walk distance (6MWD) will improve to a relevant extent at a repeated 6-minute walk test (R-6MWT)? Silke Wingart (Bad Reichenhall, Germany), Silke Wingart, Nicola Lehbert, Claudia Sachse, Leithaeuser Amoene, Wittmann Michael, Jelusic Danijel, Schuler Michael, Schultz Konrad
292
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4598
Multi-frequency bioelectric impedance ratio and physical performance in stable COPD Jane Canavan (Harefield, United Kingdom), Jane L. Canavan, Sarah E. Jones, Claire M. Nolan, Samantha S.C. Kon, Matthew Maddocks, Amy L. Clark, Faiza Chowdhury, Michael I. Polkey, Nicholas S. Hopkinson, William D.-C. Man
PA4599
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Samantha Kon (Buckinghamshire, United Kingdom), Samantha Kon, Sarah Jones, Jane Canavan, Claire Nolan, Brigitte Haselden, Michael Polkey, Paul Cullinan, William Man
PA4600
Muscle power output in older adults with COPD Lopez Saez de Asteasu (Alsasua, Spain), Mikel López, Fabrício Zambom-Ferraresi, María Hernández, Pilar Cebollero, Javier Hueto, María Milagros Antón
PA4601
Acute impact of percutaneous electrical stimulation (PES) & resistance exercise (RE) on quadriceps muscle gene expression in COPD Lorna Latimer (Rugby, United Kingdom), Lorna Latimer, Neil Greening, Despina Constantin, Michael Steiner, Paul Greenhaff
PA4602
Determinants of rapid exercise capacity decline in patients with COPD Sarah Crook (Zurich, Switzerland), Sarah Crook, Anja Frei, Tsung Yu, Gerben Ter Riet, Milo Puhan
PA4603
COPD and oxygen supplementation: Improvement in inspiratory capacity and dyspnea during exercise Liv Karin Vesteng (Hakadal, Norway), Liv Karin Vesteng, Ingunn Skjørten, Morten Melsom, Anne Edvardsen
PA4604
Reactive oxygen species regulate autophagy in COPD myotubes in vitro Pascal Pomiès (Montpellier, France), Pascal Pomiès, Marine Blaquière, Fares Gouzi, Jonathan Maury, Jacques Mercier, Maurice Hayot
PA4605
Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation C.C. De Theije (Maastricht, Netherlands), C.C. De Theije, A.M.W.J. Schols, W.H. Lamers, S.E. Köhler, R.C.J. Langen
PA4606
Inactivation of glycogen synthase kinase-3 is not required for recovery of muscle mass of disuse-atrophied muscle Ramon Langen (Maastricht, Netherlands), Ramon Langen, Nicky Pansters, Marco Kelders, Chiel De Theije, Annemie Schols
PA4607
Aerobic exercise reduces lung inflammation and fibrosis mediated by serotoninergic/Akt signaling in a model of pulmonary fibrosis Rodolfo de Paula Vieira (São José dos Campos, Brazil), Rodolfo P. Vieira, Ana Roberta Almeida-Oliveira, Paulo R. Pereira, Yves Matos, Manoel C. Oliveira-Junior, Flavia R. Greiffo, Nicole C. Rigonato-Oliveira, Adilson S. Andrade-Sousa, Thayse R. Brugemman, Humberto Delle, Regiane Albertini, Ana Paula L. De Oliveira, Nilsa R. Damaceno-Rodrigues, Isis E. Fernandez, Marisa Dolhnikoff, Hugo C. Castro-Faria-Neto, Marco Idzko, Oliver Eickelberg
PA4608
The role of growth and differentiation factor 15 (GDF-15) in the development of skeletal muscle wasting in pulmonary arterial hypertension (PAH) Benjamin Garfield (London, United Kingdom), Benjamin Garfield, Alexi Crosby, Yang Pieran, Lee Jen, Dongmin Shao, Lisa Parfitt, Carl Harries, Nicholas Morrell, Michael’ Polkey, Paul Kemp, S. John Wort
PA4609
Aerobic exercise reduces pulmonary inflammation in diet-induced obesity in a HDM model of asthma through adipokines, IL-10, IL-17 and IL-23 signaling Jefferson Comin (São Bernardo do Campo, Brazil), Jefferson C.J. Aquino-Junior, Ana Roberta Almeida-Oliveira, Manoel C. Oliveira-Junior, Adilson S. Andrade-Sousa, Erasmo A. Neto, Auriléia Aparecida-Brito, Nicole C. Rigonato-Oliveira, Dioze Guadagnini, Luiz O. Leiria, Ana Paula L. De Oliveira, Mario J. Saad, Rodolfo P. Vieira
Room D201-202
Session 469
14:45 - 16:45
Poster Discussion: Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Chairs : Esther Barreiro Portela (Barcelona, Spain), Capucine Morelot Panzini (Paris, France) PA4610
Upper airway dysfunction in amyotrophic lateral sclerosis Georgios Kaltsakas (Halandri-Athens, Greece), Georgios Kaltsakas, Michael Rentzos, Theodoros Alexakis, Vassiliki Zouvelou, Anastasios F. Palamidas, Sofia Antiopi Gennimata, Sophia Xirou, Ioannis Evdokimidis, Nickolaos G. Koulouris
PA4611
Determination of inspiratory critical pressure in healthy men Vinicius Minatel (Sao Carlos, Brazil), Vinicius Minatel, Patrícia Rehder-Santos, Bruno Araújo Ribeiro, Richard Ducatti, Camila Bianca Falasco Pantoni, Ester Silva, Anielle Cristhine de Medeiros Takahashi, Aparecida Maria Catai
293
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
PA4612
Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume Cedric Van Holsbeke (Kontich, Belgium), Cedric Van Holsbeke, Wim Vos, Wouter Van Geffen, Huib Kerstjens, Massimo Pistolesi, Omar Usmani, Bita Hajian, Anthony Cahn, Jan De Backer, Wilfried De Backer
PA4613
Determination of normal values for an isocapnic hyperventilation endurance test Marjolaine Vincent (Saint Etienne, France), Marjolaine Vincent, Isabelle Court Fortune, Jean Philippe Camdessanche, Frédéric Costes
PA4614
Assessment of diaphragmatic excursion in chronic obstructive pulmonary disease Eman Sobh (Al-Mahalla Al-Kobra, Egypt), Eman Sobh, Manal Refaat Hafez, Omaima I. Abo-Elkheir
PA4615
Transfer factor of the lung for carbon monoxide (TLCO) in morbid obese subjects Ebymar ARISMENDI NUÑEZ (Barcelona, Spain), Ebymar Arismendi, José Ríos, Josep Roca, Felip Burgos, Eva Rivas, Roberto Rodriguez-Roisin
PA4616
FEV1/FVC ratio does not reflect peripheral airway ageing in an elderly reference population Sanna Kjellberg (Skara, Sweden), Sanna Kjellberg, Birgitta Houltz, Paul Robinson, Per Gustafsson
PA4617
Thoracoabdominal asynchrony in COPD patients during quiet breathing Desiderio Cano Porras (Sao Paulo, Brazil), Desiderio C. Porras, Fernanda D. Dias, Dayse Tobelem, Evelim L.F. Danta Gomes, Dirceu Costa
PA4618
Dissociated changes in the slopes of capnogram curves during metchacholine- and histamine-induced bronchoconstriction in rabbits Adam Laszlo Balogh (Szeged, Hungary), Ferenc Petak, Gergely H. Fodor, Adam L. Balogh, Orsolya Ivankovitsne Kiss, Roberta Sudy, Barna Babik
PA4619
Diffusion capacity and CT measures of emphysema and airway wall thickness - Relation to arterial oxygen tension in COPD patients Eirunn Saure (Raadal, Norway), Eirunn Waatevik Saure, Per Bakke, Tomas Eagan, Marianne Aanerud, Robert Jensen, Ane Johannessen, Roy Miodini, Einar Thorsen, Thomas Grydeland, Jon Hardie
PA4620
Lung function is associated with left ventricular wall stress in coincident COPD and heart failure Peter Alter (Marburg, Germany), Peter Alter, Kirsten Vand de Sand, Christoph Nell, Timm Greulich, Claus Vogelmeier, Andreas Rembert Koczulla
PA4621
Single-breath washout in stable COPD patients: Association with bodyplethysmography and bronchodilator response Anna Gensmer (Wattwil, Switzerland), Anna Gensmer, Sylvia Nyilas, Michael Tamm, Philipp Latzin, Daiana Stolz
PA4622
Identification of lung mechanical properties in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)or acute heart failure (AHF) through forced oscillation technique (FOT): Preliminary results alice repossi (milano, Italy), Alice Claudia Repossi, Fabiano Di Marco, Emanuela Rancati, Mirta Cavallini, Fulvia Ribolla, Sara Job, Stefano Centanni
PA4623
Respiratory muscle strength at rest, during and after maximal exercise in healthy subjects Letícia Cardenas (Sao Paulo, Brazil), Letícia Zumpano Cardenas, Pauliane Vieira Santana, Mayra Caleffi Pereira, Jeferson George Ferreira, Luiz Fernando Orlandin, Vinicius Iamonti, Renata Pletsch, Pedro Caruso, Carlos Roberto Ribeiro de Carvalho, Andre Albuquerque
PA4624
Near-infrared spectroscopy, ventilation and gas exchange responses to 6-minute walk test in young healthy adults Laís Vidotto (Londrina, Brazil), Lais Vidotto, Cláudia Dos Santos, Mayara Da Silva, Josiane Felcar, Cosme Buzzachera, Alison McConnell, Vanessa Probst
PA4625
Volitional and non-volitional strength, synchrony and inspiratory force reserve in fibrosing interstitial lung disease at rest and during exercise Pauliane Santana (Sao Paulo, Brazil), Pauliane V. Santana, Leticia Z. Cardenas, Ozires Ramos, Jeferson G. Ferreira, Thomas N. Jaeger, Patricia Trevisan, Marcelo C. Macchione, Carlos R.R. Carvalho, Andre L.P. Albuquerque, Pedro Caruso
PA4626
Exertional dyspnea relief following bronchodilation in COPD: Role of neural respiratory drive Courtney Wilkinson-Maitland (Westmount, Canada), Courtney Wilkinson-Maitland, Benoit Borel, Helene Perrault, Alan Hamilton, Jean Bourbeau, Francois Maltais, Dennis Jensen
PA4627
Effect of abdominal binding on neuromuscular efficiency of the diaphragm, dyspnea and exercise tolerance in COPD Sara Abdallah (Montreal, Canada), Sara Abdallah, Courtney Wilkinson-Maitland, Jean Bourbeau, Dennis Jensen
294
ERS International Congress 2015 DETAILED PROGRAMME TUESDAY 29 SEPTEMBER, 2015
Room Emerald
Session 470
15:00 - 16:45
Session: The ERS and you Getting the most out of your ERS membership as an early-career researcher Aims : To launch a meeting dedicated to the relationship between the ERS and junior delegates that will show how they can benefit from each other. To facilitate the aims of this meeting, the ERS structure will be described. Target audience : Junior delegates. Chairs : Pieter S. Hiemstra (Leiden, Netherlands), Agnes Boots (Maastricht, Netherlands) 15:00
Introduction including the results of the survey Agnes Boots (Maastricht, Netherlands)
4628
15:15
ERS structure and possibilities Gernot G.U. Rohde (Maastricht, Netherlands)
4629
15:35
JMC: achievements and future plans Anders Bjerg (Gothenburg, Sweden)
4630
15:45
Opportunities for early-career researchers within the ERS Oliver Eickelberg (Munich, Germany)
4631
16:05
Panel discussion
4632
17:15-19:15 INDUSTRY EVENING SYMPOSIUM
SEE PAGE 331
17:30-19:00 INDUSTRY EVENING MINI SYMPOSIUM
SEE PAGE 331
17:30-19:30 INDUSTRY EVENING EXPERT FORUM
SEE PAGE 331
17:30-19:00 INDUSTRY EVENING MINI SYMPOSIUM
SEE PAGE 331
17:30-19:00 INDUSTRY EVENING EXPERT FORUM
SEE PAGE 331
295
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
Room G106-107
Session 486
07:00 - 08:15
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Challenging clinical cases: CC7 Pneumothorax: causes and treatment Aims : To discuss with the audience the various reasons and treatment options for a pneumothorax Tag(s) : Clinical Target audience : Radiologists, pathologists, pulmonologists, thoracic surgeons, respiratory therapists, respiratory physicians, clinical researchers, radiologists, fellows, and residents. Chairs : Anne Olland (Strasbourg, France) 07:00
Introduction
4705
07:10
The surgeons view Gilbert Massard (Strasbourg, France)
4706
07:35
The pulmonologists view Jonas Yserbyt (leuven, Belgium)
4707
08:00
Discussion
4708
Room L001
Session 487
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW25 Hands-on polysomnography Aims : To introduce and provide an overview of polysomnography, including wiring up, troubleshooting signals, scoring studies, and interpreting the report. Track(s) : Sleep Tag(s) : Clinical Target audience : Absolute beginners and anyone wishing to refresh their understanding of full polysomnographic sleep studies, including physicians, nurses, allied health professionals, students, and researchers with a professional interest in sleep medicine. Chairs : Renata L. Riha (Edinburgh, United Kingdom) Introduction
4709
Workstation 1: Approach to full polysomnography, setting up and wiring up: the basic techniques Andrew Morley (Glasgow, United Kingdom)
4710
Workstation 2: Data acquisition: what can go wrong? What does it look like when it goes right? Simone De Lacy (London, United Kingdom)
4711
Workstation 3: Scoring sleep using AASM guidelines. A brief introduction to scoring respiratory events, arousals and limb movements. Elizabeth Hill (Edinburgh, United Kingdom)
4712
Room L002
Session 488
08:00 - 10:20
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW26 Paediatric respiratory resuscitation Aims : The educational aim of the session is to teach current resuscitation techniques and skills. Track(s) : Paediatric Chairs : Roddy O'Donnell (Cambridge, United Kingdom) 08:00
Introduction
4713
08:05
Workstation 1: Airway management Xavier Moors (Rotterdam, Netherlands), Erik Bokhorst (Rotterdam, Netherlands)
4714
08:40
Workstation 2: Basic life support (BLS) and choking Denise Welsby (London, United Kingdom), Elsbeth De Jager (Rotterdam, Netherlands)
4715
09:15
Workstation 3: Team work and scenarios using the advanced life support (ALS) algorithm Liesje Andre (London, United Kingdom), Roddy O'Donnell (Cambridge, United Kingdom)
4716
296
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 09:50
Workstation 4: IO insertion Corinne Buysse (Schoten, Belgium), Sophie Skellett (London, United Kingdom)
Room L001
Session 510
4717
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW27 Hands-on polysomnography Aims : To introduce and provide an overview of polysomnography, including wiring up, troubleshooting signals, scoring studies, and interpreting the report. Track(s) : Sleep Tag(s) : Clinical Target audience : Absolute beginners and anyone wishing to refresh their understanding of full polysomnographic sleep studies, including physicians, nurses, allied health professionals, students, and researchers with a professional interest in sleep medicine. Chairs : Renata L. Riha (Edinburgh, United Kingdom) Introduction
4919
Workstation 1: Approach to full polysomnography: the basic techniques in terms of setting up and wiring up Andrew Morley (Glasgow, United Kingdom)
4920
Workstation 2: Data acquisition: what can go wrong? What does it look like when it goes right? Simone De Lacy (London, United Kingdom)
4921
Workstation 3: Scoring sleep using AASM guidelines. A brief introduction to scoring respiratory events, arousals and limb movements. Elizabeth Hill (Edinburgh, United Kingdom)
4922
Room L002
Session 511
10:40 - 13:00
Registration for this workshop is additional to the congress registration fee and is €85 or €65 for the early bird registration.
Educational skills workshop: EW28 Paediatric respiratory resuscitation Aims : The educational aim of the session is to teach current resuscitation techniques and skills. Track(s) : Paediatric Chairs : Roddy O'Donnell (Cambridge, United Kingdom) Introduction
4923
Workstation 1: Airway management Xavier Moors (Rotterdam, Netherlands), Erik Bokhorst (Rotterdam, Netherlands)
4924
Workstation 2: Basic life support (BLS) and choking Denise Welsby (London, United Kingdom), Elsbeth De Jager (Rotterdam, Netherlands)
4925
Workstation 3: Team work and scenarios using the advanced life support (ALS) algorithm Liesje Andre (London, United Kingdom), Roddy O'Donnell (Cambridge, United Kingdom)
4926
Workstation 4: IO insertion Corinne Buysse (Schoten, Belgium), Sophie Skellett (London, United Kingdom)
4927
Room Emerald
Session 484
07:00 - 08:15
How to: Involve patients in research projects From a successful application to an effective partnership Aims : To show why patient involvement is important in research, how to find patients who are able to take part in projects, and how to prepare them for the role; to delineate what funding bodies are looking for and how to fulfil their requirements in an application; and to describe how to effectively involve patients through the full lifecycle of the project to ensure that their inclusion is meaningful and effective. Target audience : Anyone involved in research, including basic scientists, clinical researchers, research fellows and trainees. Chairs : Dan Smyth (Dundalk, Ireland) 07:00
Introduction
4697
297
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 07:10
The benefits and challenges of involving patients as project partners: the professional perspective Peter Sterk (Amsterdam, Netherlands)
4698
07:35
The benefits and challenges of involving patients as project partners: the patient perspective David Supple (Newport, United Kingdom)
4699
08:00
Discussion
4700
Room G102-103
Session 485
07:00 - 08:15
How to: Make a multi-disciplinary team work Aims : To discuss the aims and benefits of working in multi-disciplinary teams and how to develop strategies to deal with difficult situations that can be encountered when cooperating with colleagues in a multi-disciplinary team. Target audience : Pulmonologists, emergency medicine doctors, respiratory therapists, respiratory physicians, general practitioners, intensivists, nurses, pathologists, radiologists, thoracic surgeons, otolaryngologists and trainees. Chairs : Mina Gaga (Athens, Greece) 07:00
Introduction
4701
07:10
Aims of working in a multi-disciplinary team Bogdan Dragos Grigoriu (Iasi, Romania)
4702
07:35
How to deal with controversy in a multi-disciplinary team Dimitrios Vassos (Athens, Greece)
4703
08:00
Discussion
4704
Room 7.1
Session 489
08:30 - 10:30
Hot topics: Iatrogenic drug Emerging and life-threatening problem Aims : Since 2010, many novel biological drugs for primary or secondary solid neoplasms and haematologic malignancies have become available. Each of these drugs or drug classes produces a well-defined pattern of respiratory involvement. These patterns must be separated from the patterns imposed by the underlying disease, the effect of other drugs/radiation, and the effect of infections. If these patterns are not discriminated, the patient is at risk of unnecessary drug withdrawal, which could have adverse consequences on the underlying respiratory condition . Those patients must also be followed in a preventive manner by pulmonologists according to established guidelines before complications develop. Moreover, many new illicit drugs, substances of abuse, drugs on the internet, and inhalants are now available. Many can cause acute respiratory emergencies or death. Identification of the culprit drug is problematic in the obtunded patient. Pulmonologists must be cognisant of these possible problems and to advise ICU and emergency department colleagues in a precise and timely manner. The risks of e-cigarettes should also be reviewed since some e-liquids contain illegal drugs. In addition, a host of non-drug compounds are now being used in orthopaedic and plastic surgery (e.g., silicone, 150 hydrogel, and methacrylate glue). These compounds can access the lung, causing mysterious and severe lung and sometimes brain involvement. Late diagnosis is common. Clinicians should be updated about these risks. Finally, it was shown that 9% of patients with drug-induced respiratory injury die (Pneumotox.com ®). Sadly, but interestingly, a sizable fraction of these fatal cases could have been avoided by implementing the guidelines, evaluating the lung adequately before therapy, ensuring the absence of premedication, making an early diagnosis, and eliminating management errors . If one wants the number of drug casualties to diminish in the future, all preventive actions should be reviewed carefully and presented to clinicians. Track(s) : Epidemiology/Environment Tag(s) : Clinical Target audience : Clinicians, intensivists, ICU physicians, emergency department doctors and nurses, radiologists, and anaesthesiologists. Chairs : Venerino Poletti (Forli, Italy), Athol Wells (London, United Kingdom) 08:30
Emerging biologicals: separating drug-related injury from the underlying disease-related lung injury Maureen Horton (Baltimore, United States of America)
4718
09:00
Respiratory emergencies caused by novel substances of abuse
4719
09:30
Pulmonary and systemic vasculopathies caused by drug excipients, cutting agents and adulterants Philippe Bonniaud (Dijon, France)
4720
10:00
Avoiding drug-induced casualties: a critical mission Philippe Camus (Dijon, France)
4721
298
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
Room Auditorium
Session 490
08:30 - 10:30
Hot topics: Severe asthma phenotyping Using clinically-relevant biomarkers Aims : To describe the state of the art regarding the four main severe asthma phenotypes, provide insights into the role of clinicallyrelevant biomarkers that relate to different phenotypes; and discuss the usefulness of biologics as add-on therapy in selected severe asthma phenotypes. Tag(s) : Translational Target audience : Clinicians, clinical researchers, research fellows, and basic scientists. Chairs : Guy Brusselle (Ghent, Belgium), Peter Sterk (Amsterdam, Netherlands) 08:30
Early-onset allergic severe asthma Ratko Djukanovic (Southampton, United Kingdom)
4722
09:00
Late-onset persistent eosinophilic severe asthma Ian Douglas Pavord (Oxford, United Kingdom)
4723
09:30
Obesity-related severe asthma Stephanie Shore (Boston, United States of America)
4724
10:00
Neutrophilic severe asthma Fabio L. M. Ricciardolo (Orbassano (Turin), Italy)
4725
Room 7.2
Session 491
08:30 - 10:30
Symposium: Resolving inflammation The crossroad between infection and immunity in airway disease Aims : To describe the role of epithelial cells and dendritic cells in the innate immune response, demonstrate the importance of oxidative stress in the resolution of inflammation, describe how the viral response to viral infection is altered in disease and highlight the effect of bacterial infection on innate immunity and infection. Tag(s) : Basic Target audience : Clinicians, scientists, clinical scientists, cellular and molecular biologists, and translational researchers. Chairs : Pascal Chanez (Marseille, France), Anne Van Der Does (Leiden, Netherlands) 08:30
The role of innate immune cells in inflammation David Cousins (Leicester, United Kingdom)
4726
09:00
Oxidative stress impacts lipid mediator formation and release Craig Wheelock (Stockholm, Sweden)
4727
09:30
Defective endogenous antiviral mediator production in response to viral infection Sebastian L. Johnston (London, United Kingdom)
4728
10:00
The microbiome affects the innate immune response and the resolution of inflammation Philip Hansbro (Callaghan, Australia)
4729
Room Elicium 2
Session 492
08:30 - 10:30
Symposium: Respiratory disease in minority groups Aims : To describe the differences between ethnic minority groups in terms of respiratory disease prevalence, provide plausible genetic and environmental explanations for such prevalence differences, describe the current challenges faced by Europe in terms of providing healthcare to ethnic minority groups and review the academic argument about how we should assess 'normal' lung function in ethnic minority groups. Track(s) : Epidemiology/Environment Target audience : Clinicians, healthcare professionals, and epidemiologists. Chairs : Bo Lundback (Gothenburg, Sweden), Giovanni Viegi (Pisa, Italy) 08:30
Health in ethnic minority groups in Europe: what are the current challenges? Aziz Sheikh (Edinburgh, United Kingdom)
4730
09:00
Respiratory disease and ethnicity: the US Experience R. Graham Barr (New York, United States of America)
4731
299
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
09:30
What is the evidence that ethnic differences in the prevalence of respiratory disease are explained by differences in genetic make-up? H. Marike Boezen (Groningen, Netherlands)
4732
10:00
COPD and ethnicity Peter Burney (London, United Kingdom)
4733
Room 4.2
Session 493
08:30 - 10:30
Symposium: Difficult-to-treat mediastinal problems Aims : To describe the differences between thymectomy and thymomectomy, explain why patients with thymoma-myasthaenia gravis may require complete thymic removal, describe the advantages of the new video-assisted approach, discuss new technologies of sternal replacement after the removal of giant tumours and present the sequence of the diagnostic and therapeutic steps that are taken when there is a medical urgency involving patients with mediastinitis. Track(s) : Oncology Tag(s) : Clinical Target audience : Pulmonologists, thoracic oncologists, and surgeons. Chairs : Dragan R. Subotic (Beograd, Republic of Serbia), Nicolas Girard (Bron, France) 08:30
Thymic tumours and thymoma-myasthaenia gravis Marco Lucchi (Pisa, Italy)
4734
09:00
Optimal approach to mediastinal lymphomas Paul E. Van Schil (Edegem (Antwerp), Belgium)
4735
09:30
Giant sternal tumours Alain R. Chapelier (Le Plessis Robinson, France)
4736
10:00
Acute mediastinitis Stefano Elia (Naples, Italy)
4737
Room 5.2
Session 494
08:30 - 10:30
Hot topics: New advances in smoking cessation interventions Aims : The first speaker will describe how to approach smoker pulmonary patients to help them quit; how to use smoking cessation interventions in smokers with pulmonary disorders; and how to assess and use smoking cessation interventions in smokers who find it difficult to quit. The second speaker will describe which smoking cessation interventions are effective and safe, and the cost-effectiveness of these interventions. The third speaker will discuss the conclusions of the most recent RCTs on the efficacy and safety of using the nicotine vaccine to induce smoking cessation. The fourth speaker will describe the clinical studies on the efficacy and safety of using ecigarettes to induce smoking cessation and the health concerns regarding these devices. Tag(s) : Clinical, Healthy Lungs for Life (HLfL) Target audience : Primary care physicians, lung physicians, nurses and physiotherapists interested in helping smokers to quit. Chairs : Christina-Georgia Gratziou (Athens, Greece), Stefano Nardini (Vittorio Veneto, Italy) 08:30
ERS Statement: Smoking cessation in COPD and other pulmonary disorders Carlos Andres Jimenez Ruiz (Madrid, Spain)
4738
09:00
Effectiveness and cost-effectiveness of smoking cessation interventions Speaker to be confirmed
4739
09:30
Nicotine vaccination for smoking cessation: is it effective and safe? Onno C. P. van Schayck (Maastricht, Netherlands)
4740
10:00
Do e-cigarettes induce smoking cessation? Speaker to be confirmed
4741
Room Elicium 1
Session 495
08:30 - 10:30
Symposium: Cystic fibrosis: not just for the specialists Aims : To describe the specific treatment of the chloride channel basic defect by using new therapies (e.g., ivacaftor), the emergency care of a CF patient who is admitted to a non-CF centre, how to overcome diagnostic dilemmas in CF, thereby ensuring that patients are not incorrectly diagnosed with non-CF bronchiectasis and recent advances regarding selection criteria and outcomes in lung transplantation. Track(s) : Paediatric Target audience : All adult and paediatric respiratory clinicians and specialists, especially non-CF specialists but also those who work in a CF centres.
300
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 Chairs : Ian Balfour-Lynn (London, United Kingdom), Jürg Barben (St. Gallen, Switzerland) 08:30
The chloride channel: pathology and specific therapy Jane C. Davies (London, United Kingdom)
4742
09:00
Diagnostic dilemmas: is it really non-CF bronchiectasis? Nico Derichs (Berlin, Germany)
4743
09:30
Emergency CF care: what a non-CF specialist needs to know Harry G.M. Heijerman (The Hague, Netherlands)
4744
10:00
Lung transplantation: selection criteria and outcomes André Simon (London, United Kingdom)
4745
Room Forum
Session 496
08:30 - 10:30
Oral Presentation: Infection in COPD: different aspects of the host/pathogen balance Chairs : Daiana Stolz (Basel, Switzerland), John R Hurst (London, United Kingdom)
OA4746
LATE-BREAKING ABSTRACT: Haemophilus dominance of the stable COPD microbiome is associated with greater bacterial load and inflammation and is modulated by prophylactic antibiotic therapy Simon Brill (London, United Kingdom), Simon Brill, Phillip James, Leah Cuthbertson, William Cookson, Miriam Moffatt, Jadwiga Wedzicha
OA4747
LATE-BREAKING ABSTRACT: Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD patients Marco Contoli (Ferrara, Italy), Marco Contoli, Alessia Pauletti, Paolo Casolari, Giulia Gnesini, Maria Sandra Magnoni, Giacomo Curradi, Giacomo Forini, Brunilda Marku, Alberto Papi
OA4748
Preliminary data from a longitudinal study of the airway microbiome in COPD Alison Dicker (Dundee, United Kingdom), Alison Dicker, Megan Crichton, Andrew Cassidy, Stuart Schembri, Sara Marshall, Colin Palmer, James Chalmers
OA4749
Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Louise Persson (Bergen, Norway), Louise Jeanette Pauline Persson, Marianne Aanerud, Per Sigvald Bakke, Tomas Mikal Eagan, Pieter Sicco Hiemstra
OA4750
Fluticasone propionate reduces influenza infection of human macrophages Karl J. Staples (Southampton, United Kingdom), Karl J. Staples, Richard T. McKendry, C. Mirella Spalluto, Tom M.A. Wilkinson
OA4751
Respiratory syncytial virus induces glucocorticoid insensitivity Yuxiu Connie Xia (Parkville, Australia), Yuxiu Connie Xia, Shenna Langenbach, Asmaa Radwan, Meina Li, Christine Keenan, Zixin Wong, Rosa Gualano, Alastair Stewart
OA4752
Point-of-care procalcitonin test to reduce antibiotics in COPD exacerbation: A quasi-randomised control trial Markus Fally (Copenhagen E, Denmark), Markus Fally, Caspar Corti, Andreas Fabricius-Bjerre, Katrine Mortensen, Birgitte Nybo Jensen, Helle Andreassen, Celeste Porsbjerg, Jenny Dahl Knudsen, Jens-Ulrik Jensen
OA4753
Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance Ana Maria Rodrigo Troyano (Barcelona, Spain), Ana Rodrigo-Troyano, Guillermo Suárez-Cuartin, Meritxell Peiro, Diego Castillo, Ingrid Solanes, Ferran Sánchez-Reus, Marcos I. Restrepo, James D. Chalmers, Vicente Plaza, Oriol Sibila
Room 5.1
Session 497
08:30 - 10:30
Oral Presentation: Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity Chairs : Raphael Heinzer (Lausanne, Switzerland), Sophia E. Schiza (Heraklion, Crete, Greece) OA4754
A prospective, randomised, controlled trial of CPAP in adults with Down syndrome Elizabeth Hill (Edinburgh, United Kingdom), Elizabeth A. Hill, Donna M. Fairley, Linda J. Williams, Sally-Ann Cooper, Renata L. Riha
OA4755
Sleep-disordered breathing is correlated to renal impairment in patients with diabetes mellitus type 2 Stefan Stadler (Regensburg, Germany), Stefan Stadler, Tanja Zimmermann, Myriam Rheinberger, Carsten Böger, Michael Arzt
301
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
OA4756
Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study Chen-Liang Tsai (Taipei, Taiwan), Chen-Liang Tsai, Yu-Huei Lin, Chih-Feng Chian, Wann-Cherng Perng, Chi-Huei Chiang
OA4757
The use of rifaximin improves sleep disorders in Hepatic Encephalopathy Marie Bruyneel (Rhode, Belgium), Marie Bruyneel, Sandra Van den Broecke, Thierry Gustot, Thomas Sersté
OA4758
Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients Carolina Vitale (Frattamaggiore, Italy), Vincenzo Russo, Marco Mosella, Federica Di Meo, Gerardo Nigro, Carolina Vitale, Maria D’Amato, Antonio Molino
OA4759
Effect of patent foramen ovale closure on obstructive sleep apnea Sebastian Ott (Bern, Switzerland), Sebastian Ott, Stefano Rimoldi, Emrush Rexhaj, Robert Von Arx, Stefano Di Marchi, Roman Brenner, Urs Scherrer, Bernhard Meier, Matthias Gugger, Yves Allemann, Christian Seiler
OA4760
Effects of co-existing asthma and OSA on objectively measured sleep and systemic inflammation Fredrik Sundbom (Uppsala, Sweden), Fredrik Sundbom, Eva Lindberg, Andrei Malinovschi, Christer Janson
OA4761
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study Renaud Tamisier (Grenoble, France), Renaud Tamisier, Thibaud Damy, Jean-Marc Davy, Patrick Levy, Laurent Morin, Jean-Louis Pepin, Marie-Pia D’Ortho
Room 13.1
Session 498
08:30 - 10:30
Oral Presentation: Early life matters: prematurity and risk factors for asthma Chairs : Stephen Turner (Aberdeen, United Kingdom), Liesbeth Duijts (Rotterdam, Netherlands) OA4762
LATE-BREAKING ABSTRACT: Does grandmaternal smoking increase the risk of asthma in grandchildren? Caroline Lodge (Melbourne, Australia), Caroline Lodge, Adrian Lowe, Shyamali Dharmage, David Olsson, Bertil Forsberg, Lennart Bråbäck
OA4763
Better respiratory outcomes for extremely preterm born children Merete S. Engeseth (Bergen, Norway), Merete S. Engeseth, Hege Clemm, Ola Røksund, Knut øymar, Trond Markestad, Thomas Halvorsen, Maria Vollsæter
OA4764
Longitudinal lung volume data in preterm children from infancy to early childhood Anne Schmidt (London, United Kingdom), Anne Schmidt, Sophie Yammine, Elena Proietti, Oliver Fuchs, Barbara Egger, Claudia Kuehni, Philipp Latzin, Urs Frey
OA4765
Fetal exposure to pregnancy complications and respiratory health in childhood: A longitudinal study Giancarlo Pesce (Verona, Italy), Giancarlo Pesce, Alessandro Marcon, Pierpaolo Marchetti, Lucia Calciano, Linda Guarda, Paolo Ricci, Vanda Pironi, Roberto De Marco
OA4766
Prenatal and infant paracetamol exposure and development of asthma Maria Christine Magnus (Oslo, Norway), Maria Christine Magnus, øystein Karlstad, Siri Eldevik Håberg, Per Nafstad, George Davey Smith, Wenche Nystad
OA4767
Infant weight trajectories and early childhood wheezing: The NINFEA birth cohort study Maja Popovic (Torino, Italy), Maja Popovic, Costanza Pizzi, Franca Rusconi, Claudia Galassi, Franco Merletti, Lorenzo Richiardi
OA4768
Content of omega-3 fatty acids partially explains the asthma-protective effect of unprocessed cow’s milk Tabea Brick (Munich, Germany), Tabea Brick, Yvonne Schober, Christian Böcking, Juha Pekkanen, Jon Genuneit, JeanCharles Dalphin, Josef Riedler, Roger Lauener, Andreas Nockher, Harald Renz, Charlotte Braun-Fahrländer, Erika V. Muitus, Markus Ege, Petra Ina Pfefferle
OA4769
Risk factors for chronic non-specific cough in 0-2 year olds: A cohort study Maja Jurca (Bern, Switzerland), Maja Jurca, Alban Ramette, Ben Spycher, Myrofora Goutaki, Jingying Wang, Philipp Latzin, Erol Gaillard, Claudia Kuehni
Room 2.1
Session 499
Oral Presentation: Paediatric asthma and allergy: e-health in management Chairs : Marielle Pijnenburg (Rotterdam, Netherlands), Alexander Möller (Zurich, Switzerland)
302
08:30 - 10:30
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
OA4770
LATE-BREAKING ABSTRACT: A randomized controlled trial of early probiotic supplementation to prevent early markers of asthma for high-risk infants Michael Cabana (San Francisco, United States of America), M. Cabana, M. McKean, A. Caughey, R. Leong, A. Wong, J. Hilton, H. Boushey
OA4771
E-monitoring of asthma therapy to improve compliance in children (E-MATIC) Erwin Vasbinder (Rotterdam, Netherlands), Erwin Vasbinder, Lucas Goossens, Hettie Janssens, Brenda De Winter, Liset Van Dijk, Arnold Vulto, Maureen Rutten-van Mölken, Patricia Van den Bemt
OA4772
Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma Robert Morton (Sheffield, United Kingdom), Robert Morton, Mark Everard, Heather Elphick
OA4773
Exploring the attitudes of adolescents with asthma towards monitoring and sharing of data on their inhaler use Sam Howard (Nottingham, United Kingdom), Sam Howard, Alexandra Lang, Caroline Youle, Harish Vyas, Sarah Sharples, Dominick Shaw
OA4774
Parental involvement and tele-monitoring decreases unscheduled outpatient visits in pediatric asthma patients Mihai Craiu (Bucuresti, Romania), Mihai Craiu, Iustina Violeta Stan, Valentina Comanici, Maria Tanasie
OA4775
Improvement in asthma control and airway inflammation during a period of electronic monitoring Anja Jochmann (Basel, Switzerland), Anja Jochmann, Prasad Nagakumar, Pippa Hall, Angela Jamalzadeh, Luca Artusio, Sejal Saglani, Andrew Bush, Louise Fleming
OA4776
Cost-effectiveness of FeNO- and web-based monitoring in pediatric asthma management Sandra Voorend-van Bergen (Rotterdam, Netherlands), Sandra Voorend-van Bergen, Thijs Beerthuizen, Wilbert Van den Hout, Anja Vaessen-Verberne, Hein Brackel, Anneke Landstra, Norbert Van den Berg, Johan De Jongste, Peter Merkus, Mariëlle Pijnenburg, Jacob Sont
OA4777
A virtual asthma clinic for children: Improved asthma control, less hospital visits Lara van den Wijngaart (Nijmegen, Netherlands), Lara Van den Wijngaart, Jolt Roukema, Peter Merkus
Room 4.1
Session 500
08:30 - 10:30
Oral Presentation: Innovations in noninvasive ventilation: is it always gold that glitters? Chairs : Michael Dreher (Aachen, Germany), Annia Fleur Schreiber (Turin, Italy) OA4778
Evaluation of the educational outcomes of simulation-based training (SBT) for NIV Michelle Chatwin (London, United Kingdom), Michelle Chatwin, Alanna Hare, Pascal Kurosinski, Dion Martin, Anita Simonds
OA4779
Home clinical telemonitoring and domiciliar pneumologic medical assistance in amyotrophic lateral sclerosis ventilated patients Cinzia Ferrero (Rivalta, Italy), Cinzia Ferrero, Marco Bardessono, Giuseppe Tabbia, Michela Bellocchia, Lucia Selvaggi, Andrea Calvo, Cristina Moglia, Jacopo Bellinati, Annalisa Carlucci, Cesare Gregoretti, Caterina Bucca, Alessio Mattei
OA4780
Home mechanical ventilation (HMV): Setup and outcome in Europe Maxime Patout (Rouen, France), Maxime Patout, Michelle Ramsay, Mike Mackie, Elodie Lhuillier, Nathalie Grey, Gill Arbane, Philip Marino, Joerg Steir, Antoine Cuvelier, Jean-François Muir, Patrick Brian Murphy, Nicholas Hart
OA4781
Prognostic value of residual hypoventilation in mechanically ventilated neuromuscular patients: A 5 years follow-up study Adam Ogna (Paris, France), Adam Ogna, Julie Nardi, Hélène Prigent, Maria-Antonia Quera Salva, Sylvie Chevret, Djillali Annane, David Orlikowski, Frederic Lofaso
OA4782
Extracorporeal CO2 removal in stable severe hypercapnic COPD patients non-responding to noninvasive ventilation (NIV): A pilot study Lara Pisani (Rome, Italy), Lara Pisani, Nadia Corcione, Eva Tonveronachi, Luca Fasano, Marco Ranieri, Aldo Guerrieri, Stefano Nava
OA4783
The efficacy of noninvasive positive pressure ventilation in patients with obesity hypoventilation syndrome according to the android/gynoid fat ratio and position of ventilation Irina Umarova (Saint Petersburg, Russian Federation), Irina Umarova, Olga Balionis, Alexander Gorelov
OA4784
Effect of NIV on right heart function assessment by two-dimensional speckle-tracking echocardiography (2D-STE) in patients with OSAS ANNA MICHELA GAETA (solofra, Italy), Anna Michela Gaeta, Antonello D’Andrea, Mariano Mazza, Anna Annunziata, Gianfranco Scotto di Frega, Antonella Marotta, Giuseppe Fiorentino
303
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
OA4785
Evaluation of cardiovascular risk after long-term c-PAP therapy in patients with obstructive sleep apnea. A 4-year follow-up Pierluigi Carratù (Bari, Italy), Pierluigi Carratù, Annapaola Zito, Vitaliano Quaranta, Rossella Carbonara, Fiorella Devito, Onofrio Resta, Marco Ciccone
Room Emerald
Session 501
08:30 - 10:30
Oral Presentation: Management of asthma and COPD in primary care Chairs : Niels Chavannes (Leiden, Netherlands), Hilary Pinnock (Edinburgh, United Kingdom)
OA4786
LATE-BREAKING ABSTRACT: Prevalence of comorbidities in patients with asthma-COPD overlap syndrome (ACOS) in primary care Job van Boven (Groningen, Netherlands), Job F.M. van Boven, Miguel Román-Rodríguez, José F. Palmer, Nuría Toledo, Borja G. Cosío, Joan B Soriano
OA4787
Microspirometry as a ’point of care’ test to enhance the diagnostic process of COPD in primary care; results of a cluster-randomised trial Lisette Van den Bemt (Nijmegen, Netherlands), Lisette Van den Bemt, Joke Grootens, Riet Cretier, Reinier Akkermans, Joke Denis, Patrick Poels, Tjard Schermer
OA4788
An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction Lynn Josephs (Christchurch, United Kingdom), Lynn Josephs, Matthew Johnson, Rosanna Orlando, David Culliford, Paul Roderick, Mike Thomas
OA4789
One year with certified asthma and COPD-clinics in Skåne, Sweden Kerstin Romberg (Falsterbo, Sweden), Kerstin Romberg, Mattias Wieloch, Magnus Kåregård, Leif Bjermer, Birgitta Jagorstrand
OA4790
Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment Sandra Dorado Arenas (Bilbao (Bizkaia), Spain), Sandra Dorado, Silvia Pascual, Isabel Urrutia, Mª Iciar Arrizubieta, Leire Sainz de Aja, Ane Antón, José María Quintana, Urko Aguirre, Mateo Larrauri, Begoña Gutiérrez, Rafael Arruabarrena, José Luis Bilbao, José Ferri, Ane Uranga, Amaia García, Helena Azcuna, Amaia Aramburu, Txomin Zabala, Amaia Artaraz, Aitor Ballaz, Alberto Capelastegui
OA4791
Comparative audit of asthma management in the easy asthma clinic and general out-patient clinic Watchara Boonsawat (Khon Kaen, Thailand), Watchara Boonsawat, Prapai Wattranagri, Kriddhiya Sriprasert
OA4792
Non-adherence to asthma medications: Relation to socio-economic status and asthma education Soham Mazumdar (Kolkata, India), Soham Mazumdar, Subhajit Ghosh, Suranjan Mukherjee
OA4793
Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations David Price (Aberdeen, United Kingdom), Mike Thomas, David Price, John Blakey, Lynn Josephs, Ian Pavord, Borislav Dimitrov, Dirkje Postma, Alberto Papi, Alexandra Dima, Todor Popov, Hilary Pinnock, Iain Small, Alan Kaplan, Cynthia Rand, Janet Holbrook, Emilio Pizzichini, Gene Colice, Sam Walker, Annie Burden, Vasilis Nikolaou
Room E104-106
Session 502
08:30 - 10:30
Poster Discussion: COPD: notable points Chairs : Mohankumar Thekkinkattil (Coimbatore, India), Marjolein Brusse-Keizer (Enschede, Netherlands) PA4794
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Evgenia A. Kochetkova (Strasbourg, France), Ludmila Ugay, Evgenia Kochetkova, Vera Nevzorova
PA4795
Co-morbidities of adult smokers at risk of COPD evaluated in a 6-year prospective study Tuula Toljamo (Rovaniemi, Finland), Tuula Toljamo, Anna Hamari, Marjo Sotkasiira, Pentti Nieminen
PA4796
Are acute changes in CO2 measurable with transcutaneous technique in patients with very severe chronic obstructive pulmonary disease? Thea Faaborg (Skørping, Denmark), Thea H. Faaborg, Lars P. Thomsen, Stephen E. Rees, Ulla M. Weinreich
PA4797
The effect of statin therapy in patients with chronic obstructive airway disease Hamdy Ali Mahmoud (Naser City, Egypt), Hamdy Ali Mohammadien Mahmoud, Faten Omeran, Emen Ahmed
PA4798
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD Ekaterina Kochetova (Petrozavodsk, Republic of Karelia, Russian Federation), Ekaterina Kochetova
PA4799
Is COPD an independent predictor of osteoporosis? Geeshath Jayasekera (Glasgow, United Kingdom), Geeshath Jayasekera, Lyn Lavelle, David Anderson
304
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4800
Patterns of initial treatment for COPD according to clinical phenotypes in Catalonia Miriam Barrecheguren Fernandez (Barcelona, Spain), Miriam Barrecheguren, Mónica Monteagudo, Carles Llor, Eulalia Borrell, Cristina Esquinas, Jaume Ferrer, Marc Miravitlles
PA4801
Impact of heart failure (HF) on COPD misdiagnosis in primary care Ivan Vishnivetsky (Kiev, Ukraine), Ivan Vishnivetsky, Iryna Boichenko, Anastasiia Borovtsova
PA4802
COPD: Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination and oxygen saturation (OS) in patients (pts) with different plasma surfactant protein D (SP-D) level Nataliia Kravchenko (Dniepropetrovsk, Ukraine), Tetyana Pertseva, Kateryna Gashynova, Nataliia Kravchenko
PA4803
Role of matrix metalloproteinase in predicting of COPD stability Bogdana Basina (Dnipropetrovsk, Ukraine), Bogdana Basina, Tetyana Pertseva, Lyudmila Konopkina
PA4804
Investigating the efficacy of cognitive behavioural therapy (CBT) on the mental health of chronic obstructive pulmonary disease (COPD) patients: A randomised control trial Tina Phan (Joondalup, Australia), Tina Phan, Owen Carter, Grant Waterer, Li Ping Chung, Maxine Hawkins, Cobie Rudd, Mel Ziman, Natalie Strobel
PA4805
Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: A systematic review and meta-analysis Magnus Ekstrom (Lyckeby, Sweden), Magnus Ekström, Fredrik Nilsson, Amy Abernethy, David Currow
PA4806
Relationship between annual change of bone mineral density, emphysema and pulmonary function in patients with COPD Kenichi Goto (Otsu, Japan), Kenichi Goto, Emiko Ogawa, Nguyen Van Tho, Yoshiki Kawata, Hidenobu Suzuki, Mikio Matsuhiro, Hironi Makita, Katsura Nagai, Noboru Niki, Masaharu Nishimura, Yasutaka Nakano, Hokkaido COPD Cohort Study Investigators
PA4807
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Annie NAVARRO ROLON (Barcelona, Spain), Annie Navarro, Ana Maria Lapuente, Julia Pareja, Angela Barrera, Sergi Yun, Alejandro De La Sierra, Jose Luis Heredia, Pere Almagro
PA4808
Noninvasive ventilation in acute respiratory failure caused by non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease Alizamin Sadigov (Baku, Azerbaijan), Alizaman Sadigov, Konul Bakhshaliyeva, Tabib Ibrahimov, Jeyhun Ismailzadeh
PA4809
Relation between vitamin D levels and anxiety and depression in COPD patients Derya Kocakaya (Istanbul, Turkey), Derya Kocakaya, Ozan Kocakaya, Berrin Bagci Ceyhan
PA4810
Circulating levels of IGF-I and IGFBP-3 in patients with COPD Ümran Toru (Kütahya, Turkey), ümran Toru, Ceylan Ayada, Osman Genç, Server Sahin, özlem Arik, Ismet Bulut
Room G102-103
Session 503
08:30 - 10:30
Poster Discussion: Physiotherapy outcomes and treatment in different patient profiles Chairs : Rainer Gloeckl (Schoenau am Koenigssee, Germany), Agnieszka Lewko (Croydon, United Kingdom)
PA4811
Comparison of peak exercise responses between survivors of adult respiratory distress syndrome with age and sex matched healthy adults Jennifer Mackney (Callaghan, Australia), Jennifer Mackney, Sue Jenkins, Daniel Robins, Ken Havill, Megan Harrold, Kylie Hill
PA4812
The clinical usefulness of manual muscle testing (MMT) in difficult-to-wean (DTW) patients Lauren Hogg (London, United Kingdom), Thomas Lunn, Lynn McDonnell, Leyla Osman, Alex Curtis, Ruth Kent, Gemma Cox, Nicholas Hart, Lauren Hogg
PA4813
Effects of respiratory physiotherapy by expiratory flow increase in controlled mechanical ventilated patients with bronchial obstruction Anne Freynet (Bordeaux, France), Anne Freynet, Guillaume Gobaille, Antoine Dewitte
PA4814
Assessing electrically quadriceps induced torque in critically ill patients Larissa Vieira Santana (Brasilia, Brazil), Larissa Santana, Natalia Pinto, Andre Souza, Marcelino Andrade, Paulo Silva, Luciana Vieira, Gerson Cipriano Jr, Joao Luiz Durigan, Vinicius Maldaner
PA4815
Reliability of hand-held dynamometer for assessment of electrically induced torque in critically ill patients Vinicius Zacarias da Silva (Brasilia, Brazil), Vinicius Silva, Larissa Santana, Natalia Pinto, Joao Luiz Durigan, Gerson Cipriano, Luciana Urache, Paulo Eugenio Silva
305
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4816
Dyspnea and exercise intolerance in breast cancer survivors: The role of inspiratory muscle weakness Daniel Langer (Leuven, Belgium), Daniel Langer, Katherine Webb, Amany Elbehairy, Alberto Neder, Deborah Dudgeon, Denis O’Donnell
PA4817
Improvement in physical performance and health-related quality of life one year after radical operation for primary or secondary lung cancer Barbara C. Brocki (Aalborg SV, Denmark), Barbara C. Brocki, Jan J. Andreasen, Elisabeth Westerdahl, Domingos S.R. De Souza
PA4818
Mucociliary clearance in patients submitted thoracic surgery subject to deep breath and positive pressure Ana Paula Coelho Figueira Freire (Presidente Prudente, Brazil), Francis Lopes Pacagnelli, Caroline Pereira Santos, Marcela Rascoviti, Carlos Alberto Alvim Franzini Junior, Juliana Gonçalves Finoti, Ana Paula Coelho Figueira Freire, Marceli Rocha Leite, Giovana Navarro Bertolini, Ercy Mara Cipulo Ramos
PA4819
Intensity and duration of exercise on inflammatory markers and oxidative stress in patients with heart failure Giane Ribeiro-Samora (Belo Horizonte, Brazil), Giane Ribeiro-Samora, Mariana Hoffman Barbosa, Luiza Antas Rabelo, Glaucevane Silva Guedes, Michelle Favero, Leani Máximo Pereira, Raquel Rodrigues Britto, Verônica Franco Parreira
PA4820
Effects of severe fatigue on pulmonary functions, dyspnea, muscle strength, exercise capacity and quality of life in allogeneic hematopoietic stem cell transplantation recipients Meral Bosnak Güçlü (Ankara, Turkey), Gülsah Bargi, Meral Bosnak Güçlü, Zeynep Sahika Aki, Gülsan Türköz Sucak
PA4821
Comparison of exercise capacity, respiratory and peripheral muscle strength and dyspnea in patients with interstitial lung disease with and without chronotropic incompetence Meral Bosnak Güçlü (Ankara, Turkey), Burcu Camcioglu, Meral Bosnak-Güçlü, Müserrefe Nur Karadalli, Nurdan Köktürk, Haluk Türktas
PA4822
Comparison of functional exercise capacity, muscle strength, anaerobic power and capacity in patients with malnourished non-cystic bronchiectasis and healthy controls Meral Bosnak Güçlü (Ankara, Turkey), Meral Bosnak Güçlü, Sema Savci, Deniz Inal Ince, Melda Saglam, Hülya Arikan, Ugur özçelik
PA4823
A comparison of aerobic and anaerobic capacity in children with primary ciliary dyskinesia and healthy peers Senem im ek (Ankara, Turkey), Senem Simsek, Deniz Inal Ince, Aslihan Cakmak, Ebru Calik Kutukcu, Melda Saglam, Naciye Vardar Yagli, Nagehan Emiroglu, Ugur Ozcelik, Hazal Sonbahar, Cemile Bozdemir Ozel, Hülya Arikan, Nural Kiper
PA4824
Clinical determinants of the incremental shuttle walk test in patients with interstitial lung disease Meral Bosnak Güçlü (Ankara, Turkey), Müserrefe Nur Karadalli, Meral Bosnak-Güçlü, Burcu Camcioglu, Nurdan Köktürk, Haluk Türktas
PA4825
Electrical activity behavior of respiratory and peripheral muscles during incremental shuttle walking test in asthmatic subjects Vanessa Resqueti Fregonezi (Natal- Rio Grande do Norte, Brazil), Vanessa Resqueti, Jéssica Cavalcanti, Kardec Alecxandro Aguiar, Lucien Gualdi, Antônio Sarmento, Ingrid Guerra, Armele de Fátima Dornelas de Andrade, Guilherme Fregonezi
PA4826
Functional capacity and peripheral muscle strength are reduced in asthmatic children and teenager Mariana Reimberg (São Paulo, Brazil), Mariana Reimberg, átila Alves dos Santos, Crislaine Santos, Beatriz Rodrigues Santos, Rejane Agnelo Silva de Castro, Matheus Elias Pacheco, Gustavo Falbo Wandalsen, Dirceu Solé, Simone Dal Corso, Fernanda De Cordoba Lanza
PA4827
Relationship between daily life activities and upper extremity exercise capacity in patients with pulmonary arterial hypertension Buse Özcan (Izmir, Turkey), Buse Ozcan, Sema Savci, Ismail Ozsoy, Serap Acar, Bahri Akdeniz, Ebru Ozpelit, Can Sevinc
PA4828
Accuracy of piezoelectric pedometer step counts in different wearing locations Alda Sofia Pires de Dias Marques (Aveiro, Portugal), Joana Cruz, Dina Brooks, Alda Marques
Room G104-105
Session 504
08:30 - 10:30
Poster Discussion: Lung cancer therapy: clinical trials Chairs : Konstantinos Zarogoulidis (Thessaloniki, Greece), Rainer G. Wiewrodt (Münster, Germany) PA4829
Survival in elderly patients undergoing lung resection for lung cancer Marija Kojicic Vukoja (Sremska Kamenica, Republic of Serbia), Marija Vukoja, Ivan Kopitovic, Dejan Djuric, Dragana Milicic, Aleksandar Bokan, Radmila Cikara
PA4830
Outcomes of radical treatment of early stage non-small cell lung cancer Carissa Yap (Burnside , Australia), Carissa Yap, Paul Hakendorf, Richard Woodman, David Lance, John Leung, Jeffrey Bowden, Anand Rose
306
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4831
Improved survival associated with neoadjuvant chemoradiation and surgery vs other means of treatment for NSCLC N2 patients (clinical stage IIIa and IIIb) Aivars Berzins (Moers, Germany), Aivars Berzins, Uldis Kopeika, Petar Traykov, Joachim Kolb, Karl Otto Kambartel, Thomas Voshaar, Thomas Krbek
PA4832
Impact of early weight loss during concurrent chemoradiotherapy on survival in advanced stage NSCLC patients Karin Sanders (Maastricht, Netherlands), K.J.C. Sanders, L.E. Hendriks, E.G.C. Troost, G.P. Bootsma, A.M.W.J. Schols, A.-M.C. Dingemans
PA4833
Accelereated hyperfractionated radiotherapy with uneven crushing daily dose in chemoradiation treatment of inoperable non-small cell lung cancer Yury Ragulin (Obninsk, Kaluga Oblast, Russian Federation), Yury Ragulin, Danil Gogolin, Igor Gulidov, Yury Mardynsky, Irina Ivanova, Larisa Kursova
PA4834
Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas Marie Bernardi (Lyon, France), Marie Bernardi, Marie-Pierre Sunyach, Ronan Tanguy
PA4835
Clinical and therapeutic characteristics of patients died due to radiation-induced pneumonitis DAVID ANGEL YABAR BEDOYA (Barcelona, Spain), David Yabar, Arturo Navarro, Susana Padrones, Ramón Palmero, Jordi Dorca, Samantha Aso
PA4836
Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule Xavier Elharrar (Sausset-Les-Pins, France), Xavier Elharrar, Dominique Barbolosi, Joseph Ciccolini, Christophe Meille, Christian Faivre, Bruno Lacarelle, Nicolas André, Fabrice Barlesi
PA4837
Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Daniel Carlos Silva Vaz (Porto, Portugal), Daniel Vaz, Sérgio Campainha, Ana Antunes, Sara Conde, Ana Barroso
PA4838
Combination of oral and parenteral vinorelbine with cisplatin or carboplatin in adjuvant chemotherapy of nonsmall cell lung cancer - SWITCH study Vít zslav Kolek (Olomouc, Czech Republic), Vitezslav Kolek, Ivona Grygarkova, Leona Koubkova, Tereza Janaskova, Jana Skrickova, Jaromir Roubec
PA4839
Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Sebastian Thiel (Berlin, Germany), Sebastian Thiel, Daniel Misch, Crolow Catharina, Torsten Blum, Christian Boch, Jens Kollmeier, Torsten Bauer
PA4840
Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic Jana Sk i ková (Brno, Czech Republic), Jana Skrickova, Zbynek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Leona Koubkova, Jaromir Roubec, Libor Havel, Frantisek Salajka, Marcela Tomiskova, Monika Satankova
PA4841
Homozygous deletion of PTEN and poor outcomes in EGFR mutant NSCLC patients with gefitinib therapy Ying-ying Gu (Guangzhou, China), Juhong Jiang, Yingying Gu
PA4842
Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC) Angelica Tiotiu (Vandoeuvre-les-Nancy, France), Angelica Tiotiu, Isabelle Clerc-Urmès, Yves Martinet
PA4843
Assesment of palliative care in lung cancer in Turkey (ASPECT study) Y lmaz Bülbül (TRABZON, Turkey), Yilmaz Bulbul, Tevfik Ozlu, Sibel Arinc, Berna A. Ozyurek, Hulya Gunbatar, Aysegul Senturk, Ayse Bahadir, Melike Ozcelik, Ufuk Yilmaz, Makbule Ozlem Akbay, Leyla Saglam, Talat Kilic, Gamze Kirkil, Neslihan Ozcelik, Dursun Tatar, Serap Argun Baris, Mehmet Yavsan, Hatice Selimoglu Sen, Serdar Berk, Murat Acat, Gulfidan Cakmak, Perran Fulden Yumuk, Yavuz Selim Intepe, Umran Toru, Sibel O. Ayik, Ilknur Basyigit, Sibel Ozkurt, Levent Cem Mutlu, Zehra Asuk Yasar, Hidir Esme, Muharrem Erol, Ozlem Oruc, Yurdanur Erdogan, Selvi Asker, Arife Ulas, Serhat Erol, Bugra Kerget, Ahmet Emin Erbaycu, Turgut Teke, Mehmet Besiroglu, Huseyin Can, Fahrettin Talay
PA4844
Impact on survival of history of diabetus mellitus in NSCLC patients Efimia Boutsikou (Thessaloniki, Greece), Sofia Lampaki, Efimia Boutsikou, Paul Zarogoulidis, Ellada Eleptheriadou, Dionisis Spyratos, Konstantinos Zarogoulidis
PA4845
Perception of the disease and its impact on life in lung cancer patients Silvija Zemnickiene (Vilnius, Lithuania), Silvija Zemnickiene, Rasa Gauronskaite, Ruta Kibarskyte, Irina Liustrickyte, Vaida Gedvilaite, Edvardas Danila
Room G106-107
Session 505
Poster Discussion: New insights into IIPs Chairs : Francesco Bonella (Düsseldorf, Germany)
307
08:30 - 10:30
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4846
Contribution of epithelial-to-mesenchymal transition to phenotypic changes in idiopathic interstitial pneumonias Gunnar Gudmundsson (Seltjarnarnes, Iceland), Gunnar Gudmundsson, Bryndis Valdimarsdottir, Ari Jon Arason, Magnus Karl Magnusson, Helgi Isaksson, Thorarinn Gudjonsson
PA4847
Diagnostic utility of surgical lung biopsies in elderly patients with interstitial lung diseases Laszlo Vaszar (Scottsdale, United States of America), Laszlo Vaszar, Brandon Larsen, Jay Ryu, Lewis Wesselius, Karen Swanson, Robert Viggiano, Henry Tazelaar
PA4848
Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing HIROYOSHI YAMAUCHI (Tochigi, Japan), Hiroyoshi Yamauchi, Masashi Bando, Tomohisa Baba, Kensuke Kataoka, Yoshikazu Inoue, Yoshihito Yamada, Hiroshi Yamamoto, Kentaro Watanabe, Yasuhiro Terasaki, Akira Hebisawa, Yoshinori Kawabata, Takeshi Johkoh, Fumikazu Sakai, Yukihiko Sugiyama, Takashi Ogura
PA4849
Genetic testing in idiopathic interstitial pneumonia Nadia Nathan (Paris, France), Nadia Nathan, Raphaël Borie, Caroline Kannengiesser, Florence Dastot Le Moal, Hilario Nunes, Dominique Valeyre, Martine Reynaud-Gaubert, Sylvain Marchand-Adam, Jean-Marc Naccache, Grégoire Prevot, Guillaume Lezmi, Christophe Delacourt, Dominique Israël Biet, Caroline Thumerelle, Antoine Deschildre, Christophe Marguet, Philippe Reix, Vincent Cottin, Marie-Laure Dalphin, Anne Gondouin, Clément Picard, Violaine Giraud, Claire Dromer, Marie Legendre, Laurent Gouya, Bruno Crestani, Annick Clement, Serge Amselem
PA4850
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases? Martina Vašáková (Prague, Czech Republic), Martina Vasakova, Martina Sterclova, Peter Paluch, Veronika Polcova, Radoslav Matej, Jelena Skibova
PA4851
Classification of different ABCA3 mutations causing interstitial lung disease Thomas Wittmann (Munich, Germany), Thomas Wittmann, Ulrike Schindlbeck, Stefanie Höppner, Susanna Kinting, Gerhard Liebisch, Ralf Zarbock, Matthias Griese
PA4852
Quality of life in interstitial lung disease: Utility of the Kings brief interstitial lung disease questionairre at baseline Nicole Taylor (Sydney , Australia), Nicole Taylor, Susanne Webster, Nathaniel Marshall, Clair Lake, Lissa Spencer, Lauren Troy, Paul Torzillo, Tamera Corte
PA4853
Prospective study of feasibility and safety of bronchoscopic transbronchial cryprobe biopsies in interstitial lung disease: Initial experience of an Irish interstitial lung disease centre Mohamed Elshafi (Dublin 8, Ireland), Mohamed Elshafi, Joanne O’Donovan, Kashif Khan, Louise Burke, Abirami Subramaniam, Marcus Kennedy, Desmond Murphy, Barry Plant, Michael Henry
PA4854
Transforming growth factor B1 polymorphism and serum levels in interstitial lung diseases Rana El-Helbawy (Shebin El-Kom, Egypt), Rana El-Helbawy, Sami Eldahdoh, Rania Elshzly, Ashraf Dawood
PA4855
A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia Nicolas Petitpierre (Bursins, Switzerland), Nicolas Petitpierre, Romain Lazor, Sylvain Marchand-Adam, Vincent Cottin, Isabelle Court-Fortune, Sandrine Hirschi, Dominique Rigaud, Stéphane Jouneau, Jean-François Cordier, The Groupe d’Etudes et de Recherche sur les Maladies ²Orphelines²
PA4856
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Lisa Nicol (Tillicoultry, United Kingdom), Lisa Nicol, David McAllister, Catriona Graham, Pauline McFarlane, Gareth Stewart, Sarah Howie, William Wallace, John Murchison, Nik Hirani
PA4857
Multidisciplinary board for interstitial lung disease: Relevance for real life? Sabina Guler (Bern, Switzerland), Sabina Guler, Sabina Anna Berezowska, Andreas Christe, Geiser Thomas, Funke Manuela
PA4858
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging Mary McElroy (Edinburgh, United Kingdom), Mary Mcelroy, David Bonnel, Emeline Falaux, Gael Picard de Muller, Fabien Pamelard, Claudio Petterino, Stuart Naylor, Stephen Madden, Jonathan Stauber
PA4859
Imaging pattern in interstitial lung diseases using probe based confocal laser endomicroscopy (pCLE) Frank Reichenberger (Gauting, Germany), Edith Silbernagel, Wolfgang Gesierich, Michael Lindner, Alicia Morresi-Hauff, Juergen Behr, Frank Reichenberger
PA4860
Clinical characteristics of patients with unclassifiable interstitial lung disease Fotios Drakopanagiotakis (Giessen, Germany), Fotios Drakopanagiotakis, Mustapha El-Guelai, Philippe Bonniaud, Carlo Vancheri, Bruno Crestani, Jasmin Wagner, Athol Wells, Andreas Guenther
PA4861
Cardiopulmonary exercise testing in interstitial lung disease Christina Priegnitz (Solingen, Germany), Christina Priegnitz, Lars Hagmeyer, Ilona Kietzmann, Kerstin Richter, Winfried Randerath
308
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4862
Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations Marina De Martino (Naples, Italy), Marina De Martino, Gaetano Rea, Tullio Valente, Annalisa Capaccio, Angelo Canora, Francesco Lassandro, Marialuisa Bocchino
PA4863
The analysis of prognostic factors in patients with interstitial lung diseases Akira Shiraki (Ogaki, Japan), Akira Shiraki, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi, Hirohisa Kano, Show Hori
Room 13.2
Session 506
08:30 - 10:30
Poster Discussion: Advances in therapeutic bronchoscopy Chairs : Antoni ROSELL GRATACOS (Barcelona, Spain), Ralf Eberhardt (Heidelberg, Germany)
PA4864
LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT) Felix J.F. Herth (Heidelberg, Germany), Felix J.F. Herth, Arschang Valipour, Ralf Eberhardt, Christian Grah, Jim Eagan, Joachim Ficker, Manfred Wagner, Pallav Shah, Christian Witt, Uta Liebers, Daniela Gompelmann, Peter Hopkins, Wolfgang Gesierich, Martin Phillips, Franz Stanzel, Christoph Petermann, Greg Snell
PA4865
Tracheal and bronchial granular cell tumours: A French retrospective study on 30 patients Maxime Roger (Rouen, France), Maxime Roger, Samy Lachkar, Mathieu Salaun, Michel Febvre, Jean Michel Vergnon, Luc Thiberville
PA4866
Tracheobronchial injuries: Our personal experience on 19 cases Luis Filipe Pires Martins (Lisbon, Portugal), Luís Martins, Salvato Feijó, Paula Monteiro, José Gonçalves, Cristina Bárbara
PA4867
Noninvasive ventilation assisted interventional bronchoscopy for hypoxemia patients with central airway stenosis Xiao-Ke Chen (Shenzhen , China), Xiao-ke Chen, Yi -ping Zhou
PA4868
Bronchoscopic dissection Franz Stanzel (Hemer, Germany), Franz Stanzel, Uta Wuelfing, Ulrich Klein
PA4869
Bronchoscopic management of post intubation tracheal stenoses Luis Filipe Pires Martins (Lisbon, Portugal), Luis Martins, Cátia Santos, Salvato Feijó, Paula Monteiro, J. Rosal Gonçalves, Cristina Bárbara
PA4870
Effect of paclitaxel delivered nanoparticles to treat tracheal stenosis Ana Montes Worboys (Sevilla, Spain), Ana Montes-Worboys, Joan Gilabert-Porres, Rosa Lopez-Lisbona, Noelia CuberoFrutos, Salvador Borros, Antoni Rosell
PA4871
Interventional bronchoscopy in the initial management of benign and malignant tracheal stenoses Ashraf Madkour (Cairo, Egypt), Ashraf Madkour, Ahmed Elmansoury, Samar Sharkawy
PA4872
The place of airway stenting in the medico-surgical management of iatrogenic tracheal injuries: A 10 years retrospective analysis Rachid Tazi Mezalek (Burgos, Spain), Rachid Tazi-Mezalek, Sophie Laroumagne, Philippe Astoul, Pascal Thomas, Hervé Dutau
PA4873
Prognostic factors for therapeutic response after stenting in patients with benign tracheal stenosis Milena Encheva (Sofia, Bulgaria), Milena Encheva, Hristo Yordanov, Kosta Kostov, Ventzislav Tzvetkov, Petar Chipev, Alexey Djelepov
PA4874
Evaluation of bronchoscopic placement of tracheobronchial silicone stents: Initial Egyptian experience Ashraf Madkour (Cairo, Egypt), Emad Korraa, Ashraf Madkour, Amany Todary, Khaled Wagieh
PA4875
Two-year experience with the use of fully covered self-expandable metal stents Antoni ROSELL GRATACOS (Barcelona, Spain), Leopoldo Carnevali, Noelia Cubero, Marta Diez, Arturo Morales, Enric Bozza, Jordi Dorca, Antoni Rosell
PA4876
Biodegradable polydioxanone stents: Preliminary results in adult patients with tracheal narrowing Lud k Stehlík (Prague, Czech Republic), Ludek Stehlik, Vladislav Hytych, Sarka Lefnerova, Martina Vasakova
PA4877
Endobronchial valve treatment for bronchopleural fistulas - Is time to treatment a predictor of success? Arve Sundset (Oslo, Norway), Arve Sundset, Inga Leuckfeld, Are Holm
309
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4878
Collapse therapy using endobronchial valves as a new approach to treat cavities in MDR tuberculosis and selected cases of mycobacteriosis: Case series report Lorenzo Corbetta (Firenze, Italy), Lorenzo Corbetta, Pier Giorgio Rogasi, Ariela Tofani, Lucio Michieletto, Fausto Leoncini, Flavio Montinaro, Stefano Orsi, Loris Ceron
PA4879
Inhalation of a particular foreign body: Pin scarf nihal souki (casablanca, Morocco), Nihal Souki, Hasna Jabri, Wiam El Khattabi, Hicham Afif
Room E102
Session 507
08:30 - 10:30
Poster Discussion: Promising novel findings in translational pulmonary research Chairs : Helmut H. Popper (Graz, Austria) PA4880
Polymorphisms in human NRF2 is associated with susceptibility to tuberculosis Guiyi Ji (Chengdu, China), Guiyi Ji, Jianqing He
PA4881
Multiplex polymerase chain reaction - An innovative clinical tool poulomi chatterjee (gurgaon, India), Poulomi Chatterjee, Naveen Kumar, Pinky Goyal, Ashish Prakash, Bornali Datta
PA4882
RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study Micha Skronski (Warszawa, Poland), Michal Skronski, Renata Langfort, Agata Gizycka, Dorota Giedronowicz, Paulina Jagus, Joanna Chorostowska-Wynimko, Renata Langfort
PA4883
The evaluation of biological and clinical significance of alpha-1 antitrypsin in non-small cell lung cancer Adam Szpechcinski (Warszawa, Poland), Adam Szpechcinski, Beata Poplawska-Wisniewska, Emilia Debek, Renata Langfort, Dorota Giedronowicz, Radoslaw Struniawski, Wlodzimierz Kupis, Piotr Rudzinski, Jolanta Zaleska, Pawel Sliwinski, Tadeusz Orlowski, Kazimierz Roszkowski-Sliz, Joanna Chorostowska-Wynimko
PA4884
EGFR mutation diagnostic program for NSCLC patients in Poland between 2011-2014 Paulina Jagus (Warszawa, Poland), Paulina Jagus, Pawel Krawczyk, Bartosz Wasag, Iwona Rzepecka, Piotr Wójcik, Karolina Tecza, Tomasz Powrozek, Bozena Konopka, Agata Gizycka, Kamila Wojas-Krawczyk, Janusz Limon, Barbara Pienkowska-Grela, Piotr Pierzchalski, Piotr Widlak, Joanna Chorostowska-Wynimko
PA4885
Molecular characterization of the ACVRL1 and ENG genes in patients with pulmonary arterial hypertension Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Diego Fontán, Adolfo Baloira, Diana Valverde
PA4886
Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients Svetlana K. Soodaeva (Moscow, Russian Federation), Svetlana Soodaeva, Larisa Postnikova, Marina Boldina, Nailja Kubysheva, Timur Li, Igor Klimanov, Lidia Nikitina
PA4887
TNF promoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population Ramcés Falfán-Valencia (Mexico, Mexico), Ramcés Falfán-Valencia, Juan Reséndiz-Hernández, Raul Sansores, Alejandra Ramírez-Venegas
PA4888
Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD Patrick Branigan (Spring House, United States of America), Huiqing Liu, Matthew Loza, Alexander Mackay, Patrick Branigan, Nancy Peffer, Swetha Patel, Gavin Donaldson, Siobhan George, Frederic Baribaud, Jadwiga Wedzicha
PA4889
The first U-BIOPRED blood handprint of severe asthma Bertrand De Meulder (Lyon, France), Bertrand De Meulder, Diane Lefaudeux, Jeanette Bigler, Matthew J. Loza, Craig E. Wheelock, Ana R. Sousa, Julie Corfield, Frédéric Baribaud, Charles Auffray, Dominic E. Shaw, Ildiko Horvath, Jacek Musial, Pascal Chanez, Norbert Krug, Paolo Montuschi, Per S. Bakke, Florian Singer, Stephen J. Fowler, Sven-Erik Dahlen, Thomas Sandström, Peter J. Sterk, Kian Fan Chung, Ian M. Adcock, Ratko Djukanovic, The U-BIOPRED Working Group
PA4890
MMP10 and MET as predictive classifiers of bronchial eosinophilic asthma in UBIOPRED Chih Hsi Kuo (London, United Kingdom), Chih Hsi Kuo, Yike Guo, Ioannis Pandis, Stelios Pavlidis, Uruji Hoda, Christos Rossios, Anthony Rowe, Susan J. Wilson, Peter Howarth, Ratko Djukanovic, Matthew J. Loza, Fred Baribaud, Peter J. Sterk, Ian M. Adcock, Kian Fan Chung
PA4891
Global gene expression analyses highlight the role of plasma membrane remodeling as a molecular functions of airway epithelium in response to interleukin-13 treatment Yuko Kureya (Ibaraki city,Osaka, Japan), Yuko Kureya, Kazuhisa Konishi, Kazuhiro Yamada, Tetsuya Watanabe, Masato Uji, Kazuhisa Asai, Hiroshi Kanazawa, Kazuto Hirata
PA4892
MTHFR 677C>T polymorphism in patients with COPD Dimo Dimov (Stara Zagora, Bulgaria), Dimo Dimov, Georgi Golemanov, Tanya Tacheva, Vanya Ilieva, Gospodinka Prakova, Maya Gulubova, Regina Komsa-Penkova, Tatyana Vlaykova
310
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4893
Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling C.C. De Theije (Maastricht, Netherlands), C.C. De Theije, A.M.W.J. Schols, W.H. Lamers, J.J.M Ceelen, J.J.R. Hermans, S.E. Köhler, R.C.J. Langen
PA4894
Urokinase plasminogen activator receptor variants drive distinct phenotypes in the bronchial epithelium Sangita Bhatti (Nottingham, United Kingdom), Sangita Bhatti, Michael Portelli, Ian Sayers
PA4895
Apoptosis in vastus lateralis muscle of patients with COPD Ramzi Lakhdar (Edinburgh, United Kingdom), Ramzi Lakhdar, Ellen Drost, William MacNee, Roberto Rabinovich
PA4896
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vitro Beata Pop awska-Wi niewska (Warszawa, Poland), Beata Poplawska-Wisniewska, Jadwiga Popow-Stellmaszyk, Radoslaw Struniawski, Aneta Stepniewska, Emil Wojda, Magdalena Wysocka, Pawel Sliwinski, Malgorzata CzajkowskaMalinowska, Beata Wajda, Dorota Krawiecka, Ewa Jassem, Sabine Wrenger, Sabina Janciauskiene, Adam Lesner, Joanna Chorostowska-Wynimko
PA4897
Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels Beatriz Martinez-Delgado (Madrid, Spain), Nerea Matamala, Beatriz Lara, Raquel Sáez, Silvia Castillo, María Molina, Ana Texido, Lara López, Alvaro Otero, Laura Perez, Ignacio Blanco, Beatriz Martinez-Delgado
Room D201-202
Session 508
08:30 - 10:30
Poster Discussion: Pulmonary hypertension: promising small molecules Chairs : Christophe Guignabert (le Plessis-Robinson, France), Soni Savai Pullamsetti (Bad Nauheim, Germany)
PA4898
LSC Abstract – Glutamatergic signaling through pulmonary vascular NMDA receptors in pulmonary hypertension Sebastien J Dumas (LE PLESSIS-ROBINSON, France), Sébastien J. Dumas, Frédéric Perros, Gilles Bru-Mercier, Audrey Courboulin, Benoit Ranchoux, Catherine Rücker-Martin, Elodie Gouadon, Matthieu Vocelle, Nicolas Raymond, Peter Dorfmüller, Elie Fadel, Marc Humbert, Sylvia Cohen-Kaminsky
PA4899
In-situ metabolite profiling of remodeled arteries in Pulmonary Arterial Hypertension (PAH) using innovative mass spectrometry imaging (MSI) tools Gregory Hamm (Loos, France), Sébastien J. Dumas, Raphael Legouffe, Fabien Pamelard, David Bonnel, Gaël Picard De Muller, Gregory Hamm, Peter Dorfmüller, Elie Fadel, Marc Humbert, Jonathan Stauber, Sylvia Cohen-Kaminsky
PA4900
Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension Morane Le Hiress (Le Plessis-Robinson, France), Morane Le Hiress, Ly Tu, Carole Phan, Raphaël Thuillet, Nicolas Ricard, Andrei Seferian, Elie Fadel, Gerald Simonneau, Alice Huertas, Yuichi Tamura, Marc Humbert, Christophe Guignabert
PA4901
CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension Latha Ramakrishnan (LONDON, United Kingdom), Latha Ramakrishnan, Sharon Mumby, John S. Wort, Gregory J. Quinlan
PA4902
Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Beatriz Ballester (Burjassot (Valencia), Spain), Beatriz Ballester, Javier Milara, Anselm Morell, Sonia Contreras, Adela Serrano, Sonia González, Julio Cortijo
PA4903
Balancing TGFbeta/BMP in pulmonary arterial hypertension Nina Rol (Amsterdam, Netherlands), Nina Rol, Robert Szulcek, Marie-José Goumans, Chris Dickhoff, Anton VonkNoordegraaf, Harm Jan Bogaard, Geerten Van Nieuw Amerongen
PA4904
Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction? Priscilla Henno (Paris, France), Priscilla Henno, Christelle Maurey, Françoise Le Pimpec-Barthes, Philippe Devillier, Christophe Delclaux, Dominique Israël-Biet
PA4905
Cystic fibrosis transmembrane conductance regulator and sphingolipids regulate hypoxic pulmonary vasoconstriction Christoph Tabeling (Berlin, Germany), Christoph Tabeling, Hanpo Yu, Liming Wang, Hannes Ranke, Neil M. Goldenberg, Diana Zabini, Elena Noe, Adrienn Krauszman, Birgitt Gutbier, Jun Yin, Michael Schaefer, Christoph Arenz, Andreas C. Hocke, Norbert Suttorp, Richard L. Proia, Martin Witzenrath, Wolfgang M. Kuebler
PA4906
Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension Claudio Schuoler (Zurich, Switzerland), Claudio Schuoler, Thomas Haider, Caroline Leuenberger, Max Gassmann, Malcolm Kohler, Lars Huber, Matthias Brock
311
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA4907
Time-resolved study of endothelial shear-responsiveness in pulmonary arterial hypertension Robert Szulcek (Amsterdam, Netherlands), Robert Szulcek, Chris Happe, Nina Rol, Ruud Fontijn, Chris Dickhoff, Frances De Man, Anton Vonk-Noordegraaf, Christophe Guignabert, Paul Yu, Geerten Van Nieuw Amerongen, Harm-Jan Bogaard
PA4908
The inflammasome adaptor ASC mediates pulmonary artery remodelling Fadila Telarevic Cero (Oslo, Norway), Fadila Telarevic Cero, Karl Otto Larsen, Vigdis Hillestad, Maria Belland Olsen, Camilla Udjus, Ivar Sjaastad, Arne Yndestad, Pål Aukrust, Else Marit Løberg, Geir Christensen, Ole Henning Skjønsberg
PA4909
Tryptophan hydroxylase-1 inhibitors reduce serotonin levels and mast cell numbers in monocrotaline-treated rat lungs William, Zavadoski (New Haven, United States of America), William Zavadoski, Patricia-Ann Bourassa, Nicole Barucci, Qing Zhang, Stephane De Lombaert, Daniel Goldberg, Jeffrey Dubins, Vishwas Paralkar, Robert Aiello
PA4910
Temporal hemodynamic and histological changes in a rat model of SUGEN-induced PAH Vincent Girod (Marseille, France), Vincent Girod, Audrey Bourdet, Sandra Robelet, Adeline Bouzereau, Delphine Revy
PA4911
Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells David Smadja (paris, France), David Smadja, Marilyne Levy, Lan Huang, Elisa Rossi, Dominique Israel-Biet, Pascale Gaussem, Joyce Bischoff
PA4912
Caspase inhibition stabilizes progressive vascular remodeling in established pulmonary hypertension Chris Happé (Amsterdam, Netherlands), C.M. Happé, R. Szulcek, N. Rol, M.A. De Raaf, I. Schalij, A. Vonk-Noordegraaf, F.S. De Man, G.P. Van Nieuw-Amerongen, H.J. Bogaard
PA4913
Effects of apoptosis signal- regulating kinase 1 (ASK1) inhibition in experimental pressure overload-induced right ventricular dysfunction Mario Boehm (Giessen, Germany), Mario Boehm, Baktybek Kojonazarov, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Norbert Weissmann, John T. Liles, Grant R. Budas, Werner Seeger, Ralph T. Schermuly
PA4914
Selective TSC1 deletion in smooth muscle activates mTOR signaling and induces pulmonary hypertension Amal HOUSSAINI (Evry, France), Amal Houssaini, Shariq Abid, Geneviève Derumeaux, Feng Wan, Aurélien Parpaleix, Dominique Rideau, Elisabeth Marcos, Kanny Kebe, Gabor Czibik, Diago Sawaki, Caroline Trains, Jean-Luc Dubois-Randé, Zhenlin Li, Valérie Amsellem, Larissa Lipskaia, Mario Pende, Serge Adnot
PA4915
Role of the TrkA receptor in experimental severe pulmonary hypertension Florence Coste (Bordeaux, France), Florence Coste, Christian Toussaint, Mathilde Dubois, Arnaud Courtois, Christelle Guibert, Roger Marthan, Jean-Pierre Savineau, Bernard Muller, Véronique Michel
Room 7.1
Session 512
10:45 - 12:45
Hot topics: Lung cancer pathology The new 2015 WHO classification and genetic heterogeneity Aims : To present the 4th edition of the WHO classification of tumours of the lung. It covers clinical, radiological, macroscopic, histological, immunohistochemical, molecular pathological, and genetic aspects of the different tumour types. The features of the main tumour types will be presented by eminent European pathologists who were co-authors of this new classification: adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumours. Track(s) : Oncology Tag(s) : Translational Target audience : Pulmologists, oncologists, pneumologic oncologists, oncologic pneumologists, thoracic surgeons, radiologists, radiotherapists, pathologists, molecular (genetic) biologists, study nurses and trainees. Chairs : Sam Janes (London, United Kingdom), Chair to be confirmed 10:45
A new WHO classification for lung cancer after 11 years: clinical implications Speaker to be confirmed
4928
11:15
Adenocarcinoma Elisabeth Brambilla (Grenoble, France)
4929
11:45
Squamous cell carcinoma Joanna Domagala-Kulawik (Warsaw, Poland)
4930
12:15
Neuroendocrine tumours Philipp A. Schnabel (Homburg/Saar, Germany)
4931
Room Auditorium
Session 513
Hot topics: Latent tuberculosis infection
312
10:45 - 12:45
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 Aims : To describe and present data showing the level of implementation of the LTBI management activities of a programme, present a baseline evaluation of the extent of ongoing activities, with a focus on major challenges and opportunities and discuss the requirements of a standardised LTBI monitoring, evaluation plan and the relevant tools. Track(s) : Infection Target audience : Clinicians and public health practitioners working on TB, and policy makers responsible for national tuberculosis control activities. Chairs : Haileyesus Getahun (Geneva, Switzerland), Graham H. Bothamley (London, United Kingdom) 10:45
LTBI management: theory and practice Giovanni Sotgiu (Porto Torres, Italy)
4932
11:15
Policies and practices on LTBI management: global WHO survey Yohhei Hamada (Geneva, Switzerland)
4933
11:45
Monitoring and evaluation of LTBI activities: country experience in UK Ibrahim Abubakar (London, United Kingdom)
4934
12:15
Monitoring and evaluation of LTBI management Alberto Matteelli (Geneva, Switzerland)
4935
Room 7.2
Session 514
10:45 - 12:45
Hot topics: Risk factors and early origins of respiratory diseases Aims : To describe how maternal complications and conditions in pregnancy and in the perinatal period can affect respiratory health in childhood, the causal role of these factors and the non-causal role of the various confounding factors that explain these associations and how early life risk factors may affect the development of chronic pulmonary obstructive disease in adults. Track(s) : Paediatric Epidemiology/Environment Target audience : Clinicians and epidemiologists who have an interest in lung development, asthma, and chronic obstructive pulmonary disease. Chairs : Claudia Kuehni (Bern, Switzerland), Fabio Midulla (Rome, Italy) 10:45
Pregnancy complications and respiratory problems in childhood Franca Rusconi (Florence, Italy)
4936
11:15
Mode of delivery or early life antibiotics and the risk of asthma in studies using sibling design Catarina Almqvist Malmros (Stockholm, Sweden)
4937
11:45
Early life risk factors and chronic pulmonary obstructive disease: is the evidence enough? Stefano Guerra (Tucson, United States of America)
4938
12:15
Antibiotics in pregnancy: do they increase the risk of wheezing and asthma in childhood? Hans Bisgaard (Copenhagen, Denmark)
4939
Room Elicium 2
Session 515
10:45 - 12:45
Symposium: Inhaled drugs: within and beyond the lungs Aims : An ERS/ISAM society joint session. This session will showcase the latest developments in inhalation medicine and cutting-edge aerosol science. The audience will hear the experiences of patients with respiratory disease and the impact inhalers have on their lives; learn about the efficiency with which new inhaler devices and nebulisers treat asthma and COPD; appreciate the influence of psychological and behavioural factors on patient non-adherence to inhaled therapy; and be aware of the novel developments in aerosol science that utilise the lungs as a portal for systemic drug delivery. Tag(s) : Translational Target audience : Multidisciplinary professionals involved in aerosol science and drug delivery to the lungs, including doctors, nurses, physiotherapists, psychologists, scientists, and general respiratory healthcare professionals involved in inhalation medicine. Chairs : Sunalene Devadason (Subiaco, Australia), Omar Usmani (London, United Kingdom) 10:45
Living with inhalers: perspectives from the patient and the parent Eddie Judd (London, United Kingdom), Silvia van Engelen (Amsterdam, Netherlands)
4940
11:15
New inhaler devices: the good, the bad, and the ugly Federico Lavorini (Florence, Italy)
4941
11:45
Achieving the impossible? Device adherence and competence Cynthia S. Rand (Baltimore, United States of America)
4942
313
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 12:15
Delivering drugs to the body through the lungs Bruce K Rubin (Winston-Salem, United States of America)
Room 4.2
Session 516
4943
10:45 - 12:45
Symposium: Long-term non-invasive ventilation (NIV) in COPD New randomised studies and future implications Aims : To discuss the controversial topic of NIV for the long-term treatment of COPD patients in terms of the recent results that were generated by randomised controlled studies. These results may change our treatment strategy for these patients in the future. Track(s) : Intensive care Tag(s) : Clinical Target audience : Clinicians, physicians, intensivists, nurses, physiotherapists and respiratory therapists. Chairs : Mark W. Elliott (Leeds, United Kingdom), Thomas Koehnlein (Leipzig, Germany) 10:45
New RCTs evaluating NIV in stable hypercapnic COPD Michael Dreher (Aachen, Germany)
4944
11:15
NIV for preventing hospital admissions for COPD exacerbations Raffaele Scala (Arezzo, Italy)
4945
11:45
NIV after acute exacerbation of COPD: results from the Dutch multicentre study Peter J. Wijkstra (Groningen, Netherlands)
4946
12:15
Telemedicine in ventilated COPD patients: concept for the future? Michele Vitacca (Gussago, Italy)
4947
Room 5.2
Session 517
10:45 - 12:45
Session: FIRS and Global Lung Health Aims : ERS is a member of the Forum for International Respiratory Societies (FIRS), which is seeking to increase awareness regarding lung health at a global level. Global Lung Health depends on better control of both communicable and non-communicable diseases. This symposium will highlight some of the important aspects of lung health. One presentation will describe the major threat that is imposed by childhood pneumonia and TB in large parts of the world, while the presentation on global COPD will show that poverty is a strong predictor of poor lung health. By attending this symposium, the audience will gain further insights into the concept of Global Lung Health. Target audience : All respiratory healthcare professionals who are interested in global health. Chairs : Jørgen Vestbo (Manchester, United Kingdom), María Montes de Oca (Caracas, Venezuela) 10:45
Introduction: FIRS and Global Lung Health Jørgen Vestbo (Manchester, United Kingdom)
4948
11:00
Childhood pneumonia: still a major threat Heather Joy Zar (Johannesburg, South Africa)
4949
11:30
Global COPD: the impact of poverty Peter Burney (London, United Kingdom)
4950
12:00
TB: the old enemy Francesco Blasi (Milan, Italy)
4951
12:30
Discussion
4952
Room Elicium 1
Session 518
10:45 - 12:45
Oral Presentation: Dyspnoea and respiratory muscle mechanics dysfunction in disease Chairs : Nick Hopkinson (London, United Kingdom), Luis Puente Maestu (Madrid, Spain)
OA4953
LATE-BREAKING ABSTRACT: Stability of cardiopulmonary exercise testing’s parameters in a three years follow up Fernanda Rodrigues (Leuven, Belgium), Fernanda Maria Machado Rodrigues, Heleen Demeyer, Miek Hornikx, Carlos Augusto Camillo, Hans Van Remoortel, Matthias Loeckx, Wim Janssens, Thierry Troosters
OA4954
Neural correlates of dyspnea in COPD Roland Esser (Hamburg, Germany), Roland W. Esser, M. Cornelia Stoeckel, Anne Kirsten, Henrik Watz, Kirsten Lehmann, Karin Taube, Christian Büchel, Helgo Magnussen, Andreas Von Leupoldt
314
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
OA4955
Respiratory muscle recruitment during mechanical ventilation: Effects of ventilator settings Lisanne Roesthuis (Nijmegen, Netherlands), Lisanne H. Roesthuis, Jonne Doorduin, Johannes G. Van der Hoeven, Leo M.A. Heunks
OA4956
Non invasive ventilation during exercise prevents quadriceps fatigue in severe COPD patients pierre labeix (Saint Etienne, France), Pierre Labeix, Mathieu Berger, Frederic Costes
OA4957
Reliability of diaphragm ultrasound to detect diaphragm dysfunction in critically ill patients Bruno-Pierre Dube (Montreal, Canada), Bruno-Pierre Dubé, Martin Dres, Hélène Prodanovic, Julien Mayaux, Julie Delemazure, Thomas Similowski, Alexandre Demoule
OA4958
Small airways dysfunction in chronic thromboembolic pulmonary hypertension Mitja Jevnikar (Trieste, Italy), Mitja Jevnikar, Laurent Godinas, Xavier Jaïs, Olivier Sitbon, Marc Humbert, Gérald Simonneau, Pierantonio Laveneziana, Gilles Garcia
OA4959
Dynamic hyperinflation impairs cardiac performance during maximal exercise test in COPD Vinicius Zacarias da Silva (Brasilia, Brazil), Vinicius Silva, Murillo Frazao, Paulo Eugenio Silva
OA4960
The contribution of each hemidiaphragm to the overall inspiratory strength in healthy subjects and unilateral diaphragmatic paralysis Mayra Caleffi Pereira (Sao Paulo, Brazil), Mayra Caleffi Pereira, Letícia Zumpano Cardenas, André Apanavicius, Renata Pletsch, Pauliane Vieira Santana, Vinicius C. Iamonti, Carlos Roberto Ribeiro de Carvalho, Pedro Caruso, André Luis Pereira de Albuquerque
Room Forum
Session 519
10:45 - 12:45
Oral Presentation: IPF: clinical aspects II Chairs : Sara Tomassetti (Forli, Italy), Elisabetta Renzoni (London, United Kingdom) OA4961
Scoring system predicting for elevation of MPAP in IPF taiki furukawa (seto, Japan), Taiki Furukawa, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama, Mitsuaki Yagi
OA4962
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Julie Morisset (San Francisco, United States of America), Julie Morisset, Brett M. Elicker, Xiaowen Hu, Stephanie Le, Jay H. Ryu, Kirk D. Jones, Brett Ley, Paul J. Wolters, Talmadge E. King, Harold R. Collard, Joyce S. Lee
OA4963
Drug-associated acute respiratory distress syndrome: A prospective observational cohort study Keisuke Anan (Iizuka, Japan), Keisuke Anan, Kazuya Ichikado, Kodai Kawamura, Masakazu Yoshioka
OA4964
Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us? Ian Glaspole (Footscray, Australia), Ian Glaspole, Nicole Goh, Peter Hopkins, Yuben Moodley, P.N. Reynolds, E.H Walters, Christopher Zappala, Heather Allan, Sally Chapman, Wendy Cooper, Samantha Ellis, Annabelle Mahar, Heather Chaplin, Robert Henson, Sacha Macansh, Sarah Richards, Susan E. Smith, Karen Symons, Eldho Paul, Tamera Corte
OA4965
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Juergen Behr (München, Germany), Jürgen Behr, Hubert Wirtz, David Pittrow, Marius Hoeper, Dirk Koschel, Stefan Andreas, Jens Klotsche, Martin Claussen, Christian Grohé, Michael Kreuter
OA4966
PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosis Atsushi Suzuki (Seto, Aichi, Japan), Atsushi Suzuki, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama, Masahiko Ando
OA4967
A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Ermanno Puxeddu (Rome, Italy), Ermanno Puxeddu, Gabirella Pezzuto, Marco Pallante, Josuel Ora, Angelo Coppola, Alessia Mari, Silvia Portalone, Francesco Cavalli, Giuseppe Liotta, Leonardo Palombi, Cesare Saltini
OA4968
Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns David Bennett (Siena, Italy), David Bennett, Elena Bargagli, Antonella Fossi, Gloria Bettini, Maria Pieroni, Rosa Metella Refini, Maria Antonietta Mazzei, Paola Rottoli
Room 5.1
Session 520
Oral Presentation: Best abstracts in functional capacity in chronic lung diseases Chairs : Pierantonio Laveneziana (Paris, France), Jose Alberto Neder Serafini (Kingston, Canada)
315
10:45 - 12:45
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
OA4969
Physical and psychological impairments in COPD patients with and without reduced left ventricular ejection fraction Rafael Mesquita (Maastricht, Netherlands), Rafael Mesquita, Frits M.E. Franssen, Sarah Wilke, Nicole H.M.K. UszkoLencer, Tim Berendsen, Fabio Pitta, Emiel F.M. Wouters, Martijn A. Spruit
OA4970
Effects of supplemental oxygen vs. room air in COPD patients: A randomized placebo-controlled trial Inga Heinzelmann (Schonau am Konigssee, Germany), Inga Heinzelmann, Rainer Gloeckl, Merve Diril, David Buhrow, Andreas Jerrentrup, Klaus Kenn
OA4971
Benefits of supplemental oxygen on exercise capacity in IPF patients with exercise-induced hypoxemia Shinichi Arizono (Hamamatsu/Shizuoka, Japan), Shinichi Arizono, Hiroyuki Taniguchi, Koji Sakamoto, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Jun Hirasawa, Ryo Kozu
OA4972
Impact of lung resection surgery on peak oxygen uptake (VO2peak) and muscle strength in non-small cell lung cancer patients (NSCLC) Monique MESSAGGI SARTOR (Barcelona, Spain), Monique Messaggi-Sartort, Sandra Chiarella, Albert Rodríguez, Elisabeth Martínez, Carolina Palomares, Josep Mª Muniesa, Rosa Mª Güell, Ester Marco
OA4973
Gait Speed as a predictor of mortality in COPD Samantha Kon (Buckinghamshire, United Kingdom), Samantha Kon, Jane Canavan, Susie Schofield, Winston Banya, Sarah Jones, Claire Nolan, Michael Pokley, Paul Cullinan, William Man
OA4974
Differences in training response between patients with alpha-1 antitrypsin deficiency and COPD patients Inga Heinzelmann (Schonau am Konigssee, Germany), Inga Heinzelmann, Sebastian Gehlert, Tobias Welte, Wilhelm Bloch, Sabina Janciauskiene, Klaus Kenn
OA4975
Simple functional performance tests as predictors of clinical outcomes in COPD Sarah Crook (Zurich, Switzerland), Sarah Crook, Anja Frei, Tsung Yu, Gerben Ter Riet, Milo Puhan
OA4976
Functionally relevant cut-point for isometric quadriceps muscle strength in patients with COPD Jane Canavan (Harefield, United Kingdom), Jane L. Canavan, Matthew Maddocks, Claire M. Nolan, Sarah E. Jones, Samantha S.C. Kon, Amy L. Clark, Michael I. Polkey, William D.-C. Man
Room 13.1
Session 521
10:45 - 12:45
Oral Presentation: New frontiers in biomedical research on thoracic tumours Chairs : Rainer G. Wiewrodt (Münster, Germany), Chair to be confirmed OA4977
NRAS mutations destine tumor cells to the lungs Anastasios Giannou (Patras, Greece), Anastasios D. Giannou, Theodora Agalioti, Nikolaos Kanellakis, Dimitra E. Zazara, Ioannis Lilis, Georgios T. Stathopoulos
OA4978
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Changhui Wang (Shanghai, China), Shuanshuan Xie, Changhui Wang, Min Tan, Xiaolian Song
OA4979
Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter Nikolaos Kanellakis (Patras, Greece), Nikolaos I. Kanellakis, Theodora Agalioti, Dimitra Zazara, Ioannis Lilis, Ioanna Giopanou, Malamati Vreka, Magda Spella, Antonia Marazioti, Georgios T. Stathopoulos, Anastasios D. Giannou
OA4980
An airway epithelial origin for tobacco carcinogen-induced lung adenocarcinoma Magda Spella (Patras, Greece), Magda Spella, Dimitra Zazara, Ioannis Lilis, Malamati Vreka, Antonia Marazioti, Ioanna Giopanou, Vassilis Aidinis, Georgios T. Stathopoulos
OA4981
Met amplification induces an aggressive phenotype in EGFR tyrosine kinase inhibitors resistant non-small-cell lung cancer Simon Baldacci (Lille, France), Simon Baldacci, Zoulika Kherrouche, Luc Stoven, Elisabeth Werkmeister, Nathalie Marchand, David Tulasne, Alexis Cortot
OA4982
A role for cAMP-responsive element binding protein in lung adenocarcinoma Antonia Marazioti (Rio, Patras, Greece), Antonia Marazioti, Nikolitsa Spiropoulou, Ioannis Lilis, Anastasios Giannou, Malamati Vreka, Nikolaos Kanellakis, Marianthi Iliopoulou, Theodora Agalioti, Magda Spella, Georgios Stathopoulos
OA4983
Placenta-derived conditioned medium with anti-tumor properties on human NSCLC Dagmar Lang (Großhansdorf, Germany), Dagmar S. Lang, Sebastian Marwitz, Tobias Zeiser, Sophie Seehase, Iris Watermann, Ekkehard Vollmer, Martin Reck, Peter Zabel, Torsten Goldmann
316
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
OA4984
LATE-BREAKING ABSTRACT: Lung tumor cell migration and metastasis formation is conversely regulated by transmembrane and cytoplasmic syndecan-1 cleavage fragments Andreas Ludwig (Aachen, Germany), Tobias Pasqualon, Aaron Babendreyer, Ester Groth, Julian Schumacher, Daniela Dreymueller, Andreas Ludwig
Room 2.1
Session 522
10:45 - 12:45
Oral Presentation: CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Chairs : Aleksandar Grgic (Homburg/Saar, Germany), Johan Coolen (Leuven, Belgium) OA4985
Parametric response mapping of COPD phenotypes: A COPDGene study Craig Galban (Ann Arbor, United States of America), Craig Galban, Ryan Chamberlain, Benjamin Hoff, Timothy Johnson, Ella Kazerooni, Fernando Martinez, Brian Ross, David Lynchg, Meilan Han
OA4986
Chest CT scans obtained in multicentre clinical routine assessments are sufficient to develop a prediction function for emphysema from lung function Rudolf A Jörres (Munich, Germany), Rudolf A. Jörres, Frank Biertz, Charlotte Vogel, Hans-Ulrich Kauczor, Jürgen Biederer, Bertram Jobst, Joachim Heinrich, Armin Koch, Henrik Watz, Tobias Welte, Claus Vogelmeier
OA4987
Computed tomography for evaluation of the small airway disease in asthma Leonello Fuso (Rome, Italy), Leonello Fuso, Carola Condoluci, Emanuele Conte, Giulia Angeletti, Chiara Contu, Giuseppe Macis, Martina Sbarra, Paolo Montuschi, Salvatore Valente 18
OA4988
F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD Gourab Choudhury (Edinburgh, United Kingdom), Gourab Choudhury, Alison Fletcher, Martin Connell, Tim Clark, Susie Ferguson, Brandon Whitcher, Iain Kilty, Vennart William, Edwin J.R. VanBeek, MacNee William
OA4989
18F-Fluorodeoxyglucose (18FDG) PET pulmonary imaging: Role in detecting vascular inflammation Gourab Choudhury (Edinburgh, United Kingdom), Janice Wong, Alex Vesey, Susie Ferguson, Alison Fletcher, Tim Clark, Martin Connell, Brandon Whitcher, Iain Kilty, William Vennart, Edwin J.R. Van Beek, William MacNee, Gourab Choudhury
OA4990
MRI-derived regional pulmonary perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy Christian Schönfeld (Hannover, Germany), Christian Schönfeld, Serghei Cebotari, Jan Hinrichs, Julius Renne, Till Kaireit, Marcel Gutberlet, Andreas Voskrebenzev, Marius Hoeper, Karen Olsson, Tobias Welte, Frank Wacker, Axel Haverich, Jens Vogel-Clausen
OA4991
Lobar comparison of CT densitometry and 3He diffusion MRI models of lung microstructure in asthmatics Ho-Fung Chan (Sheffield, United Kingdom), Ho-Fung Chan, Juan Parra-Robles, Chris Brightling, Wim Vos, Jim Wild
OA4992
Hyperpolarised gas MR lung imaging – Breaks through to clinical practice J.M. Wild (Sheffield, United Kingdom), Jim Wild, Laurie Smith, Felix Horn, Guilhem Collier, Andrew Swift, Neil Stewart, Madhwesha Rao, Graham Norquay, David Hughes, Kelechi Ugonna, Helen Marshall
Room 4.1
Session 523
10:45 - 12:45
Oral Presentation: Pulmonary hypertension: new treatment insights Chairs : Marc Humbert (Paris, France), H. Ardeschir Ghofrani (Giessen, Germany)
OA4993
LATE-BREAKING ABSTRACT: Pulmonary vascular effects after pulsed inhaled NO evaluated by functional respiratory imaging (FRI) Bita Hajian (Amsterdam, Netherlands), Bita Hajian, Francisca Ferreira, Wim Vos, Jan De Backer, Cedric Van Holsbeke, Douglas Greene, Reinilde Heyrman, Wilfried De Backer
OA4994
Initial combination therapy with ambrisentan (AMB) and tadalafil (TAD) in treatment naïve patients with pulmonary arterial hypertension (PAH): Efficacy and safety in the AMBITION study intent to treat (ITT) population Marius M. Hoeper (Hannover, Germany), Marius Hoeper, Nazzareno Galie, Joan Albert Barbera, Adaani Frost, Ardeschir Ghofrani, Valerie McLaughlin, Andrew Peacock, Gerald Simonneau, Jean-Luc Vachiery, Christiana Blair, Hunter Gillies, Julia Harris, Jon Langley, Lewis Rubin
OA4995
Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results Olivier Sitbon (Le Kremlin Bicêtre, France), Olivier Sitbon, Richard Channick, Kelly Chin, Aline Frey, Nazzareno Galiè, Hossein-Ardeschir Ghofrani, Marius M. Hoeper, Irene Lang, Franck-Olivier Le Brun, Vallerie McLaughlin, Ralph Preiss, Lewis J. Rubin, Gérald Simmonneau, Victor Tapson, Sean Gaine
317
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
OA4996
Upfront combination therapy in the treatment of scleroderma-associated pulmonary arterial hypertension: Results of an open label trial Paul M. Hassoun (Baltimore, United States of America), Paul Hassoun, Roham Zamanian, Rachel Damico, Rubina Khair, Todd Kolb, Ryan Tedford, Olivia Hulm, Chiara Pisanello, Takahiro Sato, Cecilia Corona-Villalobos, Stefan Zimmerman, Mohamed Gashouta, Omar Minai, Fernando Torres, Kelly Chin, Reda Girgis, Stephen Mathai
OA4997
Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Denielli Bos (Amsterdam, Netherlands), Denielli Da Silva Goncalves Bos, Chris Happé, Ingrid Schalij, Wioletta Pijacka, Julian F. Paton, Harm-Jan Bogaard, Nico Westerhof, Albertus C. Van Rossum, Anton Vonk-Noordegraaf, Frances S. De Man, M. Louis Handoko
OA4998
Long-term outcome of sarcoidosis-associated pulmonary hypertension in the modern treatment era Athénaïs Boucly (Paris, France), Athénaïs Boucly, Xavier Jaïs, Caroline Sattler, Andrei Seferian, David Amar, David Montani, Gerald Simonneau, Marc Humbert, Olivier Sitbon, Laurent Savale
OA4999
Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry Michael Halank (Dresden, Germany), Michael Halank, Marc Humbert, Miguel-Angel Gomez Sanchez, David Pittrow, Marius Hoeper, Ekkehard Grünig, H. Ardeschir Ghofrani, Hubert Wirtz, Hans Klose, Ralf Ewert, Tobias J. Lange, Jens Klotsche, Christian Meier, Monika Brunn, Gerald Simonneau
OA5000
Pulmonary hypertension due to lung disease – Results from COMPERA Ekkehard Grünig (Heidelberg, Germany), Ekkehard Grünig, Doerte Huscher, David Pittrow, Dario Vizza, Marius M. Hoeper
Room Emerald
Session 524
10:45 - 12:45
Oral Presentation: Emerging technologies for malignant pleural diseases management Chairs : Nick Maskell (Bristol, United Kingdom), Charlotte Leduc (Strasbourg, France)
OA5001
LATE-BREAKING ABSTRACT: Host-environmental IL-1ß drives mutant KRAS-IKKa addiction in malignant pleural effusion Antonia Marazioti (Rio, Patras, Greece), Antonia Marazioti, Malamati Vreka, Anastasios Giannou, Theodora Agalioti, Nikolaos Kanellakis, Magdalini Spella, Ioanna Giopanou, Georgios Stathopoulos
OA5002
Volatile organic compounds increase the likelihood of detecting malignant pleural mesothelioma Kevin Lamote (Gent, Belgium), Kevin Lamote, Matthijs Vynck, Joris Van Cleemput, Olivier Thas, Kristiaan Nackaerts, Jan P. Van Meerbeeck
OA5003
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study Giulia Stella (Pavia, Italy), Giulia Stella, Emanuela Cova, Simona Inghilleri, Davide Piloni, Miriam Colombo, Simona Mrakic-Sposta, Laura Pandolfi, Angelo Corsico, Ymera Pignochino, Davide Prosperi, Patrizia Morbini, Federica Meloni
OA5004
Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion Kunlin Li (Chongqing, China), Kun-lin Li, Jun Kang, Li Li, Yu-bo Wang, Yong He
OA5005
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Elisa Roca (Rezzato, BS, Italy), Elisa Roca, Romaric Lacroix, Coralie Judicone, Sophie Laroumagne, Stephane Robert, Sylvie Cointe, Alexandre Muller, Elise Kaspi, Patrice Roll, Alain Brisson, Claudio Tantucci, Philippe Astoul, Françoise Dignat-George
OA5006
Implication of adamalysin proteases in mesothelioma Christelle Sepult (Liège, Belgium), Christelle Sepult, Natacha Rocks, Sandrine Bekaert, Kim Donati, Bernard Duysinx, Agnes Noel, Didier Cataldo
OA5007
Activated KRAS signaling triggers malignant pleural effusion Theodora Agalioti (Patras, Greece), Theodora Agalioti, Anastasios Giannou, Antonia Marazioti, Nikolaos Kanellakis, Magda Spella, Ioannis Lillis, Dimitra Zazara, Konstantina Papadia, Sofia Antimisiaris, Dimitrios Kardamakis, Georgios Stathopoulos
OA5008
MET genetic lesion in pleural tumor of unknown primary origin. A preliminary report Giulia Stella (Pavia, Italy), Giulia Stella, Silvia Benvenuti, Alessandra Gentile, Michele Zorzetto, Simona Inghilleri, Patrizia Morbini, Federica Meloni
Room E104-106
Session 525
Poster Discussion: Is asthma always an easy disease to diagnose and manage? Chairs : Andreina Bruno (Palermo, Italy), Chair to be confirmed
318
10:45 - 12:45
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 PA5009
Early- and late-onsets of severe asthma are associated with divergent phenotypes of the disease Laure Folliet (Lyon, France), Laure Folliet, Nathalie Freymond, Yves Pacheco, Gilles Devouassoux
PA5010
Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Ji Young Yhi (Seoul, Republic of Korea), Ji Young Yhi, Tae-Hyung Kim, Yeon-Mok Oh, Kwang Ha Yoo, Ji-Hyun Lee
PA5011
Drug loaded liposomes of mesalamine incorporated into disease responsive microgels (Micro) for treating allergic asthma: An approach using smart drug delivery system Rama Satyanarayana Raju (Udhagamandalam, India), Rama Satyanarayana Raju, M.N. Sathish Kumar, Elango Kannan, Nilesh S. Ambhore, Shashank Mulukutla, K. Gowthamarajan
PA5012
Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients Fernando Gutierrez Pereyra (Barcelona, Spain), Fernando Gutiérrez-Pereyra, Vicente Plaza, Concepción FernándezRodríguez, Carlos Melero, Borja G. Cosío, Luis Manuel Entrenas, Luis Pérez de Llano, Eduard Tarragona, Rosa Palomino, Antolín López-Viña
PA5013
A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country Sy Duong-Quy (Da Lat, Vietnam), Sy Duong-Quy, Thong Hua-Huy, Nhu Doan-Quynh, Bao Nguyen-Quoc, Khiet LeQuang, Dinh Tran-Thanh, Jean-Paul Homasson, Anh-Tuan Dinh-Xuan
PA5014
Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Wu Lihua (Chengdu City, China), Li-Hua Wu, Juan-Juan Fu, Guan-Hong Li, Bo Qu, Bing Mao
PA5015
Limitation of life activities in disabled asthma patients Svitlana S Panina (Dniepropetrovsk, Ukraine), Svitlana Panina, Nataliia Sanina, Nataliia Gondulenko, Tetyana Igumnova
PA5016
Best practices in integrating home spirometer measurements with electronic clinical outcome assessments (eCOA) in clinical trials Jessica Thilaganathan (London, United Kingdom), Jessica Thilaganathan, Antti Heikkila, Juha Matero, Katie Garner
PA5017
Correlation among functional respiratory parameters and disease control in asthma Leonello Fuso (Rome, Italy), Carola Condoluci, Emanuele Conte, Giulia Angeletti, Chiara Contu, Leonello Fuso
PA5018
Adherence to the treatment of patients with bronchial asthma Larisa V. Bogovin (Blagoveshchensk, Amur reg., Russian Federation), Larisa V. Bogovin, Anastasia S. Shabanova, Victor P. Kolosov, Juliy M. Perelman
PA5019
Inhalation technique education and its impact in asthma and COPD Luis Miguel Vaz Rodrigues (Guarda, Portugal), Tiago Maricoto, Sofia Madanelo, Luís Rodrigues, Gilberto Teixeira, Carla Valente, Lília Andrade, Alcina Saraiva
PA5020
Overlap phenotypes of asthma in adults: Obesity and atopy Jing Zheng (Chengdu, China), Jing Zhen, Rui Liang, Honglin Li, Lei Wang, Gang Wang
PA5021
Identification and validation of asthma phenotypes in Chinese population using cluster analysis Jing Zheng (Chengdu, China), Jing Zheng, Rui Liang, Ting Zhou, Lei Wang, Gang Wang
PA5022
Factors associated with the length of hospital stay in patients with acute exacerbations of asthma and COPD overlap syndrome Juan-juan Fu (Chengdu, China), Juan-Juan Fu, Li-Hua Wu, Bo Qu, Guan-Hong Li, Bing Mao
PA5023
Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices Fernando Gutierrez Pereyra (Barcelona, Spain), Fernando Gutiérrez-Pereyra, Vicente Plaza, Antolín López-Viña, Luis Manuel Entrenas, Concepción Fernández-Rodríguez, Carlos Melero, Eduard Tarragona, Rosa Palomino, Borja G. Cosío
PA5024
Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma Jenna O'Sullivan (Cork, Ireland), Jenna O’Sullivan, Liam Chawke, Deirdre Fitzgerald, David Curran, Terry O’Connor
PA5025
Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices Sunee Lertsinudom (Khon Kaen, Thailand), Sunee Lertsinudom, Kesarin Choopunyalert, Suratsawadee Jindajumnong
PA5026
The influence of smoking on health related quality of life in asthmatics Juliy Perelman (Blagoveshchensk, Amur Oblast, Russian Federation), Natalia L. Perelman, Victor P. Kolosov, Juliy M. Perelman, Svetlana V. Naryshkina
Room G102-103
Session 526
Poster Discussion: Advances from translational research in respiratory infections
319
10:45 - 12:45
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 Chairs : Stefan Krueger (Düsseldorf, Germany), Pieter Goeminne (Bornem, Belgium)
PA5027
LATE-BREAKING ABSTRACT: Effect of vitamin D on inflammatory and antibacterial responses to cigarette smoke Nele Heulens (Oplinter, Belgium), Nele Heulens, Hannelie Korf, Karen Maes, Elien De Smidt, Conny Gysemans, Ghislaine Gayan-Ramirez, Chantal Mathieu, Wim Janssens
PA5028
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Marian Garcia-Nuñez (Sabadell, Spain), Marian Garcia-Nuñez, Sara Marti, Carmen Puig, Vicente Perez-Brocal, Laura Millares, Fina Liñares, Eduard Monso
PA5029
T and B lymphocytes, NK-cells, dendritic cells, mast cells and foxp3+ cells in lung tissue of severe Influenza A (H1N1)pdm infection Monique Buttignol (São Bernardo Do Campo, Brazil), Monique Buttignol, Ruy Pires-Neto, Marina Ballarin, Marisa Dolhnikoff, Thais Mauad
PA5030
Management of patients with an inadequate haemophilus influenzae type b antibody response Helen Davies (Cardiff, United Kingdom), S.M. White, H.E. Davies
PA5031
Decreased regulation of lung CD8+ T cells by virally-infected macrophages in COPD: Role of PD1/PDL1 axis Tom Wilkinson (Southampton, United Kingdom), Karl J. Staples, Richard T. McKendry, Hannah Burke, Ben Nicholas, C. Mirella Spalluto, Tom M.A. Wilkinson
PA5032
Genetic determinants of oropharyngeal streptococci antimicrobial resistance in COPD patients and asthma sufferers Sergey Fedosenko (Tomsk, Russian Federation), Sergey Fedosenko, Ludmila Ogorodova, Elena Ilina
PA5033
Respiratory viruses can be isolated and identified from exhaled breath Alicia Mitchell (Naremburn, Australia), Alicia Mitchell, Francesca Tang, Qi Ge, Lucy Morgan, Brian Oliver
PA5034
Airway epithelial cells from asthmatic adults support elevated human metapneumovirus infection due to impaired apoptosis Engin Baturcam (Herston, Australia), Engin Baturcam, Tiong Han Yeo, Johanna Schagen, Natale Snape, Emma Thomas, Janine Di-Masi, Sally Galbraith, Simon Phipps, Emmanuelle Fantino, Peter Sly, Kirsten Spann
PA5035
Susceptibility to influenza virus infection in asthma biopsies and the effect of topical steroids Ben Nicholas (Southampton, United Kingdom), Ben Nicholas, Sarah Dudley, Kamran Tariq, Peter Howarth, Kerry Lunn, Sandy Pink, Phillip Monk, Ian Adcock, Ratko Djukanovic, The U-BIOPRED Study Group Listed at http://www.europeanlung.org/en/assets/micros
PA5036
Neutrophils are immuno-modulatory in rhinovirus infections Francesca Tang (Glebe, Australia), Francesca Tang, Philip Hansbro, Janette Burgess, Katherine Baines, Brian Oliver
PA5037
Different innate neutrophil responses in controlled and uncontrolled asthma Francesca Tang (Glebe, Australia), Francesca Tang, Gloria Foxley, Peter Gibson, Janette Burgess, Katherine Baines, Brian Oliver
PA5038
Protein tyrosine phosphatase 1B negatively regulates S100A9 mediated apoptosis during respiratory syncytial virus infection Robert Foronjy (Scarsdale, United States of America), Pius Ochieng, Edward Eden, Matthias Salathe, Abdoulaye Dabo, Nathalie Schmid, Michael Campos, Neville Cummins, Robert Foronjy, Patrick Geraghty
PA5039
Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients Anthony De Soyza (Newcastle upon Tyne, United Kingdom), Y.K. Hilliam, A. Perry, A.J. Hall, J. Davison, K.E. Walton, J. Fothergill, A. De Soyza, C. Winstanley
PA5040
The bacteriological incidence of lung abscess using clone library analysis of 16S rRNA gene in bronchoalveolar lavage Keisuke Naito (Fukuoka, Japan), Keisuke Naito, Shingo Noguchi, Kazuhiro Yatera, Kentarou Akata, Chinatsu Nishida, Kei Yamasaki, Takeshi Orihashi, Toshinori Kawanami, Hiroshi Ishimoto, Kazumasa Fukuda, Hatsumi Taniguchi, Hiroshi Mukae
PA5041
Induction of neutrophil extracellular traps (NETs) by the pneumococcal toxin, pneumolysin (Ply) Charles Feldman (Johannesburg, South Africa), Jan-Gert Nel, Annette Theron, Chrisna Durandt, Gregory Tintinger, Roger Pool, Timothy Mitchell, Ronald Anderson, Charles Feldman
PA5042
Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice Anne Dommaschk (Hannover, Germany), Anne Dommaschk, Nadine Ding, Lara Bittersohl, Gabriele Kirchhof, Tobias Welte, Ulrich Maus
PA5043
LSC Abstract – CD3bright T cells are early IL-17A-producers during acute pneumococcal infection maya hassane (lille, France), Maya Hassane
320
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA5044
LSC Abstract – Regulation of neutrophilic inflammation in community acquired pneumonia (winner of the LSC 2015 Best Oral Presentation Award) Ricardo José (London, United Kingdom), Ricardo José, Andrew Williams, Michal Sulikowski, David Brealey, Jeremy Brown, Rachel Chambers
Room G104-105
Session 527
10:45 - 12:45
Poster Discussion: Cellular and molecular mechanisms of COPD and emphysema Chairs : Ken Bracke (Ghent, Belgium), Juanita H.J. Vernooy (Maastricht, Netherlands)
PA5045
LSC Abstract – Chronic cigarette smoke (CS) exposure alters differentiation of primary bronchial epithelial cells, cultured at the air-liquid interface (PBEC-ALI) Jasmijn Schrumpf (Leiden, Netherlands), Jasmijn Schrumpf, Joris Veldkamp, Gimano Amatngalim, Tinne Mertens, Pieter Hiemstra
PA5046
Cigarette smoke reduces pro-resolving omega-6 metabolite production by cultured human primary bronchial epithelial cells Anne van der Does (Leiden, Netherlands), Anne Van der Does, Dick-Paul Kloos, Gimano Amatngalim, Christian Taube, Martin Giera, Pieter Hiemstra
PA5047
Cigarette smoke impairs basal cell mediated epithelial wound repair and induces expression of the antimicrobial protein RNase 7 via oxidative stress Gimano Amatngalim (Leiden, Netherlands), Gimano D. Amatngalim, Winifred Broekman, Nadia M. Daniel, Lucien E.P.M. Van der Vlugt, Pieter S. Hiemstra
PA5048
Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema Lisa Wolf (Homburg/Saar, Germany), Lisa Wolf, Julia Niederstraßer, Herr Christian, Bals Robert
PA5049
Role of chronic exposure to cigarette smoke on endoglin/CD105 expression in airway epithelium Rosalia Gagliardo (Palermo, Italy), Rosalia Gagliardo, Fabio Bucchieri, Angela M. Montalbano, Roberto Marchese, Giusy D. Albano, Francesca Rappa, Alberto Fucarino, Pietro Tralongo, Giulia Anzalone, Giuseppina Chiappara, Giuseppe Paglino, Mirella Profita
PA5050
The relation of cigarette smoking to increased extracellular matrix in the layer of airway smooth muscle Robyn Jones (Perth, Australia), Robyn Jones, John Elliot, Peter Noble, Peter MvFawn, James Hogg, Alan James
PA5051
Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD Eleni Papakonstantinou (Thessaloniki, Greece), Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, George Karakiulakis, Michael Roth, Michael Tamm, Daiana Stolz
PA5052
LSC Abstract – Alpha1-antitrypsin reduces inflammation and endoplasmic reticulum stress in lung epithelial cells in vitro Izabela Nita (Bern, Switzerland), Izabela Nita, Rolf Spirig, Sylvia Miescher, Amiq Gazdhar, Thomas Geiser
PA5053
Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses Robert Foronjy (Scarsdale, United States of America), Pius Ochieng, Patrick Geraghty, Edward Eden, Michael Campos, Robert Foronjy
PA5054
Elastin peptides modulate T helper response during murine emphysema Aida Meghraoui-Kheddar (Reims, France), Aïda Meghraoui-Kheddar, Mehdi Sellami, Sandra Audonnet, Moncef Guenounou, Richard Le Naour
PA5055
Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations Hannah Greenwood (Birmingham, United Kingdom), Jack Pullan, Hannah Greenwood, Georgia M. Walton, Robert A. Stockley, Elizabeth Sapey
PA5056
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease mahdia gholamnejad (Urmia, Islamic Republic of Iran), Mahdia Gholamnejad, Nasser Jahanbakhsh, Mohammad Hossein Rahimi-Rad, Mohammad Hassan Khadem Ansari, Shaker Salari Lak
PA5057
Elastase-induced emphysema is attenuated by L-carnitine supplementation Thomas Conlon (Neuherberg, Germany), Thomas Conlon, Cornelia Prehn, Jerzy Adamski, Oliver Eickelberg, Ali önder Yildirim
PA5058
Involvement of JNK in TNF driven remodelling Niki Reynaert (Maastricht, Netherlands), Niki Reynaert, Irene Eurlings, Evi Mercken, Rafael De Cabo, Scott Aesif, Jos Van der Velden, Yvonne Janssen-Heininger, Emiel Wouters, Mieke Dentener
321
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 PA5059
Identification and characterization of mesenchymal stem cells in the human lung Tamara Cruz (Barcelona, Spain), Tamara Cruz, Alejandra Lopez, Alvar Agusti, Rosa Faner
PA5060
Pretreatment of human adipose derived mesenchymal stem cells with PPAR- agonist improved effects of regeneration in elastase induced emphysema mouse model Ryeon-Jin Cho (Seoul, Republic of Korea), Ryeon Jin Cho, You-Sun Kim, Ji-Young Kim, Seiwon Lee, Sang-Do Lee, Jin Won Huh, Yeon-Mok Oh
PA5061
Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and nonCOPD controls Winifred Broekman (Leiden, Netherlands), Winifred Broekman, Maria Zarcone, Annemarie Van Schadewijk, Helene Roelofs, Christian Taube, Jan Stolk, Pieter Hiemstra
PA5062
In search of ckit+ stem cells in lung tissue Alejandra Lopez Giraldo (Barcelona, Spain), Alejandra López-Giraldo, Tamara Cruz, Rosa Faner, Alvar Agustí
Room G106-107
Session 528
10:45 - 12:45
Poster Discussion: Epidemiology of respiratory disease Chairs : Cecilie Svanes (Bergen, Norway), Judith Garcia Aymerich (Barcelona, Spain) PA5063
Reference values for FEV1, FVC and FEV1/FVC in Norway Arnulf Langhammer (Levanger, Norway), Arnulf Langhammer, Ane Johannesssen, Turid Lingaas Holmen, Hasse Melbye, Sanja Stanojevic, May Brit Lund, Morten Nissen Melsom, Per Bakke, Philip Quanjer
PA5064
The global Lund function initiative (GLI) reference values do not reflect lung function in the Nordic countries Helena Backman (Lulea, Sweden), Helena Backman, Annette Kainu, Linda Ekerljung, Anne Lindberg, Bo Lundback, Eva Rönmark, Anssi Sovijarvi
PA5065
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Alessandro Marcon (Verona, Italy), Alessandro Marcon, Josep M. Anto, Isa Cerveri, Thorarinn Gislason, Joachim Heinrich, Christer Janson, Deborah Jarvis, Nino Kuenzli, Benedicte Leynaert, Nicole Probst-Hensch, Cecilie Svanes, Kjell Toren, Joost Weyler, Jan-Paul Zock, Peter Burney, Roberto De Marco
PA5066
Prevalence of restrictive spirometric pattern according to different definitions Helena Backman (Lulea, Sweden), Helena Backman, Linnea Hedman, Caroline Stridsman, Sven-Arne Jansson, Anne Lindberg, Eva Rönmark, Bo Lundback
PA5067
Consequences of different definitions of airway obstruction Berne Eriksson (Halmstad, Sweden), Berne Eriksson, Helena Backman, Linnea Hedman, Anne Lindberg, Eva Rönmark, Bo Lundbäck
PA5068
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Stefan Karrasch (Neuherberg, Germany), Stefan Karrasch, Irene Brüske, Maia Smith, Joachim Heinrich, Rolf Holle, KarlHeinz Ladwig, Annette Peters, Holger Schulz
PA5069
Prevalence and characteristics of the asthma-COPD overlap syndrome - or the asthma-like COPD phenotype - in a COPD high risk population Charlotte Suppli Ulrik (Virum, Denmark), Camilla Boslev Bårnes, Peter Kjeldgaard, Mia Nielsen, Charlotte Suppli Ulrik
PA5070
Predictive accuracy of a simple functional index in chronic obstructive pulmonary disease Juan Luis García Rivero (Mompía (Santa Cruz de Bezana)-Cantabria, Spain), Juan Luis Garcia-Rivero, Roberto Garrastazu, Miguel Santibáñez, Mario Ruiz, Sandra Arenal, Jose Helguera, Cristina Bonnardeaux, Carlos Leon, Javier Llorca
PA5071
Validation of the COPD lung cancer screening score in a community based cohort of COPD patients Ane Aamli (Bergen, Norway), Ane Aamli, Miriam Gjerdevik, Frode Gallefoss, Per Bakke
PA5072
Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database David Culliford (Southampton, United Kingdom), David Culliford, Matt Johnson, Lynn Josephs
PA5073
A multivariate geo-statistical Bayesian model for analyzing the spatial prevalence of COPD: Implications on risk factors Marco Caminati (Verona, Italy), Massimo Guerriero, Marco Caminati, Clarissa Ferrari, Gianenrico Senna, Carlo Pomari
PA5074
Assessing health-related quality of life in COPD: A comparison between one generic and two disease-specific instruments Margarethe Wacker (Neuherberg, Germany), Margarethe E. Wacker, Sarah Wilke, Annika Karch, Holger Schulz, Henrik Watz, Rudolf A. Jörres, Claus Vogelmeier, Rolf Holle
322
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA5075
Case-finding for COPD: Developing strategies to identify patients at risk populations Cecilia Rodríguez (Montevideo, Uruguay), Cecilia Rodriguez Flores, María Victorina Lopez Varela, Edilberto Pacheco, Mónica Mamchur, Jimena Nuñez, Karen Rabuñal, Fernando Gimenez, Ana Lía Tempone, Karina Fagundez, Carolina Silva
PA5076
LATE-BREAKING ABSTRACT: The state of asthma epidemiology - An overview of systematic reviews Jon Genuneit (Ulm, Germany), Annina M. Seibold, Jon Genuneit
PA5077
Alcohol intake, cigarette smoking and respiratory health in the general population Alessandro Marcon (Verona, Italy), Roberto De Marco, Roberto Bono, Isa Cerveri, Marcello Ferrari, Pietro Pirina, Alessandro Marcon
PA5078
Associations of fruit intake and lung function in middle-age are modified by obesity Stephanie Byrne (The University of Melbourne, Australia), Stephanie Byrne, John Burgess, Lisa Wood, Michael Abramson, Bircan Erbas, Jennifer Perret, Stephen Morrison, David Johns, Caroline Lodge, Adrian Lowe, E. Haydn Walters, Shyamali Dharmage, Melanie Matheson
PA5079
Dietary fat is not associated with lung function in middle-age: Cross-sectional results from a cohort study Stephanie Byrne (The University of Melbourne, Australia), Stephanie Byrne, John Burgess, Lisa Wood, Michael Abramson, Bircan Erbas, David Johns, Jennifer Perret, Adrian Lowe, E. Haydn Walters, Shyamali Dharmage, Melanie Matheson
PA5080
LATE-BREAKING ABSTRACT: Serum 25(OH)D concentrations are associated with lung function in adolescence Claudia Flexeder (Neuherberg, Germany), Claudia Flexeder, Elisabeth Thiering, Sibylle Koletzko, Dietrich Berdel, Irina Lehmann, Andrea von Berg, Barbara Hoffmann, Carl-Peter Bauer, Joachim Heinrich, Holger Schulz
Room 13.2
Session 529
10:45 - 12:45
Poster Discussion: Asthma mechanisms and management Chairs : Thais Mauad (Sao Paulo, Brazil), Mirjam Kool (Rotterdam, Netherlands) PA5081
LATE-BREAKING ABSTRACT: Inhibition of the ubiquitin-E3-ligase FBXW7 enhances steroid efficacy: New concept for treating steroid insensitivity Marc Kaestle (Biberach, Germany), Marc Kaestle, David Wyatt, Paul Nicklin
PA5082
LATE-BREAKING ABSTRACT: Alveolar nitric oxide, small airway physiology and plasma biomarkers following inhaled allergen challenge in asthmatic subjects Henning Svensson (Malmö, Sweden), Henning Svensson, Zuzana Diamant, Leif Bjermer, Ellen Tufvesson
PA5083
Airway hyperresponsiveness (AHR) of small airways assessed by impulse oscillation (IOS) in adult asthma Hisatoshi Hijikata (Aichi, Japan), Hisatoshi Hijikata, Masaya Takemura, Norihisa Takeda, Kensuke Fukumitsu, Hiroya Ichikawa, Takamitsu Asano, Takehiro Uemura, Osamu Takakuwa, Hirotsugu Ohkubo, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Atsushi Nakamura, Akio Niiimi
PA5084
Lung overexpression of matrix metalloproteinase-2 protects against bronchial asthma Kentaro Fujiwara (Mie, Japan), Kentaro Fujiwara, Kentaro Urata, Atsushi Tomaru, Yoshinori Takahashi, Masahiro Onishi, Takehiro Takagi, Hiroyasu Kobayashi, Corina N. D’Alessandro Gabazza, Esteban C. Gabazza, Osamu Taguchi, Tetsu Kobayashi
PA5085
Integrins regulate eosinophil adhesion to the airway smooth muscle cells in asthma patients Andrius Januskevicius (Kaunas, Lithuania), Andrius Januskevicius, Simona Lavinskiene, Reinoud Gosens, Deimante Hoppenot, Virginija Kalinauskaite-Zukauske, Ieva Janulaityte, Laura Tamasauskiene, Raimundas Sakalauskas, Kestutis Malakauskas
PA5086
Biomarkers of obesity associated with severe atopic asthma Anna Konishcheva (Moscow, Russian Federation), Anna Konishcheva, Valentina Geervazieva
PA5087
Physiology of severe vs. mild-moderate U-BIOPRED cohorts interpreted using a computational model Edward Ingenito (Cambridge, United States of America), Edward Ingenito, Jeanette Bigler, Dirk Smith, Ian Adcock, Anthony Rowe, Fan Chung, Ratko Djukanovic, Ana Sousa, Peter Sterk, Ajay Nirula
PA5088
The temporal stability of coagulation and fibrinolytic factors in patients with asthma and healthy subjects Anne de Kievit (Amsterdam, Netherlands), Anne De Kievit, Marlous Sneeboer, Christof Majoor, Joost Meijers, Rene Lutter, Tom Van der Poll, Pieter-Willem Kamphuisen, Peter Sterk, Elisabeth Bel
PA5089
D-tryptophan influences allergic airway inflammation and Th2 immune responses Katrin Milger (Munich, Germany), Katrin Milger, Constanze Müller, Inge Kepert, Petra Nathan, Juliano Fonseca, Kerstin Hochwind, Sabine Bartel, Oliver Eickelberg, Anton Hartmann, Philippe Schmitt-Kopplin, Susanne Krauss-Etschmann
PA5090
Antibody responses to rhinovirus and echovirus antigens in children with asthma exacerbations Jua Iwasaki (London, United Kingdom), Jua Iwasaki, Lee Ying Chai, Siew-Kim Khoo, Joelene Bizzintino, Ingrid A. Laing, Peter N. Le Souëf, Wayne R. Thomas, Belinda J. Hales
323
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA5091
QGE031 (ligelizumab) is more effective than omalizumab and placebo in inhibiting allergen-induced early asthmatic response: Results from a predictive modeling study Gail Gauvreau (Hamilton, Canada), Gail M. Gauvreau, Louis-Philippe Boulet, Richard Leigh, Donald W. Cockcroft, Beth E. Davis, Irvin Mayers, J. Mark FitzGerald, Barbro Dahlen, R.M. Watson, Joanne Milot, Veronica Swystun, Linda Hui, AnnSofie Lantz, Miranda Bowen, Jonathan Arm, Suzzane Maahs, Karin Meiser, Philip Lowe, Andrej Skerjanec, Christopher Carlsten, Karin Strandberg, Kieran J. Killian, Michele Laviolette, Anton Drollmann, Paul M. O’Byrne
PA5092
A PKPD mathematical model to determine efficacy of multiple doses of QGE031 (ligelizumab) vs. omalizumab and placebo in inhibiting skin responses in atopic asthmatics Philip Lowe (Basel, Switzerland), P.J. Lowe, I. Bottoli, J. Arm, A. Skerjanec, A. Groenewegen, S. Maahs
PA5093
Serum Th2 cytokine profiles in mould sensitised adults from a large population-based cohort Jeanette Reece (Melbourne, Australia), Jeanette Reece, Rangi Kandane-Rathnayake, Mimi Tang, Julie Simpson, Iain Feather, Melissa Southey, John Hopper, Stephen Morrison, Graham Giles, EHaydn Walters, Shyamali Dharmage, Melanie Matheson
PA5094
The capacity of human airway epithelium to regulate T cell proliferation is reduced in asthma Irene Heijink (Groningen, Netherlands), Irene Heijink, Paul Fitch, Janneke Heimweg, Claire Wilson, Reina Matsuda, Maarten Van den Berge, Antoon Van Oosterhout, Jurgen Schwarze
PA5095
Azithromycin exhibits interferon-inducing properties in an experimental mouse model of asthma exacerbation Mandy Menzel (Lund, Sweden), Mandy Menzel, Hamid Akbarshahi, Lena Uller
PA5096
IL-4 induced changes in the Wnt signalling of bronchial epithelial cells Katharina Dietz (Munich, Germany), Katharina Dietz, Hoeke Baarsma, Melanie Koenigshoff, Carsten Schmidt-Weber, Kathrin Suttner
PA5097
The impact of anxiety and depression on asthma-related health outcomes: A prospective study Anthony Yii (Singapore, Singapore), Anthony Yii, Chee Kiang Tay, Therese Lapperre, Li Leng Tan, Florence Yeoh, Mariko Koh
Room E102
Session 530
10:45 - 12:45
Poster Discussion: Immunomodulation: basic science and clinical aspects Chairs : Clifford Taggart (Belfast, United Kingdom), Markus Henke (Marburg, Germany)
PA5098
LATE-BREAKING ABSTRACT: A lung-resident Ly6c+ monocyte proliferates to give rise to immunosuppressive lung macrophages Catherine Sabatel (Sart-Tilman, Belgium), Catherine Sabatel, Coraline Radermecker, Svetoslav Chakarov, Laurence Fiévez, Geneviève Paulissen, Marie Toussaint, Christophe Desmet, Florent Ginhoux, Thomas Marichal, Fabrice Bureau
PA5099
HMGB1 is upregulated in ASM in asthma and induces ASM contraction via TLR4 Leonarda Di Candia (Paris, France), Leonarda Di Candia, Ruth Saunders, John Challiss, Christopher Brightling
PA5100
Wnt5a – regulator of molecular events leading to inflammation and cancer in the lung Diána Feller (Pécs, Hungary), Diána Feller, Veronika Csöngei, Tamás Kovács, József Kun, Dávid Ernszt, Zsuzsanna Helyes, Judit E Pongrácz
PA5101
LSC Abstract – Severity of lung tissue pathology is dictated by S. aureus toxins eliciting series of cytolytic and chemotactic responses Srikanth Mairpady Shambat (Stockholm, Sweden), Srikanth Mairpady Shambat, Puran Chen, Anh-Thu Nguyen Hoang, Francois Vandenesch, Gerard Lina, Ian R. Monk, Timothy J. Foster, Gayathri Arakere, Mattias Svensson, Anna NorrbyTeglund
PA5102
Tobacco smoke causes release of IL-16 protein from NK cells in vitro Anders Andersson (Gothenburg, Sweden), Anders Andersson, Carina Malmhäll, Anders Lindén, Apostolos Bossios
PA5103
Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells Jyotshna Mandal (Basel, Switzerland), Jyotshna Mandal, Michael Roth, Lukas Bubendorf, Spasenija Savic, Michael Tamm, Daiana Stolz
PA5104
Impaired synthesis and transport of immunoglobulin A in severe asthma: Role of IL-13 Maha Zohra Ladjemi (Brussels, Belgium), Maha Zohra Ladjemi, Bruno Detry, Delphine Gras, Marylène Lecocq, Sébastien Dupasquier, Jonathan Mouthuy, Chantal Fregimilicka, Caroline Bouzin, Holly Bowen, Hannah Gould, Pascal Chanez, Charles Pilette
PA5105
Cigarette smoke impairs Sirt1 activity and promotes pro-inflammatory responses in bronchial epithelial cells Serena Di Vincenzo (Palermo, Italy), Serena Di Vincenzo, Mark Gjomarkaj, Jacobien Noordhoek, Maria Ferraro, Harold De Bruin, Chiara Cipollina, Dirkje Postma, Irene Heijink, Elisabetta Pace
324
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015 PA5106
Bronchodilator responsiveness is impaired in a mouse model of cigarette smoke exposure and influenza infection Chantal Donovan (Melbourne, Australia), Chantal Donovan, Huei Jiunn Seow, Jane Bourke, Ross Vlahos
PA5107
LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved antiinflammatory activity against pulmonary infection Arlene Glasgow (Belfast, United Kingdom), Arlene Glasgow, Nicolas Camper, Megan Osbourn, Derek Quinn, Stuart Elborn, Rebecca Ingram, Sinead Weldon, Clifford Taggart
PA5108
Airway epithelial cell IP-10 production is regulated by miR-31 via the transcription factor IRF-1 Sinead Weldon (Belfast, United Kingdom), Lauren Kerrigan, Cliff Taggart, Sinead Weldon
PA5109
LSC Abstract – Cigarette smoke exposure accelerates airway mucus accumulation and inflammation in ENaCoverexpressed mice Carolina Ballester Lopez (Munich, Germany), Carolina Ballester Lopez, Jie Jia, Marcus Mall, Oliver Eickelberg, Ali önder Yildirim
PA5110
LSC Abstract – Interleukin-26 in antibacterial host defense of human lungs: Effects on neutrophil mobilization Karlhans Che (Stockholm, Sweden), Karlhans Fru Che, Sara Tengvall, Bettina Levanen, Elin Silverpil, Margaretha Smith, Muhammed Awad, Max Vikström, Lena Palmberg, Ingemar Qvarfordt, Magnus Sköld, Anders Linden
PA5111
Azithromycin differentially affects IL-13 induced periostin (POSTN), CLCA1 and SERPINB2 expression in human bronchial epithelial cells Tinne Mertens (Leiden, Netherlands), Tinne Mertens, Pieter Hiemstra, Christian Taube
PA5112
Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells David Jungck (Bochum, Germany), David Jungck, Jürgen Knobloch, Sandra Körber, Yingfeng Lin, Jürgen Konradi, Sarah Yanik, Erich Stoelben, Andrea Koch
PA5113
Cigarette smoke extract induces the release of extracellular vesicles by airway epithelial cells via cellular carbonyl stress Birke Benedikter (Maastricht, Netherlands), Birke J. Benedikter, Charlotte Volgers, Guido R.M.M. Haenen, Paul H.M. Savelkoul, Emiel F.M. Wouters, Gernot G.U. Rohde, Antje R. Weseler, Frank R.M. Stassen
PA5114
Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide Mariana Kulynych-Miskiv (Galych, Ukraine), Mariana Kulynych-Miskiv, Mykola Ostrovskyy, Oleksandr Varunkiv, Iryna Savelikhina
PA5115
The human cathelicidin LL37 and mitochondrial DAMPs induce airway inflammation in epithelial cells and mice Simon D. Pouwels (Groningen, Netherlands), Simon Pouwels, Nick Ten Hacken, Jaap Lubbers, Antoon Van Oosterhout, Martijn Nawijn, Irene Heijink
Room D201-202
Session 531
10:45 - 12:45
Poster Discussion: Epidemiology, public health and economics of tobacco Chairs : Luke J. Clancy (Dublin, Ireland) PA5116
The association between peer, parental and tobacco product features and earlier age of onset of regular smoking among adults in 27 European countries Filippos Filippidis (London, United Kingdom), Filippos Filippidis, Israel Agaku, Constantine Vardavas
PA5117
Perceived ease of access to tobacco and support of total ban of tobacco among people aged 15-24 years old in 27 European countries Filippos Filippidis (London, United Kingdom), Filippos Filippidis, Israel Agaku, Constantine Vardavas
PA5118
Cannabis use is associated with reduced harm perception towards illicit drugs and experimentation with new psychoactive substances among European adolescents and young adults Israel Agaku (London, United Kingdom), Israel Agaku, Uyoyo Omaduvie, Constantine Vardavas, Filippos Filippidis
PA5119
Comparative study about perception of tobacco package disease risk warning and aware COPD among intergenerational/institutional Tomoyasu Uno (Fukushima City, Japan), Tomoyasu Uno
PA5120
Tackling under-diagnosis of COPD using spirometry and questionnaire: A targeted, case-finding study Ariel Rokach (Jerusalem, Israel), Ariel Rokach, Abraham Bohadana, Nissim Arish, Ayal Romem, Chen Chen Shuali, Ofir Kotek, Hava Azulai, Gabriel Izbicki
325
ERS International Congress 2015 DETAILED PROGRAMME WEDNESDAY 30 SEPTEMBER, 2015
PA5121
Smoking prevalence, associated attitudes and comparison of negative automatic thoughts among high school students in Turkey Murat Acat (Karabuk, Turkey), Murat Acat, çagdas öykü Memis, Muhammet Kamil Turan, Ali Ramazan Benli, Emre Taskin, Zehra Yasar, Seda Derici Memis, ümran Toru, Aylin Pihtili
PA5122
What makes hospitality premises prone to smoke-free violation? Elif Dagli (Istanbul, Turkey), Pinar Ay, Efza Evrengil, Murat Güner, Elif Dagli
PA5123
Study protocol of the TiTAN Crete project: Development of a tobacco treatment training network in Crete, Greece Charis Girvalaki (Heraklion, Greece), Charis Girvalaki, Aristoula Saridaki, Sophia Papadakis, Constantine Vardavas, Christos Lionis
PA5124
The prevalence of smoking among residents of the Kyrgyz Republic (Utilizing the WHO STEPwise approach to surveillance (STEPS)) Alina Altymysheva (Bishkek, Kyrgyzstan), Aliina Altymysheva, Roza Djakipova, Sairagul Ryskulova, Knyazeva Valeria, Ainagul Djumagulova
PA5125
Evalaution of smoking frequency and smoking cessation training among Turkish family physicians Davut Baltaci (Duzce, Turkey), Davut Baltaci, Leyla Yilmaz Aydin, Ali Nihat Annakkaya, Usame Velioglu, Fatih Alasan, Feyza Sariguzel, Handan Ankarali
PA5126
Results of Turkish smoking cessation polyclinics data’s analysis (TUSPA study) Tevfik Özlü (TRABZON, Turkey), Tevfik özlü, Funda öztuna, Mükremin Er, Leyla Yilmaz Aydin, Atilla Uysal, Tijen Sengezer, Pelin Duru çetinkaya, Zehra Yasar, Nurhan Sarioglu, Tuspa Study Group
PA5127
Evaluation of the knowledge of health professionals about the smoking cessation program Ilda Godoy (Botucatu, Brazil), Nadja F.T.N. Fabricio, Irma Godoy, Ilda Godoy
PA5128
Nicotine dependence in an isolated population of Kashubians from North Poland: A population survey Alicja Sieminska (Gdansk, Poland), Karolina Kita-Milczarska, Alicja Sieminska, Ewa Jassem
PA5129
Assessment of smoking in a medical center hospital - What has changed after 15 years? Inês Catarina de Sales Ribeiro (Entroncamento, Portugal), Inês Sales Ribeiro, Rafaela Campanha, Francisco Martins, Margarida Raposo, Cristina Matos, Fernando Nogueira
PA5130
Smoking among people living with HIV and AIDS in Ireland: Prevalence among sub-groups Kate Babineau (Dublin, Ireland), Kate Babineau, Luke Clancy, Sheila Keogan
PA5131
The prevalence of smoking in HIV-infected patients with community-acquired pneumonia Iosif Marincu (Timisoara, Romania), Iosif Marincu, Stefan Mihaicuta, Stefan Frent, Nicoleta Bertici, Livius Tirnea
PA5132
Smoking cessation support program in Hungary Erika Pataki (Budapest XII., Hungary), Erika Pataki, Zsofia Hodovan, Marta Fényes, Gábor Kovács, Ildikó Horváth
PA5133
Association of weight perception and desire to quit smoking Juan Wisnivesky (bronx, United States of America), Juan Wisnivesky, Andrew Rundle, Tracey Revenson, Alfred Neugut
326
ERS International Congress 2015 WORLD VILLAGE SUNDAY 27 SEPTEMBER, 2015
World Village Auditorium
Session 67
09:30 - 17:15
Session World Village: World Village - Day 1 Chairs : 09:30
Opening session Speaker to be confirmed
411
09:45
Healthy Lungs for Life Campaign Organised by the European Lung Foundation (ELF) Speaker to be confirmed
412
10:45
Treatment in compliance increasing for TB patients using supportive groups Organised by the Romanian TB Patients Association (ARB-TB) Speaker to be confirmed
413
11:15
Educaxair is a mobile support serice for chronic respiratory disease management for patients Organised by Lovexair Speaker to be confirmed
414
11:30
Polish Respiratory Society - past and present Organised by the Polish Respiratory Society (PTChP) Speaker to be confirmed
415
12:15
Portuguese Language Respiratory Association Organised by the Sociedade Portuguesa de Pneumologia (SPP) Speaker to be confirmed
416
13:00
Multidisciplinary structure and educational initiatives of the Russian Respiratory Society Organised by the Russian Respiratory Society (RRS) Speaker to be confirmed
417
13:45
Meet the new editor of the ATS AJRCCM journal Organised by the American Thoracic Society (ATS) Speaker to be confirmed
418
14:30
A partnership approach to promoting lung health Organised by the Irish Thoracic Society (ITS) Speaker to be confirmed
419
15:15
Asthma Health Promotion Programmes targeting different communities Organised by the Asthma Society of Ireland (ASI) Speaker to be confirmed
420
16:00
The European Bronchiectasis Registry Organised by EMBARC Speaker to be confirmed
421
16:45
Paediatric sleep apnoea: the perspective of a patient organisation Organised by ISAT Speaker to be confirmed
422
327
ERS International Congress 2015 WORLD VILLAGE MONDAY 28 SEPTEMBER, 2015
World Village Auditorium
Session 225
08:45 - 17:15
Session World Village: World Village - Day 2 Chairs : 08:45
World Village day 2
1906
08:45
Introducing ERJ Open Research - the new scientific journal from the ERS Organised by the European Respiratory Society (ERS) Anita Simonds (London, United Kingdom)
1907
09:30
COPD affects your lungs, pocket and social life! Real experiences from hospitals to airports Organised by EFA Speaker to be confirmed
1908
10:15
Czech Pneumological and Phthisiological Society – Its Activities and Perspectives Organised by the Czech Pneumological and Phthisiologial Society(CPFS) Speaker to be confirmed
1909
11:00
> Highlights of the ILD India Registry > EMBARC India: The Bronchiectasis Registry Organised by the Indian Chest Society (ICS)
1910
11:45
Social components of health and respiratory diseases- TTS perspective as a National Society Organised by the Turkish Thoracic Society (TTS) Speaker to be confirmed
1911
12:30
Bulgarian Respiratory Society - defining scientific excellence and standards of care more than 100 years Organised by the Bulgarian Respiratory Society (BRS) Speaker to be confirmed
1912
13:15
AIMAR - AIPO -SIMeR -SIMG Joint Paper “the Clinical and Integrated Management of COPD in Italy" Organised by the Federazione Italiana della Pneumologia (FIP) Speaker to be confirmed
1913
14:00
Fresh air from Argentina Organised by the Argentinian Society of Respiratory Medicine (AAMR) Speaker to be confirmed
1914
14:45
National Societies’ role in Quality Improvement Organised by the British Thoracic Society (BTS) Speaker to be confirmed
1915
15:30
How FFAAIR is supporting patients with a lung condition in France: patients at the patients' service Organised by the Fédération française des associations et amicales de malades insuffisants ou handicapés respiratoires (FFAAIR) Speaker to be confirmed
1916
16:00
European Patient Ambassador Programme Organised by the European Lung Foundation (ELF) Speaker to be confirmed
1917
16:25
Patient Organizations influence in EU policies for Respiratory Health Organised by PHA Europe
1918
16:50
ECC - helping make every voice, every step every breath count Organised by the European COPD Coalition Speaker to be confirmed
1919
328
ERS International Congress 2015 WORLD VILLAGE TUESDAY 29 SEPTEMBER, 2015
World Village Auditorium
Session 374
08:45 - 17:15
Session World Village: World Village - Day 3 Chairs : 08:45
The challenges and values of working in transdisciplinary consortium: the AirPROM experience in realising a meaningful computation model of the lung Organised by AirPROM Speaker to be confirmed
3416
09:30
Title tbc Organised by the European LAM Foundation
3417
10:15
Working for the cohesion of the Spanish respiratory medicine promoting research and continuing educatio Organised by the Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Speaker to be confirmed
3418
11:00
Croatian Respratory Society and Croatian Medical Association - history and activity Organised by the Croatian Respiratory Society (CRS) Speaker to be confirmed
3419
11:45
The Hellenic Thoracic Society, 50 years of shaping Pulmonology in Greece Organised by the Hellenic Thoracic Society (HTS) Speaker to be confirmed
3420
12:30
Title tbc Organised by BLF Speaker to be confirmed
3421
13:15
Inhalation Aerosols - the foundation of respiratory management Organised by the International Society of Aerosols in Medicine (ISAM) Speaker to be confirmed
3422
14:00
APSR and its diversity Organised by the Asian Pacific Society of Respirology (APSR) Speaker to be confirmed
3423
14:45
The International Medical Career: how Brazilians can apply for it Organised by the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT) Speaker to be confirmed
3424
15:30
International ALAT congress in Santiago de Chile 2016 Organised by the Asociación Latino Americana de Tórax (ALAT) Speaker to be confirmed
3425
16:15
Priority Scientific and Educational respiratory projects in Kyrgyzstan Organised by the Kyrgyz Thoracic Society (KTS) Speaker to be confirmed
3426
17:00
Israeli Hi Tech in pulmonary medicine: from the bench to the bedside Organised by the Israeli Society of Pulmonary Medicine (ISPM) Speaker to be confirmed
3427
329
ERS International Congress 2015 WORLD VILLAGE WEDNESDAY 30 SEPTEMBER, 2015
World Village Auditorium
Session 509
09:00 - 12:00
Session World Village: World Village - Day 4 Chairs : 09:00
Burnout Among Healthcare Professionals in the ICU Organised by CHEST Speaker to be confirmed
4916
09:45
Awareness of respiratory problems in our region Organised by the Pakistan Respiratory Society (PRS) Speaker to be confirmed
4917
11:15
A model of partnership of the Romanina Society of Pneumology and his benefits Organised by the Romanian Society of Pneumology Speaker to be confirmed
4918
330
INDUSTRY SPONSORED INDUSTRY SPONSORED SESSIONS SESSIONS
DISCLAIMER: THE PRACTICAL WORKSHOPS, EVENING SYMPOSIA, EVENING MINI-SYMPOSIA, EVENING EXPERT FORUM SESSIONS AND EARLY MORNING SYMPOSIA ARE ORGANISED BY INDUSTRY. YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS.
DISCLAIMER : THE PRACTICAL WORKSHOPS, EVENING SYMPOSIA, EVENING MINI-SYMPOSIA, EVENING EXPERT FORUM SESSIONSS AND EARLY MORNING SYMPOSIA ARE ORGANISED BY INDUSTRY. YOU CANNOT CLAIM CME CREDITS FOR ATTENDING THESE SESSIONS.
331
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS SUNDAY 27 SEPTEMBER, 2015
Room E104-106
Session 142
13:15 - 14:30
Industry Practical Workshop: Clinical usefulness of novel modes of non-invasive ventilation (NIV) Organised by Philips Respironics Chairs : Nicholas Hart (London, United Kingdom) 13:15
Clinical Usefulness of AVAPS-AE. Nicholas Hart (London, United Kingdom)
1380
13:30
Application of Volume Targeted Pressure Support Ventilation to Reduce Hospital Readmissions Michael Dreher (Aachen, Germany)
1381
13:45
Question and Answer Session Nicholas Hart (London, United Kingdom)
1382
13:50
Hands on practical workshop with AVAPS-AE mode on the Trilogy and A40 noninvasive ventilators.
1383
Room G106-107
Session 143
13:15 - 14:30
Industry Practical Workshop: State-of-the-Art in ambulatory oxygen (AO) Organised by Invacare International SARL Chairs : Enrico Maria Clini (Pavullo, Italy) 13:15
Advances in ambulatory oxygen Enrico Maria Clini (Pavullo, Italy)
1384
13:25
Ambulatory oxygen prescription in practice: portable concentrators vs liquid oxygen Daniel Veale (Gières, France)
1385
13:40
The use of pulse dose in ambulatory oxygen João Carlos Winck (Vila Nova de Gaia, Portugal)
1386
13:50
Hands-on demonstration of AO devices
1387
Room E102
Session 144
13:15 - 14:30
Industry Practical Workshop: Practical focus on recent innovations to optimize sleep apnoea patients’ compliance and quality of care Organised by ResMed Europe Chairs : Ramón Farré Ventura (Barcelona, Spain), Holger Woehrle (Blaubeuren, Germany) 13:15
Gender differences in OSA, how can tailored therapy help? Ramón Farré Ventura (Barcelona, Spain)
1388
13:40
Patient engagement, the solution to increased compliance? Hartmut Grueger (Meerbusch, Germany)
1389
14:05
Hands-on session
1390
Room E107
Session 145
13:15 - 14:30
Industry Practical Workshop: Lung clearance index - ready to use?LCI for early detection and monitoring of ventilation inhomogeneity Organised by ndd Medizintechnik AG Chairs : Monika Gappa (Wesel, Germany) 13:20
Introduction into Ventilation Inhomogeneity, Lung Clearance Index and the clinical relevance of early detection for patients with Cystic Fibrosis and Alpha-1-Antitrypsin Deficiency Philipp Latzin
1391
13:30
Practical workshop Multiple Breath Washout with EasyOne Pro LAB MBW trials will be conducted according to the SOP (SOP by Gappa/Fuchs)
1392
332
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS SUNDAY 27 SEPTEMBER, 2015
Room E108
Session 146
13:15 - 14:30
Industry Practical Workshop: Flexible and rigid bronchoscopy in adults Organised by Karl Storz GmbH & Co.KG Chairs : Hermann Tonn (Hannover, Germany) 13:15
Presentation about Flexible and Rigid Bronchoscopy in Adults Hermann Tonn (Hannover, Germany)
1393
13:30
Hands-on-Workshop: practical demonstration and training Hermann Tonn (Hannover, Germany)
1394
Room Auditorium
Session 177
17:15 - 19:15
Industry Evening Symposium: Meeting the patient’s needs in the changing world of COPD management Organised by Boehringer Ingelheim International GmbH Chairs : Peter M.A. Calverley (Liverpool, United Kingdom) 17:15
Welcome and introduction Peter M.A. Calverley (Liverpool, United Kingdom)
1599
17:20
Chronic obstructive pulmonary disease (COPD) treatment over the years Peter M.A. Calverley (Liverpool, United Kingdom)
1600
17:45
Current maintenance treatment of COPD patients: when? Richard Russell (Windsor, United Kingdom)
1601
18:10
Current maintenance treatment of COPD patients: what? Alberto Papi (Ferrara, Italy)
1602
18:35
Challenges when treating COPD patients: COPD as a heterogeneous disease Klaus Friedrich Rabe (Grosshansdorf, Germany)
1603
19:00
Q&A session Klaus Friedrich Rabe (Grosshansdorf, Germany), Alberto Papi (Ferrara, Italy), Peter M.A. Calverley (Liverpool, United Kingdom), Speaker to be confirmed
1604
Room 7.2
Session 178
17:15 - 19:15
Industry Evening Symposium: A time to REACT: where is the ceiling of therapeutic benefit in COPD? Organised by Takeda Pharmaceuticals International GmbH Chairs : Fernando J. Martinez (Ann Arbor, United States of America) 17:15
Welcome and introduction Fernando J. Martinez (Ann Arbor, United States of America)
1605
17:25
Inhaled combination therapy in severe COPD: is it enough? Leonardo Michele Fabbri (Modena, Italy)
1606
17:55
The REACT study: breaking through the ceiling of inhaled combination therapy Fernando J. Martinez (Ann Arbor, United States of America)
1607
18:25
What do the REACT data mean for clinicians? Eric D. Bateman (Cape Town, South Africa), Leonardo Michele Fabbri (Modena, Italy), Alan Kaplan (Richmond Hill, Canada), Fernando J. Martinez (Ann Arbor, United States of America)
1608
19:05
Concluding remarks Fernando J. Martinez (Ann Arbor, United States of America)
1609
Room Elicium 2
Session 179
17:15 - 19:15
Industry Evening Symposium: COPD individualized therapy: tailored approach to symptom management Organised by AstraZeneca and Menarini Chairs : Bartolome R. Celli (Wellesley, United States of America)
333
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS SUNDAY 27 SEPTEMBER, 2015 17:15
Welcome and introduction Bartolome R. Celli (Wellesley, United States of America)
1610
17:20
Dual bronchodilation – a new approach in individualized therapy Dave Singh (Manchester, United Kingdom)
1611
17:40
Beyond lung function – impact of COPD symptoms during the 24-hour day Marc Miravitlles (Barcelona, Spain)
1612
18:00
Patient-reported outcomes – assessing benefit Bartolome R. Celli (Wellesley, United States of America)
1613
18:25
Selecting the right treatment for the right patient Claus Vogelmeier (Marburg, Germany)
1614
18:50
Panel discussion and Q&A
1615
19:10
Closing remarks
1616
Room 4.2
Session 180
17:15 - 19:15
Industry Evening Symposium: Making a difference in asthma Organised by GlaxoSmithKline Chairs : David Leather (Crewe, United Kingdom) 17:15
Introduction and welcome David Leather (Crewe, United Kingdom)
1617
17:20
Can pharmacology help? Neil C. Barnes (Uxbridge, United Kingdom)
1618
17:40
Can medicines impact outcomes? Kenneth R. Chapman (Toronto, Canada)
1619
18:10
Can technology help? Richard Costello (Dublin, Ireland)
1620
18:40
Can new approaches help? Peter Phillips (Stevenage, United Kingdom)
1621
19:00
Questions and close David Leather (Crewe, United Kingdom)
1622
Room 5.2
Session 181
17:15 - 19:15
Industry Evening Symposium: Strategies to improve treatment outcomes in IPF Organised by F. Hoffmann-La Roche Chairs : Vincent Cottin (Lyon, France), Athol Wells (London, United Kingdom) 17:15
Welcome and opening Athol Wells (London, United Kingdom)
1623
17:25
Strategies to improve early diagnosis in IPF Athol Wells (London, United Kingdom)
1624
17:50
The importance of early treatment in IPF Carlo Albera (Turin, Italy)
1625
18:15
Optimising long-term management of patients with IPF Vincent Cottin (Lyon, France)
1626
18:40
Treatment benefits with pirfenidone in IPF Steven Nathan (Falls Church, United States of America)
1627
19:05
Q&A and meeting close Vincent Cottin (Lyon, France)
1628
334
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS SUNDAY 27 SEPTEMBER, 2015
Room Elicium 1
Session 182
17:15 - 19:15
Industry Evening Symposium: IgE-mediated asthma: New revelations and future insights Organised by Novartis Pharma AG Chairs : Ratko Djukanovic (Southampton, United Kingdom) 17:15
Asthma and allergic inflammation: Why is IgE central? Ratko Djukanovic (Southampton, United Kingdom)
1629
17:35
Targeting IgE: New revelations, new concepts William Busse (Madison, United States of America)
1630
17:50
From clinical trials to real-world data: New dimensions of patient benefits Nicola Hanania (Houston, United States of America)
1631
18:10
Which patient, what assessment and by whom? David Price (Aberdeen, United Kingdom)
1632
18:30
Focusing on your crucial questions Ratko Djukanovic (Southampton, United Kingdom), William Busse (Madison, United States of America), Nicola Hanania (Houston, United States of America), David Price (Aberdeen, United Kingdom)
1633
19:00
Future insights: IgE in 2025? Ratko Djukanovic (Southampton, United Kingdom)
1634
Room 5.1
Session 183
17:15 - 19:15
Industry Evening Symposium: Inhaler devices: the past, the present, and the future Organised by TEVA Pharmaceuticals Europe BV Chairs : Richard Dekhuijzen (Nijmegen, Netherlands) 17:15
Welcome and introduction Richard Dekhuijzen (Nijmegen, Netherlands)
1635
17:20
Are inhalers failing our patients? Gary Wong (Shatin, Hong Kong)
1636
17:45
Improving patient outcomes and adherence in asthma: all devices are not equal Johann Christian Virchow (Rostock, Germany)
1637
18:10
Can an intuitive device reduce critical errors? Richard Dekhuijzen (Nijmegen, Netherlands)
1638
18:35
The future of inhaler development: what are we still missing? Henry Chrystyn (Bingley, United Kingdom)
1639
19:00
Q&A session and close Richard Dekhuijzen (Nijmegen, Netherlands)
1640
Room 13.1
Session 184
17:15 - 19:15
Industry Evening Symposium: Advancing the evidence base of coils for the treatment of severe emphysema: analyses from large-scale randomized and non-randomized programs Organised by PneumRx, Inc. Chairs : Charles-Hugo Marquette (Nice, France), Pallav L Shah (London, United Kingdom) 17:15
Welcome Charles-Hugo Marquette (Nice, France)
1641
17:20
Mechanism of action Charles-Hugo Marquette (Nice, France)
1642
17:35
Pulmonary perfusion after Coil implantation Paola Gasche Soccal (Geneva, Switzerland)
1643
17:50
The REVOLENS program: insights from a large-scale randomized controlled study Gaëtan Deslee (Reims, France)
1644
335
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS SUNDAY 27 SEPTEMBER, 2015 18:10
The European Registry: learnings of a large-scale post-market observational program Martin Hetzel (Stuttgart, Germany)
1645
18:30
The RESET Program: 12m follow-up of the first randomized controlled study with Coils Pallav L Shah (London, United Kingdom)
1646
18:45
The RENEW program: overview of methodology of the US IDE study Frank Sciurba (Pittsburgh, United States of America)
1647
19:00
Q&A Pallav L Shah (London, United Kingdom)
1648
Room 2.1
Session 185
17:15 - 19:15
Industry Evening Symposium: A comprehensive approach to PAH – the patient journey Organised by Actelion Pharmaceuticals Ltd Chairs : Gérald Simonneau (Le Kremlin-Bicêtre, France), Sanjay Mehta (London, Canada) 17:15
Introduction Gérald Simonneau (Le Kremlin-Bicêtre, France)
1649
17:25
Psychosocial aspects of PAH: what are they and how do patients cope? - A case study Karen Olsson (Hannover, Germany)
1650
17:45
PAH management - Addressing quality of life and functional capacity Marion Delcroix (Leuven, Belgium)
1651
18:05
Living with PAH - improving outcomes for our patients Sean Gaine (Dublin, Ireland)
1652
18:25
Addressing the daily impact of PAH - putting the patient at the centre Luke Howard (London, United Kingdom)
1653
18:45
The patients' voice - are they being heard by health authorities? Per Nilsson (Allschwil, Switzerland)
1654
19:00
Panel discussion
1655
Room 4.1
Session 186
17:15 - 19:15
Industry Evening Symposium: Exploring the bronchial tree in asthma: large & small airways, and real-life outcomes Organised by Mundipharma International Ltd Chairs : Thys Van Der Molen (Groningen, Netherlands) 17:15
Welcome and introduction Thys Van Der Molen (Groningen, Netherlands)
1656
17:25
Bypassing the oropharynx Omar Usmani (London, United Kingdom)
1657
17:45
Navigating to the large airways and beyond Nicolas Roche (Paris, France)
1658
18:05
Branching out to the small airways Gregory King (Sydney, Australia)
1659
18:25
Fruition in real-world practice Thys Van Der Molen (Groningen, Netherlands)
1660
18:50
Discussion
1661
19:10
Summary and close Thys Van Der Molen (Groningen, Netherlands)
1662
336
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS SUNDAY 27 SEPTEMBER, 2015
Room Emerald
Session 187
17:15 - 19:15
Industry Evening Symposium: New Horizons in COPD: detecting and managing patients with Alpha-1-Antitrypsin Deficiency Organised by Grifols Chairs : James K. Stoller (Cleveland, United States of America) 17:15
Welcome and Introduction James K. Stoller (Cleveland, United States of America)
1663
17:20
New insights on detection and awareness of alpha-1-antitrypsin (AAT) deficiency: Experience in two regions--Europe and Latin America Maria Campos Miranda Duarte Sucena (Leça da Palmeira, Portugal), Jose Roberto De Brito Jardim (Sao Paulo, Brazil)
1664
18:00
Emphysema in alpha-1 antitrypsin deficiency: clinical features and challenges Bronchiectasis and small airways disease: clinical features and challenges James K. Stoller (Cleveland, United States of America), Tobias Welte (Hannover, Germany)
1665
18:40
ALTA Award: Introduction of the 2015 winning projects
1666
18:50
ALTA Award: Presentation of the results of the 2014 winning projects Marco Fumagalli (Pavia, Italy), Cormac McCarthy (Dublin, Ireland)
1667
19:00
General discussion and closing remarks
1668
Room E104-106
Session 188
17:30 - 19:00
Industry Evening Mini Symposium: The Clinical Evidence Supporting LVR Therapy Organised by Pulmonx International SARL Chairs : Felix J.F. Herth (Heidelberg, Germany) 17:30
Welcome Felix J.F. Herth (Heidelberg, Germany)
1669
17:35
BeLieVeR full set of results Nick Hopkinson (London, United Kingdom)
1670
17:55
STELVIO Dirk-Jan Slebos (Groningen, Netherlands)
1671
18:10
Pneumothorax Algorithm with Case Reports Arschang Valipour (Vienna, Austria)
1672
18:25
Treatment algorithm Felix J.F. Herth (Heidelberg, Germany)
1673
18:40
Panel discussions - interaction with the audience
1674
Room D201-202
Session 189
17:30 - 19:00
Industry Evening Mini Symposium: Long-term NIV in COPD – who and when? Organised by ResMed Chairs : Peter J. Wijkstra (Groningen, Netherlands), Wolfram Windisch (Cologne, Germany) 17:30
NIV for chronic COPD – when and how? Thomas Koehnlein (Leipzig, Germany)
1675
18:00
Telemonitoring for COPD-patients! Christine Cheval (Hyères, France)
1676
18:30
International practise of HMV for COPD! Round table discussion with European experts Wolfram Windisch (Cologne, Germany), Peter J. Wijkstra (Groningen, Netherlands), Thomas Koehnlein (Leipzig, Germany), Stefano Nava (Bologna, Italy), Nicholas Hart (London, United Kingdom), Jean-Louis Pepin (Grenoble, France)
1677
337
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015
Room G104-105
Session 195
07:00 - 08:15
Industry Early Morning Symposium: IGRAs in Clinical Practice: Institutional Experience and Case Review Organised by Oxford Immunotec Chairs : Ali Juzar (New Orleans, United States of America) 07:00 07:50
IGRAs in Clinical Practice: Institutional Experience and Case Review Ali Juzar (New Orleans, United States of America)
1682
Question & Answer session
Room E104-106
1683
Session 298
13:15 - 14:30
Industry Practical Workshop: Bronchial Thermoplasty: Once in a lifetime treatment in severe asthma. Organised by Boston Scientific International SA Chairs : Robert Niven (Manchester, United Kingdom) 13:15
Opening Robert Niven (Manchester, United Kingdom)
2833
13:20
Efficacy and safety of BT Pallav L Shah (London, United Kingdom)
2834
13:30
BT in the guidelines. What is new? Pascal Chanez (Marseille, France)
2835
13:40
Mechanism of action of BT Robert Niven (Manchester, United Kingdom)
2836
13:50
ASMATHERM trial, latest news Michel Aubier (Paris, France)
2837
14:00
Q&A and wrap up Robert Niven (Manchester, United Kingdom)
2838
14:10
Hands on
2839
Room G106-107
Session 299
13:15 - 14:30
Industry Practical Workshop: Non-invasive ventilation in chronic respiratory failure Organised by Weinmann Chairs : Thomas Koehnlein (Leipzig, Germany) 13:15
New evidence for NIV in chronic hypercapnic COPD Thomas Koehnlein (Leipzig, Germany)
2840
13:35
Chronic NIV for COPD patients: What did we learn from the RCTs and what from the clinical practice Stefano Nava (Bologna, Italy)
2841
14:00
Hands-on session Jörg Lessau, Thomas Stuht
2842
14:25
Closing remarks Thomas Koehnlein (Leipzig, Germany)
2843
Room E102
Session 300
13:15 - 14:30
Industry Practical Workshop: Hands-on FeNO: practical workshop on monitoring airway inflammation to improve asthma outcomes Organised by Aerocrine AB Chairs : Adnan Custovic (Manchester, United Kingdom)
338
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015 13:15
Practical: HandsOn with FeNO with NIOX®
2844
13:33
Educational: Patients case stories
2845
13:51
Non-adherence in difficult asthma Liam Heaney (Belfast, United Kingdom)
2846
14:09
The value of FeNO in childhood asthma Giorgio Piacentini (Verona, Italy)
2847
Room D201-202
Session 301
13:15 - 14:30
Industry Practical Workshop: Electromagnetic Navigation Bronchoscopy™: The Evolution of Diagnosing and Treating Lung Disease – A Global Perspective Organised by Medtronic Chairs : 13:20
Lung Cancer diagnostics – Evidence and challenges
2848
13:30
ENB™ - A surgeon’s perspective Douglas James Minnich
2849
13:40
ENB™ – An interventional pulmonologist’s perspective Susan Garwood
2850
14:09
2851
Room E107
Session 302
13:15 - 14:30
Industry Practical Workshop: Hands-on practice with PneumRx Coils for treatment of severe emphysema Organised by PneumRx, Inc. Chairs : Dirk-Jan Slebos (Groningen, Netherlands) 13:15
Welcome and Introduction Dirk-Jan Slebos (Groningen, Netherlands)
2852
13:17
Mechanism of action & high-level overview of clinical results Dirk-Jan Slebos (Groningen, Netherlands)
2853
13:40
Practical Demonstration & Hands-on practice at 5 workstations Dirk-Jan Slebos (Groningen, Netherlands), Javier FLANDES ALDEYTURRIAGA (Madrid, Spain), Enrique Cases Viedma (Valencia, Spain), Hervé Dutau (Marseille, France), Thomas Blankenburg (Hohenweiden, Germany), Hans Klose (Hamburg, Germany)
2854
14:25
Conclusions and wrap-up Dirk-Jan Slebos (Groningen, Netherlands)
2855
Room E108
Session 303
13:15 - 14:30
Industry Practical Workshop: Best practice in life-support and non-life-support – meet the experts! Organised by ResMed Europe Chairs : Holger Woehrle (Blaubeuren, Germany) 13:15
Invasive ventilation with vented technology! Ruth Wakeman (London, United Kingdom)
2856
13:40
Identification and set up of COPD-patients: best practice! Martin Bachmann (Hamburg, Germany)
2857
14:05
iVAPS and AutoEPAP – why and when? Cesare Gregoretti (Turin, Italy)
2858
339
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015
Room Auditorium
Session 329
17:15 - 19:15
Industry Evening Symposium: Current thinking and new paradigm for COPD Organised by Novartis Pharma AG Chairs : Tobias Welte (Hannover, Germany) 17:15
Chair's welcome and introduction Tobias Welte (Hannover, Germany)
3074
17:20
Dual bronchodilation: back to the future Kenneth R. Chapman (Toronto, Canada)
3075
17:40
The LABA/LAMA class: current evidence and key learnings for COPD patient care Tobias Welte (Hannover, Germany)
3076
18:05
Panel Q&A session
3077
18:15
Changing our thinking about exacerbation prevention in COPD Helgo Magnussen (Grosshansdorf, Germany)
3078
18:40
From evidence to practice: choosing the appropriate therapeutic options Marc Miravitlles (Barcelona, Spain)
3079
19:05
Panel Q&A session and chair’s conclusions Tobias Welte (Hannover, Germany)
3080
Room Elicium 2
Session 330
17:15 - 19:15
Industry Evening Symposium: COPD: a journey towards individualised treatment Organised by GlaxoSmithKline Chairs : Dave Singh (Manchester, United Kingdom), Neil C. Barnes (Uxbridge, United Kingdom) 17:15
Introduction and welcome Dave Singh (Manchester, United Kingdom), Neil C. Barnes (Uxbridge, United Kingdom)
3081
17:20
Beginning the journey: considering the issues for patients and clinicians Nicolas Roche (Paris, France)
3082
17:45
The benefit of maximising bronchodilatation: new insights Dave Singh (Manchester, United Kingdom)
3083
18:10
Inhaled steroids in COPD: understanding the data behind the debate Neil C. Barnes (Uxbridge, United Kingdom)
3084
18:35
A roadmap towards individualised treatment Paul Jones (London, United Kingdom)
3085
19:00
Questions and close Dave Singh (Manchester, United Kingdom), Neil C. Barnes (Uxbridge, United Kingdom)
3086
Room 4.2
Session 331
17:15 - 19:15
Industry Evening Symposium: The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options Organised by Boehringer Ingelheim International GmbH Chairs : Huib A.M. Kerstjens (Groningen, Netherlands), Eric D. Bateman (Cape Town, South Africa) 17:15
Welcome and introduction Huib A.M. Kerstjens (Groningen, Netherlands)
3087
17:20
Current options and approaches Eric D. Bateman (Cape Town, South Africa)
3088
17:45
Anticholinergics: A recent addition Huib A.M. Kerstjens (Groningen, Netherlands)
3089
18:10
What next? Targeted treatments and personalised medicine J. Mark Fitzgerald (Vancouver, Canada)
3090
340
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015 18:35
Improving collaborative care in asthma: An introduction to motivational communication Kim Lavoie (Montréal, Canada)
3091
19:00
Q&A and closing summary Eric D. Bateman (Cape Town, South Africa)
3092
Room 5.2
Session 332
17:15 - 19:15
Industry Evening Symposium: Frontiers and perspectives for chronic obstructive pulmonary disease Organised by AstraZeneca Chairs : Klaus Friedrich Rabe (Grosshansdorf, Germany), Leonardo Michele Fabbri (Modena, Italy) 17:15
Welcome and introduction Leonardo Michele Fabbri (Modena, Italy)
3093
17:30
Delivering inhaled drugs to the lungs novel technologies Klaus Friedrich Rabe (Grosshansdorf, Germany)
3094
17:50
New clinical data for a novel drug combination Gary T. Ferguson (Livonia, United States of America)
3095
18:20
Weighing the evidence drug safety Stephen Rennard (Omaha, United States of America)
3096
18:40
Placing novel drugs in clinical practice implications and future perspectives Fernando J. Martinez (Ann Arbor, United States of America)
3097
18:55
Q&A
3098
19:10
Closing remarks Klaus Friedrich Rabe (Grosshansdorf, Germany)
3099
Room Elicium 1
Session 333
17:15 - 19:15
Industry Evening Symposium: Idiopathic pulmonary fibrosis – where real world meets science Organised by Boehringer Ingelheim International GmbH Chairs : Athol Wells (London, United Kingdom), Kevin Brown (Denver, United States of America) 17:15
Welcome and introduction Athol Wells (London, United Kingdom)
3100
17:20
Real-world management of IPF in Australia Tamera Corte (Camperdown, Australia)
3101
17:35
Real-world management of IPF in Germany: INSIGHTS-IPF Juergen Behr (München, Germany)
3102
17:50
Q&A
3103
17:55
Diagnosis of IPF: Imaging challenges David Hansell (London, United Kingdom)
3104
18:15
Strict diagnostic criteria versus a working diagnosis of IPF: A debate Athol Wells (London, United Kingdom), Kevin Brown (Denver, United States of America)
3105
18:40
Long-term experience with nintedanib in IPF: INPULSIS-ON® Bruno Crestani (Paris, France)
3106
19:10
Summary and conclusion Kevin Brown (Denver, United States of America)
3107
Room 5.1
Session 334
17:15 - 19:15
Industry Evening Symposium: Closer to asthma in clinical practice: small airways in real life Organised by Takeda Pharmaceuticals International GmbH Chairs : David Price (Daly City, United States of America)
341
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015 17:15
Welcome and introduction David Price (Aberdeen, United Kingdom)
3108
17:25
The role of small airways in the development of asthma and its clinical course Leif Bjermer (Lund, Sweden)
3109
17:55
Real-life studies: completing the clinical picture David Price (Aberdeen, United Kingdom)
3110
18:25
Extra-fine ciclesonide: a real-life perspective Thys Van Der Molen (Groningen, Netherlands)
3111
18:55
Q&A and concluding remarks David Price (Aberdeen, United Kingdom), Leif Bjermer (Lund, Sweden), Thys Van Der Molen (Groningen, Netherlands)
3112
Room 13.1
Session 335
17:15 - 19:15
Industry Evening Symposium: Treating inadequately controlled asthma: exploring the potential of phenotype-targeted therapy Organised by TEVA Pharmaceuticals Europe BV Chairs : Mario Castro (St. Louis, United States of America) 17:15
Welcome and introduction Mario Castro (St. Louis, United States of America)
3113
17:25
Inadequately controlled asthma: the unmet needs and impact on asthma management Ratko Djukanovic (Southampton, United Kingdom)
3114
17:55
Treating inadequately controlled asthma: the role of the eosinophil Michael Wechsler (Brookline, United States of America)
3115
18:25
The clinical benefits of reducing IL-5 signalling among inadequately controlled asthma patients: the latest evidence Mario Castro (St. Louis, United States of America)
3116
18:55
Q&A session and close Mario Castro (St. Louis, United States of America)
3117
Room 2.1
Session 336
17:15 - 19:15
Industry Evening Symposium: Putting the spotlight on Type 2 biomarkers in severe asthma Organised by F. Hoffmann-La Roche Ltd Chairs : Roland Buhl (Mainz, Germany) 17:15
Introduction: Managing uncontrolled asthma Roland Buhl (Mainz, Germany)
3118
17:30
Chair-led discussion - Why do we have patients with uncontrolled asthma? - Can we identify patients most likely to be uncontrolled? - What data can we collect and how can it be used to discover more about our patients' asthma? Roland Buhl (Mainz, Germany), Nicola Hanania (Houston, United States of America), Liam Heaney (Belfast, United Kingdom), Martin Myers (Preston, United Kingdom), Dirkje S. Postma (Groningen, Netherlands)
3119
18:55
Chair summary Roland Buhl (Mainz, Germany)
3120
19:00
Q&A
3121
Room 4.1
Session 337
17:15 - 19:15
Industry Evening Symposium: Changing PH patients’ lives: Long-term evidence for riociguat in the management of PH 1,2
Organised by Bayer HealthCare Pharmaceuticals Chairs : H. Ardeschir Ghofrani (Giessen, Germany), Gérald Simonneau (Le Kremlin-Bicêtre, France)
342
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015 17:15
Opening and introduction Gérald Simonneau (Le Kremlin-Bicêtre, France)
3122
17:20
Where are we now in the long-term management of PAH and CTEPH? Hits and misses of medical treatments Harrison Farber (Boston, United States of America)
3123
17:40
Can we change the long-term outlook for patients with PAH and CTEPH? Evidence from PATENT-2 and CHEST-2 Marius M. Hoeper (Hannover, Germany)
3124
18:05
Can we sustain change for patients with PAH? Long-term evidence for riociguat in PAH-CTD Chris Denton (London, United Kingdom)
3125
18:25
Can we sustain change for patients with inoperable or persistent/recurrent CTEPH? Nick Kim (La Jolla, San Diego, United States of America), Irene Lang (Vienna, Austria)
3126
19:05
Discussion and conclusion H. Ardeschir Ghofrani (Giessen, Germany)
3127
Room Emerald
Session 338
17:30 - 19:00
Industry Evening Mini Symposium: Sleep-disordered breathing in HF, SERVE HF results and beyond Organised by ResMed Chairs : Anita Simonds (London, United Kingdom), Maria Bonsignore (Palermo, Italy) 17:30
ASV impact on morbi-mortality and heart function Martin Cowie (London, United Kingdom)
3128
17:50
ASV compliance, impact on sleep & QOL Helmut Teschler (Essen, Germany)
3129
18:10
Learnings form the SERVE-HF PSG Core Lab Patrick Levy (Grenoble, France)
3130
18:30
Implication & perspective for sleep medicine, is there a room for ASV therapy after SERVE HF? Marie-Pia D'Ortho (Paris, France)
3131
18:50
Panel discussion Anita Simonds (London, United Kingdom), Maria Bonsignore (Palermo, Italy), Helmut Teschler (Essen, Germany), Patrick Levy (Grenoble, France), Holger Woehrle (Blaubeuren, Germany), Marie-Pia D'Ortho (Paris, France)
3132
Room E104-106
Session 339
17:30 - 19:00
Industry Evening Mini Symposium: Augmentation therapy in alpha-1 antitrypsin deficiency: the evidence for efficacy Organised by CSL Behring Chairs : Noel Gerard McElvaney (Dublin, Ireland) 17:30
Welcome and Introduction Noel Gerard McElvaney (Dublin, Ireland)
3133
17:35
Anti-inflammatory properties of A1-PI augmentation therapy Emer Reeves (Dublin, Ireland)
3134
17:50
Q&A Emer Reeves (Dublin, Ireland)
3135
17:55
The relevance of CT lung density for assessing emphysema in AATD David G Parr (Leamington Spa, Warwickshire, United Kingdom)
3136
18:10
Q&A David G Parr (Leamington Spa, Warwickshire, United Kingdom)
3137
18:15
Efficacy of A1-PI augmentation therapy: a review of evidence from randomised controlled trials Niels Seersholm (Copenhagen, Denmark)
3138
343
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015 18:30
The RAPID trial: evidence for the efficacy of A1-PI augmentation therapy Kenneth R. Chapman (Toronto, Canada)
3139
18:45
Q&A Niels Seersholm (Hellerup, Denmark), Kenneth R. Chapman (Toronto, Canada)
3140
18:55
Closing Remarks Noel Gerard McElvaney (Dublin, Ireland)
3141
Room G102-103
Session 340
17:30 - 19:00
Industry Evening Mini Symposium: Early diagnosis, new guidelines: a fresh view of PAH management Organised by GlaxoSmithKline Chairs : Nazzareno Galiè (Bologna, Italy), Anton Vonk Noordegraaf (Amsterdam, Netherlands) Opening Statement 17:30
3142 Anton Vonk Noordegraaf (Amsterdam, Netherlands) New guidelines for a new age of PAH management. 3143
17:35 Nazzareno Galiè (Bologna, Italy) ERAs and PDE5is: complementary modes of action?
3144
17:55 Walter E Haefeli (Heidelberg, Germany) The role of Imaging in the diagnosis of PAH
3145
18:15 Anton Vonk Noordegraaf (Amsterdam, Netherlands) 18:35
Patient choice: its role in the treatment of PAH Luke Howard (London, United Kingdom)
3146
18:55
Closing Statement Nazzareno Galiè (Bologna, Italy)
3147
Room G104-105
Session 341
17:30 - 19:00
Industry Evening Mini Symposium: Long-term oxygen therapy in real life practice Organised by Invacare Chairs : Jean-François Muir (Rouen, France) 17:30
Welcome and introduction Jean-François Muir (Rouen, France)
3148
17:40
Current indications of LTOT Michael J. Kampelmacher (Utrecht, Netherlands)
3149
18:00
LTOT during exercise Isabelle Vivodtzev (Echirolles, France)
3150
18:25
Health economic aspects of LTOT Stuart Little (Dumfries and Galloway, United Kingdom), Phyllis Murphie (Dumfries, United Kingdom)
3151
18:50
Panel Discussion - interaction with the audience Stuart Little (Dumfries and Galloway, United Kingdom), Phyllis Murphie (Dumfries, United Kingdom), JeanFrançois Muir (Rouen, France), Isabelle Vivodtzev (Echirolles, France), Michael J. Kampelmacher (Utrecht, Netherlands)
3152
344
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015
Room G106-107
Session 342
17:30 - 19:00
Industry Evening Mini Symposium: Beyond current RTI treatments: new pathways to recovery Organised by Dr. Willmar Schwabe Pharmaceuticals Chairs : Andreas Schapowal (Landquart, Switzerland) 17:30
Introduction Andreas Schapowal (Landquart, Switzerland)
3153
17:35
Viral RTIs: Situation mostly harmless – Antibiotics mostly useless Philip Tarr (Bruderholz, Switzerland)
3154
17:55
Positively moving forward: Overview of clinical data on EPs® 7630 Matthias Tisch (Ulm, Germany)
3155
18:30
Efficacy in day-to-day practice: Personal experience with EPs® 7630 Andreas Schapowal (Landquart, Switzerland)
3156
18:45
Question & Answer Session
3157
Room D203-204
Session 343
17:30 - 19:00
Industry Evening Mini Symposium: Maximizing Responder Rates with Quantitative CT Analysis and Best Practices in Valve Therapy Organised by Olympus Europa SE & Co. KG Chairs : Franz Stanzel (Hemer, Germany), Michela Bezzi (Brescia, Italy), Maren Schuhmann (Heidelberg, Germany) 17:30
Welcome and introduction to considerations to maximize responder rates in clinical practice Ralf Eberhardt (Heidelberg, Germany)
3158
17:50
Best Practices and clinical evidence in quantitative CT analysis for patient selection Maren Schuhmann (Heidelberg, Germany)
3159
18:10
Best Practices and considerations for valve placement Franz Stanzel (Hemer, Germany)
3160
18:30
Best Practices and optimal patient follow-up Michela Bezzi (Brescia, Italy)
3161
Room E102
Session 344
17:30 - 19:00
Industry Evening Mini Symposium: Targeted lung denervation in patients with moderate to severe COPD Organised by Holaira Chairs : Felix J.F. Herth (Heidelberg, Germany), Alvar Agusti Garcia-Navarro (Barcelona, Spain) 17:30
Welcome Felix J.F. Herth (Heidelberg, Germany), Alvar Agusti Garcia-Navarro (Barcelona, Spain)
3162
17:35
Cholinergic pathways and the need for new therapies in COPD Reinoud Gosens (Groningen, Netherlands)
3163
17:43
Mechanism of action and the Holaira lung denervation system Martin Mayse (Plymouth, United States of America)
3164
18:00
Long-term safety and efficacy of targeted lung denervation (TLD) in 37 COPD patients Arschang Valipour (Vienna, Austria)
3165
18:20
Phase A results from the Airflow-1 trial Dirk-Jan Slebos (Groningen, Netherlands)
3166
18:40
Panel discussion and Q&A Dirk-Jan Slebos (Groningen, Netherlands), Arschang Valipour (Vienna, Austria), Martin Mayse (Plymouth, United States of America), Felix J.F. Herth (Heidelberg, Germany), Reinoud Gosens (Groningen, Netherlands), Alvar Agusti Garcia-Navarro (Barcelona, Spain)
3167
345
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS MONDAY 28 SEPTEMBER, 2015
Room D201-202
Session 345
17:30 - 19:00
Industry Evening Mini Symposium: Prostanoid therapy: identifying responders and achieving rapid optimisation of dose. Organised by United Therapeutics Europe Ltd. Chairs : Ekkehard Grünig (Heidelberg, Germany) 17:30
Chairman's introduction Ekkehard Grünig (Heidelberg, Germany)
3168
17:35
Predicting PAH patients response to therapy: the role of haemodynamics. Nika Skoro-Sajer (Vienna, Austria)
3169
17:55
Key determinants to improve prognosis in PAH. Carmine Dario Vizza (Rome, Italy)
3170
18:15
How to use parenteral prostanoids effectively. Stephan Rosenkranz (Cologne, Germany)
3171
18:35
Faculty and audience discussion. Ekkehard Grünig (Heidelberg, Germany)
3172
18:55
Chairman's closing remarks. Ekkehard Grünig (Heidelberg, Germany)
3173
346
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS TUESDAY 29 SEPTEMBER, 2015
Room G104-105
Session 348
07:00 - 08:15
Industry Early Morning Symposium: Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient Organised by Novartis Pharma AG Track(s) : Oncology Chairs : Egbert E.F. Smit (Amsterdam, Netherlands) 07:00
Welcome and introduction Egbert E.F. Smit (Amsterdam, Netherlands)
3182
07:05
How novel targeted therapies have changed patient outcomes in ALK+ NSCLC Egbert E.F. Smit (Amsterdam, Netherlands)
3183
07:30
Molecular characterization and diagnosis of ALK+NSCLC Antonio Marchetti (Chieti-Pescara, Italy)
3184
07:50
The key role of pulmonologists in the NSCLC multidisciplinary team Jacques Cadranel (Paris, France)
3185
08:10
Closing remarks Egbert E.F. Smit (Amsterdam, Netherlands)
3186
Room E102
Session 445
13:15 - 14:30
Industry Practical Workshop: Perspectives for ASV therapy in complex sleep disordered breathing - interactive clinical cases Organised by ResMed Europe Chairs : Holger Woehrle (Blaubeuren, Germany) 13:15
Introduction Marie-Pia D'Ortho (Paris, France), Holger Woehrle (Blaubeuren, Germany)
4406
13:40
3 interactive clinical cases Michael Arzt (Regensburg, Germany)
4407
14:09
4408
Room D201-202
Session 446
13:15 - 14:30
Industry Practical Workshop: ERS Product of Outstanding Interest (POINT) Award Organised by European Respiratory Society Chairs : Brendan Cooper (Birmingham, United Kingdom) Introduction to Medical Devices 13:15
4409 Brendan Cooper (Birmingham, United Kingdom)
13:33 14:00 14:20
Top tips for entrepreneurs
4410
So you want to launch a new medical device?
4411
POINT Awards Brendan Cooper (Birmingham, United Kingdom)
Room E107
4412
Session 447
13:15 - 14:30
Industry Practical Workshop: Medical Thoracoscopy Organised by Karl Storz GmbH & Co.KG Chairs : Ralf Heine (Halle, Germany) 13:15
Presentation about Medical Thoracoscopy Ralf Heine (Halle, Germany)
4413
347
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS TUESDAY 29 SEPTEMBER, 2015 13:30
Hands-on workshop: practical demonstration and training Ralf Heine (Halle, Germany)
Room 5.2
Session 471
4414
17:15 - 19:15
Industry Evening Symposium: Addressing the goals of asthma management across the spectrum of the disease Organised by AstraZeneca Chairs : Paul M. O'Byrne (Hamilton, Canada), Reynold Panettieri (Philadelphia, United States of America) 17:15
Introduction Paul M. O'Byrne (Hamilton, Canada)
4633
17:20
Asthma control across the spectrum - Current definitions, and how well do we achieve and maintain it? Reynold Panettieri (Philadelphia, United States of America)
4634
17:40
Mild asthma - What are the current and potential future treatment options? Paul M. O'Byrne (Hamilton, Canada)
4635
18:00
Severe asthma - What are the current and potential future treatment options? Andrew Menzies-Gow (London, United Kingdom)
4636
18:20
Asthma COPD Overlap Syndrome - What is this overlap syndrome? COPD and asthma are different diseases Kjell Larsson (Stockhlom, Sweden)
4637
18:40
Asthma COPD Overlap - How do we manage COPD with asthma features and asthma with a COPD component? Peter Lange (Hvidovre, Denmark)
4638
19:00
Panel debate
4639
19:10
Closing remarks Reynold Panettieri (Philadelphia, United States of America)
4640
Room Elicium 1
Session 472
17:15 - 19:15
Industry Evening Symposium: Profiles of COPD and what can be achieved with treatment Organised by Boehringer Ingelheim International GmbH Chairs : Klaus Friedrich Rabe (Grosshansdorf, Germany) 17:15
Welcome and introduction Klaus Friedrich Rabe (Grosshansdorf, Germany)
4641
17:20
Typical patients with chronic obstructive pulmonary disease (COPD) in a primary care physician's office: What they really suffer from and what we can do Alan Kaplan (Richmond Hill, Canada)
4642
17:45
Achievable goals for the comprehensive treatment of COPD in a specialist practice Mina Gaga (Athens, Greece)
4643
18:10
Objectives of hospital treatment for patients with severe exacerbations and very severe COPD David Michael George Halpin (Exeter Devon, United Kingdom)
4644
18:35
Clinical trials in COPD: Are they relevant for clinical practice? Klaus Friedrich Rabe (Grosshansdorf, Germany)
4645
19:00
Q&A Klaus Friedrich Rabe (Grosshansdorf, Germany), Mina Gaga (Athens, Greece), David Michael George Halpin (Exeter Devon, United Kingdom), Alan Kaplan (Richmond Hill, Canada)
4646
19:10
Closing remarks Klaus Friedrich Rabe (Grosshansdorf, Germany)
4647
348
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS TUESDAY 29 SEPTEMBER, 2015
Room Forum
Session 473
17:15 - 19:15
Industry Evening Symposium: Small airways, to treat or not to treat: what is the benefit? Organised by Chiesi Farmaceutici SpA Chairs : Omar Usmani (London, United Kingdom), Dirkje S. Postma (Groningen, Netherlands) 17:15
Atlantis, the small airways study Dirkje S. Postma (Groningen, Netherlands)
4648
17:45
Inflammation and obstruction: spot the connection in asthma and COPD Nicolas Roche (Paris, France)
4649
18:15
Inhaler devices: is it all about ease of use? Federico Lavorini (Florence, Italy)
4650
18:45
Small airways, to treat or not to treat: that is the question. Omar Usmani (London, United Kingdom)
4651
Room 2.1
Session 474
17:15 - 19:15
Industry Evening Symposium: Asthma control in real life: bridging the gap Organised by CIPLA Chairs : John Haughney (Glasgow, United Kingdom), J. Christian Virchow (Davos Platz, Switzerland) 17:15
State of the union on asthma control. Monica Kraft (Tucson, United States of America)
4652
17:45
What is the missing ingredient in achieving asthma control? Eric D. Bateman (Cape Town, South Africa)
4653
18:15
Do we need real life asthma guidelines and what would they look like? David Price (Aberdeen, United Kingdom)
4654
18:45
Panel/audience discussion
4655
Room E104-106
Session 475
17:30 - 19:00
Industry Evening Mini Symposium: OncologyTreatment of advanced NSCLC: Evidence, insights and understanding Organised by Boehringer Ingelheim International GmbH Track(s) : Oncology Chairs : Egbert E.F. Smit (Amsterdam, Netherlands) 17:30
Welcome and introduction Egbert E.F. Smit (Amsterdam, Netherlands)
4656
17:35
Treatment of advanced NSCLC: Where are we now? Egbert E.F. Smit (Amsterdam, Netherlands)
4657
The role of irreversible ErbB Family Blockade in NSCLC Understanding irreversible ErbB Family Blockade 17:55
ErbB Family Blockade in EGFR mutation-positive patients: Clinical insights ErbB Family Blockade in SCC: Latest evidence Christian Grohe (Berlin, Germany)
349
4658
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS TUESDAY 29 SEPTEMBER, 2015 Targeting angiogenesis in advanced NSCLC Understanding the science of targeting angiogenesis in NSCLC 18:25
4659 Targeting angiogenesis in NSCLC: Latest evidence and clinical insights David HEIGENER (Grosshansdorf, Germany)
18:55
Final questions and meeting close Egbert E.F. Smit (Amsterdam, Netherlands)
Room G102-103
4660
Session 476
17:30 - 19:00
Industry Evening Mini Symposium: Practical use of riociguat in PAH and CTEPH Organised by Bayer HealthCare Chairs : Stephan Rosenkranz (Cologne, Germany), Mardi Gomberg-Maitland (Chicago, United States of America) 17:30
Opening and introduction Mardi Gomberg-Maitland (Chicago, United States of America)
4661
17:35
Challenge of right diagnosis of patients for optimal management and real-world experience with riociguat Ioana Preston (Boston, United States of America)
4662
18:00
Managing the transition to riociguat in patients with PAH Fernando Torres (Dallas, Texas, United States of America)
4663
18:25
Real-world experience with riociguat in CTEPH Matthias Held (Wurzburg, Germany)
4664
18:50
Summary and conclusion Stephan Rosenkranz (Cologne, Germany)
4665
Room G106-107
Session 477
17:30 - 19:00
Industry Evening Mini Symposium: Joining a conversation on cystic fibrosis classes and approaches to therapy Organised by PTC Therapeutics Chairs : Harry G.M. Heijerman (The Hague, Netherlands) 17:30
Welcome and introduction Harry G.M. Heijerman (The Hague, Netherlands)
4666
17:40
Different classes of CF: one disease, different causes Margarida D. Amaral (Lisbon, Portugal)
4667
18:00
Interactive presentation: Current and future treatment strategies for different classes of CF Dominik Hartl (Tübingen, Germany)
4668
18:30
The patient perspective: what is important? Jacquelien J. Noordhoek (Baarn, Netherlands)
4669
18:45
Concluding remarks and Q&A Harry G.M. Heijerman (The Hague, Netherlands)
4670
Room D203-204
Session 478
17:30 - 19:30
Industry Evening Expert Forum: Identifying best practice in antibiotic use in non-CF bronchiectasis (to guarantee a place registration is advisable) Organised by Bayer Pharma AG Chairs : Robert Wilson (London, United Kingdom) 17:30
Chairman’s introduction Robert Wilson (London, United Kingdom)
4671
350
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS TUESDAY 29 SEPTEMBER, 2015 17:35
Challenges in managing chronic respiratory infection in non-CF bronchiectasis (NCFB) patients Robert Wilson (London, United Kingdom)
4672
17:50
Interactive roundtable forum• During this interactive session, attendees will be allocated into small groups to discuss the available evidence, unanswered questions and best practice related to the use of antibiotics to manage chronic respiratory infections with Pseudomonas aeruginosa, non-P. aeruginosa pathogens, nontuberculous mycobacteria, and mixed infections in patients with NCFB.• Collaborative exercises between experts and participants during the roundtable discussion will allow extensive dialogue on current practices of long-term NCFB management
4673
18:45
Discussion of roundtable outcomes with expert panel Timothy Aksamit (Rochester, United States of America), Stuart Elborn (Belfast, United Kingdom), Adam Hill (Edinburgh, United Kingdom)
4674
19:25
Chair’s closing remarks Robert Wilson (London, United Kingdom)
4675
Room 13.2
Session 479
17:30 - 19:00
Industry Evening Mini Symposium: PAP and the heart: benefit or harm Organised by Philips Respironics Chairs : Teofilo Lee-Chiong (Thornton, United States of America) 17:30
Heart Failure: state of the art on PAP therapy Winfried J. Randerath (Solingen, Germany)
4676
18:10
Heart failure: update on the ADVENT-HF study Douglas Bradley (Toronto, Canada)
4677
18:50
Questions and answers
4678
Room D201-202
Session 480
17:30 - 19:00
Industry Evening Mini Symposium: Nontuberculous mycobacteria (NTM) in Europe: A clinical and scientific update Organised by Insmed Chairs : Wouter Hoefsloot (Nijmegen, Netherlands) 17:30
EU Prevalence and Epidemiology Jessica Rademacher (Hannover, Germany)
4679
17:50
NTM Diagnosis Wouter Hoefsloot (Nijmegen, Netherlands)
4680
18:05
NTM in Cystic Fibrosis Charles Haworth (Cambridge, United Kingdom)
4681
18:20
NTM Treatment Guidelines David E. Griffith (Tyler, United States of America)
4682
18:35
NTM Burden of Illness Claire Andrejak (Amiens, France)
4683
18:50
Panel Q & A
4684
Room E103
Session 481
17:30 - 19:00
Industry Evening Expert Forum: Translating PE guidelines into clinical practice Organised by Bayer HealthCare Chairs : Stavros Konstantinides (Gottingen, Germany), David Jiménez Castro (Madrid, Spain) 17:30
Welcome and Introduction Stavros Konstantinides (Gottingen, Germany)
4685
17:35
Assessing the severity of PE patients David Jiménez Castro (Madrid, Spain)
4686
351
ERS International Congress 2015 INDUSTRY SPONSORED SESSIONS & WORKSHOPS TUESDAY 29 SEPTEMBER, 2015 17:55
Facilitating the Outpatient management of PE patients Stavros Konstantinides (Gottingen, Germany)
4687
18:15
Managing the long term care of PE patients David Kiely (Sheffield, United Kingdom)
4688
18:35
Expert discussion and cases David Kiely (Sheffield, United Kingdom), David Jiménez Castro (Madrid, Spain), Stavros Konstantinides (Gottingen, Germany)
4689
18:55
Closing Stavros Konstantinides (Gottingen, Germany)
4690
Room E107
Session 483
17:30 - 19:00
Industry Evening Expert Forum: Pulmonary Alveolar Proteinosis and Severe Pulmonary Infections - Role of Immune Modulators (focus on GM-CSF) Organised by Serendex Pharmaceuticals A/S Chairs : Ulrich Costabel (Essen, Germany) 17:30
Introduction Ulrich Costabel (Essen, Germany)
4691
17:35
PAP epidemiology and classification Yoshikazu Inoue (Osaka, Japan)
4692
17:55
PAP Pathogensis and Biomarkers Francesco Bonella (Düsseldorf, Germany)
4693
18:10
PAP Treatment and Advances in Therapy Ulrich Costabel (Essen, Germany)
4694
18:30
Severe pulmonary infections - Role of Immune modulators/GM-CSF Susanne Herold (Giessen, Germany)
4695
18:55
General Discussion and Summary Ulrich Costabel (Essen, Germany)
4696
352